Substance_SID,Compound_CID,Data_Source,External_ID,Synonyms,Last_Modified_Date,Deposit_Date,Data_Source_Category,LTKBID,Compound Name,Severity Class,Label Section,vDILIConcern,Version,PUBCHEM_COMPOUND_CID,PUBCHEM_COMPOUND_CANONICALIZED,PUBCHEM_CACTVS_COMPLEXITY,PUBCHEM_CACTVS_HBOND_ACCEPTOR,PUBCHEM_CACTVS_HBOND_DONOR,PUBCHEM_CACTVS_ROTATABLE_BOND,PUBCHEM_CACTVS_SUBSKEYS,PUBCHEM_IUPAC_OPENEYE_NAME,PUBCHEM_IUPAC_CAS_NAME,PUBCHEM_IUPAC_NAME_MARKUP,PUBCHEM_IUPAC_NAME,PUBCHEM_IUPAC_SYSTEMATIC_NAME,PUBCHEM_IUPAC_TRADITIONAL_NAME,PUBCHEM_IUPAC_INCHI,PUBCHEM_IUPAC_INCHIKEY,PUBCHEM_XLOGP3,PUBCHEM_EXACT_MASS,PUBCHEM_MOLECULAR_FORMULA,PUBCHEM_MOLECULAR_WEIGHT,PUBCHEM_CACTVS_TPSA,PUBCHEM_MONOISOTOPIC_WEIGHT,PUBCHEM_TOTAL_CHARGE,PUBCHEM_HEAVY_ATOM_COUNT,PUBCHEM_ATOM_DEF_STEREO_COUNT,PUBCHEM_ATOM_UDEF_STEREO_COUNT,PUBCHEM_BOND_DEF_STEREO_COUNT,PUBCHEM_BOND_UDEF_STEREO_COUNT,PUBCHEM_ISOTOPIC_ATOM_COUNT,PUBCHEM_COMPONENT_COUNT,PUBCHEM_CACTVS_TAUTO_COUNT,PUBCHEM_COORDINATE_TYPE,SMILES,PUBCHEM_XLOGP3_AA,PUBCHEM_BONDANNOTATIONS,PUBCHEM_NONSTANDARDBOND
440791231,5732,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00164,zolpidem,20210312,20210312,Curation Efforts|Governmental Organizations,LT00164,zolpidem,7.0,Adverse reactions,Ambiguous DILI-concern,2.0,5732,1.0,417.0,2.0,0.0,3.0,AAADceB7IAAAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgB8AAAHgAAAAAADAjBnwQ/sJ8MGACoAzd3dACCgC0xEqAJ2CE4dJiIaPrA3ZGUIAhoggLIyCcciMCOQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,"N,N-dimethyl-2-[6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl]acetamide","N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)-3-imidazo[1,2-a]pyridinyl]acetamide","<I>N</I>,<I>N</I>-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide","N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide","N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]ethanamide","N,N-dimethyl-2-[6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl]acetamide","InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3",ZAFYATHCZYHLPB-UHFFFAOYSA-N,2.5,307.168462302,C19H21N3O,307.4,37.6,307.168462302,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,,"10  11  8
11  14  8
12  14  8
15  19  8
16  20  8
18  19  8
18  20  8
2  10  8
2  5  8
2  7  8
3  6  8
3  7  8
5  6  8
7  12  8
9  15  8
9  16  8",
440791230,60857,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01010,zolmitriptan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01010,zolmitriptan,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,60857,1.0,375.0,3.0,2.0,5.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAWLAAAAwAAAAAAAAAFgB8AAAHgAQAAAADCjhngY+yPPJlACoAzRnXACCgCAxAiAI2aA4ZJkKIOLAkZGNIAhklgDYyAeQwOAOiAACAAACAAAQAAQAAAQAAAAAAAAAAA==,(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one,(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone,"(4<I>S</I>)-4-[[3-[2-(dimethylamino)ethyl]-1<I>H</I>-indol-5-yl]methyl]-1,3-oxazolidin-2-one","(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one","(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one",(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one,"InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1",ULSDMUVEXKOYBU-ZDUSSCGKSA-N,,287.16337692,C16H21N3O2,287.36,57.4,287.16337692,0.0,21.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,2.2,"10  17  8
12  18  8
15  18  8
4  12  8
4  17  8
6  7  5
8  13  8
8  15  8
9  10  8
9  12  8
9  13  8",
440791229,5311497,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00262,vinorelbine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00262,vinorelbine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5311497,1.0,1690.0,11.0,2.0,10.0,AAADcfB/vAAAAAAAAAAAAAAAAAAAAWLFgAAwYMECAAAWAFiB9AAAHgAQCAAAD3zhngYyzvPJlgCoAyTyTAKCiCAhIiAImSF+bJgPJv7E9ZuGcChn8Bnb6Af62fOfqAACAgAKAABQgAYECBSgAAAAAAAAAA==,"methyl (1R,9R,10S,11R,12R,19R)-11-acetoxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate","(1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylic acid methyl ester","methyl (1<I>R</I>,9<I>R</I>,10<I>S</I>,11<I>R</I>,12<I>R</I>,19<I>R</I>)-11-acetyloxy-12-ethyl-4-[(12<I>S</I>,14<I>R</I>)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.0<SUP>3,11</SUP>.0<SUP>4,9</SUP>]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0<SUP>1,9</SUP>.0<SUP>2,7</SUP>.0<SUP>16,19</SUP>]nonadeca-2,4,6,13-tetraene-10-carboxylate","methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate","methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-5-methoxy-8-methyl-10-oxidanyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate","(1R,9R,10S,11R,12R,19R)-11-acetoxy-4-[(12S,14R)-12-carbomethoxy-16-ethyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylic acid methyl ester","InChI=1S/C45H54N4O8/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3/t28-,37-,38+,39+,42+,43+,44-,45-/m0/s1",GBABOYUKABKIAF-IELIFDKJSA-N,3.6,778.39416469,C45H54N4O8,778.9,134.0,778.39416469,0.0,57.0,8.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,,"19  1  6
11  37  8
11  48  8
13  18  6
14  58  5
15  22  5
16  59  6
17  2  6
20  23  8
20  28  8
23  30  8
28  32  8
30  33  8
32  33  8
34  38  5
37  42  8
39  82  6
42  47  8
47  48  8
47  51  8
48  52  8
51  55  8
52  56  8
55  56  8",
440791228,5665,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00969,vigabatrin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00969,vigabatrin,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,5665,1.0,112.0,3.0,2.0,4.0,AAADccBiMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAACCjBgAQACABAAgCIACDSCACAAAAgAAAIAIEAAAgAABIAgQAAQAAEkAAAAACsAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,4-aminohex-5-enoic acid,4-amino-5-hexenoic acid,4-aminohex-5-enoic acid,4-aminohex-5-enoic acid,4-azanylhex-5-enoic acid,4-aminohex-5-enoic acid,"InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)",PJDFLNIOAUIZSL-UHFFFAOYSA-N,-2.2,129.078978594,C6H11NO2,129.16,63.3,129.078978594,0.0,9.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=CC(N)CCC(=O)O,,5  12  3,
440791227,5362420,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01075,VERTEPORFIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT01075,verteporfin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5362420,1.0,1500.0,10.0,3.0,12.0,AAADcfB/vAAAAAAAAAAAAAAAAAAAAWLFiwAgAAAAAAAAAEAB/gAAHgAQCAAADwiBngIyyLLJlgCoAyTyTACCgCAhAiAImSEwZNgIJHLA8dGEdAhk0ADI6Yf/2fOfgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3-[(23S,24R)-22,23-bis(methoxycarbonyl)-5-(3-methoxy-3-oxo-propyl)-4,10,15,24-tetramethyl-14-vinyl-25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-dodecaen-9-yl]propanoic acid","3-[(23S,24R)-14-ethenyl-22,23-bis(methoxycarbonyl)-5-(3-methoxy-3-oxopropyl)-4,10,15,24-tetramethyl-25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-dodecaen-9-yl]propanoic acid","3-[(23<I>S</I>,24<I>R</I>)-14-ethenyl-22,23-bis(methoxycarbonyl)-5-(3-methoxy-3-oxopropyl)-4,10,15,24-tetramethyl-25,26,27,28-tetrazahexacyclo[16.6.1.1<SUP>3,6</SUP>.1<SUP>8,11</SUP>.1<SUP>13,16</SUP>.0<SUP>19,24</SUP>]octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-dodecaen-9-yl]propanoic acid","3-[(23S,24R)-14-ethenyl-22,23-bis(methoxycarbonyl)-5-(3-methoxy-3-oxopropyl)-4,10,15,24-tetramethyl-25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-dodecaen-9-yl]propanoic acid","3-[(23S,24R)-14-ethenyl-22,23-bis(methoxycarbonyl)-5-(3-methoxy-3-oxidanylidene-propyl)-4,10,15,24-tetramethyl-25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-dodecaen-9-yl]propanoic acid","3-[(23S,24R)-22,23-dicarbomethoxy-5-(3-keto-3-methoxy-propyl)-4,10,15,24-tetramethyl-14-vinyl-25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-dodecaen-9-yl]propionic acid","InChI=1S/C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)25(12-15-37(48)51-6)33(44-30)18-32-24(11-14-36(46)47)21(3)28(43-32)16-31(23)42-29/h9-10,13,16-19,38,42,44H,1,11-12,14-15H2,2-8H3,(H,46,47)/t38-,41+/m0/s1",YTZALCGQUPRCGW-ZSFNYQMMSA-N,,718.30026431,C41H42N4O8,718.8,174.0,718.30026431,0.0,53.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)[C@@]1(C)C3=CC=C(C(=O)OC)[C@H]1C(=O)OC,4.9,"10  25  8
10  30  8
11  28  8
11  34  8
12  37  8
12  42  8
13  17  5
14  22  6
16  23  8
19  24  8
23  25  8
24  28  8
25  27  8
27  29  8
28  31  8
29  30  8
30  36  8
31  35  8
34  35  8
34  41  8
36  37  8
41  42  8
9  16  8
9  19  8",
440791226,135400189,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01135,Vardenafil,20210312,20210312,Curation Efforts|Governmental Organizations,LT01135,vardenafil,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,135400189,1.0,854.0,8.0,1.0,8.0,AAADcfB7uABAAAAAAAAAAAAAAAAAAWAAAAA8QIAAAAAAAEABwAAAHgQYQAAADAzh3wYzl5fIFAKoAydydHDSjD0nMKAdmBm+XNiMbrrE+TuWOajuzBPIqWeQwCAOAIAAgAAIAAABAAEAABAAAAAAAAAAAA==,"2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one","2-[2-ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one","2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3<I>H</I>-imidazo[5,1-f][1,2,4]triazin-4-one","2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one","2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one","2-[2-ethoxy-5-(4-ethylpiperazino)sulfonyl-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one","InChI=1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30)",SECKRCOLJRRGGV-UHFFFAOYSA-N,,488.2205747,C23H32N6O4S,488.6,118.0,488.2205747,0.0,34.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCc1nc(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)nn12,2.5,"10  24  8
11  26  8
11  28  8
17  19  8
17  20  8
19  21  8
20  23  8
21  22  8
22  23  8
25  28  8
25  29  8
8  10  8
8  25  8
8  26  8
9  24  8
9  29  8",
440791225,135413535,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01109,Valganciclovir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01109,valganciclovir,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,135413535,1.0,528.0,8.0,4.0,9.0,AAADceBzuAAAAAAAAAAAAAAAAAAAAWAAAAAgAAAAAAAAAEABgAAAHgAQCAAADTzhlgYHuBfMFgCoAQfxfACAgC0XEKABUIGoVECDWBhASCAfQIgNEQJDAGAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxy-propyl] (2S)-2-amino-3-methyl-butanoate,(2S)-2-amino-3-methylbutanoic acid [2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] ester,[2-[(2-amino-6-oxo-1<I>H</I>-purin-9-yl)methoxy]-3-hydroxypropyl] (2<I>S</I>)-2-amino-3-methylbutanoate,[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate,[2-[(2-azanyl-6-oxidanylidene-1H-purin-9-yl)methoxy]-3-oxidanyl-propyl] (2S)-2-azanyl-3-methyl-butanoate,(2S)-2-amino-3-methyl-butyric acid [2-[(2-amino-6-keto-1H-purin-9-yl)methoxy]-3-hydroxy-propyl] ester,"InChI=1S/C14H22N6O5/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22)/t8?,9-/m0/s1",WPVFJKSGQUFQAP-GKAPJAKFSA-N,,354.16516782,C14H22N6O5,354.36,167.0,354.16516782,0.0,25.0,1.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)[nH]c(N)nc21,-1.5,"10  24  8
10  25  8
14  28  3
21  22  8
22  24  8
6  21  8
6  23  8
13  7  6
8  22  8
8  23  8
9  21  8
9  25  8",
440791224,6503,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00213,TROMETHAMINE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00213,tromethamine,6.0,Adverse reactions,Ambiguous DILI-concern,2.0,6503,1.0,54.0,4.0,4.0,3.0,AAADccBiMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAADIihgAIAAABAAgAAAAAAAAAAAAAAAAAAAAAAAAACEAAAAAAAQAABEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-amino-2-(hydroxymethyl)propane-1,3-diol","2-amino-2-(hydroxymethyl)propane-1,3-diol","2-amino-2-(hydroxymethyl)propane-1,3-diol","2-amino-2-(hydroxymethyl)propane-1,3-diol","2-azanyl-2-(hydroxymethyl)propane-1,3-diol","2-amino-2-methylol-propane-1,3-diol","InChI=1S/C4H11NO3/c5-4(1-6,2-7)3-8/h6-8H,1-3,5H2",LENZDBCJOHFCAS-UHFFFAOYSA-N,,121.07389321,C4H11NO3,121.14,86.7,121.07389321,0.0,8.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(CO)(CO)CO,-2.9,,
440791223,5584,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01844,trimipramine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01844,trimipramine,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,5584,1.0,317.0,2.0,0.0,4.0,AAADceB7AAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABYAAAAABQAAAHAAAAAAADQjBGAQywIMAAACAAiRCQACCAAAhAgAIiAAIZIgIIGLA0ZGEIAhggADIyAcQgMAOAAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethyl-propan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethyl-1-propanamine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-<I>N</I>,<I>N</I>,2-trimethylpropan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethyl-propan-1-amine","[3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-2-methyl-propyl]-dimethyl-amine","InChI=1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3",ZSCDBOWYZJWBIY-UHFFFAOYSA-N,5.8,294.209598838,C20H26N2,294.4,6.5,294.209598838,0.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,,"10  15  8
11  16  8
13  17  8
14  18  8
15  19  8
16  20  8
17  19  8
18  20  8
3  12  3
5  10  8
5  13  8
6  11  8
6  14  8",
440791222,5577,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01841,trimethobenzamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01841,trimethobenzamide,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,5577,1.0,440.0,6.0,1.0,10.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAQAAAADAThmAYyBoPABACIAiFSEACCCAAkIAAIiIEOjMgPJzKEtRuHOSrlxhWaqYe6/B7OIAABCAAAQABAAAIQAACAAAAAAAAAAA==,"N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxy-benzamide","N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide","<I>N</I>-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide","N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide","N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxy-benzamide","N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxy-benzamide","InChI=1S/C21H28N2O5/c1-23(2)10-11-28-17-8-6-15(7-9-17)14-22-21(24)16-12-18(25-3)20(27-5)19(13-16)26-4/h6-9,12-13H,10-11,14H2,1-5H3,(H,22,24)",FEZBIKUBAYAZIU-UHFFFAOYSA-N,2.3,388.199822,C21H28N2O5,388.5,69.3,388.199822,0.0,28.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC,,"12  16  8
12  17  8
13  19  8
13  20  8
14  16  8
15  17  8
19  22  8
20  21  8
21  23  8
22  23  8
9  14  8
9  15  8",
440791221,5556,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01834,triazolam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01834,triazolam,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,5556,1.0,472.0,3.0,0.0,1.0,AAADccB7gAAGAAAAAAAAAAAAAAAAAWAAAAAwYAAABAAAAACB0AAAHAIIAAAADArBGyQz0IcMEACiAyZiZACSgCshB6AdiAAwZpiIaKLBm5GUIAhgiALIyCcQgMAOAABAIAADAAAAAIBAAAYAAAAAAAAAAA==,"8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-6-(2-chlorophenyl)-1-methyl-4<I>H</I>-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloranyl-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3",JOFWLTCLBGQGBO-UHFFFAOYSA-N,2.4,342.0439018,C17H12Cl2N4,343.2,43.1,342.0439018,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,,"13  16  8
14  19  8
14  20  8
15  17  8
16  17  8
19  21  8
20  22  8
21  23  8
22  23  8
3  12  8
3  9  8
5  6  8
5  9  8
6  12  8
7  13  8
7  8  8
8  15  8",
440791220,33741,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01827,Tramadol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01827,tramadol,7.0,Adverse reactions,Ambiguous DILI-concern,2.0,33741,1.0,282.0,3.0,1.0,4.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABAAAAHgAACAAADUTBmAYyBoMABgCAAiBCAAACCAAgIAAIiAAOCIgMJiKEsRqEcCAmwBEIuAfQwPAOgAABAAAAAAAAAAIAADAAAAAAAAAAAA==,"(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol","(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-1-cyclohexanol","(1<I>R</I>,2<I>R</I>)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol","(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol","(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol","(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol","InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3/t14-,16+/m1/s1",TVYLLZQTGLZFBW-ZBFHGGJFSA-N,2.6,263.18852904,C16H25NO2,263.37,32.7,263.18852904,0.0,19.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cccc([C@@]2(O)CCCC[C@@H]2CN(C)C)c1,,"5  1  6
11  12  8
11  13  8
12  16  8
13  17  8
16  18  8
17  18  8
4  10  6",
440791219,5505,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00453,tolbutamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00453,tolbutamide,2.0,Adverse reactions,Ambiguous DILI-concern,1.0,5505,1.0,354.0,3.0,2.0,5.0,AAADceBzMABAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgQQQAAADADBWAQzAYLAAAKIAiBCEHBCABAgAAAIiJgIAIiIICKAkRCEIAAglgIIiAcAgAAOEAAAAAAAAAAgAAAAAAAAAAAAAAAAAA==,1-butyl-3-(p-tolylsulfonyl)urea,1-butyl-3-(4-methylphenyl)sulfonylurea,1-butyl-3-(4-methylphenyl)sulfonylurea,1-butyl-3-(4-methylphenyl)sulfonylurea,1-butyl-3-(4-methylphenyl)sulfonyl-urea,1-butyl-3-tosyl-urea,"InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)",JLRGJRBPOGGCBT-UHFFFAOYSA-N,2.3,270.10381361,C12H18N2O3S,270.35,83.7,270.10381361,0.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,,"10  13  8
10  14  8
13  16  8
14  17  8
15  16  8
15  17  8",
440791218,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00973,Tinzaparin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00973,tinzaparin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791217,33624,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01815,timolol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01815,timolol,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,33624,1.0,310.0,8.0,2.0,7.0,AAADceBzsABAAAAAAAAAAAAAAAAAAWAAAAAsAAAAAAAAAAABgAAAHgAQSAAADJzhggYDtBPABgCgAAIgYAQACAQBUAABAIAJEACHUAAACAAfCACCEAKTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol","(2S)-1-(tert-butylamino)-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol","(2<I>S</I>)-1-(<I>tert</I>-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol","(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol","(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol","(2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol","InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1",BLJRIMJGRPQVNF-JTQLQIEISA-N,1.8,316.15691181,C13H24N4O3S,316.42,108.0,316.15691181,0.0,21.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,,"1  7  8
1  8  8
20  21  8
11  4  5
7  20  8
8  21  8",
440791216,60648,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00989,tiagabine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00989,tiagabine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,60648,1.0,474.0,5.0,1.0,6.0,AAADceB6MABgAAAAAAAAAAAAAAAAASJAAAAsAAAAAAAAAAAB4AAAHgQACAAADQDF2ASyCYMAAgiMAiDSCAADAIAgCBBIiBkIAIgIIDqgkRCEYAAmgACoiAeYkcIOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-enyl]piperidine-3-carboxylic acid","(3R)-1-[4,4-bis(3-methyl-2-thiophenyl)but-3-enyl]-3-piperidinecarboxylic acid","(3<I>R</I>)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid","(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid","(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid","(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-enyl]nipecotic acid","InChI=1S/C20H25NO2S2/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23)/t16-/m1/s1",PBJUNZJWGZTSKL-MRXNPFEDSA-N,,375.13267139,C20H25NO2S2,375.6,97.0,375.13267139,0.0,25.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C,2.7,"1  16  8
1  24  8
16  18  8
17  19  8
18  20  8
19  21  8
2  17  8
2  25  8
20  24  8
21  25  8
6  13  6",
440791215,6018,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01239,TETRABENAZINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT01239,tetrabenazine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,6018,1.0,425.0,4.0,0.0,4.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAA8WIAAAAAAAACxAAAAHgAAAAAADSzBmAYyBoMABACIAqBSAACCCAAgIAAAiAEOjIgNJjqEsRuEMCpkwBGKqAe42POOoAABAAAQQABAAAIAACCAAAAAAAAAAA==,"3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one","9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one","9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11<I>b</I>-hexahydrobenzo[a]quinolizin-2-one","9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one","9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one","3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one","InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3",MKJIEFSOBYUXJB-UHFFFAOYSA-N,,317.19909372,C19H27NO3,317.4,38.8,317.19909372,0.0,23.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2,2.9,"10  14  8
10  16  8
14  17  8
16  20  8
17  21  8
20  21  8
5  8  3
6  12  3",
440791214,135409453,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00485,Tegaserod,20210312,20210312,Curation Efforts|Governmental Organizations,LT00485,tegaserod,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,135409453,1.0,385.0,3.0,3.0,8.0,AAADceB7oAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgB8AAAHgAYAAAADAzBngY/xvLrlACgAzRnZACSiCExIiAM2aA+bJgMJuLEsZuEMCh02BHI6Aew0PIOgEABAAACAAAAgAIAAAQAAAAAAAAAAA==,1-[(E)-(5-methoxy-1H-indol-3-yl)methyleneamino]-2-pentyl-guanidine,1-[(E)-(5-methoxy-1H-indol-3-yl)methylideneamino]-2-pentylguanidine,1-[(<I>E</I>)-(5-methoxy-1<I>H</I>-indol-3-yl)methylideneamino]-2-pentylguanidine,1-[(E)-(5-methoxy-1H-indol-3-yl)methylideneamino]-2-pentylguanidine,1-[(E)-(5-methoxy-1H-indol-3-yl)methylideneamino]-2-pentyl-guanidine,2-amyl-1-[(E)-(5-methoxy-1H-indol-3-yl)methyleneamino]guanidine,"InChI=1S/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21)/b20-11+",IKBKZGMPCYNSLU-RGVLZGJSSA-N,,301.19026037,C16H23N5O,301.39,87.8,301.19026037,0.0,22.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCC/N=C(\N)N/N=C/c1c[nH]c2ccc(OC)cc12,2.6,"10  11  8
10  13  8
10  14  8
11  17  8
13  15  8
14  18  8
17  19  8
18  19  8
2  11  8
2  15  8",
440791213,110635,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01129,Tadalafil,20210312,20210312,Curation Efforts|Governmental Organizations,LT01129,tadalafil,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,110635,1.0,702.0,4.0,1.0,1.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAWJAAAA8eIEAAAAAAFix9AAAHgAQAAAADCzBngcyzvPJlACoAyVyVACCiCAhIiAImSG+7JgdZvLEsbu0MCpk1hHO6Ae42fOeoAABAAACQABAAAIAAASAAAAAAAAAAA==,"(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione","(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione","(2<I>R</I>,8<I>R</I>)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0<SUP>3,8</SUP>.0<SUP>11,16</SUP>]heptadeca-1(10),11,13,15-tetraene-4,7-dione","(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione","(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione","(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-quinone","InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1",WOXKDUGGOYFFRN-IIBYNOLFSA-N,,389.1375561,C22H19N3O4,389.4,74.9,389.1375561,0.0,29.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O,2.3,"11  12  8
12  14  8
14  18  8
14  19  8
16  20  8
16  21  8
18  22  8
19  25  8
20  24  8
21  26  8
22  27  8
24  28  8
25  27  8
26  28  8
6  11  8
6  18  8
8  30  6
9  16  5",
440791212,5358,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01779,sumatriptan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01779,sumatriptan,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5358,1.0,405.0,4.0,2.0,6.0,AAADceBzMABAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgB8AAAHAQQQAAADAjFXgS+wPPJkAKgAzRnRHDCgCAxAiAI2aA4ZJgIIOLAkZGEIAhgkADIyAcQgMAOiAACAAACAAAQAAQAAAQAAAAAAAAAAA==,1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide,1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide,1-[3-[2-(dimethylamino)ethyl]-1<I>H</I>-indol-5-yl]-<I>N</I>-methylmethanesulfonamide,1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide,1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide,1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide,"InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3",KQKPFRSPSRPDEB-UHFFFAOYSA-N,0.9,295.13544809,C14H21N3O2S,295.4,73.6,295.13544809,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,,"10  16  8
11  13  8
11  17  8
16  17  8
4  10  8
4  14  8
7  14  8
7  8  8
8  10  8
8  13  8",
440791211,15541,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01757,Spectinomycin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01757,spectinomycin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,15541,1.0,478.0,9.0,5.0,2.0,AAADceBzOAAAAAAAAAAAAAAAAAAAAAAAAAA0SIAAAAAAAACQAAAAHgAQCAAACDzxgAcCCALABgAIAIAQAAIAAAAAAAAAAIFIAAATEBYAwAQnQAAHMAAXAAHwcA8AAAAAAAAAAAACgAAUCACgAAAAAAAAAA==,"(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one","(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one","(1<I>R</I>,3<I>S</I>,5<I>R</I>,8<I>R</I>,10<I>R</I>,11<I>S</I>,12<I>S</I>,13<I>R</I>,14<I>S</I>)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.0<SUP>3,8</SUP>]tetradecan-7-one","(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one","(1R,3S,5R,8R,10R,11S,12S,13R,14S)-5-methyl-11,13-bis(methylamino)-8,12,14-tris(oxidanyl)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one","(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one","InChI=1S/C14H24N2O7/c1-5-4-6(17)14(20)13(21-5)22-12-10(19)7(15-2)9(18)8(16-3)11(12)23-14/h5,7-13,15-16,18-20H,4H2,1-3H3/t5-,7-,8+,9+,10+,11-,12-,13+,14+/m1/s1",UNFWWIHTNXNPBV-WXKVUWSESA-N,,332.15835111,C14H24N2O7,332.35,130.0,332.15835111,0.0,23.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O,-3.1,"10  24  6
11  25  5
17  30  6
19  23  5
13  4  5
15  5  6
16  6  6
12  8  6
14  9  6",
440791210,5253,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00627,sotalol,20250421,20210312,Curation Efforts|Governmental Organizations,LT00627,sotalol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5253,1.0,330.0,5.0,3.0,6.0,AAADceBzMABAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgQQSAAADDzhmAaywILAAgKAAiRCQHCCAAAgAgAIiIAIbIgKNiKAkZGEcABk0AGY2AeQ0KEOCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,N-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide,N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide,<I>N</I>-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide,N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide,N-[4-[1-oxidanyl-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide,N-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide,"InChI=1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3",ZBMZVLHSJCTVON-UHFFFAOYSA-N,0.2,272.11946368,C12H20N2O3S,272.37,86.8,272.11946368,0.0,18.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,,"10  11  8
10  12  8
11  16  8
12  17  8
15  16  8
15  17  8
7  2  3",
440791209,154059,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01191,Solifenacin,20250421,20210312,Curation Efforts|Governmental Organizations,LT01191,solifenacin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,154059,1.0,524.0,3.0,0.0,3.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAAAAAAA8eLFiAAAAAACxQAAAHgAAAAAADTzhmAYwCIMABACIAiBCGACCAAAgAAAIiAAIBIgKICKAkRGNIAhkhgCYiAcwgMAOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"[(3R)-quinuclidin-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate","(1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid [(3R)-1-azabicyclo[2.2.2]octan-3-yl] ester","[(3<I>R</I>)-1-azabicyclo[2.2.2]octan-3-yl] (1<I>S</I>)-1-phenyl-3,4-dihydro-1<I>H</I>-isoquinoline-2-carboxylate","[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate","[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate","(1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid [(3R)-quinuclidin-3-yl] ester","InChI=1S/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1",FBOUYBDGKBSUES-VXKWHMMOSA-N,,362.199428076,C23H26N2O2,362.5,32.8,362.199428076,0.0,27.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1,4.0,"6  1  6
13  18  5
15  17  8
15  19  8
17  20  8
18  21  8
18  22  8
19  23  8
20  24  8
21  25  8
22  26  8
23  24  8
25  27  8
26  27  8",
440791208,5312125,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00656,Silodosin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00656,silodosin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5312125,1.0,654.0,9.0,3.0,13.0,AAADcfB7OYAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgBQAAAHwAQCAAADCzhmBYyxoPABgCIAiVSUACCCAAlIAAIiIEOzMgPNjrE9ZuHearm0BHa6ceYyMCOCAACAAACQAAQAAQAAASAAAAAAAAAAA==,"1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]indoline-7-carboxamide","1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide","1-(3-hydroxypropyl)-5-[(2<I>R</I>)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide","1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide","1-(3-oxidanylpropyl)-5-[(2R)-2-[2-[2-[2,2,2-tris(fluoranyl)ethoxy]phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide","1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]indoline-7-carboxamide","InChI=1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1",PNCPYILNMDWPEY-QGZVFWFLSA-N,,495.234491,C25H32F3N3O4,495.5,97.1,495.234491,0.0,35.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,3.6,"11  13  8
11  17  8
13  18  8
16  18  8
16  20  8
17  20  8
28  29  8
28  30  8
29  31  8
30  32  8
31  33  8
32  33  8
21  9  6",
440791207,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00463,Sacrosidase,20210312,20210312,Curation Efforts|Governmental Organizations,LT00463,sacrosidase,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791206,5245,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01020,Risedronate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01020,risedronate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5245,1.0,339.0,8.0,5.0,4.0,AAADccBiOAMAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAHggACCAADADBmgQ8gJIIEhCgQjBnRICCgCAxAiAI2CA4ZJgIIOLAkZGEYAhkwAHIyAewQAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,[1-hydroxy-1-phosphono-2-(3-pyridyl)ethyl]phosphonic acid,[1-hydroxy-1-phosphono-2-(3-pyridinyl)ethyl]phosphonic acid,(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid,(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid,(1-oxidanyl-1-phosphono-2-pyridin-3-yl-ethyl)phosphonic acid,[1-hydroxy-1-phosphono-2-(3-pyridyl)ethyl]phosphonic acid,"InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)",IIDJRNMFWXDHID-UHFFFAOYSA-N,,283.00107569,C7H11NO7P2,283.11,148.0,283.00107569,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,-3.1,"10  15  8
10  17  8
13  14  8
13  15  8
14  16  8
16  17  8",
440791205,6436173,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01128,Rifaximin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01128,rifaximin,7.0,Adverse reactions,Ambiguous DILI-concern,2.0,6436173,1.0,1590.0,12.0,5.0,3.0,AAADcfB/PAAAAAAAAAAAAAAAAAAAAWJAAAA8YIAAAAAAAFgB/AAAHgAQCAAADRzhnwY//v/MHgCoA7f3fAKCiC01MqAJ2CF9fNief3bW/d+2fWjv5B/c+af8/f/e6EADSgQaECDQgAaUCDQgQAAAAAAAAA==,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate","acetic acid [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] ester","[(7<I>S</I>,9<I>E</I>,11<I>S</I>,12<I>R</I>,13<I>S</I>,14<I>R</I>,15<I>R</I>,16<I>R</I>,17<I>S</I>,18<I>S</I>,19<I>E</I>,21<I>Z</I>)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.1<SUP>4,7</SUP>.0<SUP>5,35</SUP>.0<SUP>26,34</SUP>.0<SUP>27,32</SUP>]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate","[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate","[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-2,15,17,36-tetrakis(oxidanyl)-6,23-bis(oxidanylidene)-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] ethanoate","acetic acid [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-6,23-diketo-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] ester","InChI=1S/C43H51N3O11/c1-19-14-16-46-28(18-19)44-32-29-30-37(50)25(7)40-31(29)41(52)43(9,57-40)55-17-15-27(54-10)22(4)39(56-26(8)47)24(6)36(49)23(5)35(48)20(2)12-11-13-21(3)42(53)45-33(34(32)46)38(30)51/h11-18,20,22-24,27,35-36,39,48-51H,1-10H3,(H,45,53)/b12-11+,17-15+,21-13-/t20-,22+,23+,24+,27-,35-,36+,39+,43-/m0/s1",NZCRJKRKKOLAOJ-XRCRFVBUSA-N,,785.35235945,C43H51N3O11,785.9,198.0,785.35235945,0.0,57.0,9.0,0.0,3.0,0.0,0.0,1.0,-1.0,"1
5
255",CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,6.9,"17  1  5
12  41  8
12  48  8
12  51  8
13  39  8
13  48  8
15  21  5
18  24  5
19  25  6
16  2  5
23  26  6
20  3  5
30  43  5
32  33  8
32  35  8
33  38  8
33  39  8
35  42  8
38  44  8
38  46  8
39  41  8
22  4  5
41  45  8
42  44  8
45  46  8
48  53  8
51  55  8
53  54  8
54  55  8",
440791204,37542,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01730,ribavirin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01730,ribavirin,7.0,Adverse reactions,Ambiguous DILI-concern,1.0,37542,1.0,304.0,7.0,4.0,3.0,AAADccBzuAAAAAAAAAAAAAAAAAAAAWJAAAAAAAAAAAAAAAABgAAAHgAYCAAACBThgwYFEAZIFgAqAAMxNAAQgAsSgKAVQACIAACDWAIAiCAeQAAPCAITAADwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide","1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-1,2,4-triazole-3-carboxamide","1-[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide","1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide","1-[(2R,3R,4S,5R)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide","1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide","InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1",IWUCXVSUMQZMFG-AFCXAGJDSA-N,-1.8,244.0807695,C8H12N4O5,244.2,144.0,244.0807695,0.0,17.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,,"12  14  6
11  2  5
10  3  5
13  6  6
6  15  8
6  7  8
7  16  8
8  15  8
8  16  8",
440791203,3052776,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01204,rasagiline,20231222,20210312,Curation Efforts|Governmental Organizations,LT01204,rasagiline,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,3052776,1.0,212.0,1.0,1.0,2.0,AAADccByAAAAAAAAAAAAAAAAAAAAAYAAAAAwAAAAAAAAAGABAAAAHAAQAAAADCjBGAQwAILAAADAGiBCAACCAAAgAAAIiIAIBIgIICKAkRGEIAhgkACIiAcQgIAOgAAAAAAQAAAAAAAAACAAACAACQAAAA==,(1R)-N-prop-2-ynylindan-1-amine,"(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine","(1<I>R</I>)-<I>N</I>-prop-2-ynyl-2,3-dihydro-1<I>H</I>-inden-1-amine","(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine","(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine",[(1R)-indan-1-yl]-propargyl-amine,"InChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1",RUOKEQAAGRXIBM-GFCCVEGCSA-N,,171.104799419,C12H13N,171.24,12.0,171.104799419,0.0,13.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C#CCN[C@@H]1CCc2ccccc21,1.8,"2  1  6
10  11  8
5  6  8
5  7  8
6  8  8
7  10  8
8  11  8",
440791202,4911,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01698,probenecid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01698,probenecid,6.0,Adverse reactions,Ambiguous DILI-concern,2.0,4911,1.0,374.0,5.0,1.0,7.0,AAADceByOABAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgQASAAADADB2AQyCYIAAgKIAiDSCHBCABAkAAAIiBkICMgIJjKAFRCEcQAkwAGImYeIyCCOEAAAAAAAAAAgAAAAAAAAAAAAAAAAAA==,4-(dipropylsulfamoyl)benzoic acid,4-(dipropylsulfamoyl)benzoic acid,4-(dipropylsulfamoyl)benzoic acid,4-(dipropylsulfamoyl)benzoic acid,4-(dipropylsulfamoyl)benzoic acid,4-(dipropylsulfamoyl)benzoic acid,"InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)",DBABZHXKTCFAPX-UHFFFAOYSA-N,3.2,285.10347926,C13H19NO4S,285.36,83.1,285.10347926,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1,,"11  14  8
11  15  8
14  16  8
15  17  8
16  18  8
17  18  8",
440791201,4893,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00435,prazosin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00435,prazosin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,4893,1.0,544.0,8.0,1.0,4.0,AAADceB7uAAAAAAAAAAAAAAAAAAAASAAAAA8WIAAAAAAAACx/AAAHgAQAAAADAzhngYz9vdIFECoA69y9AKCiCklIqAJmCH+7NiPbrLE/f+XPSruxhva6ae41xMOIEABAgACQABAgAIEAASAAAAAAAAAAA==,"[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone","[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-(2-furanyl)methanone","[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone","[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone","[4-(4-azanyl-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone","[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazino]-(2-furyl)methanone","InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)",IENZQIKPVFGBNW-UHFFFAOYSA-N,2.0,383.15935417,C19H21N5O4,383.4,107.0,383.15935417,0.0,28.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,,"16  18  8
16  20  8
17  22  8
18  19  8
18  21  8
2  17  8
2  26  8
20  23  8
21  24  8
22  25  8
23  24  8
25  26  8
7  14  8
7  16  8
8  14  8
8  19  8",
440791200,119570,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00991,pramipexole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00991,pramipexole,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,119570,1.0,188.0,4.0,2.0,3.0,AAADceBzAABAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgBgAAAHAQQAAAACCjBVgQDkRLIEAikAQRgZAAA8KlhCDkAGJQ4QAiAIAJgkAGEAAAgkALISCMQAAAAAAAAAAAAAAAAAQAAQAACAAAAAAAAAA==,"(6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine","(6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine","(6<I>S</I>)-6-<I>N</I>-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine","(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine","(6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine","[(6S)-2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]-propyl-amine","InChI=1S/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m0/s1",FASDKYOPVNHBLU-ZETCQYMHSA-N,,211.11431873,C10H17N3S,211.33,79.2,211.11431873,0.0,14.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCN[C@H]1CCc2nc(N)sc2C1,1.9,"1  13  8
1  9  8
5  2  6
3  10  8
3  13  8
9  10  8",
440791199,135398747,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00610,pralidoxime,20210312,20210312,Curation Efforts|Governmental Organizations,LT00610,pralidoxime,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,135398747,1.0,125.0,2.0,1.0,1.0,AAADccBjIAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAHAAECAAACAjBFgQ+gJMcEACgATRnRACCgCAxAiAI2CA4ZJgIIOLAkZGEIAhggADIyAcQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2E)-1-methylpyridin-1-ium-2-carbaldehyde oxime,(2E)-1-methyl-2-pyridin-1-iumcarboxaldehyde oxime,(<I>N</I><I>E</I>)-<I>N</I>-[(1-methylpyridin-1-ium-2-yl)methylidene]hydroxylamine,(NE)-N-[(1-methylpyridin-1-ium-2-yl)methylidene]hydroxylamine,(NE)-N-[(1-methylpyridin-1-ium-2-yl)methylidene]hydroxylamine,(2E)-1-methylpyridin-1-ium-2-carbaldehyde oxime,"InChI=1S/C7H8N2O/c1-9-5-3-2-4-7(9)6-8-10/h2-6H,1H3/p+1",JBKPUQTUERUYQE-UHFFFAOYSA-O,,137.071487915,C7H9N2O+,137.16,36.5,137.071487915,1.0,10.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",C[n+]1ccccc1/C=N/O,1.0,"2  4  8
2  5  8
4  6  8
5  8  8
6  9  8
8  9  8",
440791198,4870,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01688,polythiazide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01688,polythiazide,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,4870,1.0,692.0,11.0,2.0,4.0,AAADccBzOYBkAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAACxAAAAHQYQQAAACArFUDSzwYLAAAqAACRCQHDCABAhBxAAiJwIZoiIICLBkpGEIAhokALoyCcQAAAAAAYAAEIAAYAADAAAhAADAAAAAAAAAA==,"6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-2-methyl-1,1-dioxo-3-[(2,2,2-trifluoroethylthio)methyl]-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1&lambda;<SUP>6</SUP>,2,4-benzothiadiazine-7-sulfonamide","6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloranyl-2-methyl-1,1-bis(oxidanylidene)-3-[2,2,2-tris(fluoranyl)ethylsulfanylmethyl]-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-1,1-diketo-2-methyl-3-[(2,2,2-trifluoroethylthio)methyl]-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide","InChI=1S/C11H13ClF3N3O4S3/c1-18-10(4-23-5-11(13,14)15)17-7-2-6(12)8(24(16,19)20)3-9(7)25(18,21)22/h2-3,10,17H,4-5H2,1H3,(H2,16,19,20)",CYLWJCABXYDINA-UHFFFAOYSA-N,2.6,438.9708816,C11H13ClF3N3O4S3,439.9,152.0,438.9708816,0.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,,"15  18  3
16  17  8
16  20  8
17  21  8
20  22  8
21  23  8
22  23  8",
440791197,5910,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01671,pilocarpine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01671,pilocarpine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5910,1.0,245.0,3.0,0.0,3.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAWJAAAAAAAAAAAAAAAABgAAAHgAAAAAADQjhlgYvmBcMFACoART3bAAAgC0xEqABUAE4cAiAaBJAmQCWAAAMgAJAQCG62QMegAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one","(3S,4R)-3-ethyl-4-[(3-methyl-4-imidazolyl)methyl]-2-oxolanone","(3<I>S</I>,4<I>R</I>)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one","(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one","(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one","(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one","InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1",QCHFTSOMWOSFHM-WPRPVWTQSA-N,,208.121177757,C11H16N2O2,208.26,44.1,208.121177757,0.0,15.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C,1.1,"11  13  8
3  11  8
3  14  8
4  13  8
4  14  8
5  7  5
6  9  5",
440791196,107807,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00955,PERINDOPRIL,20231222,20210312,Curation Efforts|Governmental Organizations,LT00955,perindopril,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,107807,1.0,524.0,6.0,2.0,9.0,AAADcfB7OAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgAAAAAHgAQCAAADSjhgAYCCAPABgAIAAGQGAAAAAAAAAAAAIGIAAACQBIAgCAXQAAEFgCQAAGY2aOeAAAAAAAAAAAAAAAAAAQAAAAAAAAAAA==,"(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonylbutyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid","(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]-1-oxopropyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid","(2<I>S</I>,3<I>a</I><I>S</I>,7<I>a</I><I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3<I>a</I>,4,5,6,7,7<I>a</I>-octahydroindole-2-carboxylic acid","(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid","(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxidanylidene-pentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid","(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-carbethoxybutyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid","InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14-,15-,16-/m0/s1",IPVQLZZIHOAWMC-QXKUPLGCSA-N,0.9,368.23112213,C19H32N2O5,368.5,95.9,368.23112213,0.0,26.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC,,"11  17  5
18  7  5
20  7  6
8  27  6
9  28  6",
440791195,47811,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00216,pergolide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00216,pergolide,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,47811,1.0,388.0,2.0,1.0,4.0,AAADceB7AABAAAAAAAAAAAAAAAAAAWAAAAA8YIAAAAAAAFjx8AAAHAQQAAAADSjFXgS+wPPJkAigAzRnRACCgCAxAjAI2aA4ZJgIIOLgkZGEIAhgkADIyAcQgMAOgAAAQAASAACQAASAACQAAAAAAAAAAA==,"(6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline","(6aR,9R,10aR)-9-[(methylthio)methyl]-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline","(6<I>a</I><I>R</I>,9<I>R</I>,10<I>a</I><I>R</I>)-9-(methylsulfanylmethyl)-7-propyl-6,6<I>a</I>,8,9,10,10<I>a</I>-hexahydro-4<I>H</I>-indolo[4,3-fg]quinoline","(6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline","(6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline","(6aR,9R,10aR)-9-[(methylthio)methyl]-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline","InChI=1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/t13-,16-,18-/m1/s1",YEHCICAEULNIGD-MZMPZRCHSA-N,,314.18167001,C19H26N2S,314.5,44.3,314.18167001,0.0,22.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,4.2,"10  12  8
10  16  8
11  12  8
11  17  8
12  15  8
15  19  8
16  20  8
19  20  8
3  15  8
3  17  8
4  23  6
5  24  5
7  14  5",
440791194,4740,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01652,pentoxifylline,20210312,20210312,Curation Efforts|Governmental Organizations,LT01652,pentoxifylline,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,4740,1.0,426.0,4.0,0.0,5.0,AAADceBzsAAAAAAAAAAAAAAAAAAAAWAAAAAsAAAAAAAAAFgBgAAAHgAAAAAACAzBlgQHsBcMEACoAYdxdACAgC0XEKABUAGoVECASBpAyCAUAIgIByLAAGEYAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione","3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione","3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione","3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione","3,7-dimethyl-1-(5-oxidanylidenehexyl)purine-2,6-dione","1-(5-ketohexyl)-3,7-dimethyl-xanthine","InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3",BYPFEZZEUUWMEJ-UHFFFAOYSA-N,0.3,278.13789045,C13H18N4O3,278.31,75.5,278.13789045,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,,"11  12  8
11  13  8
4  12  8
4  14  8
5  13  8
5  14  8
6  11  8
6  16  8
7  13  8
7  16  8",
440791193,37720,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00956,pentosan polysulfate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00956,pentosan polysulfate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,37720,1.0,1140.0,21.0,6.0,10.0,AAADceBwPgBwAAAAAAAAAAAAAAAAAAAAAAAkSAAAAAAAAAAAAAAAGgAACAAACBSwgAMACAAABoAAAAAAADAAAAAAAAAAAAAAAAAREAIAAAAiQAAFAAAHAADAIAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(2R,3R,4S,5R)-2-hydroxy-5-[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfooxy-tetrahydropyran-2-yl]oxy-3-sulfooxy-tetrahydropyran-4-yl] hydrogen sulfate","sulfuric acid [(2R,3R,4S,5R)-2-hydroxy-5-[[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfooxy-2-oxanyl]oxy]-3-sulfooxy-4-oxanyl] ester","[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>)-2-hydroxy-5-[(2<I>S</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>)-5-hydroxy-3,4-disulfooxyoxan-2-yl]oxy-3-sulfooxyoxan-4-yl] hydrogen sulfate","[(2R,3R,4S,5R)-2-hydroxy-5-[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfooxyoxan-2-yl]oxy-3-sulfooxyoxan-4-yl] hydrogen sulfate","[(2R,3R,4S,5R)-2-oxidanyl-5-[(2S,3R,4S,5R)-5-oxidanyl-3,4-disulfooxy-oxan-2-yl]oxy-3-sulfooxy-oxan-4-yl] hydrogen sulfate","sulfuric acid [(2R,3R,4S,5R)-2-hydroxy-5-[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfoxy-tetrahydropyran-2-yl]oxy-3-sulfoxy-tetrahydropyran-4-yl] ester","InChI=1S/C10H18O21S4/c11-3-1-26-10(8(31-35(22,23)24)5(3)28-32(13,14)15)27-4-2-25-9(12)7(30-34(19,20)21)6(4)29-33(16,17)18/h3-12H,1-2H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)/t3-,4-,5+,6+,7-,8-,9-,10+/m1/s1",FCCNSUIJIOOXEZ-SJYYZXOBSA-N,,601.92234227,C10H18O21S4,602.5,356.0,601.92234227,0.0,35.0,8.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=S(=O)(O)O[C@@H]1[C@@H](OS(=O)(=O)O)[C@H](O[C@@H]2CO[C@@H](O)[C@H](OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)OC[C@H]1O,-5.6,"30  10  6
31  11  5
32  12  5
34  13  6
26  5  5
29  5  6
27  8  6
28  9  5",
440791192,135410875,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01157,Pemetrexed,20231222,20210312,Curation Efforts|Governmental Organizations,LT01157,pemetrexed,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,135410875,1.0,748.0,7.0,6.0,9.0,AAADceB7uAAAAAAAAAAAAAAAAAAAAWAAAAAwQAAAAAAAAEABwAAAHgAQCAAADCjBmgQ9uJLJkgCoAjP3fACCgCm1ACAJ2aGoRNiKIHrA3bGEYYhklwLYyee8rsCOwAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,"(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid","(2S)-2-[[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl]-oxomethyl]amino]pentanedioic acid","(2<I>S</I>)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid","(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid","(2S)-2-[[4-[2-(2-azanyl-4-oxidanylidene-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl]carbonylamino]pentanedioic acid","(2S)-2-[[4-[2-(2-amino-4-keto-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]glutaric acid","InChI=1S/C20H21N5O6/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29)/t13-/m0/s1",WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,,427.14918341,C20H21N5O6,427.4,187.0,427.14918341,0.0,31.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1,0.2,"10  18  8
10  30  8
13  15  8
13  19  8
15  18  8
15  24  8
16  21  8
16  22  8
21  26  8
22  27  8
23  26  8
23  27  8
7  18  8
7  19  8
17  8  5
9  24  8
9  30  8",
440791191,5281104,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01015,Paricalcitol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01015,paricalcitol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5281104,1.0,676.0,3.0,3.0,5.0,AAADcfB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYAAAAAAAAGAAAAAAGgAACAAAD1SggAICAAAAAgCAAiBCAAAAAAAgAAAICAAAAAgIEAIAAQAAQAAFwAAIgAOA4MQPgAAAAAAAAAAAAAAQACAAAQAACAAAAA==,"(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-5-hydroxy-1,4,5-trimethyl-hex-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol","(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol","(1<I>R</I>,3<I>R</I>)-5-[(2<I>E</I>)-2-[(1<I>R</I>,3<I>a</I><I>S</I>,7<I>a</I><I>R</I>)-1-[(<I>E</I>,2<I>R</I>,5<I>S</I>)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7<I>a</I>-methyl-2,3,3<I>a</I>,5,6,7-hexahydro-1<I>H</I>-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol","(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol","(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-5,6-dimethyl-6-oxidanyl-hept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol","(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-5-hydroxy-1,4,5-trimethyl-hex-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol","InChI=1S/C27H44O3/c1-18(8-9-19(2)26(3,4)30)24-12-13-25-21(7-6-14-27(24,25)5)11-10-20-15-22(28)17-23(29)16-20/h8-11,18-19,22-25,28-30H,6-7,12-17H2,1-5H3/b9-8+,21-11+/t18-,19+,22-,23-,24-,25+,27-/m1/s1",BPKAHTKRCLCHEA-UBFJEZKGSA-N,,416.32904526,C27H44O3,416.6,60.7,416.32904526,0.0,30.0,7.0,0.0,2.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@]12C,5.0,"10  15  6
26  2  5
20  25  5
27  3  6
4  12  5
5  31  6
6  32  6",
440791190,4674,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01916,pamidronate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01916,pamidronate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,4674,1.0,243.0,8.0,6.0,4.0,AAADccBCOAMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHggQCCAACADBgAQAAABAAhAAQAAAAIAAAAAAAAAAAIAAAAAAAAAAAAAAQAACEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(3-amino-1-hydroxy-1-phosphono-propyl)phosphonic acid,(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid,(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid,(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid,(3-azanyl-1-oxidanyl-1-phosphono-propyl)phosphonic acid,(3-amino-1-hydroxy-1-phosphono-propyl)phosphonic acid,"InChI=1S/C3H11NO7P2/c4-2-1-3(5,12(6,7)8)13(9,10)11/h5H,1-2,4H2,(H2,6,7,8)(H2,9,10,11)",WRUUGTRCQOWXEG-UHFFFAOYSA-N,,235.00107569,C3H11NO7P2,235.07,161.0,235.00107569,0.0,13.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCCC(O)(P(=O)(O)O)P(=O)(O)O,-6.9,,
440791189,6337614,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01130,Palonosetron,20250421,20210312,Curation Efforts|Governmental Organizations,LT01130,palonosetron,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,6337614,1.0,456.0,2.0,0.0,1.0,AAADceB7IAAAAAAAAAAAAAAAAAAAAAAAAAA8eLFiAAAAAADxAAAAHgAAAAAADSjBmAQwAIMAAACIAiFSEACCAAAkAAAIiAEIBMgIYDKAlRGUIQhghgCIiYcYicCOgAACAAAQAAAAAAQAACAAAAAAAAAAAA==,"(3aS)-2-[(3S)-quinuclidin-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one","(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one","(3<I>a</I><I>S</I>)-2-[(3<I>S</I>)-1-azabicyclo[2.2.2]octan-3-yl]-3<I>a</I>,4,5,6-tetrahydro-3<I>H</I>-benzo[de]isoquinolin-1-one","(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one","(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one","(3aS)-2-[(3S)-quinuclidin-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one","InChI=1S/C19H24N2O/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-21(19)17-12-20-9-7-13(17)8-10-20/h2,4,6,13,15,17H,1,3,5,7-12H2/t15-,17-/m1/s1",CPZBLNMUGSZIPR-NVXWUHKLSA-N,,296.188863393,C19H24N2O,296.4,23.6,296.188863393,0.0,22.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2,2.8,"11  35  6
13  16  8
13  18  8
16  20  8
18  21  8
20  22  8
21  22  8
5  3  5",
440791188,4616,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00847,oxazepam,20231222,20210312,Curation Efforts|Governmental Organizations,LT00847,oxazepam,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,4616,1.0,407.0,3.0,2.0,1.0,AAADccBzMAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHgIQCAAADArhmCYwwILAAgCoAyVyVAKCAAAhBwAIiADgZpgKcKLBk5GUIAhglADYyAcQgMAOAABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one","7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one","7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one","7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one","7-chloranyl-3-oxidanyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one","7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one","InChI=1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)",ADIMAYPTOBDMTL-UHFFFAOYSA-N,2.2,286.0509053,C15H11ClN2O2,286.71,61.7,286.0509053,0.0,20.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,,"11  14  8
12  15  8
14  15  8
16  18  8
17  19  8
18  20  8
19  20  8
10  2  3
6  11  8
6  8  8
8  12  8
9  16  8
9  17  8",
440791187,65028,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02210,oseltamivir,20231222,20210312,Curation Efforts|Governmental Organizations,LT02210,oseltamivir,3.0,Adverse reactions,Ambiguous DILI-concern,1.0,65028,1.0,418.0,5.0,2.0,8.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAHgAQAAAADDzhgAYCCALABACIAiHSGAAAAAAgAAAACIEIAEgCRBIAoQAXEAAGlgCYIYO82SOQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohexene-1-carboxylate","(3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxy-1-cyclohexenecarboxylic acid ethyl ester","ethyl (3<I>R</I>,4<I>R</I>,5<I>S</I>)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate","ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate","ethyl (3R,4R,5S)-4-acetamido-5-azanyl-3-pentan-3-yloxy-cyclohexene-1-carboxylate","(3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohexene-1-carboxylic acid ethyl ester","InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1",VSZGPKBBMSAYNT-RRFJBIMHSA-N,,312.20490738,C16H28N2O4,312.4,90.7,312.20490738,0.0,22.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,1.1,"9  1  5
7  5  6
8  6  5",
440791186,158781,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01102,Olmesartan,20250421,20210312,Curation Efforts|Governmental Organizations,LT01102,olmesartan,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,158781,1.0,656.0,7.0,3.0,8.0,AAADceB7sAAAAAAAAAAAAAAAAAAAAWLAAAAwYAAAAAAAAAAB9AAAHgAYCAAADEzBnwQzmJcOEgCqAybybASCgC8nEKAd+CG4XNiKbrrAmTGUcYhugALY2WfagMAOwAAAAAAQAACAAAAAACAAAAAAAAAAAA==,5-(1-hydroxy-1-methyl-ethyl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid,5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4-imidazolecarboxylic acid,5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2<I>H</I>-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid,5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid,"5-(2-oxidanylpropan-2-yl)-2-propyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid",5-(1-hydroxy-1-methyl-ethyl)-2-propyl-3-[4-[2-(2H-tetrazol-5-yl)phenyl]benzyl]imidazole-4-carboxylic acid,"InChI=1S/C24H26N6O3/c1-4-7-19-25-21(24(2,3)33)20(23(31)32)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13,33H,4,7,14H2,1-3H3,(H,31,32)(H,26,27,28,29)",VTRAEEWXHOVJFV-UHFFFAOYSA-N,,446.20663871,C24H26N6O3,446.5,130.0,446.20663871,0.0,33.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,3.2,"11  13  8
18  21  8
18  22  8
21  25  8
22  26  8
24  25  8
24  26  8
27  28  8
27  29  8
28  30  8
29  31  8
30  33  8
31  33  8
4  12  8
4  13  8
5  11  8
5  12  8
6  32  8
6  8  8
7  32  8
7  9  8
8  9  8",
440791185,6230,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00211,norethindrone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00211,norethindrone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,6230,1.0,594.0,2.0,1.0,1.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAAD0SAgAACAAAAAgDIGqBSAAgAAAAgAAAACAEAAEgAABIAAQAAQAAEgAAIAQOIyPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-17-oxidanyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","InChI=1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18,22H,4-11H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1",VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.0,298.193280068,C20H26O2,298.4,37.3,298.193280068,0.0,22.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,,"8  1  5
11  32  5
3  23  6
4  14  5
5  24  5
6  25  6",
440791184,115355,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01092,Nitisinone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01092,nitisinone,7.0,Adverse reactions,Ambiguous DILI-concern,2.0,115355,1.0,524.0,8.0,0.0,2.0,AAADccByOYAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABAAAAHwAEAAAADQyBmBAwwIAQQACJAqRSQwCCAAAkAgAoiAEAZMoIIDqIlZGAIYBggAAIyccYi8C+QAAAQAACAACAAACAAAQAAAAAAAAAAA==,"2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione","2-[[2-nitro-4-(trifluoromethyl)phenyl]-oxomethyl]cyclohexane-1,3-dione","2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione","2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione","2-[2-nitro-4-(trifluoromethyl)phenyl]carbonylcyclohexane-1,3-dione","2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-quinone","InChI=1S/C14H10F3NO5/c15-14(16,17)7-4-5-8(9(6-7)18(22)23)13(21)12-10(19)2-1-3-11(12)20/h4-6,12H,1-3H2",OUBCNLGXQFSTLU-UHFFFAOYSA-N,,329.05110691,C14H10F3NO5,329.23,97.0,329.05110691,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-],2.3,"17  18  8
17  19  8
18  21  8
19  22  8
20  21  8
20  22  8",
440791183,4499,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00217,nisoldipine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00217,nisoldipine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,4499,1.0,704.0,7.0,1.0,7.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwQAAAAAAAAAABAAAAHgAUAAAADQihmAIyyILQRACJAiTSSwCCAAAgAgAoiAEAZMoIJDKAsZGCMABkkACI6UeY/+megAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"O5-isobutyl O3-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-(2-methylpropyl) ester","3-<I>O</I>-methyl 5-<I>O</I>-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","O3-methyl O5-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O5-isobutyl ester O3-methyl ester","InChI=1S/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3",VKQFCGNPDRICFG-UHFFFAOYSA-N,3.3,388.16343649,C20H24N2O6,388.4,110.0,388.16343649,0.0,28.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],,"12  16  8
12  17  8
16  23  8
17  24  8
23  25  8
24  25  8
9  12  3",
440791182,4497,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01601,nimodipine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01601,nimodipine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,4497,1.0,736.0,8.0,1.0,9.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwQAAAAAAAAAABAAAAHgAUAAAADRyhmAIyyILQRACJAiTSSwCCAAAgAgAoiAEAZMoJJDKAsZGCMABkkACK6UeY7uiOgAAAQAAAAAAAAACAAAAAAAAAAAAAAA==,"O5-isopropyl O3-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O3-(2-methoxyethyl) ester O5-propan-2-yl ester","3-<I>O</I>-(2-methoxyethyl) 5-<I>O</I>-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","O3-(2-methoxyethyl) O5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O5-isopropyl ester O3-(2-methoxyethyl) ester","InChI=1S/C21H26N2O7/c1-12(2)30-21(25)18-14(4)22-13(3)17(20(24)29-10-9-28-5)19(18)15-7-6-8-16(11-15)23(26)27/h6-8,11-12,19,22H,9-10H2,1-5H3",UIAGMCDKSXEBJQ-UHFFFAOYSA-N,3.1,418.17400117,C21H26N2O7,418.4,120.0,418.17400117,0.0,30.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,,"10  31  3
13  17  8
13  19  8
17  22  8
19  23  8
22  25  8
23  25  8",
440791181,4474,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01595,nicardipine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01595,nicardipine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,4474,1.0,856.0,8.0,1.0,10.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwYIAAAAAAAAABQAAAHgAUAAAADQjhmAYyyIPQRACJAiTSSwCCAAAgAgAoiAEIZMoKJDKAsZGHMAhkkACY6UeY7uiOgAAAQAAAAAAAAACAAAAAAAAAAAAAAA==,"O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-[2-[methyl-(phenylmethyl)amino]ethyl] ester","5-<I>O</I>-[2-[benzyl(methyl)amino]ethyl] 3-<I>O</I>-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","O3-methyl O5-[2-[methyl-(phenylmethyl)amino]ethyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O5-[2-[benzyl(methyl)amino]ethyl] ester O3-methyl ester","InChI=1S/C26H29N3O6/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19/h5-12,15,24,27H,13-14,16H2,1-4H3",ZBBHBTPTTSWHBA-UHFFFAOYSA-N,3.8,479.20563565,C26H29N3O6,479.5,114.0,479.20563565,0.0,35.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,,"10  13  3
13  17  8
13  18  8
17  24  8
18  25  8
24  27  8
25  27  8
28  30  8
28  31  8
30  33  8
31  34  8
33  35  8
34  35  8",
440791180,71301,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01212,Nebivolol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01212,nebivolol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,71301,1.0,483.0,7.0,3.0,6.0,AAADceB6OYAAAAAAAAAAAAAAAAAAAAAAAAA0aIEAAAAAAACRQAAAHwAQCAAADBThmA4wBoLABgCAAiBCAAACCAAgIAAIiIAOCIgPNiKEsRqGeCCm0BGbqAeQwPAOAAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,1-(6-fluorochroman-2-yl)-2-[[2-(6-fluorochroman-2-yl)-2-hydroxy-ethyl]amino]ethanol,"1-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2-hydroxyethyl]amino]ethanol","1-(6-fluoro-3,4-dihydro-2<I>H</I>-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2<I>H</I>-chromen-2-yl)-2-hydroxyethyl]amino]ethanol","1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol","1-(6-fluoranyl-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoranyl-3,4-dihydro-2H-chromen-2-yl)-2-oxidanyl-ethyl]amino]ethanol",1-(6-fluorochroman-2-yl)-2-[[2-(6-fluorochroman-2-yl)-2-hydroxy-ethyl]amino]ethanol,"InChI=1S/C22H25F2NO4/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2",KOHIRBRYDXPAMZ-UHFFFAOYSA-N,,405.1751646,C22H25F2NO4,405.4,71.0,405.1751646,0.0,29.0,0.0,4.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,3.0,"10  32  3
11  33  3
18  20  8
18  22  8
19  21  8
19  23  8
20  24  8
21  25  8
22  26  8
23  27  8
24  28  8
25  29  8
26  28  8
27  29  8
8  30  3
9  31  3",
440791179,5311309,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00594,nateglinide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00594,nateglinide,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5311309,1.0,393.0,3.0,2.0,6.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABAAAAHgAQCAAADSjBmAQyCILAAgCIAiHSGAACAAAgAAAIiIGIAIgKIDKAkTGEYAAklgCYiAeYyOCOgAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,(2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoic acid,(2R)-2-[[oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid,(2<I>R</I>)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid,(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid,(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexyl)carbonylamino]propanoic acid,(2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propionic acid,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1",OELFLUMRDSZNSF-OFLPRAFFSA-N,3.2,317.19909372,C19H27NO3,317.4,66.4,317.19909372,0.0,23.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,,"18  19  8
18  20  8
19  21  8
20  22  8
21  23  8
22  23  8
15  4  5",
440791178,4440,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01007,naratriptan,20250421,20210312,Curation Efforts|Governmental Organizations,LT01007,naratriptan,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,4440,1.0,483.0,4.0,2.0,5.0,AAADceB7MABAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgB8AAAHAQQQAAADQjFXgS+wPPJkAKgAzRnRHDCgCAxAiAI2aA4ZJgIIOLAkZGEIAhgkADIyAcQgMAOiAACAAACAAAQAAQAAAQAAAAAAAAAAA==,N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]ethanesulfonamide,N-methyl-2-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]ethanesulfonamide,<I>N</I>-methyl-2-[3-(1-methylpiperidin-4-yl)-1<I>H</I>-indol-5-yl]ethanesulfonamide,N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide,N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide,N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]ethanesulfonamide,"InChI=1S/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H3",AMKVXSZCKVJAGH-UHFFFAOYSA-N,,335.16674822,C17H25N3O2S,335.5,73.6,335.16674822,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,2.0,"12  13  8
12  14  8
13  15  8
13  17  8
15  19  8
17  18  8
18  21  8
19  21  8
5  14  8
5  15  8",
440791177,5388881,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01588,Nalmefene hydrochloride,20231222,20210312,Curation Efforts|Governmental Organizations,LT01588,nalmefene hydrochloride,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5388881,1.0,618.0,4.0,3.0,2.0,AAADceB6MAAEAAAAAAAAAAAAGAAAASAAAAA8YMEAAAAWAEjxAAAAHgAACAAAD3zhmAYwBoMABgCAAiBCAAACCAAgIAAIiAAOiIgPJiKGsRuGeCOlwBGbuAfw8P8PoAABAAAYQADQAAaQADSgAAAAAAAAAA==,"(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;hydrochloride","(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;hydrochloride","(4<I>R</I>,4<I>a</I><I>S</I>,7<I>a</I><I>S</I>,12<I>b</I><I>S</I>)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7<I>a</I>,13-hexahydro-1<I>H</I>-4,12-methanobenzofuro[3,2-e]isoquinoline-4<I>a</I>,9-diol;hydrochloride","(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;hydrochloride","(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;hydrochloride","(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;hydrochloride","InChI=1S/C21H25NO3.ClH/c1-12-6-7-21(24)16-10-14-4-5-15(23)18-17(14)20(21,19(12)25-18)8-9-22(16)11-13-2-3-13;/h4-5,13,16,19,23-24H,1-3,6-11H2;1H/t16-,19+,20+,21-;/m1./s1",GYWMRGWFQPSQLK-OPHZJPRHSA-N,,375.1601214,C21H26ClNO3,375.9,52.9,375.1601214,0.0,26.0,4.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl,,"11  15  8
11  20  8
15  23  8
20  24  8
23  26  8
24  26  8
7  3  5
6  10  5
8  27  6
9  28  5",
440791176,39147,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01582,nadolol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01582,nadolol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,39147,1.0,344.0,5.0,4.0,6.0,AAADceB6OAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAADBAAAAHgAQCAAADJzhmAYyBoLABgCAAiBCAAACCAAgIAAIiIAOCIgPNiKEMRqGeCCm0BGbqAfA4LwOgAABAAAYAABAAAIAADCAAAAAAAAAAA==,"(2R,3S)-5-[3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-2,3-diol","(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol","(2<I>R</I>,3<I>S</I>)-5-[3-(<I>tert</I>-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol","(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol","(2R,3S)-5-[3-(tert-butylamino)-2-oxidanyl-propoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol","(2R,3S)-5-[3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-2,3-diol","InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1",VWPOSFSPZNDTMJ-UCWKZMIHSA-N,0.7,309.19400834,C17H27NO4,309.4,82.0,309.19400834,0.0,22.0,2.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2,,"6  1  6
10  11  8
10  12  8
11  14  8
12  18  8
14  19  8
18  19  8
7  2  6
15  4  3",
440791175,446541,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00310,mycophenolic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT00310,mycophenolic acid,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,446541,1.0,485.0,6.0,2.0,6.0,AAADceB4OAAAAAAAAAAAAAAAAAAAASAAAAAwAAAAAAAAAEgBAAAAGgAACAAADASgmAICDoAABgCIAiDSCAACCAAkIAAAiAEECMgMJzaGNRqCcWAl4BUIuQfK7PzO4AADCAAYAADAAAYQADAAAAAAAAAAAA==,(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoic acid,(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid,(<I>E</I>)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1<I>H</I>-2-benzofuran-5-yl)-4-methylhex-4-enoic acid,(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid,(E)-6-(6-methoxy-7-methyl-4-oxidanyl-3-oxidanylidene-1H-2-benzofuran-5-yl)-4-methyl-hex-4-enoic acid,(E)-6-(4-hydroxy-3-keto-6-methoxy-7-methyl-phthalan-5-yl)-4-methyl-hex-4-enoic acid,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+",HPNSFSBZBAHARI-RUDMXATFSA-N,,320.12598835,C17H20O6,320.3,93.1,320.12598835,0.0,23.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,3.2,"10  11  8
7  10  8
7  9  8
8  11  8
8  12  8
9  12  8",
440791174,34633,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01571,MORICIZINE,20250421,20210312,Curation Efforts|Governmental Organizations,LT01571,moricizine,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,34633,1.0,601.0,6.0,1.0,6.0,AAADceB7OABAAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxQAAAHgQQAAAACAjh0AYyyYPABAiIACVSWACCAAAhChAIiB0IZIkKIGrg0dGPIAhglAD4yAcQAAAAAAQAAAQAAQAACAAACAACAAAAAAAAAA==,ethyl N-[10-(3-morpholinopropanoyl)phenothiazin-2-yl]carbamate,N-[10-[3-(4-morpholinyl)-1-oxopropyl]-2-phenothiazinyl]carbamic acid ethyl ester,ethyl <I>N</I>-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate,ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate,ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate,N-[10-(3-morpholinopropanoyl)phenothiazin-2-yl]carbamic acid ethyl ester,"InChI=1S/C22H25N3O4S/c1-2-29-22(27)23-16-7-8-20-18(15-16)25(17-5-3-4-6-19(17)30-20)21(26)9-10-24-11-13-28-14-12-24/h3-8,15H,2,9-14H2,1H3,(H,23,27)",FUBVWMNBEHXPSU-UHFFFAOYSA-N,3.0,427.15657746,C22H25N3O4S,427.5,96.4,427.15657746,0.0,30.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,,"16  18  8
16  20  8
17  19  8
17  21  8
18  22  8
19  24  8
20  23  8
21  26  8
22  25  8
23  25  8
24  27  8
26  27  8",
440791173,91270,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01567,MOEXIPRIL,20231222,20210312,Curation Efforts|Governmental Organizations,LT01567,moexipril,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,91270,1.0,742.0,8.0,2.0,12.0,AAADcfB7OAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACxQAAAHgAQCAAADCzhmAYyDoPABgCIAiHSGACCCAAgIAAIiIGOjIgPZjKEsTuXcCpk1hGaqAe42LOOoAABAAAQQABAAAIAACCAAAAAAAAAAA==,"(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid","(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid","(3<I>S</I>)-2-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1<I>H</I>-isoquinoline-3-carboxylic acid","(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid","(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid","(3S)-2-[(2S)-2-[[(1S)-1-carbethoxy-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid","InChI=1S/C27H34N2O7/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32)/t17-,21-,22-/m0/s1",UWWDHYUMIORJTA-HSQYWUDLSA-N,,498.23660143,C27H34N2O7,498.6,114.0,498.23660143,0.0,36.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O,1.2,"10  19  5
13  14  8
13  18  8
14  20  8
18  23  8
20  24  8
23  24  8
27  28  8
27  29  8
28  33  8
29  34  8
33  35  8
34  35  8
15  9  5
17  9  6",
440791172,5282381,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00922,misoprostol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00922,misoprostol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5282381,1.0,487.0,5.0,2.0,14.0,AAADcfB4OAAAAAAAAAAAAAAAAAAAAYAAAAAAAAAAAAAAAAAAAAAAGgAACAAADVSggAICCAAABgCIAKDSCAAAAAAgAAAICAEAAAgAEBYAAQAAQAAE4AAIAAOKyOCOgAAAAAAAAAAAAAAAAAAAAIAADAAAAA==,"methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-oct-1-enyl]-5-oxo-cyclopentyl]heptanoate","7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoic acid methyl ester","methyl 7-[(1<I>R</I>,2<I>R</I>,3<I>R</I>)-3-hydroxy-2-[(<I>E</I>)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate","methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate","methyl 7-[(1R,2R,3R)-2-[(E)-4-methyl-4-oxidanyl-oct-1-enyl]-3-oxidanyl-5-oxidanylidene-cyclopentyl]heptanoate","7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-oct-1-enyl]-5-keto-cyclopentyl]enanthic acid methyl ester","InChI=1S/C22H38O5/c1-4-5-14-22(2,26)15-10-12-18-17(19(23)16-20(18)24)11-8-6-7-9-13-21(25)27-3/h10,12,17-18,20,24,26H,4-9,11,13-16H2,1-3H3/b12-10+/t17-,18-,20-,22?/m1/s1",OJLOPKGSLYJEMD-URPKTTJQSA-N,3.7,382.27192431,C22H38O5,382.5,83.8,382.27192431,0.0,27.0,3.0,1.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,,"8  1  6
16  17  3
6  10  6
7  12  5",
440791171,4197,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00931,milrinone,20210804,20210312,Curation Efforts|Governmental Organizations,LT00931,milrinone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,4197,1.0,419.0,3.0,1.0,1.0,AAADccBzIAAAAAAAAAAAAAAAAAAAAAAAAAAsQAAAAAAAAAABgAAAHgAQAAAADAjBmgQ+gJLIEAC4BjV3VACigCAxAiAI2CE4ZNgIoGLAkZGEIAhglADIyYYQAAAKAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,6-methyl-2-oxo-5-(4-pyridyl)-1H-pyridine-3-carbonitrile,6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile,6-methyl-2-oxo-5-pyridin-4-yl-1<I>H</I>-pyridine-3-carbonitrile,6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile,6-methyl-2-oxidanylidene-5-pyridin-4-yl-1H-pyridine-3-carbonitrile,2-keto-6-methyl-5-(4-pyridyl)-1H-pyridine-3-carbonitrile,"InChI=1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16)",PZRHRDRVRGEVNW-UHFFFAOYSA-N,0.0,211.074561919,C12H9N3O,211.22,65.8,211.074561919,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1,,"12  14  8
13  15  8
2  11  8
2  6  8
3  14  8
3  15  8
5  6  8
5  8  8
7  12  8
7  13  8
8  9  8
9  11  8",
440791170,62937,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00946,Metoprolol succinate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00946,metoprolol succinate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,62937,1.0,308.0,12.0,6.0,21.0,AAADcfB/PAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAQCAAADDzhmAYyDoLABgCIAiDSCAACCAAgIAAIiIEOCIgPNjKEMRqGeCCm0BGbqAfDwKAOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol;succinic acid,butanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)-2-propanol,butanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol,butanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol,butanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol,1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol;succinic acid,"InChI=1S/2C15H25NO3.C4H6O4/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-3(6)1-2-4(7)8/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2H2,(H,5,6)(H,7,8)",RGHAZVBIOOEVQX-UHFFFAOYSA-N,,652.39349599,C34H56N2O10,652.8,176.0,652.39349599,0.0,46.0,0.0,2.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)CCC(=O)O,,"15  51  3
16  52  3
25  31  8
25  33  8
26  32  8
26  34  8
27  35  8
27  37  8
28  36  8
28  38  8
31  35  8
32  36  8
33  37  8
34  38  8",
440791169,4170,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02046,metolazone,20231222,20210312,Curation Efforts|Governmental Organizations,LT02046,metolazone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,4170,1.0,594.0,5.0,2.0,2.0,AAADceB7MABEAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACxQAAAHgYQQAAADArB2CQzwYPAAAKIAiVSUHDCABAlBwAIiJkIZsiIIDrB15GEIYholwLIyecYiACOBAQAgAICAIAICAEABAQBAAAAAAAAAA==,"7-chloro-2-methyl-3-(o-tolyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide","7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide","7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide","7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide","7-chloranyl-2-methyl-3-(2-methylphenyl)-4-oxidanylidene-1,2-dihydroquinazoline-6-sulfonamide","7-chloro-4-keto-2-methyl-3-(o-tolyl)-1,2-dihydroquinazoline-6-sulfonamide","InChI=1S/C16H16ClN3O3S/c1-9-5-3-4-6-14(9)20-10(2)19-13-8-12(17)15(24(18,22)23)7-11(13)16(20)21/h3-8,10,19H,1-2H3,(H2,18,22,23)",AQCHWTWZEMGIFD-UHFFFAOYSA-N,4.1,365.0600902,C16H16ClN3O3S,365.8,101.0,365.0600902,0.0,24.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,,"10  11  8
10  16  8
11  15  8
13  18  8
13  20  8
15  17  8
16  19  8
17  19  8
18  21  8
20  23  8
21  24  8
23  24  8
9  14  3",
440791168,4121,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00833,methyclothiazide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00833,methyclothiazide,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,4121,1.0,571.0,7.0,2.0,2.0,AAADccBzOABmAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAACxAAAAHAYQQAAACAvBUGQzwYLAAAKAACRCQHDCABAhBwAAiJwIZoiIICLBkpHEIAhokALIyCcQAAAAAAYAAEIAAYAADAAAhAADAAAAAAAAAA==,"6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1&lambda;<SUP>6</SUP>,2,4-benzothiadiazine-7-sulfonamide","6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloranyl-3-(chloromethyl)-2-methyl-1,1-bis(oxidanylidene)-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-3-(chloromethyl)-1,1-diketo-2-methyl-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide","InChI=1S/C9H11Cl2N3O4S2/c1-14-9(4-10)13-6-2-5(11)7(19(12,15)16)3-8(6)20(14,17)18/h2-3,9,13H,4H2,1H3,(H2,12,15,16)",CESYKOGBSMNBPD-UHFFFAOYSA-N,1.4,358.9568036,C9H11Cl2N3O4S2,360.2,126.0,358.9568036,0.0,20.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,,"12  15  3
13  14  8
13  16  8
14  18  8
16  19  8
18  20  8
19  20  8",
440791167,9034,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00803,METHOHEXITAL,20231222,20210312,Curation Efforts|Governmental Organizations,LT00803,methohexital,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,9034,1.0,497.0,3.0,1.0,3.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAAAAAAAHgAQAAAADwCBgAQDAAPAAADIECFSEAgAAAAgAAAIAAEIAAiAABoIwQAEAAAIhyIAAAAAAAAPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5-allyl-1-methyl-5-(1-methylpent-2-ynyl)hexahydropyrimidine-2,4,6-trione","5-hex-3-yn-2-yl-1-methyl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione","5-hex-3-yn-2-yl-1-methyl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione","5-hex-3-yn-2-yl-1-methyl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione","5-hex-3-yn-2-yl-1-methyl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione",5-allyl-1-methyl-5-(1-methylpent-2-ynyl)barbituric acid,"InChI=1S/C14H18N2O3/c1-5-7-8-10(3)14(9-6-2)11(17)15-13(19)16(4)12(14)18/h6,10H,2,5,9H2,1,3-4H3,(H,15,17,19)",NZXKDOXHBHYTKP-UHFFFAOYSA-N,2.3,262.13174244,C14H18N2O3,262.3,66.5,262.13174244,0.0,19.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,,"6  8  3
7  20  3",
440791166,4107,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00581,methocarbamol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00581,methocarbamol,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,4107,1.0,236.0,5.0,2.0,7.0,AAADccByOAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAACBSgkAIyDoBABgCIACBCGAACCAAgIAAIiAAGiIkNNiKEMRqKOCKlwBELqAeAQAAAAAAAAAAAQAAAAAAAAACAAAAAAAAAAA==,[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate,carbamic acid [2-hydroxy-3-(2-methoxyphenoxy)propyl] ester,[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate,[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate,[3-(2-methoxyphenoxy)-2-oxidanyl-propyl] carbamate,carbamic acid [2-hydroxy-3-(2-methoxyphenoxy)propyl] ester,"InChI=1S/C11H15NO5/c1-15-9-4-2-3-5-10(9)16-6-8(13)7-17-11(12)14/h2-5,8,13H,6-7H2,1H3,(H2,12,14)",GNXFOGHNGIVQEH-UHFFFAOYSA-N,0.6,241.09502258,C11H15NO5,241.24,91.0,241.09502258,0.0,17.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccccc1OCC(O)COC(N)=O,,"10  11  8
10  12  8
11  13  8
12  14  8
13  15  8
14  15  8
7  2  3",
440791165,4095,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00723,methadone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00723,methadone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,4095,1.0,346.0,2.0,0.0,7.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAAAAAADizBmAQyAIMAAACIAqBSAAACAAAgAAAIiAEIAIgIIDKAlRCEIAAggAAIiAcciMCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"6-(dimethylamino)-4,4-diphenyl-heptan-3-one","6-(dimethylamino)-4,4-diphenyl-3-heptanone","6-(dimethylamino)-4,4-diphenylheptan-3-one","6-(dimethylamino)-4,4-diphenylheptan-3-one","6-(dimethylamino)-4,4-diphenyl-heptan-3-one","6-(dimethylamino)-4,4-diphenyl-heptan-3-one","InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3",USSIQXCVUWKGNF-UHFFFAOYSA-N,3.9,309.209264485,C21H27NO,309.4,20.3,309.209264485,0.0,23.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,,"11  18  8
12  19  8
13  20  8
14  21  8
18  22  8
19  23  8
20  22  8
21  23  8
5  26  3
6  11  8
6  13  8
7  12  8
7  14  8",
440791164,4078,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01527,mesoridazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01527,mesoridazine,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,4078,1.0,502.0,5.0,0.0,4.0,AAADceB7IABgAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxQAAAHAQAAAAACCjBUASywYMAAAqAACRCQEDCAAAhChAIiBwIZIgIIGLg0ZGEIAxggADoyAcQgAAAAAgAACAAAQAAEAAAQAACAAAAAAAAAA==,10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfinyl-phenothiazine,10-[2-(1-methyl-2-piperidinyl)ethyl]-2-methylsulfinylphenothiazine,10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine,10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine,10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinyl-phenothiazine,10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfinyl-phenothiazine,"InChI=1S/C21H26N2OS2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(26(2)24)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3",SLVMESMUVMCQIY-UHFFFAOYSA-N,4.5,386.1486558,C21H26N2OS2,386.6,68.1,386.1486558,0.0,26.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,,"14  16  8
14  18  8
15  17  8
15  19  8
16  20  8
17  22  8
18  21  8
19  24  8
2  26  3
20  23  8
21  23  8
22  25  8
24  25  8
6  8  3",
440791163,23662354,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01526,mesna,20231222,20210312,Curation Efforts|Governmental Organizations,LT01526,mesna,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,23662354,1.0,123.0,4.0,1.0,2.0,AAADcYBAMCBgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGAQAAAAAAACEQACAAAAAAAYAAAAAAHBAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,sodium;2-sulfanylethanesulfonate,sodium;2-mercaptoethanesulfonate,sodium;2-sulfanylethanesulfonate,sodium;2-sulfanylethanesulfonate,sodium;2-sulfanylethanesulfonate,sodium;2-mercaptoethanesulfonate,"InChI=1S/C2H6O3S2.Na/c3-7(4,5)2-1-6;/h6H,1-2H2,(H,3,4,5);/q;+1/p-1",XOGTZOOQQBDUSI-UHFFFAOYSA-M,,163.95778065,C2H5NaO3S2,164.18,66.6,163.95778065,0.0,8.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",O=S(=O)([O-])CCS.[Na+],,,3  4  7
440791162,4060,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01520,MEPHENYTOIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT01520,mephenytoin,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,4060,1.0,310.0,2.0,1.0,2.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHgAQAAAADIiBmAQzAIPAAACIAiFSEACCAAAgAAAIiAGIBIiIYDKAlTGUIAholyIIiAcYiMCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5-ethyl-3-methyl-5-phenyl-imidazolidine-2,4-dione","5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione","5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione","5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione","5-ethyl-3-methyl-5-phenyl-imidazolidine-2,4-dione",5-ethyl-3-methyl-5-phenyl-hydantoin,"InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)",GMHKMTDVRCWUDX-UHFFFAOYSA-N,,218.105527694,C12H14N2O2,218.25,49.4,218.105527694,0.0,16.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC1(c2ccccc2)NC(=O)N(C)C1=O,1.5,"11  14  8
12  15  8
14  16  8
15  16  8
5  6  3
8  11  8
8  12  8",
440791161,19090,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00220,megestrol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00220,megestrol,1.0,Adverse reactions,Ambiguous DILI-concern,2.0,19090,1.0,717.0,3.0,1.0,1.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwQIAAAAAAAGCAAAAAGgAACAAAD0SAgAACAAAAAgCIAqBSAAIAAAAgAAAACAFAAEgIABIAAQAAQAAEgAAIgQOIyPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one","(8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1<I>H</I>-cyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-17-ethanoyl-6,10,13-trimethyl-17-oxidanyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one","InChI=1S/C22H30O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h11-12,16-18,25H,5-10H2,1-4H3/t16-,17+,18+,20-,21+,22+/m1/s1",VXIMPSPISRVBPZ-NWUMPJBXSA-N,,342.21949481,C22H30O3,342.5,54.4,342.21949481,0.0,25.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,2.6,"8  1  6
11  20  5
4  14  5
5  26  6
6  27  5
7  28  6",
440791160,10631,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01513,medroxyprogesterone,20210312,20210312,Curation Efforts|Governmental Organizations,LT01513,medroxyprogesterone,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,10631,1.0,664.0,3.0,1.0,1.0,AAADcfB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAAD0SAgAACAAAAAgCIAqBSAAIAAAAgAAAACAFAAEgAABIAAQAAQAAEgAAIAQOIyPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(6<I>S</I>,8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1<I>H</I>-cyclopenta[a]phenanthren-3-one","(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(6S,8R,9S,10R,13S,14S,17R)-17-ethanoyl-6,10,13-trimethyl-17-oxidanyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","InChI=1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1",FRQMUZJSZHZSGN-HBNHAYAOSA-N,3.5,344.23514488,C22H32O3,344.5,54.4,344.23514488,0.0,25.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,"9  1  6
15  23  6
4  26  6
5  17  5
6  27  5
7  28  6
8  19  5",
440791159,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01227,Mecasermin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01227,mecasermin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791158,16078,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00909,Marinol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00909,marinol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,16078,1.0,439.0,2.0,1.0,4.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAAAAAAA0QIAAAAAAAACRAAAAGgAACAAADUSAmAAyBoAABgCAAiBCAAACCAAgIAAAiAAGCIgMJyKGMRqCeCClwBUIuAeA4PwOwAABCAAIAACAAAIQABAAAAAAAAAAAA==,"(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol","(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c][1]benzopyran-1-ol","(6<I>a</I><I>R</I>,10<I>a</I><I>R</I>)-6,6,9-trimethyl-3-pentyl-6<I>a</I>,7,8,10<I>a</I>-tetrahydrobenzo[c]chromen-1-ol","(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol","(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol","(6aR,10aR)-3-amyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol","InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",CYQFCXCEBYINGO-IAGOWNOFSA-N,7.0,314.224580195,C21H30O2,314.5,29.5,314.224580195,0.0,23.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,,"11  15  8
14  18  8
15  17  8
17  18  8
3  24  6
4  25  5
7  11  8
7  14  8",
440791157,4011,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01503,maprotiline,20250421,20210312,Curation Efforts|Governmental Organizations,LT01503,maprotiline,5.0,Adverse reactions,Ambiguous DILI-concern,1.0,4011,1.0,339.0,1.0,1.0,4.0,AAADceB6AAAAAAAAAAAAAAAAAAAAAAAAAAAwYMGDAAAAAADBQAAAHAAQAAAADwDBGAQyAILAAACAAiBCAAACAAAgAAAIiIAIAIgIICKAkRCEIAAgkAAIiAcQgMAPgAAAAAAQAACAAAQAACAAAAAAAAAAAA==,"N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine","N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)-1-propanamine","<I>N</I>-methyl-3-(1-tetracyclo[6.6.2.0<SUP>2,7</SUP>.0<SUP>9,14</SUP>]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine","N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine","N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine","methyl-[3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propyl]amine","InChI=1S/C20H23N/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20/h2-5,7-10,15,21H,6,11-14H2,1H3",QSLMDECMDJKHMQ-UHFFFAOYSA-N,,277.183049738,C20H23N,277.4,12.0,277.183049738,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNCCCC12CCC(c3ccccc31)c1ccccc12,4.6,"10  15  8
12  17  8
13  18  8
14  19  8
15  20  8
17  19  8
18  20  8
6  12  8
6  9  8
7  10  8
7  13  8
9  14  8",
440791156,3964,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01501,loxapine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01501,loxapine,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,3964,1.0,450.0,3.0,0.0,1.0,AAADceB7IAAEAAAAAAAAAAAAAAAAAAAAAAA8YIAABAAAAAABQAAAHgIAAAAADA7BmCQzxoMABACgAiZiZACCCAEgJwAJiAAvbpgOZqKFu5uXOCjmwBGI6AeQwCAOACAAIAAIEAAAQABAABAgAAAAAAAAAA==,"8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine","8-chloro-6-(4-methyl-1-piperazinyl)benzo[b][1,4]benzoxazepine","8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine","8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine","8-chloranyl-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine","8-chloro-6-(4-methylpiperazino)benzo[b][1,4]benzoxazepine","InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3",XJGVXQDUIWGIRW-UHFFFAOYSA-N,,327.1138399,C18H18ClN3O,327.8,28.1,327.1138399,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,3.1,"12  13  8
12  15  8
13  17  8
14  16  8
14  20  8
15  18  8
16  21  8
17  19  8
18  19  8
20  22  8
21  23  8
22  23  8",
440791155,3948,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00574,lomefloxacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00574,lomefloxacin,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,3948,1.0,585.0,8.0,2.0,3.0,AAADceB7MYAAAAAAAAAAAAAAAAAAAAAAAAA8QIAAAAAAAACBAAAAHwAQCAAADCzBmAwyyIPAAgCIAqTWSACCAAAlAAAAiIEIRMgIZD7I1NGUYYhksADI2ceY2aOeCAAAAAQCAAAQAAAACAQAAAAAAAAAAA==,"1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid","1-ethyl-6,8-difluoro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid","1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid","1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid","1-ethyl-6,8-bis(fluoranyl)-7-(3-methylpiperazin-1-yl)-4-oxidanylidene-quinoline-3-carboxylic acid","1-ethyl-6,8-difluoro-4-keto-7-(3-methylpiperazino)quinoline-3-carboxylic acid","InChI=1S/C17H19F2N3O3/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25)",ZEKZLJVOYLTDKK-UHFFFAOYSA-N,-0.8,351.1394478,C17H19F2N3O3,351.35,72.9,351.1394478,0.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21,,"13  15  8
13  17  8
15  16  8
16  18  8
17  19  8
18  19  8
18  21  8
21  23  8
22  23  8
8  16  8
8  22  8
9  14  3",
440791154,11597698,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00571,Lisdexamfetamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00571,lisdexamfetamine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,11597698,1.0,252.0,3.0,3.0,8.0,AAADceBzIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQAAAADCjBmAQyAILAAACIAiFSEAACAAAgAAAIiIGIAIgIYDKAkRGUIAAglgCIiAcYiIAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenyl-ethyl]hexanamide","(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide","(2<I>S</I>)-2,6-diamino-<I>N</I>-[(2<I>S</I>)-1-phenylpropan-2-yl]hexanamide","(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide","(2S)-2,6-bis(azanyl)-N-[(2S)-1-phenylpropan-2-yl]hexanamide","(2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenyl-ethyl]hexanamide","InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1",VOBHXZCDAVEXEY-JSGCOSHPSA-N,,263.199762429,C15H25N3O,263.38,81.1,263.199762429,0.0,19.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN,1.2,"13  15  8
13  16  8
15  17  8
16  18  8
17  19  8
18  19  8
7  2  5
6  3  6",
440791153,5961,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00482,L-glutamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00482,l-glutamine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5961,1.0,146.0,4.0,3.0,4.0,AAADccBjMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAACCjBgAQACABAAgAIAAGQGAAAAAAAAAAAAIGAAAACABIAgAAAQAAEEAAAAACcFwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S)-2,5-diamino-5-oxo-pentanoic acid","(2S)-2,5-diamino-5-oxopentanoic acid","(2<I>S</I>)-2,5-diamino-5-oxopentanoic acid","(2S)-2,5-diamino-5-oxopentanoic acid","(2S)-2,5-bis(azanyl)-5-oxidanylidene-pentanoic acid","(2S)-2,5-diamino-5-keto-valeric acid","InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1",ZDXPYRJPNDTMRX-VKHMYHEASA-N,-3.1,146.06914219,C5H10N2O3,146.14,106.0,146.06914219,0.0,10.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)CC[C@H](N)C(=O)O,,7  4  6,
440791152,118856773,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01013,Lepirudin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01013,lepirudin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,118856773,1.0,18600.0,122.0,100.0,166.0,AAADcfB//gBwAAAAAAAAAAAAAAAAAWLFiwAwYMAAAAAAAAAB1AAAHgQQCAAADTzl3ga/npfJkgCoAzX3fAACgC2xMqAJ2YG+eIiKfj7C2TOUcAAu9hPY2Ce/36KOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[(1R,6R,9S,12S,15S,18S,24S,27S,33S,36S,39R,44R,47S,53S,56S,59S,67S,73S,76S)-15,76-bis(4-aminobutyl)-44-[[(2S)-2-[[(4R,7S,10S,13S,19S,22S,25S,28R)-28-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-4-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-carboxy-propanoyl]amino]-10-(2-amino-2-oxo-ethyl)-13-(3-amino-3-oxo-propyl)-22-(2-carboxyethyl)-25-[(1R)-1-hydroxyethyl]-19-(hydroxymethyl)-7-isobutyl-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carbonyl]amino]-4-methyl-pentanoyl]amino]-12,56,73-tris(2-amino-2-oxo-ethyl)-9,67-bis(3-amino-3-oxo-propyl)-18,47-bis(2-carboxyethyl)-24-(carboxymethyl)-27,53-bis(hydroxymethyl)-33-isobutyl-59-isopropyl-36-[(1S)-1-methylpropyl]-8,11,14,17,20,23,26,29,32,35,38,45,48,51,54,57,60,62,65,68,71,74,77-tricosaoxo-3,4,41,42-tetrathia-7,10,13,16,19,22,25,28,31,34,37,46,49,52,55,58,61,63,66,69,72,75,78-tricosazabicyclo[37.22.17]octaheptacontane-6-carbonyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-butanoyl]amino]acetyl]amino]-4-carboxy-butanoyl]amino]acetyl]amino]-3-hydroxy-butanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxo-pentanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxo-butanoyl]amino]-3-carboxy-propanoyl]amino]acetyl]amino]-3-carboxy-propanoyl]amino]-3-phenyl-propanoyl]amino]-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]amino]-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-5-oxo-pentanoic acid","(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[[(2S)-1-[(2S)-6-amino-2-[[[(2S)-1-[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[[(1R,6R,9S,12S,15S,18S,24S,27S,33S,36S,39R,44R,47S,53S,56S,59S,67S,73S,76S)-15,76-bis(4-aminobutyl)-44-[[(2S)-2-[[[(4R,7S,10S,13S,19S,22S,25S,28R)-28-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-4-methyl-1-oxopentyl]amino]-3-hydroxy-1-oxobutyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-3-hydroxy-1-oxobutyl]amino]-3-carboxy-1-oxopropyl]amino]-10-(2-amino-2-oxoethyl)-13-(3-amino-3-oxopropyl)-22-(2-carboxyethyl)-25-[(1R)-1-hydroxyethyl]-19-(hydroxymethyl)-7-(2-methylpropyl)-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacos-4-yl]-oxomethyl]amino]-4-methyl-1-oxopentyl]amino]-12,56,73-tris(2-amino-2-oxoethyl)-9,67-bis(3-amino-3-oxopropyl)-36-[(2S)-butan-2-yl]-18,47-bis(2-carboxyethyl)-24-(carboxymethyl)-27,53-bis(hydroxymethyl)-33-(2-methylpropyl)-8,11,14,17,20,23,26,29,32,35,38,45,48,51,54,57,60,62,65,68,71,74,77-tricosaoxo-59-propan-2-yl-3,4,41,42-tetrathia-7,10,13,16,19,22,25,28,31,34,37,46,49,52,55,58,61,63,66,69,72,75,78-tricosazabicyclo[37.22.17]octaheptacontan-6-yl]-oxomethyl]amino]-3-methyl-1-oxobutyl]amino]-3-hydroxy-1-oxobutyl]amino]-1-oxoethyl]amino]-4-carboxy-1-oxobutyl]amino]-1-oxoethyl]amino]-3-hydroxy-1-oxobutyl]-2-pyrrolidinyl]-oxomethyl]amino]-1-oxohexyl]-2-pyrrolidinyl]-oxomethyl]amino]-1,5-dioxopentyl]amino]-3-hydroxy-1-oxopropyl]amino]-3-(1H-imidazol-4-yl)-1-oxopropyl]amino]-1,4-dioxobutyl]amino]-3-carboxy-1-oxopropyl]amino]-1-oxoethyl]amino]-3-carboxy-1-oxopropyl]amino]-1-oxo-3-phenylpropyl]amino]-4-carboxy-1-oxobutyl]amino]-4-carboxy-1-oxobutyl]amino]-3-methyl-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-4-carboxy-1-oxobutyl]amino]-4-carboxy-1-oxobutyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-4-methyl-1-oxopentyl]amino]-5-oxopentanoic acid","(2<I>S</I>)-5-amino-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-4-amino-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-5-amino-2-[[(2<I>S</I>)-1-[(2<I>S</I>)-6-amino-2-[[(2<I>S</I>)-1-[(2<I>S</I>,3<I>R</I>)-2-[[2-[[(2<I>S</I>)-2-[[2-[[(2<I>S</I>,3<I>R</I>)-2-[[(2<I>S</I>)-2-[[(1<I>R</I>,6<I>R</I>,9<I>S</I>,12<I>S</I>,15<I>S</I>,18<I>S</I>,24<I>S</I>,27<I>S</I>,33<I>S</I>,36<I>S</I>,39<I>R</I>,44<I>R</I>,47<I>S</I>,53<I>S</I>,56<I>S</I>,59<I>S</I>,67<I>S</I>,73<I>S</I>,76<I>S</I>)-15,76-bis(4-aminobutyl)-44-[[(2<I>S</I>)-2-[[(4<I>R</I>,7<I>S</I>,10<I>S</I>,13<I>S</I>,19<I>S</I>,22<I>S</I>,25<I>S</I>,28<I>R</I>)-28-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>R</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>R</I>)-2-[[(2<I>S</I>)-2-amino-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-carboxypropanoyl]amino]-10-(2-amino-2-oxoethyl)-13-(3-amino-3-oxopropyl)-22-(2-carboxyethyl)-25-[(1<I>R</I>)-1-hydroxyethyl]-19-(hydroxymethyl)-7-(2-methylpropyl)-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carbonyl]amino]-4-methylpentanoyl]amino]-12,56,73-tris(2-amino-2-oxoethyl)-9,67-bis(3-amino-3-oxopropyl)-36-[(2<I>S</I>)-butan-2-yl]-18,47-bis(2-carboxyethyl)-24-(carboxymethyl)-27,53-bis(hydroxymethyl)-33-(2-methylpropyl)-8,11,14,17,20,23,26,29,32,35,38,45,48,51,54,57,60,62,65,68,71,74,77-tricosaoxo-59-propan-2-yl-3,4,41,42-tetrathia-7,10,13,16,19,22,25,28,31,34,37,46,49,52,55,58,61,63,66,69,72,75,78-tricosazabicyclo[37.22.17]octaheptacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1<I>H</I>-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoic acid","(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[(1R,6R,9S,12S,15S,18S,24S,27S,33S,36S,39R,44R,47S,53S,56S,59S,67S,73S,76S)-15,76-bis(4-aminobutyl)-44-[[(2S)-2-[[(4R,7S,10S,13S,19S,22S,25S,28R)-28-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-carboxypropanoyl]amino]-10-(2-amino-2-oxoethyl)-13-(3-amino-3-oxopropyl)-22-(2-carboxyethyl)-25-[(1R)-1-hydroxyethyl]-19-(hydroxymethyl)-7-(2-methylpropyl)-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carbonyl]amino]-4-methylpentanoyl]amino]-12,56,73-tris(2-amino-2-oxoethyl)-9,67-bis(3-amino-3-oxopropyl)-36-[(2S)-butan-2-yl]-18,47-bis(2-carboxyethyl)-24-(carboxymethyl)-27,53-bis(hydroxymethyl)-33-(2-methylpropyl)-8,11,14,17,20,23,26,29,32,35,38,45,48,51,54,57,60,62,65,68,71,74,77-tricosaoxo-59-propan-2-yl-3,4,41,42-tetrathia-7,10,13,16,19,22,25,28,31,34,37,46,49,52,55,58,61,63,66,69,72,75,78-tricosazabicyclo[37.22.17]octaheptacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoic acid","(2S)-5-azanyl-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[2-[[(2S)-2-[[(2S)-4-azanyl-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-azanyl-2-[[(2S)-1-[(2S)-6-azanyl-2-[[(2S)-1-[(2S,3R)-2-[2-[[(2S)-2-[2-[[(2S,3R)-2-[[(2S)-2-[[(1R,6R,9S,12S,15S,18S,24S,27S,33S,36S,39R,44R,47S,53S,56S,59S,67S,73S,76S)-15,76-bis(4-azanylbutyl)-44-[[(2S)-2-[[(4R,7S,10S,13S,19S,22S,25S,28R)-28-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-azanyl-4-methyl-pentanoyl]amino]-3-oxidanyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-oxidanyl-butanoyl]amino]-4-oxidanyl-4-oxidanylidene-butanoyl]amino]-10-(2-azanyl-2-oxidanylidene-ethyl)-13-(3-azanyl-3-oxidanylidene-propyl)-19-(hydroxymethyl)-22-(3-hydroxy-3-oxopropyl)-7-(2-methylpropyl)-25-[(1R)-1-oxidanylethyl]-6,9,12,15,18,21,24,27-octakis(oxidanylidene)-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacos-4-yl]carbonylamino]-4-methyl-pentanoyl]amino]-12,56,73-tris(2-azanyl-2-oxidanylidene-ethyl)-9,67-bis(3-azanyl-3-oxidanylidene-propyl)-36-[(2S)-butan-2-yl]-27,53-bis(hydroxymethyl)-24-(2-hydroxy-2-oxoethyl)-18,47-bis(3-hydroxy-3-oxopropyl)-33-(2-methylpropyl)-8,11,14,17,20,23,26,29,32,35,38,45,48,51,54,57,60,62,65,68,71,74,77-tricosakis(oxidanylidene)-59-propan-2-yl-3,4,41,42-tetrathia-7,10,13,16,19,22,25,28,31,34,37,46,49,52,55,58,61,63,66,69,72,75,78-tricosazabicyclo[37.22.17]octaheptacontan-6-yl]carbonylamino]-3-methyl-butanoyl]amino]-3-oxidanyl-butanoyl]amino]ethanoylamino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]ethanoylamino]-3-oxidanyl-butanoyl]pyrrolidin-2-yl]carbonylamino]hexanoyl]pyrrolidin-2-yl]carbonylamino]-5-oxidanylidene-pentanoyl]amino]-3-oxidanyl-propanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxidanylidene-butanoyl]amino]-4-oxidanyl-4-oxidanylidene-butanoyl]amino]ethanoylamino]-4-oxidanyl-4-oxidanylidene-butanoyl]amino]-3-phenyl-propanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-methyl-pentanoyl]pyrrolidin-2-yl]carbonylamino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-5-oxidanylidene-pentanoic acid","(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[(1R,6R,9S,12S,15S,18S,24S,27S,33S,36S,39R,44R,47S,53S,56S,59S,67S,73S,76S)-15,76-bis(4-aminobutyl)-12,56,73-tris(2-amino-2-keto-ethyl)-44-[[(2S)-2-[[(4R,7S,10S,13S,19S,22S,25S,28R)-10-(2-amino-2-keto-ethyl)-13-(3-amino-3-keto-propyl)-28-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-4-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-carboxy-propanoyl]amino]-22-(2-carboxyethyl)-25-[(1R)-1-hydroxyethyl]-7-isobutyl-6,9,12,15,18,21,24,27-octaketo-19-methylol-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carbonyl]amino]-4-methyl-pentanoyl]amino]-9,67-bis(3-amino-3-keto-propyl)-18,47-bis(2-carboxyethyl)-24-(carboxymethyl)-33-isobutyl-59-isopropyl-8,11,14,17,20,23,26,29,32,35,38,45,48,51,54,57,60,62,65,68,71,74,77-tricosaketo-27,53-dimethylol-36-[(1S)-1-methylpropyl]-3,4,41,42-tetrathia-7,10,13,16,19,22,25,28,31,34,37,46,49,52,55,58,61,63,66,69,72,75,78-tricosazabicyclo[37.22.17]octaheptacontane-6-carbonyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-butanoyl]amino]acetyl]amino]-4-carboxy-butanoyl]amino]acetyl]amino]-3-hydroxy-butanoyl]prolyl]amino]hexanoyl]prolyl]amino]-5-keto-pentanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-keto-butanoyl]amino]-3-carboxy-propanoyl]amino]acetyl]amino]-3-carboxy-propanoyl]amino]-3-phenyl-propanoyl]amino]-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-methyl-pentanoyl]prolyl]amino]-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-5-keto-valeric acid","InChI=1S/C287H440N80O111S6/c1-24-132(17)225-280(470)345-162(87-126(5)6)236(426)306-111-209(396)320-181(116-370)267(457)344-176(101-220(416)417)238(428)307-105-203(390)316-152(61-74-213(402)403)243(433)321-146(40-29-32-80-288)241(431)339-171(96-198(298)385)259(449)326-153(56-69-194(294)381)250(440)351-186(121-482-479-118-183-240(430)310-107-202(389)313-148(54-67-192(292)379)233(423)303-108-206(393)317-170(95-197(297)384)258(448)322-147(41-30-33-81-289)242(432)350-187(272(462)359-225)122-483-480-119-184(269(459)323-150(60-73-212(400)401)235(425)304-110-208(395)319-180(115-369)266(456)342-174(99-201(301)388)265(455)357-223(130(13)14)278(468)355-183)352-254(444)165(90-129(11)12)335-270(460)185-120-481-484-123-188(354-263(453)178(103-222(420)421)347-283(473)230(137(22)375)362-264(454)168(93-141-48-52-144(378)53-49-141)346-282(472)228(135(20)373)361-232(422)145(291)86-125(3)4)273(463)363-229(136(21)374)281(471)330-158(65-78-217(410)411)249(439)348-179(114-368)239(429)309-106-204(391)315-151(55-68-193(293)380)244(434)340-172(97-199(299)386)260(450)334-164(89-128(9)10)253(443)353-185)271(461)358-224(131(15)16)279(469)364-227(134(19)372)277(467)311-112-205(392)314-149(59-72-211(398)399)234(424)305-113-210(397)356-231(138(23)376)286(476)367-85-37-45-191(367)276(466)331-160(42-31-34-82-290)284(474)365-83-35-43-189(365)274(464)328-154(57-70-195(295)382)248(438)349-182(117-371)268(458)338-169(94-142-104-302-124-312-142)257(447)341-173(98-200(300)387)261(451)343-175(100-219(414)415)237(427)308-109-207(394)318-177(102-221(418)419)262(452)337-166(91-139-38-27-26-28-39-139)255(445)327-155(62-75-214(404)405)245(435)325-159(66-79-218(412)413)251(441)360-226(133(18)25-2)285(475)366-84-36-44-190(366)275(465)329-157(64-77-216(408)409)246(436)324-156(63-76-215(406)407)247(437)336-167(92-140-46-50-143(377)51-47-140)256(446)333-163(88-127(7)8)252(442)332-161(287(477)478)58-71-196(296)383/h26-28,38-39,46-53,104,124-138,145-191,223-231,368-378H,24-25,29-37,40-45,54-103,105-123,288-291H2,1-23H3,(H2,292,379)(H2,293,380)(H2,294,381)(H2,295,382)(H2,296,383)(H2,297,384)(H2,298,385)(H2,299,386)(H2,300,387)(H2,301,388)(H,302,312)(H,303,423)(H,304,425)(H,305,424)(H,306,426)(H,307,428)(H,308,427)(H,309,429)(H,310,430)(H,311,467)(H,313,389)(H,314,392)(H,315,391)(H,316,390)(H,317,393)(H,318,394)(H,319,395)(H,320,396)(H,321,433)(H,322,448)(H,323,459)(H,324,436)(H,325,435)(H,326,449)(H,327,445)(H,328,464)(H,329,465)(H,330,471)(H,331,466)(H,332,442)(H,333,446)(H,334,450)(H,335,460)(H,336,437)(H,337,452)(H,338,458)(H,339,431)(H,340,434)(H,341,447)(H,342,456)(H,343,451)(H,344,457)(H,345,470)(H,346,472)(H,347,473)(H,348,439)(H,349,438)(H,350,432)(H,351,440)(H,352,444)(H,353,443)(H,354,453)(H,355,468)(H,356,397)(H,357,455)(H,358,461)(H,359,462)(H,360,441)(H,361,422)(H,362,454)(H,363,463)(H,364,469)(H,398,399)(H,400,401)(H,402,403)(H,404,405)(H,406,407)(H,408,409)(H,410,411)(H,412,413)(H,414,415)(H,416,417)(H,418,419)(H,420,421)(H,477,478)/t132-,133-,134+,135+,136+,137+,138+,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,223-,224-,225-,226-,227-,228-,229-,230-,231-/m0/s1",FIBJDTSHOUXTKV-BRHMIFOHSA-N,,6977.9669487,C287H440N80O111S6,6979.0,3260.0,6974.9568842,0.0,484.0,63.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N3)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC1=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2,-41.3,"459  104  5
215  11  6
470  112  6
206  120  6
216  121  5
212  123  5
221  124  5
233  125  6
236  126  6
239  129  6
246  130  5
252  132  6
250  133  5
253  134  5
263  135  6
271  136  5
137  265  8
137  283  8
280  138  5
270  139  6
140  276  8
140  283  8
292  142  6
304  143  6
291  144  6
294  146  5
316  148  6
411  178  5
415  180  6
440  186  5
445  190  5
453  193  5
461  195  6
467  196  5
471  197  6
198  210  5
199  208  5
214  226  6
224  232  6
265  276  8
278  287  8
278  288  8
284  295  8
284  296  8
287  299  8
288  300  8
295  307  8
296  308  8
299  302  8
300  302  8
307  309  8
308  309  8
325  324  6
328  329  5
333  336  5
334  683  5
339  343  5
342  344  6
352  356  5
354  357  6
358  360  6
366  369  6
374  384  5
375  746  6
377  386  5
378  380  5
385  396  6
387  768  6
389  394  6
401  410  5
404  408  6
420  424  5
423  425  6
432  434  6
435  437  6
305  44  6
443  859  5
451  454  6
456  464  6
474  480  8
474  481  8
480  482  8
481  483  8
482  484  8
483  484  8
447  99  6",
440791151,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02907,Laronidase,20210312,20210312,Curation Efforts|Governmental Organizations,LT02907,laronidase,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791150,71349,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00617,Lanreotide acetate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00617,lanreotide acetate,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,71349,1.0,2000.0,14.0,13.0,17.0,AAADcfB//ABgAAAAAAAAAAAAAAAAAWAAAAAwYMGAAAAAAFjB9AAAHgQQCAAADTzl3ga+xvLJkgCoAzV3VACCgCAxIiAI2aG+bJgKdvbCkbOUcAhm9hHY2AeYyeCO4AACAAASAADAAAQAACQAAAAAAAAAAA==,"10-(4-aminobutyl)-19-[[2-amino-3-(2-naphthyl)propanoyl]amino]-N-(1-carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide","10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[[2-amino-3-(2-naphthalenyl)-1-oxopropyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloeicosane-4-carboxamide","10-(4-aminobutyl)-<I>N</I>-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1<I>H</I>-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide","10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide","10-(4-azanylbutyl)-19-[(2-azanyl-3-naphthalen-2-yl-propanoyl)amino]-N-(1-azanyl-3-oxidanyl-1-oxidanylidene-butan-2-yl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentakis(oxidanylidene)-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide","10-(4-aminobutyl)-19-[[2-amino-3-(2-naphthyl)propanoyl]amino]-N-(1-carbamoyl-2-hydroxy-propyl)-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaketo-1,2-dithia-5,8,11,14,17-pentazacycloeicosane-4-carboxamide","InChI=1S/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74)",PUDHBTGHUJUUFI-UHFFFAOYSA-N,,1095.46702979,C54H69N11O10S2,1096.3,406.0,1095.46702979,0.0,77.0,0.0,9.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)C1NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(NC(=O)C(N)Cc2ccc3ccccc3c2)CSSCC(C(=O)NC(C(N)=O)C(C)O)NC1=O,2.5,"18  43  8
18  45  8
46  20  3
57  22  3
24  26  3
25  27  3
28  30  3
33  39  8
33  43  8
36  42  3
39  45  8
39  48  8
41  50  3
45  52  8
48  55  8
51  59  8
51  60  8
52  56  8
54  63  3
55  56  8
59  65  8
60  66  8
64  69  8
64  70  8
65  68  8
66  68  8
69  71  8
70  73  8
71  72  8
71  74  8
72  73  8
72  75  8
74  76  8
75  77  8
76  77  8
58  9  3",
440791149,6445540,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02203,Ixabepilone,20231222,20210312,Curation Efforts|Governmental Organizations,LT02203,ixabepilone,7.0,Adverse reactions,Ambiguous DILI-concern,2.0,6445540,1.0,817.0,7.0,3.0,2.0,AAADcfB7OABAAAAAAAAAAAAAEgAAAWAAAAAAAAAAAAAAAAABgAAAHgQQCAAAD3zl1gaigRLIFgisA6VyVACC8KBhCjgAiJUYIBgIEBaggQAGQAAGtgCogAe46/SvAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione","(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-4-thiazolyl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione","(1<I>S</I>,3<I>S</I>,7<I>S</I>,10<I>R</I>,11<I>S</I>,12<I>S</I>,16<I>R</I>)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(<I>E</I>)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione","(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione","(1S,3S,7S,10R,11S,12S,16R)-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-7,11-bis(oxidanyl)-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione","(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-quinone","InChI=1S/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1",FABUFPQFXZVHFB-PVYNADRNSA-N,,506.28144362,C27H42N2O5S,506.7,140.0,506.28144362,0.0,35.0,7.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1,3.6,"1  33  8
1  34  8
10  36  6
15  20  5
17  22  5
19  27  5
18  3  5
32  33  8
24  4  5
8  32  8
8  34  8
9  13  6",
440791148,27661,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00340,isorbide mononitrate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00340,isorbide mononitrate,3.0,Adverse reactions,Ambiguous DILI-concern,1.0,27661,1.0,216.0,6.0,1.0,1.0,AAADccBiOAAAAAAAAAAAAAAAAAAAASJAAAAAAAAAAAASAAAAAAAAGgAECAAACBSggAIAAAAARgABAAAAAQAAAAAAAAAAAAAAAAABEAIAAAACQAAFAAADAAHAYAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(3S,3aR,6R,6aS)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate","nitric acid [(3S,3aR,6R,6aS)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] ester","[(3<I>S</I>,3<I>a</I><I>R</I>,6<I>R</I>,6<I>a</I><I>S</I>)-3-hydroxy-2,3,3<I>a</I>,5,6,6<I>a</I>-hexahydrofuro[3,2-b]furan-6-yl] nitrate","[(3S,3aR,6R,6aS)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate","[(3S,3aR,6R,6aS)-3-oxidanyl-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate","nitric acid [(3S,3aR,6R,6aS)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] ester","InChI=1S/C6H9NO6/c8-3-1-11-6-4(13-7(9)10)2-12-5(3)6/h3-6,8H,1-2H2/t3-,4+,5+,6+/m0/s1",YWXYYJSYQOXTPL-SLPGGIOYSA-N,-0.4,191.04298701,C6H9NO6,191.14,93.7,191.04298701,0.0,13.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=[N+]([O-])O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O,,"10  3  5
11  4  6
8  14  6
9  15  6",
440791147,3702,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01444,indapamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01444,indapamide,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,3702,1.0,580.0,5.0,2.0,3.0,AAADceB7MABEAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgBQAAAHgYYQAAADCrB2CQywYJiAAKIAiVSUHDCBBAlBwAaqBkIZsgIIDLBl5GEIQhggADIyYcYiICOBAAAgAACAIAIAAEAAAQBAAAAAAAAAA==,4-chloro-N-(2-methylindolin-1-yl)-3-sulfamoyl-benzamide,"4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide","4-chloro-<I>N</I>-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide","4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide","4-chloranyl-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoyl-benzamide",4-chloro-N-(2-methylindolin-1-yl)-3-sulfamoyl-benzamide,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",NDDAHWYSQHTHNT-UHFFFAOYSA-N,,365.0600902,C16H16ClN3O3S,365.8,101.0,365.0600902,0.0,24.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,2.9,"11  12  8
11  14  8
12  15  8
14  16  8
15  17  8
16  17  8
19  20  8
19  22  8
20  21  8
21  23  8
22  24  8
23  24  8
9  13  3",
440791146,71360,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00654,Iloperidone,20210804,20210312,Curation Efforts|Governmental Organizations,LT00654,iloperidone,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,71360,1.0,586.0,7.0,0.0,8.0,AAADceB7OQAAAAAAAAAAAAAAAAAAAWAAAAA8YIAAAAAAAFgB9AAAHwAEAAAADQzhng4yhtMQBACpA6RyQgCCCAAkIAAomCE+zNoNJrqEtZuGOaLmwBmK6ceazPDOIAABAAAIQABAAAIAABCAAAAAAAAAAA==,"1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]propoxy]-3-methoxy-phenyl]ethanone","1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]ethanone","1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanone","1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanone","1-[4-[3-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxy-phenyl]ethanone",1-[4-[3-[4-(6-fluoroindoxazen-3-yl)piperidino]propoxy]-3-methoxy-phenyl]ethanone,"InChI=1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3",XMXHEBAFVSFQEX-UHFFFAOYSA-N,,426.19548551,C24H27FN2O4,426.5,64.8,426.19548551,0.0,31.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,4.1,"14  16  8
16  17  8
16  19  8
17  20  8
19  21  8
2  17  8
2  7  8
20  22  8
21  22  8
23  24  8
23  25  8
24  26  8
25  27  8
26  28  8
27  28  8
7  14  8",
440791145,70689311,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01258,HYDROXOCOBALAMIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT01258,hydroxocobalamin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,70689311,1.0,3150.0,20.0,10.0,26.0,AAADcfB//AIAAAAQAAAAAAAAAAAAAWLEiBAwAAAAAAAAAFgB8AAAHgAQCCAAD7zhngY30LfMFxCoQyVzdICCgC0xEqAB2KE4dJiLeLLAmZGeYAhvlgLbyCf8ucKfiAAAQAAQACAQAACAACAAQAAAAAAAAA==,"cobaltous;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate","cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethyl-1-benzimidazolyl)-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl] [(2R)-1-[[1-oxo-3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propyl]amino]propan-2-yl] phosphate;hydrate","cobalt(2+);[(2<I>R</I>,3<I>S</I>,4<I>R</I>,5<I>S</I>)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2<I>R</I>)-1-[3-[(1<I>R</I>,2<I>R</I>,3<I>R</I>,4<I>Z</I>,7<I>S</I>,9<I>Z</I>,12<I>S</I>,13<I>S</I>,14<I>Z</I>,17<I>S</I>,18<I>S</I>,19<I>R</I>)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1<I>H</I>-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate","cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate","cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-2-(hydroxymethyl)-4-oxidanyl-oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-azanyl-2-oxidanylidene-ethyl)-7,12,17-tris(3-azanyl-3-oxidanylidene-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate","cobaltous;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-methylol-tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-keto-ethyl)-7,12,17-tris(3-amino-3-keto-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]ethyl] phosphate;hydrate","InChI=1S/C62H90N13O14P.Co.H2O/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;1H2/q;+2;/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1",DQOCFCZRZOAIBN-WZHZPDAFSA-L,,1346.57489,C62H90CoN13O15P,1347.4,453.0,1346.57489,0.0,92.0,14.0,0.0,3.0,0.0,0.0,3.0,-1.0,"1
5
255",C/C1=C2/[N-][C@H]([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@H]2[C@@H](O)[C@@H](n3cnc4cc(C)c(C)cc43)O[C@@H]2CO)[C@]2(C)N=C(/C(C)=C3\N=C(/C=C4\N=C1[C@@H](CCC(N)=O)C4(C)C)[C@@H](CCC(N)=O)[C@]3(C)CC(N)=O)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O.O.[Co+2],,"77  10  5
79  12  6
80  16  6
82  29  6
29  84  8
29  85  8
30  85  8
30  86  8
31  39  6
32  93  5
33  41  6
34  42  5
35  45  5
36  44  6
54  65  6
55  63  6
58  68  6
81  83  5
84  86  8
84  87  8
86  88  8
87  89  8
88  90  8
89  90  8","1  18  6
1  3  6"
440791144,5284570,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00919,hydromorphone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00919,hydromorphone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5284570,1.0,494.0,4.0,1.0,0.0,AAADceB6MAAAAAAAAAAAAAAAAAAAASAAAAA8YMEAAAAWAEjxAAAAHgAACAAADzzhmAYyBoMABgCIAqBSAAICCAAgIAAIiAFOiIgNJjKGsR+GeCOkwBGLuAe4/fffoAABAAAYQADQAAaAADSAAAAAAAAAAA==,"(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4<I>R</I>,4<I>a</I><I>R</I>,7<I>a</I><I>R</I>,12<I>b</I><I>S</I>)-9-hydroxy-3-methyl-1,2,4,4<I>a</I>,5,6,7<I>a</I>,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aR,7aR,12bS)-3-methyl-9-oxidanyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1",WVLOADHCBXTIJK-YNHQPCIGSA-N,,285.13649347,C17H19NO3,285.34,49.8,285.13649347,0.0,21.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5,1.8,"10  14  8
10  17  8
14  19  8
17  20  8
19  21  8
20  21  8
5  9  5
6  22  5
7  23  6
8  24  5",
440791143,3647,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00814,hydroflumethiazide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00814,hydroflumethiazide,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,3647,1.0,578.0,10.0,3.0,1.0,AAADccBzOYBgAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAACxAAAAHQQQQAAADAiBWBQxwYLAAAKAAiRCQHDCABAhAgAAiJwIZIiIICLAkJGEIAhgkAJIyCcQgAAOEAQAQEAEAQAgCACAgAgCAAAAAAAAAA==,"1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2<I>H</I>-1&lambda;<SUP>6</SUP>,2,4-benzothiadiazine-7-sulfonamide","1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","1,1-bis(oxidanylidene)-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","1,1-diketo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","InChI=1S/C8H8F3N3O4S2/c9-8(10,11)4-1-5-7(2-6(4)19(12,15)16)20(17,18)14-3-13-5/h1-2,13-14H,3H2,(H2,12,15,16)",DMDGGSIALPNSEE-UHFFFAOYSA-N,0.4,330.99083258,C8H8F3N3O4S2,331.3,135.0,330.99083258,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,,"13  14  8
13  17  8
14  19  8
15  16  8
15  17  8
16  19  8",
440791142,25084151,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00426,Histrelin acetate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00426,histrelin acetate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,25084151,1.0,2690.0,17.0,16.0,34.0,AAADcfB//AAAAAAAAAAAAAAAAAAAAWLFixYwYMAAAAAAAFgB/gAAHgAQCAAADSzhngY/3vfNkgCoAzX3fACCgC2xMqAJ2aG+fJiKfvbC2bOUcAhu9hPY2Cecy+COoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[(1-benzylimidazol-4-yl)methyl]-2-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide,acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)-1-pyrrolidinyl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-[1-(phenylmethyl)-4-imidazolyl]propan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxo-2-pyrrolidinecarboxamide,acetic acid;(2<I>S</I>)-<I>N</I>-[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>R</I>)-3-(1-benzylimidazol-4-yl)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-5-(diaminomethylideneamino)-1-[(2<I>S</I>)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-3-(1-benzylimidazol-4-yl)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-[bis(azanyl)methylideneamino]-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-1-oxidanylidene-3-[1-(phenylmethyl)imidazol-4-yl]propan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxidanylidene-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl]-5-oxidanylidene-pyrrolidine-2-carboxamide;ethanoic acid,acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[(1-benzylimidazol-4-yl)methyl]-2-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-2-keto-ethyl]amino]-1-(4-hydroxybenzyl)-2-keto-ethyl]amino]-2-keto-1-methylol-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-keto-ethyl]-5-keto-pyrrolidine-2-carboxamide,"InChI=1S/C66H86N18O12.C2H4O2/c1-4-70-64(95)55-17-11-25-84(55)65(96)48(16-10-24-71-66(67)68)76-58(89)49(26-38(2)3)77-62(93)53(30-43-34-83(37-74-43)33-40-12-6-5-7-13-40)81-59(90)50(27-39-18-20-44(86)21-19-39)78-63(94)54(35-85)82-60(91)51(28-41-31-72-46-15-9-8-14-45(41)46)79-61(92)52(29-42-32-69-36-73-42)80-57(88)47-22-23-56(87)75-47;1-2(3)4/h5-9,12-15,18-21,31-32,34,36-38,47-55,72,85-86H,4,10-11,16-17,22-30,33,35H2,1-3H3,(H,69,73)(H,70,95)(H,75,87)(H,76,89)(H,77,93)(H,78,94)(H,79,92)(H,80,88)(H,81,90)(H,82,91)(H4,67,68,71);1H3,(H,3,4)/t47-,48-,49-,50-,51-,52-,53+,54-,55-;/m0./s1",OWAUGAMNPZHEOJ-YKZVIGSYSA-N,,1382.68838962,C68H90N18O14,1383.6,487.0,1382.68838962,0.0,100.0,9.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1cn(Cc2ccccc2)cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,,"38  16  6
42  18  5
52  20  6
56  21  5
23  64  8
23  75  8
62  24  5
25  55  8
25  75  8
61  26  6
67  29  6
30  80  8
30  81  8
31  79  8
31  95  8
32  87  8
32  95  8
33  39  6
55  64  8
58  66  6
72  77  8
72  80  8
74  82  8
74  83  8
77  81  8
77  85  8
79  87  8
81  86  8
82  88  8
83  89  8
84  93  8
84  94  8
85  90  8
86  91  8
88  92  8
89  92  8
90  91  8
93  96  8
94  97  8
96  98  8
97  98  8",
440791141,52919,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02427,HALOPERIDOL DECANOATE,20210804,20210312,Curation Efforts|Governmental Organizations,LT02427,haloperidol decanoate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,52919,1.0,665.0,5.0,0.0,16.0,AAADcfB6MQAEAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABQAAAHwIAAAAADEbBmCwyCIMABACIAqDSCAACAAAkBQAIiAEICsgIJjKBtxiGMQAmwAGIqYecyOCOhAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxo-butyl]-4-piperidyl] decanoate,decanoic acid [4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl] ester,[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate,[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate,[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]piperidin-4-yl] decanoate,capric acid [4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-keto-butyl]-4-piperidyl] ester,"InChI=1S/C31H41ClFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3",GUTXTARXLVFHDK-UHFFFAOYSA-N,7.9,529.2759,C31H41ClFNO3,530.1,46.6,529.2759,0.0,37.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,,"12  15  8
12  16  8
15  21  8
16  22  8
21  24  8
22  24  8
30  32  8
30  33  8
32  35  8
33  36  8
35  37  8
36  37  8",
440791140,3520,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00708,guanidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00708,guanidine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,3520,1.0,26.3,1.0,3.0,0.0,AAADcYADAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABAAQAAAAAAAAAAABAABAAAAgAAAAIAAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,guanidine,guanidine,guanidine,guanidine,guanidine,guanidine,"InChI=1S/CH5N3/c2-1(3)4/h(H5,2,3,4)",ZRALSGWEFCBTJO-UHFFFAOYSA-N,,59.048347172,CH5N3,59.07,75.9,59.048347172,0.0,4.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]N=C(N)N,-1.3,,
440791139,3519,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01422,GUANFACINE,20210804,20210312,Curation Efforts|Governmental Organizations,LT01422,guanfacine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,3519,1.0,256.0,1.0,2.0,2.0,AAADccBzIAAGAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgIQAAAADAKBmCAxAIJAAACoAiFSNAACAAEgBQAIiAEAAogIIDKBlxGAIAAggAAIiAcYiICOAAAAAACBAAAAAAAAAQIAAAAAAAAAAA==,"N-(diaminomethylene)-2-(2,6-dichlorophenyl)acetamide","N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide","<I>N</I>-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide","N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide","N-[bis(azanyl)methylidene]-2-[2,6-bis(chloranyl)phenyl]ethanamide","N-(diaminomethylene)-2-(2,6-dichlorophenyl)acetamide","InChI=1S/C9H9Cl2N3O/c10-6-2-1-3-7(11)5(6)4-8(15)14-9(12)13/h1-3H,4H2,(H4,12,13,14,15)",INJOMKTZOLKMBF-UHFFFAOYSA-N,,245.0122673,C9H9Cl2N3O,246.09,81.5,245.0122673,0.0,15.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(N)=NC(=O)Cc1c(Cl)cccc1Cl,2.0,"10  12  8
11  14  8
12  14  8
7  10  8
7  9  8
9  11  8",
440791138,3510,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00557,granisetron,20231222,20210312,Curation Efforts|Governmental Organizations,LT00557,granisetron,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,3510,1.0,442.0,3.0,1.0,2.0,AAADceB7oAAAAAAAAAAAAAAAAAAAAWAAAAA8WIAAAAAYAFgB8AAAHgAYAAAADCjBngQywPPIAACqAyVyVACSBAAnggAY2KG4ZNgIYLLA1dGUpQhgngDIyQcciICOAAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide,1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-3-indazolecarboxamide,1-methyl-<I>N</I>-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide,1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide,1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide,1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide,"InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)",MFWNKCLOYSRHCJ-UHFFFAOYSA-N,,312.1950114,C18H24N4O,312.4,50.2,312.1950114,0.0,23.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2,2.8,"16  17  8
17  18  8
17  19  8
18  20  8
19  22  8
20  23  8
22  23  8
4  16  8
4  5  8
5  18  8
6  11  3
7  12  3",
440791137,5311128,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00939,goserelin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00939,goserelin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5311128,1.0,2560.0,16.0,17.0,32.0,AAADcfB//AAAAAAAAAAAAAAAAAAAAWLFiwAwYAAAAAAAAFgB/AAAHgAYCAAADWzhngY/1vfrlgCoAzV3dACCgC2xMqIf+aG+fJiKfvbC2bOXcAh+9hPY2Cecy+COoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-(tert-butoxymethyl)-2-[[(1S)-1-[[(1S)-4-guanidino-1-[(2S)-2-(ureidocarbamoyl)pyrrolidine-1-carbonyl]butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylhydrazo)-oxomethyl]-1-pyrrolidinyl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxo-2-pyrrolidinecarboxamide,(2<I>S</I>)-<I>N</I>-[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>R</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(aminocarbonylamino)carbamoyl]pyrrolidin-1-yl]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxidanylidene-propan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxidanylidene-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl]-5-oxidanylidene-pyrrolidine-2-carboxamide,(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-(tert-butoxymethyl)-2-[[(1S)-1-[[(1S)-4-guanidino-1-[(2S)-2-(ureidocarbamoyl)pyrrolidine-1-carbonyl]butyl]carbamoyl]-3-methyl-butyl]amino]-2-keto-ethyl]amino]-1-(4-hydroxybenzyl)-2-keto-ethyl]amino]-2-keto-1-methylol-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-keto-ethyl]-5-keto-pyrrolidine-2-carboxamide,"InChI=1S/C59H84N18O14/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90)/t38-,39-,40-,41-,42-,43-,44-,45+,46-/m0/s1",BLCLNMBMMGCOAS-URPVMXJPSA-N,,1268.64143943,C59H84N18O14,1269.4,496.0,1268.64143943,0.0,91.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,-1.5,"38  16  6
42  18  6
50  21  6
59  23  5
55  25  5
60  26  6
67  27  6
30  78  8
30  79  8
31  77  8
31  90  8
32  85  8
32  90  8
33  39  6
53  64  6
72  76  8
72  78  8
75  82  8
75  83  8
76  79  8
76  81  8
77  85  8
79  84  8
81  86  8
82  88  8
83  89  8
84  87  8
86  87  8
88  91  8
89  91  8",
440791136,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01419,Golimumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01419,golimumab,8.0,Adverse reactions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791135,3081884,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00985,Glatiramer acetate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00985,glatiramer acetate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,3081884,1.0,519.0,18.0,12.0,13.0,AAADcfB7vAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADCzBmAQyDoBAAgCIAiDSCAACAAAgIAAIiIGGCIgKJjKCkROAcAAk0BEImAe87qCOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"acetic acid;(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid","acetic acid;(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid","acetic acid;(2<I>S</I>)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2<I>S</I>)-2-aminopentanedioic acid;(2<I>S</I>)-2-aminopropanoic acid;(2<I>S</I>)-2,6-diaminohexanoic acid","acetic acid;(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid","(2S)-2-azanyl-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-azanylpentanedioic acid;(2S)-2-azanylpropanoic acid;(2S)-2,6-bis(azanyl)hexanoic acid;ethanoic acid","acetic acid;(2S)-2-aminoglutaric acid;(2S)-2-amino-3-(4-hydroxyphenyl)propionic acid;(2S)-2-aminopropionic acid;(2S)-2,6-diaminohexanoic acid","InChI=1S/C9H11NO3.C6H14N2O2.C5H9NO4.C3H7NO2.C2H4O2/c10-8(9(12)13)5-6-1-3-7(11)4-2-6;7-4-2-1-3-5(8)6(9)10;6-3(5(9)10)1-2-4(7)8;1-2(4)3(5)6;1-2(3)4/h1-4,8,11H,5,10H2,(H,12,13);5H,1-4,7-8H2,(H,9,10);3H,1-2,6H2,(H,7,8)(H,9,10);2H,4H2,1H3,(H,5,6);1H3,(H,3,4)/t8-;5-;3-;2-;/m0000./s1",FHEAIOHRHQGZPC-KIWGSFCNSA-N,,623.30138651,C25H45N5O13,623.7,374.0,623.30138651,0.0,43.0,4.0,0.0,0.0,0.0,0.0,5.0,-1.0,"1
5
255",CC(=O)O.C[C@H](N)C(=O)O.NCCCC[C@H](N)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O.N[C@@H](Cc1ccc(O)cc1)C(=O)O,,"22  14  6
26  16  5
29  17  6
39  18  6
27  31  8
27  32  8
31  34  8
32  35  8
34  36  8
35  36  8",
440791134,135398740,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01406,ganciclovir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01406,ganciclovir,7.0,Adverse reactions,Ambiguous DILI-concern,1.0,135398740,1.0,346.0,6.0,4.0,5.0,AAADccBzuAAAAAAAAAAAAAAAAAAAAWAAAAAgAAAAAAAAAEABgAAAHgAQCAAACByhlgYFsBfMFgCoAQdxdACAgC0XEKABUAGoVECBWAhASCAcQIgJAQJDAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-1H-purin-6-one,"2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one","2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1<I>H</I>-purin-6-one","2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one","2-azanyl-9-[1,3-bis(oxidanyl)propan-2-yloxymethyl]-1H-purin-6-one",2-amino-9-[(2-hydroxy-1-methylol-ethoxy)methyl]hypoxanthine,"InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17)",IRSCQMHQWWYFCW-UHFFFAOYSA-N,,255.09675391,C9H13N5O4,255.23,135.0,255.09675391,0.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1,-2.5,"12  13  8
13  17  8
5  12  8
5  16  8
6  13  8
6  16  8
7  12  8
7  18  8
8  17  8
8  18  8",
440791133,61635,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02064,Gallium nitrate,20250421,20210312,Curation Efforts|Governmental Organizations,LT02064,gallium nitrate,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,61635,1.0,18.8,9.0,0.0,0.0,AAADcQADPAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAQAABAAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,gallium;trinitrate,gallium;trinitrate,gallium;trinitrate,gallium;trinitrate,gallium;trinitrate,gallium;trinitrate,InChI=1S/Ga.3NO3/c;3*2-1(3)4/q+3;3*-1,CHPZKNULDCNCBW-UHFFFAOYSA-N,,254.88903,GaN3O9,255.74,189.0,254.88903,0.0,13.0,0.0,0.0,0.0,0.0,0.0,4.0,-1.0,"1
5
255",O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].[Ga+3],,,
440791132,9651,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01086,Galantamine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01086,galantamine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,9651,1.0,440.0,4.0,1.0,1.0,AAADceB6MAAAAAAAAAAAAAAAAAAAASAAAAAwQAAABYAAAEixAAAAHgAACAAADhThmAYyBoMABgCAAiBCAACCCAAgIAAIiAAOjIgNNiKEsRuGeCrlwBGKuAew8P4PoAABAAAYQABAAAIAADCAAAAAAAAAAA==,"(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol","(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol","(1<I>S</I>,12<I>S</I>,14<I>R</I>)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0<SUP>1,12</SUP>.0<SUP>6,17</SUP>]heptadeca-6(17),7,9,15-tetraen-14-ol","(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol","(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol","(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol","InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1",ASUTZQLVASHGKV-JDFRZJQESA-N,,287.15214353,C17H21NO3,287.35,41.9,287.15214353,0.0,21.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,1.8,"11  17  8
13  18  8
17  19  8
18  19  8
14  2  5
5  8  6
6  22  6
7  11  8
7  13  8",
440791131,60754,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00951,gadodiamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00951,gadodiamide,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,60754,1.0,527.0,12.0,3.0,13.0,AAADceB7vAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAAAADBgAQCCAPAAAAIAAGQGAAAAAAAAAAAAICIAAACQAAAACAQAAAAEgCQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxo-ethyl]amino]ethyl]amino]acetate;gadolinium(3+);hydrate,2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+);hydrate,2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+);hydrate,2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+);hydrate,2-[bis[2-[[2-(methylamino)-2-oxidanylidene-ethyl]-(2-oxidanidyl-2-oxidanylidene-ethyl)amino]ethyl]amino]ethanoate;gadolinium(3+);hydrate,2-[bis[2-[carboxylatomethyl-[2-keto-2-(methylamino)ethyl]amino]ethyl]amino]acetate;gadolinium(3+);hydrate,"InChI=1S/C16H29N5O8.Gd.H2O/c1-17-12(22)7-20(10-15(26)27)5-3-19(9-14(24)25)4-6-21(11-16(28)29)8-13(23)18-2;;/h3-11H2,1-2H3,(H,17,22)(H,18,23)(H,24,25)(H,26,27)(H,28,29);;1H2/q;+3;/p-3",XPCLDSMKWNNKOM-UHFFFAOYSA-K,,592.11281,C16H28GdN5O9,591.67,189.0,592.11281,0.0,31.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",CNC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)NC)CC(=O)[O-])CC(=O)[O-].O.[Gd+3],,,
440791130,3440,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00299,furosemide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00299,furosemide,2.0,Adverse reactions,Ambiguous DILI-concern,1.0,3440,1.0,481.0,7.0,3.0,5.0,AAADccBzOABEAAAAAAAAAAAAAAAAASAAAAAwAAAAAAAAAAABwAAAHgYQSAAADA7h2CYwzYLABkKIAqzSyHDCCBAlJwAIiJmObsgOJjrFt7uHeajm0BHY+ceY2SKOBAQAgAICAIAICAEABAQBAAAAAAAAAA==,4-chloro-2-(2-furylmethylamino)-5-sulfamoyl-benzoic acid,4-chloro-2-(2-furanylmethylamino)-5-sulfamoylbenzoic acid,4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid,4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid,4-chloranyl-2-(furan-2-ylmethylamino)-5-sulfamoyl-benzoic acid,4-chloro-2-(2-furfurylamino)-5-sulfamoyl-benzoic acid,"InChI=1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)",ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.0,330.0077203,C12H11ClN2O5S,330.74,131.0,330.0077203,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,"10  12  8
10  15  8
11  13  8
11  16  8
12  13  8
15  16  8
17  19  8
19  20  8
20  21  8
3  17  8
3  21  8",
440791129,104741,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00401,Fulvestrant,20231222,20210312,Curation Efforts|Governmental Organizations,LT00401,fulvestrant,7.0,Adverse reactions,Ambiguous DILI-concern,2.0,104741,1.0,854.0,9.0,2.0,14.0,AAADcfB8McBAAAAAAAAAAAAAAAAAAYAAAAAwYMAAAAAAAGDBAAAAGwQACAAADxSk2BKyBoAAAgqAAiBCAEBCAAAgIBAIiAAGCIgINiKiERKAcAAkwBEomAeAwPAPoAABAAAQAADAAAYAACAAAIAADAAAAA==,"(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","(7<I>R</I>,8<I>R</I>,9<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-[4,4,5,5,5-pentakis(fluoranyl)pentylsulfinyl]nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","InChI=1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,41?/m1/s1",VWUXBMIQPBEWFH-WCCTWKNTSA-N,9.2,606.31660734,C32H47F5O3S,606.8,76.7,606.31660734,0.0,41.0,6.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,,"1  36  3
10  42  6
11  20  5
12  43  5
13  44  6
17  23  6
21  24  8
21  26  8
24  27  8
26  29  8
27  30  8
29  30  8
15  7  5",
440791128,3415,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01397,foscarnet,20231222,20210312,Curation Efforts|Governmental Organizations,LT01397,foscarnet,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,3415,1.0,120.0,5.0,3.0,1.0,AAADcQAAOAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAggACCAAAAAAAAAACAAAAhAIQAAACIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,phosphonoformic acid,phosphonoformic acid,phosphonoformic acid,phosphonoformic acid,phosphonomethanoic acid,phosphonoformic acid,"InChI=1S/CH3O5P/c2-1(3)7(4,5)6/h(H,2,3)(H2,4,5,6)",ZJAOAACCNHFJAH-UHFFFAOYSA-N,-2.0,125.97181019,CH3O5P,126.01,94.8,125.97181019,0.0,7.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)P(=O)(O)O,,,
440791127,135413538,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01257,Fosaprepitant,20231222,20210312,Curation Efforts|Governmental Organizations,LT01257,fosaprepitant,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,135413538,1.0,997.0,15.0,3.0,7.0,AAADceB7ucIAAAAAAAAAAAAAAAAAAQAAAAA8YIAAAAAAAAABQAAAHwAYiCAADDzxmB8zCIPABBCoQiJiMICSAAAgAAAPiAAYDIiaZiKAsRm3MAh03AOcqAeQwOAOAAACAAAAAAAAAAQAAAAAAAAAAAAAAA==,"[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4H-1,2,4-triazol-1-yl]phosphonic acid","[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-5-oxo-4H-1,2,4-triazol-1-yl]phosphonic acid","[3-[[(2<I>R</I>,3<I>S</I>)-2-[(1<I>R</I>)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4<I>H</I>-1,2,4-triazol-1-yl]phosphonic acid","[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4H-1,2,4-triazol-1-yl]phosphonic acid","[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxidanylidene-4H-1,2,4-triazol-1-yl]phosphonic acid","[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-5-keto-4H-1,2,4-triazol-1-yl]phosphonic acid","InChI=1S/C23H22F7N4O6P/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)40-20-19(13-2-4-17(24)5-3-13)33(6-7-39-20)11-18-31-21(35)34(32-18)41(36,37)38/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H,31,32,35)(H2,36,37,38)/t12-,19+,20-/m1/s1",BARDROPHSZEBKC-OITMNORJSA-N,,614.11651857,C23H22F7N4O6P,614.4,124.0,614.11651857,0.0,41.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H](O[C@H]1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)C1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,1.0,"20  10  5
25  10  5
16  26  8
16  36  8
17  18  8
17  26  8
18  36  8
19  24  5
24  27  8
24  28  8
27  31  8
28  32  8
29  33  8
29  34  8
31  35  8
32  35  8
33  37  8
34  38  8
37  39  8
38  39  8",
440791126,5324346,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01396,fluvoxamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01396,fluvoxamine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5324346,1.0,327.0,7.0,1.0,9.0,AAADceBzMYAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHwAUAAAADAjhmBYyAIBQBACgAyBiAAACAAAgAAAIiIAwAJgKIKKAERCAIAAkkAAIiAeAwOAOQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine,2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine,2-[(<I>E</I>)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine,2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine,2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine,2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethylamine,"InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+",CJOFXWAVKWHTFT-XSFVSMFZSA-N,,318.1555124,C15H21F3N2O2,318.33,56.8,318.1555124,0.0,22.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1,2.6,"12  14  8
12  15  8
14  17  8
15  18  8
16  17  8
16  18  8",
440791125,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01320,FILGRASTIM,20210312,20210312,Curation Efforts|Governmental Organizations,LT01320,filgrastim,1.0,Adverse reactions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791124,3324,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00270,famciclovir,20250421,20210312,Curation Efforts|Governmental Organizations,LT00270,famciclovir,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,3324,1.0,404.0,8.0,1.0,9.0,AAADceBzuAAAAAAAAAAAAAAAAAAAAWAAAAAsAAAAAAAAAFgB+AAAHgAQAAAADQjhlwYv+L9MFACoARb3bACAgC0REqABUCA4dBCASIBAyEAWBAgNAALAACAgAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,[2-(acetoxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate,acetic acid [2-(acetyloxymethyl)-4-(2-amino-9-purinyl)butyl] ester,[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate,[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate,[2-(acetyloxymethyl)-4-(2-azanylpurin-9-yl)butyl] ethanoate,acetic acid [2-(acetoxymethyl)-4-(2-aminopurin-9-yl)butyl] ester,"InChI=1S/C14H19N5O4/c1-9(20)22-6-11(7-23-10(2)21)3-4-19-8-17-12-5-16-14(15)18-13(12)19/h5,8,11H,3-4,6-7H2,1-2H3,(H2,15,16,18)",GGXKWVWZWMLJEH-UHFFFAOYSA-N,0.0,321.1437041,C14H19N5O4,321.33,122.0,321.1437041,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O,,"15  17  8
17  18  8
5  15  8
5  16  8
6  16  8
6  17  8
7  15  8
7  21  8
8  18  8
8  21  8",
440791123,18477728,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01267,Everolimus,20231222,20210312,Curation Efforts|Governmental Organizations,LT01267,everolimus,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,18477728,1.0,1810.0,14.0,3.0,9.0,AAADcfB+PAAAAAAAAAAAAAAAAAAAAAAAAAA8SIAAAAAAAAAAAAAAHgAACAAADTzhgAYCCAMABgCIAqHSGAIAAAAgAAAICAHIAAgbFBYAoSQHUAAH5gCfsAOY6PSOAAAAAAAAAABAAAIAAACAAAAAAAAAAA==,"(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","(1<I>R</I>,9<I>S</I>,12<I>S</I>,15<I>R</I>,16<I>E</I>,18<I>R</I>,19<I>R</I>,21<I>R</I>,23<I>S</I>,24<I>Z</I>,26<I>E</I>,28<I>E</I>,30<I>S</I>,32<I>S</I>,35<I>R</I>)-1,18-dihydroxy-12-[(2<I>R</I>)-1-[(1<I>S</I>,3<I>R</I>,4<I>R</I>)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0<SUP>4,9</SUP>]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethyloxy)-3-methoxy-cyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-1,18-bis(oxidanyl)-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12-,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1",HKVAMNSJSFKALM-CPXURSODSA-N,,957.58135632,C53H83NO14,958.2,205.0,957.58135632,0.0,68.0,15.0,0.0,4.0,0.0,0.0,1.0,-1.0,"1
5
255",CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(/C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C\C=C\1C,5.9,"21  1  5
47  11  5
52  12  5
55  13  6
16  19  6
20  2  6
23  25  6
24  81  5
27  87  5
28  45  6
31  91  6
43  48  5
29  5  6
59  63  5
62  66  6",
440791122,3278,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01344,ETHACRYNIC ACID,20210312,20210312,Curation Efforts|Governmental Organizations,LT01344,ethacrynic acid,5.0,Adverse reactions,Ambiguous DILI-concern,1.0,3278,1.0,370.0,4.0,1.0,6.0,AAADccBwOAAGAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgIACAAADAagmCIyDoAABgCIAqDSCAICCAAkJEAIikFGC8gNJjOFNx6COSCkwBELrYeIzKDOIAAAIQABCARAAABCAAIQCAAAAAAAAA==,"2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid","2-[2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid","2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid","2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid","2-[2,3-bis(chloranyl)-4-(2-methylidenebutanoyl)phenoxy]ethanoic acid","2-[2,3-dichloro-4-(2-ethylacryloyl)phenoxy]acetic acid","InChI=1S/C13H12Cl2O4/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17/h4-5H,2-3,6H2,1H3,(H,16,17)",AVOLMBLBETYQHX-UHFFFAOYSA-N,,302.0112642,C13H12Cl2O4,303.13,63.6,302.0112642,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,3.8,"11  14  8
12  15  8
13  14  8
13  15  8
7  11  8
7  12  8",
440791121,969472,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01161,Eszopiclone,20210312,20210312,Curation Efforts|Governmental Organizations,LT01161,eszopiclone,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,969472,1.0,573.0,7.0,0.0,3.0,AAADceB7sAAEAAAAAAAAAAAAAAAAAWAAAAAsWLAAAAAAAFgB4AAAHgIAAAAACArhliY/uJMIFACoATd3fASCgC03FyAJ2CG4ftiKZvrB+7ndMYhuhwLY6WY2AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(7S)-6-(5-chloro-2-pyridyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate","4-methyl-1-piperazinecarboxylic acid [(7S)-6-(5-chloro-2-pyridinyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] ester","[(7<I>S</I>)-6-(5-chloropyridin-2-yl)-5-oxo-7<I>H</I>-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate","[(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate","[(7S)-6-(5-chloranylpyridin-2-yl)-5-oxidanylidene-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate","4-methylpiperazine-1-carboxylic acid [(7S)-6-(5-chloro-2-pyridyl)-5-keto-7H-pyrrolo[3,4-b]pyrazin-7-yl] ester","InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3/t16-/m0/s1",GBBSUAFBMRNDJC-INIZCTEOSA-N,,388.1050661,C17H17ClN6O3,388.8,91.8,388.1050661,0.0,27.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,0.5,"10  21  8
10  26  8
18  19  8
15  2  6
21  22  8
22  25  8
23  24  8
25  27  8
26  27  8
8  18  8
8  23  8
9  19  8
9  24  8",
440791120,5284555,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00677,Estropipate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00677,estropipate,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,5284555,1.0,650.0,7.0,3.0,2.0,AAADcfB7OABAAAAAAAAAAAAAAAAAAYAAAAA8YMEAAAAAAGDBAAAAHgAQCAAADwTBmAQyBoLAAICIAqBSADACAAAgIAAIiIEOCIgIZjKAERKQMAAk0BGIiAeIyPCPoAABAAAQAADAAAYAACAAAAAACAAAAA==,"[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine","piperazine;sulfuric acid [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] ester","[(8<I>R</I>,9<I>S</I>,13<I>S</I>,14<I>S</I>)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6<I>H</I>-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine","[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine","[(8R,9S,13S,14S)-13-methyl-17-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine","piperazine;sulfuric acid [(8R,9S,13S,14S)-17-keto-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] ester","InChI=1S/C18H22O5S.C4H10N2/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;1-2-6-4-3-5-1/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22);5-6H,1-4H2/t14-,15-,16+,18+;/m1./s1",HZEQBCVBILBTEP-ZFINNJDLSA-N,,436.2031933,C22H32N2O5S,436.6,113.0,436.2031933,0.0,30.0,4.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",C1CNCCN1.C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O,,"10  19  5
11  32  5
12  33  6
20  22  8
20  23  8
22  24  8
23  25  8
24  26  8
25  26  8
9  31  6",
440791119,23676225,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02424,Estrogens  Conjugated,20231222,20210312,Curation Efforts|Governmental Organizations,,,,,,,23676225,1.0,682.0,5.0,0.0,2.0,AAADceB4OCBAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGCBAAAAGgAAAAAADwSAmAAyBoAAAACIAqBSADACAAAgIAAIiAEGCIgIJjKAERKAMAAkwBEIiAeIyPCPoAABAAAQAADAAAYAACAAAAAACAAAAA==,"sodium;[(9S,13S,14S)-13-methyl-17-oxo-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate","sodium;[(9S,13S,14S)-13-methyl-17-oxo-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate","sodium;[(9<I>S</I>,13<I>S</I>,14<I>S</I>)-13-methyl-17-oxo-9,11,12,14,15,16-hexahydro-6<I>H</I>-cyclopenta[a]phenanthren-3-yl] sulfate","sodium;[(9S,13S,14S)-13-methyl-17-oxo-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate","sodium;[(9S,13S,14S)-13-methyl-17-oxidanylidene-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate","sodium;[(9S,13S,14S)-17-keto-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate","InChI=1S/C18H20O5S.Na/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;/h3-5,10,14,16H,2,6-9H2,1H3,(H,20,21,22);/q;+1/p-1/t14-,16+,18+;/m1./s1",QTTMOCOWZLSYSV-QWAPEVOJSA-M,,370.08508916,C18H19NaO5S,370.4,91.9,370.08508916,0.0,25.0,3.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",C[C@]12CC[C@H]3C(=CCc4cc(OS(=O)(=O)[O-])ccc43)[C@@H]1CCC2=O.[Na+],,"11  29  6
18  21  8
18  22  8
21  23  8
22  24  8
23  25  8
24  25  8
8  17  5
9  26  6",2  5  7
440791118,5281037,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01001,Eprosartan,20210804,20210312,Curation Efforts|Governmental Organizations,LT01001,eprosartan,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5281037,1.0,618.0,6.0,2.0,10.0,AAADceB7OABAAAAAAAAAAAAAAAAAAWJAAAAwAAAAAAAAAAAB8AAAHgQACAAADAjF3wS/mZcMEgisAzb3bACDgK01GrBJ2Bk4fNiIbjLgnRGUcQhswAPomaeYyDCOQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,4-[[2-butyl-5-[(E)-2-carboxy-3-(2-thienyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid,4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]-1-imidazolyl]methyl]benzoic acid,4-[[2-butyl-5-[(<I>E</I>)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid,4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid,4-[[2-butyl-5-[(E)-3-oxidanyl-3-oxidanylidene-2-(thiophen-2-ylmethyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid,4-[[2-butyl-5-[(E)-2-carboxy-3-(2-thienyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid,"InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+",OROAFUQRIXKEMV-LDADJPATSA-N,,424.14567842,C23H24N2O4S,424.5,121.0,424.14567842,0.0,30.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,4.5,"1  25  8
1  30  8
12  15  8
14  19  8
14  20  8
19  22  8
20  23  8
22  24  8
23  24  8
25  27  8
27  29  8
29  30  8
6  12  8
6  8  8
7  15  8
7  8  8",
440791117,5282411,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00971,epoprostenol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00971,epoprostenol,7.0,Adverse reactions,Ambiguous DILI-concern,2.0,5282411,1.0,484.0,5.0,3.0,10.0,AAADcfB4OAAAAAAAAAAAAAAAAAAAAaIAAAAAAAAAAAASAAAAAAAAGgAACAAADRSggAICCAAABgCIACDSCAAACAAgIAAICAEAAAgAFBIAAQACUAAFwAAIEAPI4KwOgAAAAAAAAAAAAAAAAAAAAIQADAAAAA==,"(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid","(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid","(5<I>Z</I>)-5-[(3<I>a</I><I>R</I>,4<I>R</I>,5<I>R</I>,6<I>a</I><I>S</I>)-5-hydroxy-4-[(<I>E</I>,3<I>S</I>)-3-hydroxyoct-1-enyl]-3,3<I>a</I>,4,5,6,6<I>a</I>-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid","(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid","(5Z)-5-[(3aR,4R,5R,6aS)-5-oxidanyl-4-[(E,3S)-3-oxidanyloct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid","(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]valeric acid","InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1",KAQKFAOMNZTLHT-OZUDYXHBSA-N,,352.22497412,C20H32O5,352.5,87.0,352.22497412,0.0,25.0,5.0,0.0,2.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)O[C@H]2C[C@H]1O,2.9,"9  2  5
16  3  6
6  26  6
7  27  6
8  13  6",
440791116,443872,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01149,Eplerenone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01149,eplerenone,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,443872,1.0,907.0,6.0,0.0,2.0,AAADceB4OAAAAAAAAAAAAAAAEgAAAaIAAAAwYIAABIAAAGDAAAAAGgAAAAAAD1SggAICCAAABACIAqDSCAAAAAAgAAAACAEAAEgAABIAAQACAAAEwAAIAQPK7PzPgAAAAAAAAADAAAYAADAAAYAADAAAAA==,"methyl (1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxo-spiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-tetrahydrofuran]-9-carboxylate","(1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxo-9-spiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]carboxylic acid methyl ester","methyl (1<I>R</I>,2<I>S</I>,9<I>R</I>,10<I>R</I>,11<I>S</I>,14<I>R</I>,15<I>S</I>,17<I>R</I>)-2,15-dimethyl-5,5&apos;-dioxospiro[18-oxapentacyclo[8.8.0.0<SUP>1,17</SUP>.0<SUP>2,7</SUP>.0<SUP>11,15</SUP>]octadec-6-ene-14,2&apos;-oxolane]-9-carboxylate","methyl (1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxospiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]-9-carboxylate","methyl (1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-bis(oxidanylidene)spiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]-9-carboxylate","(1R,2S,9R,10R,11S,14R,15S,17R)-5,5'-diketo-2,15-dimethyl-spiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-tetrahydrofuran]-9-carboxylic acid methyl ester","InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1",JUKPWJGBANNWMW-VWBFHTRKSA-N,1.4,414.20423867,C24H30O6,414.5,82.2,414.20423867,0.0,30.0,8.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13,,"7  1  6
10  32  6
11  33  5
12  23  5
15  24  6
14  2  5
8  31  5
9  20  5",
440791115,5462501,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00381,Enalaprilat,20210312,20210312,Curation Efforts|Governmental Organizations,LT00381,enalaprilat,7.0,Adverse reactions,Ambiguous DILI-concern,2.0,5462501,1.0,490.0,6.0,3.0,8.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHgAQCAAADCjBmAQyCIPAAgCIAiHSGAACAAAgAAAIiIGIAIgKYDKAkTCUYAAklgCYiAeY2bKOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]-1-oxopropyl]-2-pyrrolidinecarboxylic acid,(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(1<I>S</I>)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(2S)-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]propanoyl]proline,"InChI=1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1",LZFZMUMEGBBDTC-QEJZJMRPSA-N,-0.7,348.16852187,C18H24N2O5,348.4,107.0,348.16852187,0.0,25.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,,"20  21  8
20  22  8
21  23  8
22  24  8
23  25  8
24  25  8
13  7  5
15  7  5
8  14  5",
440791114,77993,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02024,Eletriptan,20231222,20210312,Curation Efforts|Governmental Organizations,LT02024,eletriptan,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,77993,1.0,582.0,3.0,1.0,6.0,AAADceB7MABAAAAAAAAAAAAAAAAAAWLAAAAwYAAAAAAAAFgB9AAAHAQQAAAADCjFXgS+wfPJkAqgAzRnRHDCgCAxCjAI2bg4ZJgIIOLgkZGEIAhgkADoyAcQgMAOiAACAAACAAAQAAQAAAQAAAAAAAAAAA==,5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole,5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-1H-indole,5-[2-(benzenesulfonyl)ethyl]-3-[[(2<I>R</I>)-1-methylpyrrolidin-2-yl]methyl]-1<I>H</I>-indole,5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole,3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole,5-(2-besylethyl)-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole,"InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1",PWVXXGRKLHYWKM-LJQANCHMSA-N,,382.17149925,C22H26N2O2S,382.5,61.6,382.17149925,0.0,27.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,4.1,"11  13  8
11  14  8
13  15  8
13  16  8
15  18  8
16  17  8
17  20  8
18  20  8
22  23  8
22  24  8
23  25  8
24  26  8
25  27  8
26  27  8
5  14  8
5  15  8
6  10  5",
440791113,5281107,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00464,Doxercalciferol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00464,doxercalciferol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5281107,1.0,712.0,2.0,2.0,5.0,AAADcfB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYAAAAAAAAGAAAAAAGgAACAAADxSggAICAAAAAgCAAiBCAAAAAAAgAAAICAAAAAgIFAIAAQAAQAAFwAAIkAOA4MQPgAAAAAAAAAAAAAAQACAAAQAACAAAAA==,"(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol","(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylenecyclohexane-1,3-diol","(1<I>R</I>,3<I>S</I>,5<I>Z</I>)-5-[(2<I>E</I>)-2-[(1<I>R</I>,3<I>a</I><I>S</I>,7<I>a</I><I>R</I>)-1-[(<I>E</I>,2<I>R</I>,5<I>R</I>)-5,6-dimethylhept-3-en-2-yl]-7<I>a</I>-methyl-2,3,3<I>a</I>,5,6,7-hexahydro-1<I>H</I>-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol","(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol","(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol","(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol","InChI=1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1",HKXBNHCUPKIYDM-CGMHZMFXSA-N,,412.334130642,C28H44O2,412.6,40.5,412.334130642,0.0,30.0,7.0,0.0,3.0,0.0,0.0,1.0,-1.0,"1
5
255",C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,6.3,"25  1  6
19  23  5
26  2  5
3  11  5
4  31  6
5  32  6
9  14  6",
440791112,3157,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01313,doxazosin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01313,doxazosin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,3157,1.0,678.0,9.0,1.0,4.0,AAADceB7uAAAAAAAAAAAAAAAAAAAAAAAAAA8eJECAAAAAACx9AAAHgAQAAAADBzhngYz9vdIFACoAydydAKCiCkhIqAJmCF+7JiPbqbE+d+XPCru5hva6Cew0BMOIEABAgACQABAgAIEAASAAAAAAAAAAA==,"[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone","[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone","[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone","[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone","[4-(4-azanyl-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone","[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazino]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone","InChI=1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26)",RUZYUOTYCVRMRZ-UHFFFAOYSA-N,2.5,451.18556891,C23H25N5O5,451.5,112.0,451.18556891,0.0,33.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,,"16  15  3
19  21  8
19  25  8
20  22  8
20  24  8
21  27  8
22  23  8
22  26  8
24  28  8
25  30  8
26  29  8
27  31  8
28  29  8
30  31  8
8  17  8
8  20  8
9  17  8
9  23  8",
440791111,73303,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00623,Doripenem,20231222,20210312,Curation Efforts|Governmental Organizations,LT00623,doripenem,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,73303,1.0,780.0,10.0,5.0,7.0,AAADceBzuABgAAAAAAAAAAAAAABYAWIAAAAAAAAABAAAAAAAAAAAHgQQSAAADTzlwAaCCAPAAgiIAAXQWDAAAAAgABAACIGIAEgCVB4ggCAUUAAGtgC4EQOYAAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(sulfamoylamino)methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4<I>R</I>,5<I>S</I>,6<I>S</I>)-6-[(1<I>R</I>)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3<I>S</I>,5<I>S</I>)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-4-methyl-6-[(1R)-1-oxidanylethyl]-7-oxidanylidene-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-7-keto-4-methyl-3-[[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","InChI=1S/C15H24N4O6S2/c1-6-11-10(7(2)20)14(21)19(11)12(15(22)23)13(6)26-9-3-8(17-5-9)4-18-27(16,24)25/h6-11,17-18,20H,3-5H2,1-2H3,(H,22,23)(H2,16,24,25)/t6-,7-,8+,9+,10-,11-/m1/s1",AVAACINZEOAHHE-VFZPANTDSA-N,,420.11372685,C15H24N4O6S2,420.5,196.0,420.11372685,0.0,27.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@H](C)[C@H]12,-3.4,"21  1  5
13  28  6
14  29  5
15  20  5
23  27  5
19  4  6",
440791110,3033818,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00986,dolasetron,20250421,20210312,Curation Efforts|Governmental Organizations,LT00986,dolasetron,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,3033818,1.0,535.0,4.0,1.0,3.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAWAAAAA8WLFiAAAYAFgB8AAAHgAQAAAADTzhngY8yPPJlACoA7T3TACCgCA1AiAI2aG4bNgIJvrAtbmGMYhm0AHI6ce8yPCOgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"[(3S,7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate","1H-indole-3-carboxylic acid [(3S,7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] ester","[(3<I>S</I>,7<I>R</I>)-10-oxo-8-azatricyclo[5.3.1.0<SUP>3,8</SUP>]undecan-5-yl] 1<I>H</I>-indole-3-carboxylate","[(3S,7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate","[(3S,7R)-10-oxidanylidene-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate","1H-indole-3-carboxylic acid [(3S,7R)-10-keto-8-azatricyclo[5.3.1.03,8]undecan-5-yl] ester","InChI=1S/C19H20N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,20H,5-8,10H2/t11?,12-,13+,14?",UKTAZPQNNNJVKR-AKJUYKBHSA-N,3.4,324.1473925,C19H20N2O3,324.4,62.4,324.1473925,0.0,24.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(OC1C[C@@H]2CC3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12,,"17  18  8
17  19  8
18  20  8
18  21  8
20  22  8
21  23  8
22  24  8
23  24  8
5  19  8
5  20  8
6  25  5
7  26  6",
440791109,3016,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00230,diazepam,20250421,20210312,Curation Efforts|Governmental Organizations,LT00230,diazepam,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,3016,1.0,403.0,2.0,0.0,1.0,AAADccB7IAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHgIAAAAADArBmCQywIMAAACoAyVyVACCAAAhBwAIiACoZpgIYKLBk5GUIAhghgDIyAcQgMAOAABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one","7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one","7-chloro-1-methyl-5-phenyl-3<I>H</I>-1,4-benzodiazepin-2-one","7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one","7-chloranyl-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one","7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one","InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",AAOVKJBEBIDNHE-UHFFFAOYSA-N,3.0,284.0716407,C16H13ClN2O,284.74,32.7,284.0716407,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,,"10  16  8
10  17  8
11  14  8
12  15  8
14  15  8
16  18  8
17  19  8
18  20  8
19  20  8
5  11  8
5  6  8
6  12  8",
440791108,71384,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01273,Dexrazoxane,20250421,20210312,Curation Efforts|Governmental Organizations,LT01273,dexrazoxane,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,71384,1.0,404.0,6.0,2.0,3.0,AAADceBzuAAAAAAAAAAAAAAAAAAAAAAAAAAsWAAAAAAAAAAAAAAAHgAQAAAACCjBgAQCAAPAAAAIAAEQEAAAAAAAAAAAAACIAAAAQAAAACAUAAAAFCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione","4-[(2S)-2-(3,5-dioxo-1-piperazinyl)propyl]piperazine-2,6-dione","4-[(2<I>S</I>)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione","4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione","4-[(2S)-2-[3,5-bis(oxidanylidene)piperazin-1-yl]propyl]piperazine-2,6-dione","4-[(2S)-2-(3,5-diketopiperazino)propyl]piperazine-2,6-quinone","InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1",BMKDZUISNHGIBY-ZETCQYMHSA-N,,268.117155,C11H16N4O4,268.27,98.8,268.117155,0.0,19.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,-1.4,9  13  5,
440791107,5311068,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01063,DEXMEDETOMIDINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT01063,dexmedetomidine,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,5311068,1.0,205.0,1.0,1.0,2.0,AAADceBzAAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHAAQAAAADQjBHgQ/kJbJkACgAzRnZAACgC2xEqAJ2YA4cIiIaCLAmRGUIAAokAJIyCcQgMAOgAACAAAQAAAAAAQAACAAAAAAAAAAAA==,"5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole","5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole","5-[(1<I>S</I>)-1-(2,3-dimethylphenyl)ethyl]-1<I>H</I>-imidazole","5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole","5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole","5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole","InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1",CUHVIMMYOGQXCV-NSHDSACASA-N,,200.131348519,C13H16N2,200.28,28.7,200.131348519,0.0,15.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cccc([C@H](C)c2cnc[nH]2)c1C,3.1,"1  15  8
1  6  8
11  12  8
2  13  8
2  15  8
3  7  6
4  5  8
4  9  8
5  8  8
6  13  8
8  11  8
9  12  8",
440791106,5743,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00082,dexamethasone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00082,dexamethasone,3.0,Adverse reactions,Ambiguous DILI-concern,1.0,5743,1.0,805.0,6.0,3.0,2.0,AAADceB4OQAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGwAACAAAD1SggAICAAAAAgCIAqBSAAIAAAAgAAAICAFAAEgAEBIAAQAAQAAFgAAIAYPIzPDPgAAAAAAAAADAAAYAADAAAYAADAAAAA==,"(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one","(8<I>S</I>,9<I>R</I>,10<I>S</I>,11<I>S</I>,13<I>S</I>,14<I>S</I>,16<I>R</I>,17<I>R</I>)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-17-(2-oxidanylethanoyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-17-glycoloyl-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one","InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",UREBDLICKHMUKA-CXSFZGCWSA-N,1.9,392.19990218,C22H29FO5,392.5,94.8,392.19990218,0.0,28.0,8.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,,"10  1  6
14  22  6
16  23  5
11  2  6
15  3  5
7  18  5
8  29  6
9  30  5",
440791105,5311065,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00896,DESMOPRESSIN,20250421,20210312,Curation Efforts|Governmental Organizations,LT00896,desmopressin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5311065,1.0,2040.0,15.0,13.0,19.0,AAADcfB//ABgAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAABQAAAHgQQCAAADCzF2ASxBoPAAgCoAiFSNAACAAEgIAAIiIGOCIgIZjqC0TOUcAAk1hGImAedy6COIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide","(2S)-N-[(2R)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-2-pyrrolidinecarboxamide","(2<I>S</I>)-<I>N</I>-[(2<I>R</I>)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(4<I>R</I>,7<I>S</I>,10<I>S</I>,13<I>S</I>,16<I>S</I>)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide","(2S)-N-[(2R)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide","(2S)-N-[(2R)-1-[(2-azanyl-2-oxidanylidene-ethyl)amino]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]-1-[[(4R,7S,10S,13S,16S)-7-(2-azanyl-2-oxidanylidene-ethyl)-10-(3-azanyl-3-oxidanylidene-propyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentakis(oxidanylidene)-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloicos-4-yl]carbonyl]pyrrolidine-2-carboxamide","(2S)-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-keto-ethyl)-10-(3-amino-3-keto-propyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaketo-1,2-dithia-5,8,11,14,17-pentazacycloeicosane-4-carbonyl]-N-[(1R)-1-[(2-amino-2-keto-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide","InChI=1S/C46H64N14O12S2/c47-35(62)15-14-29-40(67)58-32(22-36(48)63)43(70)59-33(45(72)60-18-5-9-34(60)44(71)56-28(8-4-17-52-46(50)51)39(66)53-23-37(49)64)24-74-73-19-16-38(65)54-30(21-26-10-12-27(61)13-11-26)41(68)57-31(42(69)55-29)20-25-6-2-1-3-7-25/h1-3,6-7,10-13,28-34,61H,4-5,8-9,14-24H2,(H2,47,62)(H2,48,63)(H2,49,64)(H,53,66)(H,54,65)(H,55,69)(H,56,71)(H,57,68)(H,58,67)(H,59,70)(H4,50,51,52)/t28-,29+,30+,31+,32+,33+,34+/m1/s1",NFLWUMRGJYTJIN-PNIOQBSNSA-N,,1068.42695588,C46H64N14O12S2,1069.2,489.0,1068.42695588,0.0,74.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,-4.0,"36  16  5
29  33  6
35  34  6
42  44  5
45  48  5
50  54  6
55  59  5
62  65  8
62  66  8
64  67  8
64  68  8
65  69  8
66  70  8
67  72  8
68  73  8
69  71  8
70  71  8
72  74  8
73  74  8",
440791104,2995,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01265,desipramine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01265,desipramine,3.0,Adverse reactions,Ambiguous DILI-concern,1.0,2995,1.0,267.0,2.0,1.0,4.0,AAADceB7AAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABYAAAAABQAAAHAAQAAAADAjBGAQywIPAAACAAiRCQACCAAAhAgAIiIAIZIgIIGLA0ZGEIAhgkADIyAcQgMAOAAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-1-propanamine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-<I>N</I>-methylpropan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-methyl-amine","InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3",HCYAFALTSJYZDH-UHFFFAOYSA-N,4.9,266.17829871,C18H22N2,266.4,15.3,266.17829871,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNCCCN1c2ccccc2CCc2ccccc21,,"11  16  8
12  17  8
13  18  8
14  19  8
16  18  8
17  19  8
5  11  8
5  8  8
6  12  8
6  9  8
8  13  8
9  14  8",
440791103,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01347,Denileukin diftitox,20210312,20210312,Curation Efforts|Governmental Organizations,LT01347,denileukin diftitox,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791102,5625,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00996,Delavirdine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00996,delavirdine,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,5625,1.0,749.0,7.0,3.0,6.0,AAADceB7sABAAAAAAAAAAAAAAAAAAWAAAAA8WIAAAAAAAFgB/AAAHgQQQAAADCjBngS/8PPJkAKoAzd3dHCCgCk3EiAJ2aG4dNiIYPLAnbGUIQholgLIyacYiYCeAACAQAACAAAAAQCAAAQAAAAAAAAAAA==,N-[2-[4-[3-(isopropylamino)-2-pyridyl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide,N-[2-[oxo-[4-[3-(propan-2-ylamino)-2-pyridinyl]-1-piperazinyl]methyl]-1H-indol-5-yl]methanesulfonamide,<I>N</I>-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1<I>H</I>-indol-5-yl]methanesulfonamide,N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide,N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl]methanesulfonamide,N-[2-[4-[3-(isopropylamino)-2-pyridyl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide,"InChI=1S/C22H28N6O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20/h4-8,13-15,24-26H,9-12H2,1-3H3",WHBIGIKBNXZKFE-UHFFFAOYSA-N,,456.19435995,C22H28N6O3S,456.6,119.0,456.19435995,0.0,32.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,2.4,"15  18  8
17  19  8
18  23  8
19  20  8
20  21  8
20  24  8
21  25  8
23  28  8
24  27  8
25  29  8
26  28  8
27  29  8
7  17  8
7  21  8
9  15  8
9  26  8",
440791101,16136245,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00655,Degarelix,20250421,20210312,Curation Efforts|Governmental Organizations,LT00655,degarelix,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,16136245,1.0,3390.0,18.0,17.0,41.0,AAADcfB//gAEAAAAAAAAAAAAAAAAAWAAAAA8eMGDAAAAAADB1AAAHgIQCAAADSrhmiY/wNPIEgCoAjV3VACCgCAxByAI2KG4ZpiKcP7B07GUYAhqtyLYyCcdicCOzAACAAAQAACYAAQAACAAAAAAAAAAAA==,"(4S)-N-[4-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthyl)propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-(3-pyridyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-[[(1R)-2-[[(1S)-1-[[(1S)-1-[(2S)-2-[[(1R)-2-amino-1-methyl-2-oxo-ethyl]carbamoyl]pyrrolidine-1-carbonyl]-5-(isopropylamino)pentyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-1-[(4-ureidophenyl)methyl]ethyl]amino]-3-oxo-propyl]phenyl]-2,6-dioxo-hexahydropyrimidine-4-carboxamide","(4S)-N-[4-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthalenyl)-1-oxopropyl]amino]-3-(4-chlorophenyl)-1-oxopropyl]amino]-1-oxo-3-(3-pyridinyl)propyl]amino]-3-hydroxy-1-oxopropyl]amino]-3-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[[(2R)-1-amino-1-oxopropan-2-yl]amino]-oxomethyl]-1-pyrrolidinyl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[4-(carbamoylamino)phenyl]-1-oxopropan-2-yl]amino]-3-oxopropyl]phenyl]-2,6-dioxo-1,3-diazinane-4-carboxamide","(4<I>S</I>)-<I>N</I>-[4-[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>R</I>)-2-[[(2<I>R</I>)-2-[[(2<I>R</I>)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-[[(2<I>R</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>R</I>)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[4-(carbamoylamino)phenyl]-1-oxopropan-2-yl]amino]-3-oxopropyl]phenyl]-2,6-dioxo-1,3-diazinane-4-carboxamide","(4S)-N-[4-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[4-(carbamoylamino)phenyl]-1-oxopropan-2-yl]amino]-3-oxopropyl]phenyl]-2,6-dioxo-1,3-diazinane-4-carboxamide","(4S)-N-[4-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-yl-propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-yl-propanoyl]amino]-3-oxidanyl-propanoyl]amino]-3-[[(2R)-3-[4-(aminocarbonylamino)phenyl]-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-azanyl-1-oxidanylidene-propan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxidanylidene-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-3-oxidanylidene-propyl]phenyl]-2,6-bis(oxidanylidene)-1,3-diazinane-4-carboxamide","(4S)-N-[4-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthyl)propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-(3-pyridyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-[[(1R)-2-[[(1S)-1-[[(1S)-1-[(2S)-2-[[(1R)-2-amino-2-keto-1-methyl-ethyl]carbamoyl]pyrrolidine-1-carbonyl]-5-(isopropylamino)pentyl]carbamoyl]-3-methyl-butyl]amino]-2-keto-1-(4-ureidobenzyl)ethyl]amino]-3-keto-propyl]phenyl]-2,6-diketo-hexahydropyrimidine-4-carboxamide","InChI=1S/C82H103ClN18O16/c1-45(2)35-60(72(107)92-59(16-9-10-33-87-46(3)4)80(115)101-34-12-17-68(101)79(114)88-47(5)70(84)105)93-74(109)63(38-51-23-30-58(31-24-51)91-81(85)116)95-76(111)64(39-50-21-28-57(29-22-50)90-71(106)66-42-69(104)100-82(117)99-66)97-78(113)67(44-102)98-77(112)65(41-53-13-11-32-86-43-53)96-75(110)62(37-49-19-26-56(83)27-20-49)94-73(108)61(89-48(6)103)40-52-18-25-54-14-7-8-15-55(54)36-52/h7-8,11,13-15,18-32,36,43,45-47,59-68,87,102H,9-10,12,16-17,33-35,37-42,44H2,1-6H3,(H2,84,105)(H,88,114)(H,89,103)(H,90,106)(H,92,107)(H,93,109)(H,94,108)(H,95,111)(H,96,110)(H,97,113)(H,98,112)(H3,85,91,116)(H2,99,100,104,117)/t47-,59+,60+,61-,62-,63-,64+,65-,66+,67+,68+/m1/s1",MEUCPCLKGZSHTA-XYAYPHGZSA-N,,1630.748797,C82H103ClN18O16,1632.3,513.0,1630.748797,0.0,117.0,11.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,3.5,"100  102  8
101  106  8
102  103  8
102  113  8
103  106  8
103  114  8
104  111  8
108  112  8
109  112  8
113  116  8
114  117  8
116  117  8
41  19  6
48  20  6
46  21  5
58  24  6
64  25  5
73  26  6
77  28  5
83  30  5
87  31  6
34  111  8
34  96  8
36  42  6
62  66  8
62  67  8
66  69  8
67  70  8
68  74  8
68  75  8
69  71  8
70  71  8
74  78  8
75  79  8
78  81  8
79  81  8
88  95  8
88  96  8
91  98  8
91  99  8
93  92  6
94  100  8
94  101  8
95  104  8
98  108  8
99  109  8",
440791100,451668,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00385,Decitabine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00385,decitabine,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,451668,1.0,356.0,4.0,3.0,2.0,AAADccBzuAAAAAAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAAAAAAAHgAQCAAACBThgAYBAANABgAoAAABNAAAAAEAAAABAAAIAACBEAIAiAAOQAAHBgIDAACwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one","4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-1,3,5-triazin-2-one","4-amino-1-[(2<I>R</I>,4<I>S</I>,5<I>R</I>)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one","4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one","4-azanyl-1-[(2R,4S,5R)-5-(hydroxymethyl)-4-oxidanyl-oxolan-2-yl]-1,3,5-triazin-2-one","4-amino-1-[(2R,4S,5R)-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]-s-triazin-2-one","InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1",XAUDJQYHKZQPEU-KVQBGUIXSA-N,-1.2,228.08585488,C8H12N4O4,228.21,121.0,228.08585488,0.0,16.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,,"11  13  6
9  2  5
12  5  6
5  14  8
5  15  8
6  14  8
6  16  8
7  15  8
7  16  8",
440791099,6058,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01256,CYSTEAMINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT01256,cysteamine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,6058,1.0,10.0,2.0,2.0,1.0,AAADcYBCAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAQQAAAAAADFQASAAABAAAQAAAAAAAAAAAAAAAAAAIAAAAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-aminoethanethiol,2-aminoethanethiol,2-aminoethanethiol,2-aminoethanethiol,2-azanylethanethiol,2-aminoethanethiol,"InChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2",UFULAYFCSOUIOV-UHFFFAOYSA-N,,77.0299204,C2H7NS,77.15,27.0,77.0299204,0.0,4.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCCS,-0.4,,
440791098,62816,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00881,COLESTIPOL,20250421,20210312,Curation Efforts|Governmental Organizations,LT00881,colestipol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,62816,1.0,116.0,6.0,5.0,11.0,AAADceBzoAAEAAAAAAAAAAAAEgAAAAAAAAAAAAAAAAAAAAAAAAAAHgIQAAAACBfhgEYAAALABAAAAAAAAAAAAAAAAAAAAIAIAwAAQAAAAAAQAAAAEACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;2-(chloromethyl)oxirane","N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;2-(chloromethyl)oxirane","<I>N</I>&apos;-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;2-(chloromethyl)oxirane","N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;2-(chloromethyl)oxirane","N'-[2-[2-(2-azanylethylamino)ethylamino]ethyl]ethane-1,2-diamine;2-(chloromethyl)oxirane",bis[2-(2-aminoethylamino)ethyl]amine;2-(chloromethyl)oxirane,"InChI=1S/C8H23N5.C3H5ClO/c9-1-3-11-5-7-13-8-6-12-4-2-10;4-1-3-2-5-3/h11-13H,1-10H2;3H,1-2H2",GMRWGQCZJGVHKL-UHFFFAOYSA-N,,281.1982382,C11H28ClN5O,281.83,101.0,281.1982382,0.0,18.0,0.0,1.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",ClCC1CO1.NCCNCCNCCNCCN,,8  10  3,
440791097,160051,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01080,Colesevelam,20250421,20210312,Curation Efforts|Governmental Organizations,LT01080,colesevelam,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,160051,1.0,301.0,5.0,4.0,22.0,AAADcfB7oAAGAAAAAAAAAAAAEgAAAAAAAAAAAAAAAAAAAAAAAAAAHgIQAAAACBfhgEYCAAPABACAACBCAACAAAAAAAAIAIAIAwAAAAIAgQAEAAAAEACAAAEQgIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,6-(allylamino)hexyl-trimethyl-ammonium;N-allyldecan-1-amine;2-(chloromethyl)oxirane;prop-2-en-1-amine;chloride;hydrochloride,2-(chloromethyl)oxirane;2-propen-1-amine;N-prop-2-enyl-1-decanamine;trimethyl-[6-(prop-2-enylamino)hexyl]ammonium;chloride;hydrochloride,2-(chloromethyl)oxirane;prop-2-en-1-amine;<I>N</I>-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride,allylamine;6-(allylamino)hexyl-trimethyl-ammonium;allyl(decyl)amine;2-(chloromethyl)oxirane;chloride;hydrochloride,"InChI=1S/C13H27N.C12H27N2.C3H5ClO.C3H7N.2ClH/c1-3-5-6-7-8-9-10-11-13-14-12-4-2;1-5-10-13-11-8-6-7-9-12-14(2,3)4;4-1-3-2-5-3;1-2-3-4;;/h4,14H,2-3,5-13H2,1H3;5,13H,1,6-12H2,2-4H3;3H,1-2H2;2H,1,3-4H2;2*1H/q;+1;;;;/p-1",VTAKZNRDSPNOAU-UHFFFAOYSA-M,,616.438046,C31H67Cl3N4O,618.2,62.6,616.438046,0.0,39.0,0.0,1.0,0.0,0.0,0.0,6.0,-1.0,"1
5
255",C=CCN.C=CCNCCCCCCCCCC.C=CCNCCCCCC[N+](C)(C)C.Cl.ClCC1CO1.[Cl-],,28  33  3,
440791096,6167,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00076,colchicine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00076,colchicine,6.0,Adverse reactions,Ambiguous DILI-concern,1.0,6167,1.0,740.0,6.0,1.0,5.0,AAADceB6OAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAABggAAAABAAAAHgAQAAAADCzBmAYyBoLABACIAqFSEAKCCAAgIAAAiIBOiMgNJyKEsR6EMCIl1hWKqYeQ8P8OoAABCAAYQABAAAIQADCAAAAAAAAAAA==,"N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide","N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide","<I>N</I>-[(7<I>S</I>)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5<I>H</I>-benzo[a]heptalen-7-yl]acetamide","N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide","N-[(7S)-1,2,3,10-tetramethoxy-9-oxidanylidene-6,7-dihydro-5H-benzo[a]heptalen-7-yl]ethanamide","N-[(7S)-9-keto-1,2,3,10-tetramethoxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide","InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1",IAKHMKGGTNLKSZ-INIZCTEOSA-N,1.0,399.16818752,C22H25NO6,399.4,83.1,399.16818752,0.0,29.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,,"11  14  8
11  17  8
12  13  8
12  16  8
13  15  8
14  18  8
15  19  8
16  20  8
17  21  8
18  23  8
19  20  8
21  24  8
23  24  8
8  7  5",
440791095,2803,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01231,clonidine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01231,clonidine,3.0,Adverse reactions,Ambiguous DILI-concern,1.0,2803,1.0,222.0,1.0,2.0,2.0,AAADccBzAAAGAAAAAAAAAAAAAAAAAQAAAAAwAAAAAAAAAAABAAAAHAIQAAAACArBECQxwILAAACgACRCZACCAAEhBQAJiIAIRoiIYCLBm5HUIAhokAJIyCcQAAAAAAAAAACAABAAAAAAAQAAIAAAAAAAAA==,"N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine","N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine","<I>N</I>-(2,6-dichlorophenyl)-4,5-dihydro-1<I>H</I>-imidazol-2-amine","N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine","N-[2,6-bis(chloranyl)phenyl]-4,5-dihydro-1H-imidazol-2-amine","(2,6-dichlorophenyl)-(2-imidazolin-2-yl)amine","InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)",GJSURZIOUXUGAL-UHFFFAOYSA-N,1.6,229.0173527,C9H9Cl2N3,230.09,36.4,229.0173527,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Clc1cccc(Cl)c1NC1=NCCN1,,"10  12  8
11  13  8
12  14  8
13  14  8
9  10  8
9  11  8",
440791094,2754,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01025,cilostazol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01025,cilostazol,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,2754,1.0,485.0,5.0,1.0,7.0,AAADceB7sAAAAAAAAAAAAAAAAAAAAWAAAAA8YIAAAAAAAACxwAAAHgAYAAAADCzhmwYx1obIBACqAidydACCCAMhooAdyAE+bIiMJjLEuZuGOCjk1BPI6Ae42bKeAEABAAACAAAAgAIAAAQAAAAAAAAAAA==,"6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one","6-[4-(1-cyclohexyl-5-tetrazolyl)butoxy]-3,4-dihydro-1H-quinolin-2-one","6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1<I>H</I>-quinolin-2-one","6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one","6-[4-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one","6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril","InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)",RRGUKTPIGVIEKM-UHFFFAOYSA-N,,369.21647512,C20H27N5O2,369.5,81.9,369.21647512,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,3.1,"19  21  8
19  24  8
21  26  8
23  24  8
23  27  8
26  27  8
3  14  8
3  4  8
4  6  8
5  14  8
5  6  8",
440791093,60613,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01216,Cidofovir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01216,cidofovir,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,60613,1.0,417.0,6.0,4.0,6.0,AAADccBzOAIAAAAAAAAAAAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAHggQCCAACBThgAYBAANABhCoQCJmdICAAAEAAgAIAAAYABCDEAAAAAAFQAACFgITAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,[(1S)-1-[(4-amino-2-oxo-pyrimidin-1-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid,[(2S)-1-(4-amino-2-oxo-1-pyrimidinyl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid,[(2<I>S</I>)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid,[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid,[(2S)-1-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3-oxidanyl-propan-2-yl]oxymethylphosphonic acid,[(1S)-1-[(4-amino-2-keto-pyrimidin-1-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid,"InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1",VWFCHDSQECPREK-LURJTMIESA-N,,279.06202217,C8H14N3O6P,279.19,146.0,279.06202217,0.0,18.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1,-3.6,"15  17  8
17  18  8
11  2  6
8  15  8
8  16  8
9  16  8
9  18  8",
440791092,70695641,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00328,Cholestyramine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00328,cholestyramine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,70695641,1.0,300.0,0.0,0.0,6.0,AAADceB6AAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHAAAAAAADQiBGAQywIMAAACAAiRCQACCAAAhAgAIiAAIZIgIICLAkZGEIAhggABIyAcQgMAOyAAAAAAAAACQAAAAAAAAAAAAAAAAAA==,[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-ammonium,[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethylammonium,[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethylazanium,[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethylazanium,[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-azanium,[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethyl-ammonium,"InChI=1S/C21H30N/c1-6-18-9-13-20(14-10-18)17(2)7-8-19-11-15-21(16-12-19)22(3,4)5/h9-17H,6-8H2,1-5H3/q+1",HGMSJMJPXGGEBP-UHFFFAOYSA-N,,296.237824961,C21H30N+,296.5,0.0,296.237824961,1.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCc1ccc(C(C)CCc2ccc([N+](C)(C)C)cc2)cc1,5.7,"11  14  8
12  15  8
16  19  8
17  20  8
18  19  8
18  20  8
2  13  3
5  11  8
5  12  8
6  14  8
6  15  8
7  16  8
7  17  8",
440791091,2732,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01213,chlorthalidone,20250421,20210312,Curation Efforts|Governmental Organizations,LT01213,chlorthalidone,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,2732,1.0,564.0,5.0,3.0,2.0,AAADccBzOABEAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgBQAAAHgYQSAAADA6B2CAwAYLAAgKIAiFSEHDCABAkBQAIiBkADskIJjKBlxGEcQhkxAGImYe+yOCOhAAAgAAQAIAIAAEAACABAAAAAAAAAA==,2-chloro-5-(1-hydroxy-3-oxo-isoindolin-1-yl)benzenesulfonamide,2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide,2-chloro-5-(1-hydroxy-3-oxo-2<I>H</I>-isoindol-1-yl)benzenesulfonamide,2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide,2-chloranyl-5-(1-oxidanyl-3-oxidanylidene-2H-isoindol-1-yl)benzenesulfonamide,2-chloro-5-(1-hydroxy-3-keto-isoindolin-1-yl)benzenesulfonamide,"InChI=1S/C14H11ClN2O4S/c15-11-6-5-8(7-12(11)22(16,20)21)14(19)10-4-2-1-3-9(10)13(18)17-14/h1-7,19H,(H,17,18)(H2,16,20,21)",JIVPVXMEBJLZRO-UHFFFAOYSA-N,,338.0128057,C14H11ClN2O4S,338.8,118.0,338.0128057,0.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,0.9,"10  12  8
10  15  8
11  14  8
11  16  8
12  18  8
14  17  8
15  19  8
16  20  8
17  21  8
18  22  8
19  22  8
20  21  8
9  3  3",
440791090,83898,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01048,Cevimeline,20231222,20210312,Curation Efforts|Governmental Organizations,LT01048,cevimeline,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,83898,1.0,215.0,3.0,0.0,0.0,AAADceByIABAAAAAAAAAAAAAAAAAASAAAAAsWLAAAAAAAAAAAAAAHgQAAAAADUTlwAaCAAMABAgAAAAAAAAAAAAAABAAAAAIAAACAAIggAAHAAAEAACwAAAwAAAOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine]","(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane]","(2<I>R</I>,5<I>R</I>)-2-methylspiro[1,3-oxathiolane-5,3&apos;-1-azabicyclo[2.2.2]octane]","(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane]","(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane]","(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine]","InChI=1S/C10H17NOS/c1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11/h8-9H,2-7H2,1H3/t8-,10-/m1/s1",WUTYZMFRCNBCHQ-PSASIEDQSA-N,,199.10308534,C10H17NOS,199.32,37.8,199.10308534,0.0,13.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1,1.5,"12  13  5
4  2  5",
440791089,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01412,Certolizumab pegol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01412,certolizumab pegol,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791088,38103,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01279,cephradine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01279,cephradine,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,38103,1.0,697.0,6.0,3.0,4.0,AAADceB7OABAAAAAAAAAAAAAAABYAAAAAAAgQAAAAAAQAAAAAAAAHgQQCAAADCjFwASCCAPAAgiIAiXSWACAAABgABAICIGIAEgCRBoggSAUEAAAlgC4EQIYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-(1-cyclohexa-1,4-dienyl)-1-oxoethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>R</I>)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-azanyl-2-cyclohexa-1,4-dien-1-yl-ethanoyl]amino]-3-methyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-8-keto-3-methyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C16H19N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1",RDLPVSKMFDYCOR-UEKVPHQBSA-N,0.4,349.10962727,C16H19N3O4S,349.4,138.0,349.10962727,0.0,24.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1,,"10  7  5
16  8  5
9  25  6",
440791087,6533629,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01281,ceftizoxime,20231222,20210312,Curation Efforts|Governmental Organizations,LT01281,ceftizoxime,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,6533629,1.0,669.0,10.0,3.0,5.0,AAADccBzuABgAAAAAAAAAAAAAABYAWAAAAAgAAAAAAAQAAABgAAAHgQUCAAACCjF1gajmRPYEgisASXyfAAA8KlhCjkACJW4IFiCZJggxCEUEAAAFgKwEaAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>Z</I>)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methyloximino-acetyl]amino]-8-keto-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C13H13N5O5S2/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22)/b17-7-/t8-,11-/m1/s1",NNULBSISHYWZJU-LLKWHZGFSA-N,0.0,383.03581088,C13H13N5O5S2,383.4,201.0,383.03581088,0.0,25.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=CCS[C@H]12)c1csc(N)n1,,"11  22  8
11  24  8
13  26  6
2  23  8
2  24  8
22  23  8
14  9  5",
440791086,5282242,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01183,ceftibuten,20231222,20210312,Curation Efforts|Governmental Organizations,LT01183,ceftibuten,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,5282242,1.0,755.0,10.0,4.0,6.0,AAADccBzuABgAAAAAAAAAAAAAABYAWAAAAAgAAAAAAAQAAABgAAAHgQQCAAADCjF1gShmRPIEgisAyXyfACC8KlhCjkAiJW4IFiKZBigxCEUUAAAVgK4kaYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-4-carboxy-but-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(Z)-2-(2-amino-4-thiazolyl)-4-carboxy-1-oxobut-2-enyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(<I>Z</I>)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(Z)-2-(2-azanyl-1,3-thiazol-4-yl)-5-oxidanyl-5-oxidanylidene-pent-2-enoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-4-carboxy-but-2-enoyl]amino]-8-keto-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C15H14N4O6S2/c16-15-17-7(5-27-15)6(1-2-9(20)21)11(22)18-10-12(23)19-8(14(24)25)3-4-26-13(10)19/h1,3,5,10,13H,2,4H2,(H2,16,17)(H,18,22)(H,20,21)(H,24,25)/b6-1-/t10-,13-/m1/s1",UNJFKXSSGBWRBZ-BJCIPQKHSA-N,,410.03547653,C15H14N4O6S2,410.4,216.0,410.03547653,0.0,27.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc(/C(=C/CC(=O)O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=CCS[C@H]23)cs1,-0.3,"14  10  5
11  22  8
11  26  8
13  28  6
2  25  8
2  26  8
22  25  8",
440791085,6335986,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01180,CEFPODOXIME,20231222,20210312,Curation Efforts|Governmental Organizations,LT01180,cefpodoxime,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,6335986,1.0,744.0,11.0,3.0,7.0,AAADceBzuABgAAAAAAAAAAAAAABYAWAAAAAgAAAAAAAQAAABgAAAHgQUCAAADCjl1gajmRPYFgisAwXyfAAA8KlhCjkACJW4IFiCZJgg5CEUEAAAFgKwMSAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>Z</I>)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-3-(methoxymethyl)-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methyloximino-acetyl]amino]-8-keto-3-(methoxymethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C15H17N5O6S2/c1-25-3-6-4-27-13-9(12(22)20(13)10(6)14(23)24)18-11(21)8(19-26-2)7-5-28-15(16)17-7/h5,9,13H,3-4H2,1-2H3,(H2,16,17)(H,18,21)(H,23,24)/b19-8-/t9-,13-/m1/s1",WYUSVOMTXWRGEK-HBWVYFAYSA-N,-1.4,427.06202563,C15H17N5O6S2,427.5,210.0,427.06202563,0.0,28.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",COCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC)c3csc(N)n3)[C@H]2SC1,,"15  10  5
12  24  8
12  27  8
14  29  6
2  26  8
2  27  8
24  26  8",
440791084,53025,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01178,cefotetan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01178,cefotetan,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,53025,1.0,1090.0,15.0,4.0,9.0,AAADceB7vABwAAAAAAAAAAAAAABYkWAAAAAgAAAAAAAQAAABgAAAHgQYCAAADAzFwAaDGAfIBgiqAgXQfAKAEQNAgJAFSAHIAEGCRAwoACQVUAACNgCwEQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7S)-7-[[4-(2-amino-1-carboxy-2-oxo-ethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-7-[[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]-oxomethyl]amino]-7-methoxy-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>S</I>)-7-[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-7-[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-7-[[4-[1-azanyl-3-oxidanyl-1,3-bis(oxidanylidene)propan-2-ylidene]-1,3-dithietan-2-yl]carbonylamino]-7-methoxy-3-[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanylmethyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-7-[[4-(2-amino-1-carboxy-2-keto-ethylidene)-1,3-dithietane-2-carbonyl]amino]-8-keto-7-methoxy-3-[[(1-methyltetrazol-5-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C17H17N7O8S4/c1-23-16(20-21-22-23)34-4-5-3-33-15-17(32-2,14(31)24(15)7(5)11(29)30)19-9(26)13-35-12(36-13)6(8(18)25)10(27)28/h13,15H,3-4H2,1-2H3,(H2,18,25)(H,19,26)(H,27,28)(H,29,30)/t13?,15-,17+/m1/s1",SRZNHPXWXCNNDU-RHBCBLIFSA-N,0.1,575.00214522,C17H17N7O8S4,575.6,321.0,575.00214522,0.0,36.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)O)S2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,,"14  26  1
15  17  8
15  32  8
16  18  8
16  32  8
17  18  8
21  37  6
20  5  6",
440791083,5362065,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01173,CEFIXIME,20231222,20210312,Curation Efforts|Governmental Organizations,LT01173,cefixime,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,5362065,1.0,861.0,12.0,4.0,8.0,AAADccB7uABgAAAAAAAAAAAAAABYAWAAAAAgAAAAAAAQAAABgAAAHgQUCAAADCjl1gahmRPYEgisAyXyfAIA8KlhCjkICJX4IFiLZJggxCEUEAAAFgKxkSAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>Z</I>)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-(2-hydroxy-2-oxoethyloxyimino)ethanoyl]amino]-3-ethenyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(carboxymethyloximino)acetyl]amino]-8-keto-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1",OKBVVJOGVLARMR-QSWIMTSFSA-N,-0.7,453.04129018,C16H15N5O7S2,453.5,238.0,453.04129018,0.0,30.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OCC(=O)O)c3csc(N)n3)[C@H]2SC1,,"16  11  5
13  26  8
13  28  8
15  31  6
2  27  8
2  28  8
26  27  8",
440791082,9870843,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01087,Cefditoren,20231222,20210312,Curation Efforts|Governmental Organizations,LT01087,cefditoren,2.0,Adverse reactions,Ambiguous DILI-concern,2.0,9870843,1.0,928.0,12.0,3.0,7.0,AAADceB7uABgAAAAAAAAAAAAAABYAWLAAAAgAAAAAAAQAAAB4AAAHgQUCAAADCjF1ganmRPYEgisAyXzfAAC8KlxCjkI2JW4YFiKZJjgxCEUEAAAlgL4kSYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(Z)-2-(4-methylthiazol-5-yl)vinyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-[(Z)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>Z</I>)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(<I>Z</I>)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methyloximino-acetyl]amino]-8-keto-3-[(Z)-2-(4-methylthiazol-5-yl)vinyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C19H18N6O5S3/c1-8-11(33-7-21-8)4-3-9-5-31-17-13(16(27)25(17)14(9)18(28)29)23-15(26)12(24-30-2)10-6-32-19(20)22-10/h3-4,6-7,13,17H,5H2,1-2H3,(H2,20,22)(H,23,26)(H,28,29)/b4-3-,24-12-/t13-,17-/m1/s1",KMIPKYQIOVAHOP-YLGJWRNMSA-N,0.7,506.05008122,C19H18N6O5S3,506.6,242.0,506.05008122,0.0,33.0,2.0,0.0,2.0,0.0,0.0,1.0,-1.0,"1
5
255",CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(/C=C\c3scnc3C)CS[C@H]12)c1csc(N)n1,,"16  10  5
12  27  8
12  31  8
13  28  8
13  32  8
15  34  6
2  26  8
2  32  8
26  28  8
27  29  8
3  29  8
3  31  8",
440791081,135483770,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01889,capreomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01889,capreomycin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,135483770,1.0,2470.0,23.0,27.0,19.0,AAADcfB//AAAAAAAAAAAAAAAAAAAAAAAAAAgQAAAAAAAAAAAAAAAHgAQCAAACCjhgAYDAALAAgCoAAVWdACAAAEAAgABAIGIAECCUB4AyCAUQAACNgKQAMEYCQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-2-methyl-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide","(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide","(3<I>S</I>)-3,6-diamino-<I>N</I>-[[(2<I>S</I>,5<I>S</I>,8<I>E</I>,11<I>S</I>,15<I>S</I>)-15-amino-11-[(4<I>R</I>)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3<I>S</I>)-3,6-diamino-<I>N</I>-[[(2<I>S</I>,5<I>S</I>,8<I>E</I>,11<I>S</I>,15<I>S</I>)-15-amino-11-[(4<I>R</I>)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide","(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide","(3S)-N-[[(2S,5S,8E,11S,15S)-8-[(aminocarbonylamino)methylidene]-15-azanyl-11-[(4R)-2-azanyl-1,4,5,6-tetrahydropyrimidin-4-yl]-2-(hydroxymethyl)-3,6,9,12,16-pentakis(oxidanylidene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]-3,6-bis(azanyl)hexanamide;(3S)-N-[[(2S,5S,8E,11S,15S)-8-[(aminocarbonylamino)methylidene]-15-azanyl-11-[(4R)-2-azanyl-1,4,5,6-tetrahydropyrimidin-4-yl]-2-methyl-3,6,9,12,16-pentakis(oxidanylidene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]-3,6-bis(azanyl)hexanamide","(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-3,6,9,12,16-pentaketo-2-methylol-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-3,6,9,12,16-pentaketo-2-methyl-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide","InChI=1S/C25H44N14O8.C25H44N14O7/c26-4-1-2-11(27)6-17(41)32-8-14-20(43)35-15(9-34-25(30)47)21(44)39-18(13-3-5-31-24(29)38-13)23(46)33-7-12(28)19(42)37-16(10-40)22(45)36-14;1-11-19(41)36-15(9-32-17(40)7-12(27)3-2-5-26)21(43)37-16(10-34-25(30)46)22(44)39-18(14-4-6-31-24(29)38-14)23(45)33-8-13(28)20(42)35-11/h9,11-14,16,18,40H,1-8,10,26-28H2,(H,32,41)(H,33,46)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29,31,38)(H3,30,34,47);10-15,18H,2-9,26-28H2,1H3,(H,32,40)(H,33,45)(H,35,42)(H,36,41)(H,37,43)(H,39,44)(H3,29,31,38)(H3,30,34,46)/b15-9+;16-10+/t11-,12-,13+,14-,16-,18-;11-,12-,13-,14+,15-,18-/m00/s1",VCOPTHOUUNAYKQ-WBTCAYNUSA-N,,1320.69839421,C50H88N28O15,1321.4,737.0,1320.69839421,0.0,93.0,12.0,0.0,2.0,0.0,0.0,2.0,-1.0,"1
5
255",C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@H]([C@H]2CCNC(N)=N2)NC(=O)/C(=C\NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC1=O.NCCC[C@H](N)CC(=O)NC[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@H]([C@H]2CCNC(N)=N2)NC(=O)/C(=C\NC(N)=O)NC1=O,,"58  32  6
61  33  6
69  36  6
72  37  6
44  94  6
45  95  6
46  96  5
47  97  5
62  70  5
64  73  5
67  84  5
71  89  5",
440791080,2479,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00707,butabarbital,20231222,20210312,Curation Efforts|Governmental Organizations,LT00707,butabarbital,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,2479,1.0,292.0,3.0,2.0,3.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAAAAAAAHgAQAAAADwCBgAADAALAAAAIAAEQEAAAAAAAAAAAAAEAAACAABoIwAAEAAAIBSIAAAEYAAAPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5-ethyl-5-sec-butyl-hexahydropyrimidine-2,4,6-trione","5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione","5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione","5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione","5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione",5-ethyl-5-sec-butyl-barbituric acid,"InChI=1S/C10H16N2O3/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15)",ZRIHAIZYIMGOAB-UHFFFAOYSA-N,1.6,212.11609238,C10H16N2O3,212.25,75.3,212.11609238,0.0,15.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(C)C1(CC)C(=O)NC(=O)NC1=O,,7  16  3,
440791079,2477,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01148,buspirone,20210804,20210312,Curation Efforts|Governmental Organizations,LT01148,buspirone,3.0,Adverse reactions,Ambiguous DILI-concern,1.0,2477,1.0,529.0,6.0,0.0,6.0,AAADceB7sAAAAAAAAAAAAAAAAAAAAYAAAAAsWLAAAAAAAAABgAAAHgAAAAAADgDBkgQ9kJcIEACoADF3dACAgCkRAqAJUCE4ZBCASJJAyUAUBAgIBiLAACEYiwCPAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione","8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione","8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione","8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione","8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione","8-[4-[4-(2-pyrimidyl)piperazino]butyl]-8-azaspiro[4.5]decane-7,9-quinone","InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.6,385.24777525,C21H31N5O2,385.5,69.6,385.24777525,0.0,28.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,,"26  28  8
27  28  8
6  25  8
6  26  8
7  25  8
7  27  8",
440791078,2405,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01136,BISOPROLOL,20210312,20210312,Curation Efforts|Governmental Organizations,LT01136,bisoprolol,3.0,Adverse reactions,Ambiguous DILI-concern,1.0,2405,1.0,278.0,5.0,2.0,12.0,AAADceB6OAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADDzhmAYyBoLABgCAAiBCAAACCAAgIAAIiIAOCIgPNiKEMRqGOCCm0BGbqAeA4CwOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,1-[4-(2-isopropoxyethoxymethyl)phenoxy]-3-(isopropylamino)propan-2-ol,1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]-2-propanol,1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol,1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol,1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol,1-[4-(2-isopropoxyethoxymethyl)phenoxy]-3-(isopropylamino)propan-2-ol,"InChI=1S/C18H31NO4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4/h5-8,14-15,17,19-20H,9-13H2,1-4H3",VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.9,325.22530847,C18H31NO4,325.4,60.0,325.22530847,0.0,23.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,,"12  16  8
12  17  8
13  20  8
13  21  8
16  20  8
17  21  8
7  26  3",
440791077,2369,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01132,betaxolol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01132,betaxolol,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,2369,1.0,286.0,4.0,2.0,11.0,AAADceB6MAAAAAAAAAAAAAAAGAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADTzhmAYyBoLABgCAAiBCAAACCAAgIAAIiIAOCIgPNiKEMRqGOCCm0BGbqAeAwKAOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)-2-propanol,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol,"InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3",NWIUTZDMDHAVTP-UHFFFAOYSA-N,2.8,307.21474379,C18H29NO3,307.4,50.7,307.21474379,0.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,,"11  16  8
11  17  8
12  34  3
16  21  8
17  22  8
18  21  8
18  22  8",
440791076,54585,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00512,BALSALAZIDE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00512,balsalazide,8.0,Adverse reactions,Ambiguous DILI-concern,2.0,54585,1.0,545.0,8.0,4.0,7.0,AAADccB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAYCAAADAzBmAQwzoLAAgCKAiXSWACCAAAkIgAIiIEObMgIJz6ClZOEcUhn9hGI2Ye8ySCeCEAAQAAIAAAQgACAABAAAAAAAAAAAA==,5-[4-(2-carboxyethylcarbamoyl)phenyl]azo-2-hydroxy-benzoic acid,5-[4-[(2-carboxyethylamino)-oxomethyl]phenyl]azo-2-hydroxybenzoic acid,5-[[4-(2-carboxyethylcarbamoyl)phenyl]diazenyl]-2-hydroxybenzoic acid,5-[[4-(2-carboxyethylcarbamoyl)phenyl]diazenyl]-2-hydroxybenzoic acid,5-[[4-(3-hydroxy-3-oxopropylcarbamoyl)phenyl]diazenyl]-2-oxidanyl-benzoic acid,5-[4-(2-carboxyethylcarbamoyl)phenyl]azo-2-hydroxy-benzoic acid,"InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)",IPOKCKJONYRRHP-UHFFFAOYSA-N,,357.09608521,C17H15N3O6,357.32,149.0,357.09608521,0.0,26.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1,2.2,"11  14  8
11  15  8
14  17  8
15  18  8
16  17  8
16  18  8
19  21  8
19  23  8
20  21  8
20  22  8
22  25  8
23  25  8",
440791075,5742832,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01110,aztreonam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01110,aztreonam,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,5742832,1.0,808.0,12.0,4.0,7.0,AAADceBzvABgAAAAAAAAAAAAAABYAWAAAAAAAAAAAAAAAAABgAAAHgQUSAAADGzF1gSjmRLYEoisAQXyfDIA8KlhCjkAAJX4IBiBYJggxCEUQAAAFgKBACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-[(Z)-[1-(2-aminothiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-azetidin-3-yl]amino]-2-oxo-ethylidene]amino]oxy-2-methyl-propanoic acid","2-[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid","2-[(<I>Z</I>)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2<I>S</I>,3<I>S</I>)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid","2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid","2-[(Z)-[1-(2-azanyl-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxidanylidene-1-sulfo-azetidin-3-yl]amino]-2-oxidanylidene-ethylidene]amino]oxy-2-methyl-propanoic acid","2-[(Z)-[1-(2-aminothiazol-4-yl)-2-keto-2-[[(3S,4S)-2-keto-4-methyl-1-sulfo-azetidin-3-yl]amino]ethylidene]amino]oxy-2-methyl-propionic acid","InChI=1S/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8-/t5-,7-/m0/s1",WZPBZJONDBGPKJ-VEHQQRBSSA-N,,435.05185486,C13H17N5O8S2,435.4,238.0,435.05185486,0.0,28.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O,0.3,"17  12  5
14  23  8
14  28  8
16  19  6
2  26  8
2  28  8
23  26  8",
440791074,518740,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01093,arsenic trioxide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01093,arsenic trioxide,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,518740,1.0,33.4,3.0,0.0,0.0,AAADcQAAMAAAAAAAQAAAAAAAAABIkAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2,4,5-trioxa-1,3-diarsabicyclo[1.1.1]pentane","2,4,5-trioxa-1,3-diarsabicyclo[1.1.1]pentane","2,4,5-trioxa-1,3-diarsabicyclo[1.1.1]pentane","2,4,5-trioxa-1,3-diarsabicyclo[1.1.1]pentane","2,4,5-trioxa-1,3-diarsabicyclo[1.1.1]pentane","2,4,5-trioxa-1,3-diarsabicyclo[1.1.1]pentane",InChI=1S/As2O3/c3-1-4-2(3)5-1,GOLCXWYRSKYTSP-UHFFFAOYSA-N,,197.82793,As2O3,197.841,27.7,197.82793,0.0,5.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O1[As]2O[As]1O2,,,
440791073,60795,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01143,Aripiprazole,20210804,20210312,Curation Efforts|Governmental Organizations,LT01143,aripiprazole,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,60795,1.0,559.0,4.0,1.0,7.0,AAADceB7MAAGAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxQAAAHgIQAAAADA7hmCYwxoPABACIAiVSUACCCAAhJwAIikEObogMZjLFs5vWOCjm1BnI6Ae42aOeIAAAAgICABRAAAAEBAQAKAAAAAAAAA==,"7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one","7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-1H-quinolin-2-one","7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1<I>H</I>-quinolin-2-one","7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one","7-[4-[4-[2,3-bis(chloranyl)phenyl]piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one","7-[4-[4-(2,3-dichlorophenyl)piperazino]butoxy]-3,4-dihydrocarbostyril","InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)",CEUORZQYGODEFX-UHFFFAOYSA-N,,447.1480325,C23H27Cl2N3O2,448.4,44.8,447.1480325,0.0,30.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,4.6,"14  17  8
14  18  8
17  23  8
18  24  8
19  21  8
19  28  8
21  26  8
22  26  8
22  29  8
23  27  8
24  27  8
28  29  8",
440791072,146027575,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00962,APROTININ,20250421,20210312,Curation Efforts|Governmental Organizations,LT00962,aprotinin,7.0,Adverse reactions,Ambiguous DILI-concern,2.0,146027575,1.0,16700.0,97.0,93.0,111.0,AAADcfB//gBwAAAAAAAAAAAAAAAAAWLFiwAwYMGDAAAAAAABVAAAHgQQCAAADTzl2AazDoPAAgioAiHSOAACAACgIBAJiIGOCIiKdj6i2TOUcAAm9hOYmAe/36KOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(3R)-4-[[(1S)-2-[[(1S,2aR,4R,5aR,8aR,11aR,13R,14aR,16S,17aS,19S,20aR,25S,26aR,29aR,31S,32aR,34S,35aS,37R,38aS,41aS,42R,44aS,45R,47aR,48S,50aS,51R,53aS,54R,56aR,57S,59aR,60S,62aS,63S,66S,69S,72S,75S,78S,81S,84S,87S,90S,93R)-29a,62a,69,84-tetrakis(4-aminobutyl)-35a,75,78-tris(2-amino-2-oxo-ethyl)-14a-(3-amino-3-oxo-propyl)-8a,41a,72-tribenzyl-31,60-bis(2-carboxyethyl)-42-[[2-[[2-[[(1R)-1-carboxyethyl]amino]-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-57-(carboxymethyl)-47a,48,56a,81,90-pentakis(3-guanidinopropyl)-11a,45-bis[(1S)-1-hydroxyethyl]-13-[(1R)-1-hydroxyethyl]-66-(hydroxymethyl)-2a,16,38a,44a-tetrakis[(4-hydroxyphenyl)methyl]-20a,34-diisobutyl-5a-isopropyl-26a,32a,59a,63,87-pentamethyl-50a,53a-bis[(1R)-1-methylpropyl]-51-(2-methylsulfanylethyl)-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,22a,24,25a,28a,30,31a,33,34a,36,37a,40a,43a,44,46a,47,49a,50,52a,53,55a,56,58a,59,61a,62,64a,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-39,40,66a,67a,70a,71a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,21a,23,24a,27a,29,30a,32,33a,35,36a,39a,42a,43,45a,46,48a,49,51a,52,54a,55,57a,58,60a,61,63a,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazahexacyclo[91.71.4.454,117.04,8.019,23.025,29]doheptacontahectan-37-yl]amino]-1-benzyl-2-oxo-ethyl]amino]-3-[[(2S)-1-[(2S)-2-amino-5-guanidino-pentanoyl]pyrrolidine-2-carbonyl]amino]-4-oxo-butanoic acid","(3R)-4-[[(2S)-1-[[(1S,2aR,4R,5aR,8aR,11aR,13R,14aR,16S,17aS,19S,20aR,25S,26aR,29aR,31S,32aR,34S,35aS,37R,38aS,41aS,42R,44aS,45R,47aR,48S,50aS,51R,53aS,54R,56aR,57S,59aR,60S,62aS,63S,66S,69S,72S,75S,78S,81S,84S,87S,90S,93R)-29a,62a,69,84-tetrakis(4-aminobutyl)-35a,75,78-tris(2-amino-2-oxoethyl)-14a-(3-amino-3-oxopropyl)-50a,53a-bis[(2R)-butan-2-yl]-47a,48,56a,81,90-pentakis(3-carbamimidamidopropyl)-31,60-bis(2-carboxyethyl)-42-[[[2-[[2-[[(1R)-1-carboxyethyl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-oxomethyl]-57-(carboxymethyl)-11a,45-bis[(1S)-1-hydroxyethyl]-13-[(1R)-1-hydroxyethyl]-66-(hydroxymethyl)-2a,16,38a,44a-tetrakis[(4-hydroxyphenyl)methyl]-26a,32a,59a,63,87-pentamethyl-20a,34-bis(2-methylpropyl)-51-[2-(methylthio)ethyl]-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,22a,24,25a,28a,30,31a,33,34a,36,37a,40a,43a,44,46a,47,49a,50,52a,53,55a,56,58a,59,61a,62,64a,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-8a,41a,72-tris(phenylmethyl)-5a-propan-2-yl-39,40,66a,67a,70a,71a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,21a,23,24a,27a,29,30a,32,33a,35,36a,39a,42a,43,45a,46,48a,49,51a,52,54a,55,57a,58,60a,61,63a,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazahexacyclo[91.71.4.454,117.04,8.019,23.025,29]doheptacontahectan-37-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[[[(2S)-1-[(2S)-2-amino-5-carbamimidamido-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-4-oxobutanoic acid","(3<I>R</I>)-4-[[(2<I>S</I>)-1-[[(1<I>S</I>,2<I>a</I><I>R</I>,4<I>R</I>,5<I>a</I><I>R</I>,8<I>a</I><I>R</I>,11<I>a</I><I>R</I>,13<I>R</I>,14<I>a</I><I>R</I>,16<I>S</I>,17<I>a</I><I>S</I>,19<I>S</I>,20<I>a</I><I>R</I>,25<I>S</I>,26<I>a</I><I>R</I>,29<I>a</I><I>R</I>,31<I>S</I>,32<I>a</I><I>R</I>,34<I>S</I>,35<I>a</I><I>S</I>,37<I>R</I>,38<I>a</I><I>S</I>,41<I>a</I><I>S</I>,42<I>R</I>,44<I>a</I><I>S</I>,45<I>R</I>,47<I>a</I><I>R</I>,48<I>S</I>,50<I>a</I><I>S</I>,51<I>R</I>,53<I>a</I><I>S</I>,54<I>R</I>,56<I>a</I><I>R</I>,57<I>S</I>,59<I>a</I><I>R</I>,60<I>S</I>,62<I>a</I><I>S</I>,63<I>S</I>,66<I>S</I>,69<I>S</I>,72<I>S</I>,75<I>S</I>,78<I>S</I>,81<I>S</I>,84<I>S</I>,87<I>S</I>,90<I>S</I>,93<I>R</I>)-29<I>a</I>,62<I>a</I>,69,84-tetrakis(4-aminobutyl)-35<I>a</I>,75,78-tris(2-amino-2-oxoethyl)-14<I>a</I>-(3-amino-3-oxopropyl)-8<I>a</I>,41<I>a</I>,72-tribenzyl-50<I>a</I>,53<I>a</I>-bis[(2<I>R</I>)-butan-2-yl]-47<I>a</I>,48,56<I>a</I>,81,90-pentakis(3-carbamimidamidopropyl)-31,60-bis(2-carboxyethyl)-42-[[2-[[2-[[(1<I>R</I>)-1-carboxyethyl]amino]-2-oxoethyl]amino]-2-oxoethyl]carbamoyl]-57-(carboxymethyl)-11<I>a</I>,45-bis[(1<I>S</I>)-1-hydroxyethyl]-13-[(1<I>R</I>)-1-hydroxyethyl]-66-(hydroxymethyl)-2<I>a</I>,16,38<I>a</I>,44<I>a</I>-tetrakis[(4-hydroxyphenyl)methyl]-26<I>a</I>,32<I>a</I>,59<I>a</I>,63,87-pentamethyl-20<I>a</I>,34-bis(2-methylpropyl)-51-(2-methylsulfanylethyl)-1<I>a</I>,3,4<I>a</I>,7<I>a</I>,9,10<I>a</I>,12,13<I>a</I>,15,16<I>a</I>,18,19<I>a</I>,22<I>a</I>,24,25<I>a</I>,28<I>a</I>,30,31<I>a</I>,33,34<I>a</I>,36,37<I>a</I>,40<I>a</I>,43<I>a</I>,44,46<I>a</I>,47,49<I>a</I>,50,52<I>a</I>,53,55<I>a</I>,56,58<I>a</I>,59,61<I>a</I>,62,64<I>a</I>,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-5<I>a</I>-propan-2-yl-39,40,66<I>a</I>,67<I>a</I>,70<I>a</I>,71<I>a</I>-hexathia-<I>a</I>,2,3<I>a</I>,6<I>a</I>,8,9<I>a</I>,11,12<I>a</I>,14,15<I>a</I>,17,18<I>a</I>,21<I>a</I>,23,24<I>a</I>,27<I>a</I>,29,30<I>a</I>,32,33<I>a</I>,35,36<I>a</I>,39<I>a</I>,42<I>a</I>,43,45<I>a</I>,46,48<I>a</I>,49,51<I>a</I>,52,54<I>a</I>,55,57<I>a</I>,58,60<I>a</I>,61,63<I>a</I>,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazahexacyclo[91.71.4.4<SUP>54,117</SUP>.0<SUP>4,8</SUP>.0<SUP>19,23</SUP>.0<SUP>25,29</SUP>]doheptacontahectan-37-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoic acid","(3R)-4-[[(2S)-1-[[(1S,2aR,4R,5aR,8aR,11aR,13R,14aR,16S,17aS,19S,20aR,25S,26aR,29aR,31S,32aR,34S,35aS,37R,38aS,41aS,42R,44aS,45R,47aR,48S,50aS,51R,53aS,54R,56aR,57S,59aR,60S,62aS,63S,66S,69S,72S,75S,78S,81S,84S,87S,90S,93R)-29a,62a,69,84-tetrakis(4-aminobutyl)-35a,75,78-tris(2-amino-2-oxoethyl)-14a-(3-amino-3-oxopropyl)-8a,41a,72-tribenzyl-50a,53a-bis[(2R)-butan-2-yl]-47a,48,56a,81,90-pentakis(3-carbamimidamidopropyl)-31,60-bis(2-carboxyethyl)-42-[[2-[[2-[[(1R)-1-carboxyethyl]amino]-2-oxoethyl]amino]-2-oxoethyl]carbamoyl]-57-(carboxymethyl)-11a,45-bis[(1S)-1-hydroxyethyl]-13-[(1R)-1-hydroxyethyl]-66-(hydroxymethyl)-2a,16,38a,44a-tetrakis[(4-hydroxyphenyl)methyl]-26a,32a,59a,63,87-pentamethyl-20a,34-bis(2-methylpropyl)-51-(2-methylsulfanylethyl)-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,22a,24,25a,28a,30,31a,33,34a,36,37a,40a,43a,44,46a,47,49a,50,52a,53,55a,56,58a,59,61a,62,64a,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-5a-propan-2-yl-39,40,66a,67a,70a,71a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,21a,23,24a,27a,29,30a,32,33a,35,36a,39a,42a,43,45a,46,48a,49,51a,52,54a,55,57a,58,60a,61,63a,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazahexacyclo[91.71.4.454,117.04,8.019,23.025,29]doheptacontahectan-37-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoic acid","(3R)-4-[[(2S)-1-[[(1S,2aR,4R,5aR,8aR,11aR,13R,14aR,16S,17aS,19S,20aR,25S,26aR,29aR,31S,32aR,34S,35aS,37R,38aS,41aS,42R,44aS,45R,47aR,48S,50aS,51R,53aS,54R,56aR,57S,59aR,60S,62aS,63S,66S,69S,72S,75S,78S,81S,84S,87S,90S,93R)-29a,62a,69,84-tetrakis(4-azanylbutyl)-35a,75,78-tris(2-azanyl-2-oxidanylidene-ethyl)-14a-(3-azanyl-3-oxidanylidene-propyl)-50a,53a-bis[(2R)-butan-2-yl]-47a,48,56a,81,90-pentakis(3-carbamimidamidopropyl)-66-(hydroxymethyl)-57-(2-hydroxy-2-oxoethyl)-31,60-bis(3-hydroxy-3-oxopropyl)-2a,16,38a,44a-tetrakis[(4-hydroxyphenyl)methyl]-26a,32a,59a,63,87-pentamethyl-20a,34-bis(2-methylpropyl)-51-(2-methylsulfanylethyl)-11a,45-bis[(1S)-1-oxidanylethyl]-13-[(1R)-1-oxidanylethyl]-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,22a,24,25a,28a,30,31a,33,34a,36,37a,40a,43a,44,46a,47,49a,50,52a,53,55a,56,58a,59,61a,62,64a,65,68,71,74,77,80,83,86,89,92,95,98-pentacontakis(oxidanylidene)-42-[[2-oxidanylidene-2-[[2-oxidanylidene-2-[[(2R)-1-oxidanyl-1-oxidanylidene-propan-2-yl]amino]ethyl]amino]ethyl]carbamoyl]-8a,41a,72-tris(phenylmethyl)-5a-propan-2-yl-39,40,66a,67a,70a,71a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,21a,23,24a,27a,29,30a,32,33a,35,36a,39a,42a,43,45a,46,48a,49,51a,52,54a,55,57a,58,60a,61,63a,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazahexacyclo[91.71.4.454,117.04,8.019,23.025,29]doheptacontahectan-37-yl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-3-[[(2S)-1-[(2S)-2-azanyl-5-carbamimidamido-pentanoyl]pyrrolidin-2-yl]carbonylamino]-4-oxidanylidene-butanoic acid","(3R)-4-[[(1S)-2-[[(1S,2aR,4R,5aR,8aR,11aR,13R,14aR,16S,17aS,19S,20aR,25S,26aR,29aR,31S,32aR,34S,35aS,37R,38aS,41aS,42R,44aS,45R,47aR,48S,50aS,51R,53aS,54R,56aR,57S,59aR,60S,62aS,63S,66S,69S,72S,75S,78S,81S,84S,87S,90S,93R)-29a,62a,69,84-tetrakis(4-aminobutyl)-35a,75,78-tris(2-amino-2-keto-ethyl)-14a-(3-amino-3-keto-propyl)-8a,41a,72-tribenzyl-31,60-bis(2-carboxyethyl)-42-[[2-[[2-[[(1R)-1-carboxyethyl]amino]-2-keto-ethyl]amino]-2-keto-ethyl]carbamoyl]-57-(carboxymethyl)-47a,48,56a,81,90-pentakis(3-guanidinopropyl)-2a,16,38a,44a-tetrakis(4-hydroxybenzyl)-11a,45-bis[(1S)-1-hydroxyethyl]-13-[(1R)-1-hydroxyethyl]-20a,34-diisobutyl-5a-isopropyl-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,22a,24,25a,28a,30,31a,33,34a,36,37a,40a,43a,44,46a,47,49a,50,52a,53,55a,56,58a,59,61a,62,64a,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaketo-26a,32a,59a,63,87-pentamethyl-66-methylol-50a,53a-bis[(1R)-1-methylpropyl]-51-[2-(methylthio)ethyl]-39,40,66a,67a,70a,71a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,21a,23,24a,27a,29,30a,32,33a,35,36a,39a,42a,43,45a,46,48a,49,51a,52,54a,55,57a,58,60a,61,63a,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazahexacyclo[91.71.4.454,117.04,8.019,23.025,29]doheptacontahectan-37-yl]amino]-1-benzyl-2-keto-ethyl]amino]-3-[[(2S)-1-[(2S)-2-amino-5-guanidino-pentanoyl]prolyl]amino]-4-keto-butyric acid","InChI=1S/C284H432N84O79S7/c1-21-144(9)222-271(439)337-174(68-46-105-309-282(300)301)239(407)340-187(120-160-77-85-164(374)86-78-160)251(419)341-185(116-156-55-29-24-30-56-156)250(418)342-188(121-161-79-87-165(375)88-80-161)252(420)346-191(123-208(291)378)246(414)322-149(14)230(398)326-168(62-35-39-98-285)234(402)319-146(11)227(395)314-132-215(385)324-181(113-141(3)4)247(415)354-199-137-452-453-138-200-263(431)336-179(97-112-448-20)242(410)331-176(70-48-107-311-284(304)305)244(412)363-226(154(19)372)274(442)358-197(233(401)316-129-212(382)312-130-213(383)318-151(16)278(446)447)135-449-451-139-201(355-253(421)186(117-157-57-31-25-32-58-157)344-256(424)195(127-220(393)394)350-267(435)204-72-50-109-366(204)275(443)167(289)61-43-102-306-279(294)295)265(433)339-182(114-142(5)6)248(416)338-180(93-96-218(389)390)276(444)368-111-52-74-206(368)277(445)367-110-51-73-205(367)268(436)349-189(122-162-81-89-166(376)90-82-162)259(427)362-224(152(17)370)269(437)317-133-216(386)365-108-49-71-203(365)266(434)357-202(264(432)333-169(63-36-40-99-286)235(403)320-148(13)229(397)328-175(69-47-106-310-283(302)303)243(411)360-223(145(10)22-2)272(440)361-222)140-454-450-136-198(325-214(384)131-313-211(381)128-315-232(400)183(119-159-75-83-163(373)84-76-159)351-270(438)221(143(7)8)359-258(426)190(118-158-59-33-26-34-60-158)352-273(441)225(153(18)371)364-245(413)177(335-262(199)430)91-94-207(290)377)261(429)334-172(66-44-103-307-280(296)297)236(404)321-147(12)228(396)327-170(64-37-41-100-287)237(405)330-173(67-45-104-308-281(298)299)238(406)345-192(124-209(292)379)255(423)347-193(125-210(293)380)254(422)343-184(115-155-53-27-23-28-54-155)249(417)332-171(65-38-42-101-288)240(408)353-196(134-369)260(428)323-150(15)231(399)329-178(92-95-217(387)388)241(409)348-194(126-219(391)392)257(425)356-200/h23-34,53-60,75-90,141-154,167-206,221-226,369-376H,21-22,35-52,61-74,91-140,285-289H2,1-20H3,(H2,290,377)(H2,291,378)(H2,292,379)(H2,293,380)(H,312,382)(H,313,381)(H,314,395)(H,315,400)(H,316,401)(H,317,437)(H,318,383)(H,319,402)(H,320,403)(H,321,404)(H,322,414)(H,323,428)(H,324,385)(H,325,384)(H,326,398)(H,327,396)(H,328,397)(H,329,399)(H,330,405)(H,331,410)(H,332,417)(H,333,432)(H,334,429)(H,335,430)(H,336,431)(H,337,439)(H,338,416)(H,339,433)(H,340,407)(H,341,419)(H,342,418)(H,343,422)(H,344,424)(H,345,406)(H,346,420)(H,347,423)(H,348,409)(H,349,436)(H,350,435)(H,351,438)(H,352,441)(H,353,408)(H,354,415)(H,355,421)(H,356,425)(H,357,434)(H,358,442)(H,359,426)(H,360,411)(H,361,440)(H,362,427)(H,363,412)(H,364,413)(H,387,388)(H,389,390)(H,391,392)(H,393,394)(H,446,447)(H4,294,295,306)(H4,296,297,307)(H4,298,299,308)(H4,300,301,309)(H4,302,303,310)(H4,304,305,311)/t144-,145-,146-,147+,148-,149-,150+,151-,152-,153+,154+,167+,168-,169+,170+,171+,172+,173+,174-,175-,176+,177-,178+,179-,180+,181-,182+,183-,184+,185+,186+,187+,188+,189+,190-,191+,192+,193+,194+,195-,196+,197+,198+,199-,200+,201+,202-,203-,204+,205+,206+,221-,222+,223+,224-,225-,226-/m1/s1",ZPNFWUPYTFPOJU-VKTQZXOTSA-N,,6510.0514478,C284H432N84O79S7,6511.0,2820.0,6507.0413833,0.0,454.0,57.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(/N)NCCC[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](CCCN/C(N)=N/[H])NC(=O)[C@H]2CSSC[C@H]3NC(=O)[C@H]4CCCN4C(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](Cc4ccc(O)cc4)NC(=O)[C@H]4CCCN4C(=O)[C@H]4CCCN4C(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@@H](N)CCCN/C(N)=N\[H])CSSC[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CCCN/C(N)=N/[H])NC(=O)[C@@H](CCSC)NC(=O)[C@H](CSSC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCN/C(N)=N\[H])NC(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC3=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,-25.4,"240  103  5
199  15  6
171  173  6
172  175  6
182  183  6
184  186  6
188  190  6
191  195  8
191  196  8
194  201  6
195  203  8
196  204  8
203  205  8
204  205  8
209  210  6
215  217  6
218  226  8
218  227  8
219  225  6
222  230  5
223  236  5
224  233  6
226  234  8
227  235  8
234  239  8
235  239  8
238  243  6
244  242  6
256  252  6
255  261  6
260  262  6
268  273  6
269  275  6
274  281  6
283  292  6
285  294  5
288  298  5
290  299  6
295  305  6
297  308  6
302  311  5
249  31  6
312  314  6
315  323  6
317  322  6
321  327  5
328  332  6
336  329  6
335  343  6
337  347  8
337  348  8
338  344  6
341  345  5
347  358  8
348  359  8
352  365  6
353  373  8
353  374  8
358  364  8
359  364  8
360  369  5
361  372  5
366  377  6
367  381  6
368  378  5
373  385  8
374  386  8
379  387  5
385  391  8
386  391  8
388  398  6
392  404  8
392  405  8
394  406  8
394  407  8
397  408  6
400  410  6
404  413  8
405  414  8
406  415  8
407  416  8
411  422  6
413  418  8
414  418  8
415  421  8
416  421  8
417  427  8
417  428  8
419  424  6
425  432  6
427  435  8
428  436  8
429  437  5
431  439  8
431  440  8
435  438  8
436  438  8
439  446  8
440  447  8
443  451  5
444  448  5
446  450  8
447  450  8
393  71  6
202  94  5",
440791071,135413536,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01195,Aprepitant,20210312,20210312,Curation Efforts|Governmental Organizations,LT01195,aprepitant,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,135413536,1.0,810.0,12.0,2.0,6.0,AAADceB7scAAAAAAAAAAAAAAAAAAAQAAAAA8YIAAAAAAAAABQAAAHwAYAAAADDzxmB8zCIPiBACoAiJiMACSAAAgAAAPiAAYDIiaZiKAsRm3MAh03AOcqAeQwOAOAAACAAAAAAAAAAQAAAAAAAAAAAAAAA==,"3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one","3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,4-dihydro-1,2,4-triazol-5-one","3-[[(2<I>R</I>,3<I>S</I>)-2-[(1<I>R</I>)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one","3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one","3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one","3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1,4-dihydro-1,2,4-triazol-5-one","InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1",ATALOFNDEOCMKK-OITMNORJSA-N,,534.15018768,C23H21F7N4O3,534.4,75.2,534.15018768,0.0,37.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)C1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,4.2,"12  22  8
12  34  8
13  14  8
13  22  8
14  34  8
15  19  5
19  23  8
19  24  8
23  27  8
24  28  8
25  29  8
25  30  8
27  31  8
28  31  8
29  32  8
30  33  8
32  35  8
33  35  8
16  9  5
21  9  5",
440791070,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01442,Antithymocyte globulin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01442,antithymocyte globulin,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791069,3698,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01076,Amrinone,20210312,20210312,Curation Efforts|Governmental Organizations,LT01076,amrinone,5.0,Adverse reactions,Ambiguous DILI-concern,2.0,3698,1.0,300.0,3.0,2.0,1.0,AAADccBzIAAAAAAAAAAAAAAAAAAAAAAAAAAsQAAAAAAAAAABgAAAHgAQAAAADAjBmgQ8gJLIEACoAjV3VACCgCAxAiAI2KC4ZNgIYGLAkZGUIAhgggDIyYYQAAAKAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,3-amino-5-(4-pyridyl)-1H-pyridin-2-one,3-amino-5-pyridin-4-yl-1H-pyridin-2-one,3-amino-5-pyridin-4-yl-1<I>H</I>-pyridin-2-one,3-amino-5-pyridin-4-yl-1H-pyridin-2-one,3-azanyl-5-pyridin-4-yl-1H-pyridin-2-one,3-amino-5-(4-pyridyl)-2-pyridone,"InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)",RNLQIBCLLYYYFJ-UHFFFAOYSA-N,,187.074561919,C10H9N3O,187.2,68.0,187.074561919,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1cc(-c2ccncc2)c[nH]c1=O,-0.2,"11  13  8
12  14  8
2  10  8
2  8  8
4  13  8
4  14  8
5  7  8
5  8  8
6  11  8
6  12  8
7  9  8
9  10  8",
440791068,2170,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00256,amoxapine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00256,amoxapine,3.0,Adverse reactions,Ambiguous DILI-concern,2.0,2170,1.0,424.0,3.0,1.0,1.0,AAADceB7IAAEAAAAAAAAAAAAAAAAAAAAAAA8YIAABAAAAAABQAAAHgIQAAAADA7BmCQxxoPABACgAiZiZACCCAEgJwAJiIAvbpgOZqKFu5uXOCjm0BGI6AeQwCAOACAAIAAIEAAAQABAABAgAAAAAAAAAA==,"8-chloro-6-piperazin-1-yl-benzo[b][1,4]benzoxazepine","8-chloro-6-(1-piperazinyl)benzo[b][1,4]benzoxazepine","8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine","8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine","8-chloranyl-6-piperazin-1-yl-benzo[b][1,4]benzoxazepine","8-chloro-6-piperazino-benzo[b][1,4]benzoxazepine","InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2",QWGDMFLQWFTERH-UHFFFAOYSA-N,,313.0981898,C17H16ClN3O,313.8,36.9,313.0981898,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,2.6,"11  12  8
11  14  8
12  16  8
13  15  8
13  19  8
14  17  8
15  20  8
16  18  8
17  18  8
19  21  8
20  22  8
21  22  8",
440791067,6918493,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00618,Ambrisentan,20231222,20210312,Curation Efforts|Governmental Organizations,LT00618,ambrisentan,7.0,Adverse reactions,Ambiguous DILI-concern,1.0,6918493,1.0,475.0,6.0,1.0,7.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAAB0AAAHgAACAAADFyhngIzmJYIFgCoAyTybAKCgCkhAqAJmCFwbJiJLjbA+dyMdAht4ANL6CeIyOCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid","(2S)-2-[(4,6-dimethyl-2-pyrimidinyl)oxy]-3-methoxy-3,3-diphenylpropanoic acid","(2<I>S</I>)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid","(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid","(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid","(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propionic acid","InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1",OUJTZYPIHDYQMC-LJQANCHMSA-N,,378.15795719,C22H22N2O4,378.4,81.5,378.15795719,0.0,28.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O,3.8,"10  12  8
10  14  8
11  17  8
12  18  8
13  19  8
14  20  8
17  21  8
18  22  8
19  21  8
8  2  6
20  22  8
24  26  8
25  26  8
5  23  8
5  24  8
6  23  8
6  25  8
9  11  8
9  13  8",
440791066,2123,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00502,altretamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00502,altretamine,2.0,Adverse reactions,Ambiguous DILI-concern,1.0,2123,1.0,148.0,6.0,0.0,3.0,AAADceBzgAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAFAAAAAAAAAAAAAQDEAcIEAAgAAAAJAAAAAkAAIABAAAIAACACAAAAAAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine","N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine","2-<I>N</I>,2-<I>N</I>,4-<I>N</I>,4-<I>N</I>,6-<I>N</I>,6-<I>N</I>-hexamethyl-1,3,5-triazine-2,4,6-triamine","2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine","N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine","[4,6-bis(dimethylamino)-s-triazin-2-yl]-dimethyl-amine",InChI=1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,2.7,210.1592946,C9H18N6,210.28,48.4,210.1592946,0.0,15.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)c1nc(N(C)C)nc(N(C)C)n1,,"4  7  8
4  8  8
5  7  8
5  9  8
6  8  8
6  9  8",
440791065,4775,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02343,4-PHENYLBUTYRIC ACID,20231222,20210312,Curation Efforts|Governmental Organizations,LT02343,4-phenylbutyric acid,4.0,Adverse reactions,Ambiguous DILI-concern,2.0,4775,1.0,137.0,2.0,1.0,4.0,AAADccBwMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgAACAAADACAmAAwCIAAAgCIAiDSCAACAAAgAAAIiAEAAIgIIDKAERCAYAAkgAAIiAeIyLCOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,4-phenylbutanoic acid,4-phenylbutanoic acid,4-phenylbutanoic acid,4-phenylbutanoic acid,4-phenylbutanoic acid,4-phenylbutyric acid,"InChI=1S/C10H12O2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H,11,12)",OBKXEAXTFZPCHS-UHFFFAOYSA-N,2.4,164.083729621,C10H12O2,164.2,37.3,164.083729621,0.0,12.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)CCCc1ccccc1,,"10  12  8
11  12  8
5  7  8
5  8  8
7  10  8
8  11  8",
440791064,31401,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01855,URSODEOXYCHOLIC ACID,20231222,20210312,Curation Efforts|Governmental Organizations,LT01855,ursodeoxycholic acid,0.0,Warnings and precautions,Ambiguous DILI-concern,2.0,31401,1.0,605.0,4.0,3.0,4.0,AAADcfB4OAAAAAAAAAAAAAAAAAAAAYAAAAAwYMAAAAAAAGDAAAAAGgAACAAADxSggAICCAAAAgAIAACQCAAAAAAAAAAAAAEAAAAAEBIAAAAAQAAEAAAAAAGI6PSPgAAAAAAAAADAAAYAADAAAQAACAAAAA==,"(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","(4<I>R</I>)-4-[(3<I>R</I>,5<I>S</I>,7<I>S</I>,8<I>R</I>,9<I>S</I>,10<I>S</I>,13<I>R</I>,14<I>S</I>,17<I>R</I>)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1<I>H</I>-cyclopenta[a]phenanthren-17-yl]pentanoic acid","(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid","InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1",RUDATBOHQWOJDD-UZVSRGJWSA-N,,392.29265975,C24H40O4,392.6,77.8,392.29265975,0.0,28.0,10.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,4.9,"14  1  5
10  32  6
11  33  5
24  2  6
20  26  6
5  29  6
6  19  5
7  30  5
8  31  6
9  22  5",
440791063,5583,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01843,trimetrexate,20210312,20210312,Curation Efforts|Governmental Organizations,LT01843,trimetrexate,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,5583,1.0,457.0,8.0,3.0,6.0,AAADceB7sAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACx9AAAHgAQAAAADAzBngYz9vbIFACgAyZiZACCiCkhIqAJmKA+7JiNL6LE+duENCpv0B/K6Cew8M8OiEACSgASQAAQgASUACSAAAAAAAAAAA==,"5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine","5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine","5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine","5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine","5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]quinazoline-2,4-diamine","(2,4-diamino-5-methyl-quinazolin-6-yl)methyl-(3,4,5-trimethoxyphenyl)amine","InChI=1S/C19H23N5O3/c1-10-11(5-6-13-16(10)18(20)24-19(21)23-13)9-22-12-7-14(25-2)17(27-4)15(8-12)26-3/h5-8,22H,9H2,1-4H3,(H4,20,21,23,24)",NOYPYLRCIDNJJB-UHFFFAOYSA-N,2.5,369.18008961,C19H23N5O3,369.4,118.0,369.18008961,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,,"10  12  8
12  13  8
12  18  8
13  15  8
14  15  8
17  19  8
17  20  8
19  22  8
20  21  8
21  23  8
22  23  8
5  13  8
5  24  8
6  18  8
6  24  8
9  10  8
9  14  8",
440791062,5576,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01840,trimethadione,20231222,20210312,Curation Efforts|Governmental Organizations,LT01840,trimethadione,5.0,Warnings and precautions,Ambiguous DILI-concern,2.0,5576,1.0,197.0,3.0,0.0,0.0,AAADccBiMAAAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAAAAAAAHgAAAAAADESBgAQCCAMABAAIAAEQGAIAAAAAAAAAAAFIAAACAAAAAAQNAAAABiAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3,5,5-trimethyloxazolidine-2,4-dione","3,5,5-trimethyloxazolidine-2,4-dione","3,5,5-trimethyl-1,3-oxazolidine-2,4-dione","3,5,5-trimethyl-1,3-oxazolidine-2,4-dione","3,5,5-trimethyl-1,3-oxazolidine-2,4-dione","3,5,5-trimethyloxazolidine-2,4-quinone",InChI=1S/C6H9NO3/c1-6(2)4(8)7(3)5(9)10-6/h1-3H3,IRYJRGCIQBGHIV-UHFFFAOYSA-N,,143.058243149,C6H9NO3,143.14,46.6,143.058243149,0.0,10.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C(=O)OC(C)(C)C1=O,0.3,,
440791061,5566,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00457,trifluoperazine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00457,trifluoperazine,2.0,Warnings and precautions,Ambiguous DILI-concern,1.0,5566,1.0,510.0,7.0,0.0,4.0,AAADceB7AYBAAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxQAAAHQQAAAAADAjBWBQywYMAAAiAAiRCQACCAAAhChAIiBwIZIgIYGLg0ZGUIAhggADoyAcQgAAOEAAAQAAAAQAgAACAAAACAAAAAAAAAA==,10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine,10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)phenothiazine,10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine,10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine,10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine,10-[3-(4-methylpiperazino)propyl]-2-(trifluoromethyl)phenothiazine,"InChI=1S/C21H24F3N3S/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24/h2-3,5-8,15H,4,9-14H2,1H3",ZEWQUBUPAILYHI-UHFFFAOYSA-N,5.0,407.16430344,C21H24F3N3S,407.5,35.0,407.16430344,0.0,28.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,"16  18  8
16  20  8
17  19  8
17  21  8
18  23  8
19  24  8
20  22  8
21  26  8
22  25  8
23  25  8
24  27  8
26  27  8",
440791060,444795,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00338,tretinoin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00338,tretinoin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,444795,1.0,567.0,2.0,1.0,5.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAGgAACAAADgCAgAACCAAAAgCIAiDSCAAAAAAgAAAICAAAAEgIBAIAAQAAEAAAgAAIkQMAgMAPAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid","(2<I>E</I>,4<I>E</I>,6<I>E</I>,8<I>E</I>)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid","InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+",SHGAZHPCJJPHSC-YCNIQYBTSA-N,6.3,300.208930132,C20H28O2,300.4,37.3,300.208930132,0.0,22.0,0.0,0.0,4.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,,,
440791059,3005573,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00158,toremifene,20210804,20210312,Curation Efforts|Governmental Organizations,LT00158,toremifene,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0,3005573,1.0,483.0,2.0,0.0,9.0,AAADceB6IAAEAAAAAAAAAAAAAAAAAAAAAAAwYMAAAAAAAAABUAAAHgIAAAAADAfhmEYyBoMABACAAiBCAAACCAAgIAAIiAAOCogOJiKFMRqDOCCkwBEYqAeAwOAOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"2-[4-[(Z)-4-chloro-1,2-diphenyl-but-1-enyl]phenoxy]-N,N-dimethyl-ethanamine","2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine","2-[4-[(<I>Z</I>)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-<I>N</I>,<I>N</I>-dimethylethanamine","2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine","2-[4-[(Z)-4-chloranyl-1,2-diphenyl-but-1-enyl]phenoxy]-N,N-dimethyl-ethanamine","2-[4-[(Z)-4-chloro-1,2-diphenyl-but-1-enyl]phenoxy]ethyl-dimethyl-amine","InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25-",XFCLJVABOIYOMF-QPLCGJKRSA-N,,405.1859422,C26H28ClNO,406.0,12.5,405.1859422,0.0,29.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1,7.2,"10  14  8
11  15  8
13  14  8
13  15  8
16  22  8
17  23  8
18  24  8
19  25  8
22  26  8
23  26  8
24  27  8
25  27  8
6  10  8
6  11  8
8  16  8
8  17  8
9  18  8
9  19  8",
440791058,41781,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00639,Torasemide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00639,torasemide,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0,41781,1.0,518.0,5.0,3.0,5.0,AAADceB7sABAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHgQQQAAADCjBWgQ/wZLIEAKoAjRnVHDCgDAxAiAI2Lw4ZJiIIGLA0dGEJAhglgLIyAcQgAAOAAAAQAAAAAAAAACAAAAAAAAAAAAAAA==,1-isopropyl-3-[[4-(3-methylanilino)-3-pyridyl]sulfonyl]urea,1-[[4-(3-methylanilino)-3-pyridinyl]sulfonyl]-3-propan-2-ylurea,1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea,1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea,1-[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl-3-propan-2-yl-urea,1-isopropyl-3-[[4-(m-toluidino)-3-pyridyl]sulfonyl]urea,"InChI=1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H,17,19)(H2,18,20,21)",NGBFQHCMQULJNZ-UHFFFAOYSA-N,,348.12561169,C16H20N4O3S,348.4,109.0,348.12561169,0.0,24.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,2.7,"10  11  8
10  16  8
11  17  8
12  18  8
12  20  8
17  21  8
18  19  8
19  22  8
20  23  8
22  23  8
8  16  8
8  21  8",
440791057,5483,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01818,tiopronin,20250421,20210312,Curation Efforts|Governmental Organizations,LT01818,tiopronin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,5483,1.0,148.0,4.0,3.0,3.0,AAADccBiMABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgQQCAAACADFwASCCALAAgQIAAGQGAAAAAAAAAAAAIGIAAACAAAAACAEAAAAFgCQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-(2-sulfanylpropanoylamino)acetic acid,2-[(2-mercapto-1-oxopropyl)amino]acetic acid,2-(2-sulfanylpropanoylamino)acetic acid,2-(2-sulfanylpropanoylamino)acetic acid,2-(2-sulfanylpropanoylamino)ethanoic acid,2-(2-mercaptopropanoylamino)acetic acid,"InChI=1S/C5H9NO3S/c1-3(10)5(9)6-2-4(7)8/h3,10H,2H2,1H3,(H,6,9)(H,7,8)",YTGJWQPHMWSCST-UHFFFAOYSA-N,,163.03031432,C5H9NO3S,163.2,67.4,163.03031432,0.0,10.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(S)C(=O)NCC(=O)O,-0.1,6  1  3,
440791056,54686904,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01222,Tigecycline,20210312,20210312,Curation Efforts|Governmental Organizations,LT01222,tigecycline,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0,54686904,1.0,1240.0,11.0,7.0,7.0,AAADcfB7vAAAAAAAAAAAAAAAAAAAAAAAAAAwYIEAAAAAAACBAAAAHgAQCAAADezBmAQyxoPAAgCIAqVSUAKCAAAhIgAAiIHNbMgLZz7a0POUcAhn9BHZ2Qe+zvCuiEABQAQaEADQgAaACDQgAAAAAAAAAA==,"(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)-1-oxoethyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4<I>S</I>,4<I>a</I><I>S</I>,5<I>a</I><I>R</I>,12<I>a</I><I>R</I>)-9-[[2-(<I>tert</I>-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12<I>a</I>-tetrahydroxy-3,12-dioxo-4<I>a</I>,5,5<I>a</I>,6-tetrahydro-4<I>H</I>-tetracene-2-carboxamide","(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aS,5aR,12aR)-9-[2-(tert-butylamino)ethanoylamino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrakis(oxidanyl)-3,12-bis(oxidanylidene)-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-diketo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36-37,40,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1",SOVUOXKZCCAWOJ-HJYUBDRYSA-N,,585.27986322,C29H39N5O8,585.6,206.0,585.27986322,0.0,42.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]3(O)C(=O)C1=C2O,1.1,"15  1  6
14  43  6
17  46  6
24  27  8
24  28  8
27  31  8
28  33  8
31  34  8
33  34  8
18  9  6",
440791055,941651,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01805,thiothixene,20231222,20210312,Curation Efforts|Governmental Organizations,LT01805,thiothixene,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0,941651,1.0,710.0,6.0,0.0,5.0,AAADceB7MABgAAAAAAAAAAAAAAAAAAAAAAA8aIEAAAAAAACRQAAAHAQAQAAADADBWAQyAYMAAAqAAiBCAHBCABAgCBAIiBgIAIgIYCKgERCUIAAggACoiAcAgMAOAAgAgAAEAAAAEAEAAAgAAAAAAAAAAA==,"(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide","(9Z)-N,N-dimethyl-9-[3-(4-methyl-1-piperazinyl)propylidene]-2-thioxanthenesulfonamide","(9<I>Z</I>)-<I>N</I>,<I>N</I>-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide","(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide","(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide","(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazino)propylidene]thioxanthene-2-sulfonamide","InChI=1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8-",GFBKORZTTCHDGY-UWVJOHFNSA-N,3.8,443.17011952,C23H29N3O2S2,443.6,77.5,443.17011952,0.0,30.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,,"17  19  8
17  20  8
18  21  8
18  24  8
19  23  8
20  22  8
21  26  8
22  25  8
23  25  8
24  27  8
26  28  8
27  28  8",
440791054,5391,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01785,temazepam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01785,temazepam,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,5391,1.0,434.0,3.0,1.0,1.0,AAADccB7MAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHgIACAAADArhmCYywIMAAgCoAyVyVAKCAAAhBwAIiADoZpgKcKLBk5GUIAhghgDYyAcQgMAOAABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one","7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one","7-chloro-3-hydroxy-1-methyl-5-phenyl-3<I>H</I>-1,4-benzodiazepin-2-one","7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one","7-chloranyl-1-methyl-3-oxidanyl-5-phenyl-3H-1,4-benzodiazepin-2-one","7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one","InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3",SEQDDYPDSLOBDC-UHFFFAOYSA-N,2.2,300.0665554,C16H13ClN2O2,300.74,52.9,300.0665554,0.0,21.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,,"11  17  8
11  18  8
12  15  8
13  16  8
15  16  8
17  19  8
18  20  8
19  21  8
20  21  8
6  13  8
6  7  8
7  12  8
9  22  3",
440791053,159269,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00577,Telbivudine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00577,telbivudine,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0,159269,1.0,381.0,5.0,3.0,2.0,AAADccBzOAAAAAAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAAAAAAAHgAQCAAADBThgAYDAAPABgCIAgFWUACAAAAAAAAAAAEIAECBEAIAgQAOQAAPByIDAMCwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione","1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-methylpyrimidine-2,4-dione","1-[(2<I>S</I>,4<I>R</I>,5<I>S</I>)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione","1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione","1-[(2S,4R,5S)-5-(hydroxymethyl)-4-oxidanyl-oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione","1-[(2S,4R,5S)-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-quinone","InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1",IQFYYKKMVGJFEH-CSMHCCOUSA-N,-1.2,242.09027155,C10H14N2O5,242.23,99.1,242.09027155,0.0,17.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O,,"11  12  5
13  15  8
15  16  8
8  2  6
6  13  8
6  14  8
9  6  5
7  14  8
7  16  8",
440791052,29327,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00628,streptozocin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00628,streptozocin,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0,29327,1.0,315.0,8.0,5.0,2.0,AAADccBzOAAAAAAAAAAAAAAAAAAAAAAAAAAkAAAAAAAAAAAAAAAAHgAcCAAACDzxgAcDCALABgAJAAAAEAAAAAAAAAAGAIAIAACTEAIAgAAHQAAfFgIXAAHwcAcAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]urea","1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)-3-oxanyl]urea","1-methyl-1-nitroso-3-[(2<I>S</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>,6<I>R</I>)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea","1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea","3-[(2S,3R,4R,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]-1-methyl-1-nitroso-urea","1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-methylol-tetrahydropyran-3-yl]urea","InChI=1S/C8H15N3O7/c1-11(10-17)8(16)9-4-6(14)5(13)3(2-12)18-7(4)15/h3-7,12-15H,2H2,1H3,(H,9,16)/t3-,4-,5-,6-,7+/m1/s1",ZSJLQEPLLKMAKR-GKHCUFPYSA-N,-1.4,265.09099983,C8H15N3O7,265.22,152.0,265.09099983,0.0,18.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(N=O)C(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O,,"14  16  5
11  2  5
13  3  6
15  4  6
12  8  6",
440791051,5193,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00624,secobarbital,20231222,20210312,Curation Efforts|Governmental Organizations,LT00624,secobarbital,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,5193,1.0,343.0,3.0,2.0,5.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAAAAAAAHgAQAAAADwCBgAADAALAAACIACFSEAAAAAAgAAAIAAEAAAiAABoIwQAEAAAIhSIAAAEYiAAPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5-allyl-5-(1-methylbutyl)hexahydropyrimidine-2,4,6-trione","5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione","5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione","5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione","5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione",5-allyl-5-(1-methylbutyl)barbituric acid,"InChI=1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)",KQPKPCNLIDLUMF-UHFFFAOYSA-N,2.0,238.13174244,C12H18N2O3,238.28,75.3,238.13174244,0.0,17.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,,7  18  3,
440791050,129228,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00564,Rufinamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00564,rufinamide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,129228,1.0,281.0,5.0,1.0,3.0,AAADccBzoYAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHwAYAAAADAjBngw8gJJIAACqAzV3VACCBAQ3kgAY2AG4dMgIYCrA0RGUIIhggADIiMcQgAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide","1-[(2,6-difluorophenyl)methyl]-4-triazolecarboxamide","1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide","1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide","1-[[2,6-bis(fluoranyl)phenyl]methyl]-1,2,3-triazole-4-carboxamide","1-(2,6-difluorobenzyl)triazole-4-carboxamide","InChI=1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)",POGQSBRIGCQNEG-UHFFFAOYSA-N,,238.06661722,C10H8F2N4O,238.19,73.8,238.06661722,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)c1cn(Cc2c(F)cccc2F)nn1,0.7,"10  13  8
11  14  8
12  15  8
14  16  8
15  16  8
4  10  8
4  5  8
5  6  8
6  13  8
9  11  8
9  12  8",
440791049,135403821,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01057,RIFAPENTINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01057,rifapentine,4.0,Warnings and precautions,Ambiguous DILI-concern,2.0,135403821,1.0,1730.0,15.0,6.0,6.0,AAADcfB/vAAAAAAAAAAAAAAAAAAAAaIAAAA8YIAAAAAAAEjBUAAAHgAYCAAADTzhmAYCzsPABgCoArXzWAKSCAAlIAAYiAFtTNgedzbWtZ+2eWjn7B3c+Yf6/P/O6QADSgAaEADSAAaUADQgAAAAAAAAAA==,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate","acetic acid [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentyl-1-piperazinyl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] ester","[(7<I>S</I>,9<I>E</I>,11<I>S</I>,12<I>R</I>,13<I>S</I>,14<I>R</I>,15<I>R</I>,16<I>R</I>,17<I>S</I>,18<I>S</I>,19<I>E</I>,21<I>Z</I>)-26-[(<I>E</I>)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<SUP>4,7</SUP>.0<SUP>5,28</SUP>]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate","[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate","[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-11-methoxy-3,7,12,14,16,18,22-heptamethyl-2,15,17,27,29-pentakis(oxidanyl)-6,23-bis(oxidanylidene)-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] ethanoate","acetic acid [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazino)iminomethyl]-2,15,17,27,29-pentahydroxy-6,23-diketo-11-methoxy-3,7,12,14,16,18,22-heptamethyl-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] ester","InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1",WDZCUPBHRAEYDL-GZAUEHORSA-N,,876.45207349,C47H64N4O12,877.0,220.0,876.45207349,0.0,63.0,9.0,0.0,4.0,0.0,0.0,1.0,-1.0,"1
5
255",CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,6.7,"28  1  5
25  2  5
24  32  5
29  35  6
31  3  5
30  36  6
34  37  5
33  4  6
43  49  8
43  51  8
45  59  5
47  48  8
47  49  8
47  54  8
48  53  8
51  55  8
53  56  8
54  55  8
54  58  8
56  58  8",
440791048,4946,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01706,propranolol,20250421,20210312,Curation Efforts|Governmental Organizations,LT01706,propranolol,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0,4946,1.0,257.0,3.0,2.0,6.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAADBUAAAHgAQCAAADDzhmAYyBsLABgCAAiBCAAACCAAgIAAIiIAOCIgPNiKEMRqGOCCm0BGbqAeAwLAOgAABAAAYAAAAAAIAADAAAAAAAAAAAA==,1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol,1-(1-naphthalenyloxy)-3-(propan-2-ylamino)-2-propanol,1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol,1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol,1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol,1-(isopropylamino)-3-(1-naphthoxy)propan-2-ol,"InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3",AQHHHDLHHXJYJD-UHFFFAOYSA-N,3.0,259.157228913,C16H21NO2,259.34,41.5,259.157228913,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)NCC(O)COc1cccc2ccccc12,,"10  11  8
10  13  8
11  12  8
11  14  8
12  15  8
12  17  8
13  16  8
14  18  8
15  16  8
17  19  8
18  19  8
4  2  3",
440791047,4891,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00225,praziquantel,20210312,20210312,Curation Efforts|Governmental Organizations,LT00225,praziquantel,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,4891,1.0,472.0,2.0,0.0,1.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxAAAAHgAAAAAADSjBmAQwAIMAAACIAiFSEACCAAAgAAAIiAGIBIgIYDKAkTGUIAhghgCIiAcYiICOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one","2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one","2-(cyclohexanecarbonyl)-3,6,7,11<I>b</I>-tetrahydro-1<I>H</I>-pyrazino[2,1-a]isoquinolin-4-one","2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one","2-cyclohexylcarbonyl-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one","2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazin[2,1-a]isoquinolin-4-one","InChI=1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2",FSVJFNAIGNNGKK-UHFFFAOYSA-N,,312.183778013,C19H24N2O2,312.4,40.6,312.183778013,0.0,23.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1,2.7,"13  19  8
13  20  8
19  21  8
20  22  8
21  23  8
22  23  8
5  7  3",
440791046,148121,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00673,Pralatrexate,20210312,20210312,Curation Efforts|Governmental Organizations,LT00673,pralatrexate,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,148121,1.0,809.0,11.0,5.0,10.0,AAADceB7uAAAAAAAAAAAAAAAAAAAAAAAAAA8WIAAAAAAAACx/AAAHgAQCAAADSjBnwQ9+L7IEgDoGzf3fAiCgC01EqAJ2KG4dNiKaHLA3XGUZQhslgLYyae8rsCOwAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,"(2S)-2-[[4-[1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid","(2S)-2-[[[4-[1-(2,4-diamino-6-pteridinyl)pent-4-yn-2-yl]phenyl]-oxomethyl]amino]pentanedioic acid","(2<I>S</I>)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid","(2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid","(2S)-2-[[4-[1-[2,4-bis(azanyl)pteridin-6-yl]pent-4-yn-2-yl]phenyl]carbonylamino]pentanedioic acid","(2S)-2-[[4-[1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]glutaric acid","InChI=1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1",OGSBUKJUDHAQEA-WMCAAGNKSA-N,-0.9,477.17606686,C23H23N7O5,477.5,207.0,477.17606686,0.0,35.0,1.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,,"10  33  8
10  35  8
13  16  3
15  18  8
15  19  8
17  27  8
18  23  8
19  24  8
21  23  8
21  24  8
29  31  8
29  33  8
20  6  6
7  17  8
7  29  8
8  27  8
8  31  8
9  31  8
9  35  8",
440791045,468595,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01254,Posaconazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT01254,posaconazole,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0,468595,1.0,1170.0,11.0,1.0,12.0,AAADcfB/+YAAAAAAAAAAAAAAAAAAAWJEAAA8YMEAAAAAAAAB1AAAHwAICAAADXzhmA431ocIFgCqAiRDdACSCAsxooAfyAAObIiOfiLEuZuXeCjtxhPY6Cfw0PIOgECAAAAAAAAAgQAAAAAAAAAAAAAAAA==,"4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(1S,2S)-1-ethyl-2-hydroxy-propyl]-1,2,4-triazol-3-one","4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)-3-oxolanyl]methoxy]phenyl]-1-piperazinyl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one","4-[4-[4-[4-[[(3<I>R</I>,5<I>R</I>)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2<I>S</I>,3<I>S</I>)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one","4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one","4-[4-[4-[4-[[(3R,5R)-5-[2,4-bis(fluoranyl)phenyl]-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-oxidanylpentan-3-yl]-1,2,4-triazol-3-one","4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-yl]methoxy]phenyl]piperazino]phenyl]-2-[(1S,2S)-1-ethyl-2-hydroxy-propyl]-1,2,4-triazol-3-one","InChI=1S/C37H42F2N8O4/c1-3-35(26(2)48)47-36(49)46(25-42-47)31-7-5-29(6-8-31)43-14-16-44(17-15-43)30-9-11-32(12-10-30)50-20-27-19-37(51-21-27,22-45-24-40-23-41-45)33-13-4-28(38)18-34(33)39/h4-13,18,23-27,35,48H,3,14-17,19-22H2,1-2H3/t26-,27+,35-,37-/m0/s1",RAGOYPUPXAKGKH-XAKZXMRKSA-N,4.6,700.32970817,C37H42F2N8O4,700.8,112.0,700.32970817,0.0,51.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,,"11  26  8
11  36  8
12  14  8
12  48  8
13  48  8
13  49  8
14  49  8
15  19  5
17  21  5
20  22  8
20  23  8
22  24  8
23  25  8
24  28  8
25  28  8
27  34  8
27  35  8
33  37  8
33  38  8
34  37  8
35  38  8
39  41  8
39  42  8
40  45  5
41  46  8
42  47  8
44  46  8
44  47  8
43  5  5
7  26  8
7  8  8
8  36  8",
440791044,5282452,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00668,Pitavastatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00668,pitavastatin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,5282452,1.0,631.0,6.0,3.0,8.0,AAADceB6OQAAAAAAAAAAAAAAGAAAAAAAAAA8YIAAAAAAAACx9AAAHwAACAAADRyhngowyPIIEgCoAyTyTACCgCAhAiAImCEwZJgINPbAkZGEcAhloADI2AeY7MROgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-hept-6-enoic acid","(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid","(<I>E</I>,3<I>R</I>,5<I>S</I>)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid","(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid","(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-bis(oxidanyl)hept-6-enoic acid","(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-hept-6-enoic acid","InChI=1S/C25H24FNO4/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31)/b12-11+/t18-,19-/m1/s1",VGYFMXBACGZSIL-MCBHFWOFSA-N,,421.16893641,C25H24FNO4,421.5,90.7,421.16893641,0.0,31.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,3.5,"10  11  8
11  12  8
12  14  8
13  14  8
13  19  8
14  20  8
16  25  8
16  26  8
19  23  8
18  2  5
20  24  8
23  24  8
25  28  8
26  29  8
28  30  8
29  30  8
22  3  5
6  10  8
6  13  8",
440791043,43672,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01675,piperacillin,20210804,20210312,Curation Efforts|Governmental Organizations,LT01675,piperacillin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,43672,1.0,982.0,8.0,3.0,6.0,AAADceB7uABAAAAAAAAAAAAAAABYAWAAAAA8QAAABYAAAAABAAAAHgQQCAAADCjF2ASzCIPAAgiIAiHSGACCAABgABAIiIGIBIiKYDqglTGUYAhslyK4iAcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)-oxomethyl]amino]-1-oxo-2-phenylethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2<I>S</I>,5<I>R</I>,6<I>R</I>)-6-[[(2<I>R</I>)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-[[4-ethyl-2,3-bis(oxidanylidene)piperazin-1-yl]carbonylamino]-2-phenyl-ethanoyl]amino]-3,3-dimethyl-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-diketo-piperazine-1-carbonyl)amino]-2-phenyl-acetyl]amino]-7-keto-3,3-dimethyl-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI=1S/C23H27N5O7S/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34)/t13-,14-,15+,20-/m1/s1",IVBHGBMCVLDMKU-GXNBUGAJSA-N,0.5,517.16311939,C23H27N5O7S,517.6,182.0,517.16311939,0.0,36.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O,,"17  10  5
23  11  5
14  37  6
16  21  6
24  26  8
24  27  8
26  31  8
27  32  8
31  35  8
32  35  8",
440791042,4737,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00130,pentobarbital,20231222,20210312,Curation Efforts|Governmental Organizations,LT00130,pentobarbital,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,4737,1.0,305.0,3.0,2.0,4.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAAAAAAAHgAQAAAADwCBgAADAALAAAAIAAEQEAAAAAAAAAAAAAEAAACAABoIwAAEAAAIBSIAAAEYiAAPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5-ethyl-5-(1-methylbutyl)hexahydropyrimidine-2,4,6-trione","5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione","5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione","5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione","5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione",5-ethyl-5-(1-methylbutyl)barbituric acid,"InChI=1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)",WEXRUCMBJFQVBZ-UHFFFAOYSA-N,2.1,226.13174244,C11H18N2O3,226.27,75.3,226.13174244,0.0,16.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,,7  17  3,
440791041,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01069,Pegvisomant,20210312,20210312,Curation Efforts|Governmental Organizations,LT01069,pegvisomant,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791040,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01376,Peginterferon alfa-2a,20210312,20210312,Curation Efforts|Governmental Organizations,LT01376,peginterferon alfa-2a,7.0,Warnings and precautions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791039,54675779,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00605,oxytetracycline,20210312,20210312,Curation Efforts|Governmental Organizations,LT00605,oxytetracycline,2.0,Warnings and precautions,Ambiguous DILI-concern,1.0,54675779,1.0,1000.0,10.0,7.0,2.0,AAADceB7PAAAAAAAAAAAAAAAAAAAAAAAAAAwYIEAAAAAAACBAAAAHgAQCAAADXzhmAYyBoNAAgCIAqFSEAKCAAAgIAAIiAHOCMgJNz6KkTKEcAAn4BEJmQf+/veugAABAAAYAADAAAYQADAAAAAAAAAAAA==,"(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide","(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide","(4<I>S</I>,4<I>a</I><I>R</I>,5<I>S</I>,5<I>a</I><I>R</I>,6<I>S</I>,12<I>a</I><I>R</I>)-4-(dimethylamino)-1,5,6,10,11,12<I>a</I>-hexahydroxy-6-methyl-3,12-dioxo-4,4<I>a</I>,5,5<I>a</I>-tetrahydrotetracene-2-carboxamide","(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide","(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-6-methyl-1,5,6,10,11,12a-hexakis(oxidanyl)-3,12-bis(oxidanylidene)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide","(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-3,12-diketo-6-methyl-4,4a,5,5a-tetrahydrotetracene-2-carboxamide","InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-26,28,30,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1",OWFJMIVZYSDULZ-PXOLEDIWSA-N,-1.6,460.14818035,C22H24N2O9,460.4,202.0,460.14818035,0.0,33.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12,,"14  1  5
16  10  5
12  34  5
13  35  5
15  2  5
21  26  8
21  27  8
26  30  8
27  32  8
17  3  6
30  33  8
32  33  8",
440791038,644241,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00607,Nilotinib,20231222,20210312,Curation Efforts|Governmental Organizations,LT00607,nilotinib,4.0,Warnings and precautions,Ambiguous DILI-concern,2.0,644241,1.0,817.0,9.0,2.0,6.0,AAADceB7oYAAAAAAAAAAAAAAAAAAAWAAAAA8eIEAAAAAAAAB/AAAHwAQAAAADAjBnhQ/0JfMEACoAzV3dACCgC01EqAJ2CE4dNiIaPLA3dGUJQholALIyacciACOQAAAQAQCAACAAACACAQAAAAAAAAAAA==,4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzamide,4-methyl-N-[3-(4-methyl-1-imidazolyl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide,4-methyl-<I>N</I>-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide,4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide,4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide,4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzamide,"InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)",HHZIURLSWUIHRB-UHFFFAOYSA-N,,529.18379284,C28H22F3N7O,529.5,97.6,529.18379284,0.0,39.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,4.9,"10  30  8
10  35  8
11  37  8
11  39  8
12  15  8
12  16  8
13  15  8
13  17  8
14  16  8
14  17  8
18  21  8
18  24  8
19  20  8
19  21  8
20  25  8
23  28  8
24  25  8
32  34  8
33  36  8
33  37  8
34  35  8
36  38  8
38  39  8
5  23  8
5  27  8
8  27  8
8  28  8
9  30  8
9  32  8",
440791037,5360515,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00311,naltrexone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00311,naltrexone,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0,5360515,1.0,621.0,5.0,2.0,2.0,AAADceB6OAAAAAAAAAAAAAAAGAAAASAAAAA8YMEAAAAWAEjxAAAAHgAACAAAD3zhmAYwBoMABgCIAqBSAAICCAAgIAAIiAFOiIgPJjKGsR+GeCOlwBGbuAf6/f/foAABAAAYQADQAAaQADSgAAAAAAAAAA==,"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4<I>R</I>,4<I>a</I><I>S</I>,7<I>a</I><I>R</I>,12<I>b</I><I>S</I>)-3-(cyclopropylmethyl)-4<I>a</I>,9-dihydroxy-2,4,5,6,7<I>a</I>,13-hexahydro-1<I>H</I>-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-bis(oxidanyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1",DQCKKXVULJGBQN-XFWGSAIBSA-N,1.9,341.16270821,C20H23NO4,341.4,70.0,341.16270821,0.0,25.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,,"11  15  8
11  20  8
15  23  8
7  2  5
20  24  8
23  25  8
24  25  8
6  10  5
8  26  6
9  27  5",
440791036,4421,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01587,nalidixic acid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01587,nalidixic acid,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,4421,1.0,378.0,5.0,1.0,2.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAAAAAAAsQAAAAAAAAACBgAAAHgAACAAADAzBngQzuJMIEgCoA6b2bACCgCklAiAJmCE4ZNiIJP7InZGEYYhsoALI2eeY2aKeAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid","1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid","1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid","1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid","1-ethyl-7-methyl-4-oxidanylidene-1,8-naphthyridine-3-carboxylic acid","1-ethyl-4-keto-7-methyl-1,8-naphthyridine-3-carboxylic acid","InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)",MHWLWQUZZRMNGJ-UHFFFAOYSA-N,1.4,232.08479225,C12H12N2O3,232.23,70.5,232.08479225,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,"10  11  8
12  15  8
13  15  8
4  6  8
4  9  8
5  13  8
5  6  8
6  7  8
7  11  8
7  12  8
9  10  8",
440791035,4409,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01581,nabumetone,20210312,20210312,Curation Efforts|Governmental Organizations,LT01581,nabumetone,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,4409,1.0,262.0,2.0,0.0,4.0,AAADceBwMAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAADBUAAAGgAAAAAADASAmAIyBsAABACIAqBSAAACCAAgIAAIiAEGCIgMJjKEMRqAMCAkwBEIqAeIyPCO4AADAAAQAADAAAYAACAAAAAAAAAAAA==,4-(6-methoxy-2-naphthyl)butan-2-one,4-(6-methoxy-2-naphthalenyl)-2-butanone,4-(6-methoxynaphthalen-2-yl)butan-2-one,4-(6-methoxynaphthalen-2-yl)butan-2-one,4-(6-methoxynaphthalen-2-yl)butan-2-one,4-(6-methoxy-2-naphthyl)butan-2-one,"InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3",BLXXJMDCKKHMKV-UHFFFAOYSA-N,3.1,228.115029749,C15H16O2,228.29,26.3,228.115029749,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2cc(CCC(C)=O)ccc2c1,,"11  14  8
12  13  8
13  14  8
3  7  8
3  9  8
5  11  8
5  6  8
5  7  8
6  10  8
6  12  8
9  10  8",
440791034,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01326,Muromonab-CD3,20210312,20210312,Curation Efforts|Governmental Organizations,LT01326,muromonab-cd3,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791033,21945,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00322,Methenamine hippurate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00322,methenamine hippurate,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,21945,1.0,282.0,7.0,2.0,3.0,AAADceBzsAAAAAAAAAAAAAAAAAAAAAAAAAA8WLFiAAAAAAABAAAAHgAQCAAADADBmAQxCIPAAgCIAiHSGACCAAAkAAAIiIGIBMiKIDKAlTGEIQhohgCYiYcYiACOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-benzamidoacetic acid;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane","2-benzamidoacetic acid;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane","2-benzamidoacetic acid;1,3,5,7-tetrazatricyclo[3.3.1.1<SUP>3,7</SUP>]decane","2-benzamidoacetic acid;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane","2-benzamidoethanoic acid;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane","2-benzamidoacetic acid;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane","InChI=1S/C9H9NO3.C6H12N4/c11-8(12)6-10-9(13)7-4-2-1-3-5-7;1-7-2-9-4-8(1)5-10(3-7)6-9/h1-5H,6H2,(H,10,13)(H,11,12);1-6H2",ROAIXOJGRFKICW-UHFFFAOYSA-N,,319.16443955,C15H21N5O3,319.36,79.4,319.16443955,0.0,23.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",C1N2CN3CN1CN(C2)C3.O=C(O)CNC(=O)c1ccccc1,,"15  17  8
15  18  8
17  19  8
18  20  8
19  22  8
20  22  8",
440791032,4037,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01511,meclofenamic acid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01511,meclofenamic acid,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,4037,1.0,327.0,3.0,2.0,3.0,AAADccByMAAGAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgIQCAAADAqBmCAyyILAAgCIAiTSSACCAAAlBwAIiAEAbsgIJnrBl5HEcYhm0AHI2ceYyCCOBAAAQACDABAIAACAAQYAIAAAAAAAAA==,"2-(2,6-dichloro-3-methyl-anilino)benzoic acid","2-(2,6-dichloro-3-methylanilino)benzoic acid","2-(2,6-dichloro-3-methylanilino)benzoic acid","2-(2,6-dichloro-3-methylanilino)benzoic acid","2-[[2,6-bis(chloranyl)-3-methyl-phenyl]amino]benzoic acid","2-(2,6-dichloro-3-methyl-anilino)benzoic acid","InChI=1S/C14H11Cl2NO2/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19/h2-7,17H,1H3,(H,18,19)",SBDNJUWAMKYJOX-UHFFFAOYSA-N,,295.016684,C14H11Cl2NO2,296.1,49.3,295.016684,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl,5.2,"10  15  8
11  14  8
12  14  8
13  17  8
15  18  8
17  18  8
6  11  8
6  9  8
7  10  8
7  13  8
8  12  8
8  9  8",
440791031,4033,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01509,mechlorethamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01509,mechlorethamine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,4033,1.0,43.7,1.0,0.0,4.0,AAADccBiAAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAIAAAAAAAPBAEQCAAMAAAAAAAAAAAAAAAAAAAAAAAAIAAAAAAAAAABAAAAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-chloro-N-(2-chloroethyl)-N-methyl-ethanamine,2-chloro-N-(2-chloroethyl)-N-methylethanamine,2-chloro-<I>N</I>-(2-chloroethyl)-<I>N</I>-methylethanamine,2-chloro-N-(2-chloroethyl)-N-methylethanamine,2-chloranyl-N-(2-chloroethyl)-N-methyl-ethanamine,bis(2-chloroethyl)-methyl-amine,"InChI=1S/C5H11Cl2N/c1-8(4-2-6)5-3-7/h2-5H2,1H3",HAWPXGHAZFHHAD-UHFFFAOYSA-N,0.9,155.0268547,C5H11Cl2N,156.05,3.2,155.0268547,0.0,8.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(CCCl)CCCl,,,
440791030,3958,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00181,lorazepam,20210312,20210312,Curation Efforts|Governmental Organizations,LT00181,lorazepam,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,3958,1.0,443.0,3.0,2.0,1.0,AAADccBzMAAGAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHgIQCAAADArhmCYwwILAAgCoAyVyVAKCAAAhBwAIiADgZpgKcKLBk5GUIAhglADYyAcQgMAOAABAIAADAAAAAIBAAAYAAAAAAAAAAA==,"7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one","7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one","7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one","7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one","7-chloranyl-5-(2-chlorophenyl)-3-oxidanyl-1,3-dihydro-1,4-benzodiazepin-2-one","7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one","InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)",DIWRORZWFLOCLC-UHFFFAOYSA-N,2.4,320.011933,C15H10Cl2N2O2,321.2,61.7,320.011933,0.0,21.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,,"10  17  8
10  18  8
12  15  8
14  16  8
15  16  8
17  19  8
18  20  8
19  21  8
20  21  8
11  3  3
7  12  8
7  9  8
9  14  8",
440791029,3000540,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01491,lincomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01491,lincomycin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,3000540,1.0,498.0,8.0,5.0,7.0,AAADcfB7OABAAAAAAAAAAAAAAAAAAWAAAAAkAAAAAAAAAAAAAAAAHgQQCAAADTzlwAaCAAPABggIAAEQEAAAAAAAABAAAIGIAAADUBIggCAXQAAHFgCTAAH4+aeOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide","(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-2-oxanyl]propyl]-1-methyl-4-propyl-2-pyrrolidinecarboxamide","(2<I>S</I>,4<I>R</I>)-<I>N</I>-[(1<I>R</I>,2<I>R</I>)-2-hydroxy-1-[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>,6<I>R</I>)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide","(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide","(2S,4R)-1-methyl-N-[(1R,2R)-1-[(2R,3R,4S,5R,6R)-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]-2-oxidanyl-propyl]-4-propyl-pyrrolidine-2-carboxamide","(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide","InChI=1S/C18H34N2O6S/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25)/t9-,10-,11+,12-,13+,14-,15-,16-,18-/m1/s1",OJMMVQQUTAEWLP-KIDUDLJLSA-N,0.2,406.21375798,C18H34N2O6S,406.5,148.0,406.21375798,0.0,27.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,"22  1  6
10  17  6
11  19  5
14  34  6
16  3  5
18  4  5
20  5  6
21  6  5
15  9  5",
440791028,5862,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00933,L-cysteine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00933,l-cysteine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,5862,1.0,75.3,4.0,3.0,2.0,AAADcYBCMABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgQQCAAACCjFwASACABAAgQIAACQCAAAAAAAAAAAAIGAAAACAAAAAAAAQAAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2R)-2-amino-3-sulfanyl-propanoic acid,(2R)-2-amino-3-mercaptopropanoic acid,(2<I>R</I>)-2-amino-3-sulfanylpropanoic acid,(2R)-2-amino-3-sulfanylpropanoic acid,(2R)-2-azanyl-3-sulfanyl-propanoic acid,(2R)-2-amino-3-mercapto-propionic acid,"InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1",XUJNEKJLAYXESH-REOHCLBHSA-N,-2.5,121.01974964,C3H7NO2S,121.16,64.3,121.01974964,0.0,7.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",N[C@@H](CS)C(=O)O,,5  4  6,
440791027,219078,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00660,Lacosamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00660,lacosamide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,219078,1.0,275.0,3.0,2.0,6.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQAAAADCjhmAYyAILABACIAiFSEACCAAAgAAAIiIGIBIgKYCaAkTGVIAhitgCYiAcQgAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2R)-2-acetamido-N-benzyl-3-methoxy-propanamide,(2R)-2-acetamido-3-methoxy-N-(phenylmethyl)propanamide,(2<I>R</I>)-2-acetamido-<I>N</I>-benzyl-3-methoxypropanamide,(2R)-2-acetamido-N-benzyl-3-methoxypropanamide,(2R)-2-acetamido-3-methoxy-N-(phenylmethyl)propanamide,(2R)-2-acetamido-N-benzyl-3-methoxy-propionamide,"InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1",VPPJLAIAVCUEMN-GFCCVEGCSA-N,,250.13174244,C13H18N2O3,250.29,67.4,250.13174244,0.0,18.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,0.3,"10  12  8
10  13  8
12  14  8
13  15  8
14  17  8
15  17  8
6  5  6",
440791026,3759,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01469,isocarboxazid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01469,isocarboxazid,5.0,Warnings and precautions,Ambiguous DILI-concern,1.0,3759,1.0,254.0,4.0,2.0,4.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHgAcAAAADAzBngQyhJByAACpA6VyUgCCAAAmIgI6uKG2bNoIZjqAlZOAMYBmgBgIycc/gAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,N'-benzyl-5-methyl-isoxazole-3-carbohydrazide,5-methyl-N'-(phenylmethyl)-3-isoxazolecarbohydrazide,"<I>N</I>&apos;-benzyl-5-methyl-1,2-oxazole-3-carbohydrazide","N'-benzyl-5-methyl-1,2-oxazole-3-carbohydrazide","5-methyl-N'-(phenylmethyl)-1,2-oxazole-3-carbohydrazide",N'-benzyl-5-methyl-isoxazole-3-carbohydrazide,"InChI=1S/C12H13N3O2/c1-9-7-11(15-17-9)12(16)14-13-8-10-5-3-2-4-6-10/h2-7,13H,8H2,1H3,(H,14,16)",XKFPYPQQHFEXRZ-UHFFFAOYSA-N,1.5,231.100776666,C12H13N3O2,231.25,67.2,231.100776666,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cc(C(=O)NNCc2ccccc2)no1,,"1  15  8
1  5  8
10  14  8
12  16  8
13  16  8
14  15  8
5  10  8
7  8  8
7  9  8
8  12  8
9  13  8",
440791025,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01354,Interferon gamma-1b,20210312,20210312,Curation Efforts|Governmental Organizations,LT01354,interferon gamma-1b,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791024,5362440,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01446,indinavir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01446,indinavir,8.0,Warnings and precautions,Ambiguous DILI-concern,1.0,5362440,1.0,952.0,7.0,4.0,12.0,AAADcfB/uAAAAAAAAAAAAAAAAAAAAYAAAAA8eIEAAAAAAGAB0AAAHgAQCAAADbzhmgY+gJPIEgCoAjF3VACCgCAxAiAI2KG4ZJgKcPrA0bGUYAhk1gHYyAe62fKOgAAAAAAQAAAAAAAAACAAAKAACQgAAA==,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxyindan-1-yl]amino]-5-oxo-pentyl]-N-tert-butyl-4-(3-pyridylmethyl)piperazine-2-carboxamide","(2S)-N-tert-butyl-1-[(2S,4R)-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxo-4-(phenylmethyl)pentyl]-4-(3-pyridinylmethyl)-2-piperazinecarboxamide","(2<I>S</I>)-1-[(2<I>S</I>,4<I>R</I>)-4-benzyl-2-hydroxy-5-[[(1<I>S</I>,2<I>R</I>)-2-hydroxy-2,3-dihydro-1<I>H</I>-inden-1-yl]amino]-5-oxopentyl]-<I>N</I>-<I>tert</I>-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide","(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide","(2S)-N-tert-butyl-1-[(2S,4R)-2-oxidanyl-5-[[(1S,2R)-2-oxidanyl-2,3-dihydro-1H-inden-1-yl]amino]-5-oxidanylidene-4-(phenylmethyl)pentyl]-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide","(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxyindan-1-yl]amino]-5-keto-pentyl]-N-tert-butyl-4-(3-pyridylmethyl)piperazine-2-carboxamide","InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,,613.362805,C36H47N5O4,613.8,118.0,613.362805,0.0,45.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,2.8,"15  1  5
10  19  6
17  16  6
20  2  6
23  26  8
23  29  8
26  31  8
28  37  8
28  38  8
29  35  8
30  39  8
30  40  8
31  36  8
35  36  8
37  41  8
39  42  8
40  43  8
41  45  8
42  44  8
43  44  8
18  7  6
9  38  8
9  45  8",
440791023,42890,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01440,IDARUBICIN,20210312,20210312,Curation Efforts|Governmental Organizations,LT01440,idarubicin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,42890,1.0,912.0,10.0,5.0,3.0,AAADceB6PAAAAAAAAAAAAAAAAAAAAAAAAAA0YMGCAAAAAADBQAAAHgAQCAAADHzxmAcyDoBABgCIAqBSAAICAAAkIAAIiIFECMgbNzaCtRqicUAn8BEPuYfL7PzOwQADAAAYAADCAAYQADAAAAAAAAAAAA==,"(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione","(7<I>S</I>,9<I>S</I>)-9-acetyl-7-[(2<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>S</I>)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7<I>H</I>-tetracene-5,12-dione","(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-quinone","InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1",XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.9,497.16858144,C26H27NO9,497.5,177.0,497.16858144,0.0,36.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O,,"11  1  6
17  1  5
19  10  6
15  16  8
15  22  8
16  24  8
21  27  6
22  25  8
24  26  8
25  26  8
12  3  6
31  32  8
31  33  8
32  34  8
33  35  8
34  36  8
35  36  8
20  4  6",
440791022,169870,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00110,HYDROXYPROGESTERONE CAPROATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00110,hydroxyprogesterone caproate,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0,169870,1.0,797.0,4.0,0.0,7.0,AAADcfB4OAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAAAAAAD0SAgAACCAAABACIAqDSCAIAAAAgAAAACAFAAEgAABIAAQQCAAAEgAAIAQOIyPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate","hexanoic acid [(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] ester","[(8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1<I>H</I>-cyclopenta[a]phenanthren-17-yl] hexanoate","[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate","[(8R,9S,10R,13S,14S,17R)-17-ethanoyl-10,13-dimethyl-3-oxidanylidene-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate","hexanoic acid [(8R,9S,10R,13S,14S,17R)-17-acetyl-3-keto-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] ester","InChI=1S/C27H40O4/c1-5-6-7-8-24(30)31-27(18(2)28)16-13-23-21-10-9-19-17-20(29)11-14-25(19,3)22(21)12-15-26(23,27)4/h17,21-23H,5-16H2,1-4H3/t21-,22+,23+,25+,26+,27+/m1/s1",DOMWKUIIPQCAJU-LJHIYBGHSA-N,5.7,428.29265975,C27H40O4,428.6,60.4,428.29265975,0.0,31.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,"9  1  6
11  20  5
5  16  5
6  32  6
7  33  5
8  34  6",
440791021,131536,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01194,Fosamprenavir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01194,fosamprenavir,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,131536,1.0,912.0,11.0,4.0,14.0,AAADcfB7PAJAAAAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAAABQAAAHgQQSCAADTzh2AYyyYLABRKIQiRCWPDCABAgAgAIiJgIZIkLICKA0ZGOIABllgCayAeQwKAOAAQAAAAAAAAACAAAAAAAAAAAAAAAAA==,"[(3S)-tetrahydrofuran-3-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-phosphonooxy-propyl]carbamate","N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamic acid [(3S)-3-oxolanyl] ester","[(3<I>S</I>)-oxolan-3-yl] <I>N</I>-[(2<I>S</I>,3<I>R</I>)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate","[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate","[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxy-butan-2-yl]carbamate","N-[(1S,2R)-1-benzyl-3-[isobutyl(sulfanilyl)amino]-2-phosphonooxy-propyl]carbamic acid [(3S)-tetrahydrofuran-3-yl] ester","InChI=1S/C25H36N3O9PS/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32)/t21-,23-,24+/m0/s1",MLBVMOWEQCZNCC-OEMFJLHTSA-N,,585.19098791,C25H36N3O9PS,585.6,186.0,585.19098791,0.0,39.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)CN(C[C@@H](OP(=O)(O)O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,1.8,"16  13  5
21  30  8
21  31  8
23  32  8
23  33  8
15  3  5
30  34  8
31  35  8
32  36  8
33  37  8
34  38  8
35  38  8
36  39  8
37  39  8
22  4  5",
440791020,3406,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00494,fomepizole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00494,fomepizole,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,3406,1.0,44.8,1.0,1.0,0.0,AAADcYBjAAAAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAABgAAAHAAYAAAADADBGgQugJBjAACiAhBnQACQBAAAgAAQMaAgRBAAAIAAQUAAhAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,4-methyl-1H-pyrazole,4-methyl-1H-pyrazole,4-methyl-1<I>H</I>-pyrazole,4-methyl-1H-pyrazole,4-methyl-1H-pyrazole,4-methyl-1H-pyrazole,"InChI=1S/C4H6N2/c1-4-2-5-6-3-4/h2-3H,1H3,(H,5,6)",RIKMMFOAQPJVMX-UHFFFAOYSA-N,1.4,82.0530982,C4H6N2,82.1,28.7,82.0530982,0.0,6.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cn[nH]c1,,"1  2  8
1  4  8
2  6  8
3  4  8
3  6  8",
440791019,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01953,Follitropin alfa/beta,20210312,20210312,Curation Efforts|Governmental Organizations,LT01953,follitropin alfa/beta,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440791018,3394,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00298,flurbiprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00298,flurbiprofen,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0,3394,1.0,286.0,3.0,1.0,3.0,AAADccBwMQAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAGwAACAAADQCAmAgyCIAAAgCIAiDSCAACAAAgAAAIiAEAAIgIIDKAFRCAYAAkwAEIiAeIyOCOwAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,2-(3-fluoro-4-phenyl-phenyl)propanoic acid,2-(3-fluoro-4-phenylphenyl)propanoic acid,2-(3-fluoro-4-phenylphenyl)propanoic acid,2-(3-fluoro-4-phenylphenyl)propanoic acid,2-(3-fluoranyl-4-phenyl-phenyl)propanoic acid,2-(3-fluoro-4-phenyl-phenyl)propionic acid,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)",SYTBZMRGLBWNTM-UHFFFAOYSA-N,4.2,244.08995782,C15H13FO2,244.26,37.3,244.08995782,0.0,18.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,,"12  14  8
12  15  8
14  16  8
15  17  8
16  18  8
17  18  8
4  11  3
5  7  8
5  8  8
6  10  8
6  9  8
7  9  8
8  10  8",
440791017,3372,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00400,FLUPHENAZINE,20210804,20210312,Curation Efforts|Governmental Organizations,LT00400,fluphenazine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,3372,1.0,544.0,8.0,1.0,6.0,AAADceB7IYBAAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxQAAAHwQACAAADAjh2BYwwYMAAgiAAiRCQACCAAAhChAIiBwIZIgKcGLg0ZGUIAhggAD4yAcQgAAOEAAAQAAAAQAgAACAAAACAAAAAAAAAA==,2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol,2-[4-[3-[2-(trifluoromethyl)-10-phenothiazinyl]propyl]-1-piperazinyl]ethanol,2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol,2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol,2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol,2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazino]ethanol,"InChI=1S/C22H26F3N3OS/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29/h1-2,4-7,16,29H,3,8-15H2",PLDUPXSUYLZYBN-UHFFFAOYSA-N,4.4,437.17486812,C22H26F3N3OS,437.5,55.3,437.17486812,0.0,30.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,"18  20  8
18  22  8
19  21  8
19  23  8
20  25  8
21  26  8
22  24  8
23  28  8
24  27  8
25  27  8
26  29  8
28  29  8",
440791016,6446,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02031,fluoxymesterone,20231222,20210312,Curation Efforts|Governmental Organizations,LT02031,fluoxymesterone,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0,6446,1.0,630.0,4.0,2.0,0.0,AAADceB4MQAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGwAACAAAD1SggAICAAAAAgCIAqBSAAAAAAAgAAAACAEAAEgAEBIAAQAAQAAEgAAIAQPIyPCPgAAAAAAAAADAAAYAADAAAYAADAAAAA==,"(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8<I>S</I>,9<I>R</I>,10<I>S</I>,11<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,17S)-9-fluoranyl-10,13,17-trimethyl-11,17-bis(oxidanyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","InChI=1S/C20H29FO3/c1-17-8-6-13(22)10-12(17)4-5-15-14-7-9-19(3,24)18(14,2)11-16(23)20(15,17)21/h10,14-16,23-24H,4-9,11H2,1-3H3/t14-,15-,16-,17-,18-,19-,20-/m0/s1",YLRFCQOZQXIBAB-RBZZARIASA-N,2.4,336.21007294,C20H29FO3,336.4,57.5,336.21007294,0.0,24.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,,"8  1  6
11  21  5
9  2  5
12  3  5
5  16  5
6  25  6
7  26  5",
440791015,3366,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01381,flucytosine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01381,flucytosine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,3366,1.0,208.0,3.0,2.0,0.0,AAADcYBjIQAAAAAAAAAAAAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAHwAQAAAACADBAAQBAALAAACoABBhVAAAAAAAAAAAAAAAABCAAAAAAAAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,6-amino-5-fluoro-1H-pyrimidin-2-one,6-amino-5-fluoro-1H-pyrimidin-2-one,6-amino-5-fluoro-1<I>H</I>-pyrimidin-2-one,6-amino-5-fluoro-1H-pyrimidin-2-one,6-azanyl-5-fluoranyl-1H-pyrimidin-2-one,6-amino-5-fluoro-1H-pyrimidin-2-one,"InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9)",XRECTZIEBJDKEO-UHFFFAOYSA-N,,129.03383992,C4H4FN3O,129.09,67.5,129.03383992,0.0,9.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1[nH]c(=O)ncc1F,-0.9,"3  6  8
3  8  8
5  8  8
5  9  8
6  7  8
7  9  8",
440791014,64929,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00670,Fenofibric acid,20250421,20210312,Curation Efforts|Governmental Organizations,LT00670,fenofibric acid,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0,64929,1.0,405.0,4.0,1.0,5.0,AAADccB4OAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAGgIACAAADEaAmCAyDoAABgCIAqDSCAICCAAkJQAIiAFGCsgNJjKFNx6CeSCkwBELqYeIzODOJAAAAAAAAABIAAAAAAAAAAAAAAAAAA==,2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid,2-[4-[(4-chlorophenyl)-oxomethyl]phenoxy]-2-methylpropanoic acid,2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid,2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid,2-[4-(4-chlorophenyl)carbonylphenoxy]-2-methyl-propanoic acid,2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propionic acid,"InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)",MQOBSOSZFYZQOK-UHFFFAOYSA-N,3.9,318.0658866,C17H15ClO4,318.7,63.6,318.0658866,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O,,"11  14  8
11  15  8
12  14  8
13  15  8
17  18  8
17  19  8
18  20  8
19  21  8
20  22  8
21  22  8
9  12  8
9  13  8",
440791013,6917715,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01193,ETONOGESTREL,20231222,20210312,Curation Efforts|Governmental Organizations,LT01193,etonogestrel,5.0,Warnings and precautions,Ambiguous DILI-concern,2.0,6917715,1.0,677.0,2.0,1.0,2.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAAD0SAgAACAAAAAgDIGqBSAAgAAAAgAAAACAEAAEgAABIAAQAAQAAEgAAIAQOIyPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8<I>S</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1<I>H</I>-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylidene-17-oxidanyl-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",GCKFUYQCUCGESZ-BPIQYHPVSA-N,3.3,324.208930132,C22H28O2,324.5,37.3,324.208930132,0.0,24.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC,,"7  1  5
11  34  5
3  14  5
4  25  6
5  26  5
6  27  6",
440791012,3292,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00795,ethotoin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00795,ethotoin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,3292,1.0,272.0,2.0,1.0,2.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHgAQAAAADCjBmAQzAIPAAACIAiFSEACCAAAgAAAIiIGIBIiIYDKAlTGUIAhohyKIiAcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3-ethyl-5-phenyl-imidazolidine-2,4-dione","3-ethyl-5-phenylimidazolidine-2,4-dione","3-ethyl-5-phenylimidazolidine-2,4-dione","3-ethyl-5-phenylimidazolidine-2,4-dione","3-ethyl-5-phenyl-imidazolidine-2,4-dione",3-ethyl-5-phenyl-hydantoin,"InChI=1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,15)",SZQIFWWUIBRPBZ-UHFFFAOYSA-N,1.0,204.08987763,C11H12N2O2,204.22,49.4,204.08987763,0.0,15.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN1C(=O)NC(c2ccccc2)C1=O,,"10  13  8
11  14  8
13  15  8
14  15  8
5  7  3
7  10  8
7  11  8",
440791011,3291,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00831,ethosuximide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00831,ethosuximide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,3291,1.0,188.0,2.0,1.0,1.0,AAADccBiMAAAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAAAAAAAHgAQAAAADgCBgAACAALAAAAIAAEQEAAAAAAAAAAAAAEAAAAAABIAgAAEAAAAFCCAAAAdAAALAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3-ethyl-3-methyl-pyrrolidine-2,5-dione","3-ethyl-3-methylpyrrolidine-2,5-dione","3-ethyl-3-methylpyrrolidine-2,5-dione","3-ethyl-3-methylpyrrolidine-2,5-dione","3-ethyl-3-methyl-pyrrolidine-2,5-dione",ethosuximide,"InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10)",HAPOVYFOVVWLRS-UHFFFAOYSA-N,0.4,141.078978594,C7H11NO2,141.17,46.2,141.078978594,0.0,10.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC1(C)CC(=O)NC1=O,,4  8  3,
440791010,5870,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02043,estrone,20231222,20210312,Curation Efforts|Governmental Organizations,LT02043,estrone,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0,5870,1.0,418.0,2.0,1.0,0.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYMAAAAAAAGDBAAAAGgAACAAADwSAmAAyBoAAAgCIAqBSAAACAAAgIAAIiAEGCIgIJjKCERKAcAAkwBEImAeIyPCPoAABAAAQAADAAAYAACAAAAAACAAAAA==,"(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one","(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one","(8<I>R</I>,9<I>S</I>,13<I>S</I>,14<I>S</I>)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6<I>H</I>-cyclopenta[a]phenanthren-17-one","(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one","(8R,9S,13S,14S)-13-methyl-3-oxidanyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one","(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one","InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",DNXHEGUUPJUMQT-CBZIJGRNSA-N,3.1,270.16197994,C18H22O2,270.4,37.3,270.16197994,0.0,20.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O,,"14  16  8
14  17  8
16  18  8
17  19  8
18  20  8
19  20  8
3  21  6
4  13  5
5  22  5
6  23  6",
440791009,150610,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01122,Ertapenem,20231222,20210312,Curation Efforts|Governmental Organizations,LT01122,ertapenem,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,150610,1.0,893.0,9.0,5.0,7.0,AAADceB7OABAAAAAAAAAAAAAAABYAWIAAAAwAAAABAAAAAABAAAAHgQQCAAADTzl2AayyIPAAgiIAiXSWACCAAAlAhAIiIGIbMgKdj7glbGUcQhm9gH42Ye8ySCOAAAAQAAAAAAAAACAAAAAAAAAAAAAAA==,"(4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-3-[[(3S,5S)-5-[(3-carboxyanilino)-oxomethyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4<I>R</I>,5<I>S</I>,6<I>S</I>)-3-[(3<I>S</I>,5<I>S</I>)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1<I>R</I>)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-4-methyl-6-[(1R)-1-oxidanylethyl]-7-oxidanylidene-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-3-[[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]thio]-6-[(1R)-1-hydroxyethyl]-7-keto-4-methyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","InChI=1S/C22H25N3O7S/c1-9-16-15(10(2)26)20(28)25(16)17(22(31)32)18(9)33-13-7-14(23-8-13)19(27)24-12-5-3-4-11(6-12)21(29)30/h3-6,9-10,13-16,23,26H,7-8H2,1-2H3,(H,24,27)(H,29,30)(H,31,32)/t9-,10-,13+,14+,15-,16-/m1/s1",JUZNIMUFDBIJCM-ANEDZVCMSA-N,,475.14132132,C22H25N3O7S,475.5,182.0,475.14132132,0.0,33.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)O)c4)C3)[C@H](C)[C@H]12,-1.5,"20  1  5
12  34  6
13  35  5
14  19  5
25  26  5
27  28  8
27  29  8
28  30  8
29  31  8
18  3  6
30  32  8
31  32  8",
440791008,41867,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00091,Epirubicin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00091,epirubicin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,41867,1.0,977.0,12.0,6.0,5.0,AAADceB6PAAAAAAAAAAAAAAAAAAAAAAAAAA0YMGCAAAAAADBQAAAHgAQCAAADHzxmAcyDoBABgCIAqBSAAICCAAkIAAIiIFGCMgfNzaGtRqicWAn8BEPuYfL7PzOwQADAAAYAADCAAYQADAAAAAAAAAAAA==,"(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-7-[[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione","(7<I>S</I>,9<I>S</I>)-7-[(2<I>R</I>,4<I>S</I>,5<I>R</I>,6<I>S</I>)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7<I>H</I>-tetracene-5,12-dione","(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-7-[(2R,4S,5R,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone","InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22-,27-/m0/s1",AOJJSUZBOXZQNB-VTZDEGQISA-N,1.3,543.17406074,C27H29NO11,543.5,206.0,543.17406074,0.0,39.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1,,"13  1  6
19  1  5
21  12  6
17  18  8
17  24  8
18  26  8
23  29  6
24  27  8
26  28  8
27  28  8
14  3  6
33  34  8
33  35  8
34  36  8
35  37  8
36  38  8
37  38  8
22  4  5",
440791007,135398508,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00538,Entecavir,20210312,20210312,Curation Efforts|Governmental Organizations,LT00538,entecavir,7.0,Warnings and precautions,Ambiguous DILI-concern,2.0,135398508,1.0,480.0,5.0,4.0,2.0,AAADccBzsAAAAAAAAAAAAAAAAAAAAeIAAAAgAAAAAAAAAEABgAAAHgAQCAAADTzhlgYFsBfMEgCoAwdzdACAgC03EKABUAGoVEiAWApAySAUQIgPwQLAAGGwUAMOAAAAAAAAAAAAAAAAAAAAACEABAAAAA==,"2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylene-cyclopentyl]-1H-purin-6-one","2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1H-purin-6-one","2-amino-9-[(1<I>S</I>,3<I>R</I>,4<I>S</I>)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1<I>H</I>-purin-6-one","2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one","2-azanyl-9-[(1S,3R,4S)-3-(hydroxymethyl)-2-methylidene-4-oxidanyl-cyclopentyl]-1H-purin-6-one","2-amino-9-[(1S,3R,4S)-4-hydroxy-2-methylene-3-methylol-cyclopentyl]hypoxanthine","InChI=1S/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8-/m0/s1",QDGZDCVAUDNJFG-FXQIFTODSA-N,,277.11748936,C12H15N5O3,277.28,126.0,277.11748936,0.0,20.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)[nH]c(N)nc21,-1.3,"11  1  6
10  14  5
15  18  8
18  19  8
4  15  8
4  17  8
9  4  5
5  17  8
5  18  8
6  15  8
6  20  8
7  19  8
7  20  8",
440791006,24847866,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01169,Enfuvirtide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01169,enfuvirtide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,24847866,1.0,11400.0,70.0,65.0,154.0,AAADcfB//gAAAAAAAAAAAAAAAAAAAWLFiwAwYMGDAAAAAFgB/gAAHgAYCAAADTzhngY/3vbrkgCoAzX3fACCgC2xMqIb+aG+fJiKfv7C2bOUcAhu9hPY2Ce/3+KOoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,"(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-(2-acetylhydrazino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-4-methyl-pentanoyl]amino]-3-methyl-pentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-4-methyl-pentanoyl]amino]-3-methyl-pentanoyl]amino]-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-5-amino-5-oxo-pentanoyl]amino]-4-amino-4-oxo-butanoyl]amino]-5-amino-5-oxo-pentanoyl]amino]-5-amino-5-oxo-pentanoyl]amino]-5-[[(1S)-5-amino-1-[[(1S)-3-amino-1-[[(1S)-1-[[(1S)-4-amino-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-5-amino-1-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-3-amino-1-[[(1S)-2-[[(1S)-1-benzyl-2-(carboxymethylamino)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]-3-oxo-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]-3-methyl-butyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-methyl-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]pentyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-oxo-propyl]carbamoyl]pentyl]amino]-5-oxo-pentanoic acid","(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-(acetylhydrazo)-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-3-hydroxy-1-oxobutyl]amino]-3-hydroxy-1-oxopropyl]amino]-4-methyl-1-oxopentyl]amino]-3-methyl-1-oxopentyl]amino]-3-(1H-imidazol-5-yl)-1-oxopropyl]amino]-3-hydroxy-1-oxopropyl]amino]-4-methyl-1-oxopentyl]amino]-3-methyl-1-oxopentyl]amino]-4-carboxy-1-oxobutyl]amino]-4-carboxy-1-oxobutyl]amino]-3-hydroxy-1-oxopropyl]amino]-5-amino-1,5-dioxopentyl]amino]-4-amino-1,4-dioxobutyl]amino]-5-amino-1,5-dioxopentyl]amino]-5-amino-1,5-dioxopentyl]amino]-5-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-(carboxymethylamino)-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid","(4<I>S</I>)-4-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>R</I>)-2-[[(2<I>S</I>)-2-(2-acetylhydrazinyl)-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-(1<I>H</I>-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-4-amino-4-oxobutanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-[[(2<I>S</I>)-6-amino-1-[[(2<I>S</I>)-4-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-5-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-6-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-4-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-(carboxymethylamino)-1-oxo-3-phenylpropan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid","(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-(2-acetylhydrazinyl)-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-4-amino-4-oxobutanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-(carboxymethylamino)-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid","(4S)-5-[[(2S)-6-azanyl-1-[[(2S)-4-azanyl-1-[[(2S)-1-[[(2S)-5-azanyl-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-azanyl-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-azanyl-1-[[(2S)-1-[[(2S)-1-(2-hydroxy-2-oxoethylamino)-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-1,4-bis(oxidanylidene)butan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-hexan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-1,5-bis(oxidanylidene)pentan-2-yl]amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-1,4-bis(oxidanylidene)butan-2-yl]amino]-1-oxidanylidene-hexan-2-yl]amino]-4-[[(2S)-5-azanyl-2-[[(2S)-5-azanyl-2-[[(2S)-4-azanyl-2-[[(2S)-5-azanyl-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-(2-ethanoylhydrazinyl)-3-(4-hydroxyphenyl)propanoyl]amino]-3-oxidanyl-butanoyl]amino]-3-oxidanyl-propanoyl]amino]-4-methyl-pentanoyl]amino]-3-methyl-pentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-oxidanyl-propanoyl]amino]-4-methyl-pentanoyl]amino]-3-methyl-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-oxidanyl-propanoyl]amino]-5-oxidanylidene-pentanoyl]amino]-4-oxidanylidene-butanoyl]amino]-5-oxidanylidene-pentanoyl]amino]-5-oxidanylidene-pentanoyl]amino]-5-oxidanylidene-pentanoic acid","(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-(N'-acetylhydrazino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-4-methyl-pentanoyl]amino]-3-methyl-pentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-4-methyl-pentanoyl]amino]-3-methyl-pentanoyl]amino]-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-5-amino-5-keto-pentanoyl]amino]-4-amino-4-keto-butanoyl]amino]-5-amino-5-keto-pentanoyl]amino]-5-amino-5-keto-pentanoyl]amino]-5-[[(1S)-5-amino-1-[[(1S)-3-amino-1-[[(1S)-1-[[(1S)-4-amino-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-5-amino-1-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-3-amino-1-[[(1S)-2-[[(1S)-1-benzyl-2-(carboxymethylamino)-2-keto-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]carbamoyl]-3-keto-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]carbamoyl]-3-methyl-butyl]amino]-2-keto-1-methylol-ethyl]amino]-2-keto-1-methyl-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]carbamoyl]pentyl]amino]-1-(carboxymethyl)-2-keto-ethyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-4-keto-butyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-keto-propyl]carbamoyl]pentyl]amino]-5-keto-valeric acid","InChI=1S/C206H304N52O66/c1-20-103(15)168(254-197(315)137(75-101(11)12)239-202(320)151(94-261)252-192(310)143(82-113-90-216-96-221-113)249-205(323)169(104(16)21-2)255-198(316)138(76-102(13)14)240-203(321)152(95-262)253-206(324)170(106(18)263)256-199(317)148(258-257-107(19)264)78-109-45-47-114(265)48-46-109)204(322)234-132(58-68-165(283)284)180(298)229-131(57-67-164(281)282)184(302)251-150(93-260)200(318)233-126(52-62-156(212)269)181(299)246-145(84-158(214)271)193(311)230-125(51-61-155(211)268)177(295)225-123(49-59-153(209)266)175(293)227-127(53-63-160(273)274)178(296)223-121(43-31-33-69-207)174(292)245-144(83-157(213)270)194(312)232-128(54-64-161(275)276)179(297)226-124(50-60-154(210)267)176(294)228-129(55-65-162(277)278)182(300)235-134(72-98(5)6)187(305)237-133(71-97(3)4)186(304)231-130(56-66-163(279)280)183(301)236-135(73-99(7)8)189(307)248-147(86-166(285)286)196(314)224-122(44-32-34-70-208)173(291)242-140(79-110-87-217-118-40-28-25-37-115(110)118)185(303)222-105(17)171(289)250-149(92-259)201(319)238-136(74-100(9)10)188(306)243-142(81-112-89-219-120-42-30-27-39-117(112)120)191(309)247-146(85-159(215)272)195(313)244-141(80-111-88-218-119-41-29-26-38-116(111)119)190(308)241-139(172(290)220-91-167(287)288)77-108-35-23-22-24-36-108/h22-30,35-42,45-48,87-90,96-106,121-152,168-170,217-219,258-263,265H,20-21,31-34,43-44,49-86,91-95,207-208H2,1-19H3,(H2,209,266)(H2,210,267)(H2,211,268)(H2,212,269)(H2,213,270)(H2,214,271)(H2,215,272)(H,216,221)(H,220,290)(H,222,303)(H,223,296)(H,224,314)(H,225,295)(H,226,297)(H,227,293)(H,228,294)(H,229,298)(H,230,311)(H,231,304)(H,232,312)(H,233,318)(H,234,322)(H,235,300)(H,236,301)(H,237,305)(H,238,319)(H,239,320)(H,240,321)(H,241,308)(H,242,291)(H,243,306)(H,244,313)(H,245,292)(H,246,299)(H,247,309)(H,248,307)(H,249,323)(H,250,289)(H,251,302)(H,252,310)(H,253,324)(H,254,315)(H,255,316)(H,256,317)(H,257,264)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H,287,288)/t103-,104-,105-,106+,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,168-,169-,170-/m0/s1",BWVBEUNZTQWGMR-CKVIKZOTSA-N,,4564.2097325,C206H304N52O66,4565.0,1940.0,4562.2030228,0.0,324.0,39.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NNC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O,-17.2,"259  100  5
102  261  8
102  262  8
256  104  6
267  105  6
271  106  6
268  108  5
298  109  5
110  300  8
110  301  8
119  132  6
121  135  6
170  185  8
200  21  6
219  228  8
219  239  8
228  240  8
228  255  8
240  263  8
241  252  8
241  261  8
252  262  8
252  279  8
255  275  8
258  287  8
258  288  8
262  289  8
263  276  8
275  276  8
279  294  8
284  293  8
284  300  8
287  302  8
288  303  8
289  296  8
293  301  8
293  308  8
294  296  8
301  310  8
302  306  8
303  306  8
308  316  8
310  317  8
315  318  8
315  319  8
316  317  8
318  321  8
319  322  8
321  323  8
322  323  8
120  67  6
122  68  6
123  69  5
138  70  5
137  71  5
127  72  5
139  73  5
142  74  6
141  75  6
157  76  6
173  77  6
160  78  5
165  79  6
171  80  5
81  170  8
81  199  8
184  82  6
201  83  5
190  84  5
187  85  6
86  185  8
86  199  8
192  87  5
205  88  6
206  89  5
226  90  6
213  91  5
225  92  6
235  93  5
94  239  8
94  240  8
231  95  6
223  96  6
242  97  6
237  98  5
254  99  5",
440791005,60877,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00515,Emtricitabine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00515,emtricitabine,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0,60877,1.0,374.0,5.0,2.0,2.0,AAADccBzMQBAAAAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAAAAAAAHwQQCAAACADlwAaBAANABgioAAJmdACAAAEAABAAAAAIABCBEAAAAAAKAAAABgIjAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one","4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2-pyrimidinone","4-amino-5-fluoro-1-[(2<I>R</I>,5<I>S</I>)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one","4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one","4-azanyl-5-fluoranyl-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one","4-amino-5-fluoro-1-[(2R,5S)-2-methylol-1,3-oxathiolan-5-yl]pyrimidin-2-one","InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1",XQSPYNMVSIKCOC-NTSWFWBYSA-N,-0.6,247.04269053,C8H10FN3O3S,247.25,113.0,247.04269053,0.0,16.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F,,"11  12  5
13  15  8
15  16  8
6  13  8
6  14  8
9  6  5
7  14  8
7  16  8",
440791004,6049,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00760,Edetic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT00760,edetic acid,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,6049,1.0,315.0,10.0,4.0,11.0,AAADceBzPAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAACAAAAADBgAQACAMAAgAIAACQCAAAAAAAAAAAAACIAAACQAAAACAQAAAAAACQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,2-[2-[bis(2-hydroxy-2-oxoethyl)amino]ethyl-(2-hydroxy-2-oxoethyl)amino]ethanoic acid,2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)",KCXVZYZYPLLWCC-UHFFFAOYSA-N,,292.09066547,C10H16N2O8,292.24,156.0,292.09066547,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,-5.9,,
440791003,3108,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00294,dipyridamole,20250421,20210312,Curation Efforts|Governmental Organizations,LT00294,dipyridamole,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,3108,1.0,561.0,12.0,4.0,12.0,AAADcfB7+AAAAAAAAAAAAAAAAAAAAAAAAAAsWLFgAAAAAACx+AAAHgAACAAACAjhlgYB8LcIEgCgAQZgZACCgC0hEKABmCAoVJiKeAJAyMEUBAhIAALQQCAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidyl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol","2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidinyl)-6-pyrimido[5,4-d]pyrimidinyl]-(2-hydroxyethyl)amino]ethanol","2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol","2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol","2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol","2-[[2-[bis(2-hydroxyethyl)amino]-4,8-dipiperidino-pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol","InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2",IZEKFCXSFNUWAM-UHFFFAOYSA-N,,504.31725179,C24H40N8O4,504.6,145.0,504.31725179,0.0,36.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,0.7,"10  26  8
10  28  8
23  26  8
24  25  8
25  26  8
7  23  8
7  27  8
8  24  8
8  28  8
9  25  8
9  27  8",
440791002,3019,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00865,diazoxide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00865,diazoxide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,3019,1.0,360.0,3.0,1.0,0.0,AAADcYBzMABEAAAAAAAAAAAAAAAAAAAAAAAwQAAAAAAAAACBAAAAHAYQQAAACAqBUCAzwYLAAAKgACZiYHDCABAhBwAJiBwQZogIICLBm5GEIAhgkADIyAcQAAAAAABAABAAAQAAAIAAIAACAAAAAAAAAA==,"7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide","7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide","7-chloro-3-methyl-4<I>H</I>-1&lambda;<SUP>6</SUP>,2,4-benzothiadiazine 1,1-dioxide","7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide","7-chloranyl-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide","7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide","InChI=1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11)",GDLBFKVLRPITMI-UHFFFAOYSA-N,1.2,229.9916763,C8H7ClN2O2S,230.67,66.9,229.9916763,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,,"10  12  8
11  13  8
12  13  8
7  10  8
7  8  8
8  11  8",
440791001,54680690,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00081,demeclocycline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00081,demeclocycline,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,54680690,1.0,961.0,9.0,6.0,2.0,AAADceB7PAAEAAAAAAAAAAAAAAAAAAAAAAAwYIEAAAAAAACBAAAAHgIQCAAADX7hmCYyBoNAAgCIAqFSEAKCAAAgJQAIiAHOCsgJNz6LkjKEcAAn4BEJmQf+/veugCABIAAZAADAQAZAADIAAAAAAAAAAA==,"(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4<I>S</I>,4<I>a</I><I>S</I>,5<I>a</I><I>S</I>,6<I>S</I>,12<I>a</I><I>R</I>)-7-chloro-4-(dimethylamino)-1,6,10,11,12<I>a</I>-pentahydroxy-3,12-dioxo-4<I>a</I>,5,5<I>a</I>,6-tetrahydro-4<I>H</I>-tetracene-2-carboxamide","(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aS,5aS,6S,12aR)-7-chloranyl-4-(dimethylamino)-1,6,10,11,12a-pentakis(oxidanyl)-3,12-bis(oxidanylidene)-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-diketo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","InChI=1S/C21H21ClN2O8/c1-24(2)14-7-5-6-10(16(27)12-9(25)4-3-8(22)11(12)15(6)26)18(29)21(7,32)19(30)13(17(14)28)20(23)31/h3-4,6-7,14-15,25-27,30,32H,5H2,1-2H3,(H2,23,31)/t6-,7-,14-,15-,21-/m0/s1",GUXHBMASAHGULD-SEYHBJAFSA-N,,464.0986433,C21H21ClN2O8,464.9,182.0,464.0986433,0.0,32.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12,0.7,"16  10  6
12  33  6
15  36  6
13  2  6
23  25  8
23  28  8
25  30  8
28  31  8
19  3  5
30  32  8
31  32  8",
440791000,6234,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01253,cycloserine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01253,cycloserine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,6234,1.0,92.9,3.0,2.0,0.0,AAADcYBDMAAAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAAAAAAAHgAUAAAACCjhgAYAAABQAAAIAAEQEAAAAAAAAAAgAIGAAAACQAQAAAAAAAACMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(4R)-4-aminoisoxazolidin-3-one,(4R)-4-amino-3-isoxazolidinone,"(4<I>R</I>)-4-amino-1,2-oxazolidin-3-one","(4R)-4-amino-1,2-oxazolidin-3-one","(4R)-4-azanyl-1,2-oxazolidin-3-one",(4R)-4-aminoisoxazolidin-3-one,"InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1",DYDCUQKUCUHJBH-UWTATZPHSA-N,,102.042927438,C3H6N2O2,102.09,64.4,102.042927438,0.0,7.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",N[C@@H]1CONC1=O,-1.5,5  4  6,
440790999,2809,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00341,clorazepate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00341,clorazepate,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,2809,1.0,488.0,4.0,2.0,2.0,AAADccB7MAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHgIQCAAADCrBmCQwyILAAgCoAyXyXACCAAAhBwAIiAGgZpgKYK7Jk5GUYAhitADIyAcQgMAOAABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid","7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid","7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid","7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid","7-chloranyl-2-oxidanylidene-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid","7-chloro-2-keto-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid","InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)",XDDJGVMJFWAHJX-UHFFFAOYSA-N,3.3,314.0458199,C16H11ClN2O3,314.72,78.8,314.0458199,0.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,,"10  23  3
11  17  8
11  18  8
13  15  8
14  16  8
15  16  8
17  20  8
18  21  8
20  22  8
21  22  8
7  13  8
7  9  8
9  14  8",
440790998,119182,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01206,Clofarabine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01206,clofarabine,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0,119182,1.0,370.0,8.0,3.0,2.0,AAADccBzsQAEAAAAAAAAAAAAAAAAAWJAAAAsAAAAAAAAAFgB+AAAHwIQCAAACBzhlwYF8L9MFgCgAQZhZACAgC0REKABUCAoVBCBWAJAyEAeRAgPAALDACCwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3R,4S,5R)-5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol","(2R,3R,4S,5R)-5-(6-amino-2-chloro-9-purinyl)-4-fluoro-2-(hydroxymethyl)-3-oxolanol","(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol","(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol","(2R,3R,4S,5R)-5-(6-azanyl-2-chloranyl-purin-9-yl)-4-fluoranyl-2-(hydroxymethyl)oxolan-3-ol","(2R,3R,4S,5R)-5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-methylol-tetrahydrofuran-3-ol","InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1",WDDPHFBMKLOVOX-AYQXTPAHSA-N,0.9,303.0534451,C10H11ClFN5O3,303.68,119.0,303.0534451,0.0,20.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,,"14  15  6
16  18  8
18  19  8
13  2  6
12  4  5
11  6  6
6  16  8
6  17  8
7  17  8
7  18  8
8  16  8
8  20  8
9  19  8
9  20  8",
440790997,443385,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02346,CLINDAMYCIN-2-PHOSPHATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02346,clindamycin-2-phosphate,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,443385,1.0,658.0,10.0,5.0,9.0,AAADcfB7PAJEAAAAAAAAAAAAAAAAAWAAAAAkAAAAAAAAAAAAAAAAHgYQCCAADT/lwEaCAAPABxgIQAEQEIAAAAAAABAAAIGIAgADUBIhgCBXQAAHFgCTAAH42aOOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate","[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]-oxomethyl]amino]propyl]-4,5-dihydroxy-2-(methylthio)-3-oxanyl] dihydrogen phosphate","[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>,6<I>R</I>)-6-[(1<I>S</I>,2<I>S</I>)-2-chloro-1-[[(2<I>S</I>,4<I>R</I>)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate","[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate","[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloranyl-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidin-2-yl]carbonylamino]propyl]-2-methylsulfanyl-4,5-bis(oxidanyl)oxan-3-yl] dihydrogen phosphate","[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-prolyl]amino]propyl]-4,5-dihydroxy-2-(methylthio)tetrahydropyran-3-yl] dihydrogen phosphate","InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)/t9-,10+,11-,12+,13+,14-,15+,16+,18+/m0/s1",UFUVLHLTWXBHGZ-MGZQPHGTSA-N,-1.2,504.1462019,C18H34ClN2O8PS,505.0,174.0,504.1462019,0.0,31.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,"26  1  6
19  13  5
14  22  6
15  24  5
18  38  6
25  2  6
20  5  5
23  6  6
21  7  5",
440790996,20279,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01224,Cladribine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01224,cladribine,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,20279,1.0,338.0,7.0,3.0,2.0,AAADccBzsAAEAAAAAAAAAAAAAAAAAWJAAAAsAAAAAAAAAFgB+AAAHgIQCAAACBzhlwYF8L9MFgCgAQZhZACAgC0REKABUCAoVBCBWAJAyEAeRAgPAALDACCwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol","(2R,3S,5R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-oxolanol","(2<I>R</I>,3<I>S</I>,5<I>R</I>)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol","(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol","(2R,3S,5R)-5-(6-azanyl-2-chloranyl-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol","(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-methylol-tetrahydrofuran-3-ol","InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1",PTOAARAWEBMLNO-KVQBGUIXSA-N,0.8,285.062867,C10H12ClN5O3,285.69,119.0,285.062867,0.0,19.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,,"13  14  6
15  17  8
17  18  8
11  3  5
10  5  6
5  15  8
5  16  8
6  16  8
6  17  8
7  15  8
7  19  8
8  18  8
8  19  8",
440790995,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01082,Choriogonadotropin alfa,20210312,20210312,Curation Efforts|Governmental Organizations,LT01082,choriogonadotropin alfa,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790994,10133,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00065,Chenodiol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00065,chenodiol,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0,10133,1.0,605.0,4.0,3.0,4.0,AAADcfB4OAAAAAAAAAAAAAAAAAAAAYAAAAAwYMAAAAAAAGDAAAAAGgAACAAADxSggAICCAAAAgAIAACQCAAAAAAAAAAAAAEAAAAAEBIAAAAAQAAEAAAAAAGI6PSPgAAAAAAAAADAAAYAADAAAQAACAAAAA==,"(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","(4<I>R</I>)-4-[(3<I>R</I>,5<I>S</I>,7<I>R</I>,8<I>R</I>,9<I>S</I>,10<I>S</I>,13<I>R</I>,14<I>S</I>,17<I>R</I>)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1<I>H</I>-cyclopenta[a]phenanthren-17-yl]pentanoic acid","(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid","(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]valeric acid","InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1",RUDATBOHQWOJDD-BSWAIDMHSA-N,,392.29265975,C24H40O4,392.6,77.8,392.29265975,0.0,28.0,10.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,4.9,"14  1  6
10  32  6
11  33  5
24  2  6
20  26  6
5  29  6
6  19  5
7  30  5
8  31  6
9  22  5",
440790993,25074887,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00484,Cetrorelix,20231222,20210312,Curation Efforts|Governmental Organizations,LT00484,cetrorelix,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,25074887,1.0,2840.0,16.0,16.0,38.0,AAADcfB//AAEAAAAAAAAAAAAAAAAAWAAAAA8YMGCAAAAAADB1AAAHgIQCAAADS7hmiY/htPIEgCoAjF3dACCgCExJyAI2KG+bpiKdvbDk7OUcAhm9hPY2AeYyeCO5AACAAAQAADIAAQAACAAAAAAAAAAAA==,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthyl)propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-(3-pyridyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-ureido-pentanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]-N-[(1R)-2-amino-1-methyl-2-oxo-ethyl]pyrrolidine-2-carboxamide,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthalenyl)-1-oxopropyl]amino]-3-(4-chlorophenyl)-1-oxopropyl]amino]-1-oxo-3-(3-pyridinyl)propyl]amino]-3-hydroxy-1-oxopropyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-5-(carbamoylamino)-1-oxopentyl]amino]-4-methyl-1-oxopentyl]amino]-5-(diaminomethylideneamino)-1-oxopentyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]-2-pyrrolidinecarboxamide,(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>R</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>R</I>)-2-[[(2<I>R</I>)-2-[[(2<I>R</I>)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-<I>N</I>-[(2<I>R</I>)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-yl-propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-yl-propanoyl]amino]-3-oxidanyl-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(aminocarbonylamino)pentanoyl]amino]-4-methyl-pentanoyl]amino]-5-[bis(azanyl)methylideneamino]pentanoyl]-N-[(2R)-1-azanyl-1-oxidanylidene-propan-2-yl]pyrrolidine-2-carboxamide,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthyl)propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-(3-pyridyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-ureido-pentanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]-N-[(1R)-2-amino-2-keto-1-methyl-ethyl]pyrrolidine-2-carboxamide,"InChI=1S/C70H92ClN17O14/c1-39(2)31-52(61(94)82-51(15-9-28-77-69(73)74)68(101)88-30-10-16-58(88)67(100)79-40(3)59(72)92)83-60(93)50(14-8-29-78-70(75)102)81-63(96)54(34-43-20-25-49(91)26-21-43)86-66(99)57(38-89)87-65(98)56(36-45-11-7-27-76-37-45)85-64(97)55(33-42-18-23-48(71)24-19-42)84-62(95)53(80-41(4)90)35-44-17-22-46-12-5-6-13-47(46)32-44/h5-7,11-13,17-27,32,37,39-40,50-58,89,91H,8-10,14-16,28-31,33-36,38H2,1-4H3,(H2,72,92)(H,79,100)(H,80,90)(H,81,96)(H,82,94)(H,83,93)(H,84,95)(H,85,97)(H,86,99)(H,87,98)(H4,73,74,77)(H3,75,78,102)/t40-,50-,51+,52+,53-,54+,55-,56-,57+,58+/m1/s1",SBNPWPIBESPSIF-MHWMIDJBSA-N,,1429.6698184,C70H92ClN17O14,1431.0,498.0,1429.6698184,0.0,102.0,10.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,1.9,"101  102  8
38  17  5
44  18  6
42  19  6
51  21  6
58  23  5
63  27  6
64  28  5
70  29  5
76  31  6
32  84  8
32  98  8
33  39  5
61  66  8
61  67  8
66  72  8
67  73  8
72  77  8
73  77  8
78  83  8
78  84  8
81  85  8
81  86  8
82  87  8
82  88  8
83  93  8
85  94  8
86  95  8
87  89  8
88  91  8
89  90  8
89  97  8
90  91  8
90  99  8
93  98  8
94  96  8
95  96  8
97  101  8
99  102  8",
440790992,441199,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01179,cefoxitin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01179,cefoxitin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,441199,1.0,744.0,9.0,3.0,8.0,AAADceB7OABgAAAAAAAAAAAAAABYASAAAAAgAAAAAAAQAAABgAAAHgQQCAAADAzl0AayCYPABgiMAiXSWAIDAIBgCBBIiBnIAMkKZDqgtTWdEAAglgC4uQcYCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>S</I>)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-3-(aminocarbonyloxymethyl)-7-methoxy-8-oxidanylidene-7-(2-thiophen-2-ylethanoylamino)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-3-(carbamoyloxymethyl)-8-keto-7-methoxy-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C16H17N3O7S2/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22)/t14-,16+/m1/s1",WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,0.0,427.05079224,C16H17N3O7S2,427.5,202.0,427.05079224,0.0,28.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@@H]21,,"11  20  1
14  29  6
2  24  8
2  28  8
24  25  8
25  27  8
27  28  8
13  3  6",
440790991,2826718,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01089,Caspofungin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01089,caspofungin,7.0,Warnings and precautions,Ambiguous DILI-concern,2.0,2826718,1.0,1900.0,18.0,16.0,23.0,AAADcfB//AAAAAAAAAAAAAAAAAAAAWLAAAAwAAAAAAAAAAABAAAAHgAQCAAADTzhmAYzBoPAAgCIAiFSEAACAAAgIAAIiIGOCIiLdjaCkTKUcAAu9xOZmAe66eSOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxy-propyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyl-tetradecanamide","N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide","<I>N</I>-[(3<I>S</I>,6<I>S</I>,9<I>S</I>,11<I>R</I>,15<I>S</I>,18<I>S</I>,20<I>R</I>,21<I>S</I>,24<I>S</I>,25<I>S</I>)-21-(2-aminoethylamino)-3-[(1<I>R</I>)-3-amino-1-hydroxypropyl]-6-[(1<I>S</I>,2<I>S</I>)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1<I>R</I>)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.0<SUP>9,13</SUP>]heptacosan-18-yl]-10,12-dimethyltetradecanamide","N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide","N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-azanylethylamino)-3-[(1R)-3-azanyl-1-oxidanyl-propyl]-6-[(1S,2S)-2-(4-hydroxyphenyl)-1,2-bis(oxidanyl)ethyl]-11,20,25-tris(oxidanyl)-15-[(1R)-1-oxidanylethyl]-2,5,8,14,17,23-hexakis(oxidanylidene)-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyl-tetradecanamide","N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxy-propyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaketo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyl-myristamide","InChI=1S/C52H88N10O15/c1-5-28(2)24-29(3)12-10-8-6-7-9-11-13-39(69)56-34-26-38(68)46(55-22-21-54)60-50(75)43-37(67)19-23-61(43)52(77)41(36(66)18-20-53)58-49(74)42(45(71)44(70)31-14-16-32(64)17-15-31)59-48(73)35-25-33(65)27-62(35)51(76)40(30(4)63)57-47(34)72/h14-17,28-30,33-38,40-46,55,63-68,70-71H,5-13,18-27,53-54H2,1-4H3,(H,56,69)(H,57,72)(H,58,74)(H,59,73)(H,60,75)/t28?,29?,30-,33-,34+,35+,36-,37+,38-,40+,41+,42+,43+,44+,45+,46+/m1/s1",JYIKNQVWKBUSNH-OGZDCFRISA-N,,1092.64306214,C52H88N10O15,1093.3,412.0,1092.64306214,0.0,77.0,14.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O,0.3,"27  1  5
48  10  6
51  12  5
32  2  5
42  22  5
47  23  5
26  78  5
28  80  5
34  90  5
39  91  5
41  93  5
40  5  5
53  66  3
58  71  3
60  72  8
60  73  8
72  75  8
73  76  8
75  77  8
76  77  8
43  8  5
45  9  5",
440790990,34359,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01160,carbidopa,20231222,20210312,Curation Efforts|Governmental Organizations,LT01160,carbidopa,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,34359,1.0,261.0,6.0,5.0,4.0,AAADccBzOAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAYCAAADIyBmAAyDoBiAgCIAiDSCAACAAAgIAIYqAGGiIgLJjKCkROAcAEk0BEJmAeY2PGOIAABAAAAQABAAAIAAACAAAAAAAAAAA==,"(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid","(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid","(2<I>S</I>)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid","(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid","(2S)-3-[3,4-bis(oxidanyl)phenyl]-2-diazanyl-2-methyl-propanoic acid","(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propionic acid","InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1",TZFNLOMSOLWIDK-JTQLQIEISA-N,,226.09535693,C10H14N2O4,226.23,116.0,226.09535693,0.0,16.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O,-2.2,"12  14  8
13  15  8
14  16  8
15  16  8
7  5  5
9  12  8
9  13  8",
440790989,60953,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02018,CAPECITABINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02018,capecitabine,2.0,Warnings and precautions,Ambiguous DILI-concern,2.0,60953,1.0,582.0,7.0,3.0,7.0,AAADceBzOQAAAAAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAAAAAAAHwAQCAAACBThgAYDCAPABgCoAAJmfACAAAEAAAABAAAIABGDEAIAgAAOQAAHBgITAACwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-2-oxo-pyrimidin-4-yl]carbamate","N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-2-oxolanyl]-5-fluoro-2-oxo-4-pyrimidinyl]carbamic acid pentyl ester","pentyl <I>N</I>-[1-[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate","pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate","pentyl N-[5-fluoranyl-1-[(2R,3R,4S,5R)-5-methyl-3,4-bis(oxidanyl)oxolan-2-yl]-2-oxidanylidene-pyrimidin-4-yl]carbamate","N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-2-keto-pyrimidin-4-yl]carbamic acid amyl ester","InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1",GAGWJHPBXLXJQN-UORFTKCHSA-N,,359.14926359,C15H22FN3O6,359.35,121.0,359.14926359,0.0,25.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,0.6,"14  15  6
16  18  8
18  19  8
11  3  5
12  4  5
13  8  6
8  16  8
8  17  8
9  17  8
9  19  8",
440790988,2471,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01145,bumetanide,20250421,20210312,Curation Efforts|Governmental Organizations,LT01145,bumetanide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,2471,1.0,528.0,7.0,3.0,8.0,AAADceB7OABAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgQQSAAADAzB2AQyz4LABgKIAiTSSHDCCBAlIgAIiJsPbMgOJjLEtZuHeSzk0BHY+Ye87CzOIAAAwCAAMABAAAGAQABgAAAAAAAAAA==,3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid,3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid,3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid,3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid,3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid,3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid,"InChI=1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)",MAEIEVLCKWDQJH-UHFFFAOYSA-N,,364.10929292,C17H20N2O5S,364.4,127.0,364.10929292,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,2.8,"11  12  8
11  15  8
12  13  8
13  17  8
15  16  8
16  17  8
19  21  8
19  22  8
21  23  8
22  24  8
23  25  8
24  25  8",
440790987,5360373,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01138,bleomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01138,bleomycin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,5360373,1.0,2580.0,31.0,20.0,36.0,AAADcfB//gBgAAAAAAAAAAAAAAAAAWLFgAAsSJAAAAAAAAAB/gAAHgQQCAAADTz13wevuZbJlgisAxd3fASA8K33GrgBWbW4fFmTfJ5g/em/RQhPtgL3YaHcYQwMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxo-propyl]amino]-3-oxo-propyl]-5-methyl-pyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]ethyl]thiazol-4-yl]thiazole-4-carbonyl]amino]propyl-dimethyl-sulfonium","3-[[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methyl-4-pyrimidinyl]-oxomethyl]amino]-3-[[3-[[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-3-(1H-imidazol-5-yl)-1-oxopropyl]amino]-3-hydroxy-2-methyl-1-oxopentyl]amino]-3-hydroxy-1-oxobutyl]amino]ethyl]-4-thiazolyl]-4-thiazolyl]-oxomethyl]amino]propyl-dimethylsulfonium","3-[[2-[2-[2-[[(2<I>S</I>,3<I>R</I>)-2-[[(2<I>S</I>,3<I>S</I>,4<I>R</I>)-4-[[(2<I>S</I>,3<I>R</I>)-2-[[6-amino-2-[(1<I>S</I>)-3-amino-1-[[(2<I>S</I>)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1<I>H</I>-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium","3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium","3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-3-[3-[4-aminocarbonyloxy-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-2-[[6-azanyl-2-[(1S)-3-azanyl-1-[[(2S)-2,3-bis(azanyl)-3-oxidanylidene-propyl]amino]-3-oxidanylidene-propyl]-5-methyl-pyrimidin-4-yl]carbonylamino]-3-(1H-imidazol-5-yl)propanoyl]amino]-2-methyl-3-oxidanyl-pentanoyl]amino]-3-oxidanyl-butanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazol-4-yl]carbonylamino]propyl-dimethyl-sulfanium","3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-keto-propyl]amino]-3-keto-propyl]-5-methyl-pyrimidine-4-carbonyl]amino]-3-[3-(4-carbamoyloxy-3,5-dihydroxy-6-methylol-tetrahydropyran-2-yl)oxy-4,5-dihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]ethyl]thiazol-4-yl]thiazole-4-carbonyl]amino]propyl-dimethyl-sulfonium","InChI=1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1/t21-,22+,23+,24-,25-,29?,30?,34-,35-,36-,37?,38?,39?,40?,41-,42?,43?,53?,54?/m0/s1",OYVAGSVQBOHSSS-WXFSZRTFSA-O,,1414.51898128,C55H84N17O21S3+,1415.6,685.0,1414.51898128,1.0,96.0,9.0,10.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1cnc[nH]1,-7.5,"1  85  8
1  87  8
49  10  3
48  11  3
50  12  3
61  17  6
2  88  8
2  90  8
73  20  6
55  25  6
26  56  8
26  63  8
60  27  5
28  59  8
28  63  8
70  30  6
31  66  8
31  71  8
32  71  8
32  72  8
75  33  6
82  37  5
39  85  8
39  86  8
42  4  3
46  4  3
40  88  8
40  89  8
47  52  3
51  54  3
56  59  8
64  67  6
66  69  8
69  72  8
45  7  3
53  7  5
43  8  3
86  87  8
89  90  8
44  9  3",
440790986,9444,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01028,Azacitidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01028,azacitidine,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0,9444,1.0,384.0,5.0,4.0,2.0,AAADccBzuAAAAAAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAAAAAAAHgAQCAAACBThgAYBAANABgAoAAABNAAAAAEAAAABAAAIAACDEAIAiAAOQAAHBgITAADwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one","4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-1,3,5-triazin-2-one","4-amino-1-[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one","4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one","4-azanyl-1-[(2R,3R,4S,5R)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-1,3,5-triazin-2-one","4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]-s-triazin-2-one","InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1",NMUSYJAQQFHJEW-KVTDHHQDSA-N,-2.2,244.0807695,C8H12N4O5,244.2,141.0,244.0807695,0.0,17.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,,"12  14  6
10  2  5
11  3  5
13  6  6
6  15  8
6  16  8
7  15  8
7  17  8
8  16  8
8  17  8",
440790985,74989,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01096,ATOVAQUONE,20250421,20210312,Curation Efforts|Governmental Organizations,LT01096,atovaquone,8.0,Warnings and precautions,Ambiguous DILI-concern,2.0,74989,1.0,595.0,3.0,1.0,2.0,AAADceB4MAAEAAAAAAAAAAAAAAAAAAAAAAAwYMEAAAAAAACBQAAAGgIACAAADQaAmCAwAIAAAgCIAqBSAAACAAAkJQAIiAEACsgIJjKBFxCAcQAkwAEImYeKzOCOhAAAAAAQAACIAAAAACAAAAAAAAAAAA==,"3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-naphthalene-1,2-dione","3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione","3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione","3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione","3-[4-(4-chlorophenyl)cyclohexyl]-4-oxidanyl-naphthalene-1,2-dione","3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-1,2-naphthoquinone","InChI=1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,9-13,15,24H,5-8H2",BSJMWHQBCZFXBR-UHFFFAOYSA-N,,366.1022722,C22H19ClO3,366.8,54.4,366.1022722,0.0,26.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1C(=O)c2ccccc2C(O)=C1C1CCC(c2ccc(Cl)cc2)CC1,5.2,"12  15  8
12  16  8
15  20  8
16  21  8
17  19  8
17  22  8
19  24  8
20  23  8
21  23  8
22  25  8
24  26  8
25  26  8",
440790984,9690109,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01230,Armodafinil,20231222,20210312,Curation Efforts|Governmental Organizations,LT01230,armodafinil,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,9690109,1.0,302.0,3.0,1.0,5.0,AAADccByMABAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgQQAAAADACF2ACwAIBAAAqIAiFSEEBCAAAgABAIiAAAAIgIICKgERCAIAAgkAAoiAcAgMAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-[(R)-benzhydrylsulfinyl]acetamide,2-[(R)-(diphenylmethyl)sulfinyl]acetamide,2-[(<I>R</I>)-benzhydrylsulfinyl]acetamide,2-[(R)-benzhydrylsulfinyl]acetamide,2-[(R)-(diphenylmethyl)sulfinyl]ethanamide,2-[(R)-benzhydrylsulfinyl]acetamide,"InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)/t19-/m1/s1",YFGHCGITMMYXAQ-LJQANCHMSA-N,,273.08234989,C15H15NO2S,273.4,79.4,273.08234989,0.0,19.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)C[S@@](=O)C(c1ccccc1)c1ccccc1,1.7,"1  8  6
10  14  8
11  15  8
12  16  8
13  17  8
14  18  8
15  17  8
16  18  8
6  11  8
6  9  8
7  10  8
7  12  8
9  13  8",
440790983,166548,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01203,Anidulafungin,20210804,20210312,Curation Efforts|Governmental Organizations,LT01203,anidulafungin,7.0,Warnings and precautions,Ambiguous DILI-concern,2.0,166548,1.0,2150.0,17.0,14.0,14.0,AAADcfB/vgAAAAAAAAAAAAAAAAAAAWLAAAAwYMGAAAAAAAABVAAAHgAQCAAADTzhmAYyBoPABgCIAiFSEACCCAAkIAAIiIGODMkPdjaGtTuWeSjm9hGZuYe6/faO4AAAAAAAAADAAAAAAAAAAAAAAAAAAA==,"N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide","N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide","<I>N</I>-[(3<I>S</I>,6<I>S</I>,9<I>S</I>,11<I>R</I>,15<I>S</I>,18<I>S</I>,20<I>R</I>,21<I>R</I>,24<I>S</I>,25<I>S</I>,26<I>S</I>)-6-[(1<I>S</I>,2<I>S</I>)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1<I>R</I>)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.0<SUP>9,13</SUP>]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide","N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide","N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-2-(4-hydroxyphenyl)-1,2-bis(oxidanyl)ethyl]-26-methyl-11,20,21,25-tetrakis(oxidanyl)-3,15-bis[(1R)-1-oxidanylethyl]-2,5,8,14,17,23-hexakis(oxidanylidene)-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide","4-[4-(4-amoxyphenyl)phenyl]-N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaketo-26-methyl-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide","InChI=1S/C58H73N7O17/c1-5-6-7-24-82-40-22-18-35(19-23-40)33-10-8-32(9-11-33)34-12-14-37(15-13-34)51(74)59-41-26-43(70)54(77)63-56(79)47-48(71)29(2)27-65(47)58(81)45(31(4)67)61-55(78)46(50(73)49(72)36-16-20-38(68)21-17-36)62-53(76)42-25-39(69)28-64(42)57(80)44(30(3)66)60-52(41)75/h8-23,29-31,39,41-50,54,66-73,77H,5-7,24-28H2,1-4H3,(H,59,74)(H,60,75)(H,61,78)(H,62,76)(H,63,79)/t29-,30+,31+,39+,41-,42-,43+,44-,45-,46-,47-,48-,49-,50-,54+/m0/s1",JHVAMHSQVVQIOT-MFAJLEFUSA-N,,1139.50629389,C58H73N7O17,1140.2,377.0,1139.50629389,0.0,82.0,15.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)cc2)cc1,2.3,"26  1  6
45  10  5
49  12  5
50  13  6
48  24  5
25  29  6
27  85  6
32  91  6
33  92  6
39  103  5
35  4  6
44  105  5
37  5  6
53  55  8
53  56  8
55  58  8
56  59  8
57  61  8
57  62  8
58  60  8
59  60  8
38  6  6
61  63  8
62  64  8
63  65  8
64  65  8
66  67  8
66  68  8
67  69  8
68  70  8
69  71  8
42  7  6
70  71  8
72  73  8
72  74  8
73  75  8
74  76  8
75  77  8
76  77  8",
440790982,135409400,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00964,anagrelide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00964,anagrelide,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,135409400,1.0,360.0,2.0,1.0,0.0,AAADcYBzIAAGAAAAAAAAAAAAAAAAAWAAAAAwQAAAAAAAAECBAAAAHgIQAAAADArBmCQxwIPAAACoAiVSdACCAAEgBwAJikCIZoiIYCKB2rGUIAhokQKIyAcQgAAOAABAIAIDAAQAAIBABAYACAAAAAAAAA==,"6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one","6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one","6,7-dichloro-3,5-dihydro-1<I>H</I>-imidazo[2,1-b]quinazolin-2-one","6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one","6,7-bis(chloranyl)-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one","6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one","InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)",OTBXOEAOVRKTNQ-UHFFFAOYSA-N,,254.9966172,C10H7Cl2N3O,256.08,44.7,254.9966172,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1,1.6,"10  11  8
10  13  8
11  14  8
13  15  8
14  16  8
15  16  8",
440790981,65016,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01055,amprenavir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01055,amprenavir,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,65016,1.0,745.0,8.0,3.0,12.0,AAADcfB7OABAAAAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAAABQAAAHgQQSAAADTzh2AYyyYLABgKIAiRCWHDCABAgAgAIiJgIZIkLMCKA0ZGOYABllgCayAeQwKAOAAQAAAAAAAAACAAAAAAAAAAAAAAAAA==,"[(3S)-tetrahydrofuran-3-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate","N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamic acid [(3S)-3-oxolanyl] ester","[(3<I>S</I>)-oxolan-3-yl] <I>N</I>-[(2<I>S</I>,3<I>R</I>)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate","[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate","[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-oxidanyl-1-phenyl-butan-2-yl]carbamate","N-[(1S,2R)-1-benzyl-2-hydroxy-3-[isobutyl(sulfanilyl)amino]propyl]carbamic acid [(3S)-tetrahydrofuran-3-yl] ester","InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1",YMARZQAQMVYCKC-OEMFJLHTSA-N,,505.22465702,C25H35N3O6S,505.6,140.0,505.22465702,0.0,35.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,2.9,"18  26  8
18  27  8
11  2  5
22  28  8
22  29  8
26  30  8
27  31  8
28  32  8
29  33  8
17  3  6
30  35  8
31  35  8
32  34  8
33  34  8
12  9  5",
440790980,2130,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00503,amantadine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00503,amantadine,3.0,Warnings and precautions,Ambiguous DILI-concern,1.0,2130,1.0,144.0,1.0,1.0,0.0,AAADceByAAAAAAAAAAAAAAAAAAAAAAAAAAAwYMGAAAAAAAAAAAAAHAAQAAAADYiBAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAIAgAAAAAAAEAAAAAEQgMAOAAAAAAAAAAAAAASAAAAAAAAAAAAAAA==,adamantan-1-amine,1-adamantanamine,adamantan-1-amine,adamantan-1-amine,adamantan-1-amine,1-adamantylamine,"InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2",DKNWSYNQZKUICI-UHFFFAOYSA-N,2.4,151.136099547,C10H17N,151.25,26.0,151.136099547,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC12CC3CC(CC(C3)C1)C2,,,
440790979,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01319,Aldesleukin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01319,aldesleukin,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790978,1990,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00913,acetohydroxamic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT00913,acetohydroxamic acid,3.0,Warnings and precautions,Ambiguous DILI-concern,2.0,1990,1.0,42.9,2.0,2.0,0.0,AAADcYBCMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAUCAAAAACBgAACAABQAAAIAAEQEAAAAAAAAAAgAAAAAAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,ethanehydroxamic acid,N-hydroxyacetamide,<I>N</I>-hydroxyacetamide,N-hydroxyacetamide,N-oxidanylethanamide,ethanehydroxamic acid,"InChI=1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)",RRUDCFGSUDOHDG-UHFFFAOYSA-N,-1.6,75.032028402,C2H5NO2,75.07,49.3,75.032028402,0.0,5.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)NO,,3  4  1,
440790977,5719,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00648,zaleplon,20210312,20210312,Curation Efforts|Governmental Organizations,LT00648,zaleplon,0.0,No match,vNo-DILI-Concern,2.0,5719,1.0,487.0,4.0,0.0,3.0,AAADccB7oAAAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgB8AAAHgAIAAAADAjBnwQ/8J8IEAC6Bzd3dACyhCsxgqAd2CA4ZJiIqOLA2dGEpAhojgLIyCcQgIAOAAAAQAAAAAAAAACAAAAAAAAAAAAAAA==,"N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide","N-[3-(3-cyano-7-pyrazolo[1,5-a]pyrimidinyl)phenyl]-N-ethylacetamide","<I>N</I>-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-<I>N</I>-ethylacetamide","N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide","N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-ethanamide","N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide","InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3",HUNXMJYCHXQEGX-UHFFFAOYSA-N,1.0,305.12766012,C17H15N5O,305.33,74.3,305.12766012,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,,"12  15  8
13  15  8
14  19  8
16  20  8
19  21  8
3  14  8
3  4  8
3  9  8
4  21  8
5  14  8
5  20  8
7  10  8
7  12  8
8  10  8
8  13  8
9  16  8",
440790976,5311,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00462,Vorinostat,20210312,20210312,Curation Efforts|Governmental Organizations,LT00462,vorinostat,0.0,No match,vNo-DILI-Concern,2.0,5311,1.0,276.0,3.0,3.0,8.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAUCAAACAiBkAAwwILQAACIACVSUACCAAAhAgAoiAEAZIgIIDLAkZGEIAhglADIyAcYiICAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,8-(hydroxyamino)-8-oxo-N-phenyl-octanamide,N'-hydroxy-N-phenyloctanediamide,<I>N</I>&apos;-hydroxy-<I>N</I>-phenyloctanediamide,N'-hydroxy-N-phenyloctanediamide,N'-oxidanyl-N-phenyl-octanediamide,8-(hydroxyamino)-8-keto-N-phenyl-caprylamide,"InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)",WAEXFXRVDQXREF-UHFFFAOYSA-N,1.9,264.1473925,C14H20N2O3,264.32,78.4,264.1473925,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(CCCCCCC(=O)Nc1ccccc1)NO,,"14  15  8
14  16  8
15  17  8
16  18  8
17  19  8
18  19  8",
440790975,14985,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01516,VITAMIN E,20231222,20210312,Curation Efforts|Governmental Organizations,LT01516,vitamin e,0.0,No match,vNo-DILI-Concern,2.0,14985,1.0,503.0,2.0,1.0,12.0,AAADcfB4MAAAAAAAAAAAAAAAAAAAAAAAAAA0QAAAAAAAAACRAAAAGgAACAAADUSAmAACBoAABgCAAgBAAAACCAAgIAAAiAAECIgMJiKGMBqCeCCkwBEIuAfAwPAOwQADAAAYAACCAAYAADAAAAAAAAAAAA==,"(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol","(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol","(2<I>R</I>)-2,5,7,8-tetramethyl-2-[(4<I>R</I>,8<I>R</I>)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol","(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol","(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol","(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol","InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1",GVJHHUAWPYXKBD-IEOSBIPESA-N,,430.381080833,C29H50O2,430.7,29.5,430.381080833,0.0,31.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,10.7,"12  14  8
12  19  8
14  20  8
16  23  6
19  24  8
20  22  8
22  24  8
3  11  6
7  17  6",
440790974,54670067,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02009,vitamin C,20231222,20210312,Curation Efforts|Governmental Organizations,LT02009,vitamin c,0.0,No match,vNo-DILI-Concern,2.0,54670067,1.0,232.0,6.0,4.0,2.0,AAADccBgOAAAAAAAAAAAAAAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAGgAACAAACBSggAIACAAABgCIAADQCAIAAAAgIAAACABAAEgBFAAAIAACUAAFwAALIQJAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one","(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one","(2<I>R</I>)-2-[(1<I>S</I>)-1,2-dihydroxyethyl]-3,4-dihydroxy-2<I>H</I>-furan-5-one","(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one","(2R)-2-[(1S)-1,2-bis(oxidanyl)ethyl]-3,4-bis(oxidanyl)-2H-furan-5-one","(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one","InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1",CIWBSHSKHKDKBQ-JLAZNSOCSA-N,-1.6,176.03208797,C6H8O6,176.12,107.0,176.03208797,0.0,12.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,,"8  2  5
7  13  6",
440790973,13342,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00177,vinblastine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00177,vinblastine,0.0,No match,vNo-DILI-Concern,2.0,13342,1.0,1700.0,12.0,3.0,10.0,AAADcfB/vAAAAAAAAAAAAAAAAAAAAWLFgAA8YMECAAAAAFiB9AAAHgAQCAAAD3zhngYyzvPJlgCoAyTyTAKCiCAhIiAImSF+bJgPJv7E9ZuGcChn8Bnb6Af62fOfqAACAgAKAABQgAYECBSgAAAAAAAAAA==,"methyl (1R,9R,10S,11R,12R,19R)-11-acetoxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate","(1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylic acid methyl ester","methyl (1<I>R</I>,9<I>R</I>,10<I>S</I>,11<I>R</I>,12<I>R</I>,19<I>R</I>)-11-acetyloxy-12-ethyl-4-[(13<I>S</I>,15<I>R</I>,17<I>S</I>)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.0<SUP>4,12</SUP>.0<SUP>5,10</SUP>]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0<SUP>1,9</SUP>.0<SUP>2,7</SUP>.0<SUP>16,19</SUP>]nonadeca-2,4,6,13-tetraene-10-carboxylate","methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate","methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-13-methoxycarbonyl-17-oxidanyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-5-methoxy-8-methyl-10-oxidanyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate","(1R,9R,10S,11R,12R,19R)-11-acetoxy-4-[(13S,15R,17S)-13-carbomethoxy-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylic acid methyl ester","InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1",JXLYSJRDGCGARV-CFWMRBGOSA-N,3.7,810.42037944,C46H58N4O9,811.0,154.0,810.42037944,0.0,59.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,,"20  1  6
13  38  8
13  52  8
14  19  6
15  60  5
16  61  6
17  23  5
18  2  6
21  24  8
21  29  8
24  31  8
29  33  8
31  34  8
33  34  8
35  40  5
38  45  8
39  84  6
45  51  8
51  52  8
51  54  8
52  55  8
54  58  8
55  59  8
58  59  8
46  9  5",
440790972,39765,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00916,Vecuronium,20210312,20210312,Curation Efforts|Governmental Organizations,LT00916,vecuronium,0.0,No match,vNo-DILI-Concern,2.0,39765,1.0,958.0,5.0,0.0,6.0,AAADcfB/OAAAAAAAAAAAAAAAAAAAAYAAAAA8eMECAAAAAGDAAAAAHgAAAAAADzzhgAYCCAMABAAIAACQCAAAAAAAAAAAAAAIAAACAAIAgAAHAAAEAACQAAGQ0PIPgAAAAAAAAADQAAaAACAgAKAADAgAAA==,"[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate","acetic acid [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methyl-1-piperidin-1-iumyl)-2-(1-piperidinyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] ester","[(2<I>S</I>,3<I>S</I>,5<I>S</I>,8<I>R</I>,9<I>S</I>,10<I>S</I>,13<I>S</I>,14<I>S</I>,16<I>S</I>,17<I>R</I>)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1<I>H</I>-cyclopenta[a]phenanthren-3-yl] acetate","[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate","[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] ethanoate","acetic acid [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidino-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] ester","InChI=1S/C34H57N2O4/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36/h25-32H,6-22H2,1-5H3/q+1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-/m0/s1",BGSZAXLLHYERSY-XQIGCQGXSA-N,,557.4318333,C34H57N2O4+,557.8,55.8,557.4318333,1.0,40.0,10.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1,6.5,"13  1  5
10  43  6
11  24  5
12  44  6
15  48  6
25  2  6
23  6  5
7  41  6
8  21  5
9  42  5",
440790971,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01416,Ustekinumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01416,ustekinumab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790970,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01229,Urokinase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01229,urokinase,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790969,62819,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00929,Urofollitropin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00929,urofollitropin,0.0,No match,vNo-DILI-Concern,2.0,62819,1.0,1790.0,15.0,12.0,15.0,AAADcfB//ABgAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHgQQCAAADTzl2AayBoPAAgCIAiFSEAACAAAgIAAIiIGOCIgKdj6C0TOUcAAm9hGYmAedyaCOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"1-[19-amino-7-(2-amino-2-oxo-ethyl)-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-sec-butyl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide","1-[[19-amino-7-(2-amino-2-oxoethyl)-13-butan-2-yl-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-N-[1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]-2-pyrrolidinecarboxamide","1-[19-amino-7-(2-amino-2-oxoethyl)-13-butan-2-yl-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-<I>N</I>-[1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide","1-[19-amino-7-(2-amino-2-oxoethyl)-13-butan-2-yl-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide","1-[[19-azanyl-7-(2-azanyl-2-oxidanylidene-ethyl)-13-butan-2-yl-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentakis(oxidanylidene)-1,2-dithia-5,8,11,14,17-pentazacycloicos-4-yl]carbonyl]-N-[1-[(2-azanyl-2-oxidanylidene-ethyl)amino]-4-methyl-1-oxidanylidene-pentan-2-yl]pyrrolidine-2-carboxamide","1-[19-amino-7-(2-amino-2-keto-ethyl)-16-(4-hydroxybenzyl)-10-(1-hydroxyethyl)-6,9,12,15,18-pentaketo-13-sec-butyl-1,2-dithia-5,8,11,14,17-pentazacycloeicosane-4-carbonyl]-N-[1-[(2-amino-2-keto-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide","InChI=1S/C42H65N11O12S2/c1-6-21(4)33-40(63)52-34(22(5)54)41(64)49-28(16-31(44)56)37(60)50-29(19-67-66-18-25(43)35(58)47-27(38(61)51-33)15-23-9-11-24(55)12-10-23)42(65)53-13-7-8-30(53)39(62)48-26(14-20(2)3)36(59)46-17-32(45)57/h9-12,20-22,25-30,33-34,54-55H,6-8,13-19,43H2,1-5H3,(H2,44,56)(H2,45,57)(H,46,59)(H,47,58)(H,48,62)(H,49,64)(H,50,60)(H,51,61)(H,52,63)",ZDRRIRUAESZNIH-UHFFFAOYSA-N,,979.4255589,C42H65N11O12S2,980.2,427.0,979.4255589,0.0,67.0,0.0,10.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(C)C1NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(C(C)O)NC1=O,-1.5,"57  23  3
26  30  3
32  31  3
33  34  3
39  46  3
40  48  3
41  47  3
44  49  3
51  55  3
61  63  8
61  64  8
63  65  8
64  66  8
65  67  8
66  67  8
50  8  3",
440790968,5610,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02356,tyramine,20250421,20210312,Curation Efforts|Governmental Organizations,LT02356,tyramine,0.0,No match,vNo-DILI-Concern,2.0,5610,1.0,87.3,2.0,2.0,2.0,AAADccByIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADATBmAQwBoBAAgCAAiBCAAACAAAgIAAIiIAGCIgIJiKCkROAcAAk0BEImAeQwIAOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,4-(2-aminoethyl)phenol,4-(2-aminoethyl)phenol,4-(2-aminoethyl)phenol,4-(2-aminoethyl)phenol,4-(2-azanylethyl)phenol,4-(2-aminoethyl)phenol,"InChI=1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2",DZGWFCGJZKJUFP-UHFFFAOYSA-N,1.1,137.084063974,C8H11NO,137.18,46.3,137.084063974,0.0,10.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCCc1ccc(O)cc1,,"4  6  8
4  7  8
6  8  8
7  9  8
8  10  8
9  10  8",
440790967,5284632,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00516,Trospium,20250421,20210312,Curation Efforts|Governmental Organizations,LT00516,trospium,0.0,No match,vNo-DILI-Concern,2.0,5284632,1.0,553.0,3.0,1.0,5.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAWLAAAA8YIAABgAAAAABQAAAHgAACAAADHzhmAYwCIMABgCIAiDSCAICAAAgAAAIiAFICIgJJjKAlRCGcAAmwAGLmAeYyOCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenyl-acetate","2-hydroxy-2,2-diphenylacetic acid [(1S,5R)-3-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]yl] ester","[(1<I>S</I>,5<I>R</I>)-spiro[8-azoniabicyclo[3.2.1]octane-8,1&apos;-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate","[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate","[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-oxidanyl-2,2-diphenyl-ethanoate","2-hydroxy-2,2-diphenyl-acetic acid [(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] ester","InChI=1S/C25H30NO3/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26/h1-6,9-12,21-23,28H,7-8,13-18H2/q+1/t21-,22+,23?",OYYDSUSKLWTMMQ-AIZNXBIQSA-N,,392.22256882,C25H30NO3+,392.5,46.5,392.22256882,1.0,29.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(OC1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,4.4,"18  20  8
18  22  8
19  21  8
19  23  8
20  24  8
21  25  8
22  26  8
23  27  8
24  28  8
25  29  8
26  28  8
27  29  8
5  30  5
6  31  6",
440790966,5282443,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00798,triprolidine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00798,triprolidine,0.0,No match,vNo-DILI-Concern,2.0,5282443,1.0,335.0,2.0,0.0,4.0,AAADceB7AAAAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAAABwAAAHAAAAAAADAjBHgQ+gJMIEACgAzRnRACCgCAxAiAI2CA4ZJgIIOLAkZGEIAhggADIyAcQgMAOQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,2-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine,2-[(E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)prop-1-enyl]pyridine,2-[(<I>E</I>)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine,2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine,2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-yl-prop-1-enyl]pyridine,2-[(E)-1-(p-tolyl)-3-pyrrolidino-prop-1-enyl]pyridine,"InChI=1S/C19H22N2/c1-16-7-9-17(10-8-16)18(19-6-2-3-12-20-19)11-15-21-13-4-5-14-21/h2-3,6-12H,4-5,13-15H2,1H3/b18-11+",CBEQULMOCCWAQT-WOJGMQOQSA-N,3.9,278.17829871,C19H22N2,278.4,16.1,278.17829871,0.0,21.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1,,"10  12  8
10  13  8
11  14  8
12  16  8
13  17  8
14  18  8
15  16  8
15  17  8
18  21  8
2  11  8
2  20  8
20  21  8",
440790965,5572,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01839,trihexyphenidyl,20250421,20210312,Curation Efforts|Governmental Organizations,LT01839,trihexyphenidyl,0.0,No match,vNo-DILI-Concern,2.0,5572,1.0,314.0,2.0,1.0,5.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABAAAAHgAACAAADUTBmAQwAIMAAgCAAiBCAAACAAAgAAAIiAAICIgIJiKAkRCEcAAmwAGImAeQwOAOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol,1-cyclohexyl-1-phenyl-3-(1-piperidinyl)-1-propanol,1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol,1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol,1-cyclohexyl-1-phenyl-3-piperidin-1-yl-propan-1-ol,1-cyclohexyl-1-phenyl-3-piperidino-propan-1-ol,"InChI=1S/C20H31NO/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1,4-5,10-11,19,22H,2-3,6-9,12-17H2",HWHLPVGTWGOCJO-UHFFFAOYSA-N,4.5,301.240564612,C20H31NO,301.5,23.5,301.240564612,0.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,,"4  1  3
12  18  8
12  19  8
18  20  8
19  21  8
20  22  8
21  22  8",
440790964,71433,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00375,Trientine hydrochloride,20231222,20210312,Curation Efforts|Governmental Organizations,LT00375,trientine hydrochloride,1.0,No match,vNo-DILI-Concern,2.0,71433,1.0,49.7,4.0,6.0,7.0,AAADceBjgAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAAQAAAAAADBAAQAAALAAAAAAAAAAAAAAAAAAAAAAIAIAAAAQAAAAAAQAAAAEACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride","N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride","<I>N</I>&apos;-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride","N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride","N'-[2-(2-azanylethylamino)ethyl]ethane-1,2-diamine;dihydrochloride",2-aminoethyl-[2-(2-aminoethylamino)ethyl]amine;dihydrochloride,"InChI=1S/C6H18N4.2ClH/c7-1-3-9-5-6-10-4-2-8;;/h9-10H,1-8H2;2*1H",WYHIICXRPHEJKI-UHFFFAOYSA-N,,218.106502,C6H20Cl2N4,219.15,76.1,218.106502,0.0,12.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",Cl.Cl.NCCNCCNCCN,,,
440790963,5526,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00923,tranexamic acid,20250421,20210312,Curation Efforts|Governmental Organizations,LT00923,tranexamic acid,0.0,No match,vNo-DILI-Concern,1.0,5526,1.0,139.0,3.0,2.0,2.0,AAADccByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAAAAAAAHgAQCAAADQDBgAQACABAAgAIAACQCAAAAAAAAAAAAIEAAAAAABIAgAAAQAAEEAAAAAGYyDCOAAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,4-(aminomethyl)cyclohexanecarboxylic acid,4-(aminomethyl)-1-cyclohexanecarboxylic acid,4-(aminomethyl)cyclohexane-1-carboxylic acid,4-(aminomethyl)cyclohexane-1-carboxylic acid,4-(aminomethyl)cyclohexane-1-carboxylic acid,4-(aminomethyl)cyclohexanecarboxylic acid,"InChI=1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)",GYDJEQRTZSCIOI-UHFFFAOYSA-N,,157.110278721,C8H15NO2,157.21,63.3,157.110278721,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCC1CCC(C(=O)O)CC1,-2.0,,
440790962,60700,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01824,topotecan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01824,topotecan,0.0,No match,vNo-DILI-Concern,2.0,60700,1.0,867.0,7.0,2.0,3.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAWAAAAA8QIEAAAAAAFix8AAAHgAACAAADEzhngYyzvMIFgCoAyXyXAKCgCAhIiAImCF+bNgJZvbC8ZOWcAhm5hHL+QewwPAOgEABQAAaAAAAgAKAADQAAAAAAAAAAA==,"(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione","(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]heneicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione","(19<I>S</I>)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0<SUP>2,11</SUP>.0<SUP>4,9</SUP>.0<SUP>15,20</SUP>]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione","(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione","(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-bis(oxidanyl)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione","(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]heneicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-quinone","InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1",UCFGDBYHRUNTLO-QHCPKHFHSA-N,,421.16377084,C23H23N3O5,421.4,103.0,421.16377084,0.0,31.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,0.5,"10  13  8
10  16  8
11  16  8
13  17  8
14  15  8
14  21  8
9  2  5
21  22  8
22  23  8
22  24  8
23  27  8
24  28  8
27  29  8
28  29  8
6  11  8
6  17  8
7  15  8
7  23  8",
440790961,443879,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01011,tolterodine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01011,tolterodine,0.0,No match,vNo-DILI-Concern,2.0,443879,1.0,340.0,2.0,1.0,7.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAACAAADSzBmAQyBoMAAgCAAiBCAAACAAAgIAAIiAAOCIgIJiKCkRKEcAAkwBGImAeQ0OIOoAACAAAIAABAAAQAABAAAAAAAAAAAA==,2-[(1R)-3-(diisopropylamino)-1-phenyl-propyl]-4-methyl-phenol,2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol,2-[(1<I>R</I>)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol,2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol,2-[(1R)-3-[di(propan-2-yl)amino]-1-phenyl-propyl]-4-methyl-phenol,2-[(1R)-3-(diisopropylamino)-1-phenyl-propyl]-4-methyl-phenol,"InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1",OOGJQPCLVADCPB-HXUWFJFHSA-N,,325.240564612,C22H31NO,325.5,23.5,325.240564612,0.0,24.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1,5.6,"14  18  8
15  19  8
16  21  8
17  22  8
18  20  8
19  20  8
21  23  8
22  23  8
5  4  6
8  14  8
8  15  8
9  16  8
9  17  8",
440790960,60947,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01037,tirofiban,20231222,20210312,Curation Efforts|Governmental Organizations,LT01037,tirofiban,0.0,No match,vNo-DILI-Concern,2.0,60947,1.0,579.0,7.0,3.0,14.0,AAADcfB7OABAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHgQQSAAADSzl2AayDoLABgKIAiDSCHBCCAAgIAAIiIGOCIgOJjKEsRuGeCCk0BGIqAeYyLCOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,(2S)-2-(butylsulfonylamino)-3-[4-[4-(4-piperidyl)butoxy]phenyl]propanoic acid,(2S)-2-(butylsulfonylamino)-3-[4-[4-(4-piperidinyl)butoxy]phenyl]propanoic acid,(2<I>S</I>)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid,(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid,(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid,(2S)-2-(butylsulfonylamino)-3-[4-[4-(4-piperidyl)butoxy]phenyl]propionic acid,"InChI=1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1",COKMIXFXJJXBQG-NRFANRHFSA-N,,440.23449343,C22H36N2O5S,440.6,113.0,440.23449343,0.0,30.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O,1.4,"21  25  8
21  26  8
23  27  8
23  28  8
25  27  8
26  28  8
18  8  6",
440790959,60937,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00998,Tiludronate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00998,tiludronate,0.0,No match,vNo-DILI-Concern,2.0,60937,1.0,324.0,7.0,4.0,4.0,AAADccBgOANEAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGA4ACCAACAKAUCCwAYAAABiAQCBCAIACAAAgDRAIiBgAAogIICKhExCAIAAggAAIiAcAAAAAAAIAAAAAAAAABAAAAAAAAAAAAAAAAA==,[(4-chlorophenyl)sulfanyl-phosphono-methyl]phosphonic acid,[[(4-chlorophenyl)thio]-phosphonomethyl]phosphonic acid,[(4-chlorophenyl)sulfanyl-phosphonomethyl]phosphonic acid,[(4-chlorophenyl)sulfanyl-phosphonomethyl]phosphonic acid,[(4-chlorophenyl)sulfanyl-phosphono-methyl]phosphonic acid,[[(4-chlorophenyl)thio]-phosphono-methyl]phosphonic acid,"InChI=1S/C7H9ClO6P2S/c8-5-1-3-6(4-2-5)17-7(15(9,10)11)16(12,13)14/h1-4,7H,(H2,9,10,11)(H2,12,13,14)",DKJJVAGXPKPDRL-UHFFFAOYSA-N,,317.9283609,C7H9ClO6P2S,318.61,140.0,317.9283609,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O,-0.3,"12  13  8
12  14  8
13  15  8
14  16  8
15  17  8
16  17  8",
440790958,32281,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00751,Thyrotropin alfa,20231222,20210312,Curation Efforts|Governmental Organizations,LT00751,thyrotropin alfa,0.0,No match,vNo-DILI-Concern,2.0,32281,1.0,597.0,5.0,4.0,6.0,AAADceB7uAAAAAAAAAAAAAAAAAAAAWLFgAAAAAAAAAAAAAABgAAAHgAQAAAACCjBlgQtkBfJkACoARV3dAAAgC2xEqABUYG4cAiAaBJA2SGUAAAIlgLAQCAcAwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,N-[2-(2-carbamoylpyrrolidin-1-yl)-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide,N-[1-(2-carbamoyl-1-pyrrolidinyl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxo-2-pyrrolidinecarboxamide,<I>N</I>-[1-(2-carbamoylpyrrolidin-1-yl)-3-(1<I>H</I>-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,N-[1-(2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,N-[1-(2-aminocarbonylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl]-5-oxidanylidene-pyrrolidine-2-carboxamide,N-[2-(2-carbamoylpyrrolidino)-1-(1H-imidazol-5-ylmethyl)-2-keto-ethyl]-5-keto-pyrrolidine-2-carboxamide,"InChI=1S/C16H22N6O4/c17-14(24)12-2-1-5-22(12)16(26)11(6-9-7-18-8-19-9)21-15(25)10-3-4-13(23)20-10/h7-8,10-12H,1-6H2,(H2,17,24)(H,18,19)(H,20,23)(H,21,25)",XNSAINXGIQZQOO-UHFFFAOYSA-N,-2.5,362.1702532,C16H22N6O4,362.38,150.0,362.1702532,0.0,26.0,0.0,3.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)C1CCCN1C(=O)C(Cc1cnc[nH]1)NC(=O)C1CCC(=O)N1,,"10  25  8
10  26  8
11  18  3
15  19  3
17  21  3
24  25  8
9  24  8
9  26  8",
440790957,1130,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01981,thiamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01981,thiamine,0.0,No match,vNo-DILI-Concern,2.0,1130,1.0,268.0,5.0,2.0,4.0,AAADceBzoABAAAAAAAAAAAAAAAAAAWAAAAAsAAAAAAAAAAAB4AAAHgQQCAAADAjh3wavsZdMEgikAxZnZACA8KlxCLgBWDQ4RBiAOIJgyUAERAgsQAPISCKgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-thiazol-3-ium-5-yl]ethanol,2-[3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-thiazol-3-iumyl]ethanol,"2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol","2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol","2-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol",thiamin,"InChI=1S/C12H17N4OS/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15)/q+1",JZRWCGZRTZMZEH-UHFFFAOYSA-N,,265.11230735,C12H17N4OS+,265.36,104.0,265.11230735,1.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,1.0,"1  12  8
1  9  8
11  15  8
11  16  8
3  12  8
3  7  8
4  15  8
4  17  8
5  16  8
5  17  8
7  9  8",
440790956,2153,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00154,theophylline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00154,theophylline,0.0,No match,vNo-DILI-Concern,2.0,2153,1.0,267.0,3.0,1.0,0.0,AAADccBjsAAAAAAAAAAAAAAAAAAAAWAAAAAsAAAAAAAAAFgBgAAAHgAQAAAACAgBlgQHsBfJkACoAQdxdACAgC2XEKABUYGoVECASAhASCAUAIgIByJAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1,3-dimethyl-7H-purine-2,6-dione","1,3-dimethyl-7H-purine-2,6-dione","1,3-dimethyl-7<I>H</I>-purine-2,6-dione","1,3-dimethyl-7H-purine-2,6-dione","1,3-dimethyl-7H-purine-2,6-dione",theophylline,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",ZFXYFBGIUFBOJW-UHFFFAOYSA-N,0.0,180.06472551,C7H8N4O2,180.16,69.3,180.06472551,0.0,13.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cn1c(=O)c2[nH]cnc2n(C)c1=O,,"3  10  8
3  7  8
4  10  8
4  9  8
5  13  8
5  8  8
6  13  8
6  7  8
7  8  8
8  9  8",
440790955,135402045,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01262,tetrahydrobiopterin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01262,tetrahydrobiopterin,0.0,No match,vNo-DILI-Concern,2.0,135402045,1.0,405.0,6.0,6.0,2.0,AAADccBzsAAAAAAAAAAAAAAAAAAAAAAAAAAgQAAAAAAAAACAAAAAHgAQCAAACDzhgAYDAALAAgCoAAVQdACAAAEAAAABAICIAECDUAIAiCAUQAAGEQKRAEAwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-3H-pteridin-4-one","2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-3H-pteridin-4-one","2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-3<I>H</I>-pteridin-4-one","2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-3H-pteridin-4-one","2-azanyl-6-[1,2-bis(oxidanyl)propyl]-5,6,7,8-tetrahydro-3H-pteridin-4-one","2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-3H-pteridin-4-one","InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)",FNKQXYHWGSIFBK-UHFFFAOYSA-N,,241.11748936,C9H15N5O3,241.25,132.0,241.11748936,0.0,17.0,0.0,3.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(O)C(O)C1CNc2nc(N)[nH]c(=O)c2N1,-1.9,"10  1  3
13  14  8
13  16  8
12  2  3
6  14  8
6  17  8
7  16  8
7  17  8
9  11  3",
440790954,16133850,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00932,TERIPARATIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00932,teriparatide,0.0,No match,vNo-DILI-Concern,2.0,16133850,1.0,9740.0,62.0,60.0,146.0,AAADcfB//gBgAAAAAAAAAAAAAAAAAWLFiwAwYAAAAAAAAFgB/gAAHgQQCAAADSjl3ga/2PbJkgioAzX3fACCgC2xErAJ2aG4dJiKeP7g2bGUYAhutgLYyCe/3+KOgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxy-propanoyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-4-carboxy-butanoyl]amino]-3-methyl-pentanoyl]amino]-5-oxo-pentanoyl]amino]-4-methyl-pentanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxo-butanoyl]amino]-4-methyl-pentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-oxo-butanoyl]amino]-3-hydroxy-propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-5-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-5-amino-1-[[(1S)-5-amino-1-[[(1S)-1-[[(1S)-4-amino-1-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-3-amino-1-[[(1S)-1-carboxy-2-phenyl-ethyl]carbamoyl]-3-oxo-propyl]amino]-1-(1H-imidazol-4-ylmethyl)-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-4-oxo-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]pentyl]carbamoyl]pentyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-2-methyl-propyl]carbamoyl]-4-guanidino-butyl]amino]-5-oxo-pentanoic acid","(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxy-1-oxopropyl]amino]-3-methyl-1-oxobutyl]amino]-3-hydroxy-1-oxopropyl]amino]-4-carboxy-1-oxobutyl]amino]-3-methyl-1-oxopentyl]amino]-1,5-dioxopentyl]amino]-4-methyl-1-oxopentyl]amino]-4-(methylthio)-1-oxobutyl]amino]-3-(1H-imidazol-4-yl)-1-oxopropyl]amino]-1,4-dioxobutyl]amino]-4-methyl-1-oxopentyl]amino]-1-oxoethyl]amino]-1-oxohexyl]amino]-3-(1H-imidazol-4-yl)-1-oxopropyl]amino]-4-methyl-1-oxopentyl]amino]-1,4-dioxobutyl]amino]-3-hydroxy-1-oxopropyl]amino]-4-(methylthio)-1-oxobutyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(1S)-1-carboxy-2-phenylethyl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4<I>S</I>)-4-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-4-amino-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-6-amino-2-[[2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-4-amino-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-5-amino-2-[[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-amino-3-hydroxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(1<I>H</I>-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-(1<I>H</I>-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-6-amino-1-[[(2<I>S</I>)-6-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-5-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-4-amino-1-[[(1<I>S</I>)-1-carboxy-2-phenylethyl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1<I>H</I>-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(1S)-1-carboxy-2-phenylethyl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-4-azanyl-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-azanyl-2-[2-[[(2S)-2-[[(2S)-4-azanyl-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-azanyl-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-azanyl-3-oxidanyl-propanoyl]amino]-3-methyl-butanoyl]amino]-3-oxidanyl-propanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-methyl-pentanoyl]amino]-5-oxidanylidene-pentanoyl]amino]-4-methyl-pentanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxidanylidene-butanoyl]amino]-4-methyl-pentanoyl]amino]ethanoylamino]hexanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-oxidanylidene-butanoyl]amino]-3-oxidanyl-propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-azanyl-1-[[(2S)-6-azanyl-1-[[(2S)-1-[[(2S)-5-azanyl-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-azanyl-1,4-bis(oxidanylidene)-1-[[(2S)-1-oxidanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]butan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxidanylidene-propan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-1,5-bis(oxidanylidene)pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-1-oxidanylidene-hexan-2-yl]amino]-1-oxidanylidene-hexan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-oxidanylidene-pentanoic acid","(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxy-propanoyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-4-carboxy-butanoyl]amino]-3-methyl-pentanoyl]amino]-5-keto-pentanoyl]amino]-4-methyl-pentanoyl]amino]-4-(methylthio)butanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-keto-butanoyl]amino]-4-methyl-pentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-keto-butanoyl]amino]-3-hydroxy-propanoyl]amino]-4-(methylthio)butanoyl]amino]-5-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-5-amino-1-[[(1S)-5-amino-1-[[(1S)-1-[[(1S)-4-amino-1-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-3-amino-1-[[(1S)-1-carboxy-2-phenyl-ethyl]carbamoyl]-3-keto-propyl]amino]-1-(1H-imidazol-4-ylmethyl)-2-keto-ethyl]carbamoyl]-2-methyl-propyl]amino]-1-(carboxymethyl)-2-keto-ethyl]carbamoyl]-4-keto-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]pentyl]carbamoyl]pentyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-2-methyl-propyl]carbamoyl]-4-guanidino-butyl]amino]-5-keto-valeric acid","InChI=1S/C181H291N55O51S2/c1-21-96(18)146(236-160(267)114(48-53-141(250)251)212-174(281)132(84-239)232-177(284)143(93(12)13)233-147(254)103(185)82-237)178(285)216-111(45-50-134(187)241)155(262)219-119(65-90(6)7)163(270)213-116(55-62-289-20)158(265)224-124(71-100-79-196-86-203-100)167(274)226-126(73-135(188)242)169(276)217-117(63-88(2)3)148(255)201-81-138(245)205-105(39-27-30-56-182)149(256)223-123(70-99-78-195-85-202-99)166(273)221-121(67-92(10)11)164(271)225-128(75-137(190)244)171(278)231-131(83-238)173(280)214-115(54-61-288-19)157(264)210-112(46-51-139(246)247)153(260)208-109(43-34-60-199-181(193)194)159(266)234-144(94(14)15)175(282)215-113(47-52-140(248)249)156(263)222-122(69-98-77-200-104-38-26-25-37-102(98)104)165(272)220-120(66-91(8)9)161(268)209-108(42-33-59-198-180(191)192)151(258)206-106(40-28-31-57-183)150(257)207-107(41-29-32-58-184)152(259)218-118(64-89(4)5)162(269)211-110(44-49-133(186)240)154(261)228-129(76-142(252)253)172(279)235-145(95(16)17)176(283)229-125(72-101-80-197-87-204-101)168(275)227-127(74-136(189)243)170(277)230-130(179(286)287)68-97-35-23-22-24-36-97/h22-26,35-38,77-80,85-96,103,105-132,143-146,200,237-239H,21,27-34,39-76,81-84,182-185H2,1-20H3,(H2,186,240)(H2,187,241)(H2,188,242)(H2,189,243)(H2,190,244)(H,195,202)(H,196,203)(H,197,204)(H,201,255)(H,205,245)(H,206,258)(H,207,257)(H,208,260)(H,209,268)(H,210,264)(H,211,269)(H,212,281)(H,213,270)(H,214,280)(H,215,282)(H,216,285)(H,217,276)(H,218,259)(H,219,262)(H,220,272)(H,221,273)(H,222,263)(H,223,256)(H,224,265)(H,225,271)(H,226,274)(H,227,275)(H,228,261)(H,229,283)(H,230,277)(H,231,278)(H,232,284)(H,233,254)(H,234,266)(H,235,279)(H,236,267)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,286,287)(H4,191,192,198)(H4,193,194,199)/t96-,103-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,143-,144-,145-,146-/m0/s1",OGBMKVWORPGQRR-UMXFMPSGSA-N,,4116.1342973,C181H291N55O51S2,4118.0,1800.0,4115.1309424,0.0,289.0,34.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(/N)NCCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)C(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN/C(N)=N/[H])C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C,-18.7,"102  273  8
102  277  8
103  268  8
103  281  8
278  104  6
105  276  8
105  281  8
114  138  5
146  160  8
146  168  8
160  170  8
160  183  8
170  187  8
183  194  8
187  198  8
194  198  8
231  256  8
261  273  8
268  276  8
284  285  8
284  286  8
285  287  8
286  288  8
287  289  8
288  289  8
112  54  5
110  55  6
109  56  6
113  57  5
118  58  6
116  59  5
133  60  6
122  61  5
136  62  5
151  63  5
143  64  6
148  65  5
171  66  6
150  67  6
68  168  8
68  170  8
184  70  6
169  71  6
195  74  5
192  75  5
188  76  5
190  77  5
218  79  6
223  81  6
204  82  6
222  84  5
214  86  6
219  87  5
238  89  6
233  90  6
241  91  5
236  92  5
93  231  8
93  269  8
262  95  5
96  256  8
96  269  8
258  98  5
99  261  8
99  277  8",
440790953,5401,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01787,terazosin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01787,terazosin,0.0,No match,vNo-DILI-Concern,2.0,5401,1.0,544.0,8.0,1.0,4.0,AAADceB7uAAAAAAAAAAAAAAAAAAAASAAAAA8WIAAAAAAAACx8AAAHgAQAAAADBzhngYz9vdIFACoAydydAKCiCkhIqABmCF+7JiPbrLE+N+XNCpuxhva6Ce41BMOIEABAgACQABAgAIEAASAAAAAAAAAAA==,"[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone","[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-(2-oxolanyl)methanone","[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone","[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone","[4-(4-azanyl-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone","[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazino]-(tetrahydrofuryl)methanone","InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)",VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.4,387.1906543,C19H25N5O4,387.4,103.0,387.1906543,0.0,28.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,,"10  16  3
20  21  8
20  23  8
21  22  8
21  24  8
23  25  8
24  26  8
25  26  8
7  19  8
7  20  8
8  19  8
8  22  8",
440790952,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01360,Tenecteplase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01360,tenecteplase,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790951,18293306,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01261,Temsirolimus,20231222,20210312,Curation Efforts|Governmental Organizations,LT01261,temsirolimus,0.0,No match,vNo-DILI-Concern,2.0,18293306,1.0,2010.0,16.0,4.0,11.0,AAADcfB+PgAAAAAAAAAAAAAAAAAAAAAAAAA8SIAAAAAAAAAAAAAAHgAACAAADzzhgAYCCAMABgCIAqHSGAIAAAAgAAAICAHIAAgbFBYAoSQHUAAH5gCfsAOY6PSOAAAAAAAAAABAAAIAAACAAAAAAAAAAA==,"[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxy-cyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methyl-propanoate","3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] ester","[(1<I>R</I>,2<I>R</I>,4<I>S</I>)-4-[(2<I>R</I>)-2-[(1<I>R</I>,9<I>S</I>,12<I>S</I>,15<I>R</I>,16<I>E</I>,18<I>R</I>,19<I>R</I>,21<I>R</I>,23<I>S</I>,24<I>Z</I>,26<I>E</I>,28<I>E</I>,30<I>S</I>,32<I>S</I>,35<I>R</I>)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0<SUP>4,9</SUP>]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate","[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate","[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-1,18-bis(oxidanyl)-2,3,10,14,20-pentakis(oxidanylidene)-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxy-cyclohexyl] 2-(hydroxymethyl)-2-methyl-3-oxidanyl-propanoate","3-hydroxy-2-methyl-2-methylol-propionic acid [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-2,3,10,14,20-pentaketo-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxy-cyclohexyl] ester","InChI=1S/C56H87NO16/c1-33-17-13-12-14-18-34(2)45(68-9)29-41-22-20-39(7)56(67,73-41)51(63)52(64)57-24-16-15-19-42(57)53(65)71-46(30-43(60)35(3)26-38(6)49(62)50(70-11)48(61)37(5)25-33)36(4)27-40-21-23-44(47(28-40)69-10)72-54(66)55(8,31-58)32-59/h12-14,17-18,26,33,35-37,39-42,44-47,49-50,58-59,62,67H,15-16,19-25,27-32H2,1-11H3/b14-12+,17-13-,34-18+,38-26+/t33-,35-,36-,37-,39-,40+,41+,42+,44-,45+,46+,47-,49-,50+,56-/m1/s1",CBPNZQVSJQDFBE-PXVOFZQNSA-N,,1029.60248569,C56H87NO16,1030.3,242.0,1029.60248569,0.0,73.0,15.0,0.0,4.0,0.0,0.0,1.0,-1.0,"1
5
255",CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(/C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C\C=C\1C,5.6,"22  1  6
52  13  5
57  14  5
61  15  6
18  21  6
23  2  5
25  27  6
26  86  5
29  92  5
31  48  6
39  101  6
44  53  5
32  5  6
64  68  5
67  73  6",
440790950,9838022,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00664,Tapentadol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00664,tapentadol,0.0,No match,vNo-DILI-Concern,2.0,9838022,1.0,193.0,2.0,1.0,5.0,AAADceByIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAACAAADQTBmAQyBoMAAgCAAiBCAAACAAAgIAAIiAAOCIgIJiKCkRKEcAAkwBEImAeQwPAOgAABAAAAAAAAAAIAAAAAAAAAAAAAAA==,"3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methyl-propyl]phenol","3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol","3-[(2<I>R</I>,3<I>R</I>)-1-(dimethylamino)-2-methylpentan-3-yl]phenol","3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol","3-[(2R,3R)-1-(dimethylamino)-2-methyl-pentan-3-yl]phenol","3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methyl-propyl]phenol","InChI=1S/C14H23NO/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12/h6-9,11,14,16H,5,10H2,1-4H3/t11-,14+/m0/s1",KWTWDQCKEHXFFR-SMDDNHRTSA-N,,221.177964357,C14H23NO,221.34,23.5,221.177964357,0.0,16.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C,3.5,"10  14  8
11  15  8
14  16  8
15  16  8
3  6  6
4  8  6
7  10  8
7  11  8",
440790949,41693,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00920,SUFENTANIL,20231222,20210312,Curation Efforts|Governmental Organizations,LT00920,sufentanil,0.0,No match,vNo-DILI-Concern,2.0,41693,1.0,459.0,4.0,0.0,8.0,AAADceB7MABAAAAAAAAAAAAAAAAAASAAAAA8QAAAAAAAAAABwAAAHgQAAAAADIjl0AaywYMABAiMACVSUACDAIAhChBIiBkIZIgKICLg0ZGFIAhkhAD4yAcwAAAKAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]-N-phenyl-propanamide,N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)-4-piperidinyl]-N-phenylpropanamide,<I>N</I>-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-<I>N</I>-phenylpropanamide,N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide,N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenyl-propanamide,N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]-N-phenyl-propionamide,"InChI=1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3",GGCSSNBKKAUURC-UHFFFAOYSA-N,4.0,386.20279938,C22H30N2O2S,386.6,61.0,386.20279938,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,,"1  19  8
1  27  8
13  17  8
13  18  8
17  22  8
18  23  8
19  24  8
22  25  8
23  25  8
24  26  8
26  27  8",
440790948,121494085,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00358,Sucralfate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00358,sucralfate,0.0,No match,vNo-DILI-Concern,2.0,121494085,1.0,2420.0,55.0,20.0,37.0,AAADcfBwPgB4ABAAAAAAAAAAAAAAASAAAAAkAAAAAAAAAAAAAAAAGgAACIAACBSwgAMACAAABAAAAAAAADAAAAAAAAAAAAAAAAARAAIAAAAiAAAFAAAGAAHAYAwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,,,,,,,"InChI=1S/C12H22O35S8.9Al.20H2O/c13-48(14,15)37-1-4-6(43-51(22,23)24)8(45-53(28,29)30)9(46-54(31,32)33)11(40-4)42-12(3-39-50(19,20)21)10(47-55(34,35)36)7(44-52(25,26)27)5(41-12)2-38-49(16,17)18;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h4-11H,1-3H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)(H,25,26,27)(H,28,29,30)(H,31,32,33)(H,34,35,36);;;;;;;;;;20*1H2/q;;8*+1;;;;;;;;;;;;;;;;;;;;/p-8/t4-,5-,6-,7-,8+,9-,10+,11-,12+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/m1............................./s1",YZPQNHUVIVIUCT-JTJNLBSYSA-F,,1576.753271,C12H54Al9O55S8,1577.9,536.0,1576.753271,0.0,84.0,9.0,0.0,0.0,0.0,0.0,22.0,-1.0,"1
5
255",O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O=S(=O)([O][Al])OC[C@H]1O[C@@](COS(=O)(=O)[O][Al])(O[C@H]2O[C@H](COS(=O)(=O)[O][Al])[C@@H](OS(=O)(=O)[O][Al])[C@H](OS(=O)(=O)[O][Al])[C@H]2OS(=O)(=O)[O][Al])[C@@H](OS(=O)(=O)[O][Al])[C@@H]1OS(=O)(=O)[O][Al].[Al],,"73  19  6
77  19  6
74  21  6
75  22  5
78  23  6
79  24  5
80  25  6
76  83  6
82  84  5","10  55  6
10  56  6
11  57  6
11  58  6
12  59  6
12  60  6
13  61  6
13  62  6
14  63  6
14  64  6
15  65  6
15  66  6
16  67  6
16  68  6
17  69  6
17  70  6
17  71  6
9  53  6
9  54  6"
440790947,5314,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00749,succinylcholine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00749,succinylcholine,0.0,No match,vNo-DILI-Concern,1.0,5314,1.0,284.0,4.0,0.0,11.0,AAADceBzOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAAAAAACADhgAYCCAMABAAIAACQCAAAAAAAAAAAAAEIAAACABAAAAADAAAEAAAQAABDAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,trimethyl-[2-[4-oxo-4-[2-(trimethylammonio)ethoxy]butanoyl]oxyethyl]ammonium,"2-[1,4-dioxo-4-[2-(trimethylammonio)ethoxy]butoxy]ethyl-trimethylammonium",trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium,trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium,trimethyl-[2-[4-oxidanylidene-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium,2-[4-keto-4-[2-(trimethylammonio)ethoxy]butanoyl]oxyethyl-trimethyl-ammonium,"InChI=1S/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2",AXOIZCJOOAYSMI-UHFFFAOYSA-N,0.6,290.22055744,C14H30N2O4+2,290.4,52.6,290.22055744,2.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,,,
440790946,19649,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00145,streptomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00145,streptomycin,0.0,No match,vNo-DILI-Concern,1.0,19649,1.0,940.0,15.0,12.0,9.0,AAADcfB7vAAAAAAAAAAAAAAAAAAAASAAAAA0QAAAAAAAAAAAAAAAHgAQCAAADHzxgAcDCALABgAoAAgQpAIAAAEAAAAAAIFIAAATEBYAwAAnQAAHMAAXAAHycA8KAAAAAAAAAAACgAAUCACgAAAAAAAAAA==,"2-[(1S,2R,3R,4S,5R,6R)-2-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)tetrahydropyran-2-yl]oxy-4-formyl-4-hydroxy-5-methyl-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine","2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[[(2R,3R,4R,5S)-3-[[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)-2-oxanyl]oxy]-4-formyl-4-hydroxy-5-methyl-2-oxolanyl]oxy]-2,5,6-trihydroxycyclohexyl]guanidine","2-[(1<I>R</I>,2<I>R</I>,3<I>S</I>,4<I>R</I>,5<I>R</I>,6<I>S</I>)-3-(diaminomethylideneamino)-4-[(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>)-3-[(2<I>S</I>,3<I>S</I>,4<I>S</I>,5<I>R</I>,6<I>S</I>)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine","2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine","2-[(1R,2R,3S,4R,5R,6S)-3-[bis(azanyl)methylideneamino]-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-6-(hydroxymethyl)-3-(methylamino)-4,5-bis(oxidanyl)oxan-2-yl]oxy-4-methanoyl-5-methyl-4-oxidanyl-oxolan-2-yl]oxy-2,5,6-tris(oxidanyl)cyclohexyl]guanidine","2-[(1S,2R,3R,4S,5R,6R)-2-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]oxy-4-formyl-4-hydroxy-5-methyl-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine","InChI=1S/C21H39N7O12/c1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35/h4-18,26,29,31-36H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/t5-,6-,7+,8-,9-,10-,11+,12-,13-,14+,15+,16-,17-,18-,21+/m0/s1",UCSJYZPVAKXKNQ-HZYVHMACSA-N,,581.2656697,C21H39N7O12,581.6,336.0,581.2656697,0.0,40.0,15.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O,-8.0,"21  1  6
23  1  5
33  10  5
24  13  5
29  14  5
31  15  5
27  35  6
20  3  6
30  3  5
34  37  6
22  5  6
25  6  5
26  7  6
28  8  6
32  9  6",
440790945,962,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01294,Sterile water,20210312,20210312,Curation Efforts|Governmental Organizations,LT01294,sterile water,0.0,No match,vNo-DILI-Concern,2.0,962,1.0,0.0,1.0,1.0,0.0,AAADcQAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,water,oxidane,oxidane,oxidane,oxidane,water,InChI=1S/H2O/h1H2,XLYOFNOQVPJJNP-UHFFFAOYSA-N,,18.010564683,H2O,18.015,1.0,18.010564683,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O,-0.5,,
440790944,5780,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02010,sorbitol,20250421,20210312,Curation Efforts|Governmental Organizations,LT02010,sorbitol,0.0,No match,vNo-DILI-Concern,2.0,5780,1.0,105.0,6.0,6.0,5.0,AAADccBgOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgAACAAACBSggAIAAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAABEAIAAAAAQAAFAAABAAHAYAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol","(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol","(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>)-hexane-1,2,3,4,5,6-hexol","(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol","(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol","(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol","InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5-,6-/m1/s1",FBPFZTCFMRRESA-JGWLITMVSA-N,-3.1,182.07903816,C6H14O6,182.17,121.0,182.07903816,0.0,12.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO,,"7  1  6
8  2  6
9  3  5
10  4  6",
440790943,16132356,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00888,Somatropin recombinant,20231222,20210312,Curation Efforts|Governmental Organizations,LT00888,somatropin recombinant,0.0,No match,vNo-DILI-Concern,2.0,16132356,1.0,13100.0,79.0,86.0,189.0,AAADcfB//gBAAAAAAAAAAAAAAAAAAWLAAAAwYMGAAAAAAAAB9AAAHgQQCAAADTzl3ga/npbJkgioAzX3fAACgC2xMrAJ2YG+eIiKfj7i2TOUcAAu9hPY2Ce/36KOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(4S)-4-[[2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-3-carboxy-propanoyl]amino]propanoyl]amino]-3-methyl-pentanoyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-3-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]acetyl]amino]-5-oxo-pentanoyl]amino]-4-methyl-pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-5-guanidino-pentanoyl]amino]hexanoyl]amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-carboxy-butanoyl]amino]-3-methyl-pentanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-3-carboxy-propanoyl]amino]-5-guanidino-pentanoyl]amino]-5-oxo-pentanoyl]amino]-5-oxo-pentanoyl]amino]acetyl]amino]-5-[[(1S)-1-[[(1S)-3-amino-1-[[(1S)-4-amino-1-[[(1S)-1-[[(1S)-4-amino-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-3-amino-1-carboxy-3-oxo-propyl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-4-guanidino-butyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-4-oxo-butyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-3-oxo-propyl]carbamoyl]-4-guanidino-butyl]amino]-5-oxo-pentanoic acid","(4S)-4-[[2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)-1-oxopropyl]amino]-1-oxopropyl]amino]-3-carboxy-1-oxopropyl]amino]-1-oxopropyl]amino]-3-methyl-1-oxopentyl]amino]-1-oxo-3-phenylpropyl]amino]-3-hydroxy-1-oxobutyl]amino]-3-hydroxy-1-oxopropyl]amino]-3-hydroxy-1-oxopropyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-3-methyl-1-oxopentyl]amino]-4-methyl-1-oxopentyl]amino]-1-oxoethyl]amino]-1,5-dioxopentyl]amino]-4-methyl-1-oxopentyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-1-oxopropyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-1-oxohexyl]amino]-4-methyl-1-oxopentyl]amino]-4-methyl-1-oxopentyl]amino]-3-(1H-imidazol-5-yl)-1-oxopropyl]amino]-4-carboxy-1-oxobutyl]amino]-3-methyl-1-oxopentyl]amino]-4-(methylthio)-1-oxobutyl]amino]-3-carboxy-1-oxopropyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-1,5-dioxopentyl]amino]-1,5-dioxopentyl]amino]-1-oxoethyl]amino]-5-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4<I>S</I>)-4-[[2-[[(2<I>S</I>)-5-amino-2-[[(2<I>S</I>)-5-amino-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-6-amino-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-5-amino-2-[[2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>R</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-amino-3-(1<I>H</I>-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-(1<I>H</I>-imidazol-5-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-5-[[(2<I>S</I>)-1-[[(2<I>S</I>)-4-amino-1-[[(2<I>S</I>)-5-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-5-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(1<I>S</I>)-3-amino-1-carboxy-3-oxopropyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4S)-4-[[2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4S)-4-[2-[[(2S)-5-azanyl-2-[[(2S)-5-azanyl-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-azanyl-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-azanyl-2-[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-azanyl-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-4-oxidanyl-4-oxidanylidene-butanoyl]amino]propanoyl]amino]-3-methyl-pentanoyl]amino]-3-phenyl-propanoyl]amino]-3-oxidanyl-butanoyl]amino]-3-oxidanyl-propanoyl]amino]-3-oxidanyl-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamido-pentanoyl]amino]-5-carbamimidamido-pentanoyl]amino]-3-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]ethanoylamino]-5-oxidanylidene-pentanoyl]amino]-4-methyl-pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-5-carbamimidamido-pentanoyl]amino]hexanoyl]amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-methyl-pentanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-4-oxidanyl-4-oxidanylidene-butanoyl]amino]-5-carbamimidamido-pentanoyl]amino]-5-oxidanylidene-pentanoyl]amino]-5-oxidanylidene-pentanoyl]amino]ethanoylamino]-5-[[(2S)-1-[[(2S)-4-azanyl-1-[[(2S)-5-azanyl-1-[[(2S)-1-[[(2S)-5-azanyl-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-azanyl-1-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-1,5-bis(oxidanylidene)pentan-2-yl]amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-1,5-bis(oxidanylidene)pentan-2-yl]amino]-1,4-bis(oxidanylidene)butan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-5-oxidanylidene-pentanoic acid","(4S)-4-[[2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-3-carboxy-propanoyl]amino]propanoyl]amino]-3-methyl-pentanoyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-3-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]acetyl]amino]-5-keto-pentanoyl]amino]-4-methyl-pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-5-guanidino-pentanoyl]amino]hexanoyl]amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-carboxy-butanoyl]amino]-3-methyl-pentanoyl]amino]-4-(methylthio)butanoyl]amino]-3-carboxy-propanoyl]amino]-5-guanidino-pentanoyl]amino]-5-keto-pentanoyl]amino]-5-keto-pentanoyl]amino]acetyl]amino]-5-[[(1S)-1-[[(1S)-3-amino-1-[[(1S)-4-amino-1-[[(1S)-1-[[(1S)-4-amino-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-3-amino-1-carboxy-3-keto-propyl]amino]-1-benzyl-2-keto-ethyl]carbamoyl]-4-guanidino-butyl]amino]-2-keto-1-methylol-ethyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-4-keto-butyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-4-keto-butyl]carbamoyl]-3-keto-propyl]carbamoyl]-4-guanidino-butyl]amino]-5-keto-valeric acid","InChI=1S/C225H360N76O67S/c1-20-111(12)174(298-180(329)116(17)264-201(350)154(96-172(323)324)282-179(328)114(15)262-181(330)126(227)92-122-98-249-105-260-122)215(364)293-151(89-119-40-27-24-28-41-119)210(359)301-177(117(18)305)217(366)297-159(104-304)213(362)296-158(103-303)212(361)288-150(91-121-52-56-125(307)57-53-121)205(354)272-129(44-32-77-252-220(237)238)185(334)271-134(49-37-82-257-225(247)248)198(347)299-176(113(14)22-3)216(365)292-144(84-107(4)5)183(332)259-101-168(316)265-136(59-67-161(229)309)192(341)284-146(86-109(8)9)203(352)287-148(90-120-50-54-124(306)55-51-120)200(349)263-115(16)178(327)267-128(43-31-76-251-219(235)236)184(333)268-127(42-29-30-75-226)187(336)283-145(85-108(6)7)202(351)285-147(87-110(10)11)204(353)289-152(93-123-99-250-106-261-123)207(356)280-142(65-73-171(321)322)199(348)300-175(112(13)21-2)214(363)281-143(74-83-369-19)197(346)291-155(97-173(325)326)209(358)273-130(45-33-78-253-221(239)240)186(335)276-139(61-69-163(231)311)194(343)275-135(58-66-160(228)308)182(331)258-100-167(315)266-137(63-71-169(317)318)191(340)269-131(46-34-79-254-222(241)242)189(338)290-153(94-165(233)313)208(357)279-140(62-70-164(232)312)195(344)278-141(64-72-170(319)320)196(345)277-138(60-68-162(230)310)193(342)270-133(48-36-81-256-224(245)246)190(339)295-157(102-302)211(360)274-132(47-35-80-255-223(243)244)188(337)286-149(88-118-38-25-23-26-39-118)206(355)294-156(218(367)368)95-166(234)314/h23-28,38-41,50-57,98-99,105-117,126-159,174-177,302-307H,20-22,29-37,42-49,58-97,100-104,226-227H2,1-19H3,(H2,228,308)(H2,229,309)(H2,230,310)(H2,231,311)(H2,232,312)(H2,233,313)(H2,234,314)(H,249,260)(H,250,261)(H,258,331)(H,259,332)(H,262,330)(H,263,349)(H,264,350)(H,265,316)(H,266,315)(H,267,327)(H,268,333)(H,269,340)(H,270,342)(H,271,334)(H,272,354)(H,273,358)(H,274,360)(H,275,343)(H,276,335)(H,277,345)(H,278,344)(H,279,357)(H,280,356)(H,281,363)(H,282,328)(H,283,336)(H,284,341)(H,285,351)(H,286,337)(H,287,352)(H,288,361)(H,289,353)(H,290,338)(H,291,346)(H,292,365)(H,293,364)(H,294,355)(H,295,339)(H,296,362)(H,297,366)(H,298,329)(H,299,347)(H,300,348)(H,301,359)(H,317,318)(H,319,320)(H,321,322)(H,323,324)(H,325,326)(H,367,368)(H4,235,236,251)(H4,237,238,252)(H4,239,240,253)(H4,241,242,254)(H4,243,244,255)(H4,245,246,256)(H4,247,248,257)/t111-,112-,113-,114-,115-,116-,117+,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,174-,175-,176-,177-/m0/s1",ORNDKVCWLUZAQL-FOWIMTFFSA-N,,5232.6886961,C225H360N76O67S,5234.0,2440.0,5230.6819865,0.0,369.0,45.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(/N)NCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H](CCCN/C(N)=N\[H])NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN/C(N)=N\[H])C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN/C(N)=N/[H])C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN/C(N)=N/[H])C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN/C(N)=N/[H])C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)CC,-23.5,"254  100  5
262  102  5
266  103  6
283  108  6
278  110  5
292  112  6
302  116  6
303  117  5
304  118  6
305  119  5
307  120  6
316  122  6
312  123  5
306  124  5
327  125  5
326  126  6
344  127  5
343  130  6
358  132  6
136  355  8
136  366  8
139  361  8
139  366  8
145  155  6
164  191  6
199  221  8
227  245  8
227  246  8
240  257  6
241  260  8
241  261  8
245  258  8
246  259  8
258  267  8
259  267  8
260  275  8
261  276  8
275  280  8
276  280  8
282  287  8
282  288  8
287  295  8
288  296  8
295  298  8
296  298  8
273  32  6
354  359  8
354  360  8
355  361  8
359  364  8
360  365  8
364  368  8
365  368  8
146  69  6
148  70  5
152  71  6
149  72  5
151  73  5
171  74  5
162  75  6
165  76  5
174  77  6
173  79  6
197  80  6
186  81  5
209  83  5
84  199  8
84  233  8
208  85  6
203  86  5
224  87  5
218  89  5
216  90  6
93  221  8
93  233  8
239  94  6
237  96  6
243  98  6
256  99  5",
440790942,24477,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00439,SODIUM THIOSULFATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00439,sodium thiosulfate,0.0,No match,vNo-DILI-Concern,2.0,24477,1.0,82.6,4.0,0.0,0.0,AAADcQAAMDBgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,disodium;dioxido-oxo-thioxo-lambda6-sulfane,disodium;dioxido-oxo-sulfanylidene-lambda6-sulfane,disodium;dioxido-oxo-sulfanylidene-&lambda;<SUP>6</SUP>-sulfane,disodium;dioxido-oxo-sulfanylidene-lambda6-sulfane,disodium;bis(oxidanidyl)-oxidanylidene-sulfanylidene-lambda6-sulfane,disodium;keto-dioxido-thioxo-lambda6-sulfane,"InChI=1S/2Na.H2O3S2/c;;1-5(2,3)4/h;;(H2,1,2,3,4)/q2*+1;/p-2",AKHNMLFCWUSKQB-UHFFFAOYSA-L,,157.90842477,Na2O3S2,158.11,104.0,157.90842477,0.0,7.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",O=S([O-])([O-])=S.[Na+].[Na+],,,
440790941,75905,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00801,Sodium polystyrene sulfonate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00801,Sodium polystyrene sulfonate,0.0,No match,vNo-DILI-Concern,2.0,75905,1.0,242.0,3.0,1.0,2.0,AAADccBwMABAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGAQACAAADACAWAAwAYAAAIKAAiBCAHBCAEAgAAAIiBgAAIgIICKAERCAIAAggAAIiAcAgAAOEAAAAAAAAAAgAAAAAAAAAAAAAAAAAA==,4-vinylbenzenesulfonic acid,4-ethenylbenzenesulfonic acid,4-ethenylbenzenesulfonic acid,4-ethenylbenzenesulfonic acid,4-ethenylbenzenesulfonic acid,4-vinylbesylic acid,"InChI=1S/C8H8O3S/c1-2-7-3-5-8(6-4-7)12(9,10)11/h2-6H,1H2,(H,9,10,11)",MAGFQRLKWCCTQJ-UHFFFAOYSA-N,,184.01941529,C8H8O3S,184.21,62.8,184.01941529,0.0,12.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=Cc1ccc(S(=O)(=O)O)cc1,1.4,"5  7  8
5  8  8
6  10  8
6  9  8
7  9  8
8  10  8",
440790940,23666456,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00330,SODIUM LACTATE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00330,sodium lactate,0.0,No match,vNo-DILI-Concern,2.0,23666456,1.0,63.2,3.0,1.0,1.0,AAADcYBAMCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgAACAAACBSggAICCAAAAgAIAACQCAIAAAAAAAAAAAFAAAABEAAAAAAAAAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,sodium;2-hydroxypropanoate,sodium;2-hydroxypropanoate,sodium;2-hydroxypropanoate,sodium;2-hydroxypropanoate,sodium;2-oxidanylpropanoate,sodium;lactate,"InChI=1S/C3H6O3.Na/c1-2(4)3(5)6;/h2,4H,1H3,(H,5,6);/q;+1/p-1",NGSFWBMYFKHRBD-UHFFFAOYSA-M,,112.0136383,C3H5NaO3,112.06,60.4,112.0136383,0.0,7.0,0.0,1.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CC(O)C(=O)[O-].[Na+],,5  8  3,1  3  7
440790939,516892,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02337,SODIUM BICARBONATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02337,sodium bicarbonate,0.0,No match,vNo-DILI-Concern,2.0,516892,1.0,33.9,3.0,1.0,0.0,AAADcQAAMCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAgAACAAAAAAAAAAACAAAAgAIAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,sodium;hydrogen carbonate,sodium;hydrogen carbonate,sodium;hydrogen carbonate,sodium;hydrogen carbonate,sodium;hydrogen carbonate,sodium;bicarbonate,"InChI=1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1",UIIMBOGNXHQVGW-UHFFFAOYSA-M,,83.98233817,CHNaO3,84.007,60.4,83.98233817,0.0,5.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",O=C([O-])O.[Na+],,,1  2  7
440790938,9833444,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00350,Sincalide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00350,sincalide,0.0,No match,vNo-DILI-Concern,2.0,9833444,1.0,2180.0,19.0,13.0,33.0,AAADcfB//gBgAAAAAAAAAAAAAAAAAWAAAAAwYMAAAAAAAFgB9AAAHgQQCAAADCzF3gS+zvLJkoioAzX3XDCCgCAxIjAI2aG+bJgIZvrgkbOUcAhm1hHIyAe/yeCOoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,(3S)-3-amino-4-[[(1S)-2-[[(1S)-1-[[2-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-2-amino-1-benzyl-2-oxo-ethyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-methylsulfanyl-propyl]amino]-2-oxo-1-[(4-sulfooxyphenyl)methyl]ethyl]amino]-4-oxo-butanoic acid,(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-(methylthio)-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-(methylthio)-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid,(3<I>S</I>)-3-amino-4-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[2-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid,(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid,"(3S)-3-azanyl-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-azanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-4-methylsulfanyl-1-oxidanylidene-butan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-2-oxidanylidene-ethyl]amino]-4-methylsulfanyl-1-oxidanylidene-butan-2-yl]amino]-1-oxidanylidene-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxidanylidene-butanoic acid",(3S)-3-amino-4-[[(1S)-2-[[(1S)-1-[[2-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-2-amino-1-benzyl-2-keto-ethyl]amino]-1-(carboxymethyl)-2-keto-ethyl]carbamoyl]-3-(methylthio)propyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]amino]-2-keto-ethyl]carbamoyl]-3-(methylthio)propyl]amino]-2-keto-1-(4-sulfoxybenzyl)ethyl]amino]-4-keto-butyric acid,"InChI=1S/C49H62N10O16S3/c1-76-18-16-34(55-47(69)37(58-44(66)32(50)23-41(61)62)21-28-12-14-30(15-13-28)75-78(72,73)74)45(67)53-26-40(60)54-38(22-29-25-52-33-11-7-6-10-31(29)33)48(70)56-35(17-19-77-2)46(68)59-39(24-42(63)64)49(71)57-36(43(51)65)20-27-8-4-3-5-9-27/h3-15,25,32,34-39,52H,16-24,26,50H2,1-2H3,(H2,51,65)(H,53,67)(H,54,60)(H,55,69)(H,56,70)(H,57,71)(H,58,66)(H,59,68)(H,61,62)(H,63,64)(H,72,73,74)/t32-,34-,35-,36-,37-,38-,39-/m0/s1",IZTQOLKUZKXIRV-YRVFCXMDSA-N,-2.6,1142.35073945,C49H62N10O16S3,1143.3,486.0,1142.35073945,0.0,78.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,"32  20  6
30  21  5
22  37  8
22  39  8
40  23  5
41  24  6
42  26  5
54  27  5
61  28  6
33  35  8
33  39  8
35  37  8
35  46  8
37  51  8
46  55  8
51  57  8
55  57  8
58  65  8
58  66  8
63  72  8
63  73  8
65  69  8
66  70  8
69  71  8
70  71  8
72  76  8
73  77  8
76  78  8
77  78  8",
440790937,6433516,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02171,Simethicone,20231222,20210312,Curation Efforts|Governmental Organizations,LT02171,simethicone,0.0,No match,vNo-DILI-Concern,2.0,6433516,1.0,125.0,4.0,0.0,3.0,AAADceBgOAwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEhAAAEAAAAAAAAJCAAAAAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,dioxosilane;methoxy-dimethyl-trimethylsilyloxy-silane,dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane,dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane,dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane,bis(oxidanylidene)silane;methoxy-dimethyl-trimethylsilyloxy-silane,diketosilane;methoxy-dimethyl-trimethylsilyloxy-silane,"InChI=1S/C6H18O2Si2.O2Si/c1-7-10(5,6)8-9(2,3)4;1-3-2/h1-6H3;",AMTWCFIAVKBGOD-UHFFFAOYSA-N,,238.05128865,C6H18O4Si3,238.46,52.6,238.05128865,0.0,13.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,,,
440790936,3085017,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01039,Sevelamer,20250421,20210312,Curation Efforts|Governmental Organizations,LT01039,sevelamer,0.0,No match,vNo-DILI-Concern,2.0,3085017,1.0,55.1,2.0,1.0,2.0,AAADccBiIAAEAAAAAAAAAAAAEgAAAAAAAAAAAAAAAAAAAAAAAAAAHgIQAAAACBfhgEYAAABABACAACBCAACAAAAAAAAIAIAAAwAAAAAAAQAAAAAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-(chloromethyl)oxirane;prop-2-en-1-amine,2-(chloromethyl)oxirane;2-propen-1-amine,2-(chloromethyl)oxirane;prop-2-en-1-amine,2-(chloromethyl)oxirane;prop-2-en-1-amine,2-(chloromethyl)oxirane;prop-2-en-1-amine,allylamine;2-(chloromethyl)oxirane,"InChI=1S/C3H5ClO.C3H7N/c4-1-3-2-5-3;1-2-3-4/h3H,1-2H2;2H,1,3-4H2",ZNSIZMQNQCNRBW-UHFFFAOYSA-N,,149.0607417,C6H12ClNO,149.62,38.6,149.0607417,0.0,9.0,0.0,1.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",C=CCN.ClCC1CO1,,4  6  3,
440790935,26757,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01749,selegiline,20210312,20210312,Curation Efforts|Governmental Organizations,LT01749,selegiline,0.0,No match,vNo-DILI-Concern,2.0,26757,1.0,195.0,1.0,0.0,4.0,AAADceByAAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHAAAAAAADCjBGAQyAIMAAADAGiBCAAACAAAgAAAIiAAIAIgIICKAkRGEIAAggACIiAcQgIAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2R)-N-methyl-1-phenyl-N-prop-2-ynyl-propan-2-amine,(2R)-N-methyl-1-phenyl-N-prop-2-ynyl-2-propanamine,(2<I>R</I>)-<I>N</I>-methyl-1-phenyl-<I>N</I>-prop-2-ynylpropan-2-amine,(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine,(2R)-N-methyl-1-phenyl-N-prop-2-ynyl-propan-2-amine,methyl-[(1R)-1-methyl-2-phenyl-ethyl]-propargyl-amine,"InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1",MEZLKOACVSPNER-GFCCVEGCSA-N,,187.136099547,C13H17N,187.28,3.2,187.136099547,0.0,14.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C#CCN(C)[C@H](C)Cc1ccccc1,2.8,"2  1  6
10  12  8
11  12  8
5  8  8
5  9  8
8  10  8
9  11  8",
440790934,16129665,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00355,SECRETIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00355,secretin,0.0,No match,vNo-DILI-Concern,2.0,16129665,1.0,6980.0,48.0,52.0,109.0,AAADcfB//gAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHgAQCAAADTzhmwY/mJbJkgCoAjP3fAACgC2xEqAJyYG4MIiKeD6A2TGUYAAutgKYiCe/n4KOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,5-[[1-[[2-[[1-[[1-[[1-[[2-[[2-[[2-[[1-[[1-[[4-amino-1-[[1-[[1-[[1-[[4-amino-1-[[2-[[1-[(1-carboxy-2-methyl-propyl)carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]carbamoyl]-4-oxo-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-4-oxo-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-guanidino-butyl]amino]-1-methyl-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-guanidino-butyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]-3-methyl-butyl]amino]-4-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-amino-3-(1H-imidazol-2-yl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-carboxy-propanoyl]amino]acetyl]amino]-3-hydroxy-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-5-oxo-pentanoic acid,"5-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[5-amino-1-[[2-[[1-[(1-carboxy-2-methylpropyl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-amino-3-(1H-imidazol-2-yl)-1-oxopropyl]amino]-3-hydroxy-1-oxopropyl]amino]-3-carboxy-1-oxopropyl]amino]-1-oxoethyl]amino]-3-hydroxy-1-oxobutyl]amino]-1-oxo-3-phenylpropyl]amino]-3-hydroxy-1-oxobutyl]amino]-3-hydroxy-1-oxopropyl]amino]-5-oxopentanoic acid","5-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[5-amino-1-[[2-[[1-[(1-carboxy-2-methylpropyl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-amino-3-(1<I>H</I>-imidazol-2-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoic acid","5-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[5-amino-1-[[2-[[1-[(1-carboxy-2-methylpropyl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-amino-3-(1H-imidazol-2-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoic acid","5-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[5-azanyl-1-[[1-[[1-[[1-[[5-azanyl-1-[[2-[[4-methyl-1-[(3-methyl-1-oxidanyl-1-oxidanylidene-butan-2-yl)amino]-1-oxidanylidene-pentan-2-yl]amino]-2-oxidanylidene-ethyl]amino]-1,5-bis(oxidanylidene)pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-1,5-bis(oxidanylidene)pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-4-[[2-[[2-[[2-[[2-[2-[[2-[[2-[[2-azanyl-3-(1H-imidazol-2-yl)propanoyl]amino]-3-oxidanyl-propanoyl]amino]-4-oxidanyl-4-oxidanylidene-butanoyl]amino]ethanoylamino]-3-oxidanyl-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-oxidanyl-butanoyl]amino]-3-oxidanyl-propanoyl]amino]-5-oxidanylidene-pentanoic acid",5-[[1-[[2-[[1-[[1-[[1-[[2-[[2-[[2-[[1-[[1-[[4-amino-1-[[1-[[1-[[1-[[4-amino-1-[[2-[[1-[(1-carboxy-2-methyl-propyl)carbamoyl]-3-methyl-butyl]amino]-2-keto-ethyl]carbamoyl]-4-keto-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-4-keto-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-guanidino-butyl]amino]-2-keto-1-methyl-ethyl]amino]-2-keto-1-methylol-ethyl]amino]-1-(carboxymethyl)-2-keto-ethyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-guanidino-butyl]amino]-2-keto-1-methylol-ethyl]carbamoyl]-3-methyl-butyl]amino]-4-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-amino-3-(1H-imidazol-2-yl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-carboxy-propanoyl]amino]acetyl]amino]-3-hydroxy-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-5-keto-valeric acid,"InChI=1S/C130H219N43O42/c1-59(2)43-78(118(206)172-99(65(13)14)126(214)215)151-94(182)53-148-104(192)75(31-34-91(132)180)156-113(201)81(46-62(7)8)163-115(203)82(47-63(9)10)161-107(195)72(28-22-38-145-128(136)137)153-110(198)76(32-35-92(133)181)157-114(202)80(45-61(5)6)159-106(194)71(27-21-37-144-127(134)135)152-102(190)66(15)150-120(208)87(55-174)168-117(205)86(52-98(188)189)165-109(197)73(29-23-39-146-129(138)139)154-112(200)79(44-60(3)4)160-108(196)74(30-24-40-147-130(140)141)155-121(209)89(57-176)169-116(204)83(48-64(11)12)162-111(199)77(33-36-96(184)185)158-122(210)90(58-177)170-125(213)101(68(17)179)173-119(207)84(49-69-25-19-18-20-26-69)166-124(212)100(67(16)178)171-95(183)54-149-105(193)85(51-97(186)187)164-123(211)88(56-175)167-103(191)70(131)50-93-142-41-42-143-93/h18-20,25-26,41-42,59-68,70-90,99-101,174-179H,21-24,27-40,43-58,131H2,1-17H3,(H2,132,180)(H2,133,181)(H,142,143)(H,148,192)(H,149,193)(H,150,208)(H,151,182)(H,152,190)(H,153,198)(H,154,200)(H,155,209)(H,156,201)(H,157,202)(H,158,210)(H,159,194)(H,160,196)(H,161,195)(H,162,199)(H,163,203)(H,164,211)(H,165,197)(H,166,212)(H,167,191)(H,168,205)(H,169,204)(H,170,213)(H,171,183)(H,172,206)(H,173,207)(H,184,185)(H,186,187)(H,188,189)(H,214,215)(H4,134,135,144)(H4,136,137,145)(H4,138,139,146)(H4,140,141,147)",KKNIUBFRGPFELP-UHFFFAOYSA-N,,3055.635633,C130H219N43O42,3056.4,1420.0,3054.6322782,0.0,215.0,0.0,27.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(/N)NCCCC(NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CCCN/C(N)=N/[H])NC(=O)C(CC(C)C)NC(=O)C(CCCN/C(N)=N\[H])NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(N)Cc1ncc[nH]1)C(C)O)C(C)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN/C(N)=N/[H])C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(C(=O)O)C(C)C,-13.4,"109  252  3
110  253  3
113  259  3
117  264  3
122  275  3
129  284  3
137  302  3
144  307  3
146  311  3
147  313  3
151  321  3
161  334  3
166  342  3
174  361  3
183  375  3
186  378  3
187  383  3
191  401  3
192  195  8
192  196  8
194  403  3
195  198  8
196  199  8
198  201  8
199  201  8
203  417  3
207  421  3
211  425  3
214  215  8
84  213  8
84  214  8
85  213  8
85  215  8
86  216  3
88  219  3
91  223  3
96  229  3
97  230  3",
440790933,5184,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01974,scopolamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01974,scopolamine,0.0,No match,vNo-DILI-Concern,2.0,5184,1.0,418.0,5.0,1.0,5.0,AAADceB6OAAAAAAAAAAAAAAAEgAAAWAAAAA8WIAABgAAAAABAAAAHgAACAAADTzhmAYyCIMABgCIAiDSCAACAAAgAAAIiAEIAIgKMDaAlRCHYAAn4AGYiAfY6OyOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl) 3-hydroxy-2-phenyl-propanoate","3-hydroxy-2-phenylpropanoic acid (9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl) ester","(9-methyl-3-oxa-9-azatricyclo[3.3.1.0<SUP>2,4</SUP>]nonan-7-yl) 3-hydroxy-2-phenylpropanoate","(9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl) 3-hydroxy-2-phenylpropanoate","(9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl) 3-oxidanyl-2-phenyl-propanoate","3-hydroxy-2-phenyl-propionic acid (9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl) ester","InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3",STECJAGHUSJQJN-UHFFFAOYSA-N,0.9,303.14705815,C17H21NO4,303.35,62.3,303.14705815,0.0,22.0,0.0,5.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,,"6  1  3
7  1  3
15  16  3
17  18  8
17  19  8
18  20  8
19  21  8
20  22  8
21  22  8
8  10  3
9  11  3",
440790932,11243969,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00667,Saxagliptin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00667,saxagliptin,0.0,No match,vNo-DILI-Concern,2.0,11243969,1.0,609.0,4.0,2.0,2.0,AAADceB7MAAAAAAAAAAAAAAAGAAAAWAAAAA8YMGCAAAAAAAAAAAAHgAQCAAAD2zBgAQAAANAAgAYBAEQEAAAAAAAAAAAAIGIAAAAwBIAgAAUQAAEBgCAAAm43PLPAAAAAAAAAAAAAAYAAAAAAAAAAAAAAA==,"(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile","(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)-1-oxoethyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile","(1<I>S</I>,3<I>S</I>,5<I>S</I>)-2-[(2<I>S</I>)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile","(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile","(1S,3S,5S)-2-[(2S)-2-azanyl-2-(3-oxidanyl-1-adamantyl)ethanoyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile","(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile","InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15-,17?,18?/m1/s1",QGJUIPDUBHWZPV-SGTAVMJGSA-N,,315.19467705,C18H25N3O2,315.4,90.4,315.19467705,0.0,23.0,4.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,0.7,"17  39  6
18  40  6
22  23  5
16  4  5
8  15  3
9  15  3",
440790931,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01321,Sargramostim,20210312,20210312,Curation Efforts|Governmental Organizations,LT01321,sargramostim,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790930,2083,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01051,Salbutamol,20250421,20210312,Curation Efforts|Governmental Organizations,LT01051,salbutamol,0.0,No match,vNo-DILI-Concern,1.0,2083,1.0,227.0,4.0,4.0,5.0,AAADceByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADJzhmAYyBoLAAgCAAiBCAAACAAAgIAAIiIAOCIgKNyKCkROEcAAl0BGYmAeQ4OQOIAACAAAIAABAAAQAABAAAAAAAAAAAA==,4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol,4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol,4-[2-(<I>tert</I>-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol,4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol,4-[2-(tert-butylamino)-1-oxidanyl-ethyl]-2-(hydroxymethyl)phenol,4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-methylol-phenol,"InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3",NDAUXUAQIAJITI-UHFFFAOYSA-N,0.3,239.15214353,C13H21NO3,239.31,72.7,239.15214353,0.0,17.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,,"7  1  3
11  12  8
11  13  8
12  14  8
13  16  8
14  15  8
15  16  8",
440790929,71357,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00928,RUBIDIUM CHLORIDE RB-82,20231222,20210312,Curation Efforts|Governmental Organizations,LT00928,rubidium chloride rb-82,0.0,No match,vNo-DILI-Concern,2.0,71357,1.0,2.0,1.0,0.0,0.0,AAADcQAAAAAEAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,rubidium-82(1+);chloride,rubidium-82(1+);chloride,rubidium-82(1+);chloride,rubidium-82(1+);chloride,rubidium-82(1+);chloride,rubidium-82(1+);chloride,InChI=1S/ClH.Rb/h1H;/q;+1/p-1/i;1-3,FGDZQCVHDSGLHJ-RYDPDVNUSA-M,,116.88706,ClRb,117.37,0.0,116.88706,0.0,2.0,0.0,0.0,0.0,0.0,1.0,2.0,-1.0,"1
5
255",[82Rb+].[Cl-],,,1  2  7
440790928,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01417,Romiplostim,20210312,20210312,Curation Efforts|Governmental Organizations,LT01417,romiplostim,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790927,5352062,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00669,Romidepsin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00669,romidepsin,0.0,No match,vNo-DILI-Concern,2.0,5352062,1.0,905.0,8.0,4.0,2.0,AAADcfB7uABgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgQQAAAADTzlwAaCCALABACIACXSWACAAAAgAgAICIGIAEgCRBQAoSAXEAAGtgCYIYIAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone","(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone","(1<I>S</I>,4<I>S</I>,7<I>Z</I>,10<I>S</I>,16<I>E</I>,21<I>R</I>)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone","(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone","(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone","(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone","InChI=1S/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h6-7,9,13-15,17,19-20H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17-,19-,20+/m1/s1",OHRURASPPZQGQM-GCCNXGTGSA-N,,540.20762723,C24H36N4O6S2,540.7,193.0,540.20762723,0.0,36.0,4.0,0.0,2.0,0.0,0.0,1.0,-1.0,"1
5
255",C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O,2.2,"13  14  5
15  16  5
20  48  6
22  51  6",
440790926,441290,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00957,Rocuronium,20250421,20210312,Curation Efforts|Governmental Organizations,LT00957,rocuronium,0.0,No match,vNo-DILI-Concern,2.0,441290,1.0,898.0,5.0,1.0,6.0,AAADcfB/OAAAAAAAAAAAAAAAAAAAAeIAAAA8YMEAAAAAAGDAAAAAHgAACAAADzzhgAYCCAMABgCIACDSCACAAAAAAAAIAAAIAAACEAIAgQAHQAAEAACQAAGQ0PIPgAAAAAAAAADQAAaAACAgAKAADAgAAA==,"[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-16-(1-allylpyrrolidin-1-ium-1-yl)-3-hydroxy-10,13-dimethyl-2-morpholino-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate","acetic acid [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-(4-morpholinyl)-16-(1-prop-2-enyl-1-pyrrolidin-1-iumyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] ester","[(2<I>S</I>,3<I>S</I>,5<I>S</I>,8<I>R</I>,9<I>S</I>,10<I>S</I>,13<I>S</I>,14<I>S</I>,16<I>S</I>,17<I>R</I>)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1<I>H</I>-cyclopenta[a]phenanthren-17-yl] acetate","[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate","[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-dimethyl-2-morpholin-4-yl-3-oxidanyl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] ethanoate","acetic acid [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-16-(1-allylpyrrolidin-1-ium-1-yl)-3-hydroxy-10,13-dimethyl-2-morpholino-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] ester","InChI=1S/C32H53N2O4/c1-5-14-34(15-6-7-16-34)28-20-26-24-9-8-23-19-29(36)27(33-12-17-37-18-13-33)21-32(23,4)25(24)10-11-31(26,3)30(28)38-22(2)35/h5,23-30,36H,1,6-21H2,2-4H3/q+1/t23-,24+,25-,26-,27-,28-,29-,30-,31-,32-/m0/s1",YXRDKMPIGHSVRX-OOJCLDBCSA-N,,529.40053318,C32H53N2O4+,529.8,59.0,529.40053318,1.0,38.0,10.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,5.0,"13  1  5
10  41  6
11  24  5
12  42  6
16  48  6
27  2  6
23  6  5
7  39  6
8  21  5
9  40  5",
440790925,5078,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01026,rizatriptan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01026,rizatriptan,0.0,No match,vNo-DILI-Concern,2.0,5078,1.0,309.0,3.0,1.0,5.0,AAADceBzgAAAAAAAAAAAAAAAAAAAAWLAAAAwAAAAAAAAAFgB/AAAHAAYAAAADAjBHgQ/0PfJkACiAzRnZACSgCsxgqAd2aA4ZJiIKOLAmZGEIAhokALIyAcQgMAOiAACAAACAAAQAAQAAAQAAAAAAAAAAA==,"N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine","N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine","<I>N</I>,<I>N</I>-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1<I>H</I>-indol-3-yl]ethanamine","N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine","N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine","dimethyl-[2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethyl]amine","InChI=1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3",ULFRLSNUDGIQQP-UHFFFAOYSA-N,1.7,269.16404563,C15H19N5,269.34,49.7,269.16404563,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,,"1  12  8
1  9  8
11  13  8
13  15  8
14  15  8
3  19  8
3  4  8
4  20  8
5  19  8
5  20  8
6  12  8
6  7  8
7  11  8
7  9  8
9  14  8",
440790924,5071,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00937,rimantadine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00937,rimantadine,0.0,No match,vNo-DILI-Concern,2.0,5071,1.0,180.0,1.0,1.0,1.0,AAADceByAAAAAAAAAAAAAAAAAAAAAAAAAAAwYMGAAAAAAAAAAAAAHAAQAAAADyjBAAQCAABAAAAAAAAAAAAAAAAAAAAAAIAAAAAAAAIAgAAAAAAAEAAAAAEQgMAPAAAAAAAAAAAAAAQAAAAAAAAAAAAAAA==,1-(1-adamantyl)ethanamine,1-(1-adamantyl)ethanamine,1-(1-adamantyl)ethanamine,1-(1-adamantyl)ethanamine,1-(1-adamantyl)ethanamine,1-(1-adamantyl)ethylamine,"InChI=1S/C12H21N/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12/h8-11H,2-7,13H2,1H3",UBCHPRBFMUDMNC-UHFFFAOYSA-N,,179.167399674,C12H21N,179.3,26.0,179.167399674,0.0,13.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(N)C12CC3CC(CC(C3)C1)C2,2.6,12  29  3,
440790923,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01415,Rilonacept,20210312,20210312,Curation Efforts|Governmental Organizations,LT01415,rilonacept,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790922,493570,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01479,riboflavin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01479,riboflavin,0.0,No match,vNo-DILI-Concern,2.0,493570,1.0,680.0,7.0,5.0,5.0,AAADceB7uAAAAAAAAAAAAAAAAAAAAAAAAAAwQIAAAAAAAACBAAAAHgAQCAAADBzhmAYzwIPAAgCoAydydACCAAEhAgABiAEodIiLcCrA2ZGUYAhnhSLZyAfwkIIOiAAAQAAQACAQAACAACAAQAAAAAAAAA==,"7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione","7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione","7,8-dimethyl-10-[(2<I>S</I>,3<I>S</I>,4<I>R</I>)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione","7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione","7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrakis(oxidanyl)pentyl]benzo[g]pteridine-2,4-dione","7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-quinone","InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1",AUNGANRZJHBGPY-SCRDCRAPSA-N,-1.5,376.13828437,C17H20N4O6,376.4,155.0,376.13828437,0.0,27.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C,,"11  1  6
10  24  8
10  27  8
15  17  8
15  18  8
17  22  8
18  21  8
19  24  8
13  2  5
21  23  8
22  23  8
14  3  6
7  15  8
7  16  8
8  17  8
8  19  8
9  16  8
9  27  8",
440790921,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01351,Reteplase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01351,reteplase,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790920,5770,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01729,reserpine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01729,reserpine,0.0,No match,vNo-DILI-Concern,2.0,5770,1.0,1000.0,10.0,1.0,10.0,AAADcfB/PAAAAAAAAAAAAAAAAAAAAWAAAAA8eMECAAAAAFix9AAAHgAQAAAADTzhngYyzvPJlACoAyTyTACCiCAlIiAImSE+7NgNZ/bEtZuWMSpn8B3K6Yf6/f/eoAABCgACQABAAAYUADSAAAAAAAAAAA==,"methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate","(1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[oxo-(3,4,5-trimethoxyphenyl)methoxy]-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester","methyl (1<I>R</I>,15<I>S</I>,17<I>R</I>,18<I>R</I>,19<I>S</I>,20<I>S</I>)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate","methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate","methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxyphenyl)carbonyloxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate","(1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester","InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1",QEVHRUUCFGRFIF-MDEJGZGSSA-N,,608.27338086,C33H40N2O9,608.7,118.0,608.27338086,0.0,44.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,4.0,"19  1  6
11  21  8
11  27  8
12  45  6
13  46  6
15  25  5
16  50  5
20  2  5
21  23  8
23  26  8
26  27  8
26  29  8
27  31  8
29  32  8
31  33  8
32  33  8
35  36  8
35  37  8
36  39  8
37  38  8
38  41  8
39  41  8",
440790919,219024,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00646,Regadenoson,20231222,20210312,Curation Efforts|Governmental Organizations,LT00646,regadenoson,0.0,No match,vNo-DILI-Concern,2.0,219024,1.0,587.0,10.0,5.0,4.0,AAADceBz+AAAAAAAAAAAAAAAAAAAAWLEgAAsAAAAAAAAAFgB/gAAHgAYCAAADBzhnwYv8L/MFgCqAxd3dACQhC0VkKAVUKEoVFCDWIpAyUAexIgPCgLTAODwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-2-yl]-N-methyl-pyrazole-4-carboxamide","1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-2-purinyl]-N-methyl-4-pyrazolecarboxamide","1-[6-amino-9-[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-<I>N</I>-methylpyrazole-4-carboxamide","1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide","1-[6-azanyl-9-[(2R,3R,4S,5R)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-2-yl]-N-methyl-pyrazole-4-carboxamide","1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]purin-2-yl]-N-methyl-pyrazole-4-carboxamide","InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1",LZPZPHGJDAGEJZ-AKAIJSEGSA-N,-1.5,390.1400157,C15H18N8O5,390.35,186.0,390.1400157,0.0,28.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1,,"10  12  8
10  24  8
12  26  8
17  18  6
19  21  8
14  2  5
21  22  8
24  25  8
25  26  8
16  3  5
15  6  6
6  19  8
6  20  8
7  20  8
7  21  8
8  19  8
8  23  8
9  22  8
9  23  8",
440790918,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01363,rasburicase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01363,rasburicase,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790917,56959,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01192,RANOLAZINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01192,ranolazine,0.0,No match,vNo-DILI-Concern,2.0,56959,1.0,531.0,6.0,2.0,9.0,AAADcfB7OAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABQAAAHgAQCAAADBzhmAYyxoPABgCIAiVSUACCCAAhIAAIiACOzIgPdiLEsbuWOCrm1BHb6AeQwEAOAAACAAACQAAAAAQAAASAAAAAAAAAAA==,"N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide","N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazinyl]acetamide","<I>N</I>-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide","N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide","N-(2,6-dimethylphenyl)-2-[4-[3-(2-methoxyphenoxy)-2-oxidanyl-propyl]piperazin-1-yl]ethanamide","N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazino]acetamide","InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)",XKLMZUWKNUAPSZ-UHFFFAOYSA-N,,427.24710654,C24H33N3O4,427.5,74.3,427.24710654,0.0,31.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,2.7,"14  1  3
17  19  8
17  20  8
18  23  8
18  26  8
19  21  8
20  22  8
21  27  8
22  27  8
23  28  8
26  29  8
28  30  8
29  30  8",
440790916,208902,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01217,Ramelteon,20231222,20210312,Curation Efforts|Governmental Organizations,LT01217,ramelteon,0.0,No match,vNo-DILI-Concern,2.0,208902,1.0,331.0,2.0,1.0,4.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAaIAAAAwAAAAAAAAAGgBAAAAHgAQAAAADQThmAYyBoLABACIAiFSEAACCAAgIAAIiIEOCIgMJiKEsRqGOCCk1hGIqAeQwPAOoAADAAAYAABAAAYAADAAAQAACAAAAA==,"N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e]benzofuran-8-yl]ethyl]propanamide","N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e]benzofuran-8-yl]ethyl]propanamide","<I>N</I>-[2-[(8<I>S</I>)-2,6,7,8-tetrahydro-1<I>H</I>-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide","N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide","N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide","N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e]benzofuran-8-yl]ethyl]propionamide","InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1",YLXDSYKOBKBWJQ-LBPRGKRZSA-N,,259.157228913,C16H21NO2,259.34,38.3,259.157228913,0.0,19.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3,2.7,"10  12  8
12  16  8
13  16  8
4  9  5
5  10  8
5  8  8
8  13  8",
440790915,5035,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00183,raloxifene,20231222,20210312,Curation Efforts|Governmental Organizations,LT00183,raloxifene,0.0,No match,vNo-DILI-Concern,2.0,5035,1.0,655.0,6.0,2.0,7.0,AAADceB6OABAAAAAAAAAAAAAAAAAASAAAAA8YMEAAAAAAEgB9AAAHgQACAAADATh2AYwB8MABgiMAqBSAAADCIAkKBBIiBkOCMgOJjKmtRqHeSCkwBG4uYeYzPDOoAAABAAEAABAAAAIAAgAAAAAAAAAAA==,[6-hydroxy-2-(4-hydroxyphenyl)benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]methanone,[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone,[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone,[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone,[2-(4-hydroxyphenyl)-6-oxidanyl-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone,[6-hydroxy-2-(4-hydroxyphenyl)benzothiophen-3-yl]-[4-(2-piperidinoethoxy)phenyl]methanone,"InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2",GZUITABIAKMVPG-UHFFFAOYSA-N,,473.16607952,C28H27NO4S,473.6,98.2,473.16607952,0.0,34.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,6.1,"1  17  8
1  18  8
14  21  8
14  22  8
15  16  8
15  17  8
16  18  8
16  26  8
18  27  8
19  23  8
19  24  8
21  23  8
22  24  8
25  30  8
25  31  8
26  28  8
27  29  8
28  29  8
30  32  8
31  33  8
32  34  8
33  34  8",
440790914,4999,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01721,quazepam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01721,quazepam,0.0,No match,vNo-DILI-Concern,2.0,4999,1.0,539.0,6.0,0.0,2.0,AAADccB7AcBEAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHQYAAAAADArBWDwwwIMAAACkAyRiRACCAAAhBwgIiAAoZpgIYKLBk5GUIAhggADIyAcQgMAOAABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione","7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione","7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3<I>H</I>-1,4-benzodiazepine-2-thione","7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione","7-chloranyl-5-(2-fluorophenyl)-1-[2,2,2-tris(fluoranyl)ethyl]-3H-1,4-benzodiazepine-2-thione","7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione","InChI=1S/C17H11ClF4N2S/c18-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)19)23-8-15(25)24(14)9-17(20,21)22/h1-7H,8-9H2",IKMPWMZBZSAONZ-UHFFFAOYSA-N,4.0,386.0267599,C17H11ClF4N2S,386.8,47.7,386.0267599,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,,"10  16  8
15  19  8
16  20  8
17  21  8
17  22  8
19  20  8
21  23  8
22  24  8
23  25  8
24  25  8
9  10  8
9  15  8",
440790913,1054,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01980,pyridoxine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01980,pyridoxine,0.0,No match,vNo-DILI-Concern,2.0,1054,1.0,142.0,4.0,3.0,2.0,AAADccByMAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAHgAACAAADAzhngYuhpIIEgCgAxRnRASCgCAxYCAA2CA9TJgKN2LSkZOEcAhnwBHY2AfwUAMOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol","4,5-bis(hydroxymethyl)-2-methyl-3-pyridinol","4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol","4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol","4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol","2-methyl-4,5-dimethylol-pyridin-3-ol","InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3",LXNHXLLTXMVWPM-UHFFFAOYSA-N,-0.8,169.07389321,C8H11NO3,169.18,73.6,169.07389321,0.0,12.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ncc(CO)c(CO)c1O,,"4  11  8
4  8  8
5  6  8
5  7  8
6  11  8
7  8  8",
440790912,4991,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02081,pyridostigmine,20210312,20210312,Curation Efforts|Governmental Organizations,LT02081,pyridostigmine,0.0,No match,vNo-DILI-Concern,2.0,4991,1.0,182.0,2.0,0.0,2.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAHgAAAAAACATBkgQ+jpMMFACoADBnXASCiCAxYiAI2CA/bJgOJuLEsZuNMihkwhHY6AYwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate","N,N-dimethylcarbamic acid (1-methyl-3-pyridin-1-iumyl) ester","(1-methylpyridin-1-ium-3-yl) <I>N</I>,<I>N</I>-dimethylcarbamate","(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate","(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate","N,N-dimethylcarbamic acid (1-methylpyridin-1-ium-3-yl) ester","InChI=1S/C9H13N2O2/c1-10(2)9(12)13-8-5-4-6-11(3)7-8/h4-7H,1-3H3/q+1",RVOLLAQWKVFTGE-UHFFFAOYSA-N,,181.097702662,C9H13N2O2+,181.21,33.4,181.097702662,1.0,13.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)C(=O)Oc1ccc[n+](C)c1,0.7,"3  6  8
3  7  8
5  6  8
5  8  8
7  9  8
8  9  8",
440790911,708857,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01713,PYRANTEL,20231222,20210312,Curation Efforts|Governmental Organizations,LT01713,pyrantel,0.0,No match,vNo-DILI-Concern,2.0,708857,1.0,248.0,2.0,0.0,2.0,AAADccBzAABAAAAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAABgAAAHAQAAAAACADFUASzAYMAAAikACJiJACDAIEgCBBJiBgYAJgIICKgWRCEAAAggACoiAYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-methyl-2-[(E)-2-(2-thienyl)vinyl]-5,6-dihydro-4H-pyrimidine","1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine","1-methyl-2-[(<I>E</I>)-2-thiophen-2-ylethenyl]-5,6-dihydro-4<I>H</I>-pyrimidine","1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine","1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine","1-methyl-2-[(E)-2-(2-thienyl)vinyl]-5,6-dihydro-4H-pyrimidine","InChI=1S/C11H14N2S/c1-13-8-3-7-12-11(13)6-5-10-4-2-9-14-10/h2,4-6,9H,3,7-8H2,1H3/b6-5+",YSAUAVHXTIETRK-AATRIKPKSA-N,,206.08776963,C11H14N2S,206.31,43.8,206.08776963,0.0,14.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCCN=C1/C=C/c1cccs1,1.6,"1  11  8
1  14  8
11  12  8
12  13  8
13  14  8",
440790910,7028,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00137,PSEUDOEPHEDRINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00137,pseudoephedrine,0.0,No match,vNo-DILI-Concern,2.0,7028,1.0,121.0,2.0,2.0,3.0,AAADccByIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADDzhmAYyAILAAgCAAiBCAAACAAAgAAAIiIAICIgKNiKAkRGEcAAk0AEYmAeQwKAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol","(1S,2S)-2-(methylamino)-1-phenyl-1-propanol","(1<I>S</I>,2<I>S</I>)-2-(methylamino)-1-phenylpropan-1-ol","(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol","(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol","(1S,2S)-2-(methylamino)-1-phenyl-propan-1-ol","InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10+/m0/s1",KWGRBVOPPLSCSI-WCBMZHEXSA-N,0.9,165.115364102,C10H15NO,165.23,32.3,165.115364102,0.0,12.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN[C@@H](C)[C@@H](O)c1ccccc1,,"4  1  6
10  12  8
11  12  8
3  2  5
5  7  8
5  8  8
7  10  8
8  11  8",
440790909,4976,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00848,protriptyline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00848,protriptyline,0.0,No match,vNo-DILI-Concern,2.0,4976,1.0,296.0,1.0,1.0,4.0,AAADceB6AAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHAAQAAAADQDBGAQyAILAAACAAiBCAAACAAAgAAAIiIAIAIgIICKAkRCEIAAgkAAIiAcQgMAOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine","N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)-1-propanamine","<I>N</I>-methyl-3-(2-tricyclo[9.4.0.0<SUP>3,8</SUP>]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine","N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine","N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine","methyl-[3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propyl]amine","InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3",BWPIARFWQZKAIA-UHFFFAOYSA-N,,263.167399674,C19H21N,263.4,12.0,263.167399674,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNCCCC1c2ccccc2C=Cc2ccccc21,4.4,"10  16  8
11  17  8
14  18  8
15  19  8
16  18  8
17  19  8
4  10  8
4  7  8
5  11  8
5  8  8
7  14  8
8  15  8",
440790908,638678,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00349,protirelin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00349,protirelin,0.0,No match,vNo-DILI-Concern,2.0,638678,1.0,597.0,5.0,4.0,6.0,AAADceB7uAAAAAAAAAAAAAAAAAAAAWLFgAAAAAAAAAAAAAABgAAAHgAQAAAACCjBlgQtkBfJkACoARV3dAAAgC2xEqABUYG4cAiAaBJA2SGUAAAIlgLAQCAcAwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-N-[(1S)-2-[(2S)-2-carbamoylpyrrolidin-1-yl]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[(2S)-2-carbamoyl-1-pyrrolidinyl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxo-2-pyrrolidinecarboxamide,(2<I>S</I>)-<I>N</I>-[(2<I>S</I>)-1-[(2<I>S</I>)-2-carbamoylpyrrolidin-1-yl]-3-(1<I>H</I>-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[(2S)-2-aminocarbonylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl]-5-oxidanylidene-pyrrolidine-2-carboxamide,(2S)-N-[(1S)-2-[(2S)-2-carbamoylpyrrolidino]-1-(1H-imidazol-5-ylmethyl)-2-keto-ethyl]-5-keto-pyrrolidine-2-carboxamide,"InChI=1S/C16H22N6O4/c17-14(24)12-2-1-5-22(12)16(26)11(6-9-7-18-8-19-9)21-15(25)10-3-4-13(23)20-10/h7-8,10-12H,1-6H2,(H2,17,24)(H,18,19)(H,20,23)(H,21,25)/t10-,11-,12-/m0/s1",XNSAINXGIQZQOO-SRVKXCTJSA-N,-2.5,362.1702532,C16H22N6O4,362.38,150.0,362.1702532,0.0,26.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,,"10  25  8
10  26  8
11  18  5
17  21  5
24  25  8
15  6  5
9  24  8
9  26  8",
440790907,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00728,Protamine sulfate,20210312,20210312,Curation Efforts|Governmental Organizations,LT00728,protamine sulfate,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790906,4934,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00753,propantheline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00753,propantheline,0.0,No match,vNo-DILI-Concern,2.0,4934,1.0,474.0,3.0,0.0,7.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAA0YIAAAAAAAACRQAAAHgAAAAAADSzhmAYyDoMABACIAiDSCAACCAAgIAAIiAEOCIgOJjKENRqDOCCkwBGYqAfKyOCOgAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,diisopropyl-methyl-[2-(9H-xanthene-9-carbonyloxy)ethyl]ammonium,methyl-[2-[oxo(9H-xanthen-9-yl)methoxy]ethyl]-di(propan-2-yl)ammonium,methyl-di(propan-2-yl)-[2-(9<I>H</I>-xanthene-9-carbonyloxy)ethyl]azanium,methyl-di(propan-2-yl)-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium,methyl-di(propan-2-yl)-[2-(9H-xanthen-9-ylcarbonyloxy)ethyl]azanium,diisopropyl-methyl-[2-(9H-xanthene-9-carbonyloxy)ethyl]ammonium,"InChI=1S/C23H30NO3/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22/h6-13,16-17,22H,14-15H2,1-5H3/q+1",VVWYOYDLCMFIEM-UHFFFAOYSA-N,4.2,368.22256882,C23H30NO3+,368.5,35.5,368.22256882,1.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C,,"16  18  8
16  20  8
17  19  8
17  21  8
18  22  8
19  23  8
20  24  8
21  25  8
22  26  8
23  27  8
24  26  8
25  27  8",
440790905,4919,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02219,procyclidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02219,procyclidine,0.0,No match,vNo-DILI-Concern,1.0,4919,1.0,301.0,2.0,1.0,5.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAABAAAAHgAACAAADUTBmAQwAIMAAgCAAiBCAAACAAAgAAAIiAAICIgIJiKAkRCEcAAmwAGImAeQwOAOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol,1-cyclohexyl-1-phenyl-3-(1-pyrrolidinyl)-1-propanol,1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol,1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol,1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol,1-cyclohexyl-1-phenyl-3-pyrrolidino-propan-1-ol,"InChI=1S/C19H29NO/c21-19(17-9-3-1-4-10-17,18-11-5-2-6-12-18)13-16-20-14-7-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2",WYDUSKDSKCASEF-UHFFFAOYSA-N,4.1,287.224914549,C19H29NO,287.4,23.5,287.224914549,0.0,21.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,,"12  17  8
12  18  8
17  19  8
18  20  8
19  21  8
20  21  8
4  3  3",
440790904,4909,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00261,primidone,20250421,20210312,Curation Efforts|Governmental Organizations,LT00261,primidone,0.0,No match,vNo-DILI-Concern,1.0,4909,1.0,279.0,2.0,2.0,2.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHgAQAAAADgCBmAQzAILAAACIAiFSEAACAAAgAAAIiIEIAIiIIDqI1RGEIAAogwIIiAcYiMCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5-ethyl-5-phenyl-hexahydropyrimidine-4,6-dione","5-ethyl-5-phenyl-1,3-diazinane-4,6-dione","5-ethyl-5-phenyl-1,3-diazinane-4,6-dione","5-ethyl-5-phenyl-1,3-diazinane-4,6-dione","5-ethyl-5-phenyl-1,3-diazinane-4,6-dione","5-ethyl-5-phenyl-hexahydropyrimidine-4,6-quinone","InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)",DQMZLTXERSFNPB-UHFFFAOYSA-N,0.9,218.105527694,C12H14N2O2,218.25,58.2,218.105527694,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC1(c2ccccc2)C(=O)NCNC1=O,,"12  14  8
13  15  8
14  16  8
15  16  8
7  12  8
7  13  8",
440790903,4908,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00613,PRIMAQUINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT00613,primaquine,0.0,No match,vNo-DILI-Concern,1.0,4908,1.0,262.0,4.0,2.0,6.0,AAADceBzIAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAACx8AAAHgAQAAAADCzBngY+xvLIFACgAzRnRACCiCAxMiAI2KA+fJgMZuLEsZuUMChm0BnI6Aew0LMOAEABQgACACAAgAKEAAQAQAAAAAAAAA==,"N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine","N4-(6-methoxy-8-quinolinyl)pentane-1,4-diamine","4-<I>N</I>-(6-methoxyquinolin-8-yl)pentane-1,4-diamine","4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine","N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine",(4-amino-1-methyl-butyl)-(6-methoxy-8-quinolyl)amine,"InChI=1S/C15H21N3O/c1-11(5-3-7-16)18-14-10-13(19-2)9-12-6-4-8-17-15(12)14/h4,6,8-11,18H,3,5,7,16H2,1-2H3",INDBQLZJXZLFIT-UHFFFAOYSA-N,2.2,259.168462302,C15H21N3O,259.35,60.2,259.168462302,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc(NC(C)CCCN)c2ncccc2c1,,"11  13  8
12  14  8
13  15  8
13  16  8
14  15  8
16  17  8
17  18  8
4  11  8
4  18  8
5  8  3
9  11  8
9  12  8",
440790902,16132446,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00492,Pramlintide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00492,pramlintide,0.0,No match,vNo-DILI-Concern,2.0,16132446,1.0,9620.0,59.0,58.0,122.0,AAADcfB//gBgAAAAAAAAAAAAAAAAAWLFiwAwYMAAAAAAAAAB1AAAHgQQCAAADTzl3ga/lpfJkgSoAzV3dAACgC2xMqAJ2YG+eIiKfj7C2TOUcAAu9hPY2Cedy6COIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(2S)-N-[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-3-amino-1-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-3-amino-1-[[(1S)-3-amino-1-[[(1S)-2-[[2-[(2S)-2-[[(1S,2S)-1-[[(1S)-1-[(2S)-2-[(2S)-2-[[(1S,2R)-1-[[(1S)-3-amino-1-[[(1S)-1-[[2-[[(1S)-2-[[(1S)-3-amino-1-[[(1S,2R)-1-[[(1S)-2-amino-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-3-oxo-propyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]carbamoyl]-3-oxo-propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]-3-methyl-butyl]carbamoyl]-2-methyl-butyl]carbamoyl]pyrrolidin-1-yl]-2-oxo-ethyl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-3-oxo-propyl]carbamoyl]-3-oxo-propyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]carbamoyl]-3-methyl-butyl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-3-oxo-propyl]amino]-1-methyl-2-oxo-ethyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-guanidino-butyl]-2-[[(2S,3R)-2-[[(2S)-2-[[(2R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-4-amino-2-[[(2R)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-sulfanyl-propanoyl]amino]-4-oxo-butanoyl]amino]-3-hydroxy-butanoyl]amino]propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-sulfanyl-propanoyl]amino]propanoyl]amino]-3-hydroxy-butanoyl]amino]pentanediamide","(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[(2S)-2-[[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(2S)-2-[[[(2S,3R)-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-oxomethyl]-1-pyrrolidinyl]-oxomethyl]-1-pyrrolidinyl]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-oxomethyl]-1-pyrrolidinyl]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]-2-[[(2S,3R)-2-[[(2S)-2-[[(2R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-4-amino-2-[[(2R)-2-[[(2S)-2,6-diamino-1-oxohexyl]amino]-3-mercapto-1-oxopropyl]amino]-1,4-dioxobutyl]amino]-3-hydroxy-1-oxobutyl]amino]-1-oxopropyl]amino]-3-hydroxy-1-oxobutyl]amino]-3-mercapto-1-oxopropyl]amino]-1-oxopropyl]amino]-3-hydroxy-1-oxobutyl]amino]pentanediamide","(2<I>S</I>)-<I>N</I>-[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-4-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-4-amino-1-[[(2<I>S</I>)-4-amino-1-[[(2<I>S</I>)-1-[[2-[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>S</I>)-1-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>R</I>)-1-[[(2<I>S</I>)-4-amino-1-[[(2<I>S</I>)-1-[[2-[[(2<I>S</I>)-1-[[(2<I>S</I>)-4-amino-1-[[(2<I>S</I>,3<I>R</I>)-1-[[(2<I>S</I>)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]-2-[[(2<I>S</I>,3<I>R</I>)-2-[[(2<I>S</I>)-2-[[(2<I>R</I>)-2-[[(2<I>S</I>,3<I>R</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>R</I>)-2-[[(2<I>S</I>)-4-amino-2-[[(2<I>R</I>)-2-[[(2<I>S</I>)-2,6-diaminohexanoyl]amino]-3-sulfanylpropanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]-3-sulfanylpropanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]pentanediamide","(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[(2S)-2-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[(2S)-2-[[(2S,3R)-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]-2-[[(2S,3R)-2-[[(2S)-2-[[(2R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-4-amino-2-[[(2R)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-sulfanylpropanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]-3-sulfanylpropanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]pentanediamide","(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-azanyl-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-azanyl-1-[[(2S)-4-azanyl-1-[[(2S)-1-[[2-[(2S)-2-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[(2S)-2-[[(2S,3R)-1-[[(2S)-4-azanyl-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-4-azanyl-1-[[(2S,3R)-1-[[(2S)-1-azanyl-3-(4-hydroxyphenyl)-1-oxidanylidene-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-butan-2-yl]amino]-1,4-bis(oxidanylidene)butan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-2-oxidanylidene-ethyl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-1,4-bis(oxidanylidene)butan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-butan-2-yl]carbamoyl]pyrrolidin-1-yl]carbonylpyrrolidin-1-yl]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-methyl-1-oxidanylidene-pentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxidanylidene-ethyl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-1,4-bis(oxidanylidene)butan-2-yl]amino]-1,4-bis(oxidanylidene)butan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-1,4-bis(oxidanylidene)butan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]-2-[[(2S,3R)-2-[[(2S)-2-[[(2R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-4-azanyl-2-[[(2R)-2-[[(2S)-2,6-bis(azanyl)hexanoyl]amino]-3-sulfanyl-propanoyl]amino]-4-oxidanylidene-butanoyl]amino]-3-oxidanyl-butanoyl]amino]propanoyl]amino]-3-oxidanyl-butanoyl]amino]-3-sulfanyl-propanoyl]amino]propanoyl]amino]-3-oxidanyl-butanoyl]amino]pentanediamide","(2S)-N-[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-3-amino-1-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-3-amino-1-[[(1S)-3-amino-1-[[(1S)-2-[[2-[(2S)-2-[[(1S,2S)-1-[[(1S)-1-[(2S)-2-[(2S)-2-[[(1S,2R)-1-[[(1S)-3-amino-1-[[(1S)-1-[[2-[[(1S)-2-[[(1S)-3-amino-1-[[(1S,2R)-1-[[(1S)-2-amino-1-(4-hydroxybenzyl)-2-keto-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-3-keto-propyl]amino]-2-keto-1-methylol-ethyl]amino]-2-keto-ethyl]carbamoyl]-2-methyl-propyl]carbamoyl]-3-keto-propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]-3-methyl-butyl]carbamoyl]-2-methyl-butyl]carbamoyl]pyrrolidino]-2-keto-ethyl]amino]-1-benzyl-2-keto-ethyl]carbamoyl]-3-keto-propyl]carbamoyl]-3-keto-propyl]amino]-2-keto-1-methylol-ethyl]amino]-2-keto-1-methylol-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-keto-ethyl]carbamoyl]-2-methyl-propyl]carbamoyl]-3-methyl-butyl]amino]-1-benzyl-2-keto-ethyl]carbamoyl]-3-keto-propyl]amino]-2-keto-1-methyl-ethyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-guanidino-butyl]-2-[[(2S,3R)-2-[[(2S)-2-[[(2R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-4-amino-2-[[(2R)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-mercapto-propanoyl]amino]-4-keto-butanoyl]amino]-3-hydroxy-butanoyl]amino]propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-mercapto-propanoyl]amino]propanoyl]amino]-3-hydroxy-butanoyl]amino]glutaramide","InChI=1S/C171H269N51O53S2/c1-21-81(12)130(163(268)207-110(56-78(6)7)169(274)222-53-33-42-118(222)170(275)221-52-32-41-117(221)160(265)219-135(89(20)230)167(272)206-109(66-125(180)238)151(256)212-128(79(8)9)161(266)186-68-126(239)192-111(70-223)154(259)203-107(64-123(178)236)152(257)218-134(88(19)229)166(271)195-98(136(181)241)57-92-43-45-94(231)46-44-92)214-159(264)116-40-31-51-220(116)127(240)69-187-141(246)101(58-90-34-24-22-25-35-90)199-148(253)105(62-121(176)234)201-149(254)106(63-122(177)235)202-155(260)112(71-224)209-156(261)113(72-225)208-146(251)103(60-93-67-184-75-188-93)205-162(267)129(80(10)11)213-150(255)100(55-77(4)5)198-145(250)102(59-91-36-26-23-27-37-91)200-147(252)104(61-120(175)233)196-137(242)82(13)189-144(249)99(54-76(2)3)197-142(247)96(39-30-50-185-171(182)183)193-143(248)97(47-48-119(174)232)194-165(270)132(86(17)227)215-138(243)83(14)190-157(262)114(73-276)211-168(273)133(87(18)228)216-139(244)84(15)191-164(269)131(85(16)226)217-153(258)108(65-124(179)237)204-158(263)115(74-277)210-140(245)95(173)38-28-29-49-172/h22-27,34-37,43-46,67,75-89,95-118,128-135,223-231,276-277H,21,28-33,38-42,47-66,68-74,172-173H2,1-20H3,(H2,174,232)(H2,175,233)(H2,176,234)(H2,177,235)(H2,178,236)(H2,179,237)(H2,180,238)(H2,181,241)(H,184,188)(H,186,266)(H,187,246)(H,189,249)(H,190,262)(H,191,269)(H,192,239)(H,193,248)(H,194,270)(H,195,271)(H,196,242)(H,197,247)(H,198,250)(H,199,253)(H,200,252)(H,201,254)(H,202,260)(H,203,259)(H,204,263)(H,205,267)(H,206,272)(H,207,268)(H,208,251)(H,209,261)(H,210,245)(H,211,273)(H,212,256)(H,213,255)(H,214,264)(H,215,243)(H,216,244)(H,217,258)(H,218,257)(H,219,265)(H4,182,183,185)/t81-,82-,83-,84-,85+,86+,87+,88+,89+,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,128-,129-,130-,131-,132-,133-,134-,135-/m0/s1",NRKVKVQDUCJPIZ-MKAGXXMWSA-N,,3949.9396798,C171H269N51O53S2,3951.0,1690.0,3948.936325,0.0,277.0,41.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(\N)NCCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C,-16.7,"258  100  5
260  101  6
264  102  5
268  103  5
269  104  6
107  112  6
109  118  6
126  133  5
128  132  5
152  156  8
152  157  8
156  160  8
157  161  8
160  162  8
161  162  8
191  196  8
191  197  8
194  199  8
196  205  8
197  206  8
205  207  8
206  207  8
219  232  8
219  233  8
232  237  8
233  238  8
237  243  8
238  243  8
180  27  6
244  43  6
256  47  5
263  50  5
117  58  6
121  59  5
122  60  6
138  62  5
144  63  6
148  67  6
155  68  5
163  69  6
127  7  6
166  71  5
170  72  6
173  74  6
178  75  5
181  77  5
185  78  6
187  79  6
192  81  6
82  194  8
82  208  8
198  83  5
84  199  8
84  208  8
211  85  5
214  86  6
217  87  5
224  88  5
218  89  6
229  90  6
241  92  5
249  95  6
252  98  5
254  99  6",
440790901,3086257,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00972,Porfimer,20231222,20210312,Curation Efforts|Governmental Organizations,LT00972,porfimer,0.0,No match,vNo-DILI-Concern,2.0,3086257,1.0,982.0,7.0,5.0,8.0,AAADcfB/uCAAAAAAAAAAAAAAAAAAAWLFiwAAAAAAAAAAAAAB/gAAHgAQCAAADByhngIyyLLJkgCoAyTyTACCgCAhAiAAmSEwbJgINnLA0NGEdAhm0AHI2Ae42fOegAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"sodium;3-[18-(2-carboxyethyl)-8-ethyl-13-(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid","sodium;3-[18-(2-carboxyethyl)-8-ethyl-13-(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid","sodium;3-[18-(2-carboxyethyl)-8-ethyl-13-(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid","sodium;3-[18-(2-carboxyethyl)-8-ethyl-13-(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid","sodium;3-[8-ethyl-13-(1-hydroxyethyl)-18-(3-hydroxy-3-oxopropyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid","sodium;3-[18-(2-carboxyethyl)-8-ethyl-13-(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphin-2-yl]propionic acid","InChI=1S/C34H38N4O5.Na/c1-7-21-16(2)24-12-25-17(3)22(8-10-32(40)41)29(36-25)15-30-23(9-11-33(42)43)18(4)26(37-30)14-31-34(20(6)39)19(5)27(38-31)13-28(21)35-24;/h12-15,20,35,38-39H,7-11H2,1-6H3,(H,40,41)(H,42,43);/q;+1",GPVSXPYOJDJYKH-UHFFFAOYSA-N,,605.27398961,C34H38N4NaO5+,605.7,152.0,605.27398961,1.0,44.0,0.0,1.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CCc1c(C)c2cc3nc(cc4nc(cc5[nH]c(cc1[nH]2)c(C)c5C(C)O)C(C)=C4CCC(=O)O)C(CCC(=O)O)=C3C.[Na+],,"10  28  8
10  29  8
11  13  8
11  14  8
12  13  8
12  19  8
14  25  8
15  16  8
15  19  8
16  17  8
17  18  8
18  31  8
20  2  3
23  25  8
26  33  8
28  31  8
29  33  8
7  12  8
7  14  8
8  15  8
8  18  8
9  23  8
9  26  8",
440790900,5702105,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01291,Polymyxin B sulfate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01291,polymyxin b sulfate,0.0,No match,vNo-DILI-Concern,2.0,5702105,1.0,2240.0,22.0,20.0,29.0,AAADcfB//gBAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADTzhmAYyAILAAoCIAiFSEDACAAAgAAAIiIGIAIgKcDaA0TGUYAAitgCYiAcciMCOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide;sulfuric acid","N-[4-amino-1-[[1-[[4-amino-1-oxo-1-[[6,9,18-tris(2-aminoethyl)-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-15-(phenylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide;sulfuric acid","<I>N</I>-[4-amino-1-[[1-[[4-amino-1-oxo-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide;sulfuric acid","N-[4-amino-1-[[1-[[4-amino-1-oxo-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide;sulfuric acid","N-[4-azanyl-1-[[1-[[4-azanyl-1-oxidanylidene-1-[[6,9,18-tris(2-azanylethyl)-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptakis(oxidanylidene)-15-(phenylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-butan-2-yl]amino]-1-oxidanylidene-butan-2-yl]-6-methyl-octanamide;sulfuric acid","N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaketo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-caprylamide;sulfuric acid","InChI=1S/C56H98N16O13.H2O4S/c1-7-32(4)13-11-12-16-44(75)63-36(17-23-57)51(80)72-46(34(6)74)56(85)68-39(20-26-60)48(77)67-41-22-28-62-55(84)45(33(5)73)71-52(81)40(21-27-61)65-47(76)37(18-24-58)66-53(82)42(29-31(2)3)69-54(83)43(30-35-14-9-8-10-15-35)70-49(78)38(19-25-59)64-50(41)79;1-5(2,3)4/h8-10,14-15,31-34,36-43,45-46,73-74H,7,11-13,16-30,57-61H2,1-6H3,(H,62,84)(H,63,75)(H,64,79)(H,65,76)(H,66,82)(H,67,77)(H,68,85)(H,69,83)(H,70,78)(H,71,81)(H,72,80);(H2,1,2,3,4)",HFMDLUQUEXNBOP-UHFFFAOYSA-N,,1300.71730696,C56H100N16O17S,1301.6,574.0,1300.71730696,0.0,90.0,0.0,13.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)C(CCN)NC1=O)C(C)O.O=S(=O)(O)O,,"35  91  3
38  95  3
40  98  3
41  99  3
42  101  3
45  104  3
54  122  3
55  123  3
61  130  3
64  137  3
66  139  3
70  145  3
72  86  8
72  87  8
75  150  3
86  88  8
87  89  8
88  90  8
89  90  8",
440790899,174,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00995,Polyethylene glycol 3350,20231222,20210312,Curation Efforts|Governmental Organizations,LT00995,polyethylene glycol 3350,0.0,No match,vNo-DILI-Concern,2.0,174,1.0,6.0,2.0,2.0,1.0,AAADcYBAMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgAACAAAAACggAIAAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAABEAAAAAAAAAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,ethylene glycol,"ethane-1,2-diol","ethane-1,2-diol","ethane-1,2-diol","ethane-1,2-diol",ethylene glycol,"InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",LYCAIKOWRPUZTN-UHFFFAOYSA-N,-1.4,62.03677943,C2H6O2,62.07,40.5,62.03677943,0.0,4.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OCCO,,,
440790898,65015,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02340,Plerixafor,20231222,20210312,Curation Efforts|Governmental Organizations,LT02340,plerixafor,0.0,No match,vNo-DILI-Concern,2.0,65015,1.0,456.0,8.0,6.0,4.0,AAADcfB7wAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHAAQAAAADADBGAQwAIPAAACAAiBCAACCAAAgAAAIiIAIBIgIYCKA0RGUIAhgkACIiAcQgAAOQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,"1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane","1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane","1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane","1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane","1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane","1-[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)benzyl]-1,4,8,11-tetrazacyclotetradecane","InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2",YIQPUIGJQJDJOS-UHFFFAOYSA-N,,502.44714376,C28H54N8,502.8,78.7,502.44714376,0.0,36.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,0.0,"17  23  8
17  25  8
18  24  8
18  26  8
23  24  8
25  26  8",
440790897,4828,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01673,pindolol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01673,pindolol,0.0,No match,vNo-DILI-Concern,2.0,4828,1.0,248.0,3.0,3.0,6.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgB8AAAHgAQCAAADDzhngY+xvLJlgCgAzRnRACCiCAxIiAI2aA+bJgPNuLEsZuGOCjm0Bnb6Aew0KMOAAAAAgAKAAAAAAAEABQAAAAAAAAAAA==,1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol,1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-2-propanol,1-(1<I>H</I>-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol,1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol,1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol,1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol,"InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3",JZQKKSLKJUAGIC-UHFFFAOYSA-N,1.8,248.152477885,C14H20N2O2,248.32,57.3,248.152477885,0.0,18.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)NCC(O)COc1cccc2[nH]ccc12,,"10  15  8
13  16  8
14  17  8
15  18  8
16  18  8
5  2  3
4  13  8
4  17  8
9  10  8
9  13  8
9  14  8",
440790896,16362,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01672,pimozide,20250421,20210312,Curation Efforts|Governmental Organizations,LT01672,pimozide,0.0,No match,vNo-DILI-Concern,2.0,16362,1.0,632.0,4.0,1.0,7.0,AAADceB7IYAAAAAAAAAAAAAAAAAAAWAAAAA8YMEAAAAAAFgBUAAAHwAQAAAADSjBGAwxwIPAAACIAiRCUACCAAAhAgAIiAAIdIiIYCLA0ZGUIAholgLIyCcQgMAOgAAAAAAAACAAAAAAAAAAQAAAAAAAAA==,"3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-1H-benzimidazol-2-one","3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1H-benzimidazol-2-one","3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1<I>H</I>-benzimidazol-2-one","3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one","3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one","3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-1H-benzimidazol-2-one","InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)",YVUQSNJEYSNKRX-UHFFFAOYSA-N,6.3,461.22786888,C28H29F2N3O,461.5,35.6,461.22786888,0.0,34.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,,"14  18  8
14  19  8
18  22  8
19  23  8
20  25  8
20  27  8
21  26  8
21  28  8
22  24  8
23  24  8
25  29  8
26  30  8
27  31  8
28  32  8
29  33  8
30  34  8
31  33  8
32  34  8
5  14  8
5  16  8
6  16  8
6  18  8",
440790895,5284607,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00780,phytonadione,20231222,20210312,Curation Efforts|Governmental Organizations,LT00780,phytonadione,0.0,No match,vNo-DILI-Concern,2.0,5284607,1.0,696.0,2.0,0.0,14.0,AAADcfB4MAAAAAAAAAAAAAAAAAAAAAAAAAAwQAAAAAAAAACBAAAAGgAAAAAADQSAmAAyAIAAAACIAqBSAAACAAAkAAAIiAEAAMgIIDKAFRCAIQAggAAIiYcJiMCOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione","2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione","2-methyl-3-[(<I>E</I>,7<I>R</I>,11<I>R</I>)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione","2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione","2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione","2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]-1,4-naphthoquinone","InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+/t23-,24-/m1/s1",MBWXNTAXLNYFJB-NKFFZRIASA-N,,450.349780706,C31H46O2,450.7,34.1,450.349780706,0.0,33.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1=C(C/C=C(\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O,10.9,"26  27  8
26  30  8
27  31  8
3  12  6
30  32  8
31  33  8
32  33  8
5  14  6",
440790894,5983,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00133,physostigmine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00133,physostigmine,0.0,No match,vNo-DILI-Concern,2.0,5983,1.0,403.0,4.0,1.0,2.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAWLAAAAwAAAAAAAWAFgBAAAAHgAQAAAADgzBmAQzzoPABACIAiRCWACCCAAhIgAIiIAObImMJiLEsZuMMihswhPI6Cew0PIPgEABAAACAAAAgAIAAAQAAAAAAAAAAA==,"[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate","N-methylcarbamic acid [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] ester","[(3<I>a</I><I>R</I>,8<I>b</I><I>S</I>)-3,4,8<I>b</I>-trimethyl-2,3<I>a</I>-dihydro-1<I>H</I>-pyrrolo[2,3-b]indol-7-yl] <I>N</I>-methylcarbamate","[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate","[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate","N-methylcarbamic acid [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrol[2,3-b]indol-7-yl] ester","InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1",PIJVFDBKTWXHHD-HIFRSBDPSA-N,0.7,275.16337692,C15H21N3O2,275.35,44.8,275.16337692,0.0,20.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,,"11  16  8
14  17  8
16  18  8
17  18  8
6  12  6
7  21  6
9  11  8
9  14  8",
440790893,5775,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00433,phentolamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00433,phentolamine,0.0,No match,vNo-DILI-Concern,1.0,5775,1.0,363.0,3.0,2.0,4.0,AAADceB7IAAAAAAAAAAAAAAAAAAAAQAAAAAwYAAAAAAAAAABQAAAHgAQCAAADAzBmAQzxoPAAgCgAiZiZACCAAEhIgAJiIAebIgIZmLCmZOUcAhm0BnI2AeQ0AMOCAAAAgAAAAAQAAAEAAAAAAAAAAAAAA==,"3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methyl-anilino]phenol","3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol","3-[<I>N</I>-(4,5-dihydro-1<I>H</I>-imidazol-2-ylmethyl)-4-methylanilino]phenol","3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol","3-[4,5-dihydro-1H-imidazol-2-ylmethyl-(4-methylphenyl)amino]phenol",3-[N-(2-imidazolin-2-ylmethyl)-4-methyl-anilino]phenol,"InChI=1S/C17H19N3O/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15/h2-8,11,21H,9-10,12H2,1H3,(H,18,19)",MRBDMNSDAVCSSF-UHFFFAOYSA-N,,281.152812238,C17H19N3O,281.35,47.9,281.152812238,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,2.6,"10  13  8
10  14  8
11  16  8
12  17  8
13  18  8
14  19  8
15  16  8
15  17  8
18  20  8
19  20  8
9  11  8
9  12  8",
440790892,4768,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02082,phenoxybenzamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT02082,phenoxybenzamine,0.0,No match,vNo-DILI-Concern,1.0,4768,1.0,262.0,2.0,0.0,8.0,AAADceB6IAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgIAAAAADC/hmEYyBoMABACAAiBCAACCCAAgIAAIiAAODIgOJiKEsRvHOCjkwBGYqAeQwAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,N-benzyl-N-(2-chloroethyl)-1-phenoxy-propan-2-amine,N-(2-chloroethyl)-1-phenoxy-N-(phenylmethyl)-2-propanamine,<I>N</I>-benzyl-<I>N</I>-(2-chloroethyl)-1-phenoxypropan-2-amine,N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine,N-(2-chloroethyl)-1-phenoxy-N-(phenylmethyl)propan-2-amine,benzyl-(2-chloroethyl)-(1-methyl-2-phenoxy-ethyl)amine,"InChI=1S/C18H22ClNO/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17/h2-11,16H,12-15H2,1H3",QZVCTJOXCFMACW-UHFFFAOYSA-N,,303.138992,C18H22ClNO,303.8,12.5,303.138992,0.0,21.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(COc1ccccc1)N(CCCl)Cc1ccccc1,4.4,"11  14  8
12  15  8
13  17  8
13  18  8
14  16  8
15  16  8
17  19  8
18  20  8
19  21  8
20  21  8
4  8  3
9  11  8
9  12  8",
440790891,30487,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00826,phendimetrazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00826,phendimetrazine,0.0,No match,vNo-DILI-Concern,1.0,30487,1.0,177.0,2.0,0.0,1.0,AAADceByIAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHgAAAAAADDzhmAYyAIMABACAAiBCAAACAAAgAAAIiAAICIgKJiKAsRmHMAAkwAGYqAeQwKAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,3S)-3,4-dimethyl-2-phenyl-morpholine","(2S,3S)-3,4-dimethyl-2-phenylmorpholine","(2<I>S</I>,3<I>S</I>)-3,4-dimethyl-2-phenylmorpholine","(2S,3S)-3,4-dimethyl-2-phenylmorpholine","(2S,3S)-3,4-dimethyl-2-phenyl-morpholine","(2S,3S)-3,4-dimethyl-2-phenyl-morpholine","InChI=1S/C12H17NO/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3/t10-,12+/m0/s1",MFOCDFTXLCYLKU-CMPLNLGQSA-N,,191.131014166,C12H17NO,191.27,12.5,191.131014166,0.0,14.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H]1[C@H](c2ccccc2)OCCN1C,1.9,"10  12  8
11  13  8
12  14  8
13  14  8
3  7  5
4  8  6
8  10  8
8  11  8",
440790890,6432,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01065,Perflutren,20231222,20210312,Curation Efforts|Governmental Organizations,LT01065,perflutren,0.0,No match,vNo-DILI-Concern,2.0,6432,1.0,120.0,8.0,0.0,0.0,AAADcQBAAcAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACQAAAAAACAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1,1,1,2,2,3,3,3-octafluoropropane","1,1,1,2,2,3,3,3-octafluoropropane","1,1,1,2,2,3,3,3-octafluoropropane","1,1,1,2,2,3,3,3-octafluoropropane","1,1,1,2,2,3,3,3-octakis(fluoranyl)propane","1,1,1,2,2,3,3,3-octafluoropropane","InChI=1S/C3F8/c4-1(5,2(6,7)8)3(9,10)11",QYSGYZVSCZSLHT-UHFFFAOYSA-N,,187.9872253,C3F8,188.02,0.0,187.9872253,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",FC(F)(F)C(F)(F)C(F)(F)F,3.1,,
440790889,3053,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00879,Pentetic acid,20210804,20210312,Curation Efforts|Governmental Organizations,LT00879,pentetic acid,0.0,No match,vNo-DILI-Concern,2.0,3053,1.0,481.0,13.0,5.0,16.0,AAADceBzPAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAACAAAAADBgAQACAMAAgAIAACQCAAAAAAAAAAAAACIAAACQAAAACAQAAAAAACQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid,2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid,2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid,2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid,2-[bis[2-[bis(2-hydroxy-2-oxoethyl)amino]ethyl]amino]ethanoic acid,2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid,"InChI=1S/C14H23N3O10/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27)",QPCDCPDFJACHGM-UHFFFAOYSA-N,,393.13834394,C14H23N3O10,393.35,196.0,393.13834394,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,-8.5,,
440790888,441278,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01650,pentazocine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01650,pentazocine,0.0,No match,vNo-DILI-Concern,2.0,441278,1.0,414.0,2.0,1.0,2.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAWAADBAAAAHgAACAAADyzBmAQyBoMAAgCAAiBCAACCAAAgIAAIiAAOCIgIJiKCkROEcAAkwBGImAeQwPAPoAABAAAQAADQAAaAACQAAAAAAAAAAA==,"(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol","(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol","(1<I>R</I>,9<I>R</I>,13<I>R</I>)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.0<SUP>2,7</SUP>]trideca-2(7),3,5-trien-4-ol","(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol","(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol","(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol","InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3/t14-,18+,19+/m0/s1",VOKSWYLNZZRQPF-GDIGMMSISA-N,3.3,285.209264485,C19H27NO,285.4,23.5,285.209264485,0.0,21.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)=CCN1CC[C@@]2(C)c3cc(O)ccc3C[C@@H]1[C@@H]2C,,"10  15  8
14  16  8
15  17  8
16  17  8
3  11  5
4  12  6
5  23  6
8  10  8
8  14  8",
440790887,9853654,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00869,pentagastrin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00869,pentagastrin,0.0,No match,vNo-DILI-Concern,2.0,9853654,1.0,1310.0,10.0,8.0,22.0,AAADcfB/vABAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgB9AAAHgQQCAAADGzF3gS+yPLJlgioAzX3XACCgCAxAjAI2aG4ZJkIYPrg0bGcYAhmlgDIyAc/icCOgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,(3S)-4-[[(1S)-2-amino-1-benzyl-2-oxo-ethyl]amino]-3-[[(2S)-2-[[(2S)-2-[3-(tert-butoxycarbonylamino)propanoylamino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-4-oxo-butanoic acid,(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[[3-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-1-oxopropyl]amino]-1-oxopropyl]amino]-4-(methylthio)-1-oxobutyl]amino]-4-oxobutanoic acid,(3<I>S</I>)-4-[[(2<I>S</I>)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2<I>S</I>)-2-[[(2<I>S</I>)-3-(1<I>H</I>-indol-3-yl)-2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoylamino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-oxobutanoic acid,(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoylamino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-oxobutanoic acid,(3S)-4-[[(2S)-1-azanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoylamino]propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-4-oxidanylidene-butanoic acid,(3S)-4-[[(1S)-2-amino-1-benzyl-2-keto-ethyl]amino]-3-[[(2S)-2-[[(2S)-2-[3-(tert-butoxycarbonylamino)propanoylamino]-3-(1H-indol-3-yl)propanoyl]amino]-4-(methylthio)butanoyl]amino]-4-keto-butyric acid,"InChI=1S/C37H49N7O9S/c1-37(2,3)53-36(52)39-16-14-30(45)41-28(19-23-21-40-25-13-9-8-12-24(23)25)34(50)42-26(15-17-54-4)33(49)44-29(20-31(46)47)35(51)43-27(32(38)48)18-22-10-6-5-7-11-22/h5-13,21,26-29,40H,14-20H2,1-4H3,(H2,38,48)(H,39,52)(H,41,45)(H,42,50)(H,43,51)(H,44,49)(H,46,47)/t26-,27-,28-,29-/m0/s1",NEYNJQRKHLUJRU-DZUOILHNSA-N,1.5,767.33124734,C37H49N7O9S,767.9,276.0,767.33124734,0.0,54.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,,"20  11  6
18  12  5
26  13  5
14  27  8
14  28  8
34  15  5
21  24  8
21  28  8
24  27  8
24  31  8
27  35  8
31  38  8
35  39  8
38  39  8
41  45  8
41  46  8
45  52  8
46  53  8
52  54  8
53  54  8",
440790886,6869,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01648,penicillin v,20231222,20210312,Curation Efforts|Governmental Organizations,LT01648,penicillin v,0.0,No match,vNo-DILI-Concern,2.0,6869,1.0,547.0,6.0,2.0,5.0,AAADceB7OABAAAAAAAAAAAAAAABYAWAAAAAwAAAABYAAAAABAAAAHgQQCAAADCzl0AayDoPABgiIACHSGAICCABgIBAIiIHOCIgOZjqkMT6XeCCk1hG4qAeAQAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(1-oxo-2-phenoxyethyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2<I>S</I>,5<I>R</I>,6<I>R</I>)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-3,3-dimethyl-7-oxidanylidene-6-(2-phenoxyethanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-7-keto-3,3-dimethyl-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI=1S/C16H18N2O5S/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",BPLBGHOLXOTWMN-MBNYWOFBSA-N,2.1,350.09364285,C16H18N2O5S,350.4,121.0,350.09364285,0.0,24.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O,,"11  16  6
19  20  8
19  21  8
20  22  8
21  23  8
22  24  8
23  24  8
12  8  5
9  25  6",
440790885,37464,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01644,penbutolol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01644,penbutolol,0.0,No match,vNo-DILI-Concern,1.0,37464,1.0,294.0,3.0,2.0,7.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAYAAAAAwAAAAAAAAAAABAAAAHgAQCAAADZzhmAYyBoLABgCAAiBCAAACCAAgIAAIiIAOCIgPNiKEMRqGOCCm0BGbqAeAwOAOgAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol,(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)-2-propanol,(2<I>S</I>)-1-(<I>tert</I>-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol,(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol,(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol,(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol,"InChI=1S/C18H29NO2/c1-18(2,3)19-12-15(20)13-21-17-11-7-6-10-16(17)14-8-4-5-9-14/h6-7,10-11,14-15,19-20H,4-5,8-9,12-13H2,1-3H3/t15-/m0/s1",KQXKVJAGOJTNJS-HNNXBMFYSA-N,4.2,291.219829168,C18H29NO2,291.4,41.5,291.219829168,0.0,21.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1,,"10  16  8
11  17  8
16  21  8
17  21  8
13  2  6
9  10  8
9  11  8",
440790884,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01380,Pegfilgrastim,20210312,20210312,Curation Efforts|Governmental Organizations,LT01380,pegfilgrastim,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790883,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00941,Pegademase bovine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00941,pegademase bovine,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790882,165580,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02061,paromomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT02061,paromomycin,0.0,No match,vNo-DILI-Concern,1.0,165580,1.0,870.0,19.0,13.0,9.0,AAADcfB7vAAAAAAAAAAAAAAAAAAAASAAAAA0SIAAAAAAAAAAAAAAHgAQCAAACDzxgAcACABABgAAAAAAAAAAAAAAAAAAAIAAAAATEAIAwAAjQAAHEAAHAAHwcA0AAAAAAAAAAAAAgAAUCACgAAAAAAAAAA==,"(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-6-hydroxy-cyclohexoxy]-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl]oxy-tetrahydropyran-3,4-diol","(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]oxy]oxane-3,4-diol","(2<I>S</I>,3<I>S</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-5-amino-2-(aminomethyl)-6-[(2<I>R</I>,3<I>S</I>,4<I>R</I>,5<I>S</I>)-5-[(1<I>R</I>,2<I>R</I>,3<I>S</I>,5<I>R</I>,6<I>S</I>)-3,5-diamino-2-[(2<I>S</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>,6<I>R</I>)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol","(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol","(2S,3S,4R,5R,6R)-2-(aminomethyl)-5-azanyl-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-bis(azanyl)-2-[(2S,3R,4R,5S,6R)-3-azanyl-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-6-oxidanyl-cyclohexyl]oxy-2-(hydroxymethyl)-4-oxidanyl-oxolan-3-yl]oxy-oxane-3,4-diol","(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-6-hydroxy-cyclohexoxy]-4-hydroxy-2-methylol-tetrahydrofuran-3-yl]oxy-tetrahydropyran-3,4-diol","InChI=1S/C23H45N5O14/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22/h5-23,29-36H,1-4,24-28H2/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1",UOZODPSAJZTQNH-LSWIJEOBSA-N,,615.29630113,C23H45N5O14,615.6,347.0,615.29630113,0.0,42.0,19.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,-8.7,"20  1  5
26  1  6
35  10  6
37  11  6
39  13  5
22  15  5
24  16  5
31  17  6
34  18  5
21  2  6
30  2  6
29  38  6
36  41  5
27  4  5
32  4  5
40  42  5
23  5  6
28  8  5
33  9  5",
440790881,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01408,Panitumumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01408,panitumumab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790880,441289,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00867,pancuronium,20231222,20210312,Curation Efforts|Governmental Organizations,LT00867,pancuronium,0.0,No match,vNo-DILI-Concern,2.0,441289,1.0,1000.0,4.0,0.0,6.0,AAADcfB/OAAAAAAAAAAAAAAAAAAAAYAAAAA8eMECAAAAAGDAAAAAHgAAAAAADzzhgAYCCAMABAAIAACQCAAAAAAAAAAAAAAIAAACAAIAgAAHAAAEAACQAAGQ0PIPgAAAAAAAAADQAAaAACAgAKAADAgAAA==,"[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate","acetic acid [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methyl-1-piperidin-1-iumyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] ester","[(2<I>S</I>,3<I>S</I>,5<I>S</I>,8<I>R</I>,9<I>S</I>,10<I>S</I>,13<I>S</I>,14<I>S</I>,16<I>S</I>,17<I>R</I>)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1<I>H</I>-cyclopenta[a]phenanthren-3-yl] acetate","[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate","[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] ethanoate","acetic acid [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] ester","InChI=1S/C35H60N2O4/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36/h26-33H,7-23H2,1-6H3/q+2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-/m0/s1",GVEAYVLWDAFXET-XGHATYIMSA-N,,572.4553084,C35H60N2O4+2,572.9,52.6,572.4553084,2.0,41.0,10.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1,6.6,"14  1  5
10  23  5
11  25  5
12  45  6
13  46  6
24  2  6
21  60  6
7  42  6
8  43  5
9  44  6",
440790879,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00674,Pancrelipase,20210312,20210312,Curation Efforts|Governmental Organizations,LT00674,pancrelipase,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790878,11806,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02055,PAMABROM,20231222,20210312,Curation Efforts|Governmental Organizations,LT02055,pamabrom,0.0,No match,vNo-DILI-Concern,2.0,11806,1.0,340.0,5.0,3.0,1.0,AAADceBzsAAAEAAAAAAAAAAAAAAAAWAAAAAsAAAAAAAAAFgBgAAAHgBQCAAAHIihlgYDsBfJkgCoAQdwdACAgC2HEKABEQGoVECCWAhASCAUQIgIFyJAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-amino-2-methyl-propan-1-ol;8-bromo-1,3-dimethyl-7H-purine-2,6-dione","2-amino-2-methyl-1-propanol;8-bromo-1,3-dimethyl-7H-purine-2,6-dione","2-amino-2-methylpropan-1-ol;8-bromo-1,3-dimethyl-7<I>H</I>-purine-2,6-dione","2-amino-2-methylpropan-1-ol;8-bromo-1,3-dimethyl-7H-purine-2,6-dione","2-azanyl-2-methyl-propan-1-ol;8-bromanyl-1,3-dimethyl-7H-purine-2,6-dione","2-amino-2-methyl-propan-1-ol;8-bromo-1,3-dimethyl-7H-purine-2,6-quinone","InChI=1S/C7H7BrN4O2.C4H11NO/c1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14;1-4(2,5)3-6/h1-2H3,(H,9,10);6H,3,5H2,1-2H3",ATOTUUBRFJHZQG-UHFFFAOYSA-N,,347.0593,C11H18BrN5O3,348.2,116.0,347.0593,0.0,20.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CC(C)(N)CO.Cn1c(=O)c2[nH]c(Br)nc2n(C)c1=O,,"14  15  8
15  16  8
5  14  8
5  17  8
6  16  8
6  17  8
8  15  8
8  20  8
9  14  8
9  20  8",
440790877,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01349,Palivizumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01349,palivizumab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790876,115237,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01252,Paliperidone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01252,paliperidone,0.0,No match,vNo-DILI-Concern,2.0,115237,1.0,764.0,7.0,1.0,4.0,AAADceB7sQAAAAAAAAAAAAAAAAAAAWAAAAA8WIEAAAAAAFiB8AAAHwAECAAADRzhng4zhtMQAgCpA6dydgSCAAEkIAApmCE+TNoKNrqAnZOEcYBmxhmYyce8yOCOAAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,"3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-9-oxidanyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","3-[2-[4-(6-fluoroindoxazen-3-yl)piperidino]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3",PMXMIIMHBWHSKN-UHFFFAOYSA-N,,426.2067189,C23H27FN4O3,426.5,82.2,426.2067189,0.0,31.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,2.2,"15  23  8
17  24  8
17  25  8
19  47  3
2  26  8
2  7  8
23  26  8
23  27  8
26  29  8
27  30  8
29  31  8
30  31  8
6  22  8
6  24  8
7  15  8
8  22  8
8  25  8",
440790875,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01392,Palifermin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01392,palifermin,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790874,439302,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00827,OXYTOCIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00827,oxytocin,0.0,No match,vNo-DILI-Concern,2.0,439302,1.0,1870.0,15.0,12.0,17.0,AAADcfB//ABgAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHgQQCAAADSzF2ASyBoPAAgCIAiFSEAACAAAgIAAIiIGOCIgIZjqC0TOUcAAk1hGImAedy6COIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide","(2S)-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]-2-pyrrolidinecarboxamide","(2<I>S</I>)-1-[(4<I>R</I>,7<I>S</I>,10<I>S</I>,13<I>S</I>,16<I>S</I>,19<I>R</I>)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2<I>S</I>)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-<I>N</I>-[(2<I>S</I>)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide","(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide","(2S)-1-[[(4R,7S,10S,13S,16S,19R)-19-azanyl-7-(2-azanyl-2-oxidanylidene-ethyl)-10-(3-azanyl-3-oxidanylidene-propyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentakis(oxidanylidene)-1,2-dithia-5,8,11,14,17-pentazacycloicos-4-yl]carbonyl]-N-[(2S)-1-[(2-azanyl-2-oxidanylidene-ethyl)amino]-4-methyl-1-oxidanylidene-pentan-2-yl]pyrrolidine-2-carboxamide","(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-keto-ethyl)-10-(3-amino-3-keto-propyl)-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaketo-13-[(1S)-1-methylpropyl]-1,2-dithia-5,8,11,14,17-pentazacycloeicosane-4-carbonyl]-N-[(1S)-1-[(2-amino-2-keto-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide","InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1",XNOPRXBHLZRZKH-DSZYJQQASA-N,,1006.43645793,C43H66N12O12S2,1007.2,450.0,1006.43645793,0.0,69.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,-2.6,"34  16  6
59  23  5
27  31  6
33  32  6
40  47  5
41  50  6
42  88  5
45  51  5
52  57  5
62  65  8
62  66  8
65  67  8
66  68  8
67  69  8
68  69  8",
440790873,5284604,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00808,oxymorphone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00808,oxymorphone,0.0,No match,vNo-DILI-Concern,2.0,5284604,1.0,539.0,5.0,2.0,0.0,AAADceB6OAAAAAAAAAAAAAAAAAAAASAAAAA8YMEAAAAWAEjxAAAAHgAACAAADnzhmAYyBoMABgCIAqBSAAICCAAgIAAIiAFOiIgPJjKGsR+GeCOlwBGbuAf6/f/foAABAAAYQADQAAaQADSgAAAAAAAAAA==,"(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4<I>R</I>,4<I>a</I><I>S</I>,7<I>a</I><I>R</I>,12<I>b</I><I>S</I>)-4<I>a</I>,9-dihydroxy-3-methyl-2,4,5,6,7<I>a</I>,13-hexahydro-1<I>H</I>-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-3-methyl-4a,9-bis(oxidanyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1",UQCNKQCJZOAFTQ-ISWURRPUSA-N,0.8,301.13140809,C17H19NO4,301.34,70.0,301.13140809,0.0,22.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,,"11  15  8
11  18  8
15  20  8
18  21  8
7  2  5
20  22  8
21  22  8
6  10  5
8  23  6
9  24  5",
440790872,5284603,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00979,oxycodone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00979,oxycodone,0.0,No match,vNo-DILI-Concern,2.0,5284603,1.0,553.0,5.0,1.0,1.0,AAADceB6OAAAAAAAAAAAAAAAAAAAASAAAAA8YMEAAAAWAEjxAAAAHgAACAAADnzhmAYyBoMABgCIAqBSAAICCAAgIAAIiAFOiIgPJjKEsR+GeCKlwBGaqAf6/f/foAABAAAYQADQAAaQADSgAAAAAAAAAA==,"(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4<I>R</I>,4<I>a</I><I>S</I>,7<I>a</I><I>R</I>,12<I>b</I><I>S</I>)-4<I>a</I>-hydroxy-9-methoxy-3-methyl-2,4,5,6,7<I>a</I>,13-hexahydro-1<I>H</I>-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-9-methoxy-3-methyl-4a-oxidanyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1",BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.2,315.14705815,C18H21NO4,315.4,59.0,315.14705815,0.0,23.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,,"11  15  8
11  18  8
15  20  8
18  21  8
7  2  5
20  22  8
21  22  8
6  10  5
8  24  6
9  25  5",
440790871,4634,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02084,oxybutynin,20250421,20210312,Curation Efforts|Governmental Organizations,LT02084,oxybutynin,0.0,No match,vNo-DILI-Concern,1.0,4634,1.0,490.0,4.0,1.0,8.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABAAAAHgAACAAADUThmAYyCIMABgDIEiDSCAICAAAgAAAIiAFICIgJJjKAFRCCcAAkwAGLmAeIyOCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate,2-cyclohexyl-2-hydroxy-2-phenylacetic acid 4-(diethylamino)but-2-ynyl ester,4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate,4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate,4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-oxidanyl-2-phenyl-ethanoate,2-cyclohexyl-2-hydroxy-2-phenyl-acetic acid 4-(diethylamino)but-2-ynyl ester,"InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3",XIQVNETUBQGFHX-UHFFFAOYSA-N,,357.23039385,C22H31NO3,357.5,49.8,357.23039385,0.0,26.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,4.2,"8  1  3
12  14  8
12  15  8
14  16  8
15  17  8
16  18  8
17  18  8",
440790870,4601,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02085,orphenadrine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02085,orphenadrine,0.0,No match,vNo-DILI-Concern,2.0,4601,1.0,260.0,2.0,0.0,6.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAAAAAADBThmAYyAIMABACAAiBCAAACAAAgAAAIiAAICIgKJiKAMRiDMAAkwAEYqAeAwOAOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"N,N-dimethyl-2-[o-tolyl(phenyl)methoxy]ethanamine","N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine","<I>N</I>,<I>N</I>-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine","N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine","N,N-dimethyl-2-[(2-methylphenyl)-phenyl-methoxy]ethanamine",dimethyl-[2-[o-tolyl(phenyl)methoxy]ethyl]amine,"InChI=1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3",QVYRGXJJSLMXQH-UHFFFAOYSA-N,3.8,269.177964357,C18H23NO,269.4,12.5,269.177964357,0.0,20.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccccc1C(OCCN(C)C)c1ccccc1,,"3  1  3
10  16  8
11  17  8
12  15  8
14  15  8
16  20  8
17  20  8
4  7  8
4  9  8
5  10  8
5  11  8
7  12  8
9  14  8",
440790869,4086,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02086,ORCIPRENALINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT02086,orciprenaline,0.0,No match,vNo-DILI-Concern,1.0,4086,1.0,177.0,4.0,4.0,4.0,AAADceByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADDzhmAYyBoLAAgCAAiBCAAACAAAgIAAAiIAOCIgKNyKCkROEcAAl0BWYmAfQ8LYOAAABCAAAAAAAAAIQAAAAAAAAAAAAAA==,"5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol","5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol","5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol","5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol","5-[1-oxidanyl-2-(propan-2-ylamino)ethyl]benzene-1,3-diol",5-[1-hydroxy-2-(isopropylamino)ethyl]resorcinol,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3",LMOINURANNBYCM-UHFFFAOYSA-N,0.7,211.1208434,C11H17NO3,211.26,72.7,211.1208434,0.0,15.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)NCC(O)c1cc(O)cc(O)c1,,"11  14  8
12  13  8
13  15  8
14  15  8
5  16  3
8  11  8
8  12  8",
440790868,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01339,Oprelvekin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01339,oprelvekin,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790867,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01377,Omalizumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01377,omalizumab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790866,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01421,Ofatumumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01421,ofatumumab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790865,11286230,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00602,nystatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00602,nystatin,0.0,No match,vNo-DILI-Concern,1.0,11286230,1.0,1620.0,18.0,12.0,3.0,AAADcfB+PgAAAAAAAAAAAAAAAAAAAAAAAAAkSAAAAAAAAAAAAAAAHgAQCAAADTzxgAcCCABABgCIACDSCAAAAAAgAAAICIEAAAgbFBYAoQAiUAAH8AAPoAPI7OzOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid","(1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-2-oxanyl]oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid","(1<I>S</I>,3<I>R</I>,4<I>R</I>,7<I>R</I>,9<I>R</I>,11<I>R</I>,15<I>S</I>,16<I>R</I>,17<I>R</I>,18<I>S</I>,19<I>E</I>,21<I>E</I>,25<I>E</I>,27<I>E</I>,29<I>E</I>,31<I>E</I>,33<I>R</I>,35<I>S</I>,36<I>R</I>,37<I>S</I>)-33-[(2<I>R</I>,3<I>S</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid","(1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid","(1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-azanyl-6-methyl-3,5-bis(oxidanyl)oxan-2-yl]oxy-15,16,18-trimethyl-1,3,4,7,9,11,17,37-octakis(oxidanyl)-13-oxidanylidene-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid","(1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-13-keto-15,16,18-trimethyl-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid","InChI=1S/C47H75NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(H,59,60)/b6-5+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33+,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1",VQOXZBDYSJBXMA-NQTDYLQESA-N,,925.50349992,C47H75NO17,926.1,320.0,925.50349992,0.0,65.0,19.0,0.0,6.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,-0.2,"31  10  6
34  11  5
38  12  5
42  13  5
44  14  5
48  16  5
33  18  6
19  2  5
20  66  5
21  28  5
22  3  6
35  39  6
27  4  5
30  4  6
47  53  6
49  54  6
50  55  6
26  6  5
29  8  5",
440790864,5832,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02269,Norethindrone acetate,20210312,20210312,Curation Efforts|Governmental Organizations,LT02269,norethindrone acetate,0.0,No match,vNo-DILI-Concern,2.0,5832,1.0,695.0,3.0,0.0,3.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAAAAAAD0SAgAACCAAABADIGqDSCAgAAAAgAAAACAEAAEgAABIAAQACAAAEgAAIAQOIyPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate","acetic acid [(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] ester","[(8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate","[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate","[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxidanylidene-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] ethanoate","acetic acid [(8R,9S,10R,13S,14S,17R)-17-ethynyl-3-keto-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] ester","InChI=1S/C22H28O3/c1-4-22(25-14(2)23)12-10-20-19-7-5-15-13-16(24)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20H,5-12H2,2-3H3/t17-,18+,19+,20-,21-,22-/m0/s1",IMONTRJLAWHYGT-ZCPXKWAGSA-N,3.5,340.20384475,C22H28O3,340.5,43.4,340.20384475,0.0,25.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,,"8  1  5
12  35  5
4  15  5
5  26  6
6  27  5
7  28  6",
440790863,439260,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00738,norepinephrine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00738,norepinephrine,0.0,No match,vNo-DILI-Concern,1.0,439260,1.0,142.0,4.0,4.0,2.0,AAADccByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADBThmAYwBoBAAgCAAiBCAAACAAAgIAAIiIAGiIgLNiKCkROAcAEk0BEJmAfQ8LQOIAABAAAAQABAAAIAAACAAAAAAAAAAA==,"4-[(1R)-2-amino-1-hydroxy-ethyl]benzene-1,2-diol","4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol","4-[(1<I>R</I>)-2-amino-1-hydroxyethyl]benzene-1,2-diol","4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol","4-[(1R)-2-azanyl-1-oxidanyl-ethyl]benzene-1,2-diol",4-[(1R)-2-amino-1-hydroxy-ethyl]pyrocatechol,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1",SFLSHLFXELFNJZ-QMMMGPOBSA-N,-1.2,169.07389321,C8H11NO3,169.18,86.7,169.07389321,0.0,12.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC[C@H](O)c1ccc(O)c(O)c1,,"5  1  5
10  12  8
11  12  8
6  8  8
6  9  8
8  10  8
9  11  8",
440790862,11953895,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00880,Nitroprusside,20231222,20210312,Curation Efforts|Governmental Organizations,LT00880,nitroprusside,0.0,No match,vNo-DILI-Concern,2.0,11953895,1.0,119.0,14.0,2.0,0.0,AAADcYBjsDAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABAAECAAAAAAAAAAAAAAAAAARAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,disodium;iron(4+);nitroxyl anion;pentacyanide;dihydrate,disodium;iron(4+);nitroxyl anion;pentacyanide;dihydrate,disodium;iron(4+);nitroxyl anion;pentacyanide;dihydrate,disodium;iron(4+);nitroxyl anion;pentacyanide;dihydrate,disodium;iron(4+);oxoazanide;pentacyanide;dihydrate,disodium;iron(4+);nitroxyl anion;pentacyanide;dihydrate,InChI=1S/5CN.Fe.NO.2Na.2H2O/c5*1-2;;1-2;;;;/h;;;;;;;;;2*1H2/q5*-1;+4;-1;2*+1;;,XRKMNJXYOFSTBE-UHFFFAOYSA-N,,297.948962,C5H4FeN6Na2O3,297.95,139.0,297.948962,0.0,17.0,0.0,0.0,0.0,0.0,0.0,11.0,-1.0,"1
5
255",O.O.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+4].[N-]=O.[Na+].[Na+],,,"1  13  6
1  14  6
1  15  6
1  16  6
1  17  6
1  7  6"
440790861,4510,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01608,nitroglycerin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01608,nitroglycerin,0.0,No match,vNo-DILI-Concern,2.0,4510,1.0,218.0,9.0,0.0,5.0,AAADcYBDPAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgAEAAAACBSggAIAAAAAQAABAAAAAQAAAAAAAAAAAAAAAAABAAAAAAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2,3-dinitrooxypropyl nitrate","nitric acid 1,3-dinitrooxypropan-2-yl ester","1,3-dinitrooxypropan-2-yl nitrate","1,3-dinitrooxypropan-2-yl nitrate","1,3-dinitrooxypropan-2-yl nitrate","nitric acid 2,3-dinitrooxypropyl ester","InChI=1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2",SNIOPGDIGTZGOP-UHFFFAOYSA-N,1.6,227.00257875,C3H5N3O9,227.09,165.0,227.00257875,0.0,15.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],,,
440790860,41684,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01184,NITAZOXANIDE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01184,nitazoxanide,0.0,No match,vNo-DILI-Concern,2.0,41684,1.0,428.0,7.0,1.0,4.0,AAADccBzOABAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHgQUAAAADATB2gQ/n5LYVAitAjH3fwCC+Kl1OjlpyA0OPMqMZjaEvRuWO2ju4ZMIqaeYyCCOAAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,[2-[(5-nitrothiazol-2-yl)carbamoyl]phenyl] acetate,acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester,"[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate","[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate","[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] ethanoate",acetic acid [2-[(5-nitrothiazol-2-yl)carbamoyl]phenyl] ester,"InChI=1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)",YQNQNVDNTFHQSW-UHFFFAOYSA-N,,307.02629157,C12H9N3O5S,307.28,142.0,307.02629157,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,2.0,"1  16  8
1  18  8
10  11  8
10  13  8
11  14  8
13  15  8
14  17  8
15  17  8
18  19  8
8  16  8
8  19  8",
440790859,25081014,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00465,Nesiritide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00465,nesiritide,0.0,No match,vNo-DILI-Concern,2.0,25081014,1.0,7860.0,55.0,55.0,91.0,AAADcfB//gBwAAAAAAAAAAAAAAAAAWIAAAAwAAAAAAAAAAABAAAAHgQQCAAADSjl2AazCIPAAgioAjHzPAACAAGgABAJiIG4AIiKcD6g2TGUYAAmtgKYiAe/i4COAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(4R,10S,16S,19S,22S,25S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-3-hydroxy-propanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-3-methyl-butanoyl]amino]-5-oxo-pentanoyl]amino]acetyl]amino]-3-hydroxy-propanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-34-(carboxymethyl)-31,43-bis(3-guanidinopropyl)-16,19,22,25-tetrakis(hydroxymethyl)-10-isobutyl-28-[(1S)-1-methylpropyl]-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]hexanoyl]amino]-3-methyl-butanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-3-(4H-imidazol-4-yl)propanoic acid","(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[[(4R,10S,16S,19S,22S,25S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[[(2S)-1-[(2S)-2-amino-3-hydroxy-1-oxopropyl]-2-pyrrolidinyl]-oxomethyl]amino]-1-oxohexyl]amino]-4-(methylthio)-1-oxobutyl]amino]-3-methyl-1-oxobutyl]amino]-1,5-dioxopentyl]amino]-1-oxoethyl]amino]-3-hydroxy-1-oxopropyl]amino]-1-oxoethyl]amino]-40-(4-aminobutyl)-28-[(2S)-butan-2-yl]-31,43-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,19,22,25-tetrakis(hydroxymethyl)-10-(2-methylpropyl)-37-[2-(methylthio)ethyl]-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-49-(phenylmethyl)-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacont-4-yl]-oxomethyl]amino]-1-oxohexyl]amino]-3-methyl-1-oxobutyl]amino]-4-methyl-1-oxopentyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-3-(4H-imidazol-4-yl)propanoic acid","(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-6-amino-2-[[(4<I>R</I>,10<I>S</I>,16<I>S</I>,19<I>S</I>,22<I>S</I>,25<I>S</I>,28<I>S</I>,31<I>S</I>,34<I>S</I>,37<I>S</I>,40<I>S</I>,43<I>S</I>,49<I>S</I>,52<I>R</I>)-52-[[2-[[(2<I>S</I>)-2-[[2-[[(2<I>S</I>)-5-amino-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-6-amino-2-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-amino-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-[(2<I>S</I>)-butan-2-yl]-31,43-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,19,22,25-tetrakis(hydroxymethyl)-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(4<I>H</I>-imidazol-4-yl)propanoic acid","(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(4R,10S,16S,19S,22S,25S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-[(2S)-butan-2-yl]-31,43-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,19,22,25-tetrakis(hydroxymethyl)-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(4H-imidazol-4-yl)propanoic acid","(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-azanyl-2-[[(4R,10S,16S,19S,22S,25S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[2-[[(2S)-2-[2-[[(2S)-5-azanyl-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-azanyl-2-[[(2S)-1-[(2S)-2-azanyl-3-oxidanyl-propanoyl]pyrrolidin-2-yl]carbonylamino]hexanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-3-methyl-butanoyl]amino]-5-oxidanylidene-pentanoyl]amino]ethanoylamino]-3-oxidanyl-propanoyl]amino]ethanoylamino]-40-(4-azanylbutyl)-28-[(2S)-butan-2-yl]-31,43-bis(3-carbamimidamidopropyl)-16,19,22,25-tetrakis(hydroxymethyl)-34-(2-hydroxy-2-oxoethyl)-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecakis(oxidanylidene)-49-(phenylmethyl)-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacont-4-yl]carbonylamino]hexanoyl]amino]-3-methyl-butanoyl]amino]-4-methyl-pentanoyl]amino]-5-carbamimidamido-pentanoyl]amino]-5-carbamimidamido-pentanoyl]amino]-3-(4H-imidazol-4-yl)propanoic acid","(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(4R,10S,16S,19S,22S,25S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-3-hydroxy-propanoyl]prolyl]amino]hexanoyl]amino]-4-(methylthio)butanoyl]amino]-3-methyl-butanoyl]amino]-5-keto-pentanoyl]amino]acetyl]amino]-3-hydroxy-propanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-34-(carboxymethyl)-31,43-bis(3-guanidinopropyl)-10-isobutyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaketo-16,19,22,25-tetramethylol-28-[(1S)-1-methylpropyl]-37-[2-(methylthio)ethyl]-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]hexanoyl]amino]-3-methyl-butanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-3-(4H-imidazol-4-yl)propionic acid","InChI=1S/C143H244N50O42S4/c1-13-76(10)112-137(232)189-99(68-199)131(226)188-98(67-198)130(225)187-97(66-197)129(224)186-96(65-196)117(212)166-59-105(202)169-90(52-72(2)3)114(209)163-61-107(204)171-100(132(227)177-83(32-19-22-44-146)124(219)190-111(75(8)9)136(231)184-91(53-73(4)5)127(222)175-84(34-24-46-159-141(151)152)121(216)174-85(35-25-47-160-142(153)154)122(217)185-94(139(234)235)55-78-57-157-71-167-78)69-238-239-70-101(172-108(205)62-165-116(211)95(64-195)170-106(203)60-162-113(208)87(38-39-103(148)200)181-135(230)110(74(6)7)191-126(221)89(41-51-237-12)179-120(215)82(31-18-21-43-145)180-134(229)102-37-27-49-193(102)138(233)79(147)63-194)133(228)182-92(54-77-28-15-14-16-29-77)115(210)164-58-104(201)168-80(33-23-45-158-140(149)150)118(213)173-81(30-17-20-42-144)119(214)178-88(40-50-236-11)123(218)183-93(56-109(206)207)128(223)176-86(125(220)192-112)36-26-48-161-143(155)156/h14-16,28-29,57,71-76,78-102,110-112,194-199H,13,17-27,30-56,58-70,144-147H2,1-12H3,(H2,148,200)(H,162,208)(H,163,209)(H,164,210)(H,165,211)(H,166,212)(H,168,201)(H,169,202)(H,170,203)(H,171,204)(H,172,205)(H,173,213)(H,174,216)(H,175,222)(H,176,223)(H,177,227)(H,178,214)(H,179,215)(H,180,229)(H,181,230)(H,182,228)(H,183,218)(H,184,231)(H,185,217)(H,186,224)(H,187,225)(H,188,226)(H,189,232)(H,190,219)(H,191,221)(H,192,220)(H,206,207)(H,234,235)(H4,149,150,158)(H4,151,152,159)(H4,153,154,160)(H4,155,156,161)/t76-,78?,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,110-,111-,112-/m0/s1",KSFAMFKTRGJQKV-UDZSTSFQSA-N,,3462.7410615,C143H244N50O42S4,3464.0,1610.0,3461.7377067,0.0,239.0,28.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(\N)NCCC[C@@H]1NC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CO)C(C)C)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN/C(N)=N/[H])C(=O)N[C@@H](CCCN/C(N)=N/[H])C(=O)N[C@@H](CC2C=NC=N2)C(=O)O)C(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC1=O,-17.2,"144  156  6
145  323  6
153  158  5
167  163  6
171  180  5
172  181  5
177  173  3
178  186  5
179  182  5
191  197  5
195  210  5
207  208  5
217  223  5
219  225  5
229  235  8
229  236  8
230  234  5
235  237  8
236  238  8
237  239  8
238  239  8
104  48  6
103  49  5
110  50  5
115  51  6
120  53  5
127  56  5
129  57  6
133  58  6
150  59  5
148  60  5
136  61  5
169  65  6
202  77  6
97  101  5",
440790858,8378,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00595,neomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00595,neomycin,0.0,No match,vNo-DILI-Concern,1.0,8378,1.0,872.0,19.0,13.0,9.0,AAADcfB7vAAAAAAAAAAAAAAAAAAAASAAAAA0SIAAAAAAAAAAAAAAHgAQCAAACDzxgAcACABABgAAAAAAAAAAAAAAAAAAAIAAAAATEAIAwAAjQAAHEAAHAAHwcA0AAAAAAAAAAAAAgAAUCACgAAAAAAAAAA==,"(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol","(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[[(2S,3R,4S,5R)-4-[[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-2-oxanyl]oxy]-3-hydroxy-5-(hydroxymethyl)-2-oxolanyl]oxy]-3-hydroxycyclohexyl]oxyoxane-3,4-diol","(2<I>R</I>,3<I>S</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-5-amino-2-(aminomethyl)-6-[(1<I>R</I>,2<I>R</I>,3<I>S</I>,4<I>R</I>,6<I>S</I>)-4,6-diamino-2-[(2<I>S</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>)-4-[(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>,6<I>S</I>)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol","(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol","(2R,3S,4R,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-6-(aminomethyl)-3-azanyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-5-(hydroxymethyl)-3-oxidanyl-oxolan-2-yl]oxy-4,6-bis(azanyl)-3-oxidanyl-cyclohexyl]oxy-5-azanyl-oxane-3,4-diol","(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol","InChI=1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1",PGBHMTALBVVCIT-VCIWKGPPSA-N,,614.31228554,C23H46N6O13,614.6,353.0,614.31228554,0.0,42.0,19.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,-9.0,"20  1  6
26  1  5
34  10  5
37  11  5
39  13  6
22  14  6
24  15  6
31  16  5
36  17  6
21  2  5
30  2  5
29  38  5
35  41  6
27  4  6
33  4  6
40  42  6
23  5  5
28  8  6
32  9  6",
440790857,5284596,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00592,naloxone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00592,naloxone,0.0,No match,vNo-DILI-Concern,2.0,5284596,1.0,594.0,5.0,2.0,2.0,AAADceB6OAAAAAAAAAAAAAAAAAAAASAAAAA8YMEAAAAWAEjxAAAAHgAACAAADnzhmAYwBoMABgCIAqBSAAKCCAAgIAAIiAFOiIgPJjKGsR+GeCOlwBGbuAf6/f/foAABAAAYQADQAAaQADSgAAAAAAAAAA==,"(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4<I>R</I>,4<I>a</I><I>S</I>,7<I>a</I><I>R</I>,12<I>b</I><I>S</I>)-4<I>a</I>,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7<I>a</I>,13-hexahydro-1<I>H</I>-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-4a,9-bis(oxidanyl)-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1",UZHSEJADLWPNLE-GRGSLBFTSA-N,2.1,327.14705815,C19H21NO4,327.4,70.0,327.14705815,0.0,24.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,,"11  15  8
11  18  8
15  20  8
18  21  8
7  2  5
20  22  8
21  22  8
6  10  5
8  25  6
9  26  5",
440790856,5311304,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01586,nalbuphine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01586,nalbuphine,0.0,No match,vNo-DILI-Concern,2.0,5311304,1.0,597.0,5.0,3.0,2.0,AAADceB6OAAAAAAAAAAAAAAAAABgASAAAAA8YMEAAAAWAEjxAAAAHgAACAAAD3zhmAYwBoMABgCAAiBCAAACCAAgIAAIiAAOiIgPNiKGsRuGeCOlwBGbuAfw8P8PoAABAAAYQADSAAaQADSgAAAAAAAAAA==,"(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol","(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol","(4<I>R</I>,4<I>a</I><I>S</I>,7<I>S</I>,7<I>a</I><I>R</I>,12<I>b</I><I>S</I>)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7<I>a</I>,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4<I>a</I>,7,9-triol","(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol","(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol","(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol","InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1",NETZHAKZCGBWSS-CEDHKZHLSA-N,0.2,357.19400834,C21H27NO4,357.4,73.2,357.19400834,0.0,26.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,,"11  17  8
11  18  8
17  21  8
18  24  8
7  2  5
21  26  8
24  26  8
13  3  6
6  10  5
8  27  6
9  28  5",
440790855,5284592,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00910,Nabilone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00910,nabilone,0.0,No match,vNo-DILI-Concern,2.0,5284592,1.0,524.0,3.0,1.0,6.0,AAADcfB4MAAAAAAAAAAAAAAAAAAAAAAAAAA0YIAAAAAAAACRAAAAGgAACAAAD0SAmAAyBoAABgCIAqBSAAACCAAgIAAAiAEGCIgMJzKGMRqCeCClwBUIuAeI7PzPwAABCAAIAACAAAIQADAAAAAAAAAAAA==,"(6aR,10aR)-3-(1,1-dimethylheptyl)-1-hydroxy-6,6-dimethyl-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one","(6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c][1]benzopyran-9-one","(6<I>a</I><I>R</I>,10<I>a</I><I>R</I>)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-7,8,10,10<I>a</I>-tetrahydro-6<I>a</I><I>H</I>-benzo[c]chromen-9-one","(6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one","(6aR,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-1-oxidanyl-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one","(6aR,10aR)-3-(1,1-dimethylheptyl)-1-hydroxy-6,6-dimethyl-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one","InChI=1S/C24H36O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h13-14,18-19,26H,6-12,15H2,1-5H3/t18-,19-/m1/s1",GECBBEABIDMGGL-RTBURBONSA-N,,372.26644501,C24H36O3,372.5,46.5,372.26644501,0.0,27.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(=O)C[C@@H]21,6.4,"11  18  8
15  19  8
17  18  8
17  19  8
4  28  6
5  29  5
9  11  8
9  15  8",
440790854,5288826,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00905,morphine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00905,morphine,0.0,No match,vNo-DILI-Concern,2.0,5288826,1.0,494.0,4.0,2.0,0.0,AAADceB6MAAAAAAAAAAAAAAAAAAAASAAAAA8YIEAAAAWAEjBAAAAHgAACAAADzzhmAYyBoMABgCAAiBCAAACCAAgIAAIiAAOiIgNNiKGsRuGeCOkwBGLuAew8PcPoAABAAAYQADQAAaAADSAAAAAAAAAAA==,"(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol","(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol","(4<I>R</I>,4<I>a</I><I>R</I>,7<I>S</I>,7<I>a</I><I>R</I>,12<I>b</I><I>S</I>)-3-methyl-2,4,4<I>a</I>,7,7<I>a</I>,13-hexahydro-1<I>H</I>-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol","(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol","(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol","(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol","InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",BQJCRHHNABKAKU-KBQPJGBKSA-N,0.8,285.13649347,C17H19NO3,285.34,52.9,285.13649347,0.0,21.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,,"10  13  8
10  16  8
13  19  8
16  20  8
19  21  8
14  2  6
20  21  8
5  9  5
6  22  5
7  23  6
8  24  5",
440790853,5281042,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00950,Mivacurium,20250421,20210312,Curation Efforts|Governmental Organizations,LT00950,mivacurium,0.0,No match,vNo-DILI-Concern,2.0,5281042,1.0,1550.0,14.0,0.0,30.0,AAADcfB/PAAAAAAAAAAAAAAAAAAAAAAAAAA8eMGCAAAAAACxVAAAHgAAAAAADCzhmAYyDoMABACIAiDSCACCCAAgIAAIiAEOjIgNJzKEsRuGMCpnwBWKqAew8P8OoAABCAAQQABAAAIQACCAAAAAAAAAAA==,"bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate","(E)-4-octenedioic acid bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] ester","bis[3-[(1<I>R</I>)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1<I>H</I>-isoquinolin-2-ium-2-yl]propyl] (<I>E</I>)-oct-4-enedioate","bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate","bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate","(E)-oct-4-enedioic acid bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] ester","InChI=1S/C58H80N2O14/c1-59(25-21-41-35-47(63-3)49(65-5)37-43(41)45(59)29-39-31-51(67-7)57(71-11)52(32-39)68-8)23-17-27-73-55(61)19-15-13-14-16-20-56(62)74-28-18-24-60(2)26-22-42-36-48(64-4)50(66-6)38-44(42)46(60)30-40-33-53(69-9)58(72-12)54(34-40)70-10/h13-14,31-38,45-46H,15-30H2,1-12H3/q+2/b14-13+/t45-,46-,59?,60?/m1/s1",ILVYCEVXHALBSC-OTBYEXOQSA-N,,1028.56095523,C58H80N2O14+2,1029.3,145.0,1028.56095523,2.0,74.0,2.0,2.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc2c(cc1OC)[C@@H](Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2,8.7,"15  27  3
16  28  3
17  29  6
18  30  6
23  31  8
23  35  8
24  32  8
24  36  8
31  39  8
32  40  8
35  43  8
36  44  8
37  47  8
37  49  8
38  48  8
38  50  8
39  45  8
40  46  8
43  45  8
44  46  8
47  53  8
48  54  8
49  51  8
50  52  8
51  55  8
52  56  8
53  55  8
54  56  8",
440790852,4211,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01564,mitotane,20231222,20210312,Curation Efforts|Governmental Organizations,LT01564,mitotane,0.0,No match,vNo-DILI-Concern,2.0,4211,1.0,248.0,0.0,0.0,3.0,AAADccBwAAAHAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAGAIAAAAADQOAGOAwAIAAAACAAiBCAAACAAAgBQAIiAAAAogIICKBExCAIAAggAAIiAcAgMAOhAAAAAABAAAIAAAAAAIAAAAAAAAAAA==,"1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene","1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene","1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene","1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene","1-[2,2-bis(chloranyl)-1-(2-chlorophenyl)ethyl]-4-chloranyl-benzene","1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene","InChI=1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H",JWBOIMRXGHLCPP-UHFFFAOYSA-N,,319.950711,C14H10Cl4,320.0,0.0,317.953661,0.0,18.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,6.2,"10  14  8
11  15  8
12  16  8
13  17  8
14  17  8
15  18  8
16  18  8
5  8  3
6  10  8
6  9  8
7  11  8
7  12  8
9  13  8",
440790851,4201,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00587,minoxidil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00587,minoxidil,0.0,No match,vNo-DILI-Concern,1.0,4201,1.0,329.0,3.0,3.0,1.0,AAADccBzoAAAAAAAAAAAAAAAAAAAAAAAAAAsQAAAAAAAAAAAAAAAHAAUCAAACADBAAQBAANQAACgACJiZACAAAGAAgABAAAYABCAAAIAiAAEAAAAAACAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine,3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine,3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine,3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine,2-azanylidene-3-oxidanyl-6-piperidin-1-yl-pyrimidin-4-amine,(3-hydroxy-2-imino-6-piperidino-pyrimidin-4-yl)amine,"InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6,11,15H,1-5,10H2",ZIMGGGWCDYVHOY-UHFFFAOYSA-N,1.2,209.12766012,C9H15N5O,209.25,88.9,209.12766012,0.0,15.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=c1\nc(N2CCCCC2)cc(N)n1O,,"12  13  8
13  14  8
3  12  8
3  15  8
4  14  8
4  15  8",
440790850,51634,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01126,Miglustat,20231222,20210312,Curation Efforts|Governmental Organizations,LT01126,miglustat,0.0,No match,vNo-DILI-Concern,2.0,51634,1.0,190.0,5.0,4.0,4.0,AAADceByOAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAAAAAAAHgAACAAACDzhgAYCAAMAAgAAAAAAAAAAAAAAAAAAAAAIAAADEAIAgAAEQAAHAACRAAHwYAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol","(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol","(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol","(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol","(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol","(2R,3R,4R,5S)-1-butyl-2-methylol-piperidine-3,4,5-triol","InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1",UQRORFVVSGFNRO-UTINFBMNSA-N,,219.14705815,C10H21NO4,219.28,84.2,219.14705815,0.0,15.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,-0.6,"7  1  6
8  2  5
9  3  6
6  12  5",
440790849,441314,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00992,MIGLITOL,20210312,20210312,Curation Efforts|Governmental Organizations,LT00992,miglitol,0.0,No match,vNo-DILI-Concern,2.0,441314,1.0,179.0,6.0,5.0,3.0,AAADceByOAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAAAAAAAHgAACAAACDzhgAYAAAMAAgAAAAAAAAAAAAAAAAAAAAAIAAADEAIAgAAEQAAHAACRAAHwYAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol","(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol","(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol","(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol","(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol","(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-methylol-piperidine-3,4,5-triol","InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1",IBAQFPQHRJAVAV-ULAWRXDQSA-N,,207.11067264,C8H17NO5,207.22,104.0,207.11067264,0.0,14.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,-2.6,"8  1  6
9  2  5
10  3  6
7  12  5",
440790848,55245,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00184,mifepristone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00184,mifepristone,0.0,No match,vNo-DILI-Concern,2.0,55245,1.0,921.0,3.0,1.0,3.0,AAADcfB6MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIEAAAAAAGCBAAAAHgAACAAAD0yBmAQywIMAAgDIEqRSQAiCAAAhAgAIiAEIZMgIIDLAkZGEYAhkgABIyQeYyPCPiAAAAAAAAACQAAQAACAAAYAADAAAAA==,"(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8<I>S</I>,11<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-13-methyl-17-oxidanyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1",VKHAHZOOUSRJNA-GCNJZUOMSA-N,,429.266779359,C29H35NO2,429.6,40.5,429.266779359,0.0,32.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,3.8,"7  1  5
11  17  5
17  23  8
17  24  8
23  27  8
24  28  8
27  29  8
28  29  8
4  14  5
5  33  6
6  34  5",
440790847,4195,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01558,midodrine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01558,midodrine,0.0,No match,vNo-DILI-Concern,2.0,4195,1.0,262.0,5.0,3.0,6.0,AAADceBzOAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADBThmAYyBoLABgCIAiFSEAACCAAgIAAIiICOCIgOdyKEsRuUcCAl1hGYuAfw0LIOAQABAAAIAAACAAIAABAAAAAAAAAAAA==,"2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]acetamide","2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide","2-amino-<I>N</I>-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide","2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide","2-azanyl-N-[2-(2,5-dimethoxyphenyl)-2-oxidanyl-ethyl]ethanamide","2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]acetamide","InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)",PTKSEFOSCHHMPD-UHFFFAOYSA-N,,254.12665706,C12H18N2O4,254.28,93.8,254.12665706,0.0,18.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc(OC)c(C(O)CNC(=O)CN)c1,-0.6,"10  13  8
11  12  8
12  14  8
13  14  8
7  19  3
8  10  8
8  11  8",
440790846,4192,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01557,midazolam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01557,midazolam,0.0,No match,vNo-DILI-Concern,2.0,4192,1.0,471.0,3.0,0.0,1.0,AAADccB7AQAEAAAAAAAAAAAAAAAAAWAAAAAwYAAABAAAAACB0AAAHQIAAAAADArBHyw/0JcMEACgAzZnZACCgC0xF6AJ2AA4dpiIaOLB25GUIAhogALIyCcQgMAOAABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine","8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine","8-chloro-6-(2-fluorophenyl)-1-methyl-4<I>H</I>-imidazo[1,5-a][1,4]benzodiazepine","8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine","8-chloranyl-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine","8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine","InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3",DDLIGBOFAVUZHB-UHFFFAOYSA-N,2.5,325.0782033,C18H13ClFN3,325.8,30.2,325.0782033,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,,"13  17  8
14  18  8
15  19  8
15  20  8
17  18  8
19  21  8
20  22  8
21  23  8
22  23  8
3  11  8
3  7  8
5  11  8
5  12  8
6  13  8
6  8  8
7  12  8
8  14  8",
440790845,441350,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00895,METYROSINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00895,metyrosine,0.0,No match,vNo-DILI-Concern,1.0,441350,1.0,211.0,4.0,3.0,3.0,AAADccByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADIyBmAAyDoBAAgCIAiDSCAACAAAgIAAIiAGGCIgKJjKCkROAcAAk0BEImAeYyOCOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,(2S)-2-amino-3-(4-hydroxyphenyl)-2-methyl-propanoic acid,(2S)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid,(2<I>S</I>)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid,(2S)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid,(2S)-2-azanyl-3-(4-hydroxyphenyl)-2-methyl-propanoic acid,(2S)-2-amino-3-(4-hydroxyphenyl)-2-methyl-propionic acid,"InChI=1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)/t10-/m0/s1",NHTGHBARYWONDQ-JTQLQIEISA-N,,195.08954328,C10H13NO3,195.21,83.6,195.08954328,0.0,14.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@](N)(Cc1ccc(O)cc1)C(=O)O,-1.6,"10  12  8
11  13  8
12  14  8
13  14  8
5  4  5
7  10  8
7  11  8",
440790844,4174,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00838,metyrapone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00838,metyrapone,0.0,No match,vNo-DILI-Concern,1.0,4174,1.0,275.0,3.0,0.0,3.0,AAADccBzIAAAAAAAAAAAAAAAAAAAAAAAAAAsWAAAAAAAAAAB4AAAHgAAAAAADgTBmgQ+gJIIEACoArB3RACCgCA1AiAI2CE4ZNgIIPrAlZGEIYhggADIycccicAPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-methyl-1,2-bis(3-pyridyl)propan-1-one","2-methyl-1,2-bis(3-pyridinyl)-1-propanone","2-methyl-1,2-dipyridin-3-ylpropan-1-one","2-methyl-1,2-dipyridin-3-ylpropan-1-one","2-methyl-1,2-dipyridin-3-yl-propan-1-one","2-methyl-1,2-bis(3-pyridyl)propan-1-one","InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3",FJLBFSROUSIWMA-UHFFFAOYSA-N,,226.110613074,C14H14N2O,226.27,42.9,226.110613074,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C(=O)c1cccnc1)c1cccnc1,2.0,"10  12  8
12  15  8
13  16  8
16  17  8
2  11  8
2  15  8
3  14  8
3  17  8
5  10  8
5  11  8
9  13  8
9  14  8",
440790843,9681,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02072,methysergide,20210312,20210312,Curation Efforts|Governmental Organizations,LT02072,methysergide,0.0,No match,vNo-DILI-Concern,1.0,9681,1.0,578.0,3.0,2.0,4.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAWAAAAAwYIAAAAAAAFjB8AAAHgAQCAAADSjhngY+wPPMEgCoAzV3VACCgCAxAiAI2KE4ZJgKMOrA0ZGEYAhklgDYyAcQgMAOgAAAQAASAAAQAASAACQAAAAAAAAAAA==,"(6aR,9R)-N-[(1S)-1-(hydroxymethyl)propyl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide","(6<I>a</I><I>R</I>,9<I>R</I>)-<I>N</I>-[(2<I>S</I>)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6<I>a</I>,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-4,7-dimethyl-N-[(2S)-1-oxidanylbutan-2-yl]-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-4,7-dimethyl-N-[(1S)-1-methylolpropyl]-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide","InChI=1S/C21H27N3O2/c1-4-15(12-25)22-21(26)14-8-17-16-6-5-7-18-20(16)13(10-23(18)2)9-19(17)24(3)11-14/h5-8,10,14-15,19,25H,4,9,11-12H2,1-3H3,(H,22,26)/t14-,15+,19-/m1/s1",KPJZHOPZRAFDTN-ZRGWGRIASA-N,2.3,353.21032711,C21H27N3O2,353.5,57.5,353.21032711,0.0,26.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1,,"11  13  8
11  16  8
12  13  8
12  19  8
13  15  8
15  20  8
19  21  8
20  21  8
4  15  8
4  16  8
22  5  5
6  27  5
9  18  5",
440790842,23724781,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01547,Methylscopolamine bromide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01547,methylscopolamine bromide,0.0,No match,vNo-DILI-Concern,2.0,23724781,1.0,454.0,5.0,1.0,5.0,AAADceB6OAAAEAAAAAAAAAAAEgAAAWAAAAA8WIAABgAAAAABAAAAHgAACAAADTzhmAYyCIMABgCIAiDSCAACAAAgAAAIiAEIAIgKMDaAlRCHYAAn4AGYiAfY6OyOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(1S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenyl-propanoate;bromide","(2S)-3-hydroxy-2-phenylpropanoic acid [(1S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] ester;bromide","[(1<I>S</I>,5<I>S</I>)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0<SUP>2,4</SUP>]nonan-7-yl] (2<I>S</I>)-3-hydroxy-2-phenylpropanoate;bromide","[(1S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;bromide","[(1S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-oxidanyl-2-phenyl-propanoate;bromide","(2S)-3-hydroxy-2-phenyl-propionic acid [(1S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] ester;bromide","InChI=1S/C18H24NO4.BrH/c1-19(2)14-8-12(9-15(19)17-16(14)23-17)22-18(21)13(10-20)11-6-4-3-5-7-11;/h3-7,12-17,20H,8-10H2,1-2H3;1H/q+1;/p-1/t12?,13-,14+,15+,16?,17?;/m1./s1",CXYRUNPLKGGUJF-JIRGPDKYSA-M,,397.08887,C18H24BrNO4,398.3,59.1,397.08887,0.0,24.0,3.0,2.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",C[N+]1(C)[C@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@H]1C1OC12.[Br-],,"17  18  6
19  20  8
19  21  8
10  2  3
9  2  3
20  22  8
21  23  8
22  24  8
23  24  8
7  25  6
8  26  6",
440790841,5361917,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00570,Methylnaltrexone bromide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00570,methylnaltrexone bromide,0.0,No match,vNo-DILI-Concern,2.0,5361917,1.0,664.0,5.0,2.0,2.0,AAADceB6OAAAEAAAAAAAAAAAGAAAASAAAAA8YMEAAAAWAEjxAAAAHgAACAAAD3zhmAYyBoMABgCIAqBSAAICCAAgIAAIiAFOiIgPJjKGsR+GeCOlwBGbuAf6/f/foAABAAAYQADQAAaQADSgAAAAAAAAAA==,"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one;bromide","(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one;bromide","(4<I>R</I>,4<I>a</I><I>S</I>,7<I>a</I><I>R</I>,12<I>b</I><I>S</I>)-3-(cyclopropylmethyl)-4<I>a</I>,9-dihydroxy-3-methyl-2,4,5,6,7<I>a</I>,13-hexahydro-1<I>H</I>-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one;bromide","(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one;bromide","(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-3-methyl-4a,9-bis(oxidanyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one;bromide","(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one;bromide","InChI=1S/C21H25NO4.BrH/c1-22(11-12-2-3-12)9-8-20-17-13-4-5-14(23)18(17)26-19(20)15(24)6-7-21(20,25)16(22)10-13;/h4-5,12,16,19,25H,2-3,6-11H2,1H3;1H/t16-,19+,20+,21-,22?;/m1./s1",IFGIYSGOEZJNBE-KNLJMPJLSA-N,,435.10452,C21H26BrNO4,436.3,66.8,435.10452,0.0,27.0,4.0,1.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.[Br-],,"12  33  5
13  18  8
13  22  8
18  25  8
8  2  5
22  26  8
25  27  8
26  27  8
6  19  3
7  10  5
9  28  6",
440790840,8226,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02074,methylergonovine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02074,methylergonovine,0.0,No match,vNo-DILI-Concern,2.0,8226,1.0,549.0,3.0,3.0,4.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAWAAAAAwYIAAAAAAAFjB8AAAHgAQCAAADSjhngY+wPPJkgCoAzV3VACCgCAxAiAI2aE4ZJgKMOrA0ZGEYAhklgDYyAcQgMAOgAAAQAASAAAQAASAACQAAAAAAAAAAA==,"(6aR,9R)-N-[(1S)-1-(hydroxymethyl)propyl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6<I>a</I><I>R</I>,9<I>R</I>)-<I>N</I>-[(2<I>S</I>)-1-hydroxybutan-2-yl]-7-methyl-6,6<I>a</I>,8,9-tetrahydro-4<I>H</I>-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-7-methyl-N-[(2S)-1-oxidanylbutan-2-yl]-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-7-methyl-N-[(1S)-1-methylolpropyl]-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","InChI=1S/C20H25N3O2/c1-3-14(11-24)22-20(25)13-7-16-15-5-4-6-17-19(15)12(9-21-17)8-18(16)23(2)10-13/h4-7,9,13-14,18,21,24H,3,8,10-11H2,1-2H3,(H,22,25)/t13-,14+,18-/m1/s1",UNBRKDKAWYKMIV-QWQRMKEZSA-N,2.3,339.19467705,C20H25N3O2,339.4,68.4,339.19467705,0.0,25.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,,"11  13  8
11  18  8
12  13  8
12  19  8
13  15  8
15  20  8
19  21  8
20  21  8
4  15  8
4  18  8
22  5  5
6  26  5
9  17  5",
440790839,6476,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00787,METHSUXIMIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00787,methsuximide,0.0,No match,vNo-DILI-Concern,2.0,6476,1.0,294.0,2.0,0.0,1.0,AAADccByMAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHgAAAAAADgCBmAQyAIMAAACIAiFSEAACAAAgAAAIiAEIAIgIIDKAlRGEIAAghiCIiAcdiMCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1,3-dimethyl-3-phenyl-pyrrolidine-2,5-dione","1,3-dimethyl-3-phenylpyrrolidine-2,5-dione","1,3-dimethyl-3-phenylpyrrolidine-2,5-dione","1,3-dimethyl-3-phenylpyrrolidine-2,5-dione","1,3-dimethyl-3-phenyl-pyrrolidine-2,5-dione","1,3-dimethyl-3-phenyl-pyrrolidine-2,5-quinone","InChI=1S/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-10(14)13(2)11(12)15/h3-7H,8H2,1-2H3",AJXPJJZHWIXJCJ-UHFFFAOYSA-N,,203.094628657,C12H13NO2,203.24,37.4,203.094628657,0.0,15.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C(=O)CC(C)(c2ccccc2)C1=O,1.2,"10  13  8
11  14  8
13  15  8
14  15  8
4  8  3
7  10  8
7  11  8",
440790838,10836,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00716,METHAMPHETAMINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00716,methamphetamine,0.0,No match,vNo-DILI-Concern,2.0,10836,1.0,95.0,1.0,1.0,3.0,AAADccByAAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHAAQAAAADCjBGAQyAILAAACAAiBCAAACAAAgAAAIiIAIAIgIICKAkRGEIAAgkAAIiAcQgIAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-N-methyl-1-phenyl-propan-2-amine,(2S)-N-methyl-1-phenyl-2-propanamine,(2<I>S</I>)-<I>N</I>-methyl-1-phenylpropan-2-amine,(2S)-N-methyl-1-phenylpropan-2-amine,(2S)-N-methyl-1-phenyl-propan-2-amine,methyl-[(1S)-1-methyl-2-phenyl-ethyl]amine,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1",MYWUZJCMWCOHBA-VIFPVBQESA-N,2.1,149.120449483,C10H15N,149.23,12.0,149.120449483,0.0,11.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN[C@@H](C)Cc1ccccc1,,"2  1  5
10  11  8
4  6  8
4  7  8
6  9  8
7  10  8
9  11  8",
440790837,4064,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01521,meprobamate,20210312,20210312,Curation Efforts|Governmental Organizations,LT01521,meprobamate,0.0,No match,vNo-DILI-Concern,2.0,4064,1.0,212.0,4.0,2.0,8.0,AAADceBzOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQAAAADgCggAICCABABAAIAAAAGAAAAAAAAAAAAAAAAAEAAAIAAAAIAAAFAAAAAACAAAANAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,[2-(carbamoyloxymethyl)-2-methyl-pentyl] carbamate,carbamic acid [2-(carbamoyloxymethyl)-2-methylpentyl] ester,[2-(carbamoyloxymethyl)-2-methylpentyl] carbamate,[2-(carbamoyloxymethyl)-2-methylpentyl] carbamate,[2-(aminocarbonyloxymethyl)-2-methyl-pentyl] carbamate,carbamic acid [2-(carbamoyloxymethyl)-2-methyl-pentyl] ester,"InChI=1S/C9H18N2O4/c1-3-4-9(2,5-14-7(10)12)6-15-8(11)13/h3-6H2,1-2H3,(H2,10,12)(H2,11,13)",NPPQSCRMBWNHMW-UHFFFAOYSA-N,0.7,218.12665706,C9H18N2O4,218.25,105.0,218.12665706,0.0,15.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCC(C)(COC(N)=O)COC(N)=O,,,
440790836,4062,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00822,mepivacaine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00822,mepivacaine,0.0,No match,vNo-DILI-Concern,2.0,4062,1.0,282.0,2.0,1.0,2.0,AAADceBzIAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHgAQAAAADCjBmAQywIPAAACIAiVSUACCAAAhAAAIiAGIRIgIYDLAkbGUIAhglADIyAcYiEAOAAACAAACAAAAAAQAAAQAAAAAAAAAAA==,"N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide","N-(2,6-dimethylphenyl)-1-methyl-2-piperidinecarboxamide","<I>N</I>-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide","N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide","N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide","N-(2,6-dimethylphenyl)-1-methyl-pipecolinamide","InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)",INWLQCZOYSRPNW-UHFFFAOYSA-N,1.9,246.17321333,C15H22N2O,246.35,32.3,246.17321333,0.0,18.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cccc(C)c1NC(=O)C1CCCCN1C,,"11  12  8
11  13  8
12  14  8
13  15  8
14  18  8
15  18  8
4  19  3",
440790835,4058,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00713,meperidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00713,meperidine,0.0,No match,vNo-DILI-Concern,2.0,4058,1.0,276.0,3.0,0.0,4.0,AAADceByMAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHgAAAAAADgDhmAYyCIMABACIAiDSCAACAAAgAAAIiAEIAIgIIDKAlRCGIAAkwAGIiAe8yOCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,ethyl 1-methyl-4-phenyl-piperidine-4-carboxylate,1-methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester,ethyl 1-methyl-4-phenylpiperidine-4-carboxylate,ethyl 1-methyl-4-phenylpiperidine-4-carboxylate,ethyl 1-methyl-4-phenyl-piperidine-4-carboxylate,1-methyl-4-phenyl-isonipecotic acid ethyl ester,"InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3",XADCESSVHJOZHK-UHFFFAOYSA-N,2.5,247.157228913,C15H21NO2,247.33,29.5,247.157228913,0.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)C1(c2ccccc2)CCN(C)CC1,,"12  14  8
13  15  8
14  16  8
15  16  8
9  12  8
9  13  8",
440790834,4057,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00790,mepenzolate,20210312,20210312,Curation Efforts|Governmental Organizations,LT00790,mepenzolate,0.0,No match,vNo-DILI-Concern,2.0,4057,1.0,432.0,3.0,1.0,5.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABQAAAHgAACAAADFThmAYyCIMABgCIAiDSCAICAAAgAAAIiAFICIgLJjKAlRCHcAAkwAGbmAe4yOCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate","2-hydroxy-2,2-diphenylacetic acid (1,1-dimethyl-3-piperidin-1-iumyl) ester","(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate","(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate","(1,1-dimethylpiperidin-1-ium-3-yl) 2-oxidanyl-2,2-diphenyl-ethanoate","2-hydroxy-2,2-diphenyl-acetic acid (1,1-dimethylpiperidin-1-ium-3-yl) ester","InChI=1S/C21H26NO3/c1-22(2)15-9-14-19(16-22)25-20(23)21(24,17-10-5-3-6-11-17)18-12-7-4-8-13-18/h3-8,10-13,19,24H,9,14-16H2,1-2H3/q+1",GKNPSSNBBWDAGH-UHFFFAOYSA-N,,340.19126869,C21H26NO3+,340.4,46.5,340.19126869,1.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1,3.2,"14  16  8
14  18  8
15  17  8
15  19  8
16  20  8
17  21  8
18  22  8
19  23  8
20  24  8
21  25  8
22  24  8
23  25  8
7  30  3",
440790833,4034,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00792,meclizine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00792,meclizine,0.0,No match,vNo-DILI-Concern,1.0,4034,1.0,447.0,2.0,0.0,5.0,AAADceB7AAAEAAAAAAAAAAAAAAAAAAAAAAA8YMEAAAAAAAABUAAAHAIAAAAADCrBGCQyAIMAAACAAiBCAACCAAAgBQAIiAAIBogIYCKBkxGUIAhggACIiAcQgMAOBAACAAAAAAAIAAQAAAAAAAAAAAAAAA==,1-[(4-chlorophenyl)-phenyl-methyl]-4-(m-tolylmethyl)piperazine,1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine,1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine,1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine,1-[(4-chlorophenyl)-phenyl-methyl]-4-[(3-methylphenyl)methyl]piperazine,1-[(4-chlorophenyl)-phenyl-methyl]-4-(3-methylbenzyl)piperazine,"InChI=1S/C25H27ClN2/c1-20-6-5-7-21(18-20)19-27-14-16-28(17-15-27)25(22-8-3-2-4-9-22)23-10-12-24(26)13-11-23/h2-13,18,25H,14-17,19H2,1H3",OCJYIGYOJCODJL-UHFFFAOYSA-N,,390.1862766,C25H27ClN2,390.9,6.5,390.1862766,0.0,28.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,5.8,"10  13  8
10  14  8
11  15  8
11  16  8
12  17  8
12  18  8
13  19  8
14  20  8
15  21  8
16  22  8
17  23  8
18  26  8
19  24  8
20  24  8
21  25  8
22  25  8
23  27  8
26  27  8
8  37  3",
440790832,4032,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00781,mecamylamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00781,mecamylamine,0.0,No match,vNo-DILI-Concern,2.0,4032,1.0,197.0,1.0,1.0,1.0,AAADceByAAAAAAAAAAAAAAAAAAAAAYMAAAAwAAAAAAAAAAAAAAAAHAAQAAAAD4iBAAQCAALAAAAAAAAAAAAAAAAAAAAAAIAIAAAAAAIAgAAEAAAAEAAAAAEQgMAPgAAAAAAAAAAAAASAACQAASAACQAAAA==,"N,2,3,3-tetramethylnorbornan-2-amine","N,2,3,3-tetramethyl-2-bicyclo[2.2.1]heptanamine","<I>N</I>,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine","N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine","N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine","methyl-(2,3,3-trimethylnorbornan-2-yl)amine","InChI=1S/C11H21N/c1-10(2)8-5-6-9(7-8)11(10,3)12-4/h8-9,12H,5-7H2,1-4H3",IMYZQPCYWPFTAG-UHFFFAOYSA-N,,167.167399674,C11H21N,167.29,12.0,167.167399674,0.0,12.0,0.0,3.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNC1(C)C2CCC(C2)C1(C)C,2.6,"3  11  3
4  13  3
5  14  3",
440790831,6251,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00024,mannitol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00024,mannitol,0.0,No match,vNo-DILI-Concern,1.0,6251,1.0,105.0,6.0,6.0,5.0,AAADccBgOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgAACAAACBSggAIAAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAABEAIAAAAAQAAFAAABAAHAYAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol","(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol","(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>R</I>)-hexane-1,2,3,4,5,6-hexol","(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol","(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol","(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol","InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1",FBPFZTCFMRRESA-KVTDHHQDSA-N,-3.1,182.07903816,C6H14O6,182.17,121.0,182.07903816,0.0,12.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,,"7  1  6
8  2  6
9  3  5
10  4  5",
440790830,157920,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01240,Lubiprostone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01240,lubiprostone,0.0,No match,vNo-DILI-Concern,2.0,157920,1.0,525.0,7.0,2.0,11.0,AAADcfB4OYAAAAAAAAAAAAAAAAAAAYAAAAAkAAAAAAAAAEgAAAAAGwAACAAADRSggBICCAAABgAIAICQCAAAAAAAAAAAAAEAAAAQABYAAAACQAAEIAAEAAGK6PSOgAAAAAAAAAAAAAAAAAAAAIAADAAAAA==,"7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid","7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid","7-[(2<I>R</I>,4<I>a</I><I>R</I>,5<I>R</I>,7<I>a</I><I>R</I>)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4<I>a</I>,5,7,7<I>a</I>-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid","7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid","7-[(2R,4aR,5R,7aR)-2-[1,1-bis(fluoranyl)pentyl]-2-oxidanyl-6-oxidanylidene-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid","7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-keto-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]enanthic acid","InChI=1S/C20H32F2O5/c1-2-3-11-19(21,22)20(26)12-10-15-14(16(23)13-17(15)27-20)8-6-4-5-7-9-18(24)25/h14-15,17,26H,2-13H2,1H3,(H,24,25)/t14-,15-,17-,20-/m1/s1",WGFOBBZOWHGYQH-MXHNKVEKSA-N,,390.22178044,C20H32F2O5,390.5,83.8,390.22178044,0.0,27.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1,4.0,"10  16  5
13  4  6
8  28  5
9  29  6",
440790829,3957,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01498,loratadine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01498,loratadine,0.0,No match,vNo-DILI-Concern,2.0,3957,1.0,569.0,3.0,0.0,2.0,AAADceB7MAAEAAAAAAAAAAAAAAAAAAAAAAA8WIAABgAAAAABwAAAHgIAAAAADArhniY+iJMIFACoAzRnXACCgCAxByAI2CA4ZpgIIOLBk5GMIAhghgDIyAcQgMAOhAAAIAAQAAAIAABAACAAAAAAAAAAAA==,"ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate","4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)-1-piperidinecarboxylic acid ethyl ester","ethyl 4-(13-chloro-4-azatricyclo[9.4.0.0<SUP>3,8</SUP>]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate","ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate","ethyl 4-(13-chloranyl-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate","4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylic acid ethyl ester","InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3",JCCNYMKQOSZNPW-UHFFFAOYSA-N,5.2,382.1448057,C22H23ClN2O2,382.9,42.4,382.1448057,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,,"12  14  8
12  18  8
13  17  8
14  20  8
17  21  8
18  22  8
20  23  8
21  24  8
22  23  8
24  25  8
5  13  8
5  25  8",
440790828,3955,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02087,loperamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT02087,loperamide,0.0,No match,vNo-DILI-Concern,2.0,3955,1.0,623.0,3.0,1.0,7.0,AAADcfB7MAAEAAAAAAAAAAAAAAAAAAAAAAA8YMEAAAAAAAABUAAAHgIACAAADkbBmCQyAIMAAgCIAiFSEAACAAAgBQAIiAEICogIJjKBlxGEcAAmwgGImAecyOCPhAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,"4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide","4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-N,N-dimethyl-2,2-diphenylbutanamide","4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-<I>N</I>,<I>N</I>-dimethyl-2,2-diphenylbutanamide","4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide","4-[4-(4-chlorophenyl)-4-oxidanyl-piperidin-1-yl]-N,N-dimethyl-2,2-diphenyl-butanamide","4-[4-(4-chlorophenyl)-4-hydroxy-piperidino]-N,N-dimethyl-2,2-diphenyl-butyramide","InChI=1S/C29H33ClN2O2/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23/h3-16,34H,17-22H2,1-2H3",RDOIQAHITMMDAJ-UHFFFAOYSA-N,,476.223056,C29H33ClN2O2,477.0,43.8,476.223056,0.0,34.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,5.0,"14  18  8
14  19  8
15  20  8
15  22  8
16  21  8
16  23  8
18  24  8
19  25  8
20  27  8
21  28  8
22  29  8
23  30  8
24  26  8
25  26  8
27  33  8
28  34  8
29  33  8
30  34  8",
440790827,6137,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01468,L-methionine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01468,l-methionine,0.0,No match,vNo-DILI-Concern,2.0,6137,1.0,97.0,4.0,2.0,4.0,AAADccBiMABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgQQCAAACCjFwASCCABAAggIAACQCAAAAAAAABAAAIGAAAACABAgAAAAQAAEEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-2-amino-4-methylsulfanyl-butanoic acid,(2S)-2-amino-4-(methylthio)butanoic acid,(2<I>S</I>)-2-amino-4-methylsulfanylbutanoic acid,(2S)-2-amino-4-methylsulfanylbutanoic acid,(2S)-2-azanyl-4-methylsulfanyl-butanoic acid,(2S)-2-amino-4-(methylthio)butyric acid,"InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1",FFEARJCKVFRZRR-BYPYZUCNSA-N,-1.9,149.05104977,C5H11NO2S,149.21,88.6,149.05104977,0.0,9.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CSCC[C@H](N)C(=O)O,,6  4  6,
440790826,5920,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00783,liothyronine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00783,liothyronine,0.0,No match,vNo-DILI-Concern,1.0,5920,1.0,402.0,5.0,3.0,5.0,AAADccByOAAAAwAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAwCAAADCzDmAQwDoBABgCIAiDSCAACCAAgIAAIiIGGCIgOJjKGsRuCeCCk0BEIuAfYyKCOIQAAAAAAAABCAAAAAAAAAAAAAAAAAA==,"(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid","(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid","(2<I>S</I>)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid","(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid","(2S)-2-azanyl-3-[3,5-bis(iodanyl)-4-(3-iodanyl-4-oxidanyl-phenoxy)phenyl]propanoic acid","(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propionic acid","InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",AUYYCJSJGJYCDS-LBPRGKRZSA-N,,650.7901,C15H12I3NO4,650.97,92.8,650.7901,0.0,23.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,1.7,"11  12  8
11  13  8
12  16  8
13  15  8
14  15  8
14  16  8
18  19  8
18  20  8
19  21  8
20  22  8
21  23  8
22  23  8
10  8  5",
440790825,3676,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01905,lidocaine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01905,lidocaine,0.0,No match,vNo-DILI-Concern,2.0,3676,1.0,228.0,2.0,1.0,5.0,AAADceBzIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQAAAADAjBmAQywIPAAACIAiVSUACCAAAhAAAIiACIRIgIYCLAkbGUIAhglADIyAcQgEAOAAACAAACAAAAAAQAAAQAAAAAAAAAAA==,"2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide","2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide","2-(diethylamino)-<I>N</I>-(2,6-dimethylphenyl)acetamide","2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide","2-(diethylamino)-N-(2,6-dimethylphenyl)ethanamide","2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide","InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",NNJVILVZKWQKPM-UHFFFAOYSA-N,2.3,234.17321333,C14H22N2O,234.34,32.3,234.17321333,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)CC(=O)Nc1c(C)cccc1C,,"10  14  8
13  17  8
14  17  8
7  10  8
7  9  8
9  13  8",
440790824,5359272,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00752,levorphanol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00752,levorphanol,0.0,No match,vNo-DILI-Concern,2.0,5359272,1.0,357.0,2.0,1.0,0.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAA8YMEAAAAWAADxAAAAHgAACAAADyzBmAQyBoMAAgCAAiBCAAACAAAgIAAIiAAOCIgIJiKCkROEcAAkwBGImAeQwPAPoAABAAAQAADQAAaAACQAAAAAAAAAAA==,"(1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol","(1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol","(1<I>R</I>,9<I>R</I>,10<I>R</I>)-17-methyl-17-azatetracyclo[7.5.3.0<SUP>1,10</SUP>.0<SUP>2,7</SUP>]heptadeca-2(7),3,5-trien-4-ol","(1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol","(1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol","(1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol","InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m0/s1",JAQUASYNZVUNQP-USXIJHARSA-N,3.1,257.177964357,C17H23NO,257.37,23.5,257.177964357,0.0,19.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13,,"14  17  8
15  18  8
17  19  8
18  19  8
3  7  5
4  20  5
5  21  5
9  14  8
9  15  8",
440790823,13109,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01489,Levonorgestrel,20210312,20210312,Curation Efforts|Governmental Organizations,LT01489,levonorgestrel,0.0,No match,vNo-DILI-Concern,2.0,13109,1.0,609.0,2.0,1.0,2.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAAD0SAgAACAAAAAgDIGqBSAAgAAAAgAAAACAEAAEgAABIAAQAAQAAEgAAIAQOIyPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-oxidanyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1",WWYNJERNGUHSAO-XUDSTZEESA-N,3.3,312.208930132,C21H28O2,312.4,37.3,312.208930132,0.0,23.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,,"7  1  5
11  33  5
3  14  5
4  24  6
5  25  5
6  26  6",
440790822,135564391,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02442,Levomefolate calcium,20250421,20210312,Curation Efforts|Governmental Organizations,LT02442,levomefolate calcium,0.0,No match,vNo-DILI-Concern,2.0,135564391,1.0,854.0,10.0,5.0,7.0,AAADceB7uAAAAAgAAAAAAAAAAAAAAAAAAAAwQIAAAAAAAACBAAAAHgAQAAAADCjBmAQzyIPAAACoAiXSfACCAAElAgAJiIGIZMiKYDLA3bGUIQhklwLYyce8rwCeCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,"calcium;(2S)-2-[[4-[[(6S)-2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioate","calcium;(2S)-2-[[[4-[[(6S)-2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]phenyl]-oxomethyl]amino]pentanedioate","calcium;(2<I>S</I>)-2-[[4-[[(6<I>S</I>)-2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioate","calcium;(2S)-2-[[4-[[(6S)-2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioate","calcium;(2S)-2-[[4-[[(6S)-2-azanyl-5-methyl-4-oxidanylidene-3,6,7,8-tetrahydropteridin-6-yl]methylamino]phenyl]carbonylamino]pentanedioate","calcium;(2S)-2-[[4-[[(6S)-2-amino-4-keto-5-methyl-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]glutarate","InChI=1S/C20H25N7O6.Ca/c1-27-12(9-23-16-15(27)18(31)26-20(21)25-16)8-22-11-4-2-10(3-5-11)17(30)24-13(19(32)33)6-7-14(28)29;/h2-5,12-13,22H,6-9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H4,21,23,25,26,31);/q;+2/p-2/t12-,13-;/m0./s1",VWBBRFHSPXRJQD-QNTKWALQSA-L,,497.1335723,C20H23CaN7O6,497.5,204.0,497.1335723,0.0,34.0,2.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CN1c2c(nc(N)[nH]c2=O)NC[C@@H]1CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1.[Ca+2],,"11  19  8
11  23  8
12  21  8
12  23  8
26  13  5
15  17  6
18  19  8
18  21  8
22  24  8
22  25  8
24  28  8
25  29  8
27  28  8
27  29  8",
440790821,135398559,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02437,Levoleucovorin,20231222,20210312,Curation Efforts|Governmental Organizations,LT02437,Levoleucovorin,0.0,No match,vNo-DILI-Concern,2.0,135398559,1.0,911.0,10.0,7.0,9.0,AAADceB7uAAAAAAAAAAAAAAAAAAAAAAAAAAwQIAAAAAAAACBAAAAHgAQCAAADCjBmAYxyIPAAgCoAiXS/ACCAAElAgAJiIGIZMiKYDLA3bGUYQhklwLYyce8rwCeCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,"(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid","(2S)-2-[[[4-[[(6S)-2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]phenyl]-oxomethyl]amino]pentanedioic acid","(2<I>S</I>)-2-[[4-[[(6<I>S</I>)-2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid","(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid","(2S)-2-[[4-[[(6S)-2-azanyl-5-methanoyl-4-oxidanylidene-3,6,7,8-tetrahydropteridin-6-yl]methylamino]phenyl]carbonylamino]pentanedioic acid","(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-keto-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]glutaric acid","InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12-,13-/m0/s1",VVIAGPKUTFNRDU-STQMWFEESA-N,,473.1658961,C20H23N7O7,473.4,216.0,473.1658961,0.0,34.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc2c(c(=O)[nH]1)N(C=O)[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,-1.2,"11  19  8
11  23  8
12  20  8
12  23  8
24  13  5
15  17  5
18  19  8
18  20  8
22  25  8
22  26  8
25  29  8
26  30  8
28  29  8
28  30  8",
440790820,135403648,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02192,leucovorin,20250421,20210312,Curation Efforts|Governmental Organizations,LT02192,leucovorin,0.0,No match,vNo-DILI-Concern,2.0,135403648,1.0,911.0,10.0,7.0,9.0,AAADceB7uAAAAAAAAAAAAAAAAAAAAAAAAAAwQIAAAAAAAACBAAAAHgAQCAAADCjBmAYxyIPAAgCoAiXS/ACCAAElAgAJiIGIZMiKYDLA3bGUYQhklwLYyce8rwCeCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,"(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid","(2S)-2-[[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]phenyl]-oxomethyl]amino]pentanedioic acid","(2<I>S</I>)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid","(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid","(2S)-2-[[4-[(2-azanyl-5-methanoyl-4-oxidanylidene-3,6,7,8-tetrahydropteridin-6-yl)methylamino]phenyl]carbonylamino]pentanedioic acid","(2S)-2-[[4-[(2-amino-5-formyl-4-keto-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]glutaric acid","InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12?,13-/m0/s1",VVIAGPKUTFNRDU-ABLWVSNPSA-N,,473.1658961,C20H23N7O7,473.4,216.0,473.1658961,0.0,34.0,1.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,-1.2,"11  19  8
11  23  8
12  20  8
12  23  8
24  13  5
15  17  3
18  19  8
18  20  8
22  25  8
22  26  8
25  29  8
26  30  8
28  29  8
28  30  8",
440790819,10917,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01486,L-carnitine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01486,l-carnitine,0.0,No match,vNo-DILI-Concern,1.0,10917,1.0,134.0,3.0,1.0,3.0,AAADccBiMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAACAAACBThgAYCCAMAAgAIAACQCAAAAAAAAAAAAAEIAAACEBQAgAAEQAAFIAAQAAAkAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(3R)-3-hydroxy-4-(trimethylammonio)butanoate,(3R)-3-hydroxy-4-(trimethylammonio)butanoate,(3<I>R</I>)-3-hydroxy-4-(trimethylazaniumyl)butanoate,(3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate,(3R)-3-oxidanyl-4-(trimethylazaniumyl)butanoate,(3R)-3-hydroxy-4-(trimethylammonio)butyrate,"InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1",PHIQHXFUZVPYII-ZCFIWIBFSA-N,,161.10519334,C7H15NO3,161.2,60.4,161.10519334,0.0,11.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[N+](C)(C)C[C@H](O)CC(=O)[O-],-0.2,6  1  5,
440790818,6322,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02077,L-arginine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02077,l-arginine,0.0,No match,vNo-DILI-Concern,2.0,6322,1.0,176.0,4.0,4.0,5.0,AAADccBjsAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAACCjBgAQBCAJAAgAoAACQLAAAAAEAAAAAAIGAAAACABIAgAAAQAAEEAAAAACYEQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-2-amino-5-guanidino-pentanoic acid,(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid,(2<I>S</I>)-2-amino-5-(diaminomethylideneamino)pentanoic acid,(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid,(2S)-2-azanyl-5-[bis(azanyl)methylideneamino]pentanoic acid,(2S)-2-amino-5-guanidino-valeric acid,"InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1",ODKSFYDXXFIFQN-BYPYZUCNSA-N,-4.2,174.1116757,C6H14N4O2,174.2,128.0,174.1116757,0.0,12.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(N)=NCCC[C@H](N)C(=O)O,,9  3  6,
440790817,168924,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00493,Lanthanum Carbonate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00493,lanthanum carbonate,0.0,No match,vNo-DILI-Concern,2.0,168924,1.0,18.8,9.0,0.0,0.0,AAADcQBAPAAAAAAAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAgAAAAAAAAAAAAAACAAAAAAIAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,lanthanum(3+);tricarbonate,lanthanum(3+);tricarbonate,lanthanum(3+);tricarbonate,lanthanum(3+);tricarbonate,lanthanum(3+);tricarbonate,lanthanum(3+);tricarbonate,"InChI=1S/3CH2O3.2La/c3*2-1(3)4;;/h3*(H2,2,3,4);;/q;;;2*+3/p-6",NZPIUJUFIFZSPW-UHFFFAOYSA-H,,457.76696,C3La2O9,457.84,190.0,457.76696,0.0,14.0,0.0,0.0,0.0,0.0,0.0,5.0,-1.0,"1
5
255",O=C([O-])[O-].O=C([O-])[O-].O=C([O-])[O-].[La+3].[La+3],,,
440790816,11333,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00886,lactulose,20231222,20210312,Curation Efforts|Governmental Organizations,LT00886,lactulose,0.0,No match,vNo-DILI-Concern,1.0,11333,1.0,395.0,11.0,8.0,5.0,AAADceBwPAAAAAAAAAAAAAAAAAAAASAAAAAkAAAAAAAAAAAAAAAAGgAACAAACBSwgAMACAAABgAAAAAAAAAAAAAAAAAAAAAAAAAREAIAAAAiQAAFAAAHAAHAYAwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol","(2S,3R,4S,5R,6R)-2-[[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)-3-oxolanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol","(2<I>S</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>,6<I>R</I>)-2-[(2<I>R</I>,3<I>S</I>,4<I>S</I>,5<I>R</I>)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol","(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol","(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-2,5-bis(hydroxymethyl)-4,5-bis(oxidanyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol","(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-dimethylol-tetrahydrofuran-3-yl]oxy-6-methylol-tetrahydropyran-3,4,5-triol","InChI=1S/C12H22O11/c13-1-4-6(16)7(17)8(18)11(21-4)22-9-5(2-14)23-12(20,3-15)10(9)19/h4-11,13-20H,1-3H2/t4-,5-,6+,7+,8-,9-,10+,11+,12-/m1/s1",JCQLYHFGKNRPGE-FCVZTGTOSA-N,-4.3,342.11621151,C12H22O11,342.3,190.0,342.11621151,0.0,23.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,"12  1  6
16  1  5
14  21  5
20  23  5
13  4  5
15  5  5
17  6  6
18  7  5
19  8  5",
440790815,6032,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01477,kanamycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01477,kanamycin,0.0,No match,vNo-DILI-Concern,1.0,6032,1.0,638.0,15.0,11.0,6.0,AAADcfB7vAAAAAAAAAAAAAAAAAAAAAAAAAA0SIAAAAAAAAAAAAAAHgAQCAAACDzxgAcACABABgAAAAAAAAAAAAAAAAAAAIAAAAATEAIAwAAjQAAHEAAHAAHwcA0AAAAAAAAAAAAAgAAUCACgAAAAAAAAAA==,"(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol","(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol","(2<I>R</I>,3<I>S</I>,4<I>S</I>,5<I>R</I>,6<I>R</I>)-2-(aminomethyl)-6-[(1<I>R</I>,2<I>R</I>,3<I>S</I>,4<I>R</I>,6<I>S</I>)-4,6-diamino-3-[(2<I>S</I>,3<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol","(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol","(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-bis(azanyl)-3-[(2S,3R,4S,5S,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-2-oxidanyl-cyclohexyl]oxy-oxane-3,4,5-triol","(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol","InChI=1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1",SBUJHOSQTJFQJX-NOAMYHISSA-N,,484.23805798,C18H36N4O11,484.5,283.0,484.23805798,0.0,33.0,15.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,-6.9,"16  1  5
22  1  6
30  10  6
19  12  6
20  13  6
25  14  5
17  2  5
23  2  6
29  33  5
18  3  6
31  32  5
24  6  6
26  7  6
27  8  6
28  9  5",
440790814,3783,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02089,isoxsuprine,20250421,20210312,Curation Efforts|Governmental Organizations,LT02089,isoxsuprine,0.0,No match,vNo-DILI-Concern,2.0,3783,1.0,299.0,4.0,3.0,7.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAQCAAADDzhmAYyBoLABgCAAiBCAAACCAAgIAAIiIAOCIgONiKGsRuHeCCk0BGYuAeQ4KQOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,4-[1-hydroxy-2-[(1-methyl-2-phenoxy-ethyl)amino]propyl]phenol,4-[1-hydroxy-2-(1-phenoxypropan-2-ylamino)propyl]phenol,4-[1-hydroxy-2-(1-phenoxypropan-2-ylamino)propyl]phenol,4-[1-hydroxy-2-(1-phenoxypropan-2-ylamino)propyl]phenol,4-[1-oxidanyl-2-(1-phenoxypropan-2-ylamino)propyl]phenol,4-[1-hydroxy-2-[(1-methyl-2-phenoxy-ethyl)amino]propyl]phenol,"InChI=1S/C18H23NO3/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15/h3-11,13-14,18-21H,12H2,1-2H3",BMUKKTUHUDJSNZ-UHFFFAOYSA-N,,301.1677936,C18H23NO3,301.4,61.7,301.1677936,0.0,22.0,0.0,3.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1,2.8,"6  1  3
12  14  8
13  15  8
14  16  8
15  16  8
17  18  8
17  19  8
18  20  8
19  21  8
20  22  8
21  22  8
5  8  3
7  11  3
9  12  8
9  13  8",
440790813,6883,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00818,ISOSORBIDE DINITRATE,20210804,20210312,Curation Efforts|Governmental Organizations,LT00818,isosorbide dinitrate,0.0,No match,vNo-DILI-Concern,2.0,6883,1.0,268.0,8.0,0.0,2.0,AAADccBjPAAAAAAAAAAAAAAAAAAAASJAAAAAAAAAAAASAAAAAAAAGgAEAAAACBSggAIAAAAARAABAAAAAQAAAAAAAAAAAAAAAAABAAIAAAACAAAFAAACAAHAYAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate","nitric acid [(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] ester","[(3<I>S</I>,3<I>a</I><I>S</I>,6<I>R</I>,6<I>a</I><I>S</I>)-3-nitrooxy-2,3,3<I>a</I>,5,6,6<I>a</I>-hexahydrofuro[3,2-b]furan-6-yl] nitrate","[(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate","[(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate","nitric acid [(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] ester","InChI=1S/C6H8N2O8/c9-7(10)15-3-1-13-6-4(16-8(11)12)2-14-5(3)6/h3-6H,1-2H2/t3-,4+,5-,6-/m1/s1",MOYKHGMNXAOIAT-JGWLITMVSA-N,1.3,236.02806522,C6H8N2O8,236.14,129.0,236.02806522,0.0,16.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-],,"11  17  5
12  18  5
13  3  5
14  4  6",
440790812,3779,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00200,isoproterenol,20250421,20210312,Curation Efforts|Governmental Organizations,LT00200,isoproterenol,0.0,No match,vNo-DILI-Concern,1.0,3779,1.0,187.0,4.0,4.0,4.0,AAADceByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADDzhmAYyBoLAAgCAAiBCAAACAAAgIAAIiIAOiIgLNiKCkROEcAEk0BGZmAfQ8LYOIAABAAAAQABAAAIAAACAAAAAAAAAAA==,"4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol","4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol","4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol","4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol","4-[1-oxidanyl-2-(propan-2-ylamino)ethyl]benzene-1,2-diol",4-[1-hydroxy-2-(isopropylamino)ethyl]pyrocatechol,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3",JWZZKOKVBUJMES-UHFFFAOYSA-N,-0.6,211.1208434,C11H17NO3,211.26,72.7,211.1208434,0.0,15.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)NCC(O)c1ccc(O)c(O)c1,,"5  1  3
11  13  8
12  14  8
13  15  8
14  15  8
8  11  8
8  12  8",
440790811,3741,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00419,ioversol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00419,ioversol,0.0,No match,vNo-DILI-Concern,2.0,3741,1.0,623.0,9.0,8.0,12.0,AAADceB7PAAAAwAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAwCAAADBzjmAYAwIPAAgCIAgVQUAKCAAAlAAAAiIFIRMgLMDLAlJGEYQhilgDZyQcci0COAAACQAAAAAAAAASAAAAAAAAAAAAAAA==,"N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide","N1,N3-bis(2,3-dihydroxypropyl)-5-[2-hydroxyethyl-(2-hydroxy-1-oxoethyl)amino]-2,4,6-triiodobenzene-1,3-dicarboxamide","1-<I>N</I>,3-<I>N</I>-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodobenzene-1,3-dicarboxamide","1-N,3-N-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodobenzene-1,3-dicarboxamide","N1,N3-bis[2,3-bis(oxidanyl)propyl]-5-[2-hydroxyethyl(2-oxidanylethanoyl)amino]-2,4,6-tris(iodanyl)benzene-1,3-dicarboxamide","N,N'-diglyceryl-5-[glycoloyl(2-hydroxyethyl)amino]-2,4,6-triiodo-isophthalamide","InChI=1S/C18H24I3N3O9/c19-13-11(17(32)22-3-8(29)5-26)14(20)16(24(1-2-25)10(31)7-28)15(21)12(13)18(33)23-4-9(30)6-27/h8-9,25-30H,1-7H2,(H,22,32)(H,23,33)",AMDBBAQNWSUWGN-UHFFFAOYSA-N,-3.0,806.8647,C18H24I3N3O9,807.1,200.0,806.8647,0.0,33.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I,,"16  19  8
16  20  8
17  20  8
17  22  8
18  19  8
18  22  8
27  4  3
28  5  3",
440790810,23667529,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00257,Iothalamate sodium,20231222,20210312,Curation Efforts|Governmental Organizations,LT00257,iothalamate sodium,0.0,No match,vNo-DILI-Concern,2.0,23667529,1.0,426.0,4.0,2.0,3.0,AAADccBzOCAAAwAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAwAAAADAiDmAQCyILAAACIAgXQWACCAAAlAAAAiIEITMgIJjLAlJGEMQhk1gHIyQe832KOAAACQAAAAAAAAASAAAAAAAAAAAAAAA==,"sodium;3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate","sodium;3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate","sodium;3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate","sodium;3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate","sodium;3-acetamido-2,4,6-tris(iodanyl)-5-(methylcarbamoyl)benzoate","sodium;3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate","InChI=1S/C11H9I3N2O4.Na/c1-3(17)16-9-7(13)4(10(18)15-2)6(12)5(8(9)14)11(19)20;/h1-2H3,(H,15,18)(H,16,17)(H,19,20);/q;+1/p-1",WCIMWHNSWLLELS-UHFFFAOYSA-M,,635.7516,C11H8I3N2NaO4,635.89,98.3,635.7516,0.0,21.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)[O-])c1I.[Na+],,"11  13  8
11  15  8
12  13  8
12  16  8
14  15  8
14  16  8",4  6  7
440790809,3739,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01454,IODIPAMIDE MEGLUMINE,20210804,20210312,Curation Efforts|Governmental Organizations,LT01454,iodipamide meglumine,0.0,No match,vNo-DILI-Concern,2.0,3739,1.0,714.0,6.0,4.0,9.0,AAADccB7OAAAA4AAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAwCAAADAiDmAAwyILAAgCIAiXSWACCAAAlAAAAiAEATMgIJjLAlJGEcQhk1AHI2Qe8yCCOAAAAQAAAAAAAAACAAAAAAAAAAAAAAA==,"3-[[6-(3-carboxy-2,4,6-triiodo-anilino)-6-oxo-hexanoyl]amino]-2,4,6-triiodo-benzoic acid","3-[[6-(3-carboxy-2,4,6-triiodoanilino)-1,6-dioxohexyl]amino]-2,4,6-triiodobenzoic acid","3-[[6-(3-carboxy-2,4,6-triiodoanilino)-6-oxohexanoyl]amino]-2,4,6-triiodobenzoic acid","3-[[6-(3-carboxy-2,4,6-triiodoanilino)-6-oxohexanoyl]amino]-2,4,6-triiodobenzoic acid","3-[[6-[[3-carboxy-2,4,6-tris(iodanyl)phenyl]amino]-6-oxidanylidene-hexanoyl]amino]-2,4,6-tris(iodanyl)benzoic acid","3-[[6-(3-carboxy-2,4,6-triiodo-anilino)-6-keto-hexanoyl]amino]-2,4,6-triiodo-benzoic acid","InChI=1S/C20H14I6N2O6/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34)",FFINMCNLQNTKLU-UHFFFAOYSA-N,,1139.512,C20H14I6N2O6,1139.8,133.0,1139.512,0.0,34.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I,5.5,"21  23  8
21  25  8
22  24  8
22  26  8
23  27  8
24  28  8
25  29  8
26  30  8
27  31  8
28  32  8
29  31  8
30  32  8",
440790808,11967809,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00141,indocyanine green,20231222,20210312,Curation Efforts|Governmental Organizations,LT00141,indocyanine green,0.0,No match,vNo-DILI-Concern,2.0,11967809,1.0,1520.0,7.0,0.0,12.0,AAADcfB/OCBgAAAAAAAAAAAAAAAAAWIAAAAwYMGAAAAAAFjBVAAAHAQAAAAADgjFWASywMMAAAKgAyRiRHDCAAAhAgAIiAA4ZJgIICLAkZGEIAhggADIyAcQgMAPiAACQAASAAAQAASAACQAAAAAAAAAAA==,"sodium;4-[(2E)-2-[(2E,4E,6E)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethyl-benzo[e]indol-3-yl]butane-1-sulfonate","sodium;4-[(2E)-2-[(2E,4E,6E)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)-2-benzo[e]indol-3-iumyl]hepta-2,4,6-trienylidene]-1,1-dimethyl-3-benzo[e]indolyl]-1-butanesulfonate","sodium;4-[(2<I>E</I>)-2-[(2<I>E</I>,4<I>E</I>,6<I>E</I>)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethylbenzo[e]indol-3-yl]butane-1-sulfonate","sodium;4-[(2E)-2-[(2E,4E,6E)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethylbenzo[e]indol-3-yl]butane-1-sulfonate","sodium;4-[(2E)-2-[(2E,4E,6E)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethyl-benzo[e]indol-3-yl]butane-1-sulfonate","sodium;4-[(2E)-2-[(2E,4E,6E)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benz[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethyl-benz[e]indol-3-yl]butane-1-sulfonate","InChI=1S/C43H48N2O6S2.Na/c1-42(2)38(44(28-14-16-30-52(46,47)48)36-26-24-32-18-10-12-20-34(32)40(36)42)22-8-6-5-7-9-23-39-43(3,4)41-35-21-13-11-19-33(35)25-27-37(41)45(39)29-15-17-31-53(49,50)51;/h5-13,18-27H,14-17,28-31H2,1-4H3,(H-,46,47,48,49,50,51);/q;+1/p-1",MOFVSTNWEDAEEK-UHFFFAOYSA-M,,774.27732385,C43H47N2NaO6S2,775.0,137.0,774.27732385,0.0,54.0,0.0,0.0,4.0,0.0,0.0,2.0,-1.0,"1
5
255",CC1(C)C(/C=C/C=C/C=C/C=C2/N(CCCCS(=O)(=O)[O-])c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21.[Na+],,"14  18  8
14  26  8
15  19  8
15  27  8
18  28  8
19  29  8
26  31  8
26  38  8
27  33  8
27  39  8
28  36  8
29  37  8
31  36  8
31  42  8
33  37  8
33  43  8
38  46  8
39  47  8
42  50  8
43  51  8
46  50  8
47  51  8",
440790807,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02384,Imiglucerase,20210312,20210312,Curation Efforts|Governmental Organizations,LT02384,imiglucerase,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790806,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01409,Idursulfase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01409,idursulfase,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790805,60753,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00974,Ibutilide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00974,ibutilide,0.0,No match,vNo-DILI-Concern,2.0,60753,1.0,442.0,5.0,2.0,14.0,AAADcfB7MABAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgQQSAAADBzhmAaywINAAgKAAiRCQHCCAAAgAgAIiAAIbIgINiKAkZGEcABk0AGI2Aew0KEOCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,N-[4-[4-[ethyl(heptyl)amino]-1-hydroxy-butyl]phenyl]methanesulfonamide,N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide,<I>N</I>-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide,N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide,N-[4-[4-[ethyl(heptyl)amino]-1-oxidanyl-butyl]phenyl]methanesulfonamide,N-[4-[4-[ethyl(heptyl)amino]-1-hydroxy-butyl]phenyl]methanesulfonamide,"InChI=1S/C20H36N2O3S/c1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25/h12-15,20-21,23H,4-11,16-17H2,1-3H3",ALOBUEHUHMBRLE-UHFFFAOYSA-N,,384.24466419,C20H36N2O3S,384.6,78.0,384.24466419,0.0,26.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,4.0,"15  43  3
17  20  8
17  21  8
20  23  8
21  24  8
23  25  8
24  25  8",
440790804,92002593,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01378,Ibritumomab tiuxetan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01378,ibritumomab tiuxetan,0.0,No match,vNo-DILI-Concern,2.0,92002593,1.0,862.0,14.0,7.0,19.0,AAADcfB7vAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADCjBmAQzyIPAAgCIAiTSWACCAAAhAgAIiICIZIiKYCLAkbGUIAholgLYyCcQgIAOCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,2-[[2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid,2-[[2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid,2-[[2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid,2-[[2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid,2-[[2-[bis(2-hydroxy-2-oxoethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(2-hydroxy-2-oxoethyl)amino]propyl]amino]ethanoic acid,2-[[2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid,"InChI=1S/C24H35N5O11/c1-15(28(11-20(32)33)12-21(34)35)8-27(10-19(30)31)9-18(29(13-22(36)37)14-23(38)39)7-16-3-5-17(6-4-16)26-24(40)25-2/h3-6,15,18H,7-14H2,1-2H3,(H,30,31)(H,32,33)(H,34,35)(H,36,37)(H,38,39)(H2,25,26,40)",RTQWWZBSTRGEAV-UHFFFAOYSA-N,,569.23330695,C24H35N5O11,569.6,237.0,569.23330695,0.0,40.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNC(=O)Nc1ccc(CC(CN(CC(=O)O)CC(C)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)cc1,-7.1,"17  21  3
20  26  3
25  30  8
25  31  8
30  34  8
31  35  8
34  38  8
35  38  8",
440790803,60852,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01156,Ibandronate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01156,ibandronate,0.0,No match,vNo-DILI-Concern,2.0,60852,1.0,342.0,8.0,5.0,9.0,AAADceByOAMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHggACCAACADBgAQCAAMAAhAAQAAAAIAAAAAAAAAAAAAIAAAAAAIAgAAEQAACAACAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphono-propyl]phosphonic acid,[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid,[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid,[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid,[3-[methyl(pentyl)amino]-1-oxidanyl-1-phosphono-propyl]phosphonic acid,[3-[amyl(methyl)amino]-1-hydroxy-1-phosphono-propyl]phosphonic acid,"InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17)",MPBVHIBUJCELCL-UHFFFAOYSA-N,,319.09497607,C9H23NO7P2,319.23,139.0,319.09497607,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,-4.1,,
440790802,3658,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01437,hydroxyzine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01437,hydroxyzine,0.0,No match,vNo-DILI-Concern,1.0,3658,1.0,376.0,4.0,1.0,8.0,AAADceB7MAAEAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABQAAAHgIACAAADCrhmCYwAIMABgCAAiBCAACCAAAgBQAIiAAIBogLcCKBkxGXIAhggACbiAcQgMAOBAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol,2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]ethanol,2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol,2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol,2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol,2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazino]ethoxy]ethanol,"InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2",ZQDWXGKKHFNSQK-UHFFFAOYSA-N,3.7,374.1761058,C21H27ClN2O2,374.9,35.9,374.1761058,0.0,26.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,,"10  35  3
12  15  8
12  16  8
13  17  8
13  18  8
15  19  8
16  20  8
17  21  8
18  22  8
19  23  8
20  23  8
21  24  8
22  24  8",
440790801,5754,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00188,hydrocortisone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00188,hydrocortisone,0.0,No match,vNo-DILI-Concern,2.0,5754,1.0,684.0,5.0,3.0,2.0,AAADceB4OAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAAD1SggAICAAAAAgCIAqBSAAIAAAAgAAAACAFAAEgAEBIAAQAAQAAFgAAIAQPIzPDPgAAAAAAAAADAAAYAADAAAYAADAAAAA==,"(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8<I>S</I>,9<I>S</I>,10<I>R</I>,11<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1<I>H</I>-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11,17-bis(oxidanyl)-17-(2-oxidanylethanoyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,11S,13S,14S,17R)-17-glycoloyl-11,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",JYGXADMDTFJGBT-VWUMJDOOSA-N,1.6,362.20932405,C21H30O5,362.5,94.8,362.20932405,0.0,26.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,,"10  1  6
12  21  5
13  2  5
6  17  5
7  27  6
8  28  5
9  29  6",
440790800,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02913,Hyaluronidase recombinant human,20210312,20210312,Curation Efforts|Governmental Organizations,LT02913,hyaluronidase recombinant human,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790799,91820602,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00725,Hyaluronidase,20231222,20210312,Curation Efforts|Governmental Organizations,LT00725,hyaluronidase,0.0,No match,vNo-DILI-Concern,2.0,91820602,1.0,375.0,3.0,2.0,6.0,AAADceB6MAAAEAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgBAAAAHgAACAAADgjBmAQyyIMAAgCIAiTSSACCAAAhAgAIiAEIZIgIIDLAkZGEYAhkgADIyAeYyMAPgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"6-(3,3-dimethyl-2-methylene-indolin-1-yl)hexanoic acid;hydrobromide","6-(3,3-dimethyl-2-methylene-1-indolyl)hexanoic acid;hydrobromide","6-(3,3-dimethyl-2-methylideneindol-1-yl)hexanoic acid;hydrobromide","6-(3,3-dimethyl-2-methylideneindol-1-yl)hexanoic acid;hydrobromide","6-(3,3-dimethyl-2-methylidene-indol-1-yl)hexanoic acid;hydrobromide","6-(3,3-dimethyl-2-methylene-indolin-1-yl)hexanoic acid;hydrobromide","InChI=1S/C17H23NO2.BrH/c1-13-17(2,3)14-9-6-7-10-15(14)18(13)12-8-4-5-11-16(19)20;/h6-7,9-10H,1,4-5,8,11-12H2,2-3H3,(H,19,20);1H",SVMKEDBUSSWSFY-UHFFFAOYSA-N,,353.09904,C17H24BrNO2,354.3,40.5,353.09904,0.0,21.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",Br.C=C1N(CCCCCC(=O)O)c2ccccc2C1(C)C,,"13  17  8
14  19  8
17  19  8
6  13  8
6  8  8
8  14  8",
440790798,65513,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00706,Histamine diphosphate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00706,histamine diphosphate,0.0,No match,vNo-DILI-Concern,2.0,65513,1.0,114.0,10.0,8.0,2.0,AAADccBjPAMAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAABgAAAHAAQCCAACAjBFgQtkBbJkBCgQRRnZIAAgC2xEqABUYA4cAiAaABAyQEUAAAIEAJAQCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-(1H-imidazol-5-yl)ethanamine;phosphoric acid,2-(1H-imidazol-5-yl)ethanamine;phosphoric acid,2-(1<I>H</I>-imidazol-5-yl)ethanamine;phosphoric acid,2-(1H-imidazol-5-yl)ethanamine;phosphoric acid,2-(1H-imidazol-5-yl)ethanamine;phosphoric acid,2-(1H-imidazol-5-yl)ethylamine;phosphoric acid,"InChI=1S/C5H9N3.2H3O4P/c6-2-1-5-3-7-4-8-5;2*1-5(2,3)4/h3-4H,1-2,6H2,(H,7,8);2*(H3,1,2,3,4)",ZHIBQGJKHVBLJJ-UHFFFAOYSA-N,,307.03343844,C5H15N3O8P2,307.14,210.0,307.03343844,0.0,18.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",NCCc1cnc[nH]1.O=P(O)(O)O.O=P(O)(O)O,,"11  15  8
11  18  8
13  17  8
13  18  8
15  17  8",
440790797,24846132,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02382,Hetastarch,20231222,20210312,Curation Efforts|Governmental Organizations,LT02382,Hetastarch,0.0,No match,vNo-DILI-Concern,2.0,24846132,1.0,999.0,21.0,11.0,15.0,AAADcfB4PgAAAAAAAAAAAAAAAAAAAAAAAAAkSJEgAAAAAAAAAAAAGgAACAAACBSwgAMCCAAABgAAAAAAAAAAAAAAAAAAAAAAAAAREAIAAAAiQAAFAAAHAAHA4CwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxy-tetrahydropyran-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxy-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-6-(hydroxymethyl)-2-methyl-tetrahydropyran-3,4-diol","5-[[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxy-2-oxanyl]oxymethyl]-3,4-dihydroxy-5-[[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxy-2-oxanyl]oxy]-2-oxanyl]oxy]-6-(hydroxymethyl)-2-methyloxane-3,4-diol","5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol","5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol","5-[5-[3-(2-hydroxyethyloxy)-6-(hydroxymethyl)-5-methoxy-4-oxidanyl-oxan-2-yl]oxy-6-[[6-(hydroxymethyl)-5-methoxy-3,4-bis(oxidanyl)oxan-2-yl]oxymethyl]-3,4-bis(oxidanyl)oxan-2-yl]oxy-6-(hydroxymethyl)-2-methyl-oxane-3,4-diol","5-[6-[(3,4-dihydroxy-5-methoxy-6-methylol-tetrahydropyran-2-yl)oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-5-methoxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-2-methyl-6-methylol-tetrahydropyran-3,4-diol","InChI=1S/C29H52O21/c1-10-15(34)16(35)24(13(8-33)45-10)49-28-20(39)18(37)25(50-29-26(43-5-4-30)21(40)23(42-3)12(7-32)47-29)14(48-28)9-44-27-19(38)17(36)22(41-2)11(6-31)46-27/h10-40H,4-9H2,1-3H3",CWSZBVAUYPTXTG-UHFFFAOYSA-N,,736.30010866,C29H52O21,736.7,315.0,736.30010866,0.0,50.0,0.0,20.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC1C(CO)OC(OCC2OC(OC3C(CO)OC(C)C(O)C3O)C(O)C(O)C2OC2OC(CO)C(OC)C(O)C2OCCO)C(O)C1O,-7.7,"30  11  3
34  12  3
32  13  3
35  14  3
41  15  3
39  16  3
40  17  3
22  2  3
28  2  3
23  33  3
26  3  3
27  3  3
31  42  3
36  44  3
37  45  3
43  46  3
38  6  3
24  7  3
25  8  3
29  9  3",
440790796,3518,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00829,GUANETHIDINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00829,guanethidine,0.0,No match,vNo-DILI-Concern,1.0,3518,1.0,167.0,2.0,2.0,3.0,AAADceBzgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAWAAAAAAAAHAAQAAAACADBAAQBAANAAAAgAAAAJAAAAAEAAAAAAAAIAAAAQAIAgAAUAAAAAACAAAEQgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-[2-(azocan-1-yl)ethyl]guanidine,2-[2-(1-azocanyl)ethyl]guanidine,2-[2-(azocan-1-yl)ethyl]guanidine,2-[2-(azocan-1-yl)ethyl]guanidine,2-[2-(azocan-1-yl)ethyl]guanidine,2-[2-(azocan-1-yl)ethyl]guanidine,"InChI=1S/C10H22N4/c11-10(12)13-6-9-14-7-4-2-1-3-5-8-14/h1-9H2,(H4,11,12,13)",ACGDKVXYNVEAGU-UHFFFAOYSA-N,,198.18444672,C10H22N4,198.31,67.6,198.18444672,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(N)=NCCN1CCCCCCC1,0.5,,
440790795,3516,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01100,guaifenesin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01100,guaifenesin,0.0,No match,vNo-DILI-Concern,2.0,3516,1.0,151.0,4.0,2.0,5.0,AAADccBwOAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgAACAAACBSgkAIyBoAABgCAACBCAAACCAAgIAAIiAAGiIgNNiKEMRqCeCKlwBELqAeAQAAAAAAAAAAAQAAAAAAAAACAAAAAAAAAAA==,"3-(2-methoxyphenoxy)propane-1,2-diol","3-(2-methoxyphenoxy)propane-1,2-diol","3-(2-methoxyphenoxy)propane-1,2-diol","3-(2-methoxyphenoxy)propane-1,2-diol","3-(2-methoxyphenoxy)propane-1,2-diol","3-(2-methoxyphenoxy)propane-1,2-diol","InChI=1S/C10H14O4/c1-13-9-4-2-3-5-10(9)14-7-8(12)6-11/h2-5,8,11-12H,6-7H2,1H3",HSRJKNPTNIJEKV-UHFFFAOYSA-N,1.4,198.08920892,C10H14O4,198.22,58.9,198.08920892,0.0,14.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccccc1OCC(O)CO,,"10  12  8
11  13  8
12  13  8
5  2  3
8  10  8
8  9  8
9  11  8",
440790794,11693,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00836,GLYCOPYRROLATE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00836,glycopyrrolate,0.0,No match,vNo-DILI-Concern,2.0,11693,1.0,424.0,4.0,1.0,5.0,AAADceB6MAAAEAAAAAAAAAAAAAAAAeIAAAAwAAAAAAAAAAABAAAAHgAACAAADVThmAYyCIMABgCIAiDSCAICAAAgAAAIiAFICIgLJjKAlRCHcAAmwAGbmAeIyOCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenyl-acetate;bromide","2-cyclopentyl-2-hydroxy-2-phenylacetic acid (1,1-dimethyl-3-pyrrolidin-1-iumyl) ester;bromide","(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate;bromide","(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate;bromide","(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-oxidanyl-2-phenyl-ethanoate;bromide","2-cyclopentyl-2-hydroxy-2-phenyl-acetic acid (1,1-dimethylpyrrolidin-1-ium-3-yl) ester;bromide","InChI=1S/C19H28NO3.BrH/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15;/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3;1H/q+1;/p-1",VPNYRYCIDCJBOM-UHFFFAOYSA-M,,397.12526,C19H28BrNO3,398.3,46.5,397.12526,0.0,24.0,0.0,2.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-],,"11  19  3
19  20  8
19  21  8
7  2  3
20  22  8
21  23  8
22  24  8
23  24  8",
440790793,23724914,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00475,Ganirelix acetate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00475,ganirelix acetate,0.0,No match,vNo-DILI-Concern,2.0,23724914,1.0,3060.0,20.0,18.0,48.0,AAADcfB//gAEAAAAAAAAAAAAAAAAAWAAAAA8YMGCAAAAAADB1AAAHgIQCAAADS7hmiY/jtPIEgCoAjH3fACCgCExJyAJ2KG+bpiKdvbDm7OUcAhu9hPY2AeYyeCO5AACAAAQAADIAAQAACAAAAAAAAAAAA==,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthyl)propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-(3-pyridyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-[bis(ethylamino)methyleneamino]hexanoyl]amino]-4-methyl-pentanoyl]amino]-6-[bis(ethylamino)methyleneamino]hexanoyl]-N-[(1R)-2-amino-1-methyl-2-oxo-ethyl]pyrrolidine-2-carboxamide;acetic acid,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthalenyl)-1-oxopropyl]amino]-3-(4-chlorophenyl)-1-oxopropyl]amino]-1-oxo-3-(3-pyridinyl)propyl]amino]-3-hydroxy-1-oxopropyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-6-[bis(ethylamino)methylideneamino]-1-oxohexyl]amino]-4-methyl-1-oxopentyl]amino]-6-[bis(ethylamino)methylideneamino]-1-oxohexyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]-2-pyrrolidinecarboxamide;acetic acid,(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>R</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>R</I>)-2-[[(2<I>R</I>)-2-[[(2<I>R</I>)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]amino]-4-methylpentanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]-<I>N</I>-[(2<I>R</I>)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide;acetic acid,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]amino]-4-methylpentanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide;acetic acid,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-yl-propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-yl-propanoyl]amino]-3-oxidanyl-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]amino]-4-methyl-pentanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]-N-[(2R)-1-azanyl-1-oxidanylidene-propan-2-yl]pyrrolidine-2-carboxamide;ethanoic acid,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-(2-naphthyl)propanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-(3-pyridyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-[bis(ethylamino)methyleneamino]hexanoyl]amino]-4-methyl-pentanoyl]amino]-6-[bis(ethylamino)methyleneamino]hexanoyl]-N-[(1R)-2-amino-2-keto-1-methyl-ethyl]pyrrolidine-2-carboxamide;acetic acid,"InChI=1S/C80H113ClN18O13.2C2H4O2/c1-9-84-79(85-10-2)88-38-17-15-24-60(70(104)94-62(41-49(5)6)71(105)93-61(25-16-18-39-89-80(86-11-3)87-12-4)78(112)99-40-20-26-68(99)77(111)90-50(7)69(82)103)92-73(107)64(44-53-30-35-59(102)36-31-53)97-76(110)67(48-100)98-75(109)66(46-55-21-19-37-83-47-55)96-74(108)65(43-52-28-33-58(81)34-29-52)95-72(106)63(91-51(8)101)45-54-27-32-56-22-13-14-23-57(56)42-54;2*1-2(3)4/h13-14,19,21-23,27-37,42,47,49-50,60-68,100,102H,9-12,15-18,20,24-26,38-41,43-46,48H2,1-8H3,(H2,82,103)(H,90,111)(H,91,101)(H,92,107)(H,93,105)(H,94,104)(H,95,106)(H,96,108)(H,97,110)(H,98,109)(H2,84,85,88)(H2,86,87,89);2*1H3,(H,3,4)/t50-,60-,61+,62+,63-,64+,65-,66-,67+,68+;;/m1../s1",OVBICQMTCPFEBS-SATRDZAXSA-N,,1688.8845622,C84H121ClN18O17,1690.4,526.0,1688.8845622,0.0,120.0,10.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",CC(=O)O.CC(=O)O.CCNC(=NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN=C(NCC)NCC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O)NCC,,"100  108  8
101  106  8
102  104  8
103  110  8
104  105  8
104  112  8
105  110  8
105  113  8
107  111  8
108  111  8
112  115  8
113  116  8
115  116  8
42  20  6
48  21  5
46  22  6
58  25  6
64  28  5
71  30  6
80  33  5
84  34  5
90  35  6
36  106  8
36  97  8
37  43  6
69  74  8
69  75  8
74  78  8
75  79  8
78  82  8
79  82  8
89  96  8
89  97  8
94  100  8
94  99  8
96  101  8
98  102  8
98  103  8
99  107  8",
440790792,10413,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00480,Gamma Hydroxybutyric Acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT00480,gamma hydroxybutyric acid,0.0,No match,vNo-DILI-Concern,2.0,10413,1.0,60.0,3.0,2.0,3.0,AAADccBgMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgAACAAACACggAIACAAAAgAIAACQCAAAAAAAAAAAAAEAAAAAEBAAAAAAQAAEAAAAAABCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,4-hydroxybutanoic acid,4-hydroxybutanoic acid,4-hydroxybutanoic acid,4-hydroxybutanoic acid,4-oxidanylbutanoic acid,4-hydroxybutyric acid,"InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)",SJZRECIVHVDYJC-UHFFFAOYSA-N,-0.6,104.047344113,C4H8O3,104.1,57.5,104.047344113,0.0,7.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)CCCO,,,
440790791,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01401,Galsulfase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01401,galsulfase,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790790,444013,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01044,GADOVERSETAMIDE,20250421,20210312,Curation Efforts|Governmental Organizations,LT01044,gadoversetamide,0.0,No match,vNo-DILI-Concern,2.0,444013,1.0,614.0,13.0,2.0,19.0,AAADcfB7vAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQAAAAAADhgAYCCAPABAAIAAGQGAAAAAAAAAAAAICIAAACQAAAACARAAAAFgCQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-[bis[2-[carboxylatomethyl-[2-(2-methoxyethylamino)-2-oxo-ethyl]amino]ethyl]amino]acetate;gadolinium(3+),2-[bis[2-[carboxylatomethyl-[2-(2-methoxyethylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+),2-[bis[2-[carboxylatomethyl-[2-(2-methoxyethylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+),2-[bis[2-[carboxylatomethyl-[2-(2-methoxyethylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+),2-[bis[2-[[2-(2-methoxyethylamino)-2-oxidanylidene-ethyl]-(2-oxidanidyl-2-oxidanylidene-ethyl)amino]ethyl]amino]ethanoate;gadolinium(3+),2-[bis[2-[carboxylatomethyl-[2-keto-2-(2-methoxyethylamino)ethyl]amino]ethyl]amino]acetate;gadolinium(3+),"InChI=1S/C20H37N5O10.Gd/c1-34-9-3-21-16(26)11-24(14-19(30)31)7-5-23(13-18(28)29)6-8-25(15-20(32)33)12-17(27)22-4-10-35-2;/h3-15H2,1-2H3,(H,21,26)(H,22,27)(H,28,29)(H,30,31)(H,32,33);/q;+3/p-3",HBEAOBRDTOXWRZ-UHFFFAOYSA-K,,662.15468,C20H34GdN5O10,661.8,207.0,662.15468,0.0,36.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",COCCNC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-].[Gd+3],,,
440790789,60714,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00952,GADOTERIDOL,20231222,20210312,Curation Efforts|Governmental Organizations,LT00952,gadoteridol,0.0,No match,vNo-DILI-Concern,2.0,60714,1.0,471.0,11.0,1.0,5.0,AAADceB7uAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAACAAACBThgAYCCAMAAgAIAACQCAAAAAAAAAAAAACIAAACUAAAACAUAAAAAACQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)","2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)","2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)","2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)","2-[4,7-bis(2-oxidanidyl-2-oxidanylidene-ethyl)-10-(2-oxidanylpropyl)-1,4,7,10-tetrazacyclododec-1-yl]ethanoate;gadolinium(3+)","2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)","InChI=1S/C17H32N4O7.Gd/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);/q;+3/p-3",DPNNNPAKRZOSMO-UHFFFAOYSA-K,,559.12774,C17H29GdN4O7,558.7,154.0,559.12774,0.0,29.0,0.0,1.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CC(O)CN1CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC1.[Gd+3],,22  2  3,
440790788,55466,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00935,GADOPENTETATE DIMEGLUMINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00935,gadopentetate dimeglumine,0.0,No match,vNo-DILI-Concern,2.0,55466,1.0,631.0,25.0,14.0,25.0,AAADcfB7vgAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAACBThgAYCCAPAAgAIAACQCAAAAAAAAAAAAICIAAADUAIAgCAUQAAHEACRAAHwcAYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol","2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol","2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>)-6-(methylamino)hexane-1,2,3,4,5-pentol","2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol","2-[bis[2-[2-hydroxy-2-oxoethyl-(2-oxidanidyl-2-oxidanylidene-ethyl)amino]ethyl]amino]ethanoate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol","2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol","InChI=1S/C14H23N3O10.2C7H17NO5.Gd/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;2*1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);2*4-13H,2-3H2,1H3;/q;;;+3/p-3/t;2*4-,5+,6+,7+;/m.00./s1",LGMLJQFQKXPRGA-VPVMAENOSA-K,,938.26033,C28H54GdN5O20,938.0,431.0,938.26033,0.0,54.0,8.0,0.0,0.0,0.0,0.0,4.0,-1.0,"1
5
255",CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)O)CCN(CC(=O)[O-])CC(=O)O.[Gd+3],,"27  2  6
28  3  6
29  4  6
30  5  6
31  6  6
32  7  6
33  8  5
34  9  5",
440790787,91754427,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02404,Gadolinium Ethoxybenzyl Dtpa,20231222,20210312,Curation Efforts|Governmental Organizations,LT02404,gadolinium ethoxybenzyl DTPA,0.0,No match,vNo-DILI-Concern,2.0,91754427,1.0,746.0,14.0,0.0,4.0,AAADceB7PDAAAAAAAAAAAAAgAAAAAWLFixYwAAAAAAAWLAABAAAAHgAAAAAADCzhmAYyDoMABACIAiDSCAACCAAgIAAIiACOCIgOZiKEsTuWOCCkwBGYqAeQwKAOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,disodium;2-[[2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+),disodium;2-[[2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+),disodium;2-[[2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+),disodium;2-[[2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+),disodium;2-[[2-[bis(2-oxidanidyl-2-oxidanylidene-ethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(2-oxidanidyl-2-oxidanylidene-ethyl)amino]ethyl]amino]ethanoate;gadolinium(3+),disodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-[2-[bis(carboxylatomethyl)amino]-3-p-phenetyl-propyl]amino]acetate;gadolinium(3+),"InChI=1S/C23H33N3O11.Gd.2Na/c1-2-37-18-5-3-16(4-6-18)9-17(26(14-22(33)34)15-23(35)36)10-24(11-19(27)28)7-8-25(12-20(29)30)13-21(31)32;;;/h3-6,17H,2,7-15H2,1H3,(H,27,28)(H,29,30)(H,31,32)(H,33,34)(H,35,36);;;/q;+3;2*+1/p-5",SLYTULCOCGSBBJ-UHFFFAOYSA-I,,726.07603,C23H28GdN3Na2O11,725.7,220.0,726.07603,0.0,40.0,0.0,1.0,0.0,0.0,0.0,4.0,-1.0,"1
5
255",CCOc1ccc(CC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])cc1.[Gd+3].[Na+].[Na+],,"18  32  3
33  34  8
33  35  8
34  36  8
35  37  8
36  38  8
37  38  8","1  15  6
1  16  6
1  17  6
1  4  6
1  5  6
1  6  6
1  7  6
1  8  6"
440790786,73049652,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00528,Gadofosveset trisodium,20231222,20210312,Curation Efforts|Governmental Organizations,LT00528,gadofosveset trisodium,0.0,No match,vNo-DILI-Concern,2.0,73049652,1.0,1130.0,17.0,0.0,18.0,AAADcfB/PDIAAAAAAAAAAAAgAAAAAAAAAAAwYMAAAAAAAAABQAAAHgAAACAADjzhmAYwCIMAARCIQiDSCIACAAAgAAAIiACIAIgKYCKAETCUIAAmgACYiAeAwPAPgAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"trisodium;2-[[2-[bis(carboxylatomethyl)amino]-3-[(4,4-diphenylcyclohexoxy)-oxido-phosphoryl]oxy-propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+)","trisodium;2-[[2-[bis(carboxylatomethyl)amino]-3-[(4,4-diphenylcyclohexyl)oxy-oxidophosphoryl]oxypropyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+)","trisodium;2-[[2-[bis(carboxylatomethyl)amino]-3-[(4,4-diphenylcyclohexyl)oxy-oxidophosphoryl]oxypropyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+)","trisodium;2-[[2-[bis(carboxylatomethyl)amino]-3-[(4,4-diphenylcyclohexyl)oxy-oxidophosphoryl]oxypropyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+)","trisodium;2-[[2-[bis(2-oxidanidyl-2-oxidanylidene-ethyl)amino]-3-[(4,4-diphenylcyclohexyl)oxy-oxidanidyl-phosphoryl]oxy-propyl]-[2-[bis(2-oxidanidyl-2-oxidanylidene-ethyl)amino]ethyl]amino]ethanoate;gadolinium(3+)","trisodium;2-[[2-[bis(carboxylatomethyl)amino]-3-[(4,4-diphenylcyclohexoxy)-oxido-phosphoryl]oxy-propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+)","InChI=1S/C33H44N3O14P.Gd.3Na/c37-28(38)18-34(15-16-35(19-29(39)40)20-30(41)42)17-26(36(21-31(43)44)22-32(45)46)23-49-51(47,48)50-27-11-13-33(14-12-27,24-7-3-1-4-8-24)25-9-5-2-6-10-25;;;;/h1-10,26-27H,11-23H2,(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H,45,46)(H,47,48);;;;/q;+3;3*+1/p-6",XGOSYNSWSRUASG-UHFFFAOYSA-H,,958.10256,C33H38GdN3Na3O14P,957.9,269.0,958.10256,0.0,55.0,0.0,1.0,0.0,0.0,0.0,5.0,-1.0,"1
5
255",O=C([O-])CN(CCN(CC(=O)[O-])CC(COP(=O)([O-])OC1CCC(c2ccccc2)(c2ccccc2)CC1)N(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3].[Na+].[Na+].[Na+],,"29  31  8
29  33  8
30  32  8
30  34  8
31  35  8
32  36  8
33  37  8
34  38  8
35  40  8
36  41  8
37  40  8
38  41  8
39  43  3",
440790785,6918204,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01127,Gadobenate dimeglumine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01127,gadobenate dimeglumine,0.0,No match,vNo-DILI-Concern,2.0,6918204,1.0,860.0,26.0,14.0,29.0,AAADcfB/vgAAAAAAAAAAAAAgAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADDzhmAYyCIPABgCIAiDSCAACAAAgAAAIiIGICIgLdiaAsTiXcAAn8AGZqAfw8CYOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3-benzyloxy-2-[2-[carboxylatomethyl-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]ethyl-(carboxymethyl)amino]propanoate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol","2-[2-[carboxylatomethyl-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]ethyl-(carboxymethyl)amino]-3-phenylmethoxypropanoate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol","2-[2-[carboxylatomethyl-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]ethyl-(carboxymethyl)amino]-3-phenylmethoxypropanoate;gadolinium(3+);(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>)-6-(methylamino)hexane-1,2,3,4,5-pentol","2-[2-[carboxylatomethyl-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]ethyl-(carboxymethyl)amino]-3-phenylmethoxypropanoate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol","gadolinium(3+);2-[2-hydroxy-2-oxoethyl-[2-[2-[2-hydroxy-2-oxoethyl-(2-oxidanidyl-2-oxidanylidene-ethyl)amino]ethyl-(2-oxidanidyl-2-oxidanylidene-ethyl)amino]ethyl]amino]-3-phenylmethoxy-propanoate;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol","3-benzoxy-2-[2-[carboxylatomethyl-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]ethyl-(carboxymethyl)amino]propionate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol","InChI=1S/C22H31N3O11.2C7H17NO5.Gd/c26-18(27)10-23(6-7-24(11-19(28)29)12-20(30)31)8-9-25(13-21(32)33)17(22(34)35)15-36-14-16-4-2-1-3-5-16;2*1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-5,17H,6-15H2,(H,26,27)(H,28,29)(H,30,31)(H,32,33)(H,34,35);2*4-13H,2-3H2,1H3;/q;;;+3/p-3/t;2*4-,5+,6+,7+;/m.00./s1",OCDAWJYGVOLXGZ-VPVMAENOSA-K,,1058.31784,C36H62GdN5O21,1058.1,440.0,1058.31784,0.0,63.0,8.0,1.0,0.0,0.0,0.0,4.0,-1.0,"1
5
255",CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)O)CCN(CC(=O)O)C(COCc1ccccc1)C(=O)[O-].[Gd+3],,"43  10  5
33  2  6
34  3  6
31  41  3
35  5  6
58  59  8
58  60  8
59  61  8
36  6  6
60  62  8
61  63  8
62  63  8
37  7  6
38  8  6
42  9  5",
440790784,77992,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01054,Frovatriptan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01054,frovatriptan,0.0,No match,vNo-DILI-Concern,2.0,77992,1.0,333.0,2.0,3.0,2.0,AAADceBzIAAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgB8AAAHgAQAAAADCjBngQywPLJkACoAyVyVACCgCAlAiAImaE4ZNgIIPLAlZGEIQhgkADIyYcYicCeiAACAAACAAAQAQSAAAQAAAAAAAAAAA==,"(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide","(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide","(6<I>R</I>)-6-(methylamino)-6,7,8,9-tetrahydro-5<I>H</I>-carbazole-3-carboxamide","(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide","(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide","(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide","InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1",XPSQPHWEGNHMSK-SECBINFHSA-N,,243.137162174,C14H17N3O,243.3,70.9,243.137162174,0.0,18.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,1.2,"11  12  8
11  13  8
12  14  8
13  15  8
14  17  8
15  17  8
2  10  8
2  12  8
5  3  6
8  10  8
8  11  8",
440790783,135398658,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01580,folic acid,20250421,20210312,Curation Efforts|Governmental Organizations,LT01580,folic acid,0.0,No match,vNo-DILI-Concern,1.0,135398658,1.0,767.0,10.0,6.0,9.0,AAADceB7uAAAAAAAAAAAAAAAAAAAAAAAAAA8QIAAAAAAAACBwAAAHgAQCAAADCjBngQ9+JLIEgCoAzf3fACCgC03EiAJ2IG4dMiKYHrA3bGUYYhklwLYyee8rwCeCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,(2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,(2S)-2-[[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]phenyl]-oxomethyl]amino]pentanedioic acid,(2<I>S</I>)-2-[[4-[(2-amino-4-oxo-3<I>H</I>-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,(2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,(2S)-2-[[4-[(2-azanyl-4-oxidanylidene-3H-pteridin-6-yl)methylamino]phenyl]carbonylamino]pentanedioic acid,(2S)-2-[[4-[(2-amino-4-keto-3H-pteridin-6-yl)methylamino]benzoyl]amino]glutaric acid,"InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1",OVBPIULPVIDEAO-LBPRGKRZSA-N,,441.13968135,C19H19N7O6,441.4,209.0,441.13968135,0.0,32.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc2ncc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)nc2c(=O)[nH]1,-1.1,"10  29  8
10  30  8
11  31  8
11  32  8
12  30  8
12  32  8
18  22  8
18  23  8
20  24  8
20  25  8
22  24  8
23  25  8
27  29  8
28  30  8
28  31  8
14  7  6
9  27  8
9  28  8",
440790782,16850,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00894,fluorescein,20210804,20210312,Curation Efforts|Governmental Organizations,LT00894,fluorescein,0.0,No match,vNo-DILI-Concern,2.0,16850,1.0,522.0,5.0,2.0,0.0,AAADccB4OAAAAAAAAAAAAAAAAAAAASAAAAA0YMEAAAAAAEiRUAAAGgAACAAADESAmAAwDoAABgCIAiDSCAACCAAkIAAIiAEGCMgMJzKGNRqCeSClwBUIuYeK6PyOoAAACAAYAABAAAAQADAAAAAAAAAAAA==,"3',6'-dihydroxyspiro[isobenzofuran-3,9'-xanthene]-1-one","3',6'-dihydroxy-1-spiro[isobenzofuran-3,9'-xanthene]one","3&apos;,6&apos;-dihydroxyspiro[2-benzofuran-3,9&apos;-xanthene]-1-one","3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one","3',6'-bis(oxidanyl)spiro[2-benzofuran-3,9'-xanthene]-1-one",fluorescein,"InChI=1S/C20H12O5/c21-11-5-7-15-17(9-11)24-18-10-12(22)6-8-16(18)20(15)14-4-2-1-3-13(14)19(23)25-20/h1-10,21-22H",GNBHRKFJIUUOQI-UHFFFAOYSA-N,,332.06847348,C20H12O5,332.3,76.0,332.06847348,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccccc21,3.4,"10  17  8
11  18  8
12  19  8
14  20  8
15  21  8
16  22  8
17  23  8
18  24  8
19  25  8
20  23  8
21  24  8
22  25  8
7  10  8
7  14  8
8  11  8
8  15  8
9  12  8
9  16  8",
440790781,3373,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01384,flumazenil,20210312,20210312,Curation Efforts|Governmental Organizations,LT01384,flumazenil,0.0,No match,vNo-DILI-Concern,2.0,3373,1.0,461.0,5.0,0.0,3.0,AAADccBzMQAAAAAAAAAAAAAAAAAAAWAAAAAwAAAABYAAAACxwAAAHwAAAAAADAjhng432JcMFACoAyXzfASCgC03EqAJ2AG4fMiKbnrA/bmXMYhuhgLY6ec8iACOAAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate","8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester","ethyl 8-fluoro-5-methyl-6-oxo-4<I>H</I>-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate","ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate","ethyl 8-fluoranyl-5-methyl-6-oxidanylidene-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate","8-fluoro-6-keto-5-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester","InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3",OFBIFZUFASYYRE-UHFFFAOYSA-N,1.0,303.10191948,C15H14FN3O3,303.29,64.4,303.10191948,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2,,"10  11  8
10  15  8
11  17  8
15  18  8
17  20  8
18  20  8
5  14  8
5  8  8
7  12  8
7  14  8
8  12  8",
440790780,31378,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00399,fludrocortisone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00399,fludrocortisone,0.0,No match,vNo-DILI-Concern,2.0,31378,1.0,734.0,6.0,3.0,2.0,AAADceB4OQAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGwAACAAAD1SggAICAAAAAgCIAqBSAAIAAAAgAAAACAFAAEgAEBIAAQAAQAAFgAAIAQPIzPDPgAAAAAAAAADAAAYAADAAAYAADAAAAA==,"(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8<I>S</I>,9<I>R</I>,10<I>S</I>,11<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,17R)-9-fluoranyl-10,13-dimethyl-11,17-bis(oxidanyl)-17-(2-oxidanylethanoyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-17-glycoloyl-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","InChI=1S/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1",AAXVEMMRQDVLJB-BULBTXNYSA-N,1.7,380.19990218,C21H29FO5,380.4,94.8,380.19990218,0.0,27.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F,,"10  1  6
13  22  5
11  2  6
14  3  5
7  18  5
8  28  6
9  29  5",
440790779,657237,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01382,Fludarabine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01382,fludarabine,0.0,No match,vNo-DILI-Concern,2.0,657237,1.0,367.0,9.0,4.0,2.0,AAADccBzuQAAAAAAAAAAAAAAAAAAAWJAAAAsAAAAAAAAAFgB+AAAHwAQCAAACBzhlwYF8L9MFgCgAQZhZACAgC0REKABUCAoVBCDWAJAyEAeRAgPAALTACDwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3S,4S,5R)-2-(6-amino-2-fluoro-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol","(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol","(2<I>R</I>,3<I>S</I>,4<I>S</I>,5<I>R</I>)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","(2R,3S,4S,5R)-2-(6-azanyl-2-fluoranyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","(2R,3S,4S,5R)-2-(6-amino-2-fluoro-purin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol","InChI=1S/C10H12FN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6+,9-/m1/s1",HBUBKKRHXORPQB-FJFJXFQQSA-N,-0.6,285.08733204,C10H12FN5O4,285.23,140.0,285.08733204,0.0,20.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,,"14  15  6
16  18  8
18  19  8
11  3  6
13  4  5
12  6  6
6  16  8
6  17  8
7  17  8
7  18  8
8  16  8
8  20  8
9  19  8
9  20  8",
440790778,3354,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00857,flavoxate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00857,flavoxate,0.0,No match,vNo-DILI-Concern,1.0,3354,1.0,631.0,5.0,0.0,6.0,AAADceB6OAAAAAAAAAAAAAAAAAAAAAAAAAA8YIEAAAAAAACBQAAAHgAAAAAADAThmAYyDoMABACIAqDSCAACCAAkIAAIiAEMCMgOJzaEtRqHOWCl4BGYqYeYzuCuAAACAAAIAAAAAAQAABAAAAAAAAAAAA==,2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenyl-chromene-8-carboxylate,3-methyl-4-oxo-2-phenyl-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester,2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate,2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate,2-piperidin-1-ylethyl 3-methyl-4-oxidanylidene-2-phenyl-chromene-8-carboxylate,4-keto-3-methyl-2-phenyl-chromene-8-carboxylic acid 2-piperidinoethyl ester,"InChI=1S/C24H25NO4/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25/h2,4-5,8-12H,3,6-7,13-16H2,1H3",SPIUTQOUKAMGCX-UHFFFAOYSA-N,,391.17835828,C24H25NO4,391.5,55.8,391.17835828,0.0,29.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,4.3,"13  15  8
13  20  8
15  16  8
16  19  8
16  21  8
17  18  8
17  19  8
2  15  8
2  18  8
20  23  8
21  23  8
22  25  8
22  26  8
25  27  8
26  28  8
27  29  8
28  29  8",
440790777,3348,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01370,fexofenadine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01370,fexofenadine,0.0,No match,vNo-DILI-Concern,2.0,3348,1.0,678.0,5.0,3.0,10.0,AAADcfB+OAAAAAAAAAAAAAAAAAAAAAAAAAA8YMEAAAAAAAABUAAAHgAACAAAD1ThmAYyCIMAAgCIAiDSCAACAAAgAAAIiAEICIgINjKAlRCEcAAkwAGImAe4yPCPwAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid,2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidinyl]butyl]phenyl]-2-methylpropanoic acid,2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid,2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid,2-methyl-2-[4-[1-oxidanyl-4-[4-[oxidanyl(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]propanoic acid,2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidino]butyl]phenyl]-2-methyl-propionic acid,"InChI=1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36)",RWTNPBWLLIMQHL-UHFFFAOYSA-N,,501.28790873,C32H39NO4,501.7,81.0,501.28790873,0.0,37.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,3.0,"13  17  8
13  19  8
14  18  8
14  20  8
17  22  8
18  23  8
19  24  8
20  25  8
21  58  3
22  27  8
23  28  8
24  27  8
25  28  8
26  29  8
26  30  8
29  33  8
30  34  8
32  33  8
32  34  8",
440790776,6918558,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00590,Fesoterodine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00590,fesoterodine,0.0,No match,vNo-DILI-Concern,2.0,6918558,1.0,491.0,4.0,1.0,11.0,AAADcfB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAACAAADSzhmAYyDoMABgCIAiDSCAACCAAgIAAIiAEOCIgMNiKEsRqGeiCkwBGIuAeQ8P4OoAACAAAIAABAAAQAABAAAAAAAAAAAA==,[2-[(1R)-3-(diisopropylamino)-1-phenyl-propyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate,2-methylpropanoic acid [2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] ester,[2-[(1<I>R</I>)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate,[2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate,[2-[(1R)-3-[di(propan-2-yl)amino]-1-phenyl-propyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate,2-methylpropionic acid [2-[(1R)-3-(diisopropylamino)-1-phenyl-propyl]-4-methylol-phenyl] ester,"InChI=1S/C26H37NO3/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3/t23-/m1/s1",DCCSDBARQIPTGU-HSZRJFAPSA-N,,411.27734404,C26H37NO3,411.6,49.8,411.27734404,0.0,30.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1,5.5,"10  16  8
10  17  8
11  18  8
11  19  8
16  21  8
17  20  8
18  23  8
19  24  8
20  22  8
21  22  8
23  26  8
24  26  8
7  6  6",
440790775,14789,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00650,Ferumoxytol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00650,ferumoxytol,0.0,No match,vNo-DILI-Concern,2.0,14789,1.0,27.9,4.0,2.0,0.0,AAADcQAAOAAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,hydroxy(oxo)iron;iron,hydroxy(oxo)iron;iron,hydroxy(oxo)iron;iron,hydroxy(oxo)iron;iron,iron;oxidanyl(oxidanylidene)iron,hydroxy(keto)iron;iron,InChI=1S/3Fe.2H2O.2O/h;;;2*1H2;;/q;2*+1;;;;/p-2,UCNNJGDEJXIUCC-UHFFFAOYSA-L,,233.800115,Fe3H2O4,233.55,74.6,233.800115,0.0,7.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",[Fe].[O]=[Fe][OH].[O]=[Fe][OH],,,"1  4  6
1  5  6"
440790774,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00966,Ferumoxsil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00966,ferumoxsil,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790773,6432052,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00967,Ferumoxides,20231222,20210312,Curation Efforts|Governmental Organizations,LT00967,ferumoxides,0.0,No match,vNo-DILI-Concern,2.0,6432052,1.0,0.0,4.0,0.0,0.0,AAADcQAAOAAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,diferric;ferrous;oxygen(2-),iron(2+);iron(3+);oxygen(2-),iron(2+);iron(3+);oxygen(2-),iron(2+);iron(3+);oxygen(2-),iron(2+);iron(3+);oxygen(2-),diferric;ferrous;oxygen(2-),InChI=1S/3Fe.4O/q+2;2*+3;4*-2,WTFXARWRTYJXII-UHFFFAOYSA-N,,231.784465,Fe3O4,231.53,4.0,231.784465,0.0,7.0,0.0,0.0,0.0,0.0,0.0,7.0,-1.0,"1
5
255",[Fe+2].[Fe+3].[Fe+3].[O-2].[O-2].[O-2].[O-2],,,
440790772,3341,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00944,fenoldopam,20210312,20210312,Curation Efforts|Governmental Organizations,LT00944,fenoldopam,0.0,No match,vNo-DILI-Concern,2.0,3341,1.0,348.0,4.0,4.0,1.0,AAADceB6MAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAABYAAAAABQAAAHgIQCAAADQbBmCQwBoLAAgCAAiBCAAACAAAgJEAIiIAOi4gJJiKDkxOEcAEk0BGJmAeQ0PIOoAABIQARSABAAAJCACKQAAAAAAAAAA==,"9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol","9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol","9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1<I>H</I>-3-benzazepine-7,8-diol","9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol","9-chloranyl-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol","9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol","InChI=1S/C16H16ClNO3/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21/h1-4,7,13,18-21H,5-6,8H2",TVURRHSHRRELCG-UHFFFAOYSA-N,2.4,305.0818711,C16H16ClNO3,305.75,72.7,305.0818711,0.0,21.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,,"12  16  8
12  17  8
13  15  8
14  18  8
15  18  8
16  19  8
17  20  8
19  21  8
20  21  8
6  12  3
7  13  8
7  9  8
9  14  8",
440790771,45588096,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00537,Exenatide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00537,exenatide,0.0,No match,vNo-DILI-Concern,2.0,45588096,1.0,10300.0,66.0,58.0,135.0,AAADcfB//gBAAAAAAAAAAAAAAAAAAWLFixYwYMAAAAAAAFgB/AAAHgQQCAAADTzl3ga/2PfJkgioAzX3fACCgC2xErAJ2aG4dJiKeP7g2bGUYAhutgLYyCe/n8KOgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"(4S)-5-[[2-[[(1S,2R)-1-[[(1S)-2-[[(1S,2R)-1-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-5-amino-1-[[(1S)-4-amino-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S,2S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-5-amino-1-[[(1S)-3-amino-1-[[2-[[2-[(2S)-2-[[(1S)-2-[[(1S)-2-[[2-[[(1S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[[(1S)-2-amino-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-methyl-2-oxo-ethyl]amino]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]pyrrolidin-1-yl]-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-oxo-propyl]carbamoyl]pentyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-2-methyl-butyl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-2-methyl-propyl]amino]-1-methyl-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-methylsulfanyl-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]pentyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]-3-methyl-butyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]amino]-2-oxo-ethyl]amino]-4-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]acetyl]amino]-5-oxo-pentanoic acid","(4S)-5-[[2-[[(2S,3R)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[2-[[2-[(2S)-2-[[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-oxomethyl]-1-pyrrolidinyl]-oxomethyl]-1-pyrrolidinyl]-oxomethyl]-1-pyrrolidinyl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-oxomethyl]-1-pyrrolidinyl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-(methylthio)-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-4-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)-1-oxopropyl]amino]-1-oxoethyl]amino]-5-oxopentanoic acid","(4<I>S</I>)-5-[[2-[[(2<I>S</I>,3<I>R</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>,3<I>R</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-6-amino-1-[[(2<I>S</I>)-5-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>,3<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-6-amino-1-[[(2<I>S</I>)-4-amino-1-[[2-[[2-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[2-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[(2<I>S</I>)-2-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-4-[[2-[[(2<I>S</I>)-2-amino-3-(1<I>H</I>-imidazol-4-yl)propanoyl]amino]acetyl]amino]-5-oxopentanoic acid","(4S)-5-[[2-[[(2S,3R)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-4-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]acetyl]amino]-5-oxopentanoic acid","(4S)-5-[[2-[[(2S,3R)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-azanyl-1-[[(2S)-5-azanyl-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-azanyl-1-[[(2S)-4-azanyl-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-azanyl-3-oxidanyl-1-oxidanylidene-propan-2-yl]carbamoyl]pyrrolidin-1-yl]carbonylpyrrolidin-1-yl]carbonylpyrrolidin-1-yl]-1-oxidanylidene-propan-2-yl]amino]-2-oxidanylidene-ethyl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxidanylidene-ethyl]amino]-2-oxidanylidene-ethyl]amino]-1,4-bis(oxidanylidene)butan-2-yl]amino]-1-oxidanylidene-hexan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-3-methyl-1-oxidanylidene-pentan-2-yl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-4-methylsulfanyl-1-oxidanylidene-butan-2-yl]amino]-1,5-bis(oxidanylidene)pentan-2-yl]amino]-1-oxidanylidene-hexan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-butan-2-yl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-butan-2-yl]amino]-2-oxidanylidene-ethyl]amino]-4-[2-[[(2S)-2-azanyl-3-(1H-imidazol-4-yl)propanoyl]amino]ethanoylamino]-5-oxidanylidene-pentanoic acid","(4S)-5-[[2-[[(1S,2R)-1-[[(1S)-2-[[(1S,2R)-1-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[(1S)-2-[[(1S)-5-amino-1-[[(1S)-4-amino-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S,2S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-5-amino-1-[[(1S)-3-amino-1-[[2-[[2-[(2S)-2-[[(1S)-2-[[(1S)-2-[[2-[[(1S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[[(1S)-2-amino-2-keto-1-methylol-ethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidino]-2-keto-1-methyl-ethyl]amino]-2-keto-ethyl]amino]-2-keto-1-methylol-ethyl]amino]-2-keto-1-methylol-ethyl]carbamoyl]pyrrolidino]-2-keto-ethyl]amino]-2-keto-ethyl]carbamoyl]-3-keto-propyl]carbamoyl]pentyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-2-methyl-butyl]amino]-1-benzyl-2-keto-ethyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-2-methyl-propyl]amino]-2-keto-1-methyl-ethyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-(methylthio)propyl]carbamoyl]-4-keto-butyl]carbamoyl]pentyl]amino]-2-keto-1-methylol-ethyl]carbamoyl]-3-methyl-butyl]amino]-1-(carboxymethyl)-2-keto-ethyl]amino]-2-keto-1-methylol-ethyl]carbamoyl]-2-hydroxy-propyl]amino]-1-benzyl-2-keto-ethyl]carbamoyl]-2-hydroxy-propyl]amino]-2-keto-ethyl]amino]-4-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]acetyl]amino]-5-keto-valeric acid","InChI=1S/C184H282N50O60S/c1-16-94(10)147(178(289)213-114(52-58-144(257)258)163(274)218-121(73-101-77-195-105-39-24-23-38-103(101)105)168(279)215-116(68-90(2)3)165(276)205-107(41-26-28-61-186)158(269)219-122(75-134(189)243)154(265)198-79-135(244)196-83-139(248)231-63-30-43-129(231)175(286)225-127(87-238)174(285)223-125(85-236)155(266)200-80-136(245)202-96(12)181(292)233-65-32-45-131(233)183(294)234-66-33-46-132(234)182(293)232-64-31-44-130(232)176(287)222-124(84-235)150(190)261)229-170(281)119(71-99-34-19-17-20-35-99)217-166(277)117(69-91(4)5)214-159(270)108(42-29-62-194-184(191)192)212-177(288)146(93(8)9)228-151(262)95(11)203-156(267)111(49-55-141(251)252)208-161(272)112(50-56-142(253)254)209-162(273)113(51-57-143(255)256)210-164(275)115(59-67-295-15)211-160(271)110(47-53-133(188)242)207-157(268)106(40-25-27-60-185)206-172(283)126(86-237)224-167(278)118(70-92(6)7)216-169(280)123(76-145(259)260)220-173(284)128(88-239)226-180(291)149(98(14)241)230-171(282)120(72-100-36-21-18-22-37-100)221-179(290)148(97(13)240)227-138(247)82-199-153(264)109(48-54-140(249)250)204-137(246)81-197-152(263)104(187)74-102-78-193-89-201-102/h17-24,34-39,77-78,89-98,104,106-132,146-149,195,235-241H,16,25-33,40-76,79-88,185-187H2,1-15H3,(H2,188,242)(H2,189,243)(H2,190,261)(H,193,201)(H,196,244)(H,197,263)(H,198,265)(H,199,264)(H,200,266)(H,202,245)(H,203,267)(H,204,246)(H,205,276)(H,206,283)(H,207,268)(H,208,272)(H,209,273)(H,210,275)(H,211,271)(H,212,288)(H,213,289)(H,214,270)(H,215,279)(H,216,280)(H,217,277)(H,218,274)(H,219,269)(H,220,284)(H,221,290)(H,222,287)(H,223,285)(H,224,278)(H,225,286)(H,226,291)(H,227,247)(H,228,262)(H,229,281)(H,230,282)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,259,260)(H4,191,192,194)/t94-,95-,96-,97+,98+,104-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,146-,147-,148-,149-/m0/s1",HTQBXNHDCUEHJF-XWLPCZSASA-N,,4185.0306624,C184H282N50O60S,4187.0,1780.0,4184.0273075,0.0,295.0,37.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(\N)NCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)CC,-21.0,"259  101  5
262  103  6
267  104  5
271  105  5
283  107  5
291  109  6
110  293  8
110  295  8
111  294  8
111  295  8
112  118  6
114  117  6
119  127  6
141  142  6
169  179  5
173  183  8
173  188  8
183  190  8
183  197  8
190  201  8
196  206  8
196  207  8
197  204  8
201  205  8
204  205  8
206  212  8
207  213  8
212  214  8
213  214  8
272  275  8
272  276  8
275  278  8
276  279  8
278  281  8
279  281  8
293  294  8
265  51  5
274  55  6
129  65  5
128  66  6
136  69  6
139  70  5
151  74  5
155  75  6
159  77  6
164  79  5
168  80  6
171  81  5
176  82  5
177  83  6
84  188  8
84  190  8
186  85  5
195  86  6
211  88  5
216  89  6
220  91  5
224  93  5
230  94  6
227  95  6
225  96  5
231  97  5
235  98  6
250  99  6",
440790770,9552071,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02329,Exametazime,20231222,20210312,Curation Efforts|Governmental Organizations,LT02329,exametazime,0.0,No match,vNo-DILI-Concern,2.0,9552071,1.0,297.0,6.0,4.0,8.0,AAADceBzsAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAAUCAAADijBAAQCAALQAAAgAQAgAAAAAAAAAAAAAIA4AAAAAAAAQAAEAAAAEACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3R)-3-[[3-[[(1R,2E)-2-hydroxyimino-1-methyl-propyl]amino]-2,2-dimethyl-propyl]amino]butan-2-one oxime","(3R)-3-[[3-[[(2R,3E)-3-hydroxyiminobutan-2-yl]amino]-2,2-dimethylpropyl]amino]-2-butanone oxime","(<I>N</I><I>E</I>)-<I>N</I>-[(3<I>R</I>)-3-[[3-[[(2<I>R</I>,3<I>E</I>)-3-hydroxyiminobutan-2-yl]amino]-2,2-dimethylpropyl]amino]butan-2-ylidene]hydroxylamine","(NE)-N-[(3R)-3-[[3-[[(2R,3E)-3-hydroxyiminobutan-2-yl]amino]-2,2-dimethylpropyl]amino]butan-2-ylidene]hydroxylamine","(NE)-N-[(3R)-3-[[3-[[(2R,3E)-3-hydroxyiminobutan-2-yl]amino]-2,2-dimethyl-propyl]amino]butan-2-ylidene]hydroxylamine","(3R)-3-[[3-[[(1R,2E)-2-hydroximino-1-methyl-propyl]amino]-2,2-dimethyl-propyl]amino]butan-2-one oxime","InChI=1S/C13H28N4O2/c1-9(11(3)16-18)14-7-13(5,6)8-15-10(2)12(4)17-19/h9-10,14-15,18-19H,7-8H2,1-6H3/b16-11+,17-12+/t9-,10-/m1/s1",BPNZYADGDZPRTK-UDUYQYQQSA-N,,272.22122615,C13H28N4O2,272.39,89.2,272.22122615,0.0,19.0,2.0,0.0,2.0,0.0,0.0,1.0,-1.0,"1
5
255",C/C(=N\O)[C@@H](C)NCC(C)(C)CN[C@H](C)/C(C)=N/O,1.4,"12  3  6
13  4  6",
440790769,667484,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01357,Etomidate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01357,etomidate,0.0,No match,vNo-DILI-Concern,2.0,667484,1.0,277.0,3.0,0.0,5.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHgAAAAAADCjhngY/mJcMFACoAzT3bASCgC03EqAJ2AG4fMiKbCrAuTmXIIhqgALYqOcQgIAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate,3-[(1R)-1-phenylethyl]-4-imidazolecarboxylic acid ethyl ester,ethyl 3-[(1<I>R</I>)-1-phenylethyl]imidazole-4-carboxylate,ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate,ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate,3-[(1R)-1-phenylethyl]imidazole-4-carboxylic acid ethyl ester,"InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3/t11-/m1/s1",NPUKDXXFDDZOKR-LLVKDONJSA-N,3.0,244.121177757,C14H16N2O2,244.29,44.1,244.121177757,0.0,18.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)c1cncn1[C@H](C)c1ccccc1,,"10  14  8
11  15  8
14  16  8
15  16  8
3  8  8
3  9  8
4  12  8
4  9  8
5  7  5
6  10  8
6  11  8
8  12  8",
440790768,3305,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01355,Etidronic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT01355,etidronic acid,0.0,No match,vNo-DILI-Concern,1.0,3305,1.0,211.0,7.0,5.0,2.0,AAADccBAOAMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGggACCAAAACAgAACAAAAAhAAQAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(1-hydroxy-1-phosphono-ethyl)phosphonic acid,(1-hydroxy-1-phosphonoethyl)phosphonic acid,(1-hydroxy-1-phosphonoethyl)phosphonic acid,(1-hydroxy-1-phosphonoethyl)phosphonic acid,(1-oxidanyl-1-phosphono-ethyl)phosphonic acid,(1-hydroxy-1-phosphono-ethyl)phosphonic acid,"InChI=1S/C2H8O7P2/c1-2(3,10(4,5)6)11(7,8)9/h3H,1H3,(H2,4,5,6)(H2,7,8,9)",DBVJJBKOTRCVKF-UHFFFAOYSA-N,,205.97452659,C2H8O7P2,206.03,135.0,205.97452659,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(O)(P(=O)(O)O)P(=O)(O)O,-3.7,,
440790767,5282489,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00926,ETHANOLAMINE OLEATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00926,ethanolamine oleate,0.0,No match,vNo-DILI-Concern,1.0,5282489,1.0,244.0,4.0,3.0,16.0,AAADcfB6MAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAACADhgAYCCABAAgCIACDSCAAAAAAgAAAICIEAAAgCEBIAAQAAQAAEkAAIAAOIyKCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-aminoethanol;(Z)-octadec-9-enoic acid,2-aminoethanol;(Z)-9-octadecenoic acid,2-aminoethanol;(<I>Z</I>)-octadec-9-enoic acid,2-aminoethanol;(Z)-octadec-9-enoic acid,2-azanylethanol;(Z)-octadec-9-enoic acid,2-aminoethanol;oleic acid,"InChI=1S/C18H34O2.C2H7NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;3-1-2-4/h9-10H,2-8,11-17H2,1H3,(H,19,20);4H,1-3H2/b10-9-;",KGWDUNBJIMUFAP-KVVVOXFISA-N,,343.30864417,C20H41NO3,343.5,83.6,343.30864417,0.0,24.0,0.0,0.0,1.0,0.0,0.0,2.0,-1.0,"1
5
255",CCCCCCCC/C=C\CCCCCCCC(=O)O.NCCO,,,
440790766,3261,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01334,estazolam,20210804,20210312,Curation Efforts|Governmental Organizations,LT01334,estazolam,0.0,No match,vNo-DILI-Concern,2.0,3261,1.0,407.0,3.0,0.0,1.0,AAADccB7gAAEAAAAAAAAAAAAAAAAAWAAAAAwYAAABAAAAACB0AAAHAIIAAAADArBGyQ10IcMEACiAyZjZACSgCsxh6AdyAA4ZpiIaKLBm5GUIAhgiALIyCcQgMAOAABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-6-phenyl-4<I>H</I>-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloranyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","InChI=1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2",CDCHDCWJMGXXRH-UHFFFAOYSA-N,1.7,294.0672241,C16H11ClN4,294.74,43.1,294.0672241,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,,"11  17  8
11  18  8
12  15  8
13  16  8
15  16  8
17  19  8
18  20  8
19  21  8
2  14  8
2  9  8
20  21  8
4  5  8
4  9  8
5  14  8
6  12  8
6  7  8
7  13  8",
440790765,59768,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01333,ESMOLOL,20210312,20210312,Curation Efforts|Governmental Organizations,LT01333,esmolol,0.0,No match,vNo-DILI-Concern,1.0,59768,1.0,288.0,5.0,2.0,10.0,AAADceB6OAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADDzhmAYyDoLABgCIAiDSCAACCAAgIAAIiIEOCIgPNjKEMRqGOCCm0BGbqAeIyKCOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,methyl 3-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]propanoate,3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoic acid methyl ester,methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate,methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate,methyl 3-[4-[2-oxidanyl-3-(propan-2-ylamino)propoxy]phenyl]propanoate,3-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]propionic acid methyl ester,"InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3",AQNDDEOPVVGCPG-UHFFFAOYSA-N,1.9,295.17835828,C16H25NO4,295.37,67.8,295.17835828,0.0,21.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,,"12  15  8
12  16  8
14  17  8
14  18  8
15  17  8
16  18  8
6  22  3",
440790764,11751549,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02330,ERYTHROPOIETIN,20250421,20210312,Curation Efforts|Governmental Organizations,LT02330,erythropoietin,0.0,No match,vNo-DILI-Concern,2.0,11751549,1.0,526.0,6.0,1.0,8.0,AAADceB7oAAEQAAAAAAAAAAAAAAAAWLAAAAwYAAAAAAAAAAB9AAAHgIICAAADArhnyYzkJcMEgCiAyZiZASCgC8hFKAd2CA4XpiKfKLAmRHUYAhqgALYmCcQgMAOwAAAAAAQAACAAAAAACAAAAAAAAAAAA==,"potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol","potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]-4-imidazolyl]methanol","potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol","potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol","potassium;[2-butyl-5-chloranyl-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol","potassium;[2-butyl-5-chloro-3-[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]benzyl]imidazol-4-yl]methanol","InChI=1S/C22H22ClN6O.K/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22;/h4-7,9-12,30H,2-3,8,13-14H2,1H3;/q-1;+1",OXCMYAYHXIHQOA-UHFFFAOYSA-N,,460.1180685,C22H22ClKN6O,461.0,77.7,460.1180685,0.0,31.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[n-]2)cc1.[K+],,"14  17  8
15  19  8
15  20  8
19  22  8
20  23  8
21  22  8
21  23  8
25  26  8
25  27  8
26  28  8
27  30  8
28  31  8
30  31  8
4  10  8
4  14  8
5  10  8
5  17  8
6  29  8
6  8  8
7  29  8
7  9  8
8  9  8",1  6  7
440790763,5280793,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00194,ergocalciferol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00194,ergocalciferol,0.0,No match,vNo-DILI-Concern,1.0,5280793,1.0,678.0,1.0,1.0,5.0,AAADcfB4IAAAAAAAAAAAAAAAAAAAAYAAAAAwYAAAAAAAAGAAAAAAGgAACAAADxSggAICAAAAAgCAAiBCAAAAAAAgAAAICAAAAAgIEAIAAQAAQAAEwAAIgAOAwMAPgAAAAAAAAAAAAAAAACAAAQAACAAAAA==,"(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol","(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-1-cyclohexanol","(1<I>S</I>,3<I>Z</I>)-3-[(2<I>E</I>)-2-[(1<I>R</I>,3<I>a</I><I>S</I>,7<I>a</I><I>R</I>)-1-[(<I>E</I>,2<I>R</I>,5<I>R</I>)-5,6-dimethylhept-3-en-2-yl]-7<I>a</I>-methyl-2,3,3<I>a</I>,5,6,7-hexahydro-1<I>H</I>-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol","(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol","(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol","(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol","InChI=1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1",MECHNRXZTMCUDQ-RKHKHRCZSA-N,,396.339216023,C28H44O,396.6,20.2,396.339216023,0.0,29.0,6.0,0.0,3.0,0.0,0.0,1.0,-1.0,"1
5
255",C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12,7.4,"24  1  6
18  22  5
2  10  5
3  30  6
4  31  6
8  13  6",
440790762,448812,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00999,Eptifibatide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00999,eptifibatide,0.0,No match,vNo-DILI-Concern,2.0,448812,1.0,1520.0,12.0,10.0,10.0,AAADcfB//ABgAAAAAAAAAAAAAAAAAWLAAAAwAAAAAAAAAFgB8AAAHgQQCAAADCjF3gS9yPPJkgCoAzX3fACCgCExAiAI2aG4ZJgIYPrAkbGUYAhmlgDIyAc/icCOgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-(4-guanidinobutyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid","2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid","2-[(3<I>S</I>,6<I>S</I>,12<I>S</I>,20<I>R</I>,23<I>S</I>)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1<I>H</I>-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid","2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid","2-[(3S,6S,12S,20R,23S)-20-aminocarbonyl-12-[4-[bis(azanyl)methylideneamino]butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexakis(oxidanylidene)-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]ethanoic acid","2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-(4-guanidinobutyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaketo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid","InChI=1S/C35H49N11O9S2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39)/t22-,23-,24-,25-,26-/m0/s1",CZKPOZZJODAYPZ-LROMGURASA-N,,831.31561453,C35H49N11O9S2,832.0,377.0,831.31561453,0.0,57.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)[C@@H]1CSSCCC(=O)N[C@@H](CCCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N2CCC[C@H]2C(=O)N1,-2.4,"15  35  8
15  37  8
23  58  5
28  30  6
31  33  8
31  35  8
32  39  6
33  37  8
33  40  8
36  41  6
37  42  8
40  43  8
42  44  8
43  44  8
45  47  5",
440790761,127893,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01316,EPOETIN ALFA,20231222,20210312,Curation Efforts|Governmental Organizations,LT01316,epoetin alfa,0.0,No match,vNo-DILI-Concern,2.0,127893,1.0,437.0,4.0,2.0,8.0,AAADceB6OAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAQCAAADQTBmAQwCILAAgCIAqHSGACCAAAkAAAIiIGIBMgIIDKAlTGEYQhkhgCIiYeb2eKOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,5-benzamido-2-benzyl-4-oxo-pentanoic acid,5-benzamido-4-oxo-2-(phenylmethyl)pentanoic acid,5-benzamido-2-benzyl-4-oxopentanoic acid,5-benzamido-2-benzyl-4-oxopentanoic acid,5-benzamido-4-oxidanylidene-2-(phenylmethyl)pentanoic acid,5-benzamido-2-benzyl-4-keto-valeric acid,"InChI=1S/C19H19NO4/c21-17(13-20-18(22)15-9-5-2-6-10-15)12-16(19(23)24)11-14-7-3-1-4-8-14/h1-10,16H,11-13H2,(H,20,22)(H,23,24)",PIWHBPJCPCXFEU-UHFFFAOYSA-N,,325.13140809,C19H19NO4,325.4,83.5,325.13140809,0.0,24.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(CNC(=O)c1ccccc1)CC(Cc1ccccc1)C(=O)O,2.4,"13  15  8
14  16  8
15  17  8
16  17  8
19  20  8
19  21  8
20  22  8
21  23  8
22  24  8
23  24  8
6  25  3
9  13  8
9  14  8",
440790760,5816,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00742,epinephrine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00742,epinephrine,0.0,No match,vNo-DILI-Concern,1.0,5816,1.0,154.0,4.0,4.0,3.0,AAADccByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADBThmAYyBoLAAgCAAiBCAAACAAAgIAAIiIAOiIgLNiKCkROEcAEk0BEZmAfQ8LYOIAABAAAAQABAAAIAAACAAAAAAAAAAA==,"4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol","4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol","4-[(1<I>R</I>)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol","4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol","4-[(1R)-2-(methylamino)-1-oxidanyl-ethyl]benzene-1,2-diol",4-[(1R)-1-hydroxy-2-(methylamino)ethyl]pyrocatechol,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",UCTWMZQNUQWSLP-VIFPVBQESA-N,-1.4,183.08954328,C9H13NO3,183.2,72.7,183.08954328,0.0,13.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNC[C@H](O)c1ccc(O)c(O)c1,,"5  1  5
10  12  8
11  12  8
6  8  8
6  9  8
8  10  8
9  11  8",
440790759,9294,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01666,Ephedrine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01666,ephedrine,0.0,No match,vNo-DILI-Concern,2.0,9294,1.0,121.0,2.0,2.0,3.0,AAADccByIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADDzhmAYyAILAAgCAAiBCAAACAAAgAAAIiIAICIgKNiKAkRGEcAAk0AEYmAeQwKAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1R,2S)-2-(methylamino)-1-phenyl-propan-1-ol","(1R,2S)-2-(methylamino)-1-phenyl-1-propanol","(1<I>R</I>,2<I>S</I>)-2-(methylamino)-1-phenylpropan-1-ol","(1R,2S)-2-(methylamino)-1-phenylpropan-1-ol","(1R,2S)-2-(methylamino)-1-phenyl-propan-1-ol","(1R,2S)-2-(methylamino)-1-phenyl-propan-1-ol","InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/m0/s1",KWGRBVOPPLSCSI-WPRPVWTQSA-N,0.9,165.115364102,C10H15NO,165.23,32.3,165.115364102,0.0,12.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN[C@@H](C)[C@H](O)c1ccccc1,,"4  1  5
10  12  8
11  12  8
3  2  5
5  7  8
5  8  8
7  10  8
8  11  8",
440790758,3202,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02093,edrophonium,20210312,20210312,Curation Efforts|Governmental Organizations,LT02093,edrophonium,0.0,No match,vNo-DILI-Concern,1.0,3202,1.0,145.0,1.0,1.0,2.0,AAADceByIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAACAAACAzBkAQyxoMAAgCAACRCQACCAAAhIgAIiAAObIgIJiLCkZOEcAhmwBnI2AeQUAMAAAAAAgAAAAAAAAAEAAAAAAAAAAAAAA==,ethyl-(3-hydroxyphenyl)-dimethyl-ammonium,ethyl-(3-hydroxyphenyl)-dimethylammonium,ethyl-(3-hydroxyphenyl)-dimethylazanium,ethyl-(3-hydroxyphenyl)-dimethylazanium,ethyl-(3-hydroxyphenyl)-dimethyl-azanium,ethyl-(3-hydroxyphenyl)-dimethyl-ammonium,"InChI=1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1",VWLHWLSRQJQWRG-UHFFFAOYSA-O,,166.123189134,C10H16NO+,166.24,20.2,166.123189134,1.0,12.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[N+](C)(C)c1cccc(O)c1,1.8,"10  12  8
11  12  8
4  8  8
4  9  8
8  10  8
9  11  8",
440790757,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01414,Eculizumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01414,eculizumab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790756,44152182,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00683,Ecallantide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00683,ecallantide,0.0,No match,vNo-DILI-Concern,2.0,44152182,1.0,18500.0,110.0,100.0,133.0,AAADcfB//gB4AAAAAAAAAAAAAAAAAWLFixYwYMGDAAAAAFgB/gAAHgQQCAAADTzl3ga/3vfJkgioAzX3fACCgC2xMrAJ2aG+fJiKfv7i2bOUcAhu9hPY2Cf/3+KOoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,"(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(1R,2aS,4S,5aS,8aS,11aR,13S,14aS,16S,17aS,19S,20aS,22S,23aS,25S,26aS,28S,29aS,31R,32aS,35aS,36R,38aS,39S,41aS,42S,44aS,45S,48R,50aS,51S,53aS,54S,56aS,57S,59aS,60S,63S,66S,69S,72S,75S,78S,84S,87R,96S,99S)-22,42,45-tris(4-aminobutyl)-31-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxy-butanoyl]amino]propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-phenyl-propanoyl]amino]-29a,72,78-tris(2-amino-2-oxo-ethyl)-14a,75-bis(3-amino-3-oxo-propyl)-2a,23a,25,32a,35a,66-hexabenzyl-5a,8a,51,54,63,84-hexakis(2-carboxyethyl)-13,16-bis(carboxymethyl)-17a,41a,59a,69-tetrakis(3-guanidinopropyl)-20a-[(1S)-1-hydroxyethyl]-60-(hydroxymethyl)-96-[(4-hydroxyphenyl)methyl]-50a-(1H-imidazol-5-ylmethyl)-38a-(1H-indol-3-ylmethyl)-57-isobutyl-19,28,53a,56a-tetramethyl-26a,99-bis[(1S)-1-methylpropyl]-39-(2-methylsulfanylethyl)-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,21,22a,24,25a,27,28a,30,31a,34a,37a,38,40a,41,43a,44,47,49a,50,52a,53,55a,56,58a,59,61a,62,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-33,34,63a,64a,67a,68a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,20,21a,23,24a,26,27a,29,30a,33a,36a,37,39a,40,42a,43,46,48a,49,51a,52,54a,55,57a,58,60a,61,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazapentacyclo[85.74.4.448,111.04,8.0144,148]nonahexacontahectane-36-carbonyl]amino]-3-hydroxy-butanoyl]amino]-5-guanidino-pentanoyl]amino]butanedioic acid","(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[[(1R,2aS,4S,5aS,8aS,11aR,13S,14aS,16S,17aS,19S,20aS,22S,23aS,25S,26aS,28S,29aS,31R,32aS,35aS,36R,38aS,39S,41aS,42S,44aS,45S,48R,50aS,51S,53aS,54S,56aS,57S,59aS,60S,63S,66S,69S,72S,75S,78S,84S,87R,96S,99S)-22,42,45-tris(4-aminobutyl)-31-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxy-1-oxobutyl]amino]-1-oxopropyl]amino]-4-(methylthio)-1-oxobutyl]amino]-3-(1H-imidazol-5-yl)-1-oxopropyl]amino]-3-hydroxy-1-oxopropyl]amino]-1-oxo-3-phenylpropyl]amino]-29a,72,78-tris(2-amino-2-oxoethyl)-14a,75-bis(3-amino-3-oxopropyl)-26a,99-bis[(2S)-butan-2-yl]-17a,41a,59a,69-tetrakis(3-carbamimidamidopropyl)-5a,8a,51,54,63,84-hexakis(2-carboxyethyl)-13,16-bis(carboxymethyl)-20a-[(1S)-1-hydroxyethyl]-60-(hydroxymethyl)-96-[(4-hydroxyphenyl)methyl]-50a-(1H-imidazol-5-ylmethyl)-38a-(1H-indol-3-ylmethyl)-19,28,53a,56a-tetramethyl-57-(2-methylpropyl)-39-[2-(methylthio)ethyl]-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,21,22a,24,25a,27,28a,30,31a,34a,37a,38,40a,41,43a,44,47,49a,50,52a,53,55a,56,58a,59,61a,62,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-2a,23a,25,32a,35a,66-hexakis(phenylmethyl)-33,34,63a,64a,67a,68a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,20,21a,23,24a,26,27a,29,30a,33a,36a,37,39a,40,42a,43,46,48a,49,51a,52,54a,55,57a,58,60a,61,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazapentacyclo[85.74.4.448,111.04,8.0144,148]nonahexacontahectan-36-yl]-oxomethyl]amino]-3-hydroxy-1-oxobutyl]amino]-5-carbamimidamido-1-oxopentyl]amino]butanedioic acid","(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>S</I>)-2-[[(1<I>R</I>,2<I>a</I><I>S</I>,4<I>S</I>,5<I>a</I><I>S</I>,8<I>a</I><I>S</I>,11<I>a</I><I>R</I>,13<I>S</I>,14<I>a</I><I>S</I>,16<I>S</I>,17<I>a</I><I>S</I>,19<I>S</I>,20<I>a</I><I>S</I>,22<I>S</I>,23<I>a</I><I>S</I>,25<I>S</I>,26<I>a</I><I>S</I>,28<I>S</I>,29<I>a</I><I>S</I>,31<I>R</I>,32<I>a</I><I>S</I>,35<I>a</I><I>S</I>,36<I>R</I>,38<I>a</I><I>S</I>,39<I>S</I>,41<I>a</I><I>S</I>,42<I>S</I>,44<I>a</I><I>S</I>,45<I>S</I>,48<I>R</I>,50<I>a</I><I>S</I>,51<I>S</I>,53<I>a</I><I>S</I>,54<I>S</I>,56<I>a</I><I>S</I>,57<I>S</I>,59<I>a</I><I>S</I>,60<I>S</I>,63<I>S</I>,66<I>S</I>,69<I>S</I>,72<I>S</I>,75<I>S</I>,78<I>S</I>,84<I>S</I>,87<I>R</I>,96<I>S</I>,99<I>S</I>)-22,42,45-tris(4-aminobutyl)-31-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-amino-4-carboxybutanoyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(1<I>H</I>-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-29<I>a</I>,72,78-tris(2-amino-2-oxoethyl)-14<I>a</I>,75-bis(3-amino-3-oxopropyl)-2<I>a</I>,23<I>a</I>,25,32<I>a</I>,35<I>a</I>,66-hexabenzyl-26<I>a</I>,99-bis[(2<I>S</I>)-butan-2-yl]-17<I>a</I>,41<I>a</I>,59<I>a</I>,69-tetrakis(3-carbamimidamidopropyl)-5<I>a</I>,8<I>a</I>,51,54,63,84-hexakis(2-carboxyethyl)-13,16-bis(carboxymethyl)-20<I>a</I>-[(1<I>S</I>)-1-hydroxyethyl]-60-(hydroxymethyl)-96-[(4-hydroxyphenyl)methyl]-50<I>a</I>-(1<I>H</I>-imidazol-5-ylmethyl)-38<I>a</I>-(1<I>H</I>-indol-3-ylmethyl)-19,28,53<I>a</I>,56<I>a</I>-tetramethyl-57-(2-methylpropyl)-39-(2-methylsulfanylethyl)-1<I>a</I>,3,4<I>a</I>,7<I>a</I>,9,10<I>a</I>,12,13<I>a</I>,15,16<I>a</I>,18,19<I>a</I>,21,22<I>a</I>,24,25<I>a</I>,27,28<I>a</I>,30,31<I>a</I>,34<I>a</I>,37<I>a</I>,38,40<I>a</I>,41,43<I>a</I>,44,47,49<I>a</I>,50,52<I>a</I>,53,55<I>a</I>,56,58<I>a</I>,59,61<I>a</I>,62,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-33,34,63<I>a</I>,64<I>a</I>,67<I>a</I>,68<I>a</I>-hexathia-<I>a</I>,2,3<I>a</I>,6<I>a</I>,8,9<I>a</I>,11,12<I>a</I>,14,15<I>a</I>,17,18<I>a</I>,20,21<I>a</I>,23,24<I>a</I>,26,27<I>a</I>,29,30<I>a</I>,33<I>a</I>,36<I>a</I>,37,39<I>a</I>,40,42<I>a</I>,43,46,48<I>a</I>,49,51<I>a</I>,52,54<I>a</I>,55,57<I>a</I>,58,60<I>a</I>,61,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazapentacyclo[85.74.4.4<SUP>48,111</SUP>.0<SUP>4,8</SUP>.0<SUP>144,148</SUP>]nonahexacontahectane-36-carbonyl]amino]-3-hydroxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]butanedioic acid","(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(1R,2aS,4S,5aS,8aS,11aR,13S,14aS,16S,17aS,19S,20aS,22S,23aS,25S,26aS,28S,29aS,31R,32aS,35aS,36R,38aS,39S,41aS,42S,44aS,45S,48R,50aS,51S,53aS,54S,56aS,57S,59aS,60S,63S,66S,69S,72S,75S,78S,84S,87R,96S,99S)-22,42,45-tris(4-aminobutyl)-31-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-29a,72,78-tris(2-amino-2-oxoethyl)-14a,75-bis(3-amino-3-oxopropyl)-2a,23a,25,32a,35a,66-hexabenzyl-26a,99-bis[(2S)-butan-2-yl]-17a,41a,59a,69-tetrakis(3-carbamimidamidopropyl)-5a,8a,51,54,63,84-hexakis(2-carboxyethyl)-13,16-bis(carboxymethyl)-20a-[(1S)-1-hydroxyethyl]-60-(hydroxymethyl)-96-[(4-hydroxyphenyl)methyl]-50a-(1H-imidazol-5-ylmethyl)-38a-(1H-indol-3-ylmethyl)-19,28,53a,56a-tetramethyl-57-(2-methylpropyl)-39-(2-methylsulfanylethyl)-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,21,22a,24,25a,27,28a,30,31a,34a,37a,38,40a,41,43a,44,47,49a,50,52a,53,55a,56,58a,59,61a,62,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-33,34,63a,64a,67a,68a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,20,21a,23,24a,26,27a,29,30a,33a,36a,37,39a,40,42a,43,46,48a,49,51a,52,54a,55,57a,58,60a,61,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazapentacyclo[85.74.4.448,111.04,8.0144,148]nonahexacontahectane-36-carbonyl]amino]-3-hydroxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]butanedioic acid","(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(1R,2aS,4S,5aS,8aS,11aR,13S,14aS,16S,17aS,19S,20aS,22S,23aS,25S,26aS,28S,29aS,31R,32aS,35aS,36R,38aS,39S,41aS,42S,44aS,45S,48R,50aS,51S,53aS,54S,56aS,57S,59aS,60S,63S,66S,69S,72S,75S,78S,84S,87R,96S,99S)-22,42,45-tris(4-azanylbutyl)-29a,72,78-tris(2-azanyl-2-oxidanylidene-ethyl)-14a,75-bis(3-azanyl-3-oxidanylidene-propyl)-31-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-azanyl-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-oxidanyl-propanoyl]amino]-3-phenyl-propanoyl]amino]-26a,99-bis[(2S)-butan-2-yl]-17a,41a,59a,69-tetrakis(3-carbamimidamidopropyl)-60-(hydroxymethyl)-13,16-bis(2-hydroxy-2-oxoethyl)-5a,8a,51,54,63,84-hexakis(3-hydroxy-3-oxopropyl)-96-[(4-hydroxyphenyl)methyl]-50a-(1H-imidazol-5-ylmethyl)-38a-(1H-indol-3-ylmethyl)-19,28,53a,56a-tetramethyl-57-(2-methylpropyl)-39-(2-methylsulfanylethyl)-20a-[(1S)-1-oxidanylethyl]-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,21,22a,24,25a,27,28a,30,31a,34a,37a,38,40a,41,43a,44,47,49a,50,52a,53,55a,56,58a,59,61a,62,65,68,71,74,77,80,83,86,89,92,95,98-pentacontakis(oxidanylidene)-2a,23a,25,32a,35a,66-hexakis(phenylmethyl)-33,34,63a,64a,67a,68a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,20,21a,23,24a,26,27a,29,30a,33a,36a,37,39a,40,42a,43,46,48a,49,51a,52,54a,55,57a,58,60a,61,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazapentacyclo[85.74.4.448,111.04,8.0144,148]nonahexacontahectan-36-yl]carbonylamino]-3-oxidanyl-butanoyl]amino]-5-carbamimidamido-pentanoyl]amino]butanedioic acid","(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(1R,2aS,4S,5aS,8aS,11aR,13S,14aS,16S,17aS,19S,20aS,22S,23aS,25S,26aS,28S,29aS,31R,32aS,35aS,36R,38aS,39S,41aS,42S,44aS,45S,48R,50aS,51S,53aS,54S,56aS,57S,59aS,60S,63S,66S,69S,72S,75S,78S,84S,87R,96S,99S)-22,42,45-tris(4-aminobutyl)-31-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxy-butanoyl]amino]propanoyl]amino]-4-(methylthio)butanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-phenyl-propanoyl]amino]-29a,72,78-tris(2-amino-2-keto-ethyl)-14a,75-bis(3-amino-3-keto-propyl)-2a,23a,25,32a,35a,66-hexabenzyl-5a,8a,51,54,63,84-hexakis(2-carboxyethyl)-13,16-bis(carboxymethyl)-17a,41a,59a,69-tetrakis(3-guanidinopropyl)-96-(4-hydroxybenzyl)-20a-[(1S)-1-hydroxyethyl]-50a-(1H-imidazol-5-ylmethyl)-38a-(1H-indol-3-ylmethyl)-57-isobutyl-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,21,22a,24,25a,27,28a,30,31a,34a,37a,38,40a,41,43a,44,47,49a,50,52a,53,55a,56,58a,59,61a,62,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaketo-19,28,53a,56a-tetramethyl-60-methylol-26a,99-bis[(1S)-1-methylpropyl]-39-[2-(methylthio)ethyl]-33,34,63a,64a,67a,68a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,20,21a,23,24a,26,27a,29,30a,33a,36a,37,39a,40,42a,43,46,48a,49,51a,52,54a,55,57a,58,60a,61,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazapentacyclo[85.74.4.448,111.04,8.0144,148]nonahexacontahectane-36-carbonyl]amino]-3-hydroxy-butanoyl]amino]-5-guanidino-pentanoyl]amino]succinic acid","InChI=1S/C305H442N88O91S8/c1-16-152(5)241-295(478)377-195(124-168-80-82-172(398)83-81-168)252(435)334-137-227(404)333-138-228(405)345-214-143-487-491-147-218-291(474)351-179(73-47-107-327-301(315)316)255(438)341-154(7)245(428)339-155(8)249(432)379-210(127-171-136-326-150-338-171)299(482)393-113-53-79-221(393)294(477)361-181(75-49-109-329-303(319)320)260(443)372-203(125-169-134-332-175-69-40-39-68-173(169)175)277(460)370-198(119-163-58-29-20-30-59-163)274(457)369-199(120-164-60-31-21-32-61-164)275(458)375-207(130-226(314)403)284(467)389-242(153(6)17-2)296(479)378-202(123-167-66-37-24-38-67-167)283(466)390-243(159(12)396)297(480)362-182(76-50-110-330-304(321)322)258(441)353-186(86-94-223(311)400)267(450)383-217(290(473)359-188(89-98-234(414)415)263(446)354-189(90-99-235(416)417)265(448)368-201(282(465)388-241)122-166-64-35-23-36-65-166)146-490-489-145-216(384-268(451)191(92-101-237(420)421)355-262(445)187(88-97-233(412)413)357-271(454)194(116-151(3)4)366-285(468)212(141-394)381-266(449)190(91-100-236(418)419)358-273(456)197(118-162-56-27-19-28-57-162)367-259(442)180(74-48-108-328-302(317)318)349-280(463)206(129-225(313)402)374-264(447)185(85-93-222(310)399)356-279(462)205(128-224(312)401)344-229(406)139-335-251(434)184(352-288(214)471)87-96-232(410)411)289(472)350-178(72-43-46-106-308)256(439)347-177(71-42-45-105-307)257(440)360-193(103-115-486-15)270(453)385-219(292(475)391-244(160(13)397)298(481)363-183(77-51-111-331-305(323)324)261(444)380-211(300(483)484)133-240(426)427)148-492-488-144-215(386-276(459)200(121-165-62-33-22-34-63-165)371-286(469)213(142-395)382-278(461)204(126-170-135-325-149-337-170)373-269(452)192(102-114-485-14)346-246(429)156(9)340-250(433)174(309)84-95-231(408)409)287(470)343-158(11)247(430)364-196(117-161-54-25-18-26-55-161)272(455)348-176(70-41-44-104-306)254(437)342-157(10)248(431)365-209(132-239(424)425)281(464)376-208(131-238(422)423)253(436)336-140-230(407)392-112-52-78-220(392)293(476)387-218/h18-40,54-69,80-83,134-136,149-160,174,176-221,241-244,332,394-398H,16-17,41-53,70-79,84-133,137-148,306-309H2,1-15H3,(H2,310,399)(H2,311,400)(H2,312,401)(H2,313,402)(H2,314,403)(H,325,337)(H,326,338)(H,333,404)(H,334,435)(H,335,434)(H,336,436)(H,339,428)(H,340,433)(H,341,438)(H,342,437)(H,343,470)(H,344,406)(H,345,405)(H,346,429)(H,347,439)(H,348,455)(H,349,463)(H,350,472)(H,351,474)(H,352,471)(H,353,441)(H,354,446)(H,355,445)(H,356,462)(H,357,454)(H,358,456)(H,359,473)(H,360,440)(H,361,477)(H,362,480)(H,363,481)(H,364,430)(H,365,431)(H,366,468)(H,367,442)(H,368,448)(H,369,457)(H,370,460)(H,371,469)(H,372,443)(H,373,452)(H,374,447)(H,375,458)(H,376,464)(H,377,478)(H,378,479)(H,379,432)(H,380,444)(H,381,449)(H,382,461)(H,383,450)(H,384,451)(H,385,453)(H,386,459)(H,387,476)(H,388,465)(H,389,467)(H,390,466)(H,391,475)(H,408,409)(H,410,411)(H,412,413)(H,414,415)(H,416,417)(H,418,419)(H,420,421)(H,422,423)(H,424,425)(H,426,427)(H,483,484)(H4,315,316,327)(H4,317,318,328)(H4,319,320,329)(H4,321,322,330)(H4,323,324,331)/t152-,153-,154-,155-,156-,157-,158-,159-,160-,174-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,194-,195-,196-,197-,198-,199-,200-,201-,202-,203-,204-,205-,206-,207-,208-,209-,210-,211-,212-,213-,214-,215-,216-,217-,218-,219-,220-,221-,241-,242-,243-,244-/m0/s1",VBGWSQKGUZHFPS-VGMMZINCSA-N,,7052.0530407,C305H442N88O91S8,7054.0,3120.0,7049.0429762,0.0,492.0,60.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(/N)NCCC[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H]2CSSC[C@H]3NC(=O)CNC(=O)CNC(=O)[C@@H](Cc4ccc(O)cc4)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CSSC[C@@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC3=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](CCCN/C(N)=N/[H])C(=O)N[C@H](CC(=O)O)C(=O)O)[C@H](C)O)CSSC[C@@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](CO)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](N)CCC(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](Cc3ccccc3)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)NCC(=O)N3CCC[C@@H]3C(=O)N2)NC(=O)[C@H](CCC(N)=O)NC1=O,-27.9,"104  198  8
104  208  8
107  205  8
107  208  8
110  218  8
110  220  8
355  151  5
178  459  8
178  477  8
182  473  8
182  477  8
489  187  6
188  189  6
194  196  6
195  197  6
198  205  8
202  207  6
204  206  6
210  214  8
210  218  8
211  213  6
214  220  8
214  224  8
217  223  6
219  227  6
220  228  8
224  232  8
228  235  8
229  236  6
230  239  6
232  235  8
233  241  8
233  242  8
238  243  6
241  247  8
242  248  8
247  251  8
248  251  8
249  254  8
249  255  8
250  253  6
252  256  6
254  261  8
255  262  8
258  271  6
267  259  6
261  268  8
262  268  8
263  272  6
266  273  6
276  282  6
278  283  5
281  288  6
287  294  8
287  295  8
290  297  6
292  296  6
294  302  8
295  303  8
302  307  8
303  307  8
305  311  6
310  315  6
317  323  5
319  329  8
319  330  8
320  326  6
322  328  6
327  339  6
329  340  8
330  341  8
332  335  6
333  346  6
336  343  5
338  351  8
338  352  8
340  345  8
341  345  8
344  358  6
351  361  8
352  362  8
356  363  6
293  36  6
360  369  5
361  366  8
362  366  8
365  371  6
368  376  6
373  383  8
373  384  8
377  382  5
378  385  5
383  389  8
384  390  8
393  387  5
389  394  8
390  394  8
391  403  8
391  404  8
399  405  5
400  407  6
401  410  5
403  413  8
404  414  8
406  409  6
412  424  5
413  421  8
414  421  8
415  427  6
416  422  6
420  441  8
420  442  8
423  432  5
426  446  6
428  439  5
434  447  5
437  444  5
441  456  8
442  457  8
450  467  5
456  462  8
457  462  8
458  468  6
459  473  8
466  471  5
479  482  6
481  484  6
435  77  5",
440790755,3182,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00740,dyphylline,20250421,20210312,Curation Efforts|Governmental Organizations,LT00740,dyphylline,0.0,No match,vNo-DILI-Concern,2.0,3182,1.0,364.0,5.0,2.0,3.0,AAADccBzuAAAAAAAAAAAAAAAAAAAAWAAAAAsAAAAAAAAAFgBgAAAHgAACAAACBzhlgYHsBcMEgCoAQdxdACAgC0XEKABUAGoVECDWAhASCAUQIgKByLRAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"7-(2,3-dihydroxypropyl)-1,3-dimethyl-purine-2,6-dione","7-(2,3-dihydroxypropyl)-1,3-dimethylpurine-2,6-dione","7-(2,3-dihydroxypropyl)-1,3-dimethylpurine-2,6-dione","7-(2,3-dihydroxypropyl)-1,3-dimethylpurine-2,6-dione","7-[2,3-bis(oxidanyl)propyl]-1,3-dimethyl-purine-2,6-dione","7-glyceryl-1,3-dimethyl-xanthine","InChI=1S/C10H14N4O4/c1-12-8-7(9(17)13(2)10(12)18)14(5-11-8)3-6(16)4-15/h5-6,15-16H,3-4H2,1-2H3",KSCFJBIXMNOVSH-UHFFFAOYSA-N,-1.8,254.10150494,C10H14N4O4,254.24,98.9,254.10150494,0.0,18.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O,,"12  1  3
5  14  8
5  9  8
6  11  8
6  15  8
7  13  8
7  15  8
8  11  8
8  14  8
9  11  8
9  13  8",
440790754,6918296,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01112,Dutasteride,20231222,20210312,Curation Efforts|Governmental Organizations,LT01112,dutasteride,0.0,No match,vNo-DILI-Concern,2.0,6918296,1.0,964.0,8.0,2.0,2.0,AAADceB7McAAAAAAAAAAAAAAAAAAAYAAAAAwYMEAAAAAAGDBAAAAHwAQAAAADyjBmBQywILAAACIAiVSUACCAAAhAgAIiIEIZMgIIDLAkZGEIAhglgDIyYcYiMCPwAAAQAACAACQAASAACQAAQAACAAAAA==,"(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","(1<I>S</I>,3<I>a</I><I>S</I>,3<I>b</I><I>S</I>,5<I>a</I><I>R</I>,9<I>a</I><I>R</I>,9<I>b</I><I>S</I>,11<I>a</I><I>S</I>)-<I>N</I>-[2,5-bis(trifluoromethyl)phenyl]-9<I>a</I>,11<I>a</I>-dimethyl-7-oxo-1,2,3,3<I>a</I>,3<I>b</I>,4,5,5<I>a</I>,6,9<I>b</I>,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxidanylidene-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-7-keto-9a,11a-dimethyl-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1",JWJOTENAMICLJG-QWBYCMEYSA-N,5.4,528.22114718,C27H30F6N2O2,528.5,58.2,528.22114718,0.0,37.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12C=CC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)Nc3cc(C(F)(F)F)ccc3C(F)(F)F)CC[C@@H]12,,"11  38  6
12  24  5
13  39  5
14  40  6
15  25  5
17  27  5
22  52  6
30  31  8
30  32  8
31  34  8
32  33  8
33  36  8
34  36  8",
440790753,3168,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01317,droperidol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01317,droperidol,0.0,No match,vNo-DILI-Concern,2.0,3168,1.0,615.0,4.0,1.0,6.0,AAADceB7MQAAAAAAAAAAAAAAAAAAAWAAAAAwYIAAAAAAAFgBQAAAHwAQAAAADAzBmAwxwIPAAACIAqRSUACCAAAlAgAIiAEIdMiIYDLA1ZGUIQholALIyacciICOAAAAAAAAACAAAAAAAAAAQAAAAAAAAA==,"3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one","3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one","3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2<I>H</I>-pyridin-4-yl]-1<I>H</I>-benzimidazol-2-one","3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one","3-[1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one","3-[1-[4-(4-fluorophenyl)-4-keto-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one","InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)",RMEDXOLNCUSCGS-UHFFFAOYSA-N,3.5,379.16960512,C22H22FN3O2,379.4,52.7,379.16960512,0.0,28.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,,"14  17  8
14  18  8
17  20  8
18  21  8
20  22  8
21  22  8
23  24  8
23  25  8
24  26  8
25  27  8
26  28  8
27  28  8
5  14  8
5  16  8
6  16  8
6  17  8",
440790752,3162,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00727,doxylamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00727,doxylamine,0.0,No match,vNo-DILI-Concern,2.0,3162,1.0,276.0,3.0,0.0,6.0,AAADceB7IAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHgAAAAAADEzhngY+gJMIFACgAzRnRASCgCAxAiAI2CA4bJgKJuLAsZmHMAhkwAHY6AeQwOAOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine","N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine","<I>N</I>,<I>N</I>-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine","N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine","N,N-dimethyl-2-(1-phenyl-1-pyridin-2-yl-ethoxy)ethanamine",dimethyl-[2-[1-phenyl-1-(2-pyridyl)ethoxy]ethyl]amine,"InChI=1S/C17H22N2O/c1-17(20-14-13-19(2)3,15-9-5-4-6-10-15)16-11-7-8-12-18-16/h4-12H,13-14H2,1-3H3",HCFDWZZGGLSKEP-UHFFFAOYSA-N,,270.17321333,C17H22N2O,270.37,25.4,270.17321333,0.0,20.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCOC(C)(c1ccccc1)c1ccccn1,2.5,"10  13  8
11  14  8
12  15  8
13  16  8
14  16  8
15  20  8
19  20  8
3  19  8
3  6  8
4  7  3
5  10  8
5  11  8
6  12  8",
440790751,3156,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00547,doxapram,20250421,20210312,Curation Efforts|Governmental Organizations,LT00547,doxapram,0.0,No match,vNo-DILI-Concern,2.0,3156,1.0,487.0,3.0,0.0,6.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAWAAAAA8YIAAAAAAAAABQAAAHgAAAAAADwDhmAYyAIMABACIAiFSEAACAAAgAAAIiAEIAIgKIDKAlRGHIAAghgCYiAccicCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one","1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone","1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one","1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one","1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenyl-pyrrolidin-2-one","1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidone","InChI=1S/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3",XFDJYSQDBULQSI-UHFFFAOYSA-N,,378.230728204,C24H30N2O2,378.5,32.8,378.230728204,0.0,28.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,3.3,"10  14  8
10  16  8
11  15  8
11  17  8
14  23  8
15  24  8
16  25  8
17  26  8
23  27  8
24  28  8
25  27  8
26  28  8
5  8  3",
440790750,681,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00015,dopamine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00015,dopamine,0.0,No match,vNo-DILI-Concern,2.0,681,1.0,119.0,3.0,3.0,2.0,AAADccByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADATBmAQwBoBAAgCAAiBCAAACAAAgIAAIiIAGiIgJJiKCkROAcAEk0BEJmAeQ0LAOIAABAAAAQABAAAIAAACAAAAAAAAAAA==,"4-(2-aminoethyl)benzene-1,2-diol","4-(2-aminoethyl)benzene-1,2-diol","4-(2-aminoethyl)benzene-1,2-diol","4-(2-aminoethyl)benzene-1,2-diol","4-(2-azanylethyl)benzene-1,2-diol",4-(2-aminoethyl)pyrocatechol,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",VYFYYTLLBUKUHU-UHFFFAOYSA-N,-1.0,153.078978594,C8H11NO2,153.18,66.5,153.078978594,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCCc1ccc(O)c(O)c1,,"10  11  8
5  7  8
5  8  8
7  9  8
8  10  8
9  11  8",
440790749,71329,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01040,Dofetilide,20210804,20210312,Curation Efforts|Governmental Organizations,LT01040,dofetilide,0.0,No match,vNo-DILI-Concern,2.0,71329,1.0,672.0,8.0,2.0,11.0,AAADceB7OABgAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgQQQAAADAzhmAayxoNABAKAAiRCQHCCCAAgIgAIiAAObIgOJiKEsZuHOCDk0BGY6AewwIAOCEAAAAAAAAAQgAAAAAAAAAAAAAAAAA==,N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methyl-amino]ethyl]phenyl]methanesulfonamide,N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide,<I>N</I>-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide,N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide,N-[4-[2-[methyl-[2-[4-(methylsulfonylamino)phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide,N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methyl-amino]ethyl]phenyl]methanesulfonamide,"InChI=1S/C19H27N3O5S2/c1-22(13-12-16-4-6-17(7-5-16)20-28(2,23)24)14-15-27-19-10-8-18(9-11-19)21-29(3,25)26/h4-11,20-21H,12-15H2,1-3H3",IXTMWRCNAAVVAI-UHFFFAOYSA-N,,441.13921332,C19H27N3O5S2,441.6,122.0,441.13921332,0.0,29.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,1.8,"14  17  8
14  18  8
17  20  8
18  21  8
19  20  8
19  21  8
22  24  8
22  25  8
23  26  8
23  27  8
24  26  8
25  27  8",
440790748,36811,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01308,dobutamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01308,dobutamine,0.0,No match,vNo-DILI-Concern,1.0,36811,1.0,305.0,4.0,4.0,7.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAQCAAADCzBmAQyBoLAAgCAAiBCAAACAAAgIAAIiIAOiIgJJiKCkROEcAEk0BGJmAeQ0LIOIAABAAAAQABAAAIAAACAAAAAAAAAAA==,"4-[2-[[3-(4-hydroxyphenyl)-1-methyl-propyl]amino]ethyl]benzene-1,2-diol","4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol","4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol","4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol","4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol",4-[2-[[3-(4-hydroxyphenyl)-1-methyl-propyl]amino]ethyl]pyrocatechol,"InChI=1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3",JRWZLRBJNMZMFE-UHFFFAOYSA-N,,301.1677936,C18H23NO3,301.4,72.7,301.1677936,0.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,3.4,"11  13  8
11  14  8
12  15  8
12  16  8
13  17  8
14  18  8
15  19  8
16  21  8
17  20  8
18  20  8
19  22  8
21  22  8
5  23  3",
440790747,13505,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01623,DIPHENOXYLATE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01623,diphenoxylate,0.0,No match,vNo-DILI-Concern,2.0,13505,1.0,666.0,4.0,0.0,9.0,AAADcfB7MAAAAAAAAAAAAAAAAAAAAAAAAAA8YMEAAAAAAAABUAAAHgAAAAAADgDhmAYyCIMABACYBiDSCAACAAAgAAAIiAEIAIgIoDKAlRCGIAAkwAGIiA+8yOCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate","1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylic acid ethyl ester","ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate","ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate","ethyl 1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-piperidine-4-carboxylate","1-(3-cyano-3,3-diphenyl-propyl)-4-phenyl-isonipecotic acid ethyl ester","InChI=1S/C30H32N2O2/c1-2-34-28(33)29(25-12-6-3-7-13-25)18-21-32(22-19-29)23-20-30(24-31,26-14-8-4-9-15-26)27-16-10-5-11-17-27/h3-17H,2,18-23H2,1H3",HYPPXZBJBPSRLK-UHFFFAOYSA-N,5.7,452.246378268,C30H32N2O2,452.6,53.3,452.246378268,0.0,34.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,,"11  15  8
11  16  8
15  19  8
16  20  8
17  24  8
17  26  8
18  25  8
18  27  8
19  22  8
20  22  8
24  29  8
25  30  8
26  31  8
27  32  8
29  33  8
30  34  8
31  33  8
32  34  8",
440790746,3100,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00087,diphenhydramine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00087,diphenhydramine,0.0,No match,vNo-DILI-Concern,1.0,3100,1.0,211.0,2.0,0.0,6.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAAAAAADBThmAYyAIMABACAAiBCAAACAAAgAAAIiAAICIgKJiKAMRiDMAAkwAEYqAeAwOAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-benzhydryloxy-N,N-dimethyl-ethanamine","2-(diphenylmethyl)oxy-N,N-dimethylethanamine","2-benzhydryloxy-<I>N</I>,<I>N</I>-dimethylethanamine","2-benzhydryloxy-N,N-dimethylethanamine","2-(diphenylmethyl)oxy-N,N-dimethyl-ethanamine",2-benzhydryloxyethyl(dimethyl)amine,"InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3",ZZVUWRFHKOJYTH-UHFFFAOYSA-N,3.3,255.162314293,C17H21NO,255.35,12.5,255.162314293,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCOC(c1ccccc1)c1ccccc1,,"10  16  8
11  17  8
14  18  8
15  19  8
16  18  8
17  19  8
4  10  8
4  8  8
5  11  8
5  9  8
8  14  8
9  15  8",
440790745,3080,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00074,DIMERCAPROL,20231222,20210312,Curation Efforts|Governmental Organizations,LT00074,dimercaprol,0.0,No match,vNo-DILI-Concern,2.0,3080,1.0,32.0,3.0,3.0,2.0,AAADccBAIABgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgQACAAACACkwAKAAAAAAgQAAAAAAAAAAAAAAAAAAAAAAAAAEAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2,3-bis(sulfanyl)propan-1-ol","2,3-dimercapto-1-propanol","2,3-bis(sulfanyl)propan-1-ol","2,3-bis(sulfanyl)propan-1-ol","2,3-bis(sulfanyl)propan-1-ol","2,3-dimercaptopropan-1-ol","InChI=1S/C3H8OS2/c4-1-3(6)2-5/h3-6H,1-2H2",WQABCVAJNWAXTE-UHFFFAOYSA-N,,124.00165722,C3H8OS2,124.23,22.2,124.00165722,0.0,6.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OCC(S)CS,0.2,4  7  3,
440790744,10660,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00545,DIMENHYDRINATE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00545,dimenhydrinate,0.0,No match,vNo-DILI-Concern,2.0,10660,1.0,509.0,5.0,1.0,6.0,AAADceB7sAAEAAAAAAAAAAAAAAAAAWAAAAA8YIAAAAAAAFgB0AAAHgIQAAAADBzhngYzsJfJlACoAydydACCgC2nEKAJmQGoXMiKbirAeTiXMIgsxyNYqGeAwOAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-benzhydryloxy-N,N-dimethyl-ethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dione","8-chloro-1,3-dimethyl-7H-purine-2,6-dione;2-(diphenylmethyl)oxy-N,N-dimethylethanamine","2-benzhydryloxy-<I>N</I>,<I>N</I>-dimethylethanamine;8-chloro-1,3-dimethyl-7<I>H</I>-purine-2,6-dione","2-benzhydryloxy-N,N-dimethylethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dione","8-chloranyl-1,3-dimethyl-7H-purine-2,6-dione;2-(diphenylmethyl)oxy-N,N-dimethyl-ethanamine","2-benzhydryloxyethyl(dimethyl)amine;8-chloro-1,3-dimethyl-7H-purine-2,6-quinone","InChI=1S/C17H21NO.C7H7ClN4O2/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h3-12,17H,13-14H2,1-2H3;1-2H3,(H,9,10)",NFLLKCVHYJRNRH-UHFFFAOYSA-N,,469.1880675,C24H28ClN5O3,470.0,81.8,469.1880675,0.0,33.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O,,"11  17  8
11  19  8
12  18  8
12  20  8
15  16  8
16  21  8
17  26  8
18  27  8
19  28  8
20  29  8
26  32  8
27  33  8
28  32  8
29  33  8
6  15  8
6  22  8
7  21  8
7  22  8
8  16  8
8  31  8
9  15  8
9  31  8",
440790743,10531,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02218,dihydroergotamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02218,dihydroergotamine,0.0,No match,vNo-DILI-Concern,1.0,10531,1.0,1160.0,6.0,3.0,4.0,AAADcfB/uAAAAAAAAAAAAAAAAAAAAWLFgAA8eMECAAAAAFjx9AAAHgAQCAAADSzBngQ+yPPJlgCoAzV3VAKCgCAxAiAI2aH4ZJkaYPrA0bWfYAhklgDcyAeYmcKegAAAQAASAACQAASAACQAAAAAAAAAAA==,"(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-2-hydroxy-4-methyl-5,8-dioxo-7-(phenylmethyl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6<I>a</I><I>R</I>,9<I>R</I>,10<I>a</I><I>R</I>)-<I>N</I>-[(1<I>S</I>,2<I>S</I>,4<I>R</I>,7<I>S</I>)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0<SUP>2,6</SUP>]dodecan-4-yl]-7-methyl-6,6<I>a</I>,8,9,10,10<I>a</I>-hexahydro-4<I>H</I>-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R,10aR)-7-methyl-N-[(1S,2S,4R,7S)-4-methyl-2-oxidanyl-5,8-bis(oxidanylidene)-7-(phenylmethyl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-diketo-4-methyl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","InChI=1S/C33H37N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39)/t21-,23-,25-,26+,27+,32-,33+/m1/s1",LUZRJRNZXALNLM-JGRZULCMSA-N,,583.2794693,C33H37N5O5,583.7,118.0,583.2794693,0.0,43.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,2.4,"10  33  8
10  35  8
11  44  5
13  45  6
14  46  5
16  27  6
18  28  5
12  2  6
26  29  8
26  34  8
29  30  8
29  33  8
30  35  8
33  37  8
34  38  8
36  39  8
36  40  8
37  38  8
39  41  8
40  42  8
41  43  8
42  43  8
17  9  6",
440790742,2724385,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00292,digoxin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00292,digoxin,0.0,No match,vNo-DILI-Concern,1.0,2724385,1.0,1450.0,14.0,6.0,7.0,AAADcfB8PAAAAAAAAAAAAAAAAAAAAYIAAAA0aNECAAAAAGDAAAAAGgAACAAAD1SwgAMCCAAABgCIAiDSCAAAAAAgAAAACAAAAEgRFAIAIQAiUAAFgAAPIQPA4PwPgAAAAAAAAADAAAYQADAAAYAADAAAAA==,"3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one","3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[[(2R,4S,5S,6R)-5-[[(2S,4S,5S,6R)-5-[[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-2-oxanyl]oxy]-4-hydroxy-6-methyl-2-oxanyl]oxy]-4-hydroxy-6-methyl-2-oxanyl]oxy]-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one","3-[(3<I>S</I>,5<I>R</I>,8<I>R</I>,9<I>S</I>,10<I>S</I>,12<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-3-[(2<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-5-[(2<I>S</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-5-[(2<I>S</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2<I>H</I>-furan-5-one","3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one","3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-10,13-dimethyl-3-[(2R,4S,5S,6R)-6-methyl-5-[(2S,4S,5S,6R)-6-methyl-5-[(2S,4S,5S,6R)-6-methyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxy-12,14-bis(oxidanyl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one","3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one","InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1",LTMHDMANZUZIPE-PUGKRICDSA-N,1.3,780.42960671,C41H64O14,780.9,203.0,780.42960671,0.0,55.0,21.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,,"15  1  6
48  10  6
50  10  6
46  11  6
52  13  5
54  14  5
16  56  6
17  57  5
18  29  6
19  31  6
21  2  6
20  58  6
23  34  6
33  3  6
38  3  5
41  43  5
47  49  5
53  55  6
40  7  6
42  8  6
44  8  5",
440790741,7029,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00806,DIETHYLPROPION,20231222,20210312,Curation Efforts|Governmental Organizations,LT00806,diethylpropion,0.0,No match,vNo-DILI-Concern,2.0,7029,1.0,193.0,2.0,0.0,5.0,AAADceByIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAAAAAADCzBmAQyAIMAAACIAqBSAAACAAAkAAAIiAGIAMgIIDKAlTGEIQAggACIiYcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-(diethylamino)-1-phenyl-propan-1-one,2-(diethylamino)-1-phenyl-1-propanone,2-(diethylamino)-1-phenylpropan-1-one,2-(diethylamino)-1-phenylpropan-1-one,2-(diethylamino)-1-phenyl-propan-1-one,2-(diethylamino)-1-phenyl-propan-1-one,"InChI=1S/C13H19NO/c1-4-14(5-2)11(3)13(15)12-9-7-6-8-10-12/h6-11H,4-5H2,1-3H3",XXEPPPIWZFICOJ-UHFFFAOYSA-N,,205.14666423,C13H19NO,205.3,20.3,205.14666423,0.0,15.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)C(C)C(=O)c1ccccc1,2.8,"10  11  8
10  12  8
11  13  8
12  14  8
13  15  8
14  15  8
3  16  3",
440790740,3042,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00737,dicyclomine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00737,dicyclomine,0.0,No match,vNo-DILI-Concern,2.0,3042,1.0,326.0,3.0,0.0,8.0,AAADcfB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAAAAAAAHgAAAAAADwDhgAYCCAMABAAIAACQCAAAAAAAAAAAAAEIAAACABIAAAADAAAEAACQAAGIyOCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate,1-cyclohexyl-1-cyclohexanecarboxylic acid 2-(diethylamino)ethyl ester,2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate,2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate,2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate,1-cyclohexylcyclohexanecarboxylic acid 2-(diethylamino)ethyl ester,"InChI=1S/C19H35NO2/c1-3-20(4-2)15-16-22-18(21)19(13-9-6-10-14-19)17-11-7-5-8-12-17/h17H,3-16H2,1-2H3",CURUTKGFNZGFSE-UHFFFAOYSA-N,,309.266779359,C19H35NO2,309.5,29.5,309.266779359,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,5.5,,
440790739,3038,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00802,dichlorphenamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00802,dichlorphenamide,0.0,No match,vNo-DILI-Concern,2.0,3038,1.0,452.0,6.0,2.0,2.0,AAADcYBjOABmAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGAYQQAAACAKAUCAwAYAAAAKAACBCAHBCABAgBQAAilgAAogIICKBExCAIAAggAAIiAcAAAAAAAIAAFAAAIQABAAAoAABCAAAAAAAAA==,"4,5-dichlorobenzene-1,3-disulfonamide","4,5-dichlorobenzene-1,3-disulfonamide","4,5-dichlorobenzene-1,3-disulfonamide","4,5-dichlorobenzene-1,3-disulfonamide","4,5-bis(chloranyl)benzene-1,3-disulfonamide","4,5-dichlorobenzene-1,3-disulfonamide","InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)",GJQPMPFPNINLKP-UHFFFAOYSA-N,,303.9146044,C6H6Cl2N2O4S2,305.2,137.0,303.9146044,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1,0.3,"11  13  8
11  14  8
12  13  8
12  15  8
14  16  8
15  16  8",
440790738,2140,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00774,DIATRIZOATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00774,diatrizoate,0.0,No match,vNo-DILI-Concern,2.0,2140,1.0,390.0,4.0,3.0,3.0,AAADccBzOAAAAwAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAwCAAADAiDmAACyILAAgCIAgXQWACCAAAlAAAAiAEATMgIJjLA1NGEcQhk1AHI2Qe8yCCOAAAAQAQAAAAAAACACAAAAAAAAAAAAA==,"3,5-diacetamido-2,4,6-triiodo-benzoic acid","3,5-diacetamido-2,4,6-triiodobenzoic acid","3,5-diacetamido-2,4,6-triiodobenzoic acid","3,5-diacetamido-2,4,6-triiodobenzoic acid","3,5-diacetamido-2,4,6-tris(iodanyl)benzoic acid","3,5-diacetamido-2,4,6-triiodo-benzoic acid","InChI=1S/C11H9I3N2O4/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18/h1-2H3,(H,15,17)(H,16,18)(H,19,20)",YVPYQUNUQOZFHG-UHFFFAOYSA-N,,613.7696,C11H9I3N2O4,613.91,95.5,613.7696,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I,1.8,"10  12  8
10  15  8
11  12  8
11  14  8
13  14  8
13  15  8",
440790737,5793,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00327,dextrose,20231222,20210312,Curation Efforts|Governmental Organizations,LT00327,dextrose,0.0,No match,vNo-DILI-Concern,2.0,5793,1.0,151.0,6.0,5.0,1.0,AAADccBgOAAAAAAAAAAAAAAAAAAAAAAAAAAkAAAAAAAAAAAAAAAAGgAACAAACBSwgAMACAAABgAAAAAAAAAAAAAAAAAAAAAAAAAREAIAAAACQAAFAAAHAAHAYAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3R,4S,5S,6R)-6-(hydroxymethyl)tetrahydropyran-2,3,4,5-tetrol","(3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol","(3<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol","(3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol","(3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol","(3R,4S,5S,6R)-6-methyloltetrahydropyran-2,3,4,5-tetrol","InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1",WQZGKKKJIJFFOK-GASJEMHNSA-N,,180.0633881,C6H12O6,180.16,110.0,180.0633881,0.0,12.0,4.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O,-2.6,"11  17  3
7  2  6
8  3  5
10  4  6
9  12  5",
440790736,5360696,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02056,dextromethorphan,20231222,20210312,Curation Efforts|Governmental Organizations,LT02056,dextromethorphan,0.0,No match,vNo-DILI-Concern,2.0,5360696,1.0,370.0,2.0,0.0,1.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAA8YMEAAAAWAADxAAAAHgAAAAAADyzBmAYyBoMABACAAiBCAAACCAAgIAAIiAAOCIgMJiKEsRuEMCAkwBGIqAeQwPAPoAABAAAQAADQAAaAACQAAAAAAAAAAA==,"(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene","(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene","(1<I>S</I>,9<I>S</I>,10<I>S</I>)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.0<SUP>1,10</SUP>.0<SUP>2,7</SUP>]heptadeca-2(7),3,5-triene","(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene","(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene","(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene","InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1",MKXZASYAUGDDCJ-NJAFHUGGSA-N,3.4,271.193614421,C18H25NO,271.4,12.5,271.193614421,0.0,20.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,,"14  17  8
15  18  8
17  19  8
18  19  8
3  7  6
4  21  6
5  22  6
9  14  8
9  15  8",
440790735,5826,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00870,dextroamphetamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00870,dextroamphetamine,0.0,No match,vNo-DILI-Concern,2.0,5826,1.0,84.7,1.0,1.0,2.0,AAADccByAAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHAAQAAAADCjBGAQyAIBAAACAAiBCAAACAAAgAAAIiIAAAIgIICKAkRGAIAAgkAAIiAcQgIAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-1-phenylpropan-2-amine,(2S)-1-phenyl-2-propanamine,(2<I>S</I>)-1-phenylpropan-2-amine,(2S)-1-phenylpropan-2-amine,(2S)-1-phenylpropan-2-amine,[(1S)-1-methyl-2-phenyl-ethyl]amine,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1",KWTSXDURSIMDCE-QMMMGPOBSA-N,1.8,135.104799419,C9H13N,135.21,26.0,135.104799419,0.0,10.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H](N)Cc1ccccc1,,"2  1  5
4  6  8
4  7  8
6  8  8
7  9  8
8  10  8
9  10  8",
440790734,131204,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01972,Dexpanthenol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01972,dexpanthenol,0.0,No match,vNo-DILI-Concern,2.0,131204,1.0,182.0,4.0,4.0,6.0,AAADceByOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAADhThgAYCAALAAgAIAAEQEAIAAAAAAAAAAIFIAAACEBAAgAAEQAAHFgCQAAAiAAAJAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butanamide","(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide","(2<I>R</I>)-2,4-dihydroxy-<I>N</I>-(3-hydroxypropyl)-3,3-dimethylbutanamide","(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide","(2R)-3,3-dimethyl-2,4-bis(oxidanyl)-N-(3-oxidanylpropyl)butanamide","(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethyl-butyramide","InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)/t7-/m0/s1",SNPLKNRPJHDVJA-ZETCQYMHSA-N,,205.13140809,C9H19NO4,205.25,89.8,205.13140809,0.0,14.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(CO)[C@@H](O)C(=O)NCCCO,-0.9,7  1  5,
440790733,33036,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00682,DEXCHLORPHENIRAMINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT00682,dexchlorpheniramine,0.0,No match,vNo-DILI-Concern,2.0,33036,1.0,249.0,2.0,0.0,5.0,AAADceB7AAAEAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHAIAAAAADQrBHiQ+gJMIEACgAzRnRACCgCAxByAI2CA4ZpgIIOLBk5GEIAhggADIyAcQgMAOhAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,"(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine","(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine","(3<I>S</I>)-3-(4-chlorophenyl)-<I>N</I>,<I>N</I>-dimethyl-3-pyridin-2-ylpropan-1-amine","(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine","(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine",[(3S)-3-(4-chlorophenyl)-3-(2-pyridyl)propyl]-dimethyl-amine,"InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m0/s1",SOYKEARSMXGVTM-HNNXBMFYSA-N,3.4,274.1236763,C16H19ClN2,274.79,16.1,274.1236763,0.0,19.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1,,"10  15  8
11  16  8
14  17  8
15  17  8
16  19  8
18  19  8
3  18  8
3  8  8
4  5  6
7  10  8
7  9  8
8  11  8
9  14  8",
440790732,16960,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00810,Dexbrompheniramine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00810,dexbrompheniramine,0.0,No match,vNo-DILI-Concern,2.0,16960,1.0,249.0,2.0,0.0,5.0,AAADceB7AAAAEAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHABAAAABrQjBHgQ+gJMIEACgAzRnRACCgCAxAiQI2CA4ZLgIIOLAkZGEIAhggADIyhcQgMAOggAAAAAAAAAEAAAAAAAAAAAAAAAAAA==,"(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine","(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine","(3<I>S</I>)-3-(4-bromophenyl)-<I>N</I>,<I>N</I>-dimethyl-3-pyridin-2-ylpropan-1-amine","(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine","(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine",[(3S)-3-(4-bromophenyl)-3-(2-pyridyl)propyl]-dimethyl-amine,"InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m0/s1",ZDIGNSYAACHWNL-HNNXBMFYSA-N,3.5,318.07316,C16H19BrN2,319.24,16.1,318.07316,0.0,19.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1,,"10  15  8
11  16  8
14  17  8
15  17  8
16  19  8
18  19  8
3  18  8
3  8  8
4  5  6
7  10  8
7  9  8
8  11  8
9  14  8",
440790731,30323,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00540,daunorubicin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00540,daunorubicin,0.0,No match,vNo-DILI-Concern,2.0,30323,1.0,960.0,11.0,5.0,4.0,AAADceB6PAAAAAAAAAAAAAAAAAAAAAAAAAA0YMGCAAAAAADBQAAAHgAQCAAADHzxmAcyDoBABgCIAqBSAAICCAAkIAAIiIFGCMgfNzaGtRqicWAn8BEPuYfL7PzOwQADAAAYAADCAAYQADAAAAAAAAAAAA==,"(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione","(7<I>S</I>,9<I>S</I>)-9-acetyl-7-[(2<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>S</I>)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7<I>H</I>-tetracene-5,12-dione","(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-4-methoxy-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone","InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1",STQGQHZAVUOBTE-VGBVRHCVSA-N,1.8,527.17914612,C27H29NO10,527.5,186.0,527.17914612,0.0,38.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,,"12  1  6
18  1  5
20  11  6
16  17  8
16  23  8
17  25  8
22  28  6
23  26  8
25  27  8
26  27  8
13  3  6
32  33  8
32  34  8
33  35  8
34  36  8
35  37  8
36  37  8
21  4  6",
440790730,444031,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01188,Darifenacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01188,darifenacin,0.0,No match,vNo-DILI-Concern,2.0,444031,1.0,607.0,3.0,1.0,7.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAWJAAAAwYMAAAAAAAEgBUAAAHgAQAAAADwThmAYwBoNABACIAiFSEAACCAAgIAAIiAEOCIgMJjKEtRuGOCCkwBGIqAecyfCPoAACAAAIAABAAAQAABAAAAAAAAAAAA==,"2-[(3S)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenyl-acetamide","2-[(3S)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide","2-[(3<I>S</I>)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide","2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide","2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenyl-ethanamide","2-[(3S)-1-(2-coumaran-5-ylethyl)pyrrolidin-3-yl]-2,2-diphenyl-acetamide","InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1",HXGBXQDTNZMWGS-RUZDIDTESA-N,,426.230728204,C28H30N2O2,426.5,55.6,426.230728204,0.0,32.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1,4.6,"11  15  8
11  17  8
12  16  8
12  18  8
15  20  8
16  21  8
17  22  8
18  23  8
19  24  8
19  25  8
20  26  8
21  27  8
22  26  8
23  27  8
24  28  8
25  31  8
28  29  8
29  31  8
5  33  5",
440790729,5311498,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02002,cyanocobalamin,20231222,20210312,Curation Efforts|Governmental Organizations,LT02002,cyanocobalamin,0.0,No match,vNo-DILI-Concern,1.0,5311498,1.0,3220.0,21.0,9.0,26.0,AAADcfB//AIAAAAQAAAAAAAAAAAAAWLEiBAwAAAAAAAAAFgB8AAAHgAQCCAAD7zhngY30LfMFxC4QyVzdICCgC0xEqAB2KE4dJiLeLLAmZGeYAhvlgLbyCf8ucKfiAAAQAAQACAQAACAACAAQAAAAAAAAA==,"cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxo-ethyl)-7,12,17-tris(3-amino-3-oxo-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide","cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethyl-1-benzimidazolyl)-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl] [(2R)-1-[[1-oxo-3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propyl]amino]propan-2-yl] phosphate;cyanide","cobalt(3+);[(2<I>R</I>,3<I>S</I>,4<I>R</I>,5<I>S</I>)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2<I>R</I>)-1-[3-[(1<I>R</I>,2<I>R</I>,3<I>R</I>,5<I>Z</I>,7<I>S</I>,10<I>Z</I>,12<I>S</I>,13<I>S</I>,15<I>Z</I>,17<I>S</I>,18<I>S</I>,19<I>R</I>)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1<I>H</I>-corrin-24-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide","cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide","cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-2-(hydroxymethyl)-4-oxidanyl-oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-azanyl-2-oxidanylidene-ethyl)-7,12,17-tris(3-azanyl-3-oxidanylidene-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide","cobaltic;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-methylol-tetrahydrofuran-3-yl] [(1R)-1-methyl-2-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-keto-ethyl)-7,12,17-tris(3-amino-3-keto-propyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]ethyl] phosphate;cyanide","InChI=1S/C62H90N13O14P.CN.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-2;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;/q;-1;+3/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1",FDJOLVPMNUYSCM-WZHZPDAFSA-L,,1354.567399,C63H88CoN14O14P,1355.4,476.0,1354.567399,0.0,93.0,14.0,0.0,3.0,0.0,0.0,3.0,-1.0,"1
5
255",C/C1=C2/N=C(/C=C3\N=C(/C(C)=C4\[N-][C@@](C)([C@@H]5N=C1[C@](C)(CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@H]1[C@@H](O)[C@@H](n6cnc7cc(C)c(C)cc76)O[C@@H]1CO)[C@H]5CC(N)=O)[C@@](C)(CC(N)=O)[C@@H]4CCC(N)=O)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]2CCC(N)=O.[C-]#N.[Co+3],,"78  10  5
80  11  5
81  15  5
83  29  5
29  85  8
29  86  8
30  86  8
30  87  8
31  39  6
32  40  6
33  94  5
34  42  6
35  43  5
36  45  5
51  63  6
55  65  6
57  68  6
82  84  6
85  87  8
85  88  8
87  89  8
88  90  8
89  91  8
90  91  8","1  17  6
1  69  6"
440790728,24014,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00361,CUPRIC CHLORIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00361,cupric chloride,0.0,No match,vNo-DILI-Concern,2.0,24014,1.0,2.8,0.0,0.0,0.0,AAADcQAAAAAGAAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,dichlorocopper,dichlorocopper,dichlorocopper,dichlorocopper,bis(chloranyl)copper,dichlorocopper,InChI=1S/2ClH.Cu/h2*1H;/q;;+2/p-2,ORTQZVOHEJQUHG-UHFFFAOYSA-L,,132.867303,Cl2Cu,134.45,0.0,132.867303,0.0,3.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[Cl][Cu][Cl],,,
440790727,16129617,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00855,COSYNTROPIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00855,cosyntropin,0.0,No match,vNo-DILI-Concern,2.0,16129617,1.0,6500.0,41.0,42.0,96.0,AAADcfB//gBAAAAAAAAAAAAAAAAAAWLFixYwYMGAAAAAAFgB/AAAHgQQCAAADSzl3ga/3vfJkgioAzX3fACCgC2xMrAJ2aG+fJiKfvbi2bOUcAhu9hPY2Ce83+KOoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-amino-3-hydroxy-propanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenyl-propanoyl]amino]-5-guanidino-pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methyl-butanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]pyrrolidine-2-carbonyl]amino]-3-methyl-butanoyl]amino]hexanoyl]amino]-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[[(2S)-1-[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-6-amino-2-[[2-[[(2S)-2-[[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-amino-3-hydroxy-1-oxopropyl)amino]-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-3-hydroxy-1-oxopropyl]amino]-4-(methylthio)-1-oxobutyl]amino]-4-carboxy-1-oxobutyl]amino]-3-(1H-imidazol-4-yl)-1-oxopropyl]amino]-1-oxo-3-phenylpropyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-3-(1H-indol-3-yl)-1-oxopropyl]amino]-1-oxoethyl]amino]-1-oxohexyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methyl-1-oxobutyl]amino]-1-oxoethyl]amino]-1-oxohexyl]amino]-1-oxohexyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-5-carbamimidamido-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methyl-1-oxobutyl]amino]-1-oxohexyl]amino]-3-methyl-1-oxobutyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]-2-pyrrolidinecarboxylic acid,(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-6-amino-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[(2<I>R</I>)-2-[[(2<I>R</I>)-2-[[(2<I>R</I>)-6-amino-2-[[(2<I>R</I>)-6-amino-2-[[2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[(2<I>S</I>)-6-amino-2-[[2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[(2-amino-3-hydroxypropanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1<I>H</I>-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1<I>H</I>-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-amino-3-hydroxypropanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-azanyl-2-[[(2S)-2-[[(2S)-1-[(2R)-2-[[(2R)-2-[[(2R)-6-azanyl-2-[[(2R)-6-azanyl-2-[2-[[(2S)-2-[[(2S)-1-[(2S)-6-azanyl-2-[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-azanyl-3-oxidanyl-propanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-oxidanyl-propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenyl-propanoyl]amino]-5-carbamimidamido-pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]ethanoylamino]hexanoyl]pyrrolidin-2-yl]carbonylamino]-3-methyl-butanoyl]amino]ethanoylamino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamido-pentanoyl]amino]-5-carbamimidamido-pentanoyl]pyrrolidin-2-yl]carbonylamino]-3-methyl-butanoyl]amino]hexanoyl]amino]-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-amino-3-hydroxy-propanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-4-(methylthio)butanoyl]amino]-4-carboxy-butanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenyl-propanoyl]amino]-5-guanidino-pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]prolyl]amino]-3-methyl-butanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]prolyl]amino]-3-methyl-butanoyl]amino]hexanoyl]amino]-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]proline,"InChI=1S/C136H210N40O31S/c1-75(2)109(127(200)154-71-106(181)156-88(31-13-17-52-137)114(187)158-89(32-14-18-53-138)115(188)159-91(35-21-56-149-134(142)143)116(189)164-96(37-23-58-151-136(146)147)131(204)175-60-25-39-104(175)126(199)173-111(77(5)6)128(201)163-90(33-15-19-54-139)120(193)171-110(76(3)4)129(202)169-101(65-80-43-47-84(180)48-44-80)132(205)176-61-26-40-105(176)133(206)207)172-125(198)103-38-24-59-174(103)130(203)95(34-16-20-55-140)157-107(182)70-153-113(186)99(66-81-68-152-87-30-12-11-29-85(81)87)167-117(190)92(36-22-57-150-135(144)145)160-121(194)98(63-78-27-9-8-10-28-78)166-123(196)100(67-82-69-148-74-155-82)168-118(191)93(49-50-108(183)184)161-119(192)94(51-62-208-7)162-124(197)102(73-178)170-122(195)97(165-112(185)86(141)72-177)64-79-41-45-83(179)46-42-79/h8-12,27-30,41-48,68-69,74-77,86,88-105,109-111,152,177-180H,13-26,31-40,49-67,70-73,137-141H2,1-7H3,(H,148,155)(H,153,186)(H,154,200)(H,156,181)(H,157,182)(H,158,187)(H,159,188)(H,160,194)(H,161,192)(H,162,197)(H,163,201)(H,164,189)(H,165,185)(H,166,196)(H,167,190)(H,168,191)(H,169,202)(H,170,195)(H,171,193)(H,172,198)(H,173,199)(H,183,184)(H,206,207)(H4,142,143,149)(H4,144,145,150)(H4,146,147,151)/t86?,88-,89-,90+,91-,92+,93+,94+,95+,96-,97+,98+,99+,100+,101+,102+,103+,104+,105+,109+,110+,111+/m1/s1",ZOEFCCMDUURGSE-CQVUSSRSSA-N,,2932.5839961,C136H210N40O31S,2933.4,1180.0,2931.5806412,0.0,208.0,21.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(\N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)C(N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCN/C(N)=N/[H])C(=O)N[C@H](CCCN/C(N)=N/[H])C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)C(C)C,-7.9,"101  121  5
134  143  8
134  144  8
143  151  8
144  152  8
151  153  8
152  153  8
154  158  8
154  159  8
158  160  8
158  162  8
160  164  8
162  165  8
164  168  8
165  168  8
171  175  8
171  176  8
175  178  8
176  179  8
178  182  8
179  182  8
180  185  8
200  203  8
200  204  8
203  206  8
204  207  8
206  208  8
207  208  8
87  35  5
83  36  5
92  37  5
88  38  6
102  40  6
97  41  6
115  43  5
112  45  6
124  46  5
135  49  6
145  54  6
58  159  8
58  160  8
157  60  6
169  62  5
173  63  6
183  66  5
67  180  8
67  187  8
68  185  8
68  187  8
189  69  6
194  70  5
196  71  6
202  72  3
73  82  6
77  85  6",
440790726,5745,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00734,CORTISONE ACETATE,20210312,20210312,Curation Efforts|Governmental Organizations,LT00734,cortisone acetate,0.0,No match,vNo-DILI-Concern,2.0,5745,1.0,827.0,6.0,1.0,4.0,AAADceB4OAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAAD0SggAICCAAABgCIAqDSCAIAAAAgAAAACAFAAEgAABIAAQQCQAAFgAAIAQOKyvCvgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"[2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate","acetic acid [2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] ester","[2-[(8<I>S</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate","[2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate","[2-[(8S,9S,10R,13S,14S,17R)-10,13-dimethyl-17-oxidanyl-3,11-bis(oxidanylidene)-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] ethanoate","acetic acid [2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-3,11-diketo-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-keto-ethyl] ester","InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-17,20,28H,4-9,11-12H2,1-3H3/t16-,17-,20+,21-,22-,23-/m0/s1",ITRJWOMZKQRYTA-RFZYENFJSA-N,2.1,402.20423867,C23H30O6,402.5,97.7,402.20423867,0.0,29.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C,,"11  1  6
10  32  6
12  23  5
7  30  6
8  18  5
9  31  5",
440790725,16132265,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00077,corticotropin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00077,corticotropin,0.0,No match,vNo-DILI-Concern,2.0,16132265,1.0,11200.0,68.0,63.0,148.0,AAADcfB//gBAAAAAAAAAAAAAAAAAAWLFixYwYMGDAAAAAFgB/AAAHgQQCAAADSzl3ga/3vfJkgioAzX3fACCgC2xMrAJ2aG+fJiKfv7i2bOUcAhu9hPY2Ce/3+KOoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenyl-propanoyl]amino]-5-guanidino-pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methyl-butanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]pyrrolidine-2-carbonyl]amino]-3-methyl-butanoyl]amino]hexanoyl]amino]-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-4-oxo-butanoyl]amino]acetyl]amino]propanoyl]amino]-4-carboxy-butanoyl]amino]-3-carboxy-propanoyl]amino]-4-carboxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]propanoyl]amino]-5-[[(1S)-2-[[(1S)-1-benzyl-2-[(2S)-2-[[(1S)-1-[[(1S)-3-carboxy-1-[[(1S)-1-carboxy-2-phenyl-ethyl]carbamoyl]propyl]carbamoyl]-3-methyl-butyl]carbamoyl]pyrrolidin-1-yl]-2-oxo-ethyl]amino]-1-methyl-2-oxo-ethyl]amino]-5-oxo-pentanoic acid,"(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxy-1-oxopropyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-3-hydroxy-1-oxopropyl]amino]-4-(methylthio)-1-oxobutyl]amino]-4-carboxy-1-oxobutyl]amino]-3-(1H-imidazol-5-yl)-1-oxopropyl]amino]-1-oxo-3-phenylpropyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-3-(1H-indol-3-yl)-1-oxopropyl]amino]-1-oxoethyl]amino]-1-oxohexyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methyl-1-oxobutyl]amino]-1-oxoethyl]amino]-1-oxohexyl]amino]-1-oxohexyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-5-carbamimidamido-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methyl-1-oxobutyl]amino]-1-oxohexyl]amino]-3-methyl-1-oxobutyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]-2-pyrrolidinyl]-oxomethyl]amino]-1,4-dioxobutyl]amino]-1-oxoethyl]amino]-1-oxopropyl]amino]-4-carboxy-1-oxobutyl]amino]-3-carboxy-1-oxopropyl]amino]-4-carboxy-1-oxobutyl]amino]-3-hydroxy-1-oxopropyl]amino]-1-oxopropyl]amino]-5-[[(2S)-1-[[(2S)-1-[(2S)-2-[[[(2S)-1-[[(2S)-4-carboxy-1-[[(1S)-1-carboxy-2-phenylethyl]amino]-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-oxomethyl]-1-pyrrolidinyl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid",(4<I>S</I>)-4-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[2-[[(2<I>S</I>)-4-amino-2-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-6-amino-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-6-amino-2-[[(2<I>S</I>)-6-amino-2-[[2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[(2<I>S</I>)-6-amino-2-[[2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-amino-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1<I>H</I>-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1<I>H</I>-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoyl]amino]acetyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[[(2<I>S</I>)-4-carboxy-1-[[(1<I>S</I>)-1-carboxy-2-phenylethyl]amino]-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid,(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoyl]amino]acetyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-4-carboxy-1-[[(1S)-1-carboxy-2-phenylethyl]amino]-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid,"(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[2-[[(2S)-4-azanyl-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-azanyl-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-azanyl-2-[[(2S)-6-azanyl-2-[2-[[(2S)-2-[[(2S)-1-[(2S)-6-azanyl-2-[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-azanyl-3-oxidanyl-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-oxidanyl-propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenyl-propanoyl]amino]-5-carbamimidamido-pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]ethanoylamino]hexanoyl]pyrrolidin-2-yl]carbonylamino]-3-methyl-butanoyl]amino]ethanoylamino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamido-pentanoyl]amino]-5-carbamimidamido-pentanoyl]pyrrolidin-2-yl]carbonylamino]-3-methyl-butanoyl]amino]hexanoyl]amino]-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]carbonylamino]-4-oxidanylidene-butanoyl]amino]ethanoylamino]propanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-4-oxidanyl-4-oxidanylidene-butanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-oxidanyl-propanoyl]amino]propanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-4-methyl-1-[[(2S)-5-oxidanyl-1,5-bis(oxidanylidene)-1-[[(2S)-1-oxidanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]pentan-2-yl]amino]-1-oxidanylidene-pentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-5-oxidanylidene-pentanoic acid",(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-4-(methylthio)butanoyl]amino]-4-carboxy-butanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenyl-propanoyl]amino]-5-guanidino-pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]prolyl]amino]-3-methyl-butanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]prolyl]amino]-3-methyl-butanoyl]amino]hexanoyl]amino]-3-methyl-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]prolyl]amino]-4-keto-butanoyl]amino]acetyl]amino]propanoyl]amino]-4-carboxy-butanoyl]amino]-3-carboxy-propanoyl]amino]-4-carboxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]propanoyl]amino]-5-[[(1S)-2-[[(1S)-1-benzyl-2-[(2S)-2-[[(1S)-1-[[(1S)-3-carboxy-1-[[(1S)-1-carboxy-2-phenyl-ethyl]carbamoyl]propyl]carbamoyl]-3-methyl-butyl]carbamoyl]pyrrolidino]-2-keto-ethyl]amino]-2-keto-1-methyl-ethyl]amino]-5-keto-valeric acid,"InChI=1S/C207H308N56O58S/c1-108(2)89-140(186(302)240-135(69-74-163(279)280)182(298)254-149(204(320)321)94-117-43-20-15-21-44-117)250-193(309)152-54-35-86-262(152)202(318)147(92-116-41-18-14-19-42-116)252-171(287)114(11)230-175(291)132(66-71-160(273)274)234-170(286)113(10)231-191(307)150(105-265)255-183(299)136(70-75-164(281)282)241-190(306)146(98-165(283)284)249-180(296)133(67-72-161(275)276)235-169(285)112(9)229-157(270)101-225-174(290)145(97-156(213)269)251-194(310)153-55-36-87-263(153)203(319)148(93-119-60-64-123(268)65-61-119)253-199(315)167(110(5)6)257-185(301)129(49-26-30-79-210)243-198(314)168(111(7)8)259-196(312)155-57-38-85-261(155)201(317)139(53-34-83-223-207(218)219)244-178(294)130(51-32-81-221-205(214)215)237-177(293)128(48-25-29-78-209)236-176(292)127(47-24-28-77-208)232-158(271)103-227-197(313)166(109(3)4)258-195(311)154-56-37-84-260(154)200(316)138(50-27-31-80-211)233-159(272)102-226-173(289)143(95-120-99-224-126-46-23-22-45-124(120)126)247-179(295)131(52-33-82-222-206(216)217)238-187(303)142(90-115-39-16-13-17-40-115)246-189(305)144(96-121-100-220-107-228-121)248-181(297)134(68-73-162(277)278)239-184(300)137(76-88-322-12)242-192(308)151(106-266)256-188(304)141(245-172(288)125(212)104-264)91-118-58-62-122(267)63-59-118/h13-23,39-46,58-65,99-100,107-114,125,127-155,166-168,224,264-268H,24-38,47-57,66-98,101-106,208-212H2,1-12H3,(H2,213,269)(H,220,228)(H,225,290)(H,226,289)(H,227,313)(H,229,270)(H,230,291)(H,231,307)(H,232,271)(H,233,272)(H,234,286)(H,235,285)(H,236,292)(H,237,293)(H,238,303)(H,239,300)(H,240,302)(H,241,306)(H,242,308)(H,243,314)(H,244,294)(H,245,288)(H,246,305)(H,247,295)(H,248,297)(H,249,296)(H,250,309)(H,251,310)(H,252,287)(H,253,315)(H,254,298)(H,255,299)(H,256,304)(H,257,301)(H,258,311)(H,259,312)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,320,321)(H4,214,215,221)(H4,216,217,222)(H4,218,219,223)/t112-,113-,114-,125-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,166-,167-,168-/m0/s1",IDLFZVILOHSSID-OVLDLUHVSA-N,,4540.2660828,C207H308N56O58S,4541.0,1860.0,4538.2593732,0.0,322.0,36.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(\N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN/C(N)=N/[H])C(=O)N[C@@H](CCCN/C(N)=N/[H])C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C,-19.7,"266  100  5
263  102  6
270  103  6
279  104  6
280  105  5
277  106  5
109  291  8
109  300  8
295  110  6
111  298  8
111  300  8
303  112  5
308  113  5
312  114  5
316  115  5
116  123  6
120  135  5
127  143  5
133  150  6
179  198  8
179  199  8
180  201  8
180  202  8
198  213  8
199  214  8
201  215  8
202  216  8
213  220  8
214  220  8
215  219  8
216  219  8
234  240  8
234  243  8
240  246  8
240  250  8
244  253  8
244  254  8
246  255  8
250  258  8
253  264  8
254  265  8
255  262  8
258  262  8
264  267  8
265  267  8
273  282  8
273  283  8
282  289  8
283  290  8
289  294  8
290  294  8
291  298  8
314  317  8
314  318  8
317  320  8
318  321  8
320  322  8
321  322  8
129  62  6
125  65  5
145  66  6
158  67  6
137  68  5
159  69  5
149  70  6
174  71  5
148  72  5
154  73  6
163  74  6
194  77  5
183  78  5
193  82  5
205  84  6
231  87  6
223  90  5
226  91  6
248  94  6
96  243  8
96  246  8
241  98  5
249  99  5",
440790724,16132344,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00438,Corticorelin ovine triflutate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00438,corticorelin ovine triflutate,0.0,No match,vNo-DILI-Concern,2.0,16132344,1.0,11500.0,71.0,66.0,161.0,AAADcfB//gBAAAAAAAAAAAAAAAAAAWLFiwAwAAAAAAAAAAAB8AAAHgQQCAAADTzl3ga/mJfJkgioAzX3fAACgC2xErAJ2YG4cIiKeD7g2TGUYAAutgLYyCe/n4KOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(4S)-5-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S,2R)-1-[[(1S)-5-amino-1-[[(1S)-2-[[(1S)-2-[[(1S)-4-amino-1-[[(1S)-1-[[(1S)-2-[[(1S)-4-amino-1-[[(1S)-4-amino-1-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-3-amino-1-[[(1S)-1-[[(1S)-5-amino-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S,2S)-1-[[(1S)-2-amino-1-methyl-2-oxo-ethyl]carbamoyl]-2-methyl-butyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]pentyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-3-oxo-propyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]amino]-1-methyl-2-oxo-ethyl]carbamoyl]-4-oxo-butyl]carbamoyl]-4-oxo-butyl]amino]-1-methyl-2-oxo-ethyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-oxo-butyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]amino]-1-methyl-2-oxo-ethyl]carbamoyl]pentyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-3-methylsulfanyl-propyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-methyl-butyl]carbamoyl]-2-methyl-propyl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-1-[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-hydroxy-propanoyl]amino]-5-oxo-pentanoyl]amino]-4-carboxy-butanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]-3-methyl-pentanoyl]amino]-3-hydroxy-propanoyl]amino]-4-methyl-pentanoyl]amino]-3-carboxy-propanoyl]amino]-4-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-5-oxo-pentanoic acid","(4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-(methylthio)-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-hydroxy-1-oxopropyl]amino]-1,5-dioxopentyl]amino]-4-carboxy-1-oxobutyl]-2-pyrrolidinyl]-oxomethyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methyl-1-oxopentyl]amino]-3-hydroxy-1-oxopropyl]amino]-4-methyl-1-oxopentyl]amino]-3-carboxy-1-oxopropyl]amino]-4-methyl-1-oxopentyl]amino]-3-hydroxy-1-oxobutyl]amino]-1-oxo-3-phenylpropyl]amino]-3-(1H-imidazol-5-yl)-1-oxopropyl]amino]-4-methyl-1-oxopentyl]amino]-4-methyl-1-oxopentyl]amino]-5-carbamimidamido-1-oxopentyl]amino]-5-oxopentanoic acid","(4<I>S</I>)-5-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>,3<I>R</I>)-1-[[(2<I>S</I>)-6-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-5-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-5-amino-1-[[(2<I>S</I>)-5-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-4-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-6-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>,3<I>S</I>)-1-[[(2<I>S</I>)-1-amino-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>R</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-1-[(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-5-amino-2-[[(2<I>S</I>)-2-amino-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-(1<I>H</I>-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoic acid","(4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-1-[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoic acid","(4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-6-azanyl-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-azanyl-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-azanyl-1-[[(2S)-5-azanyl-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-azanyl-1-[[(2S)-1-[[(2S)-6-azanyl-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-azanyl-1-oxidanylidene-propan-2-yl]amino]-3-methyl-1-oxidanylidene-pentan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-1-oxidanylidene-hexan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-1,4-bis(oxidanylidene)butan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1,5-bis(oxidanylidene)pentan-2-yl]amino]-1,5-bis(oxidanylidene)pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-1,5-bis(oxidanylidene)pentan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-hexan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-butan-2-yl]amino]-4-methylsulfanyl-1-oxidanylidene-butan-2-yl]amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-1-[(2S)-1-[(2S)-2-[[(2S)-5-azanyl-2-[[(2S)-2-azanyl-3-oxidanyl-propanoyl]amino]-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]pyrrolidin-2-yl]carbonylpyrrolidin-2-yl]carbonylamino]-3-methyl-pentanoyl]amino]-3-oxidanyl-propanoyl]amino]-4-methyl-pentanoyl]amino]-4-oxidanyl-4-oxidanylidene-butanoyl]amino]-4-methyl-pentanoyl]amino]-3-oxidanyl-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]-5-carbamimidamido-pentanoyl]amino]-5-oxidanylidene-pentanoic acid","(4S)-5-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S,2R)-1-[[(1S)-5-amino-1-[[(1S)-2-[[(1S)-2-[[(1S)-4-amino-1-[[(1S)-1-[[(1S)-2-[[(1S)-4-amino-1-[[(1S)-4-amino-1-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-3-amino-1-[[(1S)-1-[[(1S)-5-amino-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S,2S)-1-[[(1S)-2-amino-2-keto-1-methyl-ethyl]carbamoyl]-2-methyl-butyl]amino]-1-(carboxymethyl)-2-keto-ethyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]pentyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-3-keto-propyl]amino]-2-keto-1-methylol-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-keto-ethyl]amino]-2-keto-1-methyl-ethyl]carbamoyl]-4-keto-butyl]carbamoyl]-4-keto-butyl]amino]-2-keto-1-methyl-ethyl]carbamoyl]-3-methyl-butyl]carbamoyl]-4-keto-butyl]amino]-1-(carboxymethyl)-2-keto-ethyl]amino]-2-keto-1-methyl-ethyl]carbamoyl]pentyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-3-(methylthio)propyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-methyl-butyl]carbamoyl]-2-methyl-propyl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-1-[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-hydroxy-propanoyl]amino]-5-keto-pentanoyl]amino]-4-carboxy-butanoyl]prolyl]prolyl]amino]-3-methyl-pentanoyl]amino]-3-hydroxy-propanoyl]amino]-4-methyl-pentanoyl]amino]-3-carboxy-propanoyl]amino]-4-methyl-pentanoyl]amino]-3-hydroxy-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-5-keto-valeric acid","InChI=1S/C205H339N59O63S/c1-30-104(21)159(198(322)225-106(23)163(214)287)259-193(317)142(87-157(285)286)253-184(308)132(77-99(11)12)246-182(306)130(75-97(7)8)244-172(296)117(46-36-38-67-207)231-170(294)118(47-39-68-221-204(215)216)233-189(313)139(84-151(213)274)251-194(318)143(91-266)256-188(312)137(82-113-88-219-93-223-113)241-165(289)108(25)227-169(293)120(51-58-147(209)270)234-173(297)121(52-59-148(210)271)229-164(288)107(24)228-179(303)128(73-95(3)4)243-176(300)123(54-61-150(212)273)236-190(314)140(85-155(281)282)242-166(290)109(26)226-168(292)116(45-35-37-66-206)239-200(324)161(110(27)268)261-178(302)126(65-72-328-29)238-174(298)124(55-62-152(275)276)237-181(305)134(79-101(15)16)254-197(321)158(103(19)20)258-177(301)125(56-63-153(277)278)235-171(295)119(48-40-69-222-205(217)218)232-180(304)129(74-96(5)6)245-183(307)131(76-98(9)10)247-187(311)138(83-114-89-220-94-224-114)250-186(310)136(81-112-43-33-32-34-44-112)255-201(325)162(111(28)269)262-192(316)135(80-102(17)18)248-191(315)141(86-156(283)284)252-185(309)133(78-100(13)14)249-195(319)144(92-267)257-199(323)160(105(22)31-2)260-196(320)145-49-41-70-263(145)203(327)146-50-42-71-264(146)202(326)127(57-64-154(279)280)240-175(299)122(53-60-149(211)272)230-167(291)115(208)90-265/h32-34,43-44,88-89,93-111,115-146,158-162,265-269H,30-31,35-42,45-87,90-92,206-208H2,1-29H3,(H2,209,270)(H2,210,271)(H2,211,272)(H2,212,273)(H2,213,274)(H2,214,287)(H,219,223)(H,220,224)(H,225,322)(H,226,292)(H,227,293)(H,228,303)(H,229,288)(H,230,291)(H,231,294)(H,232,304)(H,233,313)(H,234,297)(H,235,295)(H,236,314)(H,237,305)(H,238,298)(H,239,324)(H,240,299)(H,241,289)(H,242,290)(H,243,300)(H,244,296)(H,245,307)(H,246,306)(H,247,311)(H,248,315)(H,249,319)(H,250,310)(H,251,318)(H,252,309)(H,253,308)(H,254,321)(H,255,325)(H,256,312)(H,257,323)(H,258,301)(H,259,317)(H,260,320)(H,261,302)(H,262,316)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H4,215,216,221)(H4,217,218,222)/t104-,105-,106-,107-,108-,109-,110+,111+,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,158-,159-,160-,161-,162-/m0/s1",QEEJLLNYQOBRRM-KSHGRFHLSA-N,,4669.4924539,C205H339N59O63S,4670.0,2010.0,4667.4857443,0.0,328.0,45.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(\N)NCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)NC(C(=O)N[C@@H](C)C(N)=O)[C@@H](C)CC,-18.6,"263  100  5
269  102  5
275  103  6
278  105  6
288  106  5
290  110  5
287  111  6
297  112  6
295  113  6
307  114  6
309  116  5
312  117  5
313  118  6
119  306  8
119  326  8
120  320  8
120  326  8
124  130  5
125  134  5
138  142  6
179  181  8
179  182  8
181  185  8
182  186  8
185  188  8
186  188  8
187  191  8
173  19  6
231  252  5
306  320  8
273  43  5
136  67  5
135  68  6
148  69  6
144  70  5
155  71  6
153  72  6
162  74  5
165  75  5
172  76  5
176  77  6
180  78  6
189  79  5
80  187  8
80  194  8
81  191  8
81  194  8
197  82  6
203  83  6
207  84  5
210  85  6
215  86  6
211  88  5
218  89  5
220  90  6
234  91  5
232  92  5
241  93  5
240  94  5
265  95  6
259  96  6",
440790723,151171,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01210,Conivaptan,20250421,20210312,Curation Efforts|Governmental Organizations,LT01210,conivaptan,0.0,No match,vNo-DILI-Concern,2.0,151171,1.0,820.0,3.0,2.0,4.0,AAADceB/sAAAAAAAAAAAAAAAAAAAAWAAAAAwYMGABYAAAACx1AAAHgAQAAAADAjBnwQz0JfJkACoAydydACCgC2lEqAJmSE4dNiIaLLA3ZGUIQholgLIyacYicCeiAAAAAASAAAQAAAAACQAAAAAAAAAAA==,"N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenyl-benzamide","N-[4-[(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepin-6-yl)-oxomethyl]phenyl]-2-phenylbenzamide","<I>N</I>-[4-(2-methyl-4,5-dihydro-3<I>H</I>-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide","N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide","N-[4-[(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepin-6-yl)carbonyl]phenyl]-2-phenyl-benzamide","N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenyl-benzamide","InChI=1S/C32H26N4O2/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37)",IKENVDNFQMCRTR-UHFFFAOYSA-N,,498.20557608,C32H26N4O2,498.6,78.1,498.20557608,0.0,38.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2,5.7,"11  12  8
11  15  8
12  16  8
15  18  8
16  19  8
17  21  8
17  22  8
18  19  8
21  24  8
22  25  8
23  24  8
23  25  8
26  27  8
26  30  8
27  31  8
29  34  8
29  35  8
30  32  8
31  33  8
32  33  8
34  36  8
35  37  8
36  38  8
37  38  8
4  13  8
4  9  8
5  10  8
5  13  8
9  10  8",
440790722,216258,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01275,Colistimethate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01275,colistimethate,0.0,No match,vNo-DILI-Concern,1.0,216258,1.0,3430.0,33.0,18.0,39.0,AAADcfB//jBwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgQQCAAADTzhgAaCAALAAgIIAAEQEHAIAAAAAAAAAIGIAAACUBYAwCAUQAACNgCQAAEciMCOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-diisobutyl-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate","pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-[(6-methyl-1-oxooctyl)amino]-1-oxo-4-(sulfonatomethylamino)butyl]amino]-1-oxobutyl]amino]-1-oxo-4-(sulfonatomethylamino)butyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate","pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate","pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate","pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]-3-oxidanyl-butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptakis(oxidanylidene)-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate","pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-diisobutyl-3,6,9,12,15,18,23-heptaketo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate","InChI=1S/C58H110N16O28S5.5Na/c1-9-35(6)12-10-11-13-46(77)65-38(14-20-59-28-103(88,89)90)53(82)74-48(37(8)76)58(87)70-41(17-23-62-31-106(97,98)99)50(79)68-43-19-25-64-57(86)47(36(7)75)73-54(83)42(18-24-63-32-107(100,101)102)67-49(78)39(15-21-60-29-104(91,92)93)69-55(84)44(26-33(2)3)72-56(85)45(27-34(4)5)71-52(81)40(66-51(43)80)16-22-61-30-105(94,95)96;;;;;/h33-45,47-48,59-63,75-76H,9-32H2,1-8H3,(H,64,86)(H,65,77)(H,66,80)(H,67,78)(H,68,79)(H,69,84)(H,70,87)(H,71,81)(H,72,85)(H,73,83)(H,74,82)(H,88,89,90)(H,91,92,93)(H,94,95,96)(H,97,98,99)(H,100,101,102);;;;;/q;5*+1/p-5",IQWHCHZFYPIVRV-UHFFFAOYSA-I,,1748.537624,C58H105N16Na5O28S5,1749.8,749.0,1748.537624,0.0,112.0,0.0,13.0,0.0,0.0,0.0,6.0,-1.0,"1
5
255",CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCNCS(=O)(=O)[O-])NC(=O)C(CCNCS(=O)(=O)[O-])NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCNCS(=O)(=O)[O-])NC1=O)C(C)O.[Na+].[Na+].[Na+].[Na+].[Na+],,"100  186  3
55  113  3
56  114  3
62  122  3
64  124  3
66  125  3
74  146  3
77  147  3
78  148  3
85  163  3
90  168  3
92  173  3
93  175  3",
440790721,5284371,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01269,codeine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01269,codeine,0.0,No match,vNo-DILI-Concern,2.0,5284371,1.0,509.0,4.0,1.0,1.0,AAADceB6MAAAAAAAAAAAAAAAAAAAASAAAAA8YIEAAAAWAEjBAAAAHgAACAAADzzhmAYyBoMABgCAAiBCAAACCAAgIAAIiAAOiIgNNiKEsRuGeCKkwBGLuAew8P8PoAABAAAYQADQAAaAADSAAAAAAAAAAA==,"(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol","(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol","(4<I>R</I>,4<I>a</I><I>R</I>,7<I>S</I>,7<I>a</I><I>R</I>,12<I>b</I><I>S</I>)-9-methoxy-3-methyl-2,4,4<I>a</I>,7,7<I>a</I>,13-hexahydro-1<I>H</I>-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol","(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol","(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol","(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol","InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",OROGSEYTTFOCAN-DNJOTXNNSA-N,1.1,299.15214353,C18H21NO3,299.4,41.9,299.15214353,0.0,22.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341,,"10  13  8
10  16  8
13  19  8
16  20  8
19  21  8
14  2  6
20  21  8
5  9  5
6  23  5
7  24  6
8  25  5",
440790720,153994,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00644,Clevidipine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00644,clevidipine,0.0,No match,vNo-DILI-Concern,2.0,153994,1.0,748.0,7.0,1.0,10.0,AAADceB6OAAGAAAAAAAAAAAAAAAAAAAAAAAwQAAAAAAAAAABAAAAHgIQAAAADQqBmCMyCILABACIAiTSSAACAAAgBQAIikEAAsgYJDKBMxCgMAAkkACMqUeI7uiOgAAAIAABAAQAAABAAAIACAAAAAAAAA==,"O5-(butanoyloxymethyl) O3-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-(1-oxobutoxymethyl) ester","5-<I>O</I>-(butanoyloxymethyl) 3-<I>O</I>-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","5-O-(butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","O5-(butanoyloxymethyl) O3-methyl 4-[2,3-bis(chloranyl)phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid O5-(butyryloxymethyl) ester O3-methyl ester","InChI=1S/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3",KPBZROQVTHLCDU-UHFFFAOYSA-N,4.3,455.0902428,C21H23Cl2NO6,456.3,90.9,455.0902428,0.0,30.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,,"10  31  3
13  20  8
13  21  8
20  22  8
21  23  8
22  24  8
23  24  8",
440790719,26987,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02222,clemastine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02222,clemastine,0.0,No match,vNo-DILI-Concern,1.0,26987,1.0,376.0,2.0,0.0,6.0,AAADceB6IAAEAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAABQAAAHgIAAAAADG7hmCYyAIMABACAAiBCAAACAAAgBQAIiAAICogIJiKBsxiGMAAmwAGIqAeQwOAOhAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenyl-ethoxy]ethyl]-1-methyl-pyrrolidine,(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine,(2<I>R</I>)-2-[2-[(1<I>R</I>)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine,(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine,(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenyl-ethoxy]ethyl]-1-methyl-pyrrolidine,(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenyl-ethoxy]ethyl]-1-methyl-pyrrolidine,"InChI=1S/C21H26ClNO/c1-21(17-7-4-3-5-8-17,18-10-12-19(22)13-11-18)24-16-14-20-9-6-15-23(20)2/h3-5,7-8,10-13,20H,6,9,14-16H2,1-2H3/t20-,21-/m1/s1",YNNUSGIPVFPVBX-NHCUHLMSSA-N,,343.1702921,C21H26ClNO,343.9,12.5,343.1702921,0.0,24.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,5.0,"12  15  8
12  16  8
13  17  8
13  18  8
15  19  8
16  20  8
17  21  8
18  22  8
19  23  8
11  2  6
20  23  8
21  24  8
22  24  8
4  8  5",
440790718,62886,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00978,Cisatracurium besylate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00978,cisatracurium besylate,0.0,No match,vNo-DILI-Concern,2.0,62886,1.0,1560.0,18.0,0.0,26.0,AAADcfB/PgBgAAAAAAAAAAAAAAAAAAAAAAA8eMGDAAAAAACxVAAAHgQAAAAADCzh2AYyD4MABAKIAiDSCHDCCEAgIAAIiBkOjIgNJiqEsRuGMCpmwBGKqAew8PsOoAABAAAQQABAAAIAACCAAAAAAAAAAA==,"benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate","benzenesulfonate;3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoic acid 5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]-1-oxopropoxy]pentyl ester","benzenesulfonate;5-[3-[(1<I>R</I>,2<I>R</I>)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1<I>H</I>-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1<I>R</I>,2<I>R</I>)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1<I>H</I>-isoquinolin-2-ium-2-yl]propanoate","benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate","benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate","3-[(1R,2R)-6,7-dimethoxy-2-methyl-1-veratryl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propionic acid 5-[3-[(1R,2R)-6,7-dimethoxy-2-methyl-1-veratryl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl ester;dibesylate","InChI=1S/C53H72N2O12.2C6H6O3S/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6;2*7-10(8,9)6-4-2-1-3-5-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3;2*1-5H,(H,7,8,9)/q+2;;/p-2/t42-,43-,54-,55-;;/m1../s1",XXZSQOVSEBAPGS-DONVQRBFSA-L,,1242.50040612,C65H82N2O18S2,1243.5,258.0,1242.50040612,0.0,87.0,4.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,,"21  33  5
22  34  6
23  35  6
24  36  5
29  37  8
29  41  8
30  38  8
30  42  8
37  45  8
38  46  8
41  47  8
42  48  8
43  53  8
43  55  8
44  54  8
44  56  8
45  49  8
46  50  8
47  49  8
48  50  8
53  57  8
54  58  8
55  59  8
56  60  8
57  61  8
58  62  8
59  61  8
60  62  8
76  78  8
76  80  8
77  79  8
77  81  8
78  82  8
79  83  8
80  84  8
81  85  8
82  86  8
83  87  8
84  86  8
85  87  8",
440790717,156419,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01209,Cinacalcet,20231222,20210312,Curation Efforts|Governmental Organizations,LT01209,cinacalcet,0.0,No match,vNo-DILI-Concern,2.0,156419,1.0,422.0,4.0,1.0,6.0,AAADceB6AYAAAAAAAAAAAAAAAAAAAAAAAAAwYMAAAAAAAADBVAAAHQAQAAAADCjBGBQyAMLAAACAAiBCAACCAAAgAAAIiIAIBIgIICKAkRGEIAhgkACIiAcQgMAOgAACAAAQAAAAAAQAACAAAAAAAAAAAA==,N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine,N-[(1R)-1-(1-naphthalenyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-propanamine,<I>N</I>-[(1<I>R</I>)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine,N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine,N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine,[(1R)-1-(1-naphthyl)ethyl]-[3-[3-(trifluoromethyl)phenyl]propyl]amine,"InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1",VDHAWDNDOKGFTD-MRXNPFEDSA-N,,357.17043419,C22H22F3N,357.4,12.0,357.17043419,0.0,26.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,6.1,"10  12  8
10  15  8
12  16  8
12  19  8
13  18  8
13  20  8
14  17  8
15  22  8
16  17  8
18  21  8
19  23  8
20  24  8
21  25  8
22  23  8
24  25  8
5  4  5
7  10  8
7  14  8",
440790716,2725,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00009,chlorpheniramine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00009,chlorpheniramine,0.0,No match,vNo-DILI-Concern,2.0,2725,1.0,249.0,2.0,0.0,5.0,AAADceB7AAAEAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHAIAAAAADQrBHiQ+gJMIEACgAzRnRACCgCAxByAI2CA4ZpgIIOLBk5GEIAhggADIyAcQgMAOhAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,"3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine","3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine","3-(4-chlorophenyl)-<I>N</I>,<I>N</I>-dimethyl-3-pyridin-2-ylpropan-1-amine","3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine","3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine",[3-(4-chlorophenyl)-3-(2-pyridyl)propyl]-dimethyl-amine,"InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3",SOYKEARSMXGVTM-UHFFFAOYSA-N,3.4,274.1236763,C16H19ClN2,274.79,16.1,274.1236763,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,,"10  15  8
11  16  8
14  17  8
15  17  8
16  19  8
18  19  8
3  18  8
3  8  8
4  5  3
7  10  8
7  9  8
8  11  8
9  14  8",
440790715,5959,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01196,chloramphenicol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01196,chloramphenicol,0.0,No match,vNo-DILI-Concern,2.0,5959,1.0,342.0,5.0,3.0,5.0,AAADccBzOAAGAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgIUCAAADD/hmMYwwILQQgCJAiVSUwCCAAAgAgAoiIAIbIpKNiKAkZHEcABl1gGY2AeQ0KEOCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,"2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide","2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide","2,2-dichloro-<I>N</I>-[(1<I>R</I>,2<I>R</I>)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide","2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide","2,2-bis(chloranyl)-N-[(1R,2R)-1-(4-nitrophenyl)-1,3-bis(oxidanyl)propan-2-yl]ethanamide","2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-methylol-2-(4-nitrophenyl)ethyl]acetamide","InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1",WIIZWVCIJKGZOK-RKDXNWHRSA-N,1.1,322.0123269,C11H12Cl2N2O5,323.13,115.0,322.0123269,0.0,20.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl,,"12  14  8
12  15  8
14  17  8
15  18  8
17  19  8
18  19  8
11  3  5
10  8  6",
440790714,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01389,Cetuximab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01389,cetuximab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790713,2576,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02037,carisoprodol,20210312,20210312,Curation Efforts|Governmental Organizations,LT02037,carisoprodol,0.0,No match,vNo-DILI-Concern,2.0,2576,1.0,281.0,4.0,2.0,9.0,AAADceBzOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQAAAADijhgAYCCALABAAIAAAAGAAAAAAAAAAAAIAIAAEAAAIAAAAIAAAFFgAAAACAAAANAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,[2-(carbamoyloxymethyl)-2-methyl-pentyl] N-isopropylcarbamate,N-propan-2-ylcarbamic acid [2-(carbamoyloxymethyl)-2-methylpentyl] ester,[2-(carbamoyloxymethyl)-2-methylpentyl] <I>N</I>-propan-2-ylcarbamate,[2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate,[2-(aminocarbonyloxymethyl)-2-methyl-pentyl] N-propan-2-ylcarbamate,N-isopropylcarbamic acid [2-(carbamoyloxymethyl)-2-methyl-pentyl] ester,"InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16)",OFZCIYFFPZCNJE-UHFFFAOYSA-N,1.9,260.17360725,C12H24N2O4,260.33,90.7,260.17360725,0.0,18.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCC(C)(COC(N)=O)COC(=O)NC(C)C,,7  11  3,
440790712,5281074,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00898,CARBOPROST TROMETHAMINE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00898,carboprost tromethamine,0.0,No match,vNo-DILI-Concern,2.0,5281074,1.0,527.0,9.0,8.0,15.0,AAADcfB6PAAAAAAAAAAAAAAAAAAAAYAAAAAAAAAAAAAAAAAAAAAAHgAQCAAADdyhgAICCABAAgCIACDSCAAAAAAgAAAICAEAAAgCFBIAAQAAUAAF0AAIEAPIwOAOgAAAAAAAAAAAAAAAAAAAAIQADAAAAA==,"2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyl-oct-1-enyl]cyclopentyl]hept-5-enoic acid","2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]-5-heptenoic acid","2-amino-2-(hydroxymethyl)propane-1,3-diol;(<I>Z</I>)-7-[(1<I>R</I>,2<I>R</I>,3<I>R</I>,5<I>S</I>)-3,5-dihydroxy-2-[(<I>E</I>,3<I>S</I>)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid","2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid","2-azanyl-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-2-[(E,3S)-3-methyl-3-oxidanyl-oct-1-enyl]-3,5-bis(oxidanyl)cyclopentyl]hept-5-enoic acid","2-amino-2-methylol-propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyl-oct-1-enyl]cyclopentyl]hept-5-enoic acid","InChI=1S/C21H36O5.C4H11NO3/c1-3-4-9-13-21(2,26)14-12-17-16(18(22)15-19(17)23)10-7-5-6-8-11-20(24)25;5-4(1-6,2-7)3-8/h5,7,12,14,16-19,22-23,26H,3-4,6,8-11,13,15H2,1-2H3,(H,24,25);6-8H,1-3,5H2/b7-5-,14-12+;/t16-,17-,18+,19-,21+;/m1./s1",UMMADZJLZAPZAW-XOWPVRJPSA-N,,489.33016746,C25H47NO8,489.6,185.0,489.33016746,0.0,34.0,5.0,0.0,2.0,0.0,0.0,2.0,-1.0,"1
5
255",CCCCC[C@](C)(O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O.NC(CO)(CO)CO,,"12  1  6
10  15  6
11  16  5
13  2  6
19  3  5",
440790711,2564,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00759,carbinoxamine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00759,carbinoxamine,0.0,No match,vNo-DILI-Concern,1.0,2564,1.0,267.0,3.0,0.0,6.0,AAADceB7IAAEAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHgIAAAAADB7hniY+gJMIFACgAzRnRASCgCAxByAI2CA4bpgKJuLBs5mHMAhkwAHY6AeQwOAOBAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,"2-[(4-chlorophenyl)-(2-pyridyl)methoxy]-N,N-dimethyl-ethanamine","2-[(4-chlorophenyl)-(2-pyridinyl)methoxy]-N,N-dimethylethanamine","2-[(4-chlorophenyl)-pyridin-2-ylmethoxy]-<I>N</I>,<I>N</I>-dimethylethanamine","2-[(4-chlorophenyl)-pyridin-2-ylmethoxy]-N,N-dimethylethanamine","2-[(4-chlorophenyl)-pyridin-2-yl-methoxy]-N,N-dimethyl-ethanamine",2-[(4-chlorophenyl)-(2-pyridyl)methoxy]ethyl-dimethyl-amine,"InChI=1S/C16H19ClN2O/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13/h3-10,16H,11-12H2,1-2H3",OJFSXZCBGQGRNV-UHFFFAOYSA-N,,290.1185909,C16H19ClN2O,290.79,25.4,290.1185909,0.0,20.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1,2.9,"10  15  8
11  16  8
12  18  8
15  17  8
16  17  8
18  20  8
19  20  8
4  19  8
4  9  8
5  21  3
8  10  8
8  11  8
9  12  8",
440790710,6116,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00947,Calcium acetate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00947,calcium acetate,0.0,No match,vNo-DILI-Concern,2.0,6116,1.0,25.5,4.0,0.0,0.0,AAADcYBgOAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgAAAAAAAACAgAACCAAAAAAIAACQCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,calcium;diacetate,calcium;diacetate,calcium;diacetate,calcium;diacetate,calcium;diethanoate,calcium;diacetate,"InChI=1S/2C2H4O2.Ca/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2",VSGNNIFQASZAOI-UHFFFAOYSA-L,,157.9891995,C4H6CaO4,158.17,80.3,157.9891995,0.0,9.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",CC(=O)[O-].CC(=O)[O-].[Ca+2],,,
440790709,5280453,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00899,calcitriol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00899,calcitriol,0.0,No match,vNo-DILI-Concern,2.0,5280453,1.0,688.0,3.0,3.0,6.0,AAADcfB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYAAAAAAAAGAAAAAAGgAACAAAD1SggAICAAAAAgCAAiBCAAAAAAAgAAAACAAAAAgIFAIAAQAAQAAFwAAIkAOA4PQPgAAAAAAAAAAAAAAQACAAAQAACAAAAA==,"(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol","(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylenecyclohexane-1,3-diol","(1<I>R</I>,3<I>S</I>,5<I>Z</I>)-5-[(2<I>E</I>)-2-[(1<I>R</I>,3<I>a</I><I>S</I>,7<I>a</I><I>R</I>)-1-[(2<I>R</I>)-6-hydroxy-6-methylheptan-2-yl]-7<I>a</I>-methyl-2,3,3<I>a</I>,5,6,7-hexahydro-1<I>H</I>-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol","(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol","(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methyl-6-oxidanyl-heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol","(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol","InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1",GMRQFYUYWCNGIN-NKMMMXOESA-N,,416.32904526,C27H44O3,416.6,60.7,416.32904526,0.0,30.0,6.0,0.0,2.0,0.0,0.0,1.0,-1.0,"1
5
255",C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,5.1,"10  16  6
27  2  6
28  3  5
4  12  5
5  31  6
6  32  6",
440790708,16133812,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00878,Calcitonin salmon,20231222,20210312,Curation Efforts|Governmental Organizations,LT00878,calcitonin salmon,0.0,No match,vNo-DILI-Concern,2.0,16133812,1.0,7970.0,55.0,52.0,99.0,AAADcfB//gBgAAAAAAAAAAAAAAAAAWLFgAAwAAAAAAAAAAABwAAAHgQQCAAADTzl3ga/npfJkgCoAzX3fAACgC2xMqAJ2YG+eIiKfj7C2TOUcAAu9hPY2Ce936KOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(4R,7S,10S,13S,16S,19S,22R)-22-amino-16-(2-amino-2-oxo-ethyl)-7-[(1R)-1-hydroxyethyl]-10,19-bis(hydroxymethyl)-13-isobutyl-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carbonyl]amino]-3-methyl-butanoyl]amino]-4-methyl-pentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methyl-pentanoyl]amino]-3-hydroxy-propanoyl]amino]-5-oxo-pentanoyl]amino]-5-[[(1S)-1-[[(1S)-2-[[(1S)-5-amino-1-[[(1S)-1-[[(1S)-4-amino-1-[[(1S,2R)-1-[[(1S)-2-[(2S)-2-[[(1S)-1-[[(1S,2R)-1-[[(1S)-3-amino-1-[[(1S,2R)-1-[[2-[[(1S)-2-[[2-[[(1S,2R)-1-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-2-hydroxy-propyl]amino]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-3-oxo-propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-4-guanidino-butyl]carbamoyl]pyrrolidin-1-yl]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]pentyl]amino]-1-(1H-imidazol-4-ylmethyl)-2-oxo-ethyl]carbamoyl]-3-methyl-butyl]amino]-5-oxo-pentanoic acid","(4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[[(4R,7S,10S,13S,16S,19S,22R)-22-amino-16-(2-amino-2-oxoethyl)-7-[(1R)-1-hydroxyethyl]-10,19-bis(hydroxymethyl)-13-(2-methylpropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-4-yl]-oxomethyl]amino]-3-methyl-1-oxobutyl]amino]-4-methyl-1-oxopentyl]amino]-1-oxoethyl]amino]-1-oxohexyl]amino]-4-methyl-1-oxopentyl]amino]-3-hydroxy-1-oxopropyl]amino]-1,5-dioxopentyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S,3R)-1-[[(2S)-1-[(2S)-2-[[[(2S)-1-[[(2S,3R)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-[[2-[[(2S)-1-[[2-[[(2S,3R)-1-[(2S)-2-carbamoyl-1-pyrrolidinyl]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-oxomethyl]-1-pyrrolidinyl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4<I>S</I>)-4-[[(2<I>S</I>)-5-amino-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-6-amino-2-[[2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(4<I>R</I>,7<I>S</I>,10<I>S</I>,13<I>S</I>,16<I>S</I>,19<I>S</I>,22<I>R</I>)-22-amino-16-(2-amino-2-oxoethyl)-7-[(1<I>R</I>)-1-hydroxyethyl]-10,19-bis(hydroxymethyl)-13-(2-methylpropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-6-amino-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-5-amino-1-[[(2<I>S</I>,3<I>R</I>)-1-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[[(2<I>S</I>,3<I>R</I>)-1-[[(2<I>S</I>)-4-amino-1-[[(2<I>S</I>,3<I>R</I>)-1-[[2-[[(2<I>S</I>)-1-[[2-[[(2<I>S</I>,3<I>R</I>)-1-[(2<I>S</I>)-2-carbamoylpyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1<I>H</I>-imidazol-4-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(4R,7S,10S,13S,16S,19S,22R)-22-amino-16-(2-amino-2-oxoethyl)-7-[(1R)-1-hydroxyethyl]-10,19-bis(hydroxymethyl)-13-(2-methylpropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S,3R)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S,3R)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-[[2-[[(2S)-1-[[2-[[(2S,3R)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S,3R)-1-[[2-[[(2S)-1-[[2-[[(2S,3R)-1-[(2S)-2-aminocarbonylpyrrolidin-1-yl]-3-oxidanyl-1-oxidanylidene-butan-2-yl]amino]-2-oxidanylidene-ethyl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-2-oxidanylidene-ethyl]amino]-3-oxidanyl-1-oxidanylidene-butan-2-yl]amino]-4-azanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-butan-2-yl]amino]-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxidanylidene-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-butan-2-yl]amino]-5-azanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-6-azanyl-1-oxidanylidene-hexan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxidanylidene-propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-4-[[(2S)-5-azanyl-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-azanyl-2-[2-[[(2S)-2-[[(2S)-2-[[(4R,7S,10S,13S,16S,19S,22R)-22-azanyl-16-(2-azanyl-2-oxidanylidene-ethyl)-10,19-bis(hydroxymethyl)-13-(2-methylpropyl)-7-[(1R)-1-oxidanylethyl]-6,9,12,15,18,21-hexakis(oxidanylidene)-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-4-yl]carbonylamino]-3-methyl-butanoyl]amino]-4-methyl-pentanoyl]amino]ethanoylamino]hexanoyl]amino]-4-methyl-pentanoyl]amino]-3-oxidanyl-propanoyl]amino]-5-oxidanylidene-pentanoyl]amino]-5-oxidanylidene-pentanoic acid","(4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(4R,7S,10S,13S,16S,19S,22R)-22-amino-16-(2-amino-2-keto-ethyl)-7-[(1R)-1-hydroxyethyl]-13-isobutyl-6,9,12,15,18,21-hexaketo-10,19-dimethylol-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carbonyl]amino]-3-methyl-butanoyl]amino]-4-methyl-pentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methyl-pentanoyl]amino]-3-hydroxy-propanoyl]amino]-5-keto-pentanoyl]amino]-5-[[(1S)-1-[[(1S)-2-[[(1S)-5-amino-1-[[(1S)-1-[[(1S)-4-amino-1-[[(1S,2R)-1-[[(1S)-2-[(2S)-2-[[(1S)-1-[[(1S,2R)-1-[[(1S)-3-amino-1-[[(1S,2R)-1-[[2-[[(1S)-2-[[2-[[(1S,2R)-1-[(2S)-2-carbamoylpyrrolidine-1-carbonyl]-2-hydroxy-propyl]amino]-2-keto-ethyl]amino]-2-keto-1-methylol-ethyl]amino]-2-keto-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-3-keto-propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-4-guanidino-butyl]carbamoyl]pyrrolidino]-1-(4-hydroxybenzyl)-2-keto-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-4-keto-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]pentyl]amino]-1-(1H-imidazol-4-ylmethyl)-2-keto-ethyl]carbamoyl]-3-methyl-butyl]amino]-5-keto-valeric acid","InChI=1S/C145H240N44O48S2/c1-65(2)45-86(175-139(232)110(70(11)12)183-136(229)99-63-239-238-62-79(148)117(210)178-96(59-191)134(227)174-92(52-104(151)202)131(224)172-90(49-69(9)10)129(222)180-98(61-193)135(228)187-114(74(16)197)142(235)181-99)118(211)158-55-106(204)162-80(25-18-20-40-146)120(213)169-89(48-68(7)8)128(221)179-97(60-192)133(226)167-83(34-37-102(149)200)122(215)165-85(36-39-109(207)208)123(216)171-88(47-67(5)6)127(220)173-91(51-77-54-156-64-161-77)130(223)164-81(26-19-21-41-147)121(214)170-87(46-66(3)4)126(219)166-84(35-38-103(150)201)125(218)186-113(73(15)196)141(234)177-94(50-76-30-32-78(199)33-31-76)143(236)189-44-24-29-101(189)137(230)168-82(27-22-42-157-145(154)155)124(217)185-112(72(14)195)140(233)176-93(53-105(152)203)132(225)184-111(71(13)194)138(231)160-56-107(205)163-95(58-190)119(212)159-57-108(206)182-115(75(17)198)144(237)188-43-23-28-100(188)116(153)209/h30-33,54,64-75,79-101,110-115,190-199H,18-29,34-53,55-63,146-148H2,1-17H3,(H2,149,200)(H2,150,201)(H2,151,202)(H2,152,203)(H2,153,209)(H,156,161)(H,158,211)(H,159,212)(H,160,231)(H,162,204)(H,163,205)(H,164,223)(H,165,215)(H,166,219)(H,167,226)(H,168,230)(H,169,213)(H,170,214)(H,171,216)(H,172,224)(H,173,220)(H,174,227)(H,175,232)(H,176,233)(H,177,234)(H,178,210)(H,179,221)(H,180,222)(H,181,235)(H,182,206)(H,183,229)(H,184,225)(H,185,217)(H,186,218)(H,187,228)(H,207,208)(H4,154,155,157)/t71-,72-,73-,74-,75-,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94+,95+,96+,97+,98+,99+,100+,101+,110+,111+,112+,113+,114+,115+/m1/s1",BBBFJLBPOGFECG-VJVYQDLKSA-N,,3430.7166627,C145H240N44O48S2,3431.9,1560.0,3429.7133079,0.0,239.0,34.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(/N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O,-16.6,"122  10  6
105  121  5
106  118  8
106  119  8
123  11  5
118  124  8
119  125  8
124  129  8
125  129  8
170  172  8
153  21  5
211  212  6
216  218  5
217  433  6
223  231  5
228  232  5
233  239  5
222  41  6
102  52  5
101  53  5
117  55  6
113  56  6
120  58  5
135  60  5
130  61  5
138  63  6
146  66  5
151  68  5
116  7  6
155  70  5
163  72  5
167  74  6
75  170  8
75  178  8
76  172  8
76  178  8
175  77  5
179  78  6
182  79  6
185  80  6
193  81  5
188  82  5
189  83  5
236  93  6
95  100  6",
440790707,2519,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01888,caffeine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01888,caffeine,0.0,No match,vNo-DILI-Concern,2.0,2519,1.0,293.0,3.0,0.0,0.0,AAADccBzsAAAAAAAAAAAAAAAAAAAAWAAAAAsAAAAAAAAAFgBgAAAHgAAAAAACAgBlgQHsBcMEACoAQdxdACAgC0XEKABUAGoVECASAhASCAUAIgIByJAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1,3,7-trimethylpurine-2,6-dione","1,3,7-trimethylpurine-2,6-dione","1,3,7-trimethylpurine-2,6-dione","1,3,7-trimethylpurine-2,6-dione","1,3,7-trimethylpurine-2,6-dione",caffeine,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",RYYVLZVUVIJVGH-UHFFFAOYSA-N,-0.1,194.08037557,C8H10N4O2,194.19,58.4,194.08037557,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cn1c(=O)c2c(ncn2C)n(C)c1=O,,"3  10  8
3  8  8
4  11  8
4  7  8
5  10  8
5  9  8
6  11  8
6  8  8
7  8  8
7  9  8",
440790706,54746,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01152,cabergoline,20231222,20210312,Curation Efforts|Governmental Organizations,LT01152,cabergoline,0.0,No match,vNo-DILI-Concern,2.0,54746,1.0,713.0,4.0,2.0,8.0,AAADcfB7sAAAAAAAAAAAAAAAAAAAAWAAAAA8YIAAAAAAAFjx8AAAHgAQAAAADSjBngQ/wPPJkACoAzV3VACCgCAxAiAI2aE4ZJiIIPrA0ZGEIAholyLIyAcYicCegAAAQAASAACQAASAACQAAAAAAAAAAA==,"(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6<I>a</I><I>R</I>,9<I>R</I>,10<I>a</I><I>R</I>)-<I>N</I>-[3-(dimethylamino)propyl]-<I>N</I>-(ethylcarbamoyl)-7-prop-2-enyl-6,6<I>a</I>,8,9,10,10<I>a</I>-hexahydro-4<I>H</I>-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1",KORNTPPJEAJQIU-KJXAQDMKSA-N,,451.29472544,C26H37N5O2,451.6,71.7,451.29472544,0.0,33.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,3.4,"11  18  5
14  15  8
14  20  8
15  16  8
15  19  8
16  21  8
19  22  8
20  23  8
22  23  8
4  19  8
4  21  8
8  34  6
9  35  5",
440790705,5361092,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01151,butorphanol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01151,butorphanol,0.0,No match,vNo-DILI-Concern,2.0,5361092,1.0,492.0,3.0,2.0,2.0,AAADceB6MAAAAAAAAAAAAAAAAABgAAAAAAA8YMEAAAAWAADxAAAAHgAACAAAD2zBmAQwBoMAAgCAAiBCAAACAAAgIAAIiAAOCIgKJiKCkROEcAAkwBGYmAew4PQPoAABAAAQAADQAAaAADQgAAAAAAAAAA==,"(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol","(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol","(1<I>S</I>,9<I>R</I>,10<I>S</I>)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.0<SUP>1,10</SUP>.0<SUP>2,7</SUP>]heptadeca-2(7),3,5-triene-4,10-diol","(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol","(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol","(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol","InChI=1S/C21H29NO2/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15/h6-7,13,15,19,23-24H,1-5,8-12,14H2/t19-,20+,21-/m1/s1",IFKLAQQSCNILHL-QHAWAJNXSA-N,,327.219829168,C21H29NO2,327.5,43.7,327.219829168,0.0,24.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3,3.8,"5  1  5
10  15  8
10  20  8
15  22  8
20  23  8
22  24  8
23  24  8
4  8  5
6  25  5",
440790704,5281004,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01144,budesonide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01144,budesonide,0.0,No match,vNo-DILI-Concern,2.0,5281004,1.0,862.0,6.0,2.0,4.0,AAADcfB4OAAAAAAAAAAAAAAAAAAAAaIAAAAwYIAAAAASAGDAAAAAGgAACAAAD1SwgAMCCAAABgCIAqBSAAIAAAAgAAAICAFAAEgREBYAAQQiQAAFoAAOAYPI7PzPgAAAAAAAAADAAAYAADAAAYAADCAAAA==,"(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one","(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxy-1-oxoethyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]eicosa-14,17-dien-16-one","(1<I>S</I>,2<I>S</I>,4<I>R</I>,8<I>S</I>,9<I>S</I>,11<I>S</I>,12<I>S</I>,13<I>R</I>)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.0<SUP>2,9</SUP>.0<SUP>4,8</SUP>.0<SUP>13,18</SUP>]icosa-14,17-dien-16-one","(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one","(1S,2S,4R,8S,9S,11S,12S,13R)-9,13-dimethyl-11-oxidanyl-8-(2-oxidanylethanoyl)-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one","(1S,2S,4R,8S,9S,11S,12S,13R)-8-glycoloyl-11-hydroxy-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]eicosa-14,17-dien-16-one","InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1",VOVIALXJUBGFJZ-KWVAZRHASA-N,,430.2355388,C25H34O6,430.5,93.1,430.2355388,0.0,31.0,8.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,2.5,"10  21  5
11  34  6
13  37  5
16  23  5
22  48  3
15  3  5
7  18  5
8  32  6
9  33  5",
440790703,6834,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02076,BROMPHENIRAMINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02076,brompheniramine,0.0,No match,vNo-DILI-Concern,2.0,6834,1.0,249.0,2.0,0.0,5.0,AAADceB7AAAAEAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHABAAAABrQjBHgQ+gJMIEACgAzRnRACCgCAxAiQI2CA4ZLgIIOLAkZGEIAhggADIyhcQgMAOggAAAAAAAAAEAAAAAAAAAAAAAAAAAA==,"3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine","3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine","3-(4-bromophenyl)-<I>N</I>,<I>N</I>-dimethyl-3-pyridin-2-ylpropan-1-amine","3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine","3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine",[3-(4-bromophenyl)-3-(2-pyridyl)propyl]-dimethyl-amine,"InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3",ZDIGNSYAACHWNL-UHFFFAOYSA-N,3.5,318.07316,C16H19BrN2,319.24,16.1,318.07316,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,,"10  15  8
11  16  8
14  17  8
15  17  8
16  19  8
18  19  8
3  18  8
3  8  8
4  20  3
7  10  8
7  9  8
8  11  8
9  14  8",
440790702,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01356,Botulinum toxin type B,20210312,20210312,Curation Efforts|Governmental Organizations,LT01356,botulinum toxin type b,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790701,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01305,Botulinum toxin type A,20210312,20210312,Curation Efforts|Governmental Organizations,LT01305,botulinum toxin type a,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790700,16129704,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01027,Bivalirudin,20250421,20210312,Curation Efforts|Governmental Organizations,LT01027,bivalirudin,0.0,No match,vNo-DILI-Concern,2.0,16129704,1.0,4950.0,35.0,28.0,67.0,AAADcfB//gAAAAAAAAAAAAAAAAAAAWLFgAAwYMAAAAAAAAABUAAAHgAQCAAADSzBmAQzDoPAAgCoAiHSOAACAACgIAAJiIGOCIiKZjqC2TOUcAAm1hOYmAe/36KOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[2-[[2-[[2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2R)-2-amino-3-phenyl-propanoyl]pyrrolidine-2-carbonyl]amino]-5-guanidino-pentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-4-oxo-butanoyl]amino]acetyl]amino]-3-carboxy-propanoyl]amino]-3-phenyl-propanoyl]amino]-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]amino]-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoic acid","(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[2-[[2-[[2-[[2-[[[(2S)-1-[(2S)-2-[[[(2S)-1-[(2R)-2-amino-1-oxo-3-phenylpropyl]-2-pyrrolidinyl]-oxomethyl]amino]-5-carbamimidamido-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-1-oxoethyl]amino]-1-oxoethyl]amino]-1-oxoethyl]amino]-1-oxoethyl]amino]-1,4-dioxobutyl]amino]-1-oxoethyl]amino]-3-carboxy-1-oxopropyl]amino]-1-oxo-3-phenylpropyl]amino]-4-carboxy-1-oxobutyl]amino]-4-carboxy-1-oxobutyl]amino]-3-methyl-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-4-carboxy-1-oxobutyl]amino]-4-carboxy-1-oxobutyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-4-methylpentanoic acid","(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[2-[[(2<I>S</I>)-4-amino-2-[[2-[[2-[[2-[[2-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[(2<I>R</I>)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoic acid","(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[2-[[2-[[2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2R)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoic acid","(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[2-[[(2S)-4-azanyl-2-[2-[2-[2-[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2R)-2-azanyl-3-phenyl-propanoyl]pyrrolidin-2-yl]carbonylamino]-5-carbamimidamido-pentanoyl]pyrrolidin-2-yl]carbonylamino]ethanoylamino]ethanoylamino]ethanoylamino]ethanoylamino]-4-oxidanylidene-butanoyl]amino]ethanoylamino]-4-oxidanyl-4-oxidanylidene-butanoyl]amino]-3-phenyl-propanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-methyl-pentanoyl]pyrrolidin-2-yl]carbonylamino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoic acid","(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[2-[[2-[[2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2R)-2-amino-3-phenyl-propanoyl]prolyl]amino]-5-guanidino-pentanoyl]prolyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-4-keto-butanoyl]amino]acetyl]amino]-3-carboxy-propanoyl]amino]-3-phenyl-propanoyl]amino]-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-methyl-pentanoyl]prolyl]amino]-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-valeric acid","InChI=1S/C98H138N24O33/c1-5-52(4)82(96(153)122-39-15-23-70(122)92(149)114-60(30-34-79(134)135)85(142)111-59(29-33-78(132)133)86(143)116-64(43-55-24-26-56(123)27-25-55)89(146)118-67(97(154)155)40-51(2)3)119-87(144)61(31-35-80(136)137)112-84(141)58(28-32-77(130)131)113-88(145)63(42-54-18-10-7-11-19-54)117-90(147)66(45-81(138)139)110-76(129)50-107-83(140)65(44-71(100)124)109-75(128)49-106-73(126)47-104-72(125)46-105-74(127)48-108-91(148)68-21-13-38-121(68)95(152)62(20-12-36-103-98(101)102)115-93(150)69-22-14-37-120(69)94(151)57(99)41-53-16-8-6-9-17-53/h6-11,16-19,24-27,51-52,57-70,82,123H,5,12-15,20-23,28-50,99H2,1-4H3,(H2,100,124)(H,104,125)(H,105,127)(H,106,126)(H,107,140)(H,108,148)(H,109,128)(H,110,129)(H,111,142)(H,112,141)(H,113,145)(H,114,149)(H,115,150)(H,116,143)(H,117,147)(H,118,146)(H,119,144)(H,130,131)(H,132,133)(H,134,135)(H,136,137)(H,138,139)(H,154,155)(H4,101,102,103)/t52-,57+,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,82-/m0/s1",OIRCOABEOLEUMC-GEJPAHFPSA-N,,2179.9891678,C98H138N24O33,2180.3,902.0,2178.9858129,0.0,155.0,16.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(\N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC,-7.1,"100  108  8
107  112  8
108  112  8
124  130  8
124  131  8
127  135  8
127  136  8
130  137  8
131  138  8
135  144  8
136  145  8
137  141  8
138  141  8
144  146  8
145  146  8
70  37  5
71  38  6
84  39  5
81  41  6
90  43  5
96  44  6
103  46  6
114  47  5
125  50  6
119  51  5
133  53  6
152  56  6
58  76  5
59  75  5
63  79  5
74  83  5
94  100  8
94  99  8
99  107  8",
440790699,2391,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02190,bisacodyl,20250421,20210312,Curation Efforts|Governmental Organizations,LT02190,bisacodyl,0.0,No match,vNo-DILI-Concern,2.0,2391,1.0,457.0,5.0,0.0,7.0,AAADceB6OAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAAB0AAAHgAAAAAADQzBngQ+jpIIFACoAzT3TACCiCAxIiAI2CA+bJgMJuLEsZuGOijkwBHI6AeQwPAOoAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,[4-[(4-acetoxyphenyl)-(2-pyridyl)methyl]phenyl] acetate,acetic acid [4-[(4-acetyloxyphenyl)-(2-pyridinyl)methyl]phenyl] ester,[4-[(4-acetyloxyphenyl)-pyridin-2-ylmethyl]phenyl] acetate,[4-[(4-acetyloxyphenyl)-pyridin-2-ylmethyl]phenyl] acetate,[4-[(4-acetyloxyphenyl)-pyridin-2-yl-methyl]phenyl] ethanoate,acetic acid [4-[(4-acetoxyphenyl)-(2-pyridyl)methyl]phenyl] ester,"InChI=1S/C22H19NO4/c1-15(24)26-19-10-6-17(7-11-19)22(21-5-3-4-14-23-21)18-8-12-20(13-9-18)27-16(2)25/h3-14,22H,1-2H3",KHOITXIGCFIULA-UHFFFAOYSA-N,,361.13140809,C22H19NO4,361.4,65.5,361.13140809,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1,3.8,"10  15  8
11  16  8
12  17  8
13  18  8
14  21  8
15  19  8
16  20  8
17  19  8
18  20  8
21  23  8
22  23  8
5  22  8
5  9  8
7  10  8
7  12  8
8  11  8
8  13  8
9  14  8",
440790698,2381,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00817,biperiden,20250421,20210312,Curation Efforts|Governmental Organizations,LT00817,biperiden,0.0,No match,vNo-DILI-Concern,1.0,2381,1.0,422.0,2.0,1.0,5.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAYIAAAA8QIAAAAAAAAABAAAAHgAACAAADUTBmAQwAIMAAgCAAiBCAAACAAAgAAAIiAAICIgIJiKAkRCEcAAmwAGImAeQwPAOgAAAAAAAAAAAAAAAAAAAAQAACAAAAA==,1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-(1-piperidyl)propan-1-ol,1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-(1-piperidinyl)-1-propanol,1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol,1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol,1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-yl-propan-1-ol,1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidino-propan-1-ol,"InChI=1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2",YSXKPIUOCJLQIE-UHFFFAOYSA-N,4.3,311.224914549,C21H29NO,311.5,23.5,311.224914549,0.0,23.0,0.0,4.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2,,"8  1  3
12  14  8
12  15  8
14  21  8
15  22  8
21  23  8
22  23  8
3  6  3
4  7  3
5  7  3",
440790697,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01390,Bevacizumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01390,bevacizumab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790696,2370,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00730,bethanechol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00730,bethanechol,0.0,No match,vNo-DILI-Concern,1.0,2370,1.0,140.0,2.0,1.0,4.0,AAADceBjMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQAAAACBThgAYCCANABAAIAAAAGAAAAAAAAAAAAAAIAAECAAAAAAANAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-carbamoyloxypropyl(trimethyl)ammonium,2-carbamoyloxypropyl(trimethyl)ammonium,2-carbamoyloxypropyl(trimethyl)azanium,2-carbamoyloxypropyl(trimethyl)azanium,2-aminocarbonyloxypropyl(trimethyl)azanium,2-carbamoyloxypropyl(trimethyl)ammonium,"InChI=1S/C7H16N2O2/c1-6(11-7(8)10)5-9(2,3)4/h6H,5H2,1-4H3,(H-,8,10)/p+1",NZUPCNDJBJXXRF-UHFFFAOYSA-O,,161.129002789,C7H17N2O2+,161.22,52.3,161.129002789,1.0,11.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C[N+](C)(C)C)OC(N)=O,0.0,6  14  3,
440790695,247,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02189,betaine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02189,betaine,0.0,No match,vNo-DILI-Concern,1.0,247,1.0,87.6,2.0,0.0,1.0,AAADccBiMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAAAAAAAADBgAQCCAMAAAAIAACQCAAAAAAAAAAAAACIAAACAAAAACAAAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-(trimethylammonio)acetate,2-(trimethylammonio)acetate,2-(trimethylazaniumyl)acetate,2-(trimethylazaniumyl)acetate,2-(trimethylazaniumyl)ethanoate,2-(trimethylammonio)acetate,"InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3",KWIUHFFTVRNATP-UHFFFAOYSA-N,,117.078978594,C5H11NO2,117.15,40.1,117.078978594,0.0,8.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[N+](C)(C)CC(=O)[O-],0.5,,
440790694,45266800,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01276,Benzylpenicilloyl polylysine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01276,benzylpenicilloyl polylysine,0.0,No match,vNo-DILI-Concern,2.0,45266800,1.0,819.0,13.0,9.0,17.0,AAADcfB7vABAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHgQQCAAADCjF2ASyCILAAgiIAiHSGAACAABgABAIiIGIAIgKYDqg1TGUYAAklgC4iAeYyICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,4S)-2-[2-[[(5R)-5-amino-5-carboxy-pentyl]amino]-2-oxo-1-[(2-phenylacetyl)amino]ethyl]-5,5-dimethyl-thiazolidine-4-carboxylic acid;(2R)-2,6-diaminohexanoic acid","(2R,4S)-2-[2-[[(5R)-5-amino-5-carboxypentyl]amino]-2-oxo-1-[(1-oxo-2-phenylethyl)amino]ethyl]-5,5-dimethyl-4-thiazolidinecarboxylic acid;(2R)-2,6-diaminohexanoic acid","(2<I>R</I>,4<I>S</I>)-2-[2-[[(5<I>R</I>)-5-amino-5-carboxypentyl]amino]-2-oxo-1-[(2-phenylacetyl)amino]ethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid;(2<I>R</I>)-2,6-diaminohexanoic acid","(2R,4S)-2-[2-[[(5R)-5-amino-5-carboxypentyl]amino]-2-oxo-1-[(2-phenylacetyl)amino]ethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid;(2R)-2,6-diaminohexanoic acid","(2R,4S)-2-[2-[[(5R)-5-azanyl-6-oxidanyl-6-oxidanylidene-hexyl]amino]-2-oxidanylidene-1-(2-phenylethanoylamino)ethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid;(2R)-2,6-bis(azanyl)hexanoic acid","(2R,4S)-2-[2-[[(5R)-5-amino-5-carboxy-pentyl]amino]-2-keto-1-[(2-phenylacetyl)amino]ethyl]-5,5-dimethyl-thiazolidine-4-carboxylic acid;(2R)-2,6-diaminohexanoic acid","InChI=1S/C22H32N4O6S.C6H14N2O2/c1-22(2)17(21(31)32)26-19(33-22)16(25-15(27)12-13-8-4-3-5-9-13)18(28)24-11-7-6-10-14(23)20(29)30;7-4-2-1-3-5(8)6(9)10/h3-5,8-9,14,16-17,19,26H,6-7,10-12,23H2,1-2H3,(H,24,28)(H,25,27)(H,29,30)(H,31,32);5H,1-4,7-8H2,(H,9,10)/t14-,16?,17+,19-;5-/m11/s1",IMPVZRLKKKXMKQ-SGDOCVTFSA-N,,626.30978362,C28H46N6O8S,626.8,285.0,626.30978362,0.0,43.0,4.0,1.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CC1(C)S[C@H](C(NC(=O)Cc2ccccc2)C(=O)NCCCC[C@@H](N)C(=O)O)N[C@H]1C(=O)O.NCCCC[C@@H](N)C(=O)O,,"31  13  6
41  14  5
17  22  5
18  19  6
19  23  3
30  32  8
30  33  8
32  35  8
33  36  8
35  39  8
36  39  8",
440790693,1201549,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01123,benztropine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01123,benztropine,0.0,No match,vNo-DILI-Concern,1.0,1201549,1.0,340.0,2.0,0.0,4.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAWAAAAA8YIAABgAAAAABQAAAHgAAAAAADDzhmAYyAIMABACAAiBCAAACAAAgAAAIiAAICIgIJiKAsRiGMAAmwAGIqAeQwOAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1S,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane","(1S,5R)-3-(diphenylmethyl)oxy-8-methyl-8-azabicyclo[3.2.1]octane","(1<I>S</I>,5<I>R</I>)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane","(1S,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane","(1S,5R)-3-(diphenylmethyl)oxy-8-methyl-8-azabicyclo[3.2.1]octane","(1S,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane","InChI=1S/C21H25NO/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-21H,12-15H2,1H3/t18-,19+,20?",GIJXKZJWITVLHI-YOFSQIOKSA-N,,307.193614421,C21H25NO,307.4,12.5,307.193614421,0.0,23.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1[C@@H]2CC[C@H]1CC(OC(c1ccccc1)c1ccccc1)C2,4.5,"12  14  8
12  16  8
13  15  8
13  17  8
14  18  8
15  19  8
16  20  8
17  21  8
18  22  8
19  23  8
20  22  8
21  23  8
3  24  5
4  25  6",
440790692,5311017,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00832,benzphetamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00832,benzphetamine,0.0,No match,vNo-DILI-Concern,1.0,5311017,1.0,214.0,1.0,0.0,5.0,AAADceB6AAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHAAAAAAADCjBGAQyAIMAAACAAiBCAACCAAAgAAAIiAAIBIgIICKAkRGEIAhggACIiAcQgIAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-N-benzyl-N-methyl-1-phenyl-propan-2-amine,(2S)-N-methyl-1-phenyl-N-(phenylmethyl)-2-propanamine,(2<I>S</I>)-<I>N</I>-benzyl-<I>N</I>-methyl-1-phenylpropan-2-amine,(2S)-N-benzyl-N-methyl-1-phenylpropan-2-amine,(2S)-N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine,benzyl-methyl-[(1S)-1-methyl-2-phenyl-ethyl]amine,"InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1",YXKTVDFXDRQTKV-HNNXBMFYSA-N,,239.167399674,C17H21N,239.35,3.2,239.167399674,0.0,18.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1,4.1,"2  1  5
10  14  8
11  15  8
12  16  8
13  17  8
14  17  8
15  18  8
16  18  8
6  10  8
6  9  8
8  11  8
8  12  8
9  13  8",
440790691,65628,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00659,Bendamustine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00659,bendamustine,0.0,No match,vNo-DILI-Concern,2.0,65628,1.0,380.0,4.0,1.0,9.0,AAADceB7MAAGAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgB8AAAHgIACAAACAvBl0Qz2LcMEgCoASbybACCgC0hEqAJ2CE4dJiIaLLA2dHUZAhsgALIyCeYEQIAAACAAAQAACAAAQAACAAAQAAAAAAAAA==,4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoic acid,4-[5-[bis(2-chloroethyl)amino]-1-methyl-2-benzimidazolyl]butanoic acid,4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid,4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid,4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoic acid,4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butyric acid,"InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)",YTKUWDBFDASYHO-UHFFFAOYSA-N,,357.1010823,C16H21Cl2N3O2,358.3,58.4,357.1010823,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,2.9,"10  13  8
12  13  8
12  16  8
15  16  8
5  8  8
5  9  8
7  10  8
7  9  8
8  10  8
8  15  8",
440790690,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01346,Basiliximab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01346,basiliximab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790689,439542,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02059,bacitracin,20210312,20210312,Curation Efforts|Governmental Organizations,LT02059,bacitracin,0.0,No match,vNo-DILI-Concern,1.0,439542,1.0,2850.0,21.0,17.0,31.0,AAADcfB//gBAAAAAAAAAAAAAAAAAAWIAAAAwAAAAAAAAAAABwAAAHgQQCAAADSjF3gS/mJbJkgioAzX3fAACkC2xErAJ2YG4cIiIaDrg2TGUYAAulgLoyCe/n4KOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(4R)-4-[[(2S)-2-[[2-[(1S)-1-amino-2-methyl-butyl]-4,5-dihydrothiazole-5-carbonyl]amino]-4-methyl-pentanoyl]amino]-5-[[(1S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxo-ethyl)-18-(3-aminopropyl)-12-benzyl-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-15-sec-butyl-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]carbamoyl]-2-methyl-butyl]amino]-5-oxo-pentanoic acid","(4R)-4-[[(2S)-2-[[[2-[(1S)-1-amino-2-methylbutyl]-4,5-dihydrothiazol-5-yl]-oxomethyl]amino]-4-methyl-1-oxopentyl]amino]-5-[[(2S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-15-butan-2-yl-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-12-(phenylmethyl)-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4<I>R</I>)-4-[[(2<I>S</I>)-2-[[2-[(1<I>S</I>)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-5-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2<I>S</I>)-1-[[(3<I>S</I>,6<I>R</I>,9<I>S</I>,12<I>R</I>,15<I>S</I>,18<I>R</I>,21<I>S</I>)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-butan-2-yl-6-(carboxymethyl)-9-(1<I>H</I>-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4R)-4-[[(2S)-2-[[2-[(1S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-5-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-butan-2-yl-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid","(4R)-4-[[(2S)-2-[[2-[(1S)-1-azanyl-2-methyl-butyl]-4,5-dihydro-1,3-thiazol-5-yl]carbonylamino]-4-methyl-pentanoyl]amino]-5-[[(2S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-azanyl-2-oxidanylidene-ethyl)-18-(3-azanylpropyl)-15-butan-2-yl-6-(2-hydroxy-2-oxoethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptakis(oxidanylidene)-12-(phenylmethyl)-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxidanylidene-pentan-2-yl]amino]-5-oxidanylidene-pentanoic acid","(4R)-5-[[(1S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-keto-ethyl)-18-(3-aminopropyl)-12-benzyl-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaketo-15-sec-butyl-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]carbamoyl]-2-methyl-butyl]amino]-4-[[(2S)-2-[[2-[(1S)-1-amino-2-methyl-butyl]-2-thiazoline-5-carbonyl]amino]-4-methyl-pentanoyl]amino]-5-keto-valeric acid","InChI=1S/C66H103N17O16S/c1-9-35(6)52(69)66-72-32-48(100-66)63(97)80-43(26-34(4)5)59(93)75-42(22-23-50(85)86)58(92)83-53(36(7)10-2)64(98)76-40-20-15-16-25-71-55(89)46(29-49(68)84)78-62(96)47(30-51(87)88)79-61(95)45(28-39-31-70-33-73-39)77-60(94)44(27-38-18-13-12-14-19-38)81-65(99)54(37(8)11-3)82-57(91)41(21-17-24-67)74-56(40)90/h12-14,18-19,31,33-37,40-48,52-54H,9-11,15-17,20-30,32,67,69H2,1-8H3,(H2,68,84)(H,70,73)(H,71,89)(H,74,90)(H,75,93)(H,76,98)(H,77,94)(H,78,96)(H,79,95)(H,80,97)(H,81,99)(H,82,91)(H,83,92)(H,85,86)(H,87,88)/t35?,36?,37?,40-,41+,42+,43-,44+,45-,46-,47+,48?,52-,53-,54-/m0/s1",MNJKVJAYSVAQLU-YOJCIBLDSA-N,,1421.74894144,C66H103N17O16S,1422.7,556.0,1421.74894144,0.0,100.0,11.0,4.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(C)[C@H](N)C1=NCC(C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](C(C)CC)NC(=O)[C@@H](CCCN)NC2=O)C(C)CC)S1,-4.3,"37  18  6
35  19  5
44  22  5
49  23  5
63  27  5
32  100  8
32  92  8
33  100  8
33  98  8
36  46  3
38  39  5
39  56  3
41  48  6
62  77  3
64  69  3
65  74  6
79  85  5
81  89  8
81  90  8
82  88  5
87  93  6
89  94  8
90  95  8
92  98  8
94  97  8
95  97  8",
440790688,174174,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00511,ATROPINE,20250421,20210312,Curation Efforts|Governmental Organizations,LT00511,atropine,0.0,No match,vNo-DILI-Concern,1.0,174174,1.0,353.0,4.0,1.0,5.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAWAAAAA8QAAABgAAAAABAAAAHgAACAAADTzhmAYyCIMABgCIAiDSCAACAAAgAAAIiAEIAIgIMDaAlRCGYAAn4AGIiAeYyOCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate","3-hydroxy-2-phenylpropanoic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester","[(1<I>R</I>,5<I>S</I>)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate","[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate","[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-oxidanyl-2-phenyl-propanoate","3-hydroxy-2-phenyl-propionic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester","InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16?",RKUNBYITZUJHSG-PJPHBNEVSA-N,1.8,289.1677936,C17H23NO3,289.4,49.8,289.1677936,0.0,21.0,2.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1[C@@H]2CC[C@H]1CC(OC(=O)C(CO)c1ccccc1)C2,,"14  16  3
15  17  8
15  18  8
17  19  8
18  20  8
19  21  8
20  21  8
5  22  5
6  23  6",
440790687,47319,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00917,Atracurium,20231222,20210312,Curation Efforts|Governmental Organizations,LT00917,atracurium,0.0,No match,vNo-DILI-Concern,1.0,47319,1.0,1390.0,12.0,0.0,26.0,AAADcfB/PAAAAAAAAAAAAAAAAAAAAAAAAAA8eMGCAAAAAACxVAAAHgAAAAAADCzhmAYyDoMABACIAiDSCACCCAAgIAAIiAEOjIgNJiqEsRuGMCpmwBGKqAew8PsOoAABAAAQQABAAAIAACCAAAAAAAAAAA==,"5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate","3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoic acid 5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]-1-oxopropoxy]pentyl ester","5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1<I>H</I>-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1<I>H</I>-isoquinolin-2-ium-2-yl]propanoate","5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate","5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate","3-(6,7-dimethoxy-2-methyl-1-veratryl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl)propionic acid 5-[3-(6,7-dimethoxy-2-methyl-1-veratryl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl)propanoyloxy]pentyl ester","InChI=1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2",YXSLJKQTIDHPOT-UHFFFAOYSA-N,,928.50852574,C53H72N2O12+2,929.1,126.0,928.50852574,2.0,67.0,0.0,4.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,7.9,"13  25  3
14  26  3
15  27  3
16  28  3
21  29  8
21  33  8
22  30  8
22  34  8
29  37  8
30  38  8
33  39  8
34  40  8
35  45  8
35  47  8
36  46  8
36  48  8
37  41  8
38  42  8
39  41  8
40  42  8
45  49  8
46  50  8
47  51  8
48  52  8
49  53  8
50  54  8
51  53  8
52  54  8",
440790686,8230,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02331,ARGIPRESSIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT02331,Argipressin,0.0,No match,vNo-DILI-Concern,2.0,8230,1.0,2070.0,16.0,14.0,19.0,AAADcfB//ABgAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAABQAAAHgQQCAAADCzF2ASxBoPAAgCoAiFSNAACAAEgIAAIiIGOCIgIZjqC0TOUcAAk1hGImAedy6COIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"1-[19-amino-7-(2-amino-2-oxo-ethyl)-10-(3-amino-3-oxo-propyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxo-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide","1-[[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-2-pyrrolidinecarboxamide","1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-<I>N</I>-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide","1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide","1-[[19-azanyl-7-(2-azanyl-2-oxidanylidene-ethyl)-10-(3-azanyl-3-oxidanylidene-propyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentakis(oxidanylidene)-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloicos-4-yl]carbonyl]-N-[1-[(2-azanyl-2-oxidanylidene-ethyl)amino]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]pyrrolidine-2-carboxamide","1-[19-amino-7-(2-amino-2-keto-ethyl)-10-(3-amino-3-keto-propyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaketo-1,2-dithia-5,8,11,14,17-pentazacycloeicosane-4-carbonyl]-N-[1-[(2-amino-2-keto-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide","InChI=1S/C46H65N15O12S2/c47-27-22-74-75-23-33(45(73)61-17-5-9-34(61)44(72)56-28(8-4-16-53-46(51)52)39(67)54-21-37(50)65)60-43(71)32(20-36(49)64)59-40(68)29(14-15-35(48)63)55-41(69)31(18-24-6-2-1-3-7-24)58-42(70)30(57-38(27)66)19-25-10-12-26(62)13-11-25/h1-3,6-7,10-13,27-34,62H,4-5,8-9,14-23,47H2,(H2,48,63)(H2,49,64)(H2,50,65)(H,54,67)(H,55,69)(H,56,72)(H,57,66)(H,58,70)(H,59,68)(H,60,71)(H4,51,52,53)",KBZOIRJILGZLEJ-UHFFFAOYSA-N,,1083.43785492,C46H65N15O12S2,1084.2,515.0,1083.43785492,0.0,75.0,0.0,8.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O,-4.8,"53  25  3
30  34  3
36  35  3
37  39  3
43  45  3
46  49  3
52  57  3
55  61  3
63  66  8
63  67  8
65  68  8
65  69  8
66  70  8
67  71  8
68  73  8
69  74  8
70  72  8
71  72  8
73  75  8
74  75  8",
440790685,92722,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01030,argatroban,20210312,20210312,Curation Efforts|Governmental Organizations,LT01030,argatroban,0.0,No match,vNo-DILI-Concern,2.0,92722,1.0,887.0,8.0,5.0,9.0,AAADcfB7uABAAAAAAAAAAAAAAAAAAAAAAAA8WIAAAAAAAACxAAAAHgQQSAAADSjB2AQzyYPAAgKoAiXSfHDCABEhAAAIiJ2IRIgKYDLAkbGUYAhklgDYyAeYycAOAAAAgAACAQAAAAEAAAQCAAAAAAAAAA==,"(2R,4R)-1-[(2S)-5-guanidino-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid","(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic acid","(2<I>R</I>,4<I>R</I>)-1-[(2<I>S</I>)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid","(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid","(2R,4R)-1-[(2S)-5-[bis(azanyl)methylideneamino]-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid","(2R,4R)-1-[(2S)-5-guanidino-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methyl-pipecolinic acid","InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15?,17+,18-/m1/s1",KXNPVXPOPUZYGB-IOVMHBDKSA-N,,508.24678944,C23H36N6O5S,508.6,189.0,508.24678944,0.0,35.0,3.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1,1.3,"13  20  6
15  21  5
23  50  3
25  26  8
25  28  8
26  31  8
28  32  8
31  34  8
32  34  8
18  8  6",
440790684,6005,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02217,apomorphine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02217,apomorphine,0.0,No match,vNo-DILI-Concern,2.0,6005,1.0,374.0,3.0,2.0,0.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAA8YMEAAAAAAADxQAAAHgAACAAADCzBmAQyBoMAAgCAAiBCAACCAAAgIAAIiAAOjIgJJiKCkROEcAlkwBGJmAeQ0PMOoAADAAAYQADQAAaAADSAAAAAAAAAAA==,"(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol","(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol","(6<I>a</I><I>R</I>)-6-methyl-5,6,6<I>a</I>,7-tetrahydro-4<I>H</I>-dibenzo[de,g]quinoline-10,11-diol","(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol","(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol","(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol","InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m1/s1",VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.3,267.125928785,C17H17NO2,267.32,43.7,267.125928785,0.0,20.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,"10  15  8
11  12  8
11  16  8
12  17  8
14  18  8
15  18  8
16  20  8
17  19  8
19  20  8
4  21  5
5  10  8
5  7  8
7  14  8",
440790683,25517,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02067,AMMONIUM CHLORIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02067,ammonium chloride,0.0,No match,vNo-DILI-Concern,2.0,25517,1.0,0.0,1.0,1.0,0.0,AAADcYACAAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,ammonium;chloride,ammonium;chloride,azanium;chloride,azanium;chloride,azanium;chloride,ammonium;chloride,InChI=1S/ClH.H3N/h1H;1H3,NLXLAEXVIDQMFP-UHFFFAOYSA-N,,53.0032268,ClH4N,53.49,1.0,53.0032268,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",[Cl-].[NH4+],,,
440790682,9433,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00711,aminophylline,20250421,20210312,Curation Efforts|Governmental Organizations,LT00711,aminophylline,0.0,No match,vNo-DILI-Concern,2.0,9433,1.0,273.0,8.0,4.0,1.0,AAADceB7+AAAAAAAAAAAAAAAAAAAAWLAAAAsWAAAAAAAAFgB4AAAHgAQAAAACAjBlgQHsBfJkACoAQdxdACAgC2XEKABUYGoVECASAhASCAUAIgIFyJAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine","1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine","1,3-dimethyl-7<I>H</I>-purine-2,6-dione;ethane-1,2-diamine","1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine","1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine",2-aminoethylamine;theophylline,"InChI=1S/2C7H8N4O2.C2H8N2/c2*1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2-4/h2*3H,1-2H3,(H,8,9);1-4H2",FQPFAHBPWDRTLU-UHFFFAOYSA-N,,420.19819929,C16H24N10O4,420.43,191.0,420.19819929,0.0,30.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN,,"10  18  8
10  28  8
11  15  8
11  27  8
12  16  8
12  28  8
15  17  8
16  18  8
17  19  8
18  20  8
5  15  8
5  21  8
6  16  8
6  22  8
7  19  8
7  21  8
8  20  8
8  22  8
9  17  8
9  27  8",
440790681,2148,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00054,Aminohippurate,20210312,20210312,Curation Efforts|Governmental Organizations,LT00054,aminohippurate,0.0,No match,vNo-DILI-Concern,2.0,2148,1.0,222.0,4.0,3.0,3.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADAjBmAQwyILAAgCIAiXSWACCAAAkAgAIiIGIZMgKIDKAlbGEIQhglgCYyYcYiQCeCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,2-[(4-aminobenzoyl)amino]acetic acid,2-[[(4-aminophenyl)-oxomethyl]amino]acetic acid,2-[(4-aminobenzoyl)amino]acetic acid,2-[(4-aminobenzoyl)amino]acetic acid,2-[(4-aminophenyl)carbonylamino]ethanoic acid,2-[(4-aminobenzoyl)amino]acetic acid,"InChI=1S/C9H10N2O3/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13/h1-4H,5,10H2,(H,11,14)(H,12,13)",HSMNQINEKMPTIC-UHFFFAOYSA-N,-0.9,194.06914219,C9H10N2O3,194.19,92.4,194.06914219,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ccc(C(=O)NCC(=O)O)cc1,,"10  11  8
10  12  8
6  8  8
6  9  8
8  11  8
9  12  8",
440790680,564,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01071,aminocaproic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT01071,aminocaproic acid,0.0,No match,vNo-DILI-Concern,2.0,564,1.0,83.1,3.0,2.0,5.0,AAADccBiMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAACADBgAQACABAAgAIAACQCAAAAAAAAAAAAIEAAAAAABIAgAAAQAAEEAAAAAGYSAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,6-aminohexanoic acid,6-aminohexanoic acid,6-aminohexanoic acid,6-aminohexanoic acid,6-azanylhexanoic acid,6-aminohexanoic acid,"InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)",SLXKOJJOQWFEFD-UHFFFAOYSA-N,-3.0,131.094628657,C6H13NO2,131.17,63.3,131.094628657,0.0,9.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCCCCCC(=O)O,,,
440790679,37768,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01068,amikacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01068,amikacin,0.0,No match,vNo-DILI-Concern,2.0,37768,1.0,819.0,17.0,13.0,10.0,AAADcfB7vAAAAAAAAAAAAAAAAAAAAAAAAAA0SIAAAAAAAAAAAAAAHgAQCAAACDzxgAcACALABgAIAAEQEAIAAAAAAAAAAIFIAAATEBIAwAAnQAAHFgCXAAH0cA8AAAAAAAAAAAAAgAAUCACgAAAAAAAAAA==,"(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide","(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-4-[[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-2-oxanyl]oxy]-3-hydroxycyclohexyl]-2-hydroxybutanamide","(2<I>S</I>)-4-amino-<I>N</I>-[(1<I>R</I>,2<I>S</I>,3<I>S</I>,4<I>R</I>,5<I>S</I>)-5-amino-2-[(2<I>S</I>,3<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide","(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide","(2S)-N-[(1R,2S,3S,4R,5S)-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-azanyl-2-[(2S,3R,4S,5S,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]-4-azanyl-2-oxidanyl-butanamide","(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butyramide","InChI=1S/C22H43N5O13/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+/m0/s1",LKCWBDHBTVXHDL-RMDFUYIESA-N,,585.28573644,C22H43N5O13,585.6,332.0,585.28573644,0.0,40.0,16.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,-7.9,"19  1  6
25  1  6
33  10  6
38  13  6
21  14  5
23  15  5
28  16  5
20  2  6
26  2  6
22  3  5
32  36  5
34  37  5
27  6  6
29  7  6
30  8  6
31  9  5",
440790678,2141,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01067,amifostine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01067,amifostine,0.0,No match,vNo-DILI-Concern,1.0,2141,1.0,152.0,6.0,4.0,7.0,AAADccBjMAJAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAQQCCAACADFQASAAALAABAAQAAAAIAAAAAAAAAAAIAIAAAAAAAAQAAEAAAAEACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-(3-aminopropylamino)ethylsulfanylphosphonic acid,[2-(3-aminopropylamino)ethylthio]phosphonic acid,2-(3-aminopropylamino)ethylsulfanylphosphonic acid,2-(3-aminopropylamino)ethylsulfanylphosphonic acid,2-(3-azanylpropylamino)ethylsulfanylphosphonic acid,[2-(3-aminopropylamino)ethylthio]phosphonic acid,"InChI=1S/C5H15N2O3PS/c6-2-1-3-7-4-5-12-11(8,9)10/h7H,1-6H2,(H2,8,9,10)",JKOQGQFVAUAYPM-UHFFFAOYSA-N,,214.05410052,C5H15N2O3PS,214.23,121.0,214.05410052,0.0,12.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCCCNCCSP(=O)(O)O,-4.5,,
440790677,2131,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01629,ambenonium,20250421,20210312,Curation Efforts|Governmental Organizations,LT01629,ambenonium,0.0,No match,vNo-DILI-Concern,2.0,2131,1.0,614.0,2.0,2.0,14.0,AAADcfB7sAAGAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgIQAAAADALBmCQyAIPAAACIAiFSEACCAAAgBQAIiICIBogIYCKBkzGUIAhglgCIiAcQgAAOAAAAAAABAAAAAAAAAAIAAAAAAAAAAA==,(2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethyl-ammonio]ethylamino]-2-oxo-acetyl]amino]ethyl]-diethyl-ammonium,"(2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethylammonio]ethylamino]-1,2-dioxoethyl]amino]ethyl]-diethylammonium",(2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethylazaniumyl]ethylamino]-2-oxoacetyl]amino]ethyl]-diethylazanium,(2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethylazaniumyl]ethylamino]-2-oxoacetyl]amino]ethyl]-diethylazanium,(2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethyl-azaniumyl]ethylamino]-2-oxidanylidene-ethanoyl]amino]ethyl]-diethyl-azanium,(2-chlorobenzyl)-[2-[[2-[2-[(2-chlorobenzyl)-diethyl-ammonio]ethylamino]-2-keto-acetyl]amino]ethyl]-diethyl-ammonium,"InChI=1S/C28H40Cl2N4O2/c1-5-33(6-2,21-23-13-9-11-15-25(23)29)19-17-31-27(35)28(36)32-18-20-34(7-3,8-4)22-24-14-10-12-16-26(24)30/h9-16H,5-8,17-22H2,1-4H3/p+2",OMHBPUNFVFNHJK-UHFFFAOYSA-P,,536.268482,C28H42Cl2N4O2+2,537.6,58.2,536.268482,2.0,36.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl,5.1,"19  25  8
19  27  8
20  26  8
20  28  8
25  31  8
26  32  8
27  33  8
28  34  8
31  35  8
32  36  8
33  35  8
34  36  8",
440790676,5488548,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01215,Alvimopan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01215,alvimopan,0.0,No match,vNo-DILI-Concern,2.0,5488548,1.0,606.0,5.0,3.0,8.0,AAADcfB7OAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABQAAAHgAQCAAADwTBmAQyDoPAAgCIAiHSGAACAAAgIAAIiIGOCIgKJjqC0TKEcAAk1hGYmAeYyPCPgAABAAAAAAAAAAIAAAAAAAAAAAAAAA==,"2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidyl]propanoyl]amino]acetic acid","2-[[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]amino]acetic acid","2-[[(2<I>S</I>)-2-benzyl-3-[(3<I>R</I>,4<I>R</I>)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid","2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid","2-[[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-piperidin-1-yl]methyl]-3-phenyl-propanoyl]amino]ethanoic acid","2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-piperidino]propanoyl]amino]acetic acid","InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1",UPNUIXSCZBYVBB-JVFUWBCBSA-N,,424.23620751,C25H32N2O4,424.5,89.9,424.23620751,0.0,31.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1,1.7,"12  17  8
12  18  8
16  20  6
17  21  8
18  22  8
21  23  8
22  23  8
24  25  8
24  26  8
25  28  8
26  29  8
28  30  8
29  30  8
7  13  5
8  14  6",
440790675,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01315,Alteplase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01315,alteplase,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790674,123606,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01053,Almotriptan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01053,almotriptan,0.0,No match,vNo-DILI-Concern,2.0,123606,1.0,483.0,4.0,1.0,6.0,AAADceB7MABAAAAAAAAAAAAAAAAAAWLAAAAwAAAAAAAAAFgB8AAAHAQQQAAADAjFXgS+wPPJkAKgAzRnRHDCgCAxAiAI2aA4ZJgIIOLAkZGEIAhgkADIyAcQgMAOiAACAAACAAAQAAQAAAQAAAAAAAAAAA==,"N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine","N,N-dimethyl-2-[5-(1-pyrrolidinylsulfonylmethyl)-1H-indol-3-yl]ethanamine","<I>N</I>,<I>N</I>-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1<I>H</I>-indol-3-yl]ethanamine","N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine","N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine",dimethyl-[2-[5-(pyrrolidinosulfonylmethyl)-1H-indol-3-yl]ethyl]amine,"InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3",WKEMJKQOLOHJLZ-UHFFFAOYSA-N,1.6,335.16674822,C17H25N3O2S,335.5,64.8,335.16674822,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,,"12  14  8
12  17  8
13  14  8
13  15  8
13  16  8
15  20  8
16  19  8
17  19  8
5  16  8
5  20  8",
440790673,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01404,Alglucosidase alfa,20210312,20210312,Curation Efforts|Governmental Organizations,LT01404,alglucosidase alfa,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790672,51263,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00925,ALFENTANIL,20250421,20210312,Curation Efforts|Governmental Organizations,LT00925,alfentanil,0.0,No match,vNo-DILI-Concern,2.0,51263,1.0,614.0,6.0,0.0,9.0,AAADcfB7sAAAAAAAAAAAAAAAAAAAAQAAAAA8QAAAAAAAAAABAAAAHgAIAAAADIjhkAYzwIMABACKACVSUACCAAAhAgAeiAEIZIiKYCLA0ZGVIAhshgLYyAcwAAAKAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,N-[1-[2-(4-ethyl-5-oxo-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]-N-phenyl-propanamide,N-[1-[2-(4-ethyl-5-oxo-1-tetrazolyl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide,<I>N</I>-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-<I>N</I>-phenylpropanamide,N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide,"N-[1-[2-(4-ethyl-5-oxidanylidene-1,2,3,4-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenyl-propanamide",N-[1-[2-(4-ethyl-5-keto-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]-N-phenyl-propionamide,"InChI=1S/C21H32N6O3/c1-4-19(28)27(18-9-7-6-8-10-18)21(17-30-3)11-13-24(14-12-21)15-16-26-20(29)25(5-2)22-23-26/h6-10H,4-5,11-17H2,1-3H3",IDBPHNDTYPBSNI-UHFFFAOYSA-N,2.2,416.2535889,C21H32N6O3,416.5,81.1,416.2535889,0.0,30.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,,"17  21  8
17  22  8
21  25  8
22  26  8
25  28  8
26  28  8
6  27  8
6  7  8
7  9  8
8  27  8
8  9  8",
440790671,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01364,Alemtuzumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01364,alemtuzumab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790670,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02385,Agalsidase beta,20210312,20210312,Curation Efforts|Governmental Organizations,LT02385,agalsidase beta,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790669,60961,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01047,adenosine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01047,adenosine,0.0,No match,vNo-DILI-Concern,2.0,60961,1.0,335.0,8.0,4.0,2.0,AAADccBzuAAAAAAAAAAAAAAAAAAAAWJAAAAsAAAAAAAAAFgB+AAAHgAQCAAACBzhlwYF8L9MFgCgAQZhZACAgC0REKABUCAoVBCDWAJAyEAeRAgPAALTACDwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol","(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","(2R,3R,4S,5R)-2-adenin-9-yl-5-methylol-tetrahydrofuran-3,4-diol","InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",OIRDTQYFTABQOQ-KQYNXXCUSA-N,-1.1,267.09675391,C10H13N5O4,267.24,140.0,267.09675391,0.0,19.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,"13  14  5
15  17  8
17  18  8
10  2  6
12  3  6
11  5  5
5  15  8
5  16  8
6  16  8
6  17  8
7  15  8
7  19  8
8  18  8
8  19  8",
440790668,12035,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01041,acetylcysteine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01041,acetylcysteine,0.0,No match,vNo-DILI-Concern,2.0,12035,1.0,148.0,4.0,3.0,3.0,AAADccBiMABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgQQCAAACCjFwASCCALAAgQIAAGQGAAAAAAAAAAAAIGIAAACAAAAACAAQAAAFgCQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2R)-2-acetamido-3-sulfanyl-propanoic acid,(2R)-2-acetamido-3-mercaptopropanoic acid,(2<I>R</I>)-2-acetamido-3-sulfanylpropanoic acid,(2R)-2-acetamido-3-sulfanylpropanoic acid,(2R)-2-acetamido-3-sulfanyl-propanoic acid,(2R)-2-acetamido-3-mercapto-propionic acid,"InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1",PWKSKIMOESPYIA-BYPYZUCNSA-N,0.4,163.03031432,C5H9NO3S,163.2,67.4,163.03031432,0.0,10.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)N[C@@H](CS)C(=O)O,,6  5  6,
440790667,6060,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02096,ACETYLCHOLINE CHLORIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02096,acetylcholine chloride,0.0,No match,vNo-DILI-Concern,2.0,6060,1.0,115.0,3.0,0.0,4.0,AAADceBiMAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAAAAAAAADhgAYCCAMABAAIAACQCAAAAAAAAAAAAAAIAAACAAAAAAADAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-acetoxyethyl(trimethyl)ammonium;chloride,2-acetyloxyethyl(trimethyl)ammonium;chloride,2-acetyloxyethyl(trimethyl)azanium;chloride,2-acetyloxyethyl(trimethyl)azanium;chloride,2-acetyloxyethyl(trimethyl)azanium;chloride,2-acetoxyethyl(trimethyl)ammonium;chloride,"InChI=1S/C7H16NO2.ClH/c1-7(9)10-6-5-8(2,3)4;/h5-6H2,1-4H3;1H/q+1;/p-1",JUGOREOARAHOCO-UHFFFAOYSA-M,,181.0869564,C7H16ClNO2,181.66,26.3,181.0869564,0.0,11.0,0.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CC(=O)OCC[N+](C)(C)C.[Cl-],,,
440790666,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01330,Abciximab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01330,abciximab,0.0,No match,vNo-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790665,68740,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01088,Zoledronate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01088,zoledronate,0.0,No match,vLess-DILI-Concern,2.0,68740,1.0,327.0,8.0,5.0,4.0,AAADccBjOAMAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAABgAAAHggACCAAAADBggQtkBcMEhCgQBAnZIAAgC0REqAJQAAYMACCSAAACAAQAAAIAAKQACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid,[1-hydroxy-2-(1-imidazolyl)-1-phosphonoethyl]phosphonic acid,(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid,(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid,(2-imidazol-1-yl-1-oxidanyl-1-phosphono-ethyl)phosphonic acid,(1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid,"InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14)",XRASPMIURGNCCH-UHFFFAOYSA-N,,271.99632466,C5H10N2O7P2,272.09,153.0,271.99632466,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,-4.3,"10  14  8
10  15  8
11  15  8
11  16  8
14  16  8",
440790664,14969,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00161,VANCOMYCIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00161,vancomycin,0.0,No match,vLess-DILI-Concern,1.0,14969,1.0,2960.0,26.0,19.0,13.0,AAADcfB//gAGAAAAAAAAAAAAAAAAAAAAAAA0aMGDAAAAAAABVAAAHgIQCAAADb7xmCcyDoLABgCIAiHSGACCCAAgJUAIiIGOj4gfdz+H9zu2eCrn9hWfuAf9/P/OoAADKAAYSABAAAZQADCQAAAAAAAAAA==,"(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-22-(2-amino-2-oxo-ethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid","(1S,2R,18R,19R,22S,25R,28R,40S)-48-[[(2S,3R,4S,5S,6R)-3-[[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyl-2-oxanyl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)-1-oxopentyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid","(1<I>S</I>,2<I>R</I>,18<I>R</I>,19<I>R</I>,22<I>S</I>,25<I>R</I>,28<I>R</I>,40<I>S</I>)-48-[(2<I>S</I>,3<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-3-[(2<I>S</I>,4<I>S</I>,5<I>S</I>,6<I>S</I>)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2<I>R</I>)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.2<SUP>3,6</SUP>.2<SUP>14,17</SUP>.1<SUP>8,12</SUP>.1<SUP>29,33</SUP>.0<SUP>10,25</SUP>.0<SUP>34,39</SUP>]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid","(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid","(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-azanyl-4,6-dimethyl-5-oxidanyl-oxan-2-yl]oxy-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-22-(2-azanyl-2-oxidanylidene-ethyl)-5,15-bis(chloranyl)-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-2,18,32,35,37-pentakis(oxidanyl)-20,23,26,42,44-pentakis(oxidanylidene)-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid","(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-22-(2-amino-2-keto-ethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-20,23,26,42,44-pentaketo-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid","InChI=1S/C66H75Cl2N9O24/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95)/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-/m0/s1",MYPYJXKWCTUITO-LYRMYLQWSA-N,,1447.4301997,C66H75Cl2N9O24,1449.2,530.0,1447.4301997,0.0,101.0,18.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,-2.6,"100  101  8
66  15  5
69  16  6
36  27  6
67  32  5
80  34  6
39  4  5
41  4  6
40  47  6
46  48  5
49  50  8
49  51  8
50  52  8
51  53  8
52  54  8
53  54  8
55  128  6
57  62  8
57  63  8
58  64  8
58  65  8
37  6  6
60  131  5
61  78  5
62  72  8
63  73  8
64  74  8
65  75  8
68  72  8
68  73  8
42  7  5
70  74  8
70  75  8
71  138  5
76  83  8
76  86  8
45  8  5
83  87  8
86  93  8
87  92  8
88  98  6
89  90  8
89  96  8
44  9  6
90  97  8
92  93  8
96  101  8
97  100  8",
440790663,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01352,Trastuzumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01352,trastuzumab,0.0,No match,vLess-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790662,129211,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00982,TAMSULOSIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00982,tamsulosin,0.0,No match,vLess-DILI-Concern,1.0,129211,1.0,539.0,7.0,2.0,11.0,AAADceB7OABAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgQQQAAADCzh2AYyB4LABAKAAiBCAHBCCBAgIAAIiJoOiIgPJiKEsRuHOCKk0BGaqAeQwKAOIAAAgAAAYABAAAEAAADAAAAAAAAAAA==,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,5-[(2<I>R</I>)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",DRHKJLXJIQTDTD-OAHLLOKOSA-N,,408.17189317,C20H28N2O5S,408.5,108.0,408.17189317,0.0,28.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,2.7,"11  14  8
11  16  8
14  15  8
15  18  8
16  19  8
18  19  8
20  21  8
20  22  8
21  24  8
22  25  8
24  26  8
25  26  8
9  7  6",
440790661,5328,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01933,sulfamethizole,20250421,20210312,Curation Efforts|Governmental Organizations,LT01933,sulfamethizole,0.0,No match,vLess-DILI-Concern,2.0,5328,1.0,348.0,7.0,2.0,3.0,AAADccBzsABgAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHAQYQAAACAiBUgAz0YBAAAqmACRiYHDSAJJgAhEciBgQZIgIICKAkZGAIABwmAAIyAcQAAAAAAQAAAAAAAAACAAAAAAAAAAAAAAAAA==,"4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide","4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide","4-amino-<I>N</I>-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide","4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide","4-azanyl-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide","4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide","InChI=1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13)",VACCAVUAMIDAGB-UHFFFAOYSA-N,0.5,270.02451792,C9H10N4O2S2,270.3,135.0,270.02451792,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1,,"10  13  8
11  14  8
12  13  8
12  14  8
2  15  8
2  16  8
6  15  8
6  8  8
8  16  8
9  10  8
9  11  8",
440790660,5486971,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01154,Pregabalin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01154,pregabalin,0.0,No match,vLess-DILI-Concern,2.0,5486971,1.0,123.0,3.0,2.0,5.0,AAADceByMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAADQDBgAQCCABAAgAIAACQCAAAAAAAAAAAAIEAAAAAABIAgAAAQAAEEAAAAAG8SBAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(3S)-3-(aminomethyl)-5-methyl-hexanoic acid,(3S)-3-(aminomethyl)-5-methylhexanoic acid,(3<I>S</I>)-3-(aminomethyl)-5-methylhexanoic acid,(3S)-3-(aminomethyl)-5-methylhexanoic acid,(3S)-3-(aminomethyl)-5-methyl-hexanoic acid,(3S)-3-(aminomethyl)-5-methyl-hexanoic acid,"InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1",AYXYPKUFHZROOJ-ZETCQYMHSA-N,,159.125928785,C8H17NO2,159.23,63.3,159.125928785,0.0,11.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)C[C@H](CN)CC(=O)O,-1.6,4  5  6,
440790659,10158453,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00665,Prasugrel hydrochloride,20231222,20210312,Curation Efforts|Governmental Organizations,LT00665,prasugrel hydrochloride,0.0,No match,vLess-DILI-Concern,2.0,10158453,1.0,555.0,6.0,1.0,6.0,AAADceB6MQBEAAAAAAAAAAAAGAAAASAAAAA8QAAAAAAAAFgBwAAAHwQAAAAADSzB2AwyDYMABAiMAqDSCACDCIAgKBBIiBmODIgMJjKktTuGOijkwBGoqAe4yMCOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxo-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride","acetic acid [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] ester;hydrochloride","[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4<I>H</I>-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride","[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride","[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxidanylidene-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] ethanoate;hydrochloride","acetic acid [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-keto-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] ester;hydrochloride","InChI=1S/C20H20FNO3S.ClH/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21;/h2-5,10,13,19H,6-9,11H2,1H3;1H",JALHGCPDPSNJNY-UHFFFAOYSA-N,,409.0914706,C20H21ClFNO3S,409.9,74.9,409.0914706,0.0,27.0,0.0,1.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2.Cl,,"12  11  3
15  19  8
15  20  8
17  18  8
17  21  8
19  23  8
2  18  8
2  22  8
20  24  8
21  22  8
23  25  8
24  25  8",
440790658,4771,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00805,phentermine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00805,phentermine,0.0,No match,vLess-DILI-Concern,1.0,4771,1.0,112.0,1.0,1.0,2.0,AAADccByAAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHAAQAAAADIiBGAAyAIBAAACAAiBCAAACAAAgAAAIiAAAAIgIICKAkRGAIAAgkAAIiAcQgMAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-methyl-1-phenyl-propan-2-amine,2-methyl-1-phenyl-2-propanamine,2-methyl-1-phenylpropan-2-amine,2-methyl-1-phenylpropan-2-amine,2-methyl-1-phenyl-propan-2-amine,"(1,1-dimethyl-2-phenyl-ethyl)amine","InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3",DHHVAGZRUROJKS-UHFFFAOYSA-N,1.9,149.120449483,C10H15N,149.23,26.0,149.120449483,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(N)Cc1ccccc1,,"10  11  8
6  7  8
6  8  8
7  9  8
8  10  8
9  11  8",
440790657,5746,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00588,Mitomycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00588,mitomycin,0.0,No match,vLess-DILI-Concern,1.0,5746,1.0,757.0,8.0,3.0,4.0,AAADceBzuAAAAAAAAAAAAAAAFgAAAWIAAAAsQAAAAAAQAEAAAAAAHgAQAAAADSzhgAYCCAPABACIAoRQWAAAAAAgAAAACIGIAEkCQBIAwCAdAAAH0ACYAUO+2YGeAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate","carbamic acid [(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl ester","[(4<I>S</I>,6<I>S</I>,7<I>R</I>,8<I>S</I>)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0<SUP>2,7</SUP>.0<SUP>4,6</SUP>]trideca-1(9),11-dien-8-yl]methyl carbamate","[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate","[(4S,6S,7R,8S)-11-azanyl-7-methoxy-12-methyl-10,13-bis(oxidanylidene)-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate","carbamic acid [(4S,6S,7R,8S)-11-amino-10,13-diketo-7-methoxy-12-methyl-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl ester","InChI=1S/C15H18N4O5/c1-5-9(16)12(21)8-6(4-24-14(17)22)15(23-2)13-7(18-13)3-19(15)10(8)11(5)20/h6-7,13,18H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,13+,15-/m1/s1",NWIBSHFKIJFRCO-WUDYKRTCSA-N,-0.4,334.12771969,C15H18N4O5,334.33,147.0,334.12771969,0.0,24.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,,"11  1  5
14  17  6
10  6  6
12  6  6",
440790656,4173,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00584,metronidazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00584,metronidazole,3.0,No match,vLess-DILI-Concern,1.0,4173,1.0,170.0,4.0,1.0,2.0,AAADccBjMAAAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAABgAAAHgAECAAAAADhgwYvsBccUgChABInZwAAgC0REqAhQAAYMAKCWAAACAAQAAAIAIKQACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-(2-methyl-5-nitro-imidazol-1-yl)ethanol,2-(2-methyl-5-nitro-1-imidazolyl)ethanol,2-(2-methyl-5-nitroimidazol-1-yl)ethanol,2-(2-methyl-5-nitroimidazol-1-yl)ethanol,2-(2-methyl-5-nitro-imidazol-1-yl)ethanol,2-(2-methyl-5-nitro-imidazol-1-yl)ethanol,"InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3",VAOCPAMSLUNLGC-UHFFFAOYSA-N,0.0,171.06439116,C6H9N3O3,171.15,83.9,171.06439116,0.0,12.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ncc([N+](=O)[O-])n1CCO,,"4  8  8
4  9  8
5  11  8
5  8  8
9  11  8",
440790655,4091,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00119,metformin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00119,metformin,0.0,No match,vLess-DILI-Concern,2.0,4091,1.0,132.0,1.0,3.0,2.0,AAADccBjgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAFAAQAAAAAAAAAAQDAANAAAAgAAAAJAAAAAGAAAABAAAIAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3-(diaminomethylene)-1,1-dimethyl-guanidine","3-(diaminomethylidene)-1,1-dimethylguanidine","3-(diaminomethylidene)-1,1-dimethylguanidine","3-(diaminomethylidene)-1,1-dimethylguanidine","3-[bis(azanyl)methylidene]-1,1-dimethyl-guanidine","3-(diaminomethylene)-1,1-dimethyl-guanidine","InChI=1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)",XZWYZXLIPXDOLR-UHFFFAOYSA-N,,129.10144537,C4H11N5,129.16,91.5,129.10144537,0.0,9.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(/N=C(N)N)N(C)C,-1.3,2  8  1,
440790654,3821,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00859,ketamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00859,ketamine,0.0,No match,vLess-DILI-Concern,1.0,3821,1.0,269.0,2.0,1.0,2.0,AAADceByIAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABAAAAHgIQAAAADI6BmCQyAILAAACIAqBSAACCAAAgBQAIiIGIBogIIDKBlzGEIAhgkAAIiAcYiMCOgAAAAAABAAAAAAAAAAIAAAAAAAAAAA==,2-(2-chlorophenyl)-2-(methylamino)cyclohexanone,2-(2-chlorophenyl)-2-(methylamino)-1-cyclohexanone,2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one,2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one,2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one,2-(2-chlorophenyl)-2-(methylamino)cyclohexanone,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",YQEZLKZALYSWHR-UHFFFAOYSA-N,2.2,237.0920418,C13H16ClNO,237.72,29.1,237.0920418,0.0,16.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNC1(c2ccccc2Cl)CCCCC1=O,,"10  11  8
10  12  8
11  14  8
12  15  8
14  16  8
15  16  8
4  3  3",
440790653,3038498,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00658,Fospropofol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00658,fospropofol,0.0,No match,vLess-DILI-Concern,2.0,3038498,1.0,296.0,5.0,2.0,6.0,AAADceBwOAIAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgAACCAADQSAmAMyDoAABRCAQiBCAIACCAAgIAAIiAAECIgcJiKEMRqAMCAkwBEMqAeAwOAOgAACAAAIAAAAAAQAABAAAAAAAAAAAA==,"(2,6-diisopropylphenoxy)methyl dihydrogen phosphate","[2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate","[2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate","[2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate","[2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate","(2,6-diisopropylphenoxy)methyl dihydrogen phosphate","InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16)",QVNNONOFASOXQV-UHFFFAOYSA-N,,288.11266076,C13H21O5P,288.28,76.0,288.11266076,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O,2.5,"10  11  8
10  13  8
12  18  8
13  18  8
9  11  8
9  12  8",
440790652,3385,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01029,fluorouracil,20210312,20210312,Curation Efforts|Governmental Organizations,LT01029,fluorouracil,0.0,No match,vLess-DILI-Concern,2.0,3385,1.0,199.0,3.0,2.0,0.0,AAADcQBjMQAAAAAAAAAAAAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAHwAQAAAACADBgAQBAALAAACIAAFWUACAAAAAAAAAAIAIAECAAAAAAAAAAAAIByIAAMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5-fluoro-1H-pyrimidine-2,4-dione","5-fluoro-1H-pyrimidine-2,4-dione","5-fluoro-1<I>H</I>-pyrimidine-2,4-dione","5-fluoro-1H-pyrimidine-2,4-dione","5-fluoranyl-1H-pyrimidine-2,4-dione",5-fluorouracil,"InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)",GHASVSINZRGABV-UHFFFAOYSA-N,-0.9,130.0178555,C4H3FN2O2,130.08,58.2,130.0178555,0.0,9.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=c1[nH]cc(F)c(=O)[nH]1,,"4  6  8
4  7  8
5  7  8
5  9  8
6  8  8
8  9  8",
440790651,57363,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00167,finasteride,20210312,20210312,Curation Efforts|Governmental Organizations,LT00167,finasteride,0.0,No match,vLess-DILI-Concern,2.0,57363,1.0,678.0,2.0,2.0,2.0,AAADcfB7MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAHgAQAAAAD6jBgAQCAALAAACIACFSEACAAAAgAAAICIEIAEgAABIAgAAEAAAAlgCIAYMYiMCPgAAAAAAAAACQAASAACQAAQAACAAAAA==,"(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","(1<I>S</I>,3<I>a</I><I>S</I>,3<I>b</I><I>S</I>,5<I>a</I><I>R</I>,9<I>a</I><I>R</I>,9<I>b</I><I>S</I>,11<I>a</I><I>S</I>)-<I>N</I>-<I>tert</I>-butyl-9<I>a</I>,11<I>a</I>-dimethyl-7-oxo-1,2,3,3<I>a</I>,3<I>b</I>,4,5,5<I>a</I>,6,9<I>b</I>,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxidanylidene-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-7-keto-9a,11a-dimethyl-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1",DBEPLOCGEIEOCV-WSBQPABSSA-N,3.0,372.277678395,C23H36N2O2,372.5,58.2,372.277678395,0.0,27.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,,"10  21  5
16  42  6
5  28  6
6  18  5
7  29  5
8  30  6
9  19  5",
440790650,5281081,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01968,ENTACAPONE,20231222,20210312,Curation Efforts|Governmental Organizations,LT01968,entacapone,0.0,No match,vLess-DILI-Concern,2.0,5281081,1.0,500.0,6.0,2.0,4.0,AAADccBzOAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAECAAADAzBmAQyxoMQQgCZBiVSUwCiAAAgIgAgiAEP7MoLpiKSkZOEcAFmxlmJ2YeQ0BEOIAABQgAAUABAAAKEAACgAAAAAAAAAA==,"(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide","(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide","(<I>E</I>)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-<I>N</I>,<I>N</I>-diethylprop-2-enamide","(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide","(E)-2-cyano-N,N-diethyl-3-[3-nitro-4,5-bis(oxidanyl)phenyl]prop-2-enamide","(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-acrylamide","InChI=1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+",JRURYQJSLYLRLN-BJMVGYQFSA-N,,305.10117059,C14H15N3O5,305.29,130.0,305.10117059,0.0,22.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1,2.1,"14  17  8
14  18  8
17  19  8
18  20  8
19  21  8
20  21  8",
440790649,2973,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00386,deferoxamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00386,deferoxamine,0.0,No match,vLess-DILI-Concern,1.0,2973,1.0,739.0,9.0,6.0,23.0,AAADcfB7vAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAUCAAACADBgAQCAALQAAAIAAEQEAAAAAAAAAAgAIEIAAAAABIAgAAEAAAAFgCAAAAVAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxo-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-butanediamide,"N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-1,4-dioxobutyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide",<I>N</I>-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-<I>N</I>&apos;-(5-aminopentyl)-<I>N</I>&apos;-hydroxybutanediamide,N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide,N'-(5-azanylpentyl)-N-[5-[[4-[5-[ethanoyl(oxidanyl)amino]pentylamino]-4-oxidanylidene-butanoyl]-oxidanyl-amino]pentyl]-N'-oxidanyl-butanediamide,N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-keto-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-succinamide,"InChI=1S/C25H48N6O8/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34)",UBQYURCVBFRUQT-UHFFFAOYSA-N,,560.35336251,C25H48N6O8,560.7,206.0,560.35336251,0.0,39.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,-2.1,,
440790648,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01374,Darbepoetin alfa,20210312,20210312,Curation Efforts|Governmental Organizations,LT01374,darbepoetin alfa,0.0,No match,vLess-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790647,2710,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00066,chlorcyclizine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00066,chlorcyclizine,0.0,No match,vLess-DILI-Concern,2.0,2710,1.0,300.0,2.0,0.0,3.0,AAADceB7AAAEAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABQAAAHAIAAAAADCrBGCQyAIMAAACAAiBCAACCAAAgBQAIiAAIBogIYCKBkxGUIAhggACIiAcQgMAOBAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,1-[(4-chlorophenyl)-phenyl-methyl]-4-methyl-piperazine,1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine,1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine,1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine,1-[(4-chlorophenyl)-phenyl-methyl]-4-methyl-piperazine,1-[(4-chlorophenyl)-phenyl-methyl]-4-methyl-piperazine,"InChI=1S/C18H21ClN2/c1-20-11-13-21(14-12-20)18(15-5-3-2-4-6-15)16-7-9-17(19)10-8-16/h2-10,18H,11-14H2,1H3",WFNAKBGANONZEQ-UHFFFAOYSA-N,4.5,300.1393264,C18H21ClN2,300.8,6.5,300.1393264,0.0,21.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,,"10  14  8
10  15  8
12  16  8
13  17  8
14  18  8
15  19  8
16  20  8
17  20  8
18  21  8
19  21  8
6  26  3
9  12  8
9  13  8",
440790646,7699,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00800,Benzonatate,20210804,20210312,Curation Efforts|Governmental Organizations,LT00800,benzonatate,0.0,No match,vLess-DILI-Concern,1.0,7699,1.0,565.0,12.0,1.0,33.0,AAADcfB6PAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQAAAADAjhmAYyyILABACIAiTSSACCAAAlAgAIiIEIbMgJJjLAtZmGMQhk0AHK6YeY2SOeCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate,4-(butylamino)benzoic acid 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl ester,2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate,2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate,2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate,4-(butylamino)benzoic acid 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl ester,"InChI=1S/C30H53NO11/c1-3-4-9-31-29-7-5-28(6-8-29)30(32)42-27-26-41-25-24-40-23-22-39-21-20-38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-33-2/h5-8,31H,3-4,9-27H2,1-2H3",MAFMQEKGGFWBAB-UHFFFAOYSA-N,2.4,603.36186151,C30H53NO11,603.7,121.0,603.36186151,0.0,42.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1,,"16  18  8
16  19  8
18  21  8
19  22  8
20  21  8
20  22  8",
440790645,2244,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00053,aspirin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00053,aspirin,0.0,No match,vLess-DILI-Concern,2.0,2244,1.0,212.0,4.0,1.0,3.0,AAADccBwOAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgAACAAADASAmAAyDoAABgCIAiDSCAACCAAkIAAIiAEGCMgMJzaENRqCe2Cl4BEIuYeIyCCOAAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,2-acetoxybenzoic acid,2-acetyloxybenzoic acid,2-acetyloxybenzoic acid,2-acetyloxybenzoic acid,2-acetyloxybenzoic acid,2-acetoxybenzoic acid,"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",BSYNRYMUTXBXSQ-UHFFFAOYSA-N,1.2,180.04225873,C9H8O4,180.16,63.6,180.04225873,0.0,13.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)Oc1ccccc1C(=O)O,,"5  6  8
5  7  8
6  8  8
7  9  8
8  10  8
9  10  8",
440790644,139595263,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01373,Anakinra,20210312,20210312,Curation Efforts|Governmental Organizations,LT01373,anakinra,0.0,No match,vLess-DILI-Concern,2.0,139595263,1.0,961.0,12.0,3.0,10.0,AAADceB7uABgAAAAAAAAAAAAAABYAWAAAAAgAAAAAAAQAAABgAAAHgQUCAAADijF1gejmRPYFgisAyXyfAAA8KlhCjkICJW4IFiaZJggxCEUEAAAFgK0kSAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"7-[[2-(2-aminothiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","7-[[2-(2-amino-4-thiazolyl)-2-[(2,2-dimethyl-1-oxopropoxy)methoxyimino]-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","7-[[2-(2-azanyl-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)ethanoyl]amino]-3-ethenyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",7-[[2-(2-aminothiazol-4-yl)-2-(pivaloyloxymethyloximino)acetyl]amino]-8-keto-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,"InChI=1S/C20H23N5O7S2/c1-5-9-6-33-16-12(15(27)25(16)13(9)17(28)29)23-14(26)11(10-7-34-19(21)22-10)24-32-8-31-18(30)20(2,3)4/h5,7,12,16H,1,6,8H2,2-4H3,(H2,21,22)(H,23,26)(H,28,29)",HMLGSIZOMSVISS-UHFFFAOYSA-N,1.1,509.10389044,C20H23N5O7S2,509.6,227.0,509.10389044,0.0,34.0,0.0,2.0,0.0,1.0,0.0,1.0,-1.0,"1
5
255",C=CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(=NOCOC(=O)C(C)(C)C)c3csc(N)n3)C2SC1,,"15  1  3
16  11  3
12  24  1
13  27  8
13  34  8
2  32  8
2  34  8
27  32  8",
440790643,3007,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02100,AMPHETAMINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02100,amphetamine,0.0,No match,vLess-DILI-Concern,2.0,3007,1.0,84.7,1.0,1.0,2.0,AAADccByAAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHAAQAAAADCjBGAQyAIBAAACAAiBCAAACAAAgAAAIiIAAAIgIICKAkRGAIAAgkAAIiAcQgIAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,1-phenylpropan-2-amine,1-phenyl-2-propanamine,1-phenylpropan-2-amine,1-phenylpropan-2-amine,1-phenylpropan-2-amine,(1-methyl-2-phenyl-ethyl)amine,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3",KWTSXDURSIMDCE-UHFFFAOYSA-N,1.8,135.104799419,C9H13N,135.21,26.0,135.104799419,0.0,10.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(N)Cc1ccccc1,,"2  11  3
4  6  8
4  7  8
6  8  8
7  9  8
8  10  8
9  10  8",
440790642,5493444,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01244,Aliskiren,20231222,20210312,Curation Efforts|Governmental Organizations,LT01244,aliskiren,0.0,No match,vLess-DILI-Concern,2.0,5493444,1.0,717.0,7.0,4.0,19.0,AAADcfB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADzzhmAYyBoLABgCIAiFSEAACCAAgIAAIiIEOiIgPNjqE8RqGeCKl1hGKqAe6yfCeoAABAAAAQABAAAIAAACAAAAAAAAAAA==,"(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxo-propyl)-4-hydroxy-2-isopropyl-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-nonanamide","(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide","(2<I>S</I>,4<I>S</I>,5<I>S</I>,7<I>S</I>)-5-amino-<I>N</I>-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide","(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide","(2S,4S,5S,7S)-5-azanyl-N-(3-azanyl-2,2-dimethyl-3-oxidanylidene-propyl)-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-4-oxidanyl-2-propan-2-yl-nonanamide","(2S,4S,5S,7S)-5-amino-N-(3-amino-3-keto-2,2-dimethyl-propyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-pelargonamide","InChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1",UXOWGYHJODZGMF-QORCZRPOSA-N,,551.39343642,C30H53N3O6,551.8,146.0,551.39343642,0.0,39.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,3.5,"13  1  6
10  11  5
16  15  6
22  27  8
22  28  8
27  29  8
28  30  8
29  33  8
30  33  8
12  7  6",
440790641,2088,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00980,alendronate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00980,alendronate,0.0,No match,vLess-DILI-Concern,1.0,2088,1.0,257.0,8.0,6.0,5.0,AAADccBiOAMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHggQCCAACADBgAQAAABAAhAAQAAAAIAAAAAAAAAAAIAAAAAAAAAAgAAAQAAEEAAAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(4-amino-1-hydroxy-1-phosphono-butyl)phosphonic acid,(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid,(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid,(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid,(4-azanyl-1-oxidanyl-1-phosphono-butyl)phosphonic acid,(4-amino-1-hydroxy-1-phosphono-butyl)phosphonic acid,"InChI=1S/C4H13NO7P2/c5-3-1-2-4(6,13(7,8)9)14(10,11)12/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12)",OGSPWJRAVKPPFI-UHFFFAOYSA-N,,249.01672575,C4H13NO7P2,249.1,161.0,249.01672575,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCCCC(O)(P(=O)(O)O)P(=O)(O)O,-6.5,,
440790640,71771,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01853,Aceclofenac,20231222,20210312,Curation Efforts|Governmental Organizations,LT01853,aceclofenac,0.0,No match,vLess-DILI-Concern,2.0,71771,1.0,411.0,5.0,2.0,7.0,AAADccB6OAAGAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgIQCAAADAqhmCIwyILABgCIAiTSSAKCAAAhBwAIiAFAZogJIHLBl5XGIAhk0AHLyAe8yKCOAAAAAACCABAAAAAAAQQAIAAAAAAAAA==,"2-[2-[2-(2,6-dichloroanilino)phenyl]acetyl]oxyacetic acid","2-[2-[2-(2,6-dichloroanilino)phenyl]-1-oxoethoxy]acetic acid","2-[2-[2-(2,6-dichloroanilino)phenyl]acetyl]oxyacetic acid","2-[2-[2-(2,6-dichloroanilino)phenyl]acetyl]oxyacetic acid","2-[2-[2-[[2,6-bis(chloranyl)phenyl]amino]phenyl]ethanoyloxy]ethanoic acid","2-[2-[2-(2,6-dichloroanilino)phenyl]acetyl]oxyacetic acid","InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",MNIPYSSQXLZQLJ-UHFFFAOYSA-N,4.3,353.0221633,C16H13Cl2NO4,354.2,75.6,353.0221633,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,,"11  14  8
12  15  8
13  17  8
13  18  8
14  15  8
17  19  8
18  20  8
19  21  8
20  21  8
8  11  8
8  9  8
9  12  8",
440790639,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01402,Abatacept,20210312,20210312,Curation Efforts|Governmental Organizations,LT01402,abatacept,0.0,No match,vLess-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790638,5734,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00165,zonisamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00165,zonisamide,2.0,Adverse reactions,vLess-DILI-Concern,2.0,5734,1.0,298.0,5.0,1.0,2.0,AAADccBzMABAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgB8AAAHgQUQAAADAyF3gCwhtAQAAKpA6RyQnDCAAAkIAAomCE2TNoIJrqAlZOAMYBmwBkIyceYyKCOAAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,"1,2-benzoxazol-3-ylmethanesulfonamide","1,2-benzoxazol-3-ylmethanesulfonamide","1,2-benzoxazol-3-ylmethanesulfonamide","1,2-benzoxazol-3-ylmethanesulfonamide","1,2-benzoxazol-3-ylmethanesulfonamide",indoxazen-3-ylmethanesulfonamide,"InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)",UBQNRHZMVUUOMG-UHFFFAOYSA-N,,212.0255633,C8H8N2O3S,212.23,94.6,212.0255633,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NS(=O)(=O)Cc1noc2ccccc12,0.2,"10  12  8
11  13  8
12  14  8
13  14  8
2  10  8
2  5  8
5  8  8
8  9  8
9  10  8
9  11  8",
440790637,60854,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01017,Ziprasidone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01017,ziprasidone,3.0,Adverse reactions,vLess-DILI-Concern,2.0,60854,1.0,573.0,5.0,1.0,4.0,AAADceB7oABEAAAAAAAAAAAAAAAAAWLAAAA8YIAAAAAAAFgB9AAAHgYQQAAADArB2iQx8dPAAACsAidycACDABAhBwBJmDkoZpiIYLLBn5GUIAxglALIyAcciMCODAACAAIHAAAYAAQABA4AAAAAAAAAAA==,"5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one","5-[2-[4-(1,2-benzothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydroindol-2-one","5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one","5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one","5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloranyl-1,3-dihydroindol-2-one","5-[2-[4-(1,2-benzothiazol-3-yl)piperazino]ethyl]-6-chloro-oxindole","InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)",MVWVFYHBGMAFLY-UHFFFAOYSA-N,,412.1124602,C21H21ClN4OS,412.9,76.7,412.1124602,0.0,28.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,4.0,"14  16  8
15  18  8
15  20  8
16  22  8
16  25  8
17  18  8
17  19  8
19  23  8
2  22  8
2  6  8
20  23  8
22  26  8
25  27  8
26  28  8
27  28  8
6  14  8",
440790636,54678486,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00647,warfarin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00647,warfarin,5.0,Adverse reactions,vLess-DILI-Concern,1.0,54678486,1.0,501.0,4.0,1.0,4.0,AAADceB4OAAAAAAAAAAAAAAAAAAAAAAAAAAwYIAAAAAAAACBQAAAGgAACAAADQSAmAAyDoAABgCIAqDSCAACCAAgIAAIiAEGCMgMJzKEMRqCeiClwBEIuQeIzuCugAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,4-hydroxy-3-(3-oxo-1-phenyl-butyl)chromen-2-one,4-hydroxy-3-(3-oxo-1-phenylbutyl)-1-benzopyran-2-one,4-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one,4-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one,4-oxidanyl-3-(3-oxidanylidene-1-phenyl-butyl)chromen-2-one,warfarin,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",PJVWKTKQMONHTI-UHFFFAOYSA-N,2.7,308.10485899,C19H16O4,308.3,63.6,308.10485899,0.0,23.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,,"1  11  8
1  15  8
10  15  8
10  16  8
13  17  8
14  18  8
15  19  8
16  22  8
17  21  8
18  21  8
19  23  8
22  23  8
5  7  3
6  11  8
6  9  8
8  13  8
8  14  8
9  10  8",
440790635,5978,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01862,vincristine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01862,vincristine,8.0,Adverse reactions,vLess-DILI-Concern,2.0,5978,1.0,1750.0,12.0,3.0,10.0,AAADcfB/vAAAAAAAAAAAAAAAAAAAAWLFgAA8YMECAAAAAFiB9AAAHgAQCAAAD3zhngYyzvPJlgCoAyTy3AKCiCAhIiAImSF+bJgPJv7E9ZuGcChn9hnb6Af62fOfqAACAgAKAABQgAYECBSgAAAAAAAAAA==,"methyl (1R,9R,10S,11R,12R,19R)-11-acetoxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate","(1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylic acid methyl ester","methyl (1<I>R</I>,9<I>R</I>,10<I>S</I>,11<I>R</I>,12<I>R</I>,19<I>R</I>)-11-acetyloxy-12-ethyl-4-[(13<I>S</I>,15<I>S</I>,17<I>S</I>)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.0<SUP>4,12</SUP>.0<SUP>5,10</SUP>]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.0<SUP>1,9</SUP>.0<SUP>2,7</SUP>.0<SUP>16,19</SUP>]nonadeca-2,4,6,13-tetraene-10-carboxylate","methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate","methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-oxidanyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-methanoyl-5-methoxy-10-oxidanyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate","(1R,9R,10S,11R,12R,19R)-11-acetoxy-4-[(13S,15S,17S)-13-carbomethoxy-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-12-ethyl-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylic acid methyl ester","InChI=1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3/t28-,37+,38-,39-,42+,43-,44-,45+,46+/m1/s1",OGWKCGZFUXNPDA-XQKSVPLYSA-N,2.8,824.399644,C46H56N4O10,825.0,171.0,824.399644,0.0,60.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,,"21  1  6
47  10  5
14  39  8
14  53  8
15  20  6
16  61  5
17  24  5
18  62  6
19  2  6
22  26  8
22  30  8
26  32  8
30  34  8
32  35  8
34  35  8
36  41  5
39  46  8
40  83  5
46  51  8
51  53  8
51  55  8
53  56  8
55  59  8
56  60  8
59  60  8",
440790634,5656,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00174,venlafaxine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00174,venlafaxine,7.0,Adverse reactions,vLess-DILI-Concern,1.0,5656,1.0,279.0,3.0,1.0,5.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABAAAAHgAACAAADUTBmAYyBoMABgCAAiBCAAACCAAgIAAIiAAOCIgMJiKEsRuEcCAmwBEIqAeQwPAOoAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-1-cyclohexanol,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol,"InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3",PNVNVHUZROJLTJ-UHFFFAOYSA-N,,277.204179104,C17H27NO2,277.4,32.7,277.204179104,0.0,20.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,2.9,"12  13  8
12  14  8
13  17  8
14  18  8
17  19  8
18  19  8
5  21  3",
440790633,170361,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01242,Varenicline,20231222,20210312,Curation Efforts|Governmental Organizations,LT01242,varenicline,2.0,Adverse reactions,vLess-DILI-Concern,2.0,170361,1.0,254.0,3.0,1.0,0.0,AAADccBzAAAAAAAAAAAAAAAAAAAAAYAAAAA8WIAABYAAAGCx8AAAHAAQAAAADQjBHgQ8wLLIEACgAzRnRACCgCQxEiAI2KA4dJgIYOLAkZGUIAhgkADIyAcQgMAOiAAAQAAQACAQAACAACAAQQAACAAAAA==,"5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene","5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene","5,8,14-triazatetracyclo[10.3.1.0<SUP>2,11</SUP>.0<SUP>4,9</SUP>]hexadeca-2,4,6,8,10-pentaene","5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene","5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene","5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene","InChI=1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2",JQSHBVHOMNKWFT-UHFFFAOYSA-N,,211.110947427,C13H13N3,211.26,37.8,211.110947427,0.0,16.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",c1cnc2cc3c(cc2n1)C1CNCC3C1,0.8,"11  13  8
12  14  8
13  14  8
15  16  8
2  13  8
2  15  8
3  14  8
3  16  8
4  6  3
5  6  3
7  11  8
7  8  8
8  12  8",
440790632,60846,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01857,valsartan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01857,valsartan,3.0,Adverse reactions,vLess-DILI-Concern,2.0,60846,1.0,608.0,6.0,2.0,10.0,AAADceB7sAAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAAB0AAAHgAYCAAADSjBmwQzGIcCAgCqAiPyOACCAAIgAAAcqCGoBJgKILKAkTGEYAhkhgCYiAcYgMAOwAAAAAAQAACAAAAAACAAAAAAAAAAAA==,(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid,(2S)-3-methyl-2-[1-oxopentyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid,(2<I>S</I>)-3-methyl-2-[pentanoyl-[[4-[2-(2<I>H</I>-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid,(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid,"(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid",(2S)-3-methyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]benzyl]-valeryl-amino]butyric acid,"InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1",ACWBQPMHZXGDFX-QFIPXVFZSA-N,,435.2270398,C24H29N5O3,435.5,112.0,435.2270398,0.0,32.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C,4.4,"17  20  8
17  21  8
20  23  8
21  24  8
22  23  8
22  24  8
26  27  8
26  28  8
27  29  8
28  30  8
29  32  8
30  32  8
9  4  6
5  31  8
5  7  8
6  31  8
6  8  8
7  8  8",
440790631,135398742,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01856,Valaciclovir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01856,valaciclovir,3.0,Adverse reactions,vLess-DILI-Concern,2.0,135398742,1.0,483.0,7.0,3.0,8.0,AAADceBzuAAAAAAAAAAAAAAAAAAAAWAAAAAgAAAAAAAAAEABgAAAHgAQAAAADSjhlgYHuBfMFACoAQfxfACAgC0XEKABUIGoVECDSBhASCAfAIgMEQJCAGAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methyl-butanoate,(2S)-2-amino-3-methylbutanoic acid 2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl ester,2-[(2-amino-6-oxo-1<I>H</I>-purin-9-yl)methoxy]ethyl (2<I>S</I>)-2-amino-3-methylbutanoate,2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate,2-[(2-azanyl-6-oxidanylidene-1H-purin-9-yl)methoxy]ethyl (2S)-2-azanyl-3-methyl-butanoate,(2S)-2-amino-3-methyl-butyric acid 2-[(2-amino-6-keto-1H-purin-9-yl)methoxy]ethyl ester,"InChI=1S/C13H20N6O4/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20)/t8-/m0/s1",HDOVUKNUBWVHOX-QMMMGPOBSA-N,,324.15460314,C13H20N6O4,324.34,147.0,324.15460314,0.0,23.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)[nH]c(N)nc21,-0.9,"17  20  8
20  22  8
5  17  8
5  21  8
12  6  6
7  20  8
7  21  8
8  17  8
8  23  8
9  22  8
9  23  8",
440790630,25074470,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00460,Triptorelin pamoate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00460,triptorelin pamoate,3.0,Adverse reactions,vLess-DILI-Concern,2.0,25074470,1.0,2710.0,15.0,17.0,33.0,AAADcfB//AAAAAAAAAAAAAAAAAAAAWLFixYwYMAAAAAAAFgB/gAAHgAQCAAADSzhngY/1vfJkgCoAzV3dACCgC2xMqAJ2aG+fJiKfvbC2bOUcAhu9hPY2Cecy+COoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-2-[[(1S)-1-[[(1S)-1-[(2S)-2-[(2-amino-2-oxo-ethyl)carbamoyl]pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2-amino-2-oxoethyl)amino]-oxomethyl]-1-pyrrolidinyl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxo-2-pyrrolidinecarboxamide,(2<I>S</I>)-<I>N</I>-[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>R</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-azanyl-2-oxidanylidene-ethyl)carbamoyl]pyrrolidin-1-yl]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxidanylidene-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl]-5-oxidanylidene-pyrrolidine-2-carboxamide,(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-2-[[(1S)-1-[[(1S)-1-[(2S)-2-[(2-amino-2-keto-ethyl)carbamoyl]pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]amino]-1-(4-hydroxybenzyl)-2-keto-ethyl]amino]-2-keto-1-methylol-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-keto-ethyl]-5-keto-pyrrolidine-2-carboxamide,"InChI=1S/C64H82N18O13/c1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44/h3-6,9-12,15-18,28-30,33-34,44-52,70-71,83-84H,7-8,13-14,19-27,31-32H2,1-2H3,(H2,65,85)(H,68,73)(H,72,94)(H,74,86)(H,75,88)(H,76,90)(H,77,93)(H,78,89)(H,79,92)(H,80,87)(H,81,91)(H4,66,67,69)/t44-,45-,46-,47-,48+,49-,50-,51-,52-/m0/s1",VXKHXGOKWPXYNA-PGBVPBMZSA-N,,1310.63087474,C64H82N18O13,1311.4,490.0,1310.63087474,0.0,95.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,-0.3,"37  15  5
41  17  6
47  19  5
21  59  8
21  60  8
54  22  5
64  24  5
63  25  5
68  26  6
29  83  8
29  84  8
30  82  8
30  95  8
31  89  8
31  95  8
32  38  5
53  56  8
53  59  8
56  60  8
56  69  8
58  67  5
60  77  8
69  79  8
74  78  8
74  83  8
76  85  8
76  86  8
77  80  8
78  84  8
78  87  8
79  80  8
82  89  8
84  88  8
85  90  8
86  91  8
87  92  8
88  93  8
90  94  8
91  94  8
92  93  8",
440790629,5578,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01842,trimethoprim,20250421,20210312,Curation Efforts|Governmental Organizations,LT01842,trimethoprim,4.0,Adverse reactions,vLess-DILI-Concern,2.0,5578,1.0,307.0,7.0,2.0,5.0,AAADceBzsAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHgAQAAAADATBmgY/tpZIFACgAjJnZACCiCkxIKAB2CAuzJiNL6LE+VqENCotwBdK6CeQ4PwOIAABCAAAQABAAAIQAACAAAAAAAAAAA==,"5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine","5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine","5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine","5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine","5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine","[2-amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-4-yl]amine","InChI=1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18)",IEDVJHCEMCRBQM-UHFFFAOYSA-N,0.9,290.13789045,C14H18N4O3,290.32,106.0,290.13789045,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,"10  16  8
10  17  8
11  14  8
12  13  8
13  15  8
14  15  8
4  16  8
4  18  8
5  17  8
5  18  8
9  11  8
9  12  8",
440790628,5546,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01833,triamterene,20231222,20210312,Curation Efforts|Governmental Organizations,LT01833,triamterene,5.0,Adverse reactions,vLess-DILI-Concern,2.0,5546,1.0,306.0,7.0,3.0,1.0,AAADccBzgAAAAAAAAAAAAAAAAAAAAAAAAAA8WIAAAAAAAACx/AAAHAAQAAAADAiBHwAx8L5IEACgAyZiZACCgC0hEKAJmCAgVJiIaOLA2VGUJAhogALIyCcQgIAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"6-phenylpteridine-2,4,7-triamine","6-phenylpteridine-2,4,7-triamine","6-phenylpteridine-2,4,7-triamine","6-phenylpteridine-2,4,7-triamine","6-phenylpteridine-2,4,7-triamine","(2,4-diamino-6-phenyl-pteridin-7-yl)amine","InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19)",FNYLWPVRPXGIIP-UHFFFAOYSA-N,1.0,253.10759338,C12H11N7,253.26,130.0,253.10759338,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,,"1  8  8
1  9  8
10  14  8
10  15  8
14  17  8
15  18  8
17  19  8
18  19  8
2  11  8
2  12  8
3  11  8
3  16  8
4  13  8
4  16  8
8  12  8
9  11  8
9  13  8",
440790627,5533,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01830,trazodone,20210804,20210312,Curation Efforts|Governmental Organizations,LT01830,trazodone,5.0,Adverse reactions,vLess-DILI-Concern,1.0,5533,1.0,611.0,4.0,0.0,5.0,AAADceB7oAAEAAAAAAAAAAAAAAAAAQAAAAA8QIAAAAAAAEABAAAAHgIIAAAACArBECQxwIMAAACoACZmcACSAAAhBwAfiAAYZpiIYCLB05GUIAhojgLIyAcQAAAAAAAAAAIAAAAAAAAABAAAAAAAAAAAAA==,"2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one","2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one","2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one","2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one","2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one","2-[3-[4-(3-chlorophenyl)piperazino]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one","InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2",PHLBKPHSAVXXEF-UHFFFAOYSA-N,,371.151288,C19H22ClN5O,371.9,42.4,371.151288,0.0,26.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,2.8,"15  16  8
15  17  8
16  20  8
17  21  8
19  24  8
20  22  8
21  22  8
23  25  8
24  26  8
25  26  8
5  18  8
5  7  8
6  18  8
6  19  8
6  23  8
7  19  8",
440790626,5530,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01829,tranylcypromine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01829,tranylcypromine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5530,1.0,116.0,1.0,1.0,1.0,AAADccByAAAAAAAAAAAAAAAAGAAAAAAAAAAwAAAAAAAAAAABAAAAHAAQAAAADSjBGAQwAIBAAACAAiBCAAACAAAgAAAIiIAAAIgIICKAkRGAIAAgkAAIiAcQgMAOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-phenylcyclopropanamine,2-phenyl-1-cyclopropanamine,2-phenylcyclopropan-1-amine,2-phenylcyclopropan-1-amine,2-phenylcyclopropan-1-amine,(2-phenylcyclopropyl)amine,"InChI=1S/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2",AELCINSCMGFISI-UHFFFAOYSA-N,1.5,133.089149355,C9H11N,133.19,26.0,133.089149355,0.0,10.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC1CC1c1ccccc1,,"2  11  3
3  12  3
5  6  8
5  7  8
6  8  8
7  9  8
8  10  8
9  10  8",
440790625,5484727,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01828,trandolapril,20231222,20210312,Curation Efforts|Governmental Organizations,LT01828,trandolapril,4.0,Adverse reactions,vLess-DILI-Concern,2.0,5484727,1.0,633.0,6.0,2.0,10.0,AAADcfB7OAAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgBAAAAHgAQCAAADSjhmAYyCIPABgCIAiHSGAACAAAgAAAIiIGIAIgKYDKAkTCXYAAklgCYiAeY2bOeAAAAAAAAAAAAAAAAAAQAAAAAAAAAAA==,"(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid","(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid","(2<I>S</I>,3<I>a</I><I>R</I>,7<I>a</I><I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3<I>a</I>,4,5,6,7,7<I>a</I>-octahydroindole-2-carboxylic acid","(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid","(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid","(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-carbethoxy-3-phenyl-propyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid","InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1",VXFJYXUZANRPDJ-WTNASJBWSA-N,2.0,430.24677219,C24H34N2O5,430.5,95.9,430.24677219,0.0,31.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21,,"11  17  5
24  26  8
24  27  8
26  28  8
27  29  8
28  31  8
29  31  8
18  7  5
20  7  6
8  32  5
9  33  6",
440790624,5284627,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00455,topiramate,20210312,20210312,Curation Efforts|Governmental Organizations,LT00455,topiramate,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5284627,1.0,556.0,9.0,1.0,3.0,AAADceByPABAAAAAAAAAAAAAAAAAASJAAAAkAAAAAAAAAEgAAAAAGgAQQAAACBSggAICCAAABAAAAAAAADAAAAAAAAAAAAAAAAARAAIAAAAiAAAFAAAGAAHAYAwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate","sulfamic acid [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl ester","[(1<I>R</I>,2<I>S</I>,6<I>S</I>,9<I>R</I>)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0<SUP>2,6</SUP>]dodecan-6-yl]methyl sulfamate","[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate","[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate","sulfamic acid [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl ester","InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1",KJADKKWYZYXHBB-XBWDGYHZSA-N,,339.0987878,C12H21NO8S,339.36,124.0,339.0987878,0.0,22.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1,-0.8,"11  23  6
12  24  5
13  18  6
14  25  5",
440790623,5509,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01820,tolmetin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01820,tolmetin,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5509,1.0,347.0,3.0,1.0,4.0,AAADccByMAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHgAACAAADAyBngQyiJMMEgCoA6TyTACCgCAnAiAI2CG4ZNgIIPrAlbGEYQhmwAHIyYeYyeCeQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetic acid,2-[1-methyl-5-[(4-methylphenyl)-oxomethyl]-2-pyrrolyl]acetic acid,2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetic acid,2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetic acid,2-[1-methyl-5-(4-methylphenyl)carbonyl-pyrrol-2-yl]ethanoic acid,2-(1-methyl-5-p-toluoyl-pyrrol-2-yl)acetic acid,"InChI=1S/C15H15NO3/c1-10-3-5-11(6-4-10)15(19)13-8-7-12(16(13)2)9-14(17)18/h3-8H,9H2,1-2H3,(H,17,18)",UPSPUYADGBWSHF-UHFFFAOYSA-N,2.8,257.10519334,C15H15NO3,257.28,59.3,257.10519334,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1,,"12  13  8
12  14  8
13  16  8
14  17  8
15  16  8
15  17  8
4  5  8
4  6  8
5  7  8
6  8  8
7  8  8",
440790622,5503,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00266,tolazamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00266,tolazamide,2.0,Adverse reactions,vLess-DILI-Concern,2.0,5503,1.0,431.0,4.0,2.0,3.0,AAADceBzMABAAAAAAAAAAAAAAAAAAAAAAAAwAAAABYAAAAABAAAAHgQYQAAADADBWAQzAYJiAAKIAiBCEHBCABAgAAAeqBgIAIgIICKAkRCEIAAwgACIiAcQgAAOEAAAAAAAAAAgAAAAAAAAAAAAAAAAAA==,1-(azepan-1-yl)-3-(p-tolylsulfonyl)urea,1-(1-azepanyl)-3-(4-methylphenyl)sulfonylurea,1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea,1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea,1-(azepan-1-yl)-3-(4-methylphenyl)sulfonyl-urea,1-(azepan-1-yl)-3-tosyl-urea,"InChI=1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)",OUDSBRTVNLOZBN-UHFFFAOYSA-N,1.5,311.13036271,C14H21N3O3S,311.4,86.9,311.13036271,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1,,"15  16  8
15  17  8
16  19  8
17  20  8
18  19  8
18  20  8",
440790621,5479,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00637,tinidazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00637,tinidazole,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5479,1.0,345.0,5.0,0.0,4.0,AAADccBzOABAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAABgAAAHAQEAAAAAADFQwSvsBccUAqhABInZ3BAgC0RErAhQAAYMAKASAAACAAQAAAIAIKgACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,1-(2-ethylsulfonylethyl)-2-methyl-5-nitro-imidazole,1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole,1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole,1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole,1-(2-ethylsulfonylethyl)-2-methyl-5-nitro-imidazole,1-(2-esylethyl)-2-methyl-5-nitro-imidazole,"InChI=1S/C8H13N3O4S/c1-3-16(14,15)5-4-10-7(2)9-6-8(10)11(12)13/h6H,3-5H2,1-2H3",HJLSLZFTEKNLFI-UHFFFAOYSA-N,-0.4,247.06267708,C8H13N3O4S,247.27,106.0,247.06267708,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C,,"13  15  8
6  12  8
6  13  8
7  12  8
7  15  8",
440790620,5452,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00451,thioridazine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00451,thioridazine,5.0,Adverse reactions,vLess-DILI-Concern,2.0,5452,1.0,432.0,4.0,0.0,4.0,AAADceB7AABgAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxQAAAHAQAAAAACCjBUASywYMAAAiAACRCQACCAAAhChAIiBwIZIgIIGLg0ZGEIAxggADoyAcQgAAAAAgAACAAAQAAEAAAQAACAAAAAAAAAA==,10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine,10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)phenothiazine,10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine,10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine,10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanyl-phenothiazine,10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylthio)phenothiazine,"InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3",KLBQZWRITKRQQV-UHFFFAOYSA-N,5.9,370.15374118,C21H26N2S2,370.6,57.1,370.15374118,0.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,,"13  15  8
13  17  8
14  16  8
14  18  8
15  19  8
16  20  8
17  21  8
18  22  8
19  23  8
20  24  8
21  23  8
22  24  8
5  7  3",
440790619,5426,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00450,thalidomide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00450,thalidomide,4.0,Adverse reactions,vLess-DILI-Concern,2.0,5426,1.0,449.0,4.0,1.0,1.0,AAADccBzOAAAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgBAAAAHgAQAAAADCjBmAQwAIPAAACIAiFSEACCAAAkAAAIiAGIBMgIYDKAlTGUIQhgliCIiYcdi4COgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione","2-(2,6-dioxo-3-piperidinyl)isoindole-1,3-dione","2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione","2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione","2-[2,6-bis(oxidanylidene)piperidin-3-yl]isoindole-1,3-dione",thalidomide,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",UEJJHQNACJXSKW-UHFFFAOYSA-N,0.3,258.0640568,C13H10N2O4,258.23,83.6,258.0640568,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,,"13  14  8
13  16  8
14  17  8
16  18  8
17  19  8
18  19  8
7  5  3",
440790618,5403,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00877,terbutaline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00877,terbutaline,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5403,1.0,205.0,4.0,4.0,4.0,AAADceByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADJzhmAYyBoLAAgCAAiBCAAACAAAgIAAAiIAOCIgKNyKCkROEcAAl0BWYmAfQ8LYOAAABCAAAAAAAAAIQAAAAAAAAAAAAAA==,"5-[2-(tert-butylamino)-1-hydroxy-ethyl]benzene-1,3-diol","5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol","5-[2-(<I>tert</I>-butylamino)-1-hydroxyethyl]benzene-1,3-diol","5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol","5-[2-(tert-butylamino)-1-oxidanyl-ethyl]benzene-1,3-diol",5-[2-(tert-butylamino)-1-hydroxy-ethyl]resorcinol,"InChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3",XWTYSIMOBUGWOL-UHFFFAOYSA-N,0.9,225.13649347,C12H19NO3,225.28,72.7,225.13649347,0.0,16.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C)NCC(O)c1cc(O)cc(O)c1,,"11  12  8
11  13  8
12  15  8
13  14  8
14  16  8
15  16  8
7  20  3",
440790617,5394,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00153,temozolomide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00153,temozolomide,4.0,Adverse reactions,vLess-DILI-Concern,2.0,5394,1.0,315.0,5.0,1.0,1.0,AAADcYBjsAAAAAAAAAAAAAAAAAAAAWAAAAAgAAAAAAAAAEABgAAAHgAYAAAACAgBlgQHsBdMEACqAQdxdACAgC0XEKAHUAGoVECASAhASCAUAIAIBwJAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide","3-methyl-4-oxo-8-imidazo[5,1-d][1,2,3,5]tetrazinecarboxamide","3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide","3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide","3-methyl-4-oxidanylidene-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide","4-keto-3-methyl-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide","InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)",BPEGJWRSRHCHSN-UHFFFAOYSA-N,-1.1,194.05522346,C6H6N6O2,194.15,106.0,194.05522346,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cn1nnc2c(C(N)=O)ncn2c1=O,,"3  11  8
3  12  8
3  9  8
4  11  8
4  7  8
5  10  8
5  12  8
6  7  8
6  9  8
9  10  8",
440790616,65999,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02063,Telmisartan,20250421,20210312,Curation Efforts|Governmental Organizations,LT02063,telmisartan,3.0,Adverse reactions,vLess-DILI-Concern,2.0,65999,1.0,831.0,4.0,1.0,7.0,AAADceB/sAAAAAAAAAAAAAAAAAAAAWLAAAAwYMGAAAAAAFgB/gAAHgAACAAADAjBnwQz2LcMEgCoAybybACCgC0lEqAJ2CE4fNiIbrLAnZGUcQhswAPI2aeYyOCOyAACQAASACCQAASAACQAQAAAAAAAAA==,2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid,2-[4-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]phenyl]benzoic acid,2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid,2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid,2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid,2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid,"InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)",RMMXLENWKUUMAY-UHFFFAOYSA-N,,514.23687621,C33H30N4O2,514.6,72.9,514.23687621,0.0,39.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,6.9,"12  13  8
12  15  8
14  15  8
17  22  8
17  23  8
20  21  8
20  29  8
21  30  8
22  27  8
23  28  8
26  27  8
26  28  8
29  32  8
3  7  8
3  8  8
30  33  8
31  34  8
31  35  8
32  33  8
34  36  8
35  37  8
36  38  8
37  38  8
4  8  8
4  9  8
5  16  8
5  20  8
6  16  8
6  21  8
7  13  8
7  9  8
9  14  8",
440790615,445643,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00448,tacrolimus,20231222,20210312,Curation Efforts|Governmental Organizations,LT00448,tacrolimus,5.0,Adverse reactions,vLess-DILI-Concern,1.0,445643,1.0,1480.0,12.0,3.0,7.0,AAADcfB+PAAAAAAAAAAAAAAAAAAAAAAAAAA8SIAAAAAAAAAAAAAAHgAACAAADTzhgAYCCAMABgCIAqHSGAIAAAAgAAAICAHIAAgTFBYAoSQHUAAHpgCfIAPY7PTOAAAAAAAAAABAAAIAAACAAAAAAAAAAA==,"(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-17-allyl-1,14-dihydroxy-12-[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl]-1-methyl-vinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone","(1<I>R</I>,9<I>S</I>,12<I>S</I>,13<I>R</I>,14<I>S</I>,17<I>R</I>,18<I>E</I>,21<I>S</I>,23<I>S</I>,24<I>R</I>,25<I>S</I>,27<I>R</I>)-1,14-dihydroxy-12-[(<I>E</I>)-1-[(1<I>R</I>,3<I>R</I>,4<I>R</I>)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.0<SUP>4,9</SUP>]octacos-18-ene-2,3,10,16-tetrone","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-23,25-dimethoxy-12-[(E)-1-[(1R,3R,4R)-3-methoxy-4-oxidanyl-cyclohexyl]prop-1-en-2-yl]-13,19,21,27-tetramethyl-1,14-bis(oxidanyl)-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-17-allyl-1,14-dihydroxy-12-[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl]-1-methyl-vinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-diquinone","InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1",QJJXYPPXXYFBGM-LFZNUXCKSA-N,2.7,803.48197664,C44H69NO12,804.0,178.0,803.48197664,0.0,57.0,14.0,0.0,2.0,0.0,0.0,1.0,-1.0,"1
5
255",C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,,"42  10  6
14  58  6
15  22  6
16  2  6
21  41  6
23  36  5
19  3  5
30  79  5
33  40  5
37  48  6
18  4  6
49  54  5
27  6  5
28  8  6",
440790614,5215,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00146,sulfadiazine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00146,sulfadiazine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5215,1.0,327.0,6.0,2.0,3.0,AAADccBzsABAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHAQQQAAACAjBUgQ90ZZIEAKgADRnZHDCgDkxAqAJ2Dg4ZJiIKKLA2dGEJAhokAJIyCcQAAAAAAQAAAAAAAAACAAAAAAAAAAAAAAAAA==,4-amino-N-pyrimidin-2-yl-benzenesulfonamide,4-amino-N-(2-pyrimidinyl)benzenesulfonamide,4-amino-<I>N</I>-pyrimidin-2-ylbenzenesulfonamide,4-amino-N-pyrimidin-2-ylbenzenesulfonamide,4-azanyl-N-pyrimidin-2-yl-benzenesulfonamide,4-amino-N-(2-pyrimidyl)benzenesulfonamide,"InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)",SEEPANYCNGTZFQ-UHFFFAOYSA-N,-0.1,250.05244675,C10H10N4O2S,250.28,106.0,250.05244675,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,,"10  13  8
11  12  8
11  13  8
15  17  8
16  17  8
6  14  8
6  15  8
7  14  8
7  16  8
8  10  8
8  9  8
9  12  8",
440790613,5833,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00143,spironolactone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00143,spironolactone,2.0,Adverse reactions,vLess-DILI-Concern,1.0,5833,1.0,818.0,5.0,0.0,2.0,AAADcfB4OABAAAAAAAAAAAAAAAAAAaIAAAAwYIAAAAAAAGDAAAAAGgQAAAAAD0SEwACCCAAABAiIAqDSCAAAAAAgABAACAEAAEgAABIgAQACAAAEgAAoAQOKyPCPgAAAAAAAAACgAAUAACgAAYAADAAAAA==,"S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxo-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-tetrahydrofuran]-7-yl] ethanethioate","ethanethioic acid S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxo-7-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]yl] ester","<I>S</I>-[(7<I>R</I>,8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-10,13-dimethyl-3,5&apos;-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1<I>H</I>-cyclopenta[a]phenanthrene-17,2&apos;-oxolane]-7-yl] ethanethioate","S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate","S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-bis(oxidanylidene)spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate","ethanethioic acid S-[(7R,8R,9S,10R,13S,14S,17R)-3,5'-diketo-10,13-dimethyl-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-tetrahydrofuran]-7-yl] ester","InChI=1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1",LXMSZDCAJNLERA-ZHYRCANASA-N,2.9,416.20213067,C24H32O4S,416.6,85.7,416.20213067,0.0,29.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,,"16  1  6
10  32  6
13  22  5
9  2  5
6  17  5
7  30  6
8  31  5",
440790612,4369359,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01251,Sitagliptin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01251,sitagliptin,4.0,Adverse reactions,vLess-DILI-Concern,2.0,4369359,1.0,566.0,10.0,1.0,4.0,AAADccB7ocAAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgBwAAAHwAYAAAADCjBmxwxEIdMEACqAiNyNAASgAsgAKAVyIEYAIiIaDqA2RGUIAAgngKIiAcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one","(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)-1-butanone","(3<I>R</I>)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5<I>H</I>-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one","(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one","(3R)-3-azanyl-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-[2,4,5-tris(fluoranyl)phenyl]butan-1-one","(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one","InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1",MFFMDFFZMYYVKS-SECBINFHSA-N,,407.11807909,C16H15F6N5O,407.31,77.0,407.11807909,0.0,28.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,0.7,"10  12  8
10  16  8
18  11  6
12  21  8
22  24  8
22  25  8
24  27  8
25  26  8
26  28  8
27  28  8
9  16  8
9  21  8",
440790611,21944094,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00443,Sirolimus,20231222,20210312,Curation Efforts|Governmental Organizations,LT00443,sirolimus,8.0,Adverse reactions,vLess-DILI-Concern,2.0,21944094,1.0,1760.0,13.0,3.0,6.0,AAADcfB+PAAAAAAAAAAAAAAAAAAAAAAAAAA8SIAAAAAAAAAAAAAAHgAACAAADTzhgAYCCAMABgCIAqHSGAIAAAAgAAAICAHIAAgbFBYAoSQHUAAH5gCfsAOY6PSOAAAAAAAAAABAAAIAAACAAAAAAAAAAA==,"(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl]-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","(1<I>R</I>,9<I>S</I>,12<I>S</I>,15<I>R</I>,16<I>E</I>,18<I>R</I>,19<I>R</I>,21<I>R</I>,23<I>S</I>,24<I>Z</I>,26<I>E</I>,28<I>E</I>,30<I>S</I>,32<I>S</I>,35<I>R</I>)-1,18-dihydroxy-12-[(2<I>R</I>)-1-[(1<I>S</I>,3<I>R</I>,4<I>R</I>)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0<SUP>4,9</SUP>]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-19,30-dimethoxy-12-[(2R)-1-[(1S,3R,4R)-3-methoxy-4-oxidanyl-cyclohexyl]propan-2-yl]-15,17,21,23,29,35-hexamethyl-1,18-bis(oxidanyl)-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl]-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12-,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1",QFJCIRLUMZQUOT-KADBNGAOSA-N,,913.55514157,C51H79NO13,914.2,195.0,913.55514157,0.0,65.0,15.0,0.0,4.0,0.0,0.0,1.0,-1.0,"1
5
255",CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(/C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C\C=C\1C,6.0,"19  1  6
49  11  5
52  12  6
15  18  6
21  2  5
22  24  6
23  78  5
26  42  6
27  86  5
29  87  6
43  45  5
28  5  6
55  60  5
59  63  6
44  9  5",
440790610,135398744,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01033,sildenafil,20231222,20210312,Curation Efforts|Governmental Organizations,LT01033,sildenafil,3.0,Adverse reactions,vLess-DILI-Concern,2.0,135398744,1.0,838.0,8.0,1.0,7.0,AAADceB7uABAAAAAAAAAAAAAAAAAAWAAAAA8QIAAAAAAAEABwAAAHgQYQAAADAzh3gYzx5PIBAKqAydydHDSDBEnsAAZ2Dm+XNgMZrrE/fuWvajmzBHI6UecyCCOAIAAgAAIAAABAAEAABAAAAAAAAAAAA==,"5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one","5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one","5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6<I>H</I>-pyrazolo[4,3-d]pyrimidin-7-one","5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one","5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one","5-[2-ethoxy-5-(4-methylpiperazino)sulfonyl-phenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one","InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)",BNRNXUUZRGQAQC-UHFFFAOYSA-N,,474.20492463,C22H30N6O4S,474.6,118.0,474.20492463,0.0,33.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,1.5,"10  22  8
10  24  8
11  26  8
16  18  8
16  20  8
18  19  8
19  21  8
20  23  8
21  23  8
24  25  8
24  26  8
25  28  8
8  22  8
8  28  8
9  11  8
9  25  8",
440790609,5210,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00988,sibutramine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00988,sibutramine,4.0,Adverse reactions,vLess-DILI-Concern,2.0,5210,1.0,275.0,1.0,0.0,5.0,AAADceB6AAAEAAAAAAAAAAAAAABgAAAAAAAwAAAAAAAAAAABAAAAHAIAAAAADyrBGCQyAIMAAACAAiBCAAACAAAgBQAIiAAIAogIICKBkxGEIAAggAAIiAcQgMAPhAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,"1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethyl-butan-1-amine","1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethyl-1-butanamine","1-[1-(4-chlorophenyl)cyclobutyl]-<I>N</I>,<I>N</I>,3-trimethylbutan-1-amine","1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine","1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethyl-butan-1-amine",[1-[1-(4-chlorophenyl)cyclobutyl]-3-methyl-butyl]-dimethyl-amine,"InChI=1S/C17H26ClN/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14/h6-9,13,16H,5,10-12H2,1-4H3",UNAANXDKBXWMLN-UHFFFAOYSA-N,,279.1753775,C17H26ClN,279.8,3.2,279.1753775,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1,5.4,"11  17  8
12  18  8
17  19  8
18  19  8
6  24  3
8  11  8
8  12  8",
440790608,68617,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00625,sertraline,20210312,20210312,Curation Efforts|Governmental Organizations,LT00625,sertraline,3.0,Adverse reactions,vLess-DILI-Concern,1.0,68617,1.0,322.0,1.0,1.0,2.0,AAADceB6AAAGAAAAAAAAAAAAAAAAAAAAAAAwYMAAAAAAAADBQAAAHAIQAAAADSrBGCQyAILAAACAAiBCAACCAAAgBQAIisAIBogIICKBkxGEIAhgkAAIiAcQgMAOhAAAIAAQAAQYAATAACQACAAAAAAAAA==,"(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-tetralin-1-amine","(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine","(1<I>S</I>,4<I>S</I>)-4-(3,4-dichlorophenyl)-<I>N</I>-methyl-1,2,3,4-tetrahydronaphthalen-1-amine","(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine","(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine","[(1S,4S)-4-(3,4-dichlorophenyl)tetralin-1-yl]-methyl-amine","InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1",VGKDLMBJGBXTGI-SJCJKPOMSA-N,,305.0738049,C17H17Cl2N,306.2,12.0,305.0738049,0.0,20.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,4.8,"10  13  8
10  14  8
11  15  8
12  16  8
13  18  8
14  19  8
15  16  8
18  20  8
19  20  8
6  3  6
4  10  6
8  11  8
8  9  8
9  12  8",
440790607,5095,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00990,ropinirole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00990,ropinirole,4.0,Adverse reactions,vLess-DILI-Concern,2.0,5095,1.0,286.0,2.0,1.0,7.0,AAADceB7IAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgBAAAAHgAQAAAADAjBmAQywIPAAACIAiVSUACCAAAhAgAIiAEIZIgIIDLAlZGEIAhglADIyAcciICOgAAAQAASAAAAAACAACQAAAAAAAAAAA==,4-[2-(dipropylamino)ethyl]indolin-2-one,"4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one","4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one","4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one","4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one",4-[2-(dipropylamino)ethyl]oxindole,"InChI=1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19)",UHSKFQJFRQCDBE-UHFFFAOYSA-N,2.7,260.188863393,C16H24N2O,260.37,32.3,260.188863393,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCN(CCC)CCc1cccc2c1CC(=O)N2,,"11  16  8
14  17  8
16  17  8
6  14  8
6  9  8
9  11  8",
440790606,77991,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01016,rivastigmine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01016,rivastigmine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,77991,1.0,269.0,3.0,0.0,5.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAAAAAADCzBmAQyDoMABACIAiBCGACCCAAgIAAIiAAODIgMJiKEsRuMMihkxhEIqAewwLAOAAABAAAAAAAAAAIAAAAAAAAAAAAAAA==,[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methyl-carbamate,N-ethyl-N-methylcarbamic acid [3-[(1S)-1-(dimethylamino)ethyl]phenyl] ester,[3-[(1<I>S</I>)-1-(dimethylamino)ethyl]phenyl] <I>N</I>-ethyl-<I>N</I>-methylcarbamate,[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate,[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methyl-carbamate,N-ethyl-N-methyl-carbamic acid [3-[(1S)-1-(dimethylamino)ethyl]phenyl] ester,"InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1",XSVMFMHYUFZWBK-NSHDSACASA-N,,250.168127949,C14H22N2O2,250.34,32.8,250.168127949,0.0,18.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,2.3,"12  14  8
13  14  8
5  3  6
6  8  8
6  9  8
8  12  8
9  13  8",
440790605,5073,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01735,risperidone,20210804,20210312,Curation Efforts|Governmental Organizations,LT01735,risperidone,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5073,1.0,731.0,6.0,0.0,4.0,AAADceB7sQAAAAAAAAAAAAAAAAAAAWAAAAA8WIEAAAAAAFiB8AAAHwAEAAAADQzBngwzhtMQAACpA6dydgCCAAEkIAApmCE+TNoIJrqAnZOEMYBmxhmIycecyOCOAAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,"3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","3-[2-[4-(6-fluoroindoxazen-3-yl)piperidino]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3",RAPZEAPATHNIPO-UHFFFAOYSA-N,,410.21180428,C23H27FN4O2,410.5,61.9,410.21180428,0.0,30.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,2.7,"14  17  8
16  23  8
16  24  8
17  25  8
17  26  8
2  25  8
2  6  8
25  28  8
26  29  8
28  30  8
29  30  8
5  20  8
5  23  8
6  14  8
7  20  8
7  24  8",
440790604,135415564,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00139,RIFABUTIN,20210312,20210312,Curation Efforts|Governmental Organizations,LT00139,rifabutin,5.0,Adverse reactions,vLess-DILI-Concern,2.0,135415564,1.0,1880.0,14.0,5.0,5.0,AAADcfB/vAAAAAAAAAAAAAAAAAAAASIAAAA8QIAAAAAAAEABAAAAHgAQCAAADRzhmAYDDoPABgCoA6XyXAKCCAAkIAAIiAFsCNgcNzaG9R6meWCl5BWMuYfY7PzO4AADCAAYAADAAAYQADAAAAAAAAAAAA==,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-1'-isobutyl-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-spiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4'-piperidine]-13-yl] acetate","acetic acid [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxo-13-spiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4'-piperidine]yl] ester","[(7<I>S</I>,9<I>E</I>,11<I>S</I>,12<I>R</I>,13<I>S</I>,14<I>R</I>,15<I>R</I>,16<I>R</I>,17<I>S</I>,18<I>S</I>,19<I>E</I>,21<I>Z</I>)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1&apos;-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.1<SUP>4,7</SUP>.0<SUP>5,31</SUP>.0<SUP>26,30</SUP>]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4&apos;-piperidine]-13-yl] acetate","[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4'-piperidine]-13-yl] acetate","[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-2,15,17,32-tetrakis(oxidanyl)-6,23-bis(oxidanylidene)spiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4'-piperidine]-13-yl] ethanoate","acetic acid [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-1'-isobutyl-6,23-diketo-11-methoxy-3,7,12,14,16,18,22-heptamethyl-spiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4'-piperidine]-13-yl] ester","InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,52-55H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1",AZFBLLCNOQPJGJ-VXTBVIBXSA-N,,846.44150881,C46H62N4O11,847.0,209.0,846.44150881,0.0,61.0,9.0,0.0,3.0,0.0,0.0,1.0,-1.0,"1
5
255",CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(c4c3C2=O)=NC2(CCN(CC(C)C)CC2)N=5)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,5.6,"23  1  5
22  2  6
21  32  5
24  35  6
25  39  6
27  29  8
27  30  8
29  36  8
28  3  5
30  37  8
30  38  8
34  49  6
36  40  8
37  40  8
37  46  8
38  41  8
41  47  8
42  51  5
46  47  8
33  5  6",
440790603,65981,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01002,Repaglinide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01002,repaglinide,5.0,Adverse reactions,vLess-DILI-Concern,2.0,65981,1.0,619.0,5.0,2.0,10.0,AAADcfB7OAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABQAAAHgAQCAAADSzhmAYyzoPABgCIAiXSWACCCAAlIgAIiIEObMgMJzbE9ZuGeWjl9hHI+YeY3PLOQAABAAAKAACAAAIAABQAAAAAAAAAAA==,2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidyl)phenyl]butyl]amino]-2-oxo-ethyl]benzoic acid,2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid,2-ethoxy-4-[2-[[(1<I>S</I>)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid,2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid,2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxidanylidene-ethyl]benzoic acid,2-ethoxy-4-[2-keto-2-[[(1S)-3-methyl-1-(2-piperidinophenyl)butyl]amino]ethyl]benzoic acid,"InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1",FAEKWTJYAYMJKF-QHCPKHFHSA-N,,452.26750763,C27H36N2O4,452.6,78.9,452.26750763,0.0,33.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,5.2,"13  14  8
13  17  8
14  18  8
17  21  8
18  22  8
21  22  8
25  26  8
25  27  8
26  28  8
27  29  8
28  30  8
29  30  8
12  6  5",
440790602,60815,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00987,REMIFENTANIL,20250421,20210312,Curation Efforts|Governmental Organizations,LT00987,remifentanil,3.0,Adverse reactions,vLess-DILI-Concern,2.0,60815,1.0,522.0,6.0,0.0,9.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHgAAAAAADIjBkAYyyIMABACIACXSWACCAAAhAgAIiAGIZIgKIDrA0bGFIAhmhADYyAc0AAAKAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,methyl 1-(3-methoxy-3-oxo-propyl)-4-(N-propanoylanilino)piperidine-4-carboxylate,1-(3-methoxy-3-oxopropyl)-4-[N-(1-oxopropyl)anilino]-4-piperidinecarboxylic acid methyl ester,methyl 1-(3-methoxy-3-oxopropyl)-4-(<I>N</I>-propanoylanilino)piperidine-4-carboxylate,methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate,methyl 1-(3-methoxy-3-oxidanylidene-propyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate,1-(3-keto-3-methoxy-propyl)-4-(N-propionylanilino)isonipecotic acid methyl ester,"InChI=1S/C20H28N2O5/c1-4-17(23)22(16-8-6-5-7-9-16)20(19(25)27-3)11-14-21(15-12-20)13-10-18(24)26-2/h5-9H,4,10-15H2,1-3H3",ZTVQQQVZCWLTDF-UHFFFAOYSA-N,,376.199822,C20H28N2O5,376.4,76.2,376.199822,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,1.9,"15  19  8
15  20  8
19  24  8
20  25  8
24  26  8
25  26  8",
440790601,3001055,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00138,ranitidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00138,ranitidine,5.0,Adverse reactions,vLess-DILI-Concern,1.0,3001055,1.0,347.0,7.0,2.0,9.0,AAADceBzsABAAAAAAAAAAAAAAAAAASAAAAAAAAAAAAAAAAABgAAAHgQUAAAACATF0ASzBIPQREiJAKBWQwCCCAAkIhAIiIGODMiOJjKktTuHGSjs0BM4qYeYEQIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine","(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine","(<I>E</I>)-1-<I>N</I>&apos;-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-<I>N</I>-methyl-2-nitroethene-1,1-diamine","(E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine","(E)-N1'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine",dimethyl-[[5-[[2-[[(E)-1-(methylamino)-2-nitro-vinyl]amino]ethylthio]methyl]-2-furyl]methyl]amine,"InChI=1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+",VMXUWOKSQNHOCA-UKTHLTGXSA-N,0.3,314.14126175,C13H22N4O3S,314.41,112.0,314.14126175,0.0,21.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CN/C(=C\[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,,"10  13  8
11  14  8
13  14  8
2  10  8
2  11  8",
440790600,5362129,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01726,ramipril,20210312,20210312,Curation Efforts|Governmental Organizations,LT01726,ramipril,7.0,Adverse reactions,vLess-DILI-Concern,2.0,5362129,1.0,619.0,6.0,2.0,10.0,AAADcfB7OAAAAAAAAAAAAAAAAAAAAeIAAAAwAAAAAAAWAAABAAAAHgAQCAAADSjhmAYyCIPABgCIAiHSGAACAAAgAAAIiIGIAIgKYDKAkTCXYAAklgCYiAeY2bOeAAAAAAAAAAAAAAAAAAAAAAAAAQAAAA==,"(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid","(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid","(2<I>S</I>,3<I>a</I><I>S</I>,6<I>a</I><I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3<I>a</I>,4,5,6,6<I>a</I>-hexahydro-2<I>H</I>-cyclopenta[b]pyrrole-2-carboxylic acid","(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid","(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid","(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-carbethoxy-3-phenyl-propyl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid","InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1",HDACQVRGBOVJII-JBDAPHQKSA-N,1.4,416.23112213,C23H32N2O5,416.5,95.9,416.23112213,0.0,30.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,,"13  16  5
23  24  8
23  25  8
24  27  8
25  28  8
27  30  8
28  30  8
17  7  5
19  7  6
8  31  6
9  32  6",
440790599,5029,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00264,rabeprazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00264,rabeprazole,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5029,1.0,440.0,6.0,1.0,8.0,AAADceB7MABAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgB/AAAHgQQAAAADAzl3ga/1rbJlAqgAzRnZEDK2i3xMrAJ2SA+fJiMbuLkuZuWOCjvkBrI6CcQAAAOAAAAAAAAACAAAAAAAAAAQAAAAAAAAA==,2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]-1H-benzimidazole,2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]-1H-benzimidazole,2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1<I>H</I>-benzimidazole,2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole,2-[[4-(3-methoxypropoxy)-3-methyl-pyridin-2-yl]methylsulfinyl]-1H-benzimidazole,2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]-1H-benzimidazole,"InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)",YREYEVIYCVEVJK-UHFFFAOYSA-N,1.9,359.13036271,C18H21N3O3S,359.4,96.3,359.13036271,0.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C,,"1  8  3
10  11  8
11  18  8
13  16  8
13  20  8
16  22  8
18  21  8
20  23  8
22  24  8
23  24  8
5  12  8
5  13  8
6  12  8
6  16  8
7  21  8
7  9  8
9  10  8",
440790598,441074,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01725,quinidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01725,quinidine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,441074,1.0,457.0,4.0,1.0,4.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAAAAAAA8WLFiAAAAAACx8AAAHgAACAAADTzhngY+xvMIFgCgAzRnRACCiCAxIiAI2CA+bJgONuLEsZuEcChkwBHY+Aew4PwOgEABAAACAAAAgAIAAAQAAAAAAAAAAA==,"(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol","(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxy-4-quinolinyl)methanol","(<I>S</I>)-[(2<I>R</I>,4<I>S</I>,5<I>R</I>)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol","(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol","(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol","(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol","InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19+,20-/m0/s1",LOUPRKONTZGTKE-LHHVKLHASA-N,2.9,324.183778013,C20H24N2O2,324.4,45.6,324.183778013,0.0,24.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,,"12  1  6
14  16  8
14  17  8
16  18  8
16  19  8
17  20  8
18  21  8
19  22  8
21  23  8
22  23  8
4  18  8
4  20  8
5  25  5
6  26  5
8  13  5",
440790597,54892,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01723,quinapril,20210312,20210312,Curation Efforts|Governmental Organizations,LT01723,quinapril,3.0,Adverse reactions,vLess-DILI-Concern,2.0,54892,1.0,648.0,6.0,2.0,10.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACxQAAAHgAQCAAADCjhmAYyCIPABgCIAiHSGACCAAAgAAAIiIGIBIgKYDKAkTGXYAhklgCYiAeYyLCOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid","(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid","(3<I>S</I>)-2-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1<I>H</I>-isoquinoline-3-carboxylic acid","(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid","(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid","(3S)-2-[(2S)-2-[[(1S)-1-carbethoxy-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid","InChI=1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1",JSDRRTOADPPCHY-HSQYWUDLSA-N,,438.21547206,C25H30N2O5,438.5,95.9,438.21547206,0.0,32.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,1.2,"11  12  8
11  18  8
12  19  8
18  22  8
19  23  8
22  23  8
25  26  8
25  27  8
26  29  8
27  30  8
29  31  8
30  31  8
13  7  5
15  7  6
8  16  5",
440790596,10100,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00083,propoxyphene,20250421,20210312,Curation Efforts|Governmental Organizations,LT00083,propoxyphene,3.0,Adverse reactions,vLess-DILI-Concern,2.0,10100,1.0,397.0,3.0,0.0,9.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAAAAAADUTBmAQyCIMABACIAiDSCAACAAAgAAAIiAEICIgIJiKAsRiGMAAmwAEIqAeQwOAOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate","propanoic acid [(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] ester","[(2<I>S</I>,3<I>R</I>)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate","[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate","[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenyl-butan-2-yl] propanoate","propionic acid [(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] ester","InChI=1S/C22H29NO2/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19/h6-15,18H,5,16-17H2,1-4H3/t18-,22+/m1/s1",XLMALTXPSGQGBX-GCJKJVERSA-N,4.2,339.219829168,C22H29NO2,339.5,29.5,339.219829168,0.0,25.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C,,"4  1  6
10  16  8
10  17  8
11  18  8
12  19  8
16  22  8
17  23  8
18  21  8
19  21  8
22  24  8
23  24  8
5  9  5
8  11  8
8  12  8",
440790595,4943,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01708,propofol,20250421,20210312,Curation Efforts|Governmental Organizations,LT01708,propofol,3.0,Adverse reactions,vLess-DILI-Concern,2.0,4943,1.0,135.0,1.0,1.0,2.0,AAADceBwIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgAACAAADQSAmAAyBoAAAgCAAiBCAAACAAAgIAAIiAAECIgIJiKCERKAcAAkwBEImAeAwOAOgAACAAAIAAAAAAQAABAAAAAAAAAAAA==,"2,6-diisopropylphenol","2,6-di(propan-2-yl)phenol","2,6-di(propan-2-yl)phenol","2,6-di(propan-2-yl)phenol","2,6-di(propan-2-yl)phenol","2,6-diisopropylphenol","InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3",OLBCVFGFOZPWHH-UHFFFAOYSA-N,3.8,178.135765193,C12H18O,178.27,20.2,178.135765193,0.0,13.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)c1cccc(C(C)C)c1O,,"4  6  8
4  7  8
5  6  8
5  8  8
7  13  8
8  13  8",
440790594,4932,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01705,propafenone,20210312,20210312,Curation Efforts|Governmental Organizations,LT01705,propafenone,3.0,Adverse reactions,vLess-DILI-Concern,2.0,4932,1.0,368.0,4.0,2.0,11.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAQCAAADBThmAYyBoLABgCIAqBSAAACCAAkIAAIiIEOCMgPNjaENRqGOWCm8BGbqYeIyOCOAAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one,1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-1-propanone,1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one,1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one,1-[2-[2-oxidanyl-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one,1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one,"InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3",JWHAUXFOSRPERK-UHFFFAOYSA-N,,341.19909372,C21H27NO3,341.4,58.6,341.19909372,0.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,3.3,"12  13  8
12  16  8
13  17  8
15  20  8
15  21  8
16  19  8
17  22  8
19  22  8
5  2  3
20  23  8
21  24  8
23  25  8
24  25  8",
440790593,4927,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00205,promethazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00205,promethazine,5.0,Adverse reactions,vLess-DILI-Concern,2.0,4927,1.0,298.0,3.0,0.0,3.0,AAADceB7AABAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACxQAAAHAQAAAAACCjBUAQywYMAAAiAACRCQACCAAAhChAIiBwIZIgIYGLgkZGUIAhggADoyAcQAAAAAAAAAAAAAQAAAAAAAAACAAAAAAAAAA==,"N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine","N,N-dimethyl-1-(10-phenothiazinyl)-2-propanamine","<I>N</I>,<I>N</I>-dimethyl-1-phenothiazin-10-ylpropan-2-amine","N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine","N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine",dimethyl-(1-methyl-2-phenothiazin-10-yl-ethyl)amine,"InChI=1S/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3",PWWVAXIEGOYWEE-UHFFFAOYSA-N,4.8,284.13471982,C17H20N2S,284.4,31.8,284.13471982,0.0,20.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(CN1c2ccccc2Sc2ccccc21)N(C)C,,"10  16  8
13  17  8
14  18  8
15  19  8
16  20  8
17  19  8
18  20  8
4  8  3
6  13  8
6  9  8
7  10  8
7  14  8
9  15  8",
440790592,5994,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00192,progesterone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00192,progesterone,2.0,Adverse reactions,vLess-DILI-Concern,2.0,5994,1.0,589.0,2.0,0.0,1.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAAAAAADwSAgAACAAAAAACIAqBSAAAAAAAgAAAACAEAAEgAABIAAQAAAAAAgAAIAQMIiMCPgAAAAAAAAACAAAQAACAAAQAACAAAAA==,"(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","(8<I>S</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","(8S,9S,10R,13S,14S,17S)-17-ethanoyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1",RJKFOVLPORLFTN-LEKSSAKUSA-N,3.9,314.224580195,C21H30O2,314.5,34.1,314.224580195,0.0,23.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,,"3  24  6
4  15  5
5  25  5
6  26  6
7  18  5
8  19  5",
440790591,4917,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00437,prochlorperazine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00437,prochlorperazine,2.0,Adverse reactions,vLess-DILI-Concern,2.0,4917,1.0,429.0,4.0,0.0,4.0,AAADceB7AABEAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxQAAAHAYAAAAACArBUCQywYMAAAiAACRCQACCAAAhDxAIiBwIZogIYGLh05GUIAhggADoyAcQAAAAAAIAAAIAAQAABAAABAACAAAAAAAAAA==,2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine,2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine,2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine,2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine,2-chloranyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine,2-chloro-10-[3-(4-methylpiperazino)propyl]phenothiazine,"InChI=1S/C20H24ClN3S/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24/h2-3,5-8,15H,4,9-14H2,1H3",WIKYUJGCLQQFNW-UHFFFAOYSA-N,4.9,373.1379466,C20H24ClN3S,373.9,35.0,373.1379466,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,,"14  16  8
14  18  8
15  17  8
15  19  8
16  20  8
17  21  8
18  22  8
19  23  8
20  24  8
21  25  8
22  24  8
23  25  8",
440790590,4913,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01699,PROCAINAMIDE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01699,procainamide,4.0,Adverse reactions,vLess-DILI-Concern,2.0,4913,1.0,221.0,3.0,2.0,6.0,AAADceBzIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQAAAADAjBmAQywIPAAACIAiVSUACCAAAkAgAIiIEIZMgIYDKAlZGUIQhglgCIyYcYiQCeCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,4-amino-N-[2-(diethylamino)ethyl]benzamide,4-amino-N-[2-(diethylamino)ethyl]benzamide,4-amino-<I>N</I>-[2-(diethylamino)ethyl]benzamide,4-amino-N-[2-(diethylamino)ethyl]benzamide,4-azanyl-N-[2-(diethylamino)ethyl]benzamide,4-amino-N-[2-(diethylamino)ethyl]benzamide,"InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)",REQCZEXYDRLIBE-UHFFFAOYSA-N,0.9,235.168462302,C13H21N3O,235.33,58.4,235.168462302,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)CCNC(=O)c1ccc(N)cc1,,"12  13  8
12  14  8
13  15  8
14  16  8
15  17  8
16  17  8",
440790589,5865,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00180,prednisone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00180,prednisone,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5865,1.0,764.0,5.0,2.0,2.0,AAADceB4OAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAAD0SggAICAAAAAgCIAqBSAAIAAAAgAAAICAFAAEgAEBIAAQAAQAAFgAAIAYOKyvCvgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione","(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione","(8<I>S</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione","(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione","(8S,9S,10R,13S,14S,17R)-10,13-dimethyl-17-oxidanyl-17-(2-oxidanylethanoyl)-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione","(8S,9S,10R,13S,14S,17R)-17-glycoloyl-17-hydroxy-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-quinone","InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.5,358.17802393,C21H26O5,358.4,91.7,358.17802393,0.0,26.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,,"10  1  6
14  21  5
6  17  5
7  27  6
8  28  5
9  29  6",
440790588,5755,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00612,prednisolone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00612,prednisolone,3.0,Adverse reactions,vLess-DILI-Concern,1.0,5755,1.0,724.0,5.0,3.0,2.0,AAADceB4OAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAAD1SggAICAAAAAgCIAqBSAAIAAAAgAAAICAFAAEgAEBIAAQAAQAAFgAAIAYPIzPDPgAAAAAAAAADAAAYAADAAAYAADAAAAA==,"(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","(8<I>S</I>,9<I>S</I>,10<I>R</I>,11<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6<I>H</I>-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11,17-bis(oxidanyl)-17-(2-oxidanylethanoyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","(8S,9S,10R,11S,13S,14S,17R)-17-glycoloyl-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",OIGNJSKKLXVSLS-VWUMJDOOSA-N,1.6,360.19367399,C21H28O5,360.4,94.8,360.19367399,0.0,26.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,,"10  1  6
14  21  5
13  2  5
6  17  5
7  27  6
8  28  5
9  29  6",
440790587,3675,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01657,Phenelzine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01657,phenelzine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,3675,1.0,77.3,2.0,2.0,3.0,AAADccBzAAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHAAYAAAADADBGAQwAIBiAACAAiBCAAACAAAgAAIYqIAAAIgIICKAkRGAIAAgkAAIiAcQgIAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-phenylethylhydrazine,2-phenylethylhydrazine,2-phenylethylhydrazine,2-phenylethylhydrazine,2-phenylethyldiazane,phenethylhydrazine,"InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2",RMUCZJUITONUFY-UHFFFAOYSA-N,1.2,136.100048391,C8H12N2,136.19,38.1,136.100048391,0.0,10.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NNCCc1ccccc1,,"4  6  8
4  7  8
6  8  8
7  9  8
8  10  8
9  10  8",
440790586,5904,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01646,penicillin g,20231222,20210312,Curation Efforts|Governmental Organizations,LT01646,penicillin g,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5904,1.0,530.0,5.0,2.0,4.0,AAADceB7OABAAAAAAAAAAAAAAABYAWAAAAAwAAAABYAAAAABAAAAHgQQCAAADCjF2ASyCIPAAgiIAiHSGAACAABgABAIiIGIAIgKYDqglTGUYAAklgC4iAcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(1-oxo-2-phenylethyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2<I>S</I>,5<I>R</I>,6<I>R</I>)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-3,3-dimethyl-7-oxidanylidene-6-(2-phenylethanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-7-keto-3,3-dimethyl-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",JGSARLDLIJGVTE-MBNYWOFBSA-N,1.8,334.09872823,C16H18N2O4S,334.4,112.0,334.09872823,0.0,23.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,,"10  15  6
18  19  8
18  20  8
19  21  8
20  22  8
21  23  8
22  23  8
11  7  5
8  24  6",
440790585,436058,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01322,Pegaspargase,20210312,20210312,Curation Efforts|Governmental Organizations,LT01322,pegaspargase,3.0,Adverse reactions,vLess-DILI-Concern,2.0,436058,1.0,270.0,2.0,0.0,4.0,AAADceByIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAAAAAADATBmAQyAIMAAACIAqBSAACCAAAkAAAIiAEIAMgIIDqAlRCEIQAggAAIiYcYiMCOwAACAAAQAACAAAQAACAAAAAAAAAAAA==,"2-[(dimethylamino)methyl]-1-(2,4-dimethylphenyl)prop-2-en-1-one","2-[(dimethylamino)methyl]-1-(2,4-dimethylphenyl)-2-propen-1-one","2-[(dimethylamino)methyl]-1-(2,4-dimethylphenyl)prop-2-en-1-one","2-[(dimethylamino)methyl]-1-(2,4-dimethylphenyl)prop-2-en-1-one","2-[(dimethylamino)methyl]-1-(2,4-dimethylphenyl)prop-2-en-1-one","2-[(dimethylamino)methyl]-1-(2,4-dimethylphenyl)prop-2-en-1-one","InChI=1S/C14H19NO/c1-10-6-7-13(11(2)8-10)14(16)12(3)9-15(4)5/h6-8H,3,9H2,1-2,4-5H3",QXLQZLBNPTZMRK-UHFFFAOYSA-N,,217.14666423,C14H19NO,217.31,20.3,217.14666423,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=C(CN(C)C)C(=O)c1ccc(C)cc1C,2.8,"10  11  8
3  10  8
3  5  8
5  9  8
8  11  8
8  9  8",
440790584,43815,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00128,paroxetine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00128,paroxetine,8.0,Adverse reactions,vLess-DILI-Concern,1.0,43815,1.0,402.0,5.0,1.0,4.0,AAADceB6MQAAAAAAAAAAAAAAAAAAASAAAAA8YIAAAAAAAEgBQAAAHwAQAAAADQThmA8wDoLABACAAiBCAAACCAAgIAAIiIAOiIgdJyKEsRqmOCKn0BWOqAfQ8O4OgQAACAAAQAACAAAQAACAAAAAAAAAAA==,"(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine","(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine","(3<I>S</I>,4<I>R</I>)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine","(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine","(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine","(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine","InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1",AHOUBRCZNHFOSL-YOEHRIQHSA-N,,329.14272166,C19H20FNO3,329.4,39.7,329.14272166,0.0,24.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,3.5,"12  13  8
12  14  8
13  15  8
14  16  8
15  18  8
16  18  8
17  19  8
17  20  8
19  21  8
20  23  8
21  22  8
22  23  8
6  12  6
7  11  5",
440790583,4679,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00606,pantoprazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00606,pantoprazole,3.0,Adverse reactions,vLess-DILI-Concern,2.0,4679,1.0,490.0,9.0,1.0,7.0,AAADccB7OYBAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgB/AAAHwQQAAAACAzF1ha/1rbJlAqgATRnZETK2i3xcrAJ2SA//JiPbuLkuZuVMCpu0Bva6CewUAMAAEAAAgAAACAAgAAEAAAAQAAAAAAAAA==,"6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole","6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole","6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1<I>H</I>-benzimidazole","6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole","6-[bis(fluoranyl)methoxy]-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole","6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole","InChI=1S/C16H15F2N3O4S/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21)",IQPSEEYGBUAQFF-UHFFFAOYSA-N,,383.07513347,C16H15F2N3O4S,383.4,106.0,383.07513347,0.0,26.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,2.4,"1  14  3
10  15  8
10  23  8
11  13  8
11  16  8
13  17  8
15  18  8
16  19  8
17  20  8
18  21  8
19  20  8
21  22  8
22  23  8
8  11  8
8  12  8
9  12  8
9  13  8",
440790582,36314,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00430,paclitaxel,20210804,20210312,Curation Efforts|Governmental Organizations,LT00430,paclitaxel,4.0,Adverse reactions,vLess-DILI-Concern,2.0,36314,1.0,1790.0,14.0,4.0,14.0,AAADcfB+PAAAAAAAAAAAAAAAAABIAAAAAAAwYMGCAAAaIACBUAAAHgAQCAAAD3zhmAYyCILABgCIAqHSGAKCAAAkAAAIiIFIDMgLNj6AtR2GcQhn9gGbqYfa7PzPgAAAAAAAAABCAAYQADCAAAAAAAAAAA==,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetoxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenyl-propanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate","benzoic acid [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-1-oxo-3-phenylpropoxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] ester","[(1<I>S</I>,2<I>S</I>,3<I>R</I>,4<I>S</I>,7<I>R</I>,9<I>S</I>,10<I>S</I>,12<I>R</I>,15<I>S</I>)-4,12-diacetyloxy-15-[(2<I>R</I>,3<I>S</I>)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0<SUP>3,10</SUP>.0<SUP>4,7</SUP>]heptadec-13-en-2-yl] benzoate","[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate","[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-oxidanyl-3-phenyl-propanoyl]oxy-10,14,17,17-tetramethyl-1,9-bis(oxidanyl)-11-oxidanylidene-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate","benzoic acid [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetoxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenyl-propanoyl]oxy-1,9-dihydroxy-11-keto-10,14,17,17-tetramethyl-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] ester","InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1",RCINICONZNJXQF-MZXODVADSA-N,2.5,853.3309553,C47H51NO14,853.9,221.0,853.3309553,0.0,62.0,11.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,,"42  13  5
46  15  5
16  63  5
18  29  6
19  64  5
17  2  5
20  3  5
21  4  6
41  44  8
41  45  8
44  47  8
45  48  8
47  49  8
48  49  8
22  5  6
50  51  8
50  52  8
51  54  8
52  55  8
54  57  8
55  57  8
56  58  8
56  59  8
58  60  8
59  61  8
30  6  6
60  62  8
61  62  8
31  8  5",
440790581,4595,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01619,ondansetron,20210312,20210312,Curation Efforts|Governmental Organizations,LT01619,ondansetron,7.0,Adverse reactions,vLess-DILI-Concern,2.0,4595,1.0,440.0,2.0,0.0,2.0,AAADceB7IAAAAAAAAAAAAAAAAAAAAWLAAAAwYAAAAAAAAFgB/AAAHgAAAAAADQzBnwQ/0PcMEACoA7Z3ZACCgC01EqAJ2CE4dNiIaPrAnZGUIYhogALIyWccicCegAAAAAACAAAQAAQAAAQAAAAAAAAAAA==,"9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one","9-methyl-3-[(2-methyl-1-imidazolyl)methyl]-2,3-dihydro-1H-carbazol-4-one","9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1<I>H</I>-carbazol-4-one","9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one","9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one","9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one","InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3",FELGMEQIXOGIFQ-UHFFFAOYSA-N,,293.152812238,C18H19N3O,293.4,39.8,293.152812238,0.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,2.3,"12  13  8
12  15  8
13  16  8
15  19  8
16  20  8
18  21  8
19  20  8
2  13  8
2  8  8
3  17  8
3  18  8
4  17  8
4  21  8
5  11  3
8  9  8
9  12  8",
440790580,4594,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00206,omeprazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00206,omeprazole,4.0,Adverse reactions,vLess-DILI-Concern,2.0,4594,1.0,453.0,6.0,1.0,5.0,AAADceB7MABAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgB/AAAHgQQAAAADAzF3ga/1rbJlAqgAzRnZEDK2i3xMrAJ2SA+fJiMbuLkuZuUMChu0BvI6CewUAMOAEAAAgAAACAAgAAEAAAAQAAAAAAAAA==,"6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole","6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole","6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1<I>H</I>-benzimidazole","6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole","6-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-1H-benzimidazole","6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole","InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",SUBDBMMJDZJVOS-UHFFFAOYSA-N,2.2,345.11471265,C17H19N3O3S,345.4,96.3,345.11471265,0.0,24.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,,"1  8  3
10  13  8
12  14  8
12  17  8
13  15  8
14  19  8
15  18  8
17  20  8
19  21  8
20  21  8
5  11  8
5  12  8
6  11  8
6  14  8
7  18  8
7  9  8
9  10  8",
440790579,22419,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00126,Olsalazine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00126,olsalazine,8.0,Adverse reactions,vLess-DILI-Concern,2.0,22419,1.0,415.0,8.0,4.0,4.0,AAADccBzOAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAICAAADAyBmAAwzoAAAgCKAiTSSACCAAAkIgAIiAEGbMgIJzaClZOAcUBl4BEI2Ye8yCCOAEAAQAAIAAAAgACAABAAAAAAAAAAAA==,5-(3-carboxy-4-hydroxy-phenyl)azo-2-hydroxy-benzoic acid,5-(3-carboxy-4-hydroxyphenyl)azo-2-hydroxybenzoic acid,5-[(3-carboxy-4-hydroxyphenyl)diazenyl]-2-hydroxybenzoic acid,5-[(3-carboxy-4-hydroxyphenyl)diazenyl]-2-hydroxybenzoic acid,5-[(3-carboxy-4-oxidanyl-phenyl)diazenyl]-2-oxidanyl-benzoic acid,5-(3-carboxy-4-hydroxy-phenyl)azo-2-hydroxy-benzoic acid,"InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)",QQBDLJCYGRGAKP-UHFFFAOYSA-N,,302.05388604,C14H10N2O6,302.24,140.0,302.05388604,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)c1cc(/N=N/c2ccc(O)c(C(=O)O)c2)ccc1O,3.1,"10  14  8
10  18  8
11  13  8
11  15  8
12  14  8
12  16  8
15  19  8
16  20  8
17  19  8
18  20  8
9  13  8
9  17  8",
440790578,135398745,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00259,olanzapine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00259,olanzapine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,135398745,1.0,432.0,4.0,1.0,1.0,AAADceB7gABAAAAAAAAAAAAAAAAAASAAAAA8QAAABAAAAACBwAAAHAQQAAAADAjBWAQzwYPAAAikAiZiZACDAIFhChlJiBgodJgIYOLg2ZGUIAhgkADoyAcQAAAMAAAAAAAAACAAAAAAAAAAQAAAAAAAAA==,"2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine","2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine","2-methyl-4-(4-methylpiperazin-1-yl)-10<I>H</I>-thieno[2,3-b][1,5]benzodiazepine","2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine","2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine","2-methyl-4-(4-methylpiperazino)-10H-thieno[2,3-b][1,5]benzodiazepine","InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3",KVWDHTXUZHCGIO-UHFFFAOYSA-N,,312.14086783,C17H20N4S,312.4,59.1,312.14086783,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,2.9,"1  13  8
1  17  8
11  13  8
11  14  8
14  17  8
15  16  8
15  18  8
16  19  8
18  21  8
19  22  8
21  22  8",
440790577,3033637,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00315,nizatidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00315,nizatidine,5.0,Adverse reactions,vLess-DILI-Concern,1.0,3033637,1.0,349.0,8.0,2.0,9.0,AAADceBzsABgAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAABgAAAHAQUAAAACAjFVgSjgRPYUAilAQRmRwAA8KBBCjgAAJQYIACAQAAgAQAQAAAIEAKgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(E)-N1'-[2-[[2-[(dimethylamino)methyl]thiazol-4-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine","(E)-N1'-[2-[[2-[(dimethylamino)methyl]-4-thiazolyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine","(<I>E</I>)-1-<I>N</I>&apos;-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-<I>N</I>-methyl-2-nitroethene-1,1-diamine","(E)-1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine","(E)-N1'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine",dimethyl-[[4-[[2-[[(E)-1-(methylamino)-2-nitro-vinyl]amino]ethylthio]methyl]thiazol-2-yl]methyl]amine,"InChI=1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3/b11-6+",SGXXNSQHWDMGGP-IZZDOVSWSA-N,,331.11366728,C12H21N5O2S2,331.5,140.0,331.11366728,0.0,21.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CN/C(=C\[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1,1.6,"13  16  8
2  11  8
2  16  8
6  11  8
6  13  8",
440790576,64143,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01012,nelfinavir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01012,nelfinavir,3.0,Adverse reactions,vLess-DILI-Concern,2.0,64143,1.0,829.0,6.0,4.0,10.0,AAADcfB/OABAAAAAAAAAAAAAAAAAAAAAAAA8YMEAAAAAAACxQAAAHgQQCAAADbzl2AayB4PAAgiIAiFSEACCAAAkKBAIiJmODMgKdjKi1TOUcQhk1hG4mYe6yLCOgAABAAAYAAAAAAIAADAAAAAAAAAAAA==,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide","(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[[(3-hydroxy-2-methylphenyl)-oxomethyl]amino]-4-(phenylthio)butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide","(3<I>S</I>,4<I>a</I><I>S</I>,8<I>a</I><I>S</I>)-<I>N</I>-<I>tert</I>-butyl-2-[(2<I>R</I>,3<I>R</I>)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4<I>a</I>,5,6,7,8,8<I>a</I>-octahydro-1<I>H</I>-isoquinoline-3-carboxamide","(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide","(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-3-[(2-methyl-3-oxidanyl-phenyl)carbonylamino]-2-oxidanyl-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide","(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-(phenylthio)butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide","InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,,567.3130781,C32H45N3O4S,567.8,127.0,567.3130781,0.0,40.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,5.7,"10  42  6
15  19  5
28  30  8
28  31  8
29  32  8
29  33  8
20  3  6
30  34  8
31  36  8
32  37  8
33  38  8
34  39  8
36  39  8
37  40  8
38  40  8
21  8  6
9  41  6",
440790575,3011155,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01233,Nelarabine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01233,nelarabine,4.0,Adverse reactions,vLess-DILI-Concern,2.0,3011155,1.0,377.0,9.0,4.0,3.0,AAADccBzuAAAAAAAAAAAAAAAAAAAAWJAAAAsAAAAAAAAAFgB+AAAHgAQCAAACBzhlwYH9L9MFgCgAQZhZASAiC0RcKABUCAtXBCHXAJE6EgfRCgPAArTICDwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3S,4S,5R)-2-(2-amino-6-methoxy-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol","(2R,3S,4S,5R)-2-(2-amino-6-methoxy-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol","(2<I>R</I>,3<I>S</I>,4<I>S</I>,5<I>R</I>)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","(2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","(2R,3S,4S,5R)-2-(2-azanyl-6-methoxy-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","(2R,3S,4S,5R)-2-(2-amino-6-methoxy-purin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol","InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1",IXOXBSCIXZEQEQ-UHTZMRCNSA-N,-0.7,297.1073186,C11H15N5O5,297.27,149.0,297.1073186,0.0,21.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,,"14  15  6
16  18  8
18  19  8
11  2  6
13  3  5
12  6  6
6  16  8
6  17  8
7  17  8
7  18  8
8  16  8
8  20  8
9  19  8
9  20  8",
440790574,5281078,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01288,mycophenolate mofetil,20231222,20210312,Curation Efforts|Governmental Organizations,LT01288,mycophenolate mofetil,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5281078,1.0,646.0,8.0,1.0,10.0,AAADceB6OAAAAAAAAAAAAAAAAAAAASAAAAA8QAAAAAAAAEgBAAAAHgAACAAADAThmAYCDoMABgCIAiDSCAACCAAkIAAAiAEMCMgOJzaGNRqDcWAl4BWYuQfK7PzO4AADCAAYAADAAAYQADAAAAAAAAAAAA==,2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate,(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester,2-morpholin-4-ylethyl (<I>E</I>)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1<I>H</I>-2-benzofuran-5-yl)-4-methylhex-4-enoate,2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate,2-morpholin-4-ylethyl (E)-6-(6-methoxy-7-methyl-4-oxidanyl-3-oxidanylidene-1H-2-benzofuran-5-yl)-4-methyl-hex-4-enoate,(E)-6-(4-hydroxy-3-keto-6-methoxy-7-methyl-phthalan-5-yl)-4-methyl-hex-4-enoic acid 2-morpholinoethyl ester,"InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+",RTGDFNSFWBGLEC-SYZQJQIISA-N,,433.21005233,C23H31NO7,433.5,94.5,433.21005233,0.0,31.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,3.2,"14  16  8
14  17  8
15  19  8
15  20  8
16  20  8
17  19  8",
440790573,152946,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02008,moxifloxacin,20210312,20210312,Curation Efforts|Governmental Organizations,LT02008,moxifloxacin,8.0,Adverse reactions,vLess-DILI-Concern,2.0,152946,1.0,727.0,8.0,2.0,4.0,AAADceB7OQAAAAAAAAAAAAAAGAAAAWAAAAA8QIAAAAAAAFiBAAAAHwAQCAAADSzBmA4yzoPABgCIAqTWSACCCAAlIAAAiIENTMgOZj7M9NuVcahk8BHY+cea2bOeCAABAAQCEAAQAAIACAQgAAAAAAAAAA==,"7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid","7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-3-quinolinecarboxylic acid","7-[(4<I>a</I><I>S</I>,7<I>a</I><I>S</I>)-1,2,3,4,4<I>a</I>,5,7,7<I>a</I>-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid","7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid","7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoranyl-8-methoxy-4-oxidanylidene-quinoline-3-carboxylic acid","7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-4-keto-8-methoxy-quinoline-3-carboxylic acid","InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1",FABPRXSRWADJSP-MEDUHNTESA-N,,401.17508442,C21H24FN3O4,401.4,82.1,401.17508442,0.0,29.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,0.6,"10  31  6
19  21  8
19  23  8
20  21  8
20  22  8
22  25  8
22  27  8
23  25  8
24  26  8
26  27  8
8  20  8
8  24  8
9  30  6",
440790572,5281040,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02007,montelukast,20210312,20210312,Curation Efforts|Governmental Organizations,LT02007,montelukast,3.0,Adverse reactions,vLess-DILI-Concern,1.0,5281040,1.0,891.0,5.0,2.0,12.0,AAADcfB+MABEAAAAAAAAAAAAGAAAAAAAAAA8YMEAAAAAAACx9AAAHgYACAAADk6F3iCyyPIIEgioAyTyTACCgCAhBzAImCEwbpgIJvLhk5GEcAhkwAHo2AeYwOAPhAACAAISAAAIAAQABCQAAAAAAAAAAA==,2-[1-[[(1R)-1-[3-[(E)-2-(7-chloro-2-quinolyl)vinyl]phenyl]-3-[2-(1-hydroxy-1-methyl-ethyl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid,2-[1-[[[(1R)-1-[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]thio]methyl]cyclopropyl]acetic acid,2-[1-[[(1<I>R</I>)-1-[3-[(<I>E</I>)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid,2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid,2-[1-[[(1R)-1-[3-[(E)-2-(7-chloranylquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-oxidanylpropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]ethanoic acid,2-[1-[[[(1R)-1-[3-[(E)-2-(7-chloro-2-quinolyl)vinyl]phenyl]-3-[2-(1-hydroxy-1-methyl-ethyl)phenyl]propyl]thio]methyl]cyclopropyl]acetic acid,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",UCHDWCPVSPXUMX-TZIWLTJVSA-N,,585.2104429,C35H36ClNO3S,586.2,95.7,585.2104429,0.0,41.0,1.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,7.7,"13  14  5
15  17  8
15  18  8
17  21  8
18  22  8
19  20  8
19  24  8
20  26  8
21  25  8
22  25  8
24  27  8
26  31  8
27  31  8
33  34  8
34  36  8
35  37  8
35  38  8
36  37  8
37  39  8
38  40  8
39  41  8
40  41  8
6  33  8
6  35  8",
440790571,4171,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00309,metoprolol,20250421,20210312,Curation Efforts|Governmental Organizations,LT00309,metoprolol,5.0,Adverse reactions,vLess-DILI-Concern,1.0,4171,1.0,215.0,4.0,2.0,9.0,AAADceByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADDzhmAYyBoLABgCAAiBCAAACCAAgIAAIiIAOCIgPNiKEMRqGOCCm0BGbqAeAwKAOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol,1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)-2-propanol,1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol,1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol,1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol,1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol,"InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3",IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.9,267.18344366,C15H25NO3,267.36,50.7,267.18344366,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COCCc1ccc(OCC(O)CNC(C)C)cc1,,"11  14  8
11  15  8
12  16  8
12  17  8
14  16  8
15  17  8
5  2  3",
440790570,4168,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01549,metoclopramide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01549,metoclopramide,5.0,Adverse reactions,vLess-DILI-Concern,2.0,4168,1.0,300.0,4.0,2.0,7.0,AAADceBzMAAEAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgIQAAAADA7BmCYyxoPABACIAiVSUACCCAAkJwAAiIEObsgMZjaFtpuUMWhm9hmI6YeY2SGeCCAAIgAIABAQQABEABAAIAAAAAAAAA==,4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide,4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide,4-amino-5-chloro-<I>N</I>-[2-(diethylamino)ethyl]-2-methoxybenzamide,4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide,4-azanyl-5-chloranyl-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide,4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide,"InChI=1S/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)",TTWJBBZEZQICBI-UHFFFAOYSA-N,2.6,299.1400546,C14H22ClN3O2,299.79,67.6,299.1400546,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,,"14  15  8
14  16  8
15  17  8
16  19  8
17  18  8
18  19  8",
440790569,6741,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00478,methylprednisolone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00478,methylprednisolone,3.0,Adverse reactions,vLess-DILI-Concern,2.0,6741,1.0,754.0,5.0,3.0,2.0,AAADceB4OAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAAD1SggAICAAAAAgCIAqBSAAIAAAAgAAAICAFAAEgAEBIAAQAAQAAFgAAIAYPIzPDPgAAAAAAAAADAAAYAADAAAYAADAAAAA==,"(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","(6<I>S</I>,8<I>S</I>,9<I>S</I>,10<I>R</I>,11<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>R</I>)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6<I>H</I>-cyclopenta[a]phenanthren-3-one","(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","(6S,8S,9S,10R,11S,13S,14S,17R)-6,10,13-trimethyl-11,17-bis(oxidanyl)-17-(2-oxidanylethanoyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","(6S,8S,9S,10R,11S,13S,14S,17R)-17-glycoloyl-11,17-dihydroxy-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1",VHRSUDSXCMQTMA-PJHHCJLFSA-N,1.9,374.20932405,C22H30O5,374.5,94.8,374.20932405,0.0,27.0,8.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12,,"10  1  6
14  21  5
17  23  6
12  2  5
6  18  5
7  28  6
8  29  5
9  30  6",
440790568,4158,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01545,methylphenidate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01545,methylphenidate,3.0,Adverse reactions,vLess-DILI-Concern,2.0,4158,1.0,249.0,3.0,1.0,4.0,AAADceByMAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHgAQAAAADSjBmAYyCILABACIAiDSCAACAAAgAAAIiIEIAIgIIDqAlRGEIAAm0AGIiAeYyOCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,methyl 2-phenyl-2-(2-piperidyl)acetate,2-phenyl-2-(2-piperidinyl)acetic acid methyl ester,methyl 2-phenyl-2-piperidin-2-ylacetate,methyl 2-phenyl-2-piperidin-2-ylacetate,methyl 2-phenyl-2-piperidin-2-yl-ethanoate,2-phenyl-2-(2-piperidyl)acetic acid methyl ester,"InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3",DUGOZIWVEXMGBE-UHFFFAOYSA-N,0.2,233.141578849,C14H19NO2,233.31,38.3,233.141578849,0.0,17.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)C(c1ccccc1)C1CCCCN1,,"10  12  8
10  13  8
12  14  8
13  15  8
14  16  8
15  16  8
4  18  3
6  21  3",
440790567,4100,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01532,methazolamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01532,methazolamide,7.0,Adverse reactions,vLess-DILI-Concern,2.0,4100,1.0,419.0,6.0,1.0,1.0,AAADccBjsABgAAAAAAAAAAAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAHgQYQAAAAACBgAQDAAIAAAooAAEQNHAQEQFAAAABAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide","N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide","<I>N</I>-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide","N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide","N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)ethanamide","N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide","InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)",FLOSMHQXBMRNHR-UHFFFAOYSA-N,0.1,236.00378248,C5H8N4O3S2,236.3,139.0,236.00378248,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)/N=c1\sc(S(N)(=O)=O)nn1C,,"2  10  8
2  11  8
6  11  8
6  7  8
7  10  8",
440790566,15459,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00841,METAXALONE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00841,metaxalone,5.0,Adverse reactions,vLess-DILI-Concern,2.0,15459,1.0,247.0,3.0,1.0,3.0,AAADccByMAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHgAQAAAADBThmAYyDoLABACIAiBCGAACCAAgIAAAiIAOCIkPJiKEMRqPOCCm1hEaqAeAwFAOAAADAAAAAAAAAAYAAAAAAAAAAAAAAA==,"5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one","5-[(3,5-dimethylphenoxy)methyl]-2-oxazolidinone","5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one","5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one","5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one","5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one","InChI=1S/C12H15NO3/c1-8-3-9(2)5-10(4-8)15-7-11-6-13-12(14)16-11/h3-5,11H,6-7H2,1-2H3,(H,13,14)",IMWZZHHPURKASS-UHFFFAOYSA-N,,221.10519334,C12H15NO3,221.25,47.6,221.10519334,0.0,16.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cc(C)cc(OCC2CNC(=O)O2)c1,2.2,"10  12  8
11  13  8
12  14  8
13  14  8
5  17  3
9  10  8
9  11  8",
440790565,4075,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00414,Mesalazine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00414,mesalazine,7.0,Adverse reactions,vLess-DILI-Concern,2.0,4075,1.0,160.0,4.0,3.0,1.0,AAADcYBiMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADAyBmAAwzoBAAgCIAiTSSACCAAAkIgAIiAEGbMgIJzaClZOAcUBl8BEI2Ye8yCCOAEAAQAAIAAAAgACAABAAAAAAAAAAAA==,5-amino-2-hydroxy-benzoic acid,5-amino-2-hydroxybenzoic acid,5-amino-2-hydroxybenzoic acid,5-amino-2-hydroxybenzoic acid,5-azanyl-2-oxidanyl-benzoic acid,5-amino-2-hydroxy-benzoic acid,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",KBOPZPXVLCULAV-UHFFFAOYSA-N,1.3,153.042593085,C7H7NO3,153.14,83.6,153.042593085,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ccc(O)c(C(=O)O)c1,,"5  7  8
5  8  8
6  7  8
6  9  8
8  10  8
9  10  8",
440790564,4054,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01908,memantine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01908,memantine,7.0,Adverse reactions,vLess-DILI-Concern,2.0,4054,1.0,240.0,1.0,1.0,0.0,AAADceByAAAAAAAAAAAAAAAAAAAAAAAAAAAwYMGAAAAAAAAAAAAAHAAQAAAAD4iBAAACAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAIAgAAAAAAAEAAAAAEQgMAPAAAAAAAAAAAAAASAAAAAAAAAAAAAAA==,"3,5-dimethyladamantan-1-amine","3,5-dimethyl-1-adamantanamine","3,5-dimethyladamantan-1-amine","3,5-dimethyladamantan-1-amine","3,5-dimethyladamantan-1-amine","(3,5-dimethyl-1-adamantyl)amine","InChI=1S/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3",BUGYDGFZZOZRHP-UHFFFAOYSA-N,3.3,179.167399674,C12H21N,179.3,26.0,179.167399674,0.0,13.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC12CC3CC(C)(C1)CC(N)(C3)C2,,"2  12  3
3  13  3",
440790563,460612,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01517,melphalan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01517,melphalan,5.0,Adverse reactions,vLess-DILI-Concern,2.0,460612,1.0,265.0,4.0,2.0,8.0,AAADceBzMAAGAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgIQCAAADCvBmEQwyINAAgCIAiTSSACCAAAhAgAIiIGIZIgKIDLAkZHEYAhkkADIyAeYyKCOCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,(2<I>S</I>)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,(2S)-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propionic acid,"InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1",SGDBTWWWUNNDEQ-LBPRGKRZSA-N,-0.5,304.0745332,C13H18Cl2N2O2,305.2,66.6,304.0745332,0.0,19.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,,"13  15  8
14  16  8
12  6  5
7  13  8
7  14  8
9  15  8
9  16  8",
440790562,4046,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01514,mefloquine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01514,mefloquine,7.0,Adverse reactions,vLess-DILI-Concern,2.0,4046,1.0,483.0,9.0,2.0,2.0,AAADceB7IcAAAAAAAAAAAAAAAAAAAAAAAAA8WIAAAAAAAACx8AAAHwAQCAAADDzhnhYwwPLIEgCgAyRiRACCgCAhAiAImKA4bJgKNuLAkZGEcAhk0AHY2AewwPAOgAACAAACAAAAAAQAAAQAAAAAAAAAAA==,"[2,8-bis(trifluoromethyl)-4-quinolyl]-(2-piperidyl)methanol","[2,8-bis(trifluoromethyl)-4-quinolinyl]-(2-piperidinyl)methanol","[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol","[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol","[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-yl-methanol","[2,8-bis(trifluoromethyl)-4-quinolyl]-(2-piperidyl)methanol","InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2",XEEQGYMUWCZPDN-UHFFFAOYSA-N,,378.11668211,C17H16F6N2O,378.31,45.2,378.11668211,0.0,26.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1,3.6,"10  27  3
16  17  8
16  18  8
17  19  8
17  21  8
18  20  8
19  22  8
21  23  8
22  24  8
23  24  8
12  7  3
9  19  8
9  20  8",
440790561,3961,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01499,losartan,20210804,20210312,Curation Efforts|Governmental Organizations,LT01499,losartan,4.0,Adverse reactions,vLess-DILI-Concern,2.0,3961,1.0,520.0,5.0,2.0,8.0,AAADceB7oAAEAAAAAAAAAAAAAAAAAWLAAAAwYAAAAAAAAAAB9AAAHgIYCAAADArhnyYzkJcOEgCiAyZiZASCgC8hFKAd+CA4XpiKfKLAmRHUYAhqgALYmCcQgMAOwAAAAAAQAACAAAAAACAAAAAAAAAAAA==,[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol,[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4-imidazolyl]methanol,[2-butyl-5-chloro-3-[[4-[2-(2<I>H</I>-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol,[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol,"[2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol",[2-butyl-5-chloro-3-[4-[2-(2H-tetrazol-5-yl)phenyl]benzyl]imidazol-4-yl]methanol,"InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)",PSIFNNKUMBGKDQ-UHFFFAOYSA-N,,422.1621871,C22H23ClN6O,422.9,92.5,422.1621871,0.0,30.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,4.3,"13  16  8
14  18  8
14  19  8
18  21  8
19  22  8
20  21  8
20  22  8
24  25  8
24  26  8
25  27  8
26  28  8
27  30  8
28  30  8
3  13  8
3  9  8
4  16  8
4  9  8
5  29  8
5  7  8
6  29  8
6  8  8
7  8  8",
440790560,5284585,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01497,loracarbef,20231222,20210312,Curation Efforts|Governmental Organizations,LT01497,loracarbef,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5284585,1.0,600.0,5.0,3.0,4.0,AAADceB7OAAEAAAAAAAAAAAAAABYAAAAAAAwQAAAAAAQAAABAAAAHgIQCAAADCrBmAQwCIPAAgCIAiXSWACCAAAgAAAIiIGIBsgKZDqBlTGUMABglgCYmQcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7S)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-7-[[(2R)-2-amino-1-oxo-2-phenylethyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>S</I>)-7-[[(2<I>R</I>)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-7-[[(2R)-2-azanyl-2-phenyl-ethanoyl]amino]-3-chloranyl-8-oxidanylidene-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7S)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-keto-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C16H16ClN3O4/c17-9-6-7-10-12(15(22)20(10)13(9)16(23)24)19-14(21)11(18)8-4-2-1-3-5-8/h1-5,10-12H,6-7,18H2,(H,19,21)(H,23,24)/t10-,11-,12+/m1/s1",JAPHQRWPEGVNBT-UTUOFQBUSA-N,-1.7,349.0829337,C16H16ClN3O4,349.77,113.0,349.0829337,0.0,24.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1,,"19  20  8
19  21  8
20  22  8
21  23  8
22  24  8
23  24  8
10  7  6
18  8  6
9  25  5",
440790559,5362119,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01492,lisinopril,20210804,20210312,Curation Efforts|Governmental Organizations,LT01492,lisinopril,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5362119,1.0,550.0,7.0,4.0,12.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHgAQCAAADCjBmAQwCIPAAgCIAiHSGAACAAAgAAAIiIGIAIgKYDKAkTCUYAAklgCYiAeY2bKOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]-1-oxohexyl]-2-pyrrolidinecarboxylic acid,(2<I>S</I>)-1-[(2<I>S</I>)-6-amino-2-[[(1<I>S</I>)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-6-azanyl-2-[[(2S)-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]proline,"InChI=1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1",RLAWWYSOJDYHDC-BZSNNMDCSA-N,-2.9,405.2263711,C21H31N3O5,405.5,133.0,405.2263711,0.0,29.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,,"24  25  8
24  26  8
25  27  8
26  28  8
27  29  8
28  29  8
13  7  5
16  7  5
9  18  5",
440790558,441401,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01077,linezolid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01077,linezolid,3.0,Adverse reactions,vLess-DILI-Concern,2.0,441401,1.0,472.0,6.0,1.0,4.0,AAADceB7OQAAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAAABAAAAHwAQAAAACBzhkA4yyIPABACIACVSWACCAAAhAgAIiIAIZIgKICLA0ZGPIAhglgDYyAcQAAAAAACAAAAAAAAAAQAAAAAAAAAAAAAAAA==,N-[[(5S)-3-(3-fluoro-4-morpholino-phenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide,N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide,"<I>N</I>-[[(5<I>S</I>)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide","N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide","N-[[(5S)-3-(3-fluoranyl-4-morpholin-4-yl-phenyl)-2-oxidanylidene-1,3-oxazolidin-5-yl]methyl]ethanamide",N-[[(5S)-3-(3-fluoro-4-morpholino-phenyl)-2-keto-oxazolidin-5-yl]methyl]acetamide,"InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1",TYZROVQLWOKYKF-ZDUSSCGKSA-N,,337.14378429,C16H20FN3O4,337.35,71.1,337.14378429,0.0,24.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,0.7,"13  19  8
13  20  8
15  21  8
15  22  8
19  21  8
20  22  8
9  14  6",
440790557,5819,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01072,levothyroxine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01072,levothyroxine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5819,1.0,420.0,5.0,3.0,5.0,AAADccByOAAAA4AAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAwCAAADCzDmAQwDoBABgCIAiDSCAACCAAgIAAAiIGGCIgOJjKGsRuCeCCk0BEIuAfYyKCOIQAAAAAAAABCAAAAAAAAAAAAAAAAAA==,"(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid","(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid","(2<I>S</I>)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid","(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid","(2S)-2-azanyl-3-[4-[3,5-bis(iodanyl)-4-oxidanyl-phenoxy]-3,5-bis(iodanyl)phenyl]propanoic acid","(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propionic acid","InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1",XUIIKFGFIJCVMT-LBPRGKRZSA-N,,776.6867,C15H11I4NO4,776.87,92.8,776.6867,0.0,24.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,2.4,"12  13  8
12  14  8
13  17  8
14  16  8
15  16  8
15  17  8
19  20  8
19  21  8
20  23  8
21  22  8
22  24  8
23  24  8
11  9  5",
440790556,9955977,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00600,Levocetirizine dihydrochloride,20231222,20210312,Curation Efforts|Governmental Organizations,LT00600,levocetirizine dihydrochloride,4.0,Adverse reactions,vLess-DILI-Concern,2.0,9955977,1.0,443.0,5.0,3.0,8.0,AAADceB7MAAGAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABQAAAHgIACAAADCrhmCYwCIMABgCIAiDSCAKCAAAgBQAIiABIBogLYCKBkxWXIAhggACbiAcQgMAOBAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,2-[2-[4-[(R)-(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride,2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid;dihydrochloride,2-[2-[4-[(<I>R</I>)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride,2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride,2-[2-[4-[(R)-(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanoic acid;dihydrochloride,2-[2-[4-[(R)-(4-chlorophenyl)-phenyl-methyl]piperazino]ethoxy]acetic acid;dihydrochloride,"InChI=1S/C21H25ClN2O3.2ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H/t21-;;/m1../s1",PGLIUCLTXOYQMV-GHVWMZMZSA-N,,460.108726,C21H27Cl3N2O3,461.8,53.0,460.108726,0.0,29.0,1.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",Cl.Cl.O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1,,"15  18  8
15  19  8
16  20  8
16  21  8
18  22  8
19  23  8
20  24  8
21  25  8
22  26  8
23  26  8
24  27  8
25  27  8
13  7  6",
440790555,5284583,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01059,Levetiracetam,20210312,20210312,Curation Efforts|Governmental Organizations,LT01059,levetiracetam,8.0,Adverse reactions,vLess-DILI-Concern,2.0,5284583,1.0,203.0,2.0,1.0,3.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAAAAAAAHgAQAAAACCjBgAQCAANAAAAIAAEQEAAAAAAAAAAAAAGIAAAAQBAAgCAUAAAAFgCAAAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-2-(2-oxopyrrolidin-1-yl)butanamide,(2S)-2-(2-oxo-1-pyrrolidinyl)butanamide,(2<I>S</I>)-2-(2-oxopyrrolidin-1-yl)butanamide,(2S)-2-(2-oxopyrrolidin-1-yl)butanamide,(2S)-2-(2-oxidanylidenepyrrolidin-1-yl)butanamide,(2S)-2-(2-ketopyrrolidino)butyramide,"InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1",HPHUVLMMVZITSG-LURJTMIESA-N,,170.105527694,C8H14N2O2,170.21,63.4,170.105527694,0.0,12.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@@H](C(N)=O)N1CCCC1=O,-0.3,6  10  5,
440790554,657181,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02019,leuprolide,20250421,20210312,Curation Efforts|Governmental Organizations,LT02019,leuprolide,3.0,Adverse reactions,vLess-DILI-Concern,2.0,657181,1.0,2390.0,14.0,15.0,32.0,AAADcfB//AAAAAAAAAAAAAAAAAAAAWLFiwAwYAAAAAAAAFgB/AAAHgAQCAAADSzhngY/1vfJkgCoAzV3dACCgC2xMqAJ2aG+fJiKfvbC2bOUcAhu9hPY2Cecy+COoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)-1-pyrrolidinyl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxo-2-pyrrolidinecarboxamide,(2<I>S</I>)-<I>N</I>-[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-1-[[(2<I>R</I>)-1-[[(2<I>S</I>)-1-[[(2<I>S</I>)-5-(diaminomethylideneamino)-1-[(2<I>S</I>)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1<I>H</I>-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-[bis(azanyl)methylideneamino]-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxidanylidene-propan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxidanylidene-propan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl]-5-oxidanylidene-pyrrolidine-2-carboxamide,(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-(4-hydroxybenzyl)-2-keto-ethyl]amino]-2-keto-1-methylol-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-keto-ethyl]-5-keto-pyrrolidine-2-carboxamide,"InChI=1S/C59H84N16O12/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64)/t40-,41-,42-,43+,44-,45-,46-,47-,48-/m0/s1",GFIJNRVAKGFPGQ-LIJARHBVSA-N,,1208.64546218,C59H84N16O12,1209.4,432.0,1208.64546218,0.0,87.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,0.7,"34  14  6
38  16  6
44  17  6
53  19  5
60  21  5
59  22  6
62  23  6
26  75  8
26  76  8
27  74  8
27  87  8
28  83  8
28  87  8
29  35  6
56  64  6
66  77  8
66  78  8
71  72  8
71  75  8
72  76  8
72  79  8
74  83  8
76  80  8
77  81  8
78  82  8
79  85  8
80  86  8
81  84  8
82  84  8
85  86  8",
440790553,3883,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00307,lansoprazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00307,lansoprazole,3.0,Adverse reactions,vLess-DILI-Concern,2.0,3883,1.0,480.0,8.0,1.0,5.0,AAADccB7MYBAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgB/AAAHwQQAAAADAzl3ha/1rbJlAqgAzRnZEDK2i3xMrAJ2SA+fJiMbuLkuZuWOCjukBrI6CcQAAAOAAAAAAAAACAAAAAAAAAAQAAAAAAAAA==,"2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole","2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole","2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1<I>H</I>-benzimidazole","2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole","2-[[3-methyl-4-[2,2,2-tris(fluoranyl)ethoxy]pyridin-2-yl]methylsulfinyl]-1H-benzimidazole","2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole","InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)",MJIHNNLFOKEZEW-UHFFFAOYSA-N,2.8,369.07588236,C16H14F3N3O2S,369.4,87.1,369.07588236,0.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1,,"1  10  3
11  12  8
12  16  8
14  15  8
14  18  8
15  20  8
16  19  8
18  22  8
19  21  8
20  23  8
22  23  8
7  13  8
7  14  8
8  13  8
8  15  8
9  11  8
9  21  8",
440790552,6321424,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00568,IVERMECTIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00568,ivermectin,3.0,Adverse reactions,vLess-DILI-Concern,2.0,6321424,1.0,1680.0,14.0,3.0,8.0,AAADcfB8PAAAAAAAAAAAAAAAAAAAASAAAAAkSJEiAAAAAEAAAAAAGgAACAAADVSwgAMCCAAABgCIAiDSCAAAAAAgAAAICAEAAAgZFBYAIQAiUAAF4AAPsAPK7OzOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-5',11,13,22-tetramethyl-6'-[(1S)-1-methylpropyl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-tetrahydropyran]-2-one","(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[[(2R,4S,5S,6S)-5-[[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-2-oxanyl]oxy]-4-methoxy-6-methyl-2-oxanyl]oxy]-5',11,13,22-tetramethyl-2-spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]one","(1<I>R</I>,4<I>S</I>,5&apos;<I>S</I>,6<I>R</I>,6&apos;<I>R</I>,8<I>R</I>,10<I>E</I>,12<I>S</I>,13<I>S</I>,14<I>E</I>,16<I>E</I>,20<I>R</I>,21<I>R</I>,24<I>S</I>)-6&apos;-[(2<I>S</I>)-butan-2-yl]-21,24-dihydroxy-12-[(2<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>S</I>)-5-[(2<I>S</I>,4<I>S</I>,5<I>S</I>,6<I>S</I>)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5&apos;,11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.1<SUP>4,8</SUP>.0<SUP>20,24</SUP>]pentacosa-10,14,16,22-tetraene-6,2&apos;-oxane]-2-one","(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one","(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-12-[(2R,4S,5S,6S)-4-methoxy-5-[(2S,4S,5S,6S)-4-methoxy-6-methyl-5-oxidanyl-oxan-2-yl]oxy-6-methyl-oxan-2-yl]oxy-5',11,13,22-tetramethyl-21,24-bis(oxidanyl)spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one","(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-5',11,13,22-tetramethyl-6'-[(1S)-1-methylpropyl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-tetrahydropyran]-2-one","InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1",AZSNMRSAGSSBNP-XPNPUAGNSA-N,,874.50785703,C48H74O14,875.1,170.0,874.50785703,0.0,62.0,20.0,0.0,3.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2,4.1,"15  1  5
47  10  5
54  10  5
48  11  6
56  13  6
57  14  5
16  63  6
17  28  6
21  71  5
22  72  5
24  33  6
26  76  6
27  77  5
44  53  5
25  5  5
51  58  6
59  60  6
31  6  6
42  8  5
46  8  5",
440790551,3784,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01475,isradipine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01475,isradipine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,3784,1.0,685.0,8.0,1.0,6.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAWAAAAAwQAAAAAAAAFgB8AAAHgAUAAAADRyhngIyyLLQBACpAyTySgCCAAQgEgAomCEwdNoIZLKAsZGCMABkkICI6UeY/+megAAAQAACACAAAACAAAQAQAAAAAAAAA==,"O5-isopropyl O3-methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-propan-2-yl ester","3-<I>O</I>-methyl 5-<I>O</I>-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","O3-methyl O5-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","4-benzofurazan-4-yl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid O5-isopropyl ester O3-methyl ester","InChI=1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3",HMJIYCCIJYRONP-UHFFFAOYSA-N,4.3,371.14812078,C19H21N3O5,371.4,104.0,371.14812078,0.0,27.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12,,"12  15  8
12  17  8
15  21  8
17  22  8
21  23  8
22  23  8
4  7  8
4  8  8
7  15  8
8  21  8
9  28  3",
440790550,60838,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01466,irinotecan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01466,irinotecan,3.0,Adverse reactions,vLess-DILI-Concern,2.0,60838,1.0,1200.0,8.0,1.0,5.0,AAADcfB/uAAAAAAAAAAAAAAAAAAAAWAAAAA8WLECAAAAAFix8AAAHgAACAAADGzhngYyzvMIFgCoAyXyXAKCiCAhIiAImCF+bNgNZvbE8Zuecihm5hHL+QewwPAOgEABAAACAAAAgAIAAAQAAAAAAAAAAA==,"[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-(1-piperidyl)piperidine-1-carboxylate","4-(1-piperidinyl)-1-piperidinecarboxylic acid [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]heneicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] ester","[(19<I>S</I>)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0<SUP>2,11</SUP>.0<SUP>4,9</SUP>.0<SUP>15,20</SUP>]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate","[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate","[(19S)-10,19-diethyl-19-oxidanyl-14,18-bis(oxidanylidene)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate","4-piperidinopiperidine-1-carboxylic acid [(19S)-10,19-diethyl-19-hydroxy-14,18-diketo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]heneicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] ester","InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1",UWKQSNNFCGGAFS-XIFFEERXSA-N,,586.27913494,C33H38N4O6,586.7,113.0,586.27913494,0.0,43.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,3.0,"10  27  8
10  35  8
22  30  8
23  27  8
23  29  8
25  28  8
25  30  8
28  31  8
29  32  8
32  35  8
32  39  8
35  40  8
38  39  8
38  41  8
26  4  5
40  41  8
9  22  8
9  31  8",
440790549,3749,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01005,irbesartan,20210312,20210312,Curation Efforts|Governmental Organizations,LT01005,irbesartan,5.0,Adverse reactions,vLess-DILI-Concern,2.0,3749,1.0,682.0,5.0,1.0,7.0,AAADceB7oAAAAAAAAAAAAAAAAAAAAeIEAAAwYAAAAAAAAAAB0AAAHgAYAAAADIjBmwQzEIcCAACqAiNyNACCAAMgAAAdqCG4BJgIYLKAmRGUIAhghgCIiAcYiMAOwAAAAAAQAACAAAAAACAAAAAAAAAAAA==,"2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one","2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one","2-butyl-3-[[4-[2-(2<I>H</I>-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one","2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one","2-butyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one","2-butyl-3-[4-[2-(2H-tetrazol-5-yl)phenyl]benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one","InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",YOSHYTLCDANDAN-UHFFFAOYSA-N,,428.23245954,C25H28N6O,428.5,87.1,428.23245954,0.0,32.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,4.1,"18  20  8
18  21  8
20  23  8
21  24  8
23  25  8
24  25  8
26  27  8
26  28  8
27  29  8
28  30  8
29  32  8
30  32  8
4  31  8
4  6  8
5  31  8
5  7  8
6  7  8",
440790548,3696,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00108,imipramine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00108,imipramine,3.0,Adverse reactions,vLess-DILI-Concern,1.0,3696,1.0,291.0,2.0,0.0,4.0,AAADceB7AAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABYAAAAABQAAAHAAAAAAADAjBGAQywIMAAACAAiRCQACCAAAhAgAIiAAIZIgIIGLA0ZGEIAhggADIyAcQgMAOAAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-1-propanamine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-<I>N</I>,<I>N</I>-dimethylpropan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine","3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-dimethyl-amine","InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3",BCGWQEUPMDMJNV-UHFFFAOYSA-N,4.8,280.193948774,C19H24N2,280.4,6.5,280.193948774,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCCN1c2ccccc2CCc2ccccc21,,"12  16  8
13  17  8
14  18  8
15  19  8
16  18  8
17  19  8
4  12  8
4  8  8
5  13  8
5  9  8
8  14  8
9  15  8",
440790547,3690,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00562,ifosfamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00562,ifosfamide,4.0,Adverse reactions,vLess-DILI-Concern,1.0,3690,1.0,218.0,4.0,1.0,5.0,AAADccBjMAIGAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAAAAAAAHgIQgCAACAPhgEYAAAJAARAAQAAAAIAAAAAAAAAAAIAIAAAAAAAAAABEAAACEACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine","N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphorinan-2-amine","<I>N</I>,3-bis(2-chloroethyl)-2-oxo-1,3,2&lambda;<SUP>5</SUP>-oxazaphosphinan-2-amine","N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine","N,3-bis(2-chloroethyl)-2-oxidanylidene-1,3,2lambda5-oxazaphosphinan-2-amine","2-chloroethyl-[3-(2-chloroethyl)-2-keto-1,3,2lambda5-oxazaphosphorinan-2-yl]amine","InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",HOMGKSMUEGBAAB-UHFFFAOYSA-N,0.9,260.0248201,C7H15Cl2N2O2P,261.08,41.6,260.0248201,0.0,14.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=P1(NCCCl)OCCCN1CCCl,,3  7  3,
440790546,3652,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02026,hydroxychloroquine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02026,hydroxychloroquine,7.0,Adverse reactions,vLess-DILI-Concern,2.0,3652,1.0,331.0,4.0,2.0,9.0,AAADceB7IAAEAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAACx8AAAHgIQCAAADCrhniY+wPPIEgCgAzRnRACCgCAxByAI2KA4ZpgKMOLB09GEJAhgkADYyAcQgIAOBAAAAAICAAAIAAAABAQAAAAAAAAAAA==,2-[4-[(7-chloro-4-quinolyl)amino]pentyl-ethyl-amino]ethanol,2-[4-[(7-chloro-4-quinolinyl)amino]pentyl-ethylamino]ethanol,2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol,2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol,2-[4-[(7-chloranylquinolin-4-yl)amino]pentyl-ethyl-amino]ethanol,2-[4-[(7-chloro-4-quinolyl)amino]pentyl-ethyl-amino]ethanol,"InChI=1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21)",XXSMGPRMXLTPCZ-UHFFFAOYSA-N,3.6,335.1764402,C18H26ClN3O,335.9,48.4,335.1764402,0.0,23.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,,"13  16  8
13  17  8
16  18  8
16  19  8
17  20  8
18  21  8
19  22  8
21  23  8
22  23  8
5  18  8
5  20  8
8  28  3",
440790545,3639,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01433,hydrochlorothiazide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01433,hydrochlorothiazide,2.0,Adverse reactions,vLess-DILI-Concern,2.0,3639,1.0,494.0,7.0,3.0,1.0,AAADccBjOABkAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAACxAAAAHAYQQAAACAqBUCQxwYLAAAKAACRCQHDCABAhBwAAiJwIZoiIICLBkpGEIAhgkAJIyCcQAAAAAAYAAEIAAYAADAAAhAADAAAAAAAAAA==,"6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-1,1-dioxo-3,4-dihydro-2<I>H</I>-1&lambda;<SUP>6</SUP>,2,4-benzothiadiazine-7-sulfonamide","6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloranyl-1,1-bis(oxidanylidene)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-1,1-diketo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","InChI=1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)",JZUFKLXOESDKRF-UHFFFAOYSA-N,-0.1,296.9644758,C7H8ClN3O4S2,297.7,135.0,296.9644758,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,,"11  12  8
11  14  8
12  16  8
14  15  8
15  17  8
16  17  8",
440790544,3637,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00559,hydralazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00559,hydralazine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,3637,1.0,150.0,4.0,2.0,1.0,AAADccBzgAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAACx8AAAHAAYAAAADADBGgQ9sNBiAACiAjJnYACSBAIggAIcuCAgRJgIIKKAkZGAoABwiAAIyAcQgIAOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,phthalazin-1-ylhydrazine,1-phthalazinylhydrazine,phthalazin-1-ylhydrazine,phthalazin-1-ylhydrazine,phthalazin-1-yldiazane,phthalazin-1-ylhydrazine,"InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)",RPTUSVTUFVMDQK-UHFFFAOYSA-N,0.7,160.074896272,C8H8N4,160.18,63.8,160.074896272,0.0,12.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NNc1nncc2ccccc12,,"10  12  8
2  3  8
2  7  8
3  11  8
5  6  8
5  7  8
5  8  8
6  11  8
6  9  8
8  10  8
9  12  8",
440790543,772,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01426,Heparin sodium,20231222,20210312,Curation Efforts|Governmental Organizations,LT01426,heparin sodium,3.0,Adverse reactions,vLess-DILI-Concern,2.0,772,1.0,2410.0,38.0,15.0,21.0,AAADcfB7PgBwAAAAAAAAAAAAAAAAAAAAAAAkSJEgAAAAAAAAAAAAHgAQSAAACDzxgAcCCALABoAIAAGQGDIAAAAAAAAAAIFIAAATEBYAgAQnQAAHNgCXAAH6fA9AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxy-tetrahydropyran-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxy-tetrahydropyran-3-yl]oxy-3,4-dihydroxy-5-sulfooxy-tetrahydropyran-2-carboxylic acid","6-[[6-[[6-[[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)-3-oxanyl]oxy]-2-carboxy-4-hydroxy-5-sulfooxy-3-oxanyl]oxy]-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxy-3-oxanyl]oxy]-3,4-dihydroxy-5-sulfooxy-2-oxanecarboxylic acid","6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid","6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid","6-[6-[6-[5-acetamido-4,6-bis(oxidanyl)-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-oxidanyl-5-sulfooxy-oxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxy-oxan-3-yl]oxy-3,4-bis(oxidanyl)-5-sulfooxy-oxane-2-carboxylic acid","6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfoxymethyl)tetrahydropyran-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfoxy-tetrahydropyran-3-yl]oxy-2-methylol-5-(sulfoamino)-4-sulfoxy-tetrahydropyran-3-yl]oxy-3,4-dihydroxy-5-sulfoxy-tetrahydropyran-2-carboxylic acid","InChI=1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)",HTTJABKRGRZYRN-UHFFFAOYSA-N,,1134.0069961,C26H42N2O37S5,1134.9,652.0,1134.0069961,0.0,70.0,0.0,20.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)NC1C(O)OC(COS(=O)(=O)O)C(OC2OC(C(=O)O)C(OC3OC(CO)C(OC4OC(C(=O)O)C(O)C(O)C4OS(=O)(=O)O)C(OS(=O)(=O)O)C3NS(=O)(=O)O)C(O)C2OS(=O)(=O)O)C1O,-10.8,"53  10  3
55  10  3
46  11  3
52  14  3
51  15  3
57  16  3
61  17  3
62  19  3
63  20  3
64  21  3
45  43  3
59  44  3
49  60  3
54  66  3
58  67  3
65  68  3
48  7  3
50  7  3
47  8  3
56  8  3",
440790542,3559,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00405,haloperidol,20250421,20210312,Curation Efforts|Governmental Organizations,LT00405,haloperidol,5.0,Adverse reactions,vLess-DILI-Concern,1.0,3559,1.0,451.0,4.0,1.0,6.0,AAADceB6MQAEAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABQAAAHwIACAAADEbBmCwwAIMAAgCIAqBSAAACAAAkBQAIiAEICsgIJjKBlxCEcQAmwAGImYecyOCOhAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one,4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone,4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,4-[4-(4-chlorophenyl)-4-oxidanyl-piperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,4-[4-(4-chlorophenyl)-4-hydroxy-piperidino]-1-(4-fluorophenyl)butan-1-one,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",LNEPOXFFQSENCJ-UHFFFAOYSA-N,3.2,375.1401348,C21H23ClFNO2,375.9,40.5,375.1401348,0.0,26.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,"12  14  8
12  15  8
14  17  8
15  18  8
17  20  8
18  20  8
21  22  8
21  23  8
22  24  8
23  25  8
24  26  8
25  26  8",
440790541,3478,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00243,glipizide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00243,glipizide,3.0,Adverse reactions,vLess-DILI-Concern,2.0,3478,1.0,697.0,6.0,3.0,7.0,AAADceB7uABAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABwAAAHgQQQAAADCjB3gQ/gZLIEAKoAzV3VHDCgDQ3EiAI2Jm4dMiIYGrA0TGUIIgglgLIiMcQgIAOEAAAAAAAAAAgAAAAAAAAAAAAAAAAAA==,N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide,N-[2-[4-[[(cyclohexylamino)-oxomethyl]sulfamoyl]phenyl]ethyl]-5-methyl-2-pyrazinecarboxamide,<I>N</I>-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide,N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide,N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide,N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazinamide,"InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)",ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.9,445.17837553,C21H27N5O4S,445.5,139.0,445.17837553,0.0,31.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1,,"10  28  8
10  29  8
18  20  8
18  21  8
19  23  8
19  24  8
20  23  8
21  24  8
27  28  8
29  30  8
9  27  8
9  30  8",
440790540,3476,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00173,glimepiride,20210804,20210312,Curation Efforts|Governmental Organizations,LT00173,glimepiride,7.0,Adverse reactions,vLess-DILI-Concern,1.0,3476,1.0,895.0,5.0,3.0,7.0,AAADcfB7uABAAAAAAAAAAAAAAAAAAQAAAAAwYAAAAAAAAAABAAAAHgQQQAAADSjB2AQzAYPAAAKIAiFSEHDCABAgAAAIiJkIAMiIIDKAkRGEIAAolyKIiQcQgIAOEAAAAAAAAAAwAAAAAAAAAAAAAAAAAA==,4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide,4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide,4-ethyl-3-methyl-<I>N</I>-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2<I>H</I>-pyrrole-1-carboxamide,4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide,4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxidanylidene-2H-pyrrole-1-carboxamide,3-ethyl-2-keto-4-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-3-pyrroline-1-carboxamide,"InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)",WIGIZIANZCJQQY-UHFFFAOYSA-N,,490.22499137,C24H34N4O5S,490.6,133.0,490.22499137,0.0,34.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC(C)CC3)cc2)C1=O,3.9,"22  29  8
22  30  8
26  32  8
26  33  8
29  32  8
30  33  8",
440790539,3488,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00302,Glibenclamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00302,glibenclamide,3.0,Adverse reactions,vLess-DILI-Concern,2.0,3488,1.0,746.0,5.0,3.0,8.0,AAADceB7OABEAAAAAAAAAAAAAAAAAAAAAAAwYMAAAAAAAAABQAAAHgYQQAAADC7B2CYzB4LABAKIAiFSEHDCCBAkJQAIiJkODsiMJjaFtxuEMWhm9hOIqYeYyKCOECAAIAAIAAAgQABAABAAAAAAAAAAAA==,5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide,5-chloro-N-[2-[4-[[(cyclohexylamino)-oxomethyl]sulfamoyl]phenyl]ethyl]-2-methoxybenzamide,5-chloro-<I>N</I>-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide,5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide,5-chloranyl-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide,5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide,"InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)",ZNNLBTZKUZBEKO-UHFFFAOYSA-N,4.8,493.1438199,C23H28ClN3O5S,494.0,122.0,493.1438199,0.0,33.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,,"18  21  8
18  22  8
19  23  8
19  24  8
21  23  8
22  24  8
27  28  8
27  29  8
28  30  8
29  31  8
30  32  8
31  32  8",
440790538,55891,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01399,fosinopril,20210312,20210312,Curation Efforts|Governmental Organizations,LT01399,fosinopril,3.0,Adverse reactions,vLess-DILI-Concern,2.0,55891,1.0,850.0,7.0,1.0,15.0,AAADcfB6OAIAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAABAAAAHggACCAADSj5mAcyCIMABzCIQiHSGIACAAAgAAAIiAGIAIgaIDKAkTCGYAAkhgCciAeY2fKOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxy-propoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid","(2S,4S)-4-cyclohexyl-1-[2-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphoryl]-1-oxoethyl]-2-pyrrolidinecarboxylic acid","(2<I>S</I>,4<I>S</I>)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid","(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid","(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxy-propoxy)-(4-phenylbutyl)phosphoryl]ethanoyl]pyrrolidine-2-carboxylic acid","(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenylbutyl)phosphoryl]acetyl]proline","InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30?,39?/m1/s1",BIDNLKIUORFRQP-FKDWWROVSA-N,,563.3011898,C30H46NO7P,563.7,110.0,563.3011898,0.0,39.0,2.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)C(C)C,6.2,"1  23  3
10  40  5
16  21  5
25  64  3
31  33  8
31  34  8
33  36  8
34  37  8
36  38  8
37  38  8",
440790537,446987,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01398,FOSFOMYCIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT01398,fosfomycin,6.0,Adverse reactions,vLess-DILI-Concern,2.0,446987,1.0,138.0,4.0,2.0,1.0,AAADcYBAOAIAAAAAAAAAAAAAEgAAAAAAAAAAAAAAAAAAAAAAAAAAGggACCAACBSogAICAAAABBAAQAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(2R,3S)-3-methyloxiran-2-yl]phosphonic acid","[(2R,3S)-3-methyl-2-oxiranyl]phosphonic acid","[(2<I>R</I>,3<I>S</I>)-3-methyloxiran-2-yl]phosphonic acid","[(2R,3S)-3-methyloxiran-2-yl]phosphonic acid","[(2R,3S)-3-methyloxiran-2-yl]phosphonic acid","[(2R,3S)-3-methyloxiran-2-yl]phosphonic acid","InChI=1S/C3H7O4P/c1-2-3(7-2)8(4,5)6/h2-3H,1H3,(H2,4,5,6)/t2-,3+/m0/s1",YMDXZJFXQJVXBF-STHAYSLISA-N,,138.0081957,C3H7O4P,138.06,70.1,138.0081957,0.0,8.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H]1O[C@@H]1P(=O)(O)O,-1.4,"6  1  5
7  8  5",
440790536,636380,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01125,Fondaparinux sodium,20231222,20210312,Curation Efforts|Governmental Organizations,LT01125,fondaparinux sodium,3.0,Adverse reactions,vLess-DILI-Concern,2.0,636380,1.0,3330.0,52.0,9.0,20.0,AAADcfB7PjB4AAAAAAAAAAAAAAAAAAAAAAAkSJEiQAAAAAAAAAAAHgAQSAAACDzxgAcCCABABgAIAACQCDIAAAAAAAAAAIFAAAATEBYAgAQjQAAHMAAHAAH6fA1AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"decasodium;(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-5-sulfonatooxy-tetrahydropyran-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)tetrahydropyran-2-yl]oxy-4,5-dihydroxy-tetrahydropyran-2-carboxylate","decasodium;(2S,3S,4R,5R,6R)-6-[[(2R,3R,4R,5R,6R)-6-[[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-[[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)-3-oxanyl]oxy]-5-sulfonatooxy-3-oxanyl]oxy]-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)-3-oxanyl]oxy]-3-[[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)-2-oxanyl]oxy]-4,5-dihydroxy-2-oxanecarboxylate","decasodium;(2<I>S</I>,3<I>S</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-6-[(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-6-[(2<I>R</I>,3<I>S</I>,4<I>S</I>,5<I>R</I>,6<I>R</I>)-2-carboxylato-4-hydroxy-6-[(2<I>R</I>,3<I>S</I>,4<I>R</I>,5<I>R</I>,6<I>S</I>)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxyoxan-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3-[(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>,6<I>R</I>)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4,5-dihydroxyoxane-2-carboxylate","decasodium;(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxyoxan-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4,5-dihydroxyoxane-2-carboxylate","decasodium;(2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-bis(oxidanyl)-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxylato-6-[(2R,3S,4R,5R,6S)-6-methoxy-4-oxidanyl-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-4-oxidanyl-5-sulfonatooxy-oxan-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-4,5-bis(oxidanyl)oxane-2-carboxylate","decasodium;(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-2-(sulfatomethyl)-5-(sulfonatoamino)tetrahydropyran-3-yl]oxy-5-sulfato-tetrahydropyran-3-yl]oxy-4-sulfato-2-(sulfatomethyl)-5-(sulfonatoamino)tetrahydropyran-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(sulfatomethyl)-3-(sulfonatoamino)tetrahydropyran-2-yl]oxy-4,5-dihydroxy-tetrahydropyran-2-carboxylate","InChI=1S/C31H53N3O49S8.10Na/c1-69-27-9(33-85(48,49)50)13(37)17(6(74-27)3-71-88(57,58)59)76-31-22(83-91(66,67)68)16(40)21(24(81-31)26(43)44)79-29-10(34-86(51,52)53)19(82-90(63,64)65)18(7(75-29)4-72-89(60,61)62)77-30-15(39)14(38)20(23(80-30)25(41)42)78-28-8(32-84(45,46)47)12(36)11(35)5(73-28)2-70-87(54,55)56;;;;;;;;;;/h5-24,27-40H,2-4H2,1H3,(H,41,42)(H,43,44)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68);;;;;;;;;;/q;10*+1/p-10/t5-,6-,7-,8-,9-,10-,11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22-,23+,24-,27+,28-,29-,30-,31-;;;;;;;;;;/m1........../s1",XEKSTYNIJLDDAZ-JASSWCPGSA-D,,1726.7707769,C31H43N3Na10O49S8,1728.1,901.0,1726.7707769,0.0,101.0,25.0,0.0,0.0,0.0,0.0,11.0,-1.0,"1
5
255",CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)[O-])[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)[O-])[C@H]3NS(=O)(=O)[O-])[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](O)[C@H]1NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,"74  20  6
76  20  5
71  21  6
78  21  6
80  23  6
85  23  6
72  24  5
81  26  5
91  26  6
79  29  5
77  30  6
82  31  5
84  32  6
86  34  5
94  35  6
93  36  5
95  37  6
73  68  6
90  69  6
92  70  6
75  88  5
83  98  5
87  99  6
89  97  5
96  100  5",
440790535,3393,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01394,flurazepam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01394,flurazepam,4.0,Adverse reactions,vLess-DILI-Concern,2.0,3393,1.0,540.0,4.0,0.0,6.0,AAADceB7IQAEAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHwIAAAAADArBmCwywIMAAACoAyVyVACCAAAhBwAIiACoZpgIYKLBk5GUIAhghgDIyAcQgMAOAABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one","7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one","7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3<I>H</I>-1,4-benzodiazepin-2-one","7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one","7-chloranyl-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one","7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one","InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3",SAADBVWGJQAEFS-UHFFFAOYSA-N,3.0,387.1513682,C21H23ClFN3O,387.9,35.9,387.1513682,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,,"12  17  8
16  21  8
17  22  8
20  23  8
20  24  8
21  22  8
23  25  8
24  26  8
25  27  8
26  27  8
9  12  8
9  16  8",
440790534,3386,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00018,fluoxetine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00018,fluoxetine,3.0,Adverse reactions,vLess-DILI-Concern,1.0,3386,1.0,308.0,5.0,1.0,6.0,AAADceB6IYAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHwAQAAAADBThmBYyBoLABACAAiBCAAACCAAgIAAIiIAOCIgMJiKEsRqGOCCm0BEIqAeQwKAOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine,<I>N</I>-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,methyl-[3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]amine,"InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4.0,309.13404868,C17H18F3NO,309.33,21.3,309.13404868,0.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,,"10  13  8
11  14  8
12  15  8
12  16  8
13  18  8
14  18  8
15  20  8
16  21  8
17  20  8
17  21  8
6  7  3
8  10  8
8  11  8",
440790533,3356,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01375,flecainide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01375,flecainide,7.0,Adverse reactions,vLess-DILI-Concern,2.0,3356,1.0,500.0,10.0,2.0,7.0,AAADceB7McAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHwAQAAAADCzhmBYwBoLABACIAiFSEACCCAAkIAAIiIEODMgMZjaEtRuWOWjm9hGIqYf6yDCOAQABAAAIAAACAAIAABAAAAAAAAAAAA==,"N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide","N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide","<I>N</I>-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide","N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide","N-(piperidin-2-ylmethyl)-2,5-bis[2,2,2-tris(fluoranyl)ethoxy]benzamide","N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide","InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)",DJBNUMBKLMJRSA-UHFFFAOYSA-N,3.8,414.13781148,C17H20F6N2O3,414.34,59.6,414.13781148,0.0,28.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,,"12  29  3
19  20  8
19  21  8
20  23  8
21  22  8
22  24  8
23  24  8",
440790532,3333,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00397,felodipine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00397,felodipine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,3333,1.0,614.0,5.0,1.0,6.0,AAADceB6OAAGAAAAAAAAAAAAAAAAAAAAAAAwQAAAAAAAAAABAAAAHgIQAAAADQqhmCIyCILABACIAiTSSAACAAAgBQAIikEAAsgIJDKBMxCCMAAkkACIqUeI7uiOgAAAIAABAAQAAABAAAIACAAAAAAAAA==,"O5-ethyl O3-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid O5-ethyl ester O3-methyl ester","5-<I>O</I>-ethyl 3-<I>O</I>-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","O5-ethyl O3-methyl 4-[2,3-bis(chloranyl)phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid O5-ethyl ester O3-methyl ester","InChI=1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3",RZTAMFZIAATZDJ-UHFFFAOYSA-N,3.9,383.0691135,C18H19Cl2NO4,384.2,64.6,383.0691135,0.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,,"11  18  8
11  19  8
18  20  8
19  21  8
20  22  8
21  22  8
8  26  3",
440790531,3325,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00095,famotidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00095,famotidine,3.0,Adverse reactions,vLess-DILI-Concern,1.0,3325,1.0,469.0,8.0,4.0,7.0,AAADccBzsABgAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAABgAAAHAQQQAAACAiFVgChkRJIEAikAQZiZDAA8KlBCjgAABQwIACAAAAgAQAAAAAAEAIgACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N'-sulfamoyl-propanamidine,3-[[2-(diaminomethylideneamino)-4-thiazolyl]methylthio]-N'-sulfamoylpropanimidamide,"3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-<I>N</I>&apos;-sulfamoylpropanimidamide","3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide","3-[[2-[bis(azanyl)methylideneamino]-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoyl-propanimidamide",3-[(2-guanidinothiazol-4-yl)methylthio]-N'-sulfamoyl-propionamidine,"InChI=1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)",XUFQPHANEAPEMJ-UHFFFAOYSA-N,-0.6,337.04493627,C8H15N7O2S3,337.5,238.0,337.04493627,0.0,20.0,0.0,0.0,0.0,1.0,0.0,1.0,-1.0,"1
5
255",NC(N)=Nc1nc(CSCCC(N)=NS(N)(=O)=O)cs1,,"17  18  8
3  18  8
3  19  8
6  16  1
7  17  8
7  19  8",
440790530,36462,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00094,etoposide,20210804,20210312,Curation Efforts|Governmental Organizations,LT00094,etoposide,3.0,Adverse reactions,vLess-DILI-Concern,2.0,36462,1.0,969.0,13.0,3.0,5.0,AAADcfB4PAAAAAAAAAAAAAAAAAAAASJAAAA0aMECAAAAAEjRQAAAGgAACAAADRSwmAMyDoAABgCIAiDSCAACCAAgIAAAiAEGiIgdNzKGMRqicCMlwBUPuAfK6PyOoAABCAAQQADAAAYQADCAAAAAAAAAAA==,"(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one","(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one","(5<I>S</I>,5<I>a</I><I>R</I>,8<I>a</I><I>R</I>,9<I>R</I>)-5-[[(2<I>R</I>,4<I>a</I><I>R</I>,6<I>R</I>,7<I>R</I>,8<I>R</I>,8<I>a</I><I>S</I>)-7,8-dihydroxy-2-methyl-4,4<I>a</I>,6,7,8,8<I>a</I>-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5<I>a</I>,6,8<I>a</I>,9-tetrahydro-5<I>H</I>-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one","(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one","(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-2-methyl-7,8-bis(oxidanyl)-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(3,5-dimethoxy-4-oxidanyl-phenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one","(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one","InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1",VJJPUSNTGOMMGY-MRVIYFEKSA-N,0.6,588.18429107,C29H32O13,588.6,161.0,588.18429107,0.0,42.0,10.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,,"16  1  5
22  1  5
14  43  6
15  44  5
17  23  6
18  19  8
18  28  8
19  29  8
23  33  8
23  34  8
25  51  5
27  53  6
28  31  8
29  32  8
31  32  8
33  37  8
34  36  8
35  40  6
36  39  8
37  39  8
24  6  6
26  8  5",
440790529,5757,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00016,estradiol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00016,estradiol,2.0,Adverse reactions,vLess-DILI-Concern,1.0,5757,1.0,382.0,2.0,2.0,0.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYMAAAAAAAGDBAAAAGgAACAAADxSgmAIyBoAAAgCAAiBCAAACAAAgIAAIiAAGCIgINiKCERKAcAAkwBEImAeAwPAPoAABAAAQAADAAAYAACAAAIAADAAAAA==,"(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","(8<I>R</I>,9<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.0,272.177630004,C18H24O2,272.4,40.5,272.177630004,0.0,20.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,,"7  1  5
14  16  8
14  17  8
16  18  8
17  19  8
18  20  8
19  20  8
3  13  5
4  21  6
5  22  5
6  23  6",
440790528,9579578,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01589,Esomeprazole Sodium,20231222,20210312,Curation Efforts|Governmental Organizations,LT01589,esomeprazole Sodium,4.0,Adverse reactions,vLess-DILI-Concern,2.0,9579578,1.0,453.0,6.0,1.0,5.0,AAADceB7MABAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgB/AAAHgQQAAAADAzF3ga/1rbJlAqgAzRnZEDK2i3xMrAJ2SA+fJiMbuLkuZuUMChu0BvI6CewUAMOAEAAAgAAACAAgAAEAAAAQAAAAAAAAA==,"6-methoxy-2-[(R)-(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole","6-methoxy-2-[(R)-(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole","6-methoxy-2-[(<I>R</I>)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1<I>H</I>-benzimidazole","6-methoxy-2-[(R)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole","6-methoxy-2-[(R)-(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-1H-benzimidazole","6-methoxy-2-[(R)-(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole","InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m1/s1",SUBDBMMJDZJVOS-XMMPIXPASA-N,2.2,345.11471265,C17H19N3O3S,345.4,96.3,345.11471265,0.0,24.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2nc([S@](=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,,"1  8  6
10  13  8
12  14  8
12  17  8
13  15  8
14  19  8
15  18  8
17  20  8
19  21  8
20  21  8
5  11  8
5  12  8
6  11  8
6  14  8
7  18  8
7  9  8
9  10  8",
440790527,146570,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02929,Escitalopram,20210312,20210312,Curation Efforts|Governmental Organizations,LT02929,escitalopram,7.0,Adverse reactions,vLess-DILI-Concern,2.0,146570,1.0,466.0,4.0,0.0,5.0,AAADceB7IQAAAAAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAEgBQAAAHwAAAAAADEThmA4yAIMABACQBiBCAAAiAAAgAAAIiAAICIgIpiKAsRiGMAAkwAEIqA+wwPAOwAACAAAQAACAAAQAACAAAAAAAAAAAA==,(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile,(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile,(1<I>S</I>)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3<I>H</I>-2-benzofuran-5-carbonitrile,(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile,(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile,(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)phthalan-5-carbonitrile,"InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1",WSEQXVZVJXJVFP-FQEVSTJZSA-N,,324.16379146,C20H21FN2O,324.4,36.3,324.16379146,0.0,24.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,3.2,"10  15  8
10  16  8
13  17  8
14  18  8
15  19  8
16  20  8
17  18  8
19  21  8
20  21  8
5  6  5
7  13  8
7  8  8
8  14  8",
440790526,16667706,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00954,enoxaparin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00954,enoxaparin,3.0,Adverse reactions,vLess-DILI-Concern,2.0,16667706,1.0,3810.0,53.0,20.0,29.0,AAADcfB/vjBgAAAAAAAAAAAAAAAAAAAAAAAkSJEiQAAAAAAAAAAAHgAQCAAACDzxgAcCCALABgCIACHSGDIACAAgIAAACIFIAEgTFBYAgAQnUAAH9gCfEYP6fA9AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"tetrasodium;(2R,4S)-2-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6S)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-methoxy-tetrahydropyran-3-yl]oxy-2-carboxy-4,5-dihydroxy-tetrahydropyran-3-yl]oxy-4-hydroxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-2-carboxy-4,5-dihydroxy-tetrahydropyran-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)tetrahydropyran-3-yl]oxy-2-carboxy-4,5-dihydroxy-tetrahydropyran-3-yl]oxy-4-hydroxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-4-hydroxy-3-sulfonatooxy-3,4-dihydro-2H-pyran-6-carboxylate","tetrasodium;(2R,4S)-2-[[(2R,4R,5R,6R)-5-acetamido-6-[[(3S,4R,5R,6R)-6-[[(2R,4R,5R,6R)-5-acetamido-6-[[(3S,4R,5R,6R)-6-[[(2R,4R,5R,6R)-5-acetamido-6-[[(3S,4R,5R,6R)-6-[[(2R,4R,5R,6S)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-methoxy-3-oxanyl]oxy]-2-carboxy-4,5-dihydroxy-3-oxanyl]oxy]-4-hydroxy-2-(sulfonatooxymethyl)-3-oxanyl]oxy]-2-carboxy-4,5-dihydroxy-3-oxanyl]oxy]-4-hydroxy-2-(hydroxymethyl)-3-oxanyl]oxy]-2-carboxy-4,5-dihydroxy-3-oxanyl]oxy]-4-hydroxy-2-(sulfonatooxymethyl)-3-oxanyl]oxy]-4-hydroxy-3-sulfonatooxy-3,4-dihydro-2H-pyran-6-carboxylate","tetrasodium;(2<I>R</I>,4<I>S</I>)-2-[(2<I>R</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-5-acetamido-6-[(3<I>S</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-6-[(2<I>R</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-5-acetamido-6-[(3<I>S</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-6-[(2<I>R</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-5-acetamido-6-[(3<I>S</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-6-[(2<I>R</I>,4<I>R</I>,5<I>R</I>,6<I>S</I>)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-4-hydroxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-4-hydroxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-4-hydroxy-3-sulfonatooxy-3,4-dihydro-2<I>H</I>-pyran-6-carboxylate","tetrasodium;(2R,4S)-2-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6S)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-4-hydroxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-4-hydroxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-4-hydroxy-3-sulfonatooxy-3,4-dihydro-2H-pyran-6-carboxylate","tetrasodium;(2R,4S)-2-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6S)-5-acetamido-2-(hydroxymethyl)-6-methoxy-4-oxidanyl-oxan-3-yl]oxy-2-carboxy-4,5-bis(oxidanyl)oxan-3-yl]oxy-4-oxidanyl-2-(sulfonatooxymethyl)oxan-3-yl]oxy-2-carboxy-4,5-bis(oxidanyl)oxan-3-yl]oxy-2-(hydroxymethyl)-4-oxidanyl-oxan-3-yl]oxy-2-carboxy-4,5-bis(oxidanyl)oxan-3-yl]oxy-4-oxidanyl-2-(sulfonatooxymethyl)oxan-3-yl]oxy-4-oxidanyl-3-sulfonatooxy-3,4-dihydro-2H-pyran-6-carboxylate","tetrasodium;(2R,4S)-2-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6R)-5-acetamido-6-[(3S,4R,5R,6R)-6-[(2R,4R,5R,6S)-5-acetamido-4-hydroxy-6-methoxy-2-methylol-tetrahydropyran-3-yl]oxy-2-carboxy-4,5-dihydroxy-tetrahydropyran-3-yl]oxy-4-hydroxy-2-(sulfatomethyl)tetrahydropyran-3-yl]oxy-2-carboxy-4,5-dihydroxy-tetrahydropyran-3-yl]oxy-4-hydroxy-2-methylol-tetrahydropyran-3-yl]oxy-2-carboxy-4,5-dihydroxy-tetrahydropyran-3-yl]oxy-4-hydroxy-2-(sulfatomethyl)tetrahydropyran-3-yl]oxy-4-hydroxy-3-sulfato-3,4-dihydro-2H-pyran-6-carboxylate","InChI=1S/C57H86N4O53S3.4Na/c1-11(64)58-21-25(69)36(17(7-62)100-50(21)96-5)104-54-32(76)29(73)41(44(111-54)48(83)84)109-52-23(60-13(3)66)27(71)38(19(102-52)9-97-115(87,88)89)106-56-34(78)31(75)40(43(113-56)47(81)82)108-51-22(59-12(2)65)26(70)37(18(8-63)101-51)105-55-33(77)30(74)42(45(112-55)49(85)86)110-53-24(61-14(4)67)28(72)39(20(103-53)10-98-116(90,91)92)107-57-35(114-117(93,94)95)15(68)6-16(99-57)46(79)80;;;;/h6,15,17-45,50-57,62-63,68-78H,7-10H2,1-5H3,(H,58,64)(H,59,65)(H,60,66)(H,61,67)(H,79,80)(H,81,82)(H,83,84)(H,85,86)(H,87,88,89)(H,90,91,92)(H,93,94,95);;;;/q;4*+1/p-4/t15-,17+,18+,19+,20+,21+,22+,23+,24+,25+,26+,27+,28+,29+,30+,31+,32+,33+,34+,35?,36?,37?,38?,39?,40-,41-,42-,43?,44?,45?,50-,51+,52+,53+,54+,55+,56+,57-;;;;/m0..../s1",XQBRZOQYSSXWAB-ZWUZPHRPSA-J,,1858.2597141,C57H82N4Na4O53S3,1859.4,904.0,1858.2597141,0.0,121.0,30.0,8.0,0.0,0.0,0.0,5.0,-1.0,"1
5
255",CO[C@H]1O[C@H](CO)C(O[C@@H]2OC(C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])C(O[C@@H]4OC(C(=O)O)[C@@H](O[C@H]5O[C@H](CO)C(O[C@@H]6OC(C(=O)O)[C@@H](O[C@H]7O[C@H](COS(=O)(=O)[O-])C(O[C@@H]8OC(C(=O)[O-])=C[C@H](O)C8OS(=O)(=O)[O-])[C@H](O)[C@H]7NC(C)=O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5NC(C)=O)[C@H](O)C4O)[C@H](O)[C@H]3NC(C)=O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1NC(C)=O.[Na+].[Na+].[Na+].[Na+],,"66  12  3
82  12  5
75  13  5
81  13  6
79  15  6
87  15  5
93  19  5
96  19  3
68  20  5
69  21  6
76  22  6
78  23  5
106  24  5
90  24  3
83  25  5
84  26  6
86  28  5
89  29  6
91  30  6
98  33  6
102  34  5
110  45  3
112  48  5
67  61  6
70  62  5
85  63  5
100  64  5
73  95  6
74  97  5
65  8  3
77  8  6
80  101  3
88  104  3
71  9  6
72  9  5
92  105  3
94  103  6
99  109  6",
440790525,5388962,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00296,enalapril,20231222,20210312,Curation Efforts|Governmental Organizations,LT00296,enalapril,7.0,Adverse reactions,vLess-DILI-Concern,1.0,5388962,1.0,519.0,6.0,2.0,10.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHgAQCAAADCjhmAYyCIPABgCIAiHSGAACAAAgAAAIiIGIAIgKYDKAkTCXYAAklgCYiAeY2bKOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-2-pyrrolidinecarboxylic acid,(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-[[(1S)-1-carbethoxy-3-phenyl-propyl]amino]propanoyl]proline,"InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1",GBXSMTUPTTWBMN-XIRDDKMYSA-N,-0.1,376.199822,C20H28N2O5,376.4,95.9,376.199822,0.0,27.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O,,"20  21  8
20  22  8
21  24  8
22  25  8
24  26  8
25  26  8
13  7  5
15  7  5
8  14  5",
440790524,54671203,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00393,doxycycline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00393,doxycycline,3.0,Adverse reactions,vLess-DILI-Concern,1.0,54671203,1.0,956.0,9.0,6.0,2.0,AAADceB7PAAAAAAAAAAAAAAAAAAAAAAAAAAwYIEAAAAAAACBAAAAHgAQCAAADXzhmAYyBoNAAgCIAqFSEAKCAAAgIAAIiAHOCMgJNz6KkTKEcAAn4BEJmQf+7vSugAABAAAYAADAAAYQADAAAAAAAAAAAA==,"(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4<I>S</I>,4<I>a</I><I>R</I>,5<I>S</I>,5<I>a</I><I>R</I>,6<I>R</I>,12<I>a</I><I>R</I>)-4-(dimethylamino)-1,5,10,11,12<I>a</I>-pentahydroxy-6-methyl-3,12-dioxo-4<I>a</I>,5,5<I>a</I>,6-tetrahydro-4<I>H</I>-tetracene-2-carboxamide","(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-6-methyl-1,5,10,11,12a-pentakis(oxidanyl)-3,12-bis(oxidanylidene)-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-3,12-diketo-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","InChI=1S/C22H24N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-7,10,14-15,17,25-27,30,32H,1-3H3,(H2,23,31)/t7-,10+,14+,15-,17-,22-/m0/s1",SGKRLCUYIXIAHR-AKNGSSGZSA-N,-0.7,444.15326573,C22H24N2O8,444.4,182.0,444.15326573,0.0,32.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H]1c2cccc(O)c2C(O)=C2C(=O)[C@]3(O)C(O)=C(C(N)=O)C(=O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,,"13  1  6
11  33  6
12  34  6
16  25  6
14  2  6
20  24  8
20  26  8
24  29  8
26  31  8
29  32  8
31  32  8
15  9  6",
440790523,31703,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00335,doxorubicin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00335,doxorubicin,3.0,Adverse reactions,vLess-DILI-Concern,2.0,31703,1.0,977.0,12.0,6.0,5.0,AAADceB6PAAAAAAAAAAAAAAAAAAAAAAAAAA0YMGCAAAAAADBQAAAHgAQCAAADHzxmAcyDoBABgCIAqBSAAICCAAkIAAIiIFGCMgfNzaGtRqicWAn8BEPuYfL7PzOwQADAAAYAADCAAYQADAAAAAAAAAAAA==,"(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione","(7<I>S</I>,9<I>S</I>)-7-[(2<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>S</I>)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7<I>H</I>-tetracene-5,12-dione","(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione","(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone","InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1",AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.3,543.17406074,C27H29NO11,543.5,206.0,543.17406074,0.0,39.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,,"13  1  6
19  1  5
21  12  6
17  18  8
17  24  8
18  26  8
23  29  6
24  27  8
26  28  8
27  28  8
14  3  6
33  34  8
33  35  8
34  36  8
35  37  8
36  38  8
37  38  8
22  4  6",
440790522,667477,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01314,doxepin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01314,doxepin,4.0,Adverse reactions,vLess-DILI-Concern,2.0,667477,1.0,363.0,2.0,0.0,3.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABIAAAAABQAAAHgAAAAAADAThmAYyBoMABACAAiBCAAACCAAgIAAIiAAOCIgMJiKEMRqGOCCkwBEIqAeAwPAOgAAAAAAYAAAAAAAAADAAAAAAAAAAAA==,"(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine","(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-1-propanamine","(3<I>E</I>)-3-(6<I>H</I>-benzo[c][1]benzoxepin-11-ylidene)-<I>N</I>,<I>N</I>-dimethylpropan-1-amine","(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine","(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine",[(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)propyl]-dimethyl-amine,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3/b17-11+",ODQWQRRAPPTVAG-GZTJUZNOSA-N,4.3,279.162314293,C19H21NO,279.4,12.5,279.162314293,0.0,21.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CC/C=C1\c2ccccc2COc2ccccc21,,"11  15  8
12  16  8
13  17  8
14  18  8
15  19  8
16  17  8
18  19  8
4  12  8
4  6  8
5  11  8
5  14  8
6  13  8",
440790521,3152,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00052,donepezil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00052,donepezil,3.0,Adverse reactions,vLess-DILI-Concern,2.0,3152,1.0,510.0,4.0,0.0,6.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAYAAAAA8YIAAAAAAAGABQAAAHgAAAAAADQTBmAYyBoMABACIAqBSAACCCAAkIAAIiAEOjMgNJjKEtRuEMSpkwBGKqYeazPDOoAABAAAQQABAAAIAACCAAQAACAAAAA==,"2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-one","5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-2,3-dihydroinden-1-one","2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one","2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one","5,6-dimethoxy-2-[[1-(phenylmethyl)piperidin-4-yl]methyl]-2,3-dihydroinden-1-one","2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-one","InChI=1S/C24H29NO3/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18/h3-7,14-15,17,20H,8-13,16H2,1-2H3",ADEBPBSSDYVVLD-UHFFFAOYSA-N,,379.21474379,C24H29NO3,379.5,38.8,379.21474379,0.0,28.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,4.3,"14  15  8
14  17  8
15  18  8
17  20  8
18  21  8
19  22  8
19  23  8
20  21  8
22  24  8
23  25  8
24  26  8
25  26  8
7  6  3",
440790520,3114,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01302,disopyramide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01302,disopyramide,2.0,Adverse reactions,vLess-DILI-Concern,2.0,3114,1.0,409.0,3.0,1.0,8.0,AAADceB7IAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHgAQAAAADijBngQ+gJNIEACoAzV3VACCgCAxAiAI2CE4ZJgIIPrA1ZGEIAhggADIyAcciMCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,4-(diisopropylamino)-2-phenyl-2-(2-pyridyl)butanamide,4-[di(propan-2-yl)amino]-2-phenyl-2-(2-pyridinyl)butanamide,4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide,4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide,4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-yl-butanamide,4-(diisopropylamino)-2-phenyl-2-(2-pyridyl)butyramide,"InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)",UVTNFZQICZKOEM-UHFFFAOYSA-N,,339.231062557,C21H29N3O,339.5,59.2,339.231062557,0.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,3.2,"10  17  8
10  18  8
11  19  8
17  20  8
18  21  8
19  22  8
20  23  8
21  23  8
22  25  8
24  25  8
3  11  8
3  24  8
5  6  3",
440790519,154101,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02909,Dexmethylphenidate,20250421,20210312,Curation Efforts|Governmental Organizations,LT02909,dexmethylphenidate,7.0,Adverse reactions,vLess-DILI-Concern,2.0,154101,1.0,249.0,3.0,1.0,4.0,AAADceByMAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHgAQAAAADSjBmAYyCILABACIAiDSCAACAAAgAAAIiIEIAIgIIDqAlRGEIAAm0AGIiAeYyOCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,methyl (2R)-2-phenyl-2-[(2R)-2-piperidyl]acetate,(2R)-2-phenyl-2-[(2R)-2-piperidinyl]acetic acid methyl ester,methyl (2<I>R</I>)-2-phenyl-2-[(2<I>R</I>)-piperidin-2-yl]acetate,methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate,methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]ethanoate,(2R)-2-phenyl-2-[(2R)-2-piperidyl]acetic acid methyl ester,"InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1",DUGOZIWVEXMGBE-CHWSQXEVSA-N,0.2,233.141578849,C14H19NO2,233.31,38.3,233.141578849,0.0,17.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1,,"10  12  8
10  13  8
12  14  8
13  15  8
14  16  8
15  16  8
4  18  6
6  11  6",
440790518,9578005,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01266,dexlansoprazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT01266,dexlansoprazole,4.0,Adverse reactions,vLess-DILI-Concern,2.0,9578005,1.0,480.0,8.0,1.0,5.0,AAADccB7MYBAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgB/AAAHwQQAAAADAzl3ha/1rbJlAqgAzRnZEDK2i3xMrAJ2SA+fJiMbuLkuZuWOCjukBrI6CcQAAAOAAAAAAAAACAAAAAAAAAAQAAAAAAAAA==,"2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole","2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole","2-[(<I>R</I>)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1<I>H</I>-benzimidazole","2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole","2-[(R)-[3-methyl-4-[2,2,2-tris(fluoranyl)ethoxy]pyridin-2-yl]methylsulfinyl]-1H-benzimidazole","2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole","InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m1/s1",MJIHNNLFOKEZEW-RUZDIDTESA-N,2.8,369.07588236,C16H14F3N3O2S,369.4,87.1,369.07588236,0.0,25.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1,,"1  10  6
11  12  8
12  16  8
14  15  8
14  18  8
15  20  8
16  19  8
18  22  8
19  21  8
20  23  8
22  23  8
7  13  8
7  14  8
8  13  8
8  15  8
9  11  8
9  21  8",
440790517,125017,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00573,Desvenlafaxine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00573,desvenlafaxine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,125017,1.0,266.0,3.0,2.0,4.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABAAAAHgAACAAADUTBmAQyBoMAAgCAAiBCAAACAAAgIAAIiAAOCIgIJiKCkROEcAAmwBEImAeQwPAOoAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol,4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol,4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol,4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol,4-[2-(dimethylamino)-1-(1-oxidanylcyclohexyl)ethyl]phenol,4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol,"InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3",KYYIDSXMWOZKMP-UHFFFAOYSA-N,,263.18852904,C16H25NO2,263.37,43.7,263.18852904,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,2.6,"12  13  8
12  14  8
13  17  8
14  18  8
17  19  8
18  19  8
5  20  3",
440790516,124087,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01085,Desloratadine,20210804,20210312,Curation Efforts|Governmental Organizations,LT01085,desloratadine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,124087,1.0,425.0,2.0,1.0,0.0,AAADceB7AAAEAAAAAAAAAAAAAAAAAAAAAAA8WIAABgAAAAABwAAAHAIQAAAADArBHiQ8gJLIEACgAzRnRACCgCAxByAI2KA4ZpgIIOLBk5GEIAhgkADIyAcQgMAOhAAAIAAQAAAIAABAACAAAAAAAAAAAA==,"13-chloro-2-(4-piperidylidene)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene","13-chloro-2-(4-piperidinylidene)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene","13-chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.0<SUP>3,8</SUP>]pentadeca-1(11),3(8),4,6,12,14-hexaene","13-chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene","13-chloranyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene","13-chloro-2-(4-piperidylidene)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene","InChI=1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2",JAUOIFJMECXRGI-UHFFFAOYSA-N,4.5,310.1236763,C19H19ClN2,310.8,24.9,310.1236763,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,,"10  13  8
10  16  8
11  15  8
13  17  8
15  18  8
16  19  8
17  20  8
18  21  8
19  20  8
21  22  8
3  11  8
3  22  8",
440790515,3062316,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01248,Dasatinib,20250421,20210312,Curation Efforts|Governmental Organizations,LT01248,dasatinib,4.0,Adverse reactions,vLess-DILI-Concern,2.0,3062316,1.0,642.0,9.0,3.0,7.0,AAADceB7sABEAAAAAAAAAAAAAAAAAWAAAAA8WIAAAAAAAAAB8AAAHgYQCAAADArh2yY/8ZfIEgisAjd3dACC8Kl1D7lJ2C04ZtiKeCrB29HUJIholALYyOcQgAAOAAAAIAACABAAAABAAAQAIAAAAAAAAA==,N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide,N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide,"<I>N</I>-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide","N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide","N-(2-chloranyl-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide",N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazino]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide,"InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)",ZBNZXTGUTAYRHI-UHFFFAOYSA-N,,487.155722,C22H26ClN7O2S,488.0,135.0,487.155722,0.0,33.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,3.6,"10  23  8
10  26  8
17  19  8
19  20  8
2  23  8
2  24  8
24  26  8
25  27  8
25  29  8
27  30  8
29  32  8
30  33  8
32  33  8
7  17  8
7  21  8
8  20  8
8  21  8",
440790514,16134395,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01200,DAPTOMYCIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT01200,daptomycin,5.0,Adverse reactions,vLess-DILI-Concern,2.0,16134395,1.0,3480.0,28.0,22.0,35.0,AAADcfB//gAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgB9AAAHgAQCAAADTzhngY+yPLJlgCoA7X3XACCgCA1AiAI2aG4ZNgKcP7A1bGXYYhmtgDYyce/3/KOgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"(3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxo-butanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxo-ethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methyl-ethyl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxo-butanoic acid","(3S)-3-[[(2S)-4-amino-2-[[(2S)-3-(1H-indol-3-yl)-1-oxo-2-(1-oxodecylamino)propyl]amino]-1,4-dioxobutyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid","(3<I>S</I>)-3-[[(2<I>S</I>)-4-amino-2-[[(2<I>S</I>)-2-(decanoylamino)-3-(1<I>H</I>-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3<I>S</I>,6<I>S</I>,9<I>R</I>,15<I>S</I>,18<I>R</I>,21<I>S</I>,24<I>S</I>,30<I>S</I>,31<I>R</I>)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2<I>R</I>)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid","(3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid","(3S)-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxidanylidene-ethyl]-24-(3-azanylpropyl)-9-(hydroxymethyl)-15,21-bis(2-hydroxy-2-oxoethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decakis(oxidanylidene)-6-[(2R)-4-oxidanyl-4-oxidanylidene-butan-2-yl]-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-3-[[(2S)-4-azanyl-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxidanylidene-butanoyl]amino]-4-oxidanylidene-butanoic acid","(3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(caprylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-keto-butanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-keto-ethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methyl-ethyl]-2,5,8,11,14,17,20,23,26,29-decaketo-18,31-dimethyl-9-methylol-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-keto-butyric acid","InChI=1S/C72H101N17O26/c1-5-6-7-8-9-10-11-22-53(93)81-44(25-38-31-76-42-20-15-13-17-39(38)42)66(108)84-45(27-52(75)92)67(109)86-48(30-59(102)103)68(110)89-61-37(4)115-72(114)49(26-51(91)40-18-12-14-19-41(40)74)87-71(113)60(35(2)24-56(96)97)88-69(111)50(34-90)82-55(95)32-77-63(105)46(28-57(98)99)83-62(104)36(3)79-65(107)47(29-58(100)101)85-64(106)43(21-16-23-73)80-54(94)33-78-70(61)112/h12-15,17-20,31,35-37,43-50,60-61,76,90H,5-11,16,21-30,32-34,73-74H2,1-4H3,(H2,75,92)(H,77,105)(H,78,112)(H,79,107)(H,80,94)(H,81,93)(H,82,95)(H,83,104)(H,84,108)(H,85,106)(H,86,109)(H,87,113)(H,88,111)(H,89,110)(H,96,97)(H,98,99)(H,100,101)(H,102,103)/t35-,36-,37-,43+,44+,45+,46+,47+,48+,49+,50-,60+,61+/m1/s1",DOAKLVKFURWEDJ-RWDRXURGSA-N,,1619.71036639,C72H101N17O26,1620.7,702.0,1619.71036639,0.0,115.0,13.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,-5.1,"100  107  8
102  109  8
105  113  6
106  112  5
107  111  8
109  111  8
50  29  6
56  30  6
63  31  6
68  32  5
33  75  8
33  76  8
44  48  5
45  117  6
49  61  5
57  73  6
60  70  8
60  76  8
64  82  6
70  75  8
70  84  8
75  86  8
83  85  5
84  92  8
86  95  8
88  100  8
88  102  8
92  95  8
96  103  5",
440790513,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00961,Dalteparin sodium,20210312,20210312,Curation Efforts|Governmental Organizations,LT00961,dalteparin sodium,3.0,Adverse reactions,vLess-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790512,2913,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01255,CYPROHEPTADINE,20210804,20210312,Curation Efforts|Governmental Organizations,LT01255,cyproheptadine,7.0,Adverse reactions,vLess-DILI-Concern,2.0,2913,1.0,423.0,1.0,0.0,0.0,AAADceB6AAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAABAAAAAABQAAAHAAAAAAADADBGAQyAIMAAACAAiBCAAACAAAgAAAIiAAIAIgIICKAkRCEIAAggACIiAcQgMAOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine","1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine","1-methyl-4-(2-tricyclo[9.4.0.0<SUP>3,8</SUP>]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine","1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine","1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine","1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine","InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3",JJCFRYNCJDLXIK-UHFFFAOYSA-N,4.7,287.167399674,C21H21N,287.4,3.2,287.167399674,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,,"11  17  8
12  18  8
13  19  8
14  20  8
17  21  8
18  22  8
19  21  8
20  22  8
8  11  8
8  13  8
9  12  8
9  14  8",
440790511,2907,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00013,cyclophosphamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00013,cyclophosphamide,5.0,Adverse reactions,vLess-DILI-Concern,1.0,2907,1.0,212.0,4.0,1.0,5.0,AAADccBjMAIGAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAAAAAAAHgIQgCAACAPhgEYAAAJAARAAQAAAAIAAAAAAAAAAAIAIAAAAAAAAAABAAAACEACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine","N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphorinan-2-amine","<I>N</I>,<I>N</I>-bis(2-chloroethyl)-2-oxo-1,3,2&lambda;<SUP>5</SUP>-oxazaphosphinan-2-amine","N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine","N,N-bis(2-chloroethyl)-2-oxidanylidene-1,3,2lambda5-oxazaphosphinan-2-amine","bis(2-chloroethyl)-(2-keto-1,3,2lambda5-oxazaphosphorinan-2-yl)amine","InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)",CMSMOCZEIVJLDB-UHFFFAOYSA-N,0.6,260.0248201,C7H15Cl2N2O2P,261.08,41.6,260.0248201,0.0,14.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=P1(N(CCCl)CCCl)NCCCO1,,3  6  3,
440790510,2895,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01249,cyclobenzaprine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01249,cyclobenzaprine,5.0,Adverse reactions,vLess-DILI-Concern,2.0,2895,1.0,365.0,1.0,0.0,3.0,AAADceB6AAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHAAAAAAADADBGAQyAIMAAACAAiBCAAACAAAgAAAIiAAIAIgIICKAERCEIAAggAAIiAcAgMAOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine","N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)-1-propanamine","<I>N</I>,<I>N</I>-dimethyl-3-(2-tricyclo[9.4.0.0<SUP>3,8</SUP>]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine","N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine","N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine","dimethyl-[3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propyl]amine","InChI=1S/C20H21N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-14H,7,15H2,1-2H3",JURKNVYFZMSNLP-UHFFFAOYSA-N,5.2,275.167399674,C20H21N,275.4,3.2,275.167399674,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,,"12  16  8
13  17  8
14  18  8
15  19  8
16  18  8
17  19  8
3  12  8
3  8  8
4  13  8
4  9  8
8  14  8
9  15  8",
440790509,2882,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02004,Cromoglicate,20231222,20210312,Curation Efforts|Governmental Organizations,LT02004,cromoglicate,3.0,Adverse reactions,vLess-DILI-Concern,1.0,2882,1.0,835.0,11.0,3.0,8.0,AAADceB4PAAAAAAAAAAAAAAAAAAAAAAAAAAwYIEAAAAAAACBQAAAGgAACAAADBSgmAIwDoAABgCIAqDSCAICCAAkIAAIiAFGCMgNNzaENR6COWCl4BULuYeI6KyOAAAACAAIAAAAAAAQABAAAAAAAAAAAA==,5-[3-(2-carboxy-4-oxo-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-oxo-chromene-2-carboxylic acid,5-[3-[(2-carboxy-4-oxo-1-benzopyran-5-yl)oxy]-2-hydroxypropoxy]-4-oxo-1-benzopyran-2-carboxylic acid,5-[3-(2-carboxy-4-oxochromen-5-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylic acid,5-[3-(2-carboxy-4-oxochromen-5-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylic acid,5-[3-(2-carboxy-4-oxidanylidene-chromen-5-yl)oxy-2-oxidanyl-propoxy]-4-oxidanylidene-chromene-2-carboxylic acid,5-[3-(2-carboxy-4-keto-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-keto-chromene-2-carboxylic acid,"InChI=1S/C23H16O11/c24-11(9-31-14-3-1-5-16-20(14)12(25)7-18(33-16)22(27)28)10-32-15-4-2-6-17-21(15)13(26)8-19(34-17)23(29)30/h1-8,11,24H,9-10H2,(H,27,28)(H,29,30)",IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.9,468.06926132,C23H16O11,468.4,166.0,468.06926132,0.0,34.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1,,"15  17  8
15  21  8
16  18  8
16  22  8
17  19  8
17  23  8
18  20  8
18  24  8
19  25  8
20  26  8
21  27  8
22  28  8
23  29  8
24  30  8
25  27  8
26  28  8
29  31  8
30  32  8
4  19  8
4  31  8
5  20  8
5  32  8",
440790508,60606,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01023,clopidogrel,20210312,20210312,Curation Efforts|Governmental Organizations,LT01023,clopidogrel,7.0,Adverse reactions,vLess-DILI-Concern,2.0,60606,1.0,381.0,4.0,0.0,4.0,AAADceB6MABEAAAAAAAAAAAAAAAAASAAAAA8QAAAAAAAAFgBwAAAHgYAAAAADCrF2CayCYMABAiMAiDSCACDAIAgDRBIiBmIBogKIDKhlzGFIAhkwAG4iAeYyKCOAAAAAAABAAAAAAAAAAIAAAAAAAAAAA==,"methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate","(2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetic acid methyl ester","methyl (2<I>S</I>)-2-(2-chlorophenyl)-2-(6,7-dihydro-4<I>H</I>-thieno[3,2-c]pyridin-5-yl)acetate","methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate","methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)ethanoate","(2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetic acid methyl ester","InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1",GKTWGGQPFAXNFI-HNNXBMFYSA-N,,321.0590276,C16H16ClNO2S,321.8,57.8,321.0590276,0.0,21.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,3.8,"10  11  8
10  13  8
12  16  8
12  17  8
13  15  8
16  18  8
17  19  8
18  20  8
19  20  8
2  11  8
2  15  8
8  14  5",
440790507,2802,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00532,clonazepam,20231222,20210312,Curation Efforts|Governmental Organizations,LT00532,clonazepam,3.0,Adverse reactions,vLess-DILI-Concern,2.0,2802,1.0,491.0,4.0,1.0,1.0,AAADccBzMAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHgIUAAAADArBmCQwwILQQACpAyVyVwCCAAAhBwAoiACgZpoIYKLBk5GUIAhglADIyAcQgMAOAACAQAADAAAAAQCAAAYAAAAAAAAAAA==,"5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one","5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one","5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one","5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one","5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one","5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one","InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)",DGBIGWXXNGSACT-UHFFFAOYSA-N,2.4,315.0410689,C15H10ClN3O3,315.71,87.3,315.0410689,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,,"11  18  8
11  19  8
12  15  8
13  17  8
15  17  8
18  20  8
19  21  8
20  22  8
21  22  8
8  12  8
8  9  8
9  13  8",
440790506,2771,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00219,citalopram,20210312,20210312,Curation Efforts|Governmental Organizations,LT00219,citalopram,7.0,Adverse reactions,vLess-DILI-Concern,2.0,2771,1.0,466.0,4.0,0.0,5.0,AAADceB7IQAAAAAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAEgBQAAAHwAAAAAADEThmA4yAIMABACQBiBCAAAiAAAgAAAIiAAICIgIpiKAsRiGMAAkwAEIqA+wwPAOwAACAAAQAACAAAQAACAAAAAAAAAAAA==,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3<I>H</I>-2-benzofuran-5-carbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)phthalan-5-carbonitrile,"InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3",WSEQXVZVJXJVFP-UHFFFAOYSA-N,,324.16379146,C20H21FN2O,324.4,36.3,324.16379146,0.0,24.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,3.2,"10  15  8
10  16  8
13  17  8
14  18  8
15  19  8
16  20  8
17  18  8
19  21  8
20  21  8
5  6  3
7  13  8
7  8  8
8  14  8",
440790505,2756,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01218,cimetidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01218,cimetidine,2.0,Adverse reactions,vLess-DILI-Concern,1.0,2756,1.0,296.0,4.0,3.0,7.0,AAADceBzgABAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAABgAAAHAQQAAAACAjFVgSHkBbJkAiwAQRhZAAAgC2RELABWYA4UACASABgCAAUAAAIEAJgACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine,1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine,1-cyano-2-methyl-3-[2-[(5-methyl-1<I>H</I>-imidazol-4-yl)methylsulfanyl]ethyl]guanidine,1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine,1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine,1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine,"InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)",AQIXAKUUQRKLND-UHFFFAOYSA-N,0.4,252.11571571,C10H16N6S,252.34,114.0,252.11571571,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C/N=C(\NC#N)NCCSCc1nc[nH]c1C,,"2  12  8
2  14  8
4  14  8
4  8  8
8  12  8",
440790504,2727,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00379,chlorpropamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT00379,chlorpropamide,2.0,Adverse reactions,vLess-DILI-Concern,1.0,2727,1.0,345.0,3.0,2.0,4.0,AAADccBzMABEAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgYQQAAACALBUCQzAYLAAAKIACBCEHBCABAgBQAIiJgIAoiIICKBExCEIAAglgIIiAcAAAAAAAIAAAAAAAAABAAAAAAAAAAAAAAAAA==,1-(4-chlorophenyl)sulfonyl-3-propyl-urea,1-(4-chlorophenyl)sulfonyl-3-propylurea,1-(4-chlorophenyl)sulfonyl-3-propylurea,1-(4-chlorophenyl)sulfonyl-3-propylurea,1-(4-chlorophenyl)sulfonyl-3-propyl-urea,1-(4-chlorophenyl)sulfonyl-3-propyl-urea,"InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)",RKWGIWYCVPQPMF-UHFFFAOYSA-N,2.3,276.0335411,C10H13ClN2O3S,276.74,83.7,276.0335411,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,,"12  15  8
13  16  8
15  17  8
16  17  8
9  12  8
9  13  8",
440790503,2726,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00068,chlorpromazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00068,chlorpromazine,2.0,Adverse reactions,vLess-DILI-Concern,1.0,2726,1.0,339.0,3.0,0.0,4.0,AAADceB7AABEAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACxQAAAHAYAAAAACArBUCQywYMAAAiAACRCQACCAAAhDxAIiBwIZogIIGLh05GEIAhggADoyAcQAAAAAAIAAAIAAQAABAAABAACAAAAAAAAAA==,"3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine","3-(2-chloro-10-phenothiazinyl)-N,N-dimethyl-1-propanamine","3-(2-chlorophenothiazin-10-yl)-<I>N</I>,<I>N</I>-dimethylpropan-1-amine","3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine","3-(2-chloranylphenothiazin-10-yl)-N,N-dimethyl-propan-1-amine",3-(2-chlorophenothiazin-10-yl)propyl-dimethyl-amine,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",ZPEIMTDSQAKGNT-UHFFFAOYSA-N,5.2,318.0957475,C17H19ClN2S,318.9,31.8,318.0957475,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,,"10  14  8
11  15  8
12  18  8
13  19  8
14  20  8
15  21  8
18  20  8
19  21  8
8  10  8
8  12  8
9  11  8
9  13  8",
440790502,2720,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01208,chlorothiazide,20210312,20210312,Curation Efforts|Governmental Organizations,LT01208,chlorothiazide,2.0,Adverse reactions,vLess-DILI-Concern,2.0,2720,1.0,532.0,6.0,2.0,1.0,AAADcYBjOABkAAAAAAAAAAAAAAAAAAAAAAAwQAAAAAAAAACBAAAAHAYQQAAACAqBUCQxwYLAAAKgACRDYHDCABAhBwABiJwIZogIICLBmpGEIAhgkABIyAcQAAAAAAYAAEIAAYAADAAAhAADAAAAAAAAAA==,"6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-1,1-dioxo-4<I>H</I>-1&lambda;<SUP>6</SUP>,2,4-benzothiadiazine-7-sulfonamide","6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloranyl-1,1-bis(oxidanylidene)-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","6-chloro-1,1-diketo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","InChI=1S/C7H6ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-3H,(H,10,11)(H2,9,12,13)",JBMKAUGHUNFTOL-UHFFFAOYSA-N,-0.2,294.9488257,C7H6ClN3O4S2,295.7,135.0,294.9488257,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,,"11  12  8
11  14  8
12  15  8
13  14  8
13  16  8
15  16  8",
440790501,2719,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01207,chloroquine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01207,chloroquine,3.0,Adverse reactions,vLess-DILI-Concern,1.0,2719,1.0,309.0,3.0,1.0,8.0,AAADceB7AAAEAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAACx8AAAHAIQAAAADCrBHiQ+wPPIEACgAzRnRACCgCAxByAI2KA4ZpgIIOLB09GEJAhgkADIyAcQgIAOBAAAAAICAAAIAAAABAQAAAAAAAAAAA==,"N4-(7-chloro-4-quinolyl)-N1,N1-diethyl-pentane-1,4-diamine","N4-(7-chloro-4-quinolinyl)-N1,N1-diethylpentane-1,4-diamine","4-<I>N</I>-(7-chloroquinolin-4-yl)-1-<I>N</I>,1-<I>N</I>-diethylpentane-1,4-diamine","4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine","N4-(7-chloranylquinolin-4-yl)-N1,N1-diethyl-pentane-1,4-diamine",4-[(7-chloro-4-quinolyl)amino]pentyl-diethyl-amine,"InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)",WHTVZRBIWZFKQO-UHFFFAOYSA-N,4.6,319.1815255,C18H26ClN3,319.9,28.2,319.1815255,0.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,,"12  13  8
12  16  8
13  17  8
13  18  8
16  19  8
17  20  8
18  21  8
20  22  8
21  22  8
4  17  8
4  19  8
7  27  3",
440790500,2712,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01198,chlordiazepoxide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01198,chlordiazepoxide,5.0,Adverse reactions,vLess-DILI-Concern,2.0,2712,1.0,580.0,3.0,1.0,1.0,AAADccB7IAAEAAAAAAAAAAAAAAAAAAAAAAAwQAAABAAAAAABAAAAHAIECAAADArBGAQzAIIQAACgAyZiZACCAAEgAAAoiAA4BJgIYCKAkRGUIAhggACIiAcQgAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine","7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine","7-chloro-4-hydroxy-<I>N</I>-methyl-5-phenyl-3<I>H</I>-1,4-benzodiazepin-2-imine","7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine","7-chloranyl-N-methyl-4-oxidanyl-5-phenyl-3H-1,4-benzodiazepin-2-imine","(7-chloro-4-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-ylidene)-methyl-amine","InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9,21H,10H2,1H3",BUCORZSTKDOEKQ-UHFFFAOYSA-N,2.4,299.0825398,C16H14ClN3O,299.75,48.2,299.0825398,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C/N=C1/CN(O)C(c2ccccc2)=c2cc(Cl)ccc2=N1,,"10  13  8
12  16  8
13  17  8
14  18  8
15  19  8
16  17  8
18  20  8
19  20  8
7  10  8
7  12  8
9  14  8
9  15  8",
440790499,2678,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01190,cetirizine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01190,cetirizine,3.0,Adverse reactions,vLess-DILI-Concern,2.0,2678,1.0,443.0,5.0,1.0,8.0,AAADceB7MAAEAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAABQAAAHgIACAAADCrhmCYwCIMABgCIAiDSCAKCAAAgBQAIiABIBogLYCKBkxWXIAhggACbiAcQgMAOBAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid,2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid,2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid,2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid,2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanoic acid,2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazino]ethoxy]acetic acid,"InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)",ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.7,388.1553704,C21H25ClN2O3,388.9,53.0,388.1553704,0.0,27.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,,"11  36  3
13  16  8
13  17  8
14  18  8
14  19  8
16  20  8
17  21  8
18  22  8
19  23  8
20  24  8
21  24  8
22  25  8
23  25  8",
440790498,27447,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01189,cephalexin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01189,cephalexin,4.0,Adverse reactions,vLess-DILI-Concern,2.0,27447,1.0,600.0,6.0,3.0,4.0,AAADceB7OABAAAAAAAAAAAAAAABYAAAAAAAwQAAAAAAQAAABAAAAHgQQCAAADCjF2ASyCIPAAgiIAiXSWACCAABgABAIiIGIBMgKZDqglTGUMABglgC4mQcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-1-oxo-2-phenylethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>R</I>)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-azanyl-2-phenyl-ethanoyl]amino]-3-methyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-8-keto-3-methyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1",ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,0.6,347.09397721,C16H17N3O4S,347.4,138.0,347.09397721,0.0,24.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1,,"19  20  8
19  21  8
20  22  8
21  23  8
22  24  8
23  24  8
10  7  5
18  8  5
9  25  6",
440790497,5479529,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01186,cefuroxime,20231222,20210312,Curation Efforts|Governmental Organizations,LT01186,cefuroxime,5.0,Adverse reactions,vLess-DILI-Concern,2.0,5479529,1.0,798.0,10.0,3.0,8.0,AAADceB7vABAAAAAAAAAAAAAAABYASAAAAAgAAAAAAAQAAABgAAAHgQUCAAADCzl0AayDIPQBkioA63y2AQCCABkIBAIiIGuCNkOZr6stTueGSCm9hG4uYeYSAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-3-(carbamoyloxymethyl)-7-[[(2<I>Z</I>)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-(aminocarbonyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyimino-ethanoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methyloximino-acetyl]amino]-8-keto-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C16H16N4O8S/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24)/b19-9-/t10-,14-/m1/s1",JFPVXVDWJQMJEE-IZRZKJBUSA-N,-0.2,424.06888465,C16H16N4O8S,424.4,199.0,424.06888465,0.0,29.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,"15  11  5
14  30  6
24  26  8
26  27  8
27  28  8
7  24  8
7  28  8",
440790496,5479530,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01185,ceftriaxone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01185,ceftriaxone,4.0,Adverse reactions,vLess-DILI-Concern,2.0,5479530,1.0,1110.0,13.0,4.0,8.0,AAADceB7+ABgAAAAAAAAAAAAAABYAWAAAAAgQAAAAAAQAAABgAAAHgQcCAAADCjF1gajmRP6EgisAwXyfAAA8KlhCjkTKJW4IFiCZJggxCEUEAAAFgKwESAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-[[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>Z</I>)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1<I>H</I>-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-3-[[2-methyl-5,6-bis(oxidanylidene)-1H-1,2,4-triazin-3-yl]sulfanylmethyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methyloximino-acetyl]amino]-3-[[(5,6-diketo-2-methyl-1H-1,2,4-triazin-3-yl)thio]methyl]-8-keto-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C18H18N8O7S3/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32)/b24-8-/t9-,15-/m1/s1",VAAUVRVFOQPIGI-SPQHTLEESA-N,-1.3,554.04605846,C18H18N8O7S3,554.6,288.0,554.04605846,0.0,36.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(=O)[nH]n3C)CS[C@H]12)c1csc(N)n1,,"20  12  5
13  16  8
13  29  8
15  29  8
15  33  8
16  34  8
17  30  8
17  35  8
19  37  6
3  31  8
3  35  8
30  31  8
33  34  8",
440790495,5481173,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00062,ceftazidime,20231222,20210312,Curation Efforts|Governmental Organizations,LT00062,ceftazidime,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5481173,1.0,1020.0,12.0,3.0,8.0,AAADceB7uABgAAAAAAAAAAAAAABYAWAAAAAsQAAAAAAQAAAB4AAAHgQUCAAADGzF1gS/mZPcEgisAzX3fAKC8KlxCjkI2LX4ZNiLZPrg1bGUcAhglgL5ySYQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(2-carboxypropan-2-yloxyimino)-1-oxoethyl]amino]-8-oxo-3-(1-pyridin-1-iumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>Z</I>)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","(6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-(2-methyl-1-oxidanyl-1-oxidanylidene-propan-2-yl)oxyimino-ethanoyl]amino]-8-oxidanylidene-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethyl)oximino-acetyl]amino]-8-keto-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/b26-13-/t14-,18-/m1/s1",ORFOPKXBNMVMKC-DWVKKRMSSA-N,0.4,546.09913941,C22H22N6O7S2,546.6,245.0,546.09913941,0.0,37.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)O,,"17  11  5
12  26  8
12  27  8
14  28  8
14  37  8
16  38  6
2  33  8
2  37  8
26  29  8
27  30  8
28  33  8
29  31  8
30  31  8",
440790494,5281006,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01182,cefprozil,20250421,20210312,Curation Efforts|Governmental Organizations,LT01182,cefprozil,4.0,Adverse reactions,vLess-DILI-Concern,2.0,5281006,1.0,699.0,7.0,4.0,5.0,AAADceB7OABAAAAAAAAAAAAAAABYAAAAAAAwQAAAAAAQAAABAAAAHgQQCAAADCzF2ASyDoPAAgiIAiXSWACCAABgIBAIiIGODMgKZjqilTOUcABk1hG4mQeY2IGOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>R</I>)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(<I>E</I>)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-azanyl-2-(4-hydroxyphenyl)ethanoyl]amino]-8-oxidanylidene-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-keto-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C18H19N3O5S/c1-2-3-10-8-27-17-13(16(24)21(17)14(10)18(25)26)20-15(23)12(19)9-4-6-11(22)7-5-9/h2-7,12-13,17,22H,8,19H2,1H3,(H,20,23)(H,25,26)/b3-2+/t12-,13-,17-/m1/s1",WDLWHQDACQUCJR-ZAMMOSSLSA-N,-1.4,389.10454189,C18H19N3O5S,389.4,158.0,389.10454189,0.0,27.0,3.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",C/C=C/C1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1,,"10  28  6
20  22  8
20  23  8
22  25  8
23  26  8
25  27  8
26  27  8
11  8  5
18  9  5",
440790493,5742673,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01177,cefotaxime,20231222,20210312,Curation Efforts|Governmental Organizations,LT01177,cefotaxime,5.0,Adverse reactions,vLess-DILI-Concern,2.0,5742673,1.0,833.0,12.0,3.0,8.0,AAADceB7uABgAAAAAAAAAAAAAABYAWAAAAAgAAAAAAAQAAABgAAAHgQUCAAADCjl1gajmRPYFgisAwXyfAAA8KlhCjkACJW4IFiCZJgg5CEWEAAAFgKwMSAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-3-(acetyloxymethyl)-7-[[(2<I>Z</I>)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methyloximino-acetyl]amino]-8-keto-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9-/t10-,14-/m1/s1",GPRBEKHLDVQUJE-QSWIMTSFSA-N,-1.4,455.05694025,C16H17N5O7S2,455.5,227.0,455.05694025,0.0,30.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1,,"16  11  5
13  25  8
13  29  8
15  31  6
2  27  8
2  29  8
25  27  8",
440790492,44187,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01176,cefoperazone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01176,cefoperazone,3.0,Adverse reactions,vLess-DILI-Concern,2.0,44187,1.0,1250.0,13.0,4.0,9.0,AAADceB7/ABgAAAAAAAAAAAAAABYAWAAAAA8QIAAAAAQAAABwAAAHgQYCAAADCzF2ASzHofIAgiqAiXSfACCEANgoJANyIGODMiKZjqilTOUcAhs1zO4mQeY2IOOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)-oxomethyl]amino]-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>R</I>)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-[[4-ethyl-2,3-bis(oxidanylidene)piperazin-1-yl]carbonylamino]-2-(4-hydroxyphenyl)ethanoyl]amino]-3-[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanylmethyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-diketo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-keto-3-[[(1-methyltetrazol-5-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C25H27N9O8S2/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41)/t15-,16-,22-/m1/s1",GCFBRXLSHGKWDP-XCGNWRKASA-N,-0.7,645.1424012,C25H27N9O8S2,645.7,271.0,645.1424012,0.0,44.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O,,"21  12  5
28  13  5
16  18  8
16  38  8
17  19  8
17  38  8
18  19  8
20  45  6
30  34  8
30  35  8
34  40  8
35  41  8
40  42  8
41  42  8",
440790491,5479537,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01172,cefepime,20231222,20210312,Curation Efforts|Governmental Organizations,LT01172,cefepime,3.0,Adverse reactions,vLess-DILI-Concern,2.0,5479537,1.0,869.0,10.0,2.0,6.0,AAADceB7uABgAAAAAAAAAAAAAABYAWLAAAAgAAAAAAAQAAABgAAAHgQUAAAADCjF1gajmRPYEAisAwXyfACA8KlhCjkACJW4IFiCZJggxCEUEAAAFgKwASAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-[(1-methyl-1-pyrrolidin-1-iumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>Z</I>)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","(6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methyloximino-acetyl]amino]-8-keto-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","InChI=1S/C19H24N6O5S2/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29)/b23-12-/t13-,17-/m1/s1",HVFLCNVBZFFHBT-ZKDACBOMSA-N,-0.1,480.12496023,C19H24N6O5S2,480.6,204.0,480.12496023,0.0,32.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1,,"22  10  5
12  29  8
12  31  8
2  30  8
2  31  8
21  46  6
29  30  8",
440790490,6915944,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01289,cefdinir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01289,cefdinir,7.0,Adverse reactions,vLess-DILI-Concern,2.0,6915944,1.0,739.0,10.0,4.0,5.0,AAADccBzuABgAAAAAAAAAAAAAABYAWAAAAAgAAAAAAAQAAABgAAAHgQUCAAADCjF1gShmRPYEgisAyXyfAAA8KlhCjkICJW4IFiKZJggxCEUEAAAFgKwkSAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetyl]amino]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>Z</I>)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-hydroxyimino-ethanoyl]amino]-3-ethenyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-hydroximino-acetyl]amino]-8-keto-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C14H13N5O5S2/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1",RTXOFQZKPXMALH-GHXIOONMSA-N,0.0,395.03581088,C14H13N5O5S2,395.4,212.0,395.03581088,0.0,26.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1,,"11  24  8
11  26  8
13  27  6
2  25  8
2  26  8
24  25  8
14  9  5",
440790489,33255,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01171,cefazolin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01171,cefazolin,3.0,Adverse reactions,vLess-DILI-Concern,2.0,33255,1.0,740.0,12.0,2.0,7.0,AAADccBz+ABgAAAAAAAAAAAAAABYAWLAAAAgAAAAAAAQAAAB4AAAHgQYCAAADCjFwgSHGAfIAgiuAgXxfAAQAYNQgJAVSIGYAECCRAggCCAUEAAAHgKwEQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxidanylidene-7-[2-(1,2,3,4-tetrazol-1-yl)ethanoylamino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-8-keto-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1",MLYYVTUWGNIJIB-BXKDBHETSA-N,-0.4,454.03001448,C14H14N8O4S3,454.5,235.0,454.03001448,0.0,29.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,"10  11  8
10  27  8
11  14  8
12  15  8
12  26  8
13  14  8
13  27  8
15  28  8
16  30  6
3  26  8
3  28  8
17  9  5",
440790488,47965,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01167,cefadroxil,20250421,20210312,Curation Efforts|Governmental Organizations,LT01167,cefadroxil,7.0,Adverse reactions,vLess-DILI-Concern,2.0,47965,1.0,629.0,7.0,4.0,4.0,AAADceB7OABAAAAAAAAAAAAAAABYAAAAAAAwQAAAAAAQAAABAAAAHgQQCAAADCzF2ASyDoPAAgiIAiXSWACCAABgIBAIiIGODMgKZjqilTOUcABk1hG4mQeY2IGOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>R</I>)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-azanyl-2-(4-hydroxyphenyl)ethanoyl]amino]-3-methyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-keto-3-methyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C16H17N3O5S/c1-7-6-25-15-11(14(22)19(15)12(7)16(23)24)18-13(21)10(17)8-2-4-9(20)5-3-8/h2-5,10-11,15,20H,6,17H2,1H3,(H,18,21)(H,23,24)/t10-,11-,15-/m1/s1",BOEGTKLJZSQCCD-UEKVPHQBSA-N,-2.1,363.08889182,C16H17N3O5S,363.4,158.0,363.08889182,0.0,25.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1,,"10  26  6
20  21  8
20  22  8
21  23  8
22  24  8
23  25  8
24  25  8
11  8  5
19  9  5",
440790487,51039,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01166,cefaclor,20231222,20210312,Curation Efforts|Governmental Organizations,LT01166,cefaclor,3.0,Adverse reactions,vLess-DILI-Concern,2.0,51039,1.0,606.0,6.0,3.0,4.0,AAADccBzOABEAAAAAAAAAAAAAABYAAAAAAAwQAAAAAAQAAABAAAAHgYQCAAADCrF2ASwCIPAAgiIAiXSWACCAABgABAIiIGIBMgKZDqglTGUMABglgC4mQcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-1-oxo-2-phenylethyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6<I>R</I>,7<I>R</I>)-7-[[(2<I>R</I>)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-azanyl-2-phenyl-ethanoyl]amino]-3-chloranyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-keto-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid","InChI=1S/C15H14ClN3O4S/c16-8-6-24-14-10(13(21)19(14)11(8)15(22)23)18-12(20)9(17)7-4-2-1-3-5-7/h1-5,9-10,14H,6,17H2,(H,18,20)(H,22,23)/t9-,10-,14-/m1/s1",QYIYFLOTGYLRGG-GPCCPHFNSA-N,-1.8,367.0393548,C15H14ClN3O4S,367.8,138.0,367.0393548,0.0,24.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1,,"10  25  6
19  20  8
19  21  8
20  22  8
21  23  8
22  24  8
23  24  8
11  8  5
17  9  5",
440790486,2585,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00207,carvedilol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00207,carvedilol,3.0,Adverse reactions,vLess-DILI-Concern,2.0,2585,1.0,508.0,5.0,3.0,10.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAWAAAAAwYMAAAAAAAFgB/AAAHgAQCAAADBzhngYyxvLJlgCgAyRiRACCiCAhIiAImaA+7JgPNuLEsZuHOCrm0Bnb6Aew0OMOgAAAAgAKQAAAAAAEABSAAAAAAAAAAA==,1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol,1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanol,1-(9<I>H</I>-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol,1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol,1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol,1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",OGHNVEJMJSYVRP-UHFFFAOYSA-N,4.2,406.18925731,C24H26N2O4,406.5,75.7,406.18925731,0.0,30.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,,"10  18  8
11  17  8
15  19  8
16  21  8
17  19  8
18  22  8
12  2  3
21  22  8
24  25  8
24  26  8
25  27  8
26  28  8
27  29  8
28  29  8
5  10  8
5  9  8
7  11  8
7  8  8
7  9  8
8  10  8
8  16  8
9  15  8",
440790485,44093,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00059,captopril,20210312,20210312,Curation Efforts|Governmental Organizations,LT00059,captopril,7.0,Adverse reactions,vLess-DILI-Concern,1.0,44093,1.0,244.0,4.0,2.0,3.0,AAADccByMABAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAAAAAAAHgQACAAADSjFwASCCAMAAgQIAAGQGAAAAAAAAAAAAAGIAAACABIAgCAEQAAEBgCQAACYEQIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]-2-pyrrolidinecarboxylic acid,(2<I>S</I>)-1-[(2<I>S</I>)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid,(2S)-1-[(2S)-3-mercapto-2-methyl-propanoyl]proline,"InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1",FAKRSMQSSFJEIM-RQJHMYQMSA-N,0.3,217.07726451,C9H15NO3S,217.29,58.6,217.07726451,0.0,14.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,,"11  14  5
6  12  5",
440790484,2541,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01022,candesartan,20210804,20210312,Curation Efforts|Governmental Organizations,LT01022,candesartan,3.0,Adverse reactions,vLess-DILI-Concern,2.0,2541,1.0,660.0,7.0,2.0,7.0,AAADceB7sAAAAAAAAAAAAAAAAAAAAWLAAAAwYMAAAAAAAFgB/AAAHgAYCAAADAjhnwYz2LcOFgCqAybybACCgC8lEqAd+CE4fNiIbrrAnZGccYhuwAPI2ee8yOCOwAAAQAASACCAAACAACQAQAAAAAAAAA==,2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid,2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4-benzimidazolecarboxylic acid,2-ethoxy-3-[[4-[2-(2<I>H</I>-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid,2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid,"2-ethoxy-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid",2-ethoxy-3-[4-[2-(2H-tetrazol-5-yl)phenyl]benzyl]benzimidazole-4-carboxylic acid,"InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)",HTQMVQVXFRQIKW-UHFFFAOYSA-N,,440.15968852,C24H20N6O3,440.5,119.0,440.15968852,0.0,33.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,4.1,"11  13  8
11  15  8
12  16  8
12  17  8
13  19  8
15  22  8
16  20  8
17  21  8
18  20  8
18  21  8
19  24  8
22  24  8
23  25  8
23  28  8
25  29  8
28  30  8
29  32  8
30  32  8
4  11  8
4  14  8
5  13  8
5  14  8
6  31  8
6  8  8
7  31  8
7  9  8
8  9  8",
440790483,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02432,Canakinumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT02432,canakinumab,3.0,Adverse reactions,vLess-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790482,444,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00058,bupropion,20210312,20210312,Curation Efforts|Governmental Organizations,LT00058,bupropion,5.0,Adverse reactions,vLess-DILI-Concern,1.0,444,1.0,247.0,2.0,1.0,4.0,AAADceByIAAEAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgIQAAAADK7BmCQyAILAAACIAqBSAAACAAAkBQAIiIGIAsgIIDKBlzGEIQAgkACIiYcYiICOAAAAIAAAAAAAAABAAAAAAAAAAAAAAA==,2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,2-(tert-butylamino)-1-(3-chlorophenyl)-1-propanone,2-(<I>tert</I>-butylamino)-1-(3-chlorophenyl)propan-1-one,2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,"InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3",SNPPWIUOZRMYNY-UHFFFAOYSA-N,,239.1076919,C13H18ClNO,239.74,29.1,239.1076919,0.0,16.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,3.2,"11  12  8
11  13  8
12  14  8
13  15  8
14  16  8
15  16  8
5  9  3",
440790481,2315,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00825,BENDROFLUMETHIAZIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00825,bendroflumethiazide,5.0,Adverse reactions,vLess-DILI-Concern,2.0,2315,1.0,740.0,10.0,3.0,3.0,AAADccBzOYBgAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACxQAAAHQQQQAAADAjBWBQxwYLAAAKAAiRCQHDCABAhAgAIiJwIZIiIICLAkZGEIAhgkALIyCcQgIAOEAQAQEAEAQAgCACAgAgCAAAAAAAAAA==,"3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","1,1-dioxo-3-(phenylmethyl)-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2<I>H</I>-1&lambda;<SUP>6</SUP>,2,4-benzothiadiazine-7-sulfonamide","3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","1,1-bis(oxidanylidene)-3-(phenylmethyl)-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","3-benzyl-1,1-diketo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","InChI=1S/C15H14F3N3O4S2/c16-15(17,18)10-7-11-13(8-12(10)26(19,22)23)27(24,25)21-14(20-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,20-21H,6H2,(H2,19,22,23)",HDWIHXWEUNVBIY-UHFFFAOYSA-N,1.2,421.03778277,C15H14F3N3O4S2,421.4,135.0,421.03778277,0.0,27.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,,"13  16  3
14  15  8
14  17  8
15  18  8
17  19  8
18  20  8
19  20  8
21  23  8
21  24  8
23  25  8
24  26  8
25  27  8
26  27  8",
440790480,5362124,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01116,benazepril,20210312,20210312,Curation Efforts|Governmental Organizations,LT01116,benazepril,4.0,Adverse reactions,vLess-DILI-Concern,2.0,5362124,1.0,619.0,6.0,2.0,10.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABYAAAAABQAAAHgAQCAAADCjhmAYyyIPABgCIAiXSWACCAAAhAgAIiIGIZIgKYDLAkbGXIAhklgDYyAeYyLCOAAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid","2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid","2-[(3<I>S</I>)-3-[[(2<I>S</I>)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3<I>H</I>-1-benzazepin-1-yl]acetic acid","2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid","2-[(3S)-3-[[(2S)-1-ethoxy-1-oxidanylidene-4-phenyl-butan-2-yl]amino]-2-oxidanylidene-4,5-dihydro-3H-1-benzazepin-1-yl]ethanoic acid","2-[(3S)-3-[[(1S)-1-carbethoxy-3-phenyl-propyl]amino]-2-keto-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid","InChI=1S/C24H28N2O5/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28)/t19-,20-/m0/s1",XPCFTKFZXHTYIP-PMACEKPBSA-N,,424.199822,C24H28N2O5,424.5,95.9,424.199822,0.0,31.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O,1.3,"13  14  8
13  19  8
14  20  8
19  22  8
20  23  8
21  25  8
21  26  8
22  23  8
25  28  8
26  29  8
28  30  8
29  30  8
11  6  6
8  6  5",
440790479,2284,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01113,baclofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT01113,baclofen,3.0,Adverse reactions,vLess-DILI-Concern,2.0,2284,1.0,191.0,3.0,2.0,4.0,AAADccByMAAEAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgIQCAAADQLBmCQwCIBAAgCIAiDSCAACAAAgBQAIiIEAAogIIDKBkxGAYAAkkAAIiAe8yOCOhAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,4-amino-3-(4-chlorophenyl)butanoic acid,4-amino-3-(4-chlorophenyl)butanoic acid,4-amino-3-(4-chlorophenyl)butanoic acid,4-amino-3-(4-chlorophenyl)butanoic acid,4-azanyl-3-(4-chlorophenyl)butanoic acid,4-amino-3-(4-chlorophenyl)butyric acid,"InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)",KPYSYYIEGFHWSV-UHFFFAOYSA-N,-1.0,213.0556563,C10H12ClNO2,213.66,63.3,213.0556563,0.0,14.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCC(CC(=O)O)c1ccc(Cl)cc1,,"10  13  8
12  14  8
13  14  8
5  15  3
6  10  8
6  9  8
9  12  8",
440790478,447043,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00265,azithromycin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00265,azithromycin,7.0,Adverse reactions,vLess-DILI-Concern,2.0,447043,1.0,1150.0,14.0,5.0,7.0,AAADcfB/PAAAAAAAAAAAAAAAAAAAAAAAAAAkSAAAAAAAAAAAAAAAHgAACAAADXzxgAcCCAMABgAIAACQCAAAAAAAAAAAAAEIAAATEBYAgAAmQAAHIACXAAH4/P7OAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one","(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-2-oxanyl]oxy]-2-ethyl-3,4,10-trihydroxy-13-[[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-2-oxanyl]oxy]-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one","(2<I>R</I>,3<I>S</I>,4<I>R</I>,5<I>R</I>,8<I>R</I>,10<I>R</I>,11<I>R</I>,12<I>S</I>,13<I>S</I>,14<I>R</I>)-11-[(2<I>S</I>,3<I>R</I>,4<I>S</I>,6<I>R</I>)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2<I>R</I>,4<I>R</I>,5<I>S</I>,6<I>S</I>)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one","(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one","(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-6-methyl-3-oxidanyl-oxan-2-yl]oxy-2-ethyl-13-[(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-oxidanyl-oxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-3,4,10-tris(oxidanyl)-1-oxa-6-azacyclopentadecan-15-one","(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one","InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",MQTOSJVFKKJCRP-BICOPXKESA-N,4.0,748.50852574,C38H72N2O12,749.0,180.0,748.50852574,0.0,52.0,18.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,"15  1  6
22  1  5
33  10  5
35  11  6
29  14  5
16  23  5
18  2  6
24  2  5
20  39  6
21  41  5
17  3  5
32  43  5
36  47  6
37  48  5
38  45  6
26  7  5
27  8  6
31  9  5",
440790477,2249,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00277,atenolol,20250421,20210312,Curation Efforts|Governmental Organizations,LT00277,atenolol,4.0,Adverse reactions,vLess-DILI-Concern,2.0,2249,1.0,263.0,4.0,3.0,8.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADDzhmAYyBoLABgCIAiFSEAACCAAgIAAIiIEOCIgPNjKEtRuGOCCm0BGbqAeYyICOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide,2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide,2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide,2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide,2-[4-[2-oxidanyl-3-(propan-2-ylamino)propoxy]phenyl]ethanamide,2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide,"InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)",METKIMKYRPQLGS-UHFFFAOYSA-N,0.2,266.16304257,C14H22N2O3,266.34,84.6,266.16304257,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,,"12  14  8
12  15  8
13  16  8
13  17  8
14  16  8
15  17  8
7  2  3",
440790476,2187,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00263,anastrozole,20250421,20210312,Curation Efforts|Governmental Organizations,LT00263,anastrozole,3.0,Adverse reactions,vLess-DILI-Concern,2.0,2187,1.0,456.0,4.0,0.0,4.0,AAADceB7gAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHAAIAAAADgDBGAQ3EIYIEACyBiBDJACSAAswgIAVyAAIBIiIqCKAmRGEIAhogAIIiA8QgMAPgAACAAAAAAAAAAQAAAAAAAAAAAAAAA==,"2-[3-(1-cyano-1-methyl-ethyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile","2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile","2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile","2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile","2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile","2-[3-(1-cyano-1-methyl-ethyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propionitrile","InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3",YBBLVLTVTVSKRW-UHFFFAOYSA-N,2.1,293.16404563,C17H19N5,293.4,78.3,293.16404563,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,,"1  2  8
1  21  8
11  12  8
11  13  8
2  22  8
5  21  8
5  22  8
8  10  8
8  12  8
9  10  8
9  13  8",
440790475,33613,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00507,amoxicillin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00507,amoxicillin,5.0,Adverse reactions,vLess-DILI-Concern,1.0,33613,1.0,590.0,7.0,4.0,4.0,AAADceB7OABAAAAAAAAAAAAAAABYAWAAAAAwAAAABYAAAAABAAAAHgQQCAAADCzF2ASyDoPAAgiIAiHSGACCAABgIBAIiIGODIgKZjqilTOUcABk1hG4mAeY2IGOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2<I>S</I>,5<I>R</I>,6<I>R</I>)-6-[[(2<I>R</I>)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-azanyl-2-(4-hydroxyphenyl)ethanoyl]amino]-3,3-dimethyl-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-7-keto-3,3-dimethyl-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1",LSQZJLSUYDQPKJ-NJBDSQKTSA-N,-2.0,365.10454189,C16H19N3O5S,365.4,158.0,365.10454189,0.0,25.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,,"10  26  6
12  17  6
20  21  8
20  22  8
21  23  8
22  24  8
23  25  8
24  25  8
13  8  5
19  9  5",
440790474,2162,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00175,amlodipine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00175,amlodipine,5.0,Adverse reactions,vLess-DILI-Concern,2.0,2162,1.0,647.0,7.0,2.0,10.0,AAADceB7OAAEAAAAAAAAAAAAAAAAAAAAAAAwQAAAAAAAAAABAAAAHgIQAAAADQrhmCYyCILABACIAiTSSAACAAAgBQAIiIEAAsgKJDKBMxCDMAAkkACYqUeI7uiOgAAAAAABAAAAAAAAAAIAAAAAAAAAAA==,"O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate","2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid O3-ethyl ester O5-methyl ester","3-<I>O</I>-ethyl 5-<I>O</I>-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate","3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate","O3-ethyl O5-methyl 2-(2-azanylethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate","2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid O3-ethyl ester O5-methyl ester","InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3",HTIQEAQVCYTUBX-UHFFFAOYSA-N,3.0,408.1451996,C20H25ClN2O5,408.9,99.9,408.1451996,0.0,28.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,,"14  19  8
14  20  8
19  21  8
20  22  8
21  23  8
22  23  8
9  14  3",
440790473,2160,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00047,amitriptyline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00047,amitriptyline,5.0,Adverse reactions,vLess-DILI-Concern,2.0,2160,1.0,331.0,1.0,0.0,3.0,AAADceB6AAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABgAAAAABQAAAHAAAAAAADADBGAQyAIMAAACAAiBCAAACAAAgAAAIiAAIAIgIICKAERCEIAAggAAIiAcAgMAOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine","N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)-1-propanamine","<I>N</I>,<I>N</I>-dimethyl-3-(2-tricyclo[9.4.0.0<SUP>3,8</SUP>]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine","N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine","N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine","dimethyl-[3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propyl]amine","InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3",KRMDCWKBEZIMAB-UHFFFAOYSA-N,5.0,277.183049738,C20H23N,277.4,3.2,277.183049738,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCC=C1c2ccccc2CCc2ccccc21,,"11  16  8
12  17  8
13  18  8
14  19  8
16  18  8
17  19  8
5  11  8
5  7  8
6  12  8
6  8  8
7  13  8
8  14  8",
440790472,16231,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02070,AMILORIDE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02070,amiloride,3.0,Adverse reactions,vLess-DILI-Concern,2.0,16231,1.0,279.0,5.0,4.0,1.0,AAADccBjoAAEAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAADgIQAAAACAoBliABsBJIEACoAQdwdACAgC0HECAAEAGgVECAQEhAQCBUAIAAAALAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3,5-diamino-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide","3,5-diamino-6-chloro-N-(diaminomethylidene)-2-pyrazinecarboxamide","3,5-diamino-6-chloro-<I>N</I>-(diaminomethylidene)pyrazine-2-carboxamide","3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide","3,5-bis(azanyl)-N-[bis(azanyl)methylidene]-6-chloranyl-pyrazine-2-carboxamide","3,5-diamino-6-chloro-N-(diaminomethylene)pyrazinamide","InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)",XSDQTOBWRPYKKA-UHFFFAOYSA-N,,229.0478856,C6H8ClN7O,229.63,159.0,229.0478856,0.0,15.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(N)=NC(=O)c1nc(Cl)c(N)nc1N,-0.7,"10  11  8
12  13  8
3  11  8
3  12  8
4  10  8
4  13  8",
440790471,2118,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00501,alprazolam,20250421,20210312,Curation Efforts|Governmental Organizations,LT00501,alprazolam,7.0,Adverse reactions,vLess-DILI-Concern,2.0,2118,1.0,434.0,3.0,0.0,1.0,AAADccB7gAAEAAAAAAAAAAAAAAAAAWAAAAAwYAAABAAAAACB0AAAHAIIAAAADArBGyQz0IcMEACiAyZiZACSgCshB6AdiAAwZpiIaKLBm5GUIAhgiALIyCcQgMAOAABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-1-methyl-6-phenyl-4<I>H</I>-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloranyl-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3",VREFGVBLTWBCJP-UHFFFAOYSA-N,2.1,308.0828741,C17H13ClN4,308.8,43.1,308.0828741,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,,"12  15  8
13  16  8
14  18  8
14  19  8
15  16  8
18  20  8
19  21  8
2  11  8
2  8  8
20  22  8
21  22  8
4  5  8
4  8  8
5  11  8
6  12  8
6  7  8
7  13  8",
440790470,2099,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01070,alosetron,20210312,20210312,Curation Efforts|Governmental Organizations,LT01070,alosetron,4.0,Adverse reactions,vLess-DILI-Concern,2.0,2099,1.0,442.0,2.0,1.0,2.0,AAADceB7oAAAAAAAAAAAAAAAAAAAAWLAAAA8QAAAAAAAAFgB/AAAHgAQAAAADAjBngQ30PfNkACoAyVzdACCgC21EqAJ2aE4dNiIaPrA3ZGUIYholgLIyWccicCOgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one","5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one","5-methyl-2-[(5-methyl-1<I>H</I>-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one","5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one","5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one","5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrid[4,3-b]indol-1-one","InChI=1S/C17H18N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-6,10H,7-9H2,1-2H3,(H,18,19)",JSWZEAMFRNKZNL-UHFFFAOYSA-N,,294.14806121,C17H18N4O,294.35,53.9,294.14806121,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,1.6,"10  11  8
10  15  8
11  16  8
15  18  8
16  19  8
17  20  8
18  19  8
3  11  8
3  6  8
4  17  8
4  22  8
5  20  8
5  22  8
6  8  8
8  10  8",
440790469,2092,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01107,alfuzosin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01107,alfuzosin,5.0,Adverse reactions,vLess-DILI-Concern,2.0,2092,1.0,511.0,8.0,2.0,8.0,AAADceB7uAAAAAAAAAAAAAAAAAAAASAAAAA8QAAAAAAAAACx8AAAHgAQAAAADBzhngYz9vfIFACoAydydAKCiCkhIqABmKF+7JiPLrLE+N+HNCpu1hva6Ce41BMOIEABAgACQABAgAIEAASAAAAAAAAAAA==,"N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]tetrahydrofuran-2-carboxamide","N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-methylamino]propyl]-2-oxolanecarboxamide","<I>N</I>-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide","N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide","N-[3-[(4-azanyl-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]oxolane-2-carboxamide","N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]tetrahydrofuran-2-carboxamide","InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)",WNMJYKCGWZFFKR-UHFFFAOYSA-N,,389.20630436,C19H27N5O4,389.4,112.0,389.20630436,0.0,28.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC,1.7,"10  14  3
20  21  8
20  22  8
20  23  8
21  24  8
23  25  8
24  26  8
25  26  8
7  18  8
7  21  8
8  18  8
8  22  8",
440790468,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01387,Adalimumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01387,adalimumab,7.0,Adverse reactions,vLess-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790467,135398513,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00041,Aciclovir,20210312,20210312,Curation Efforts|Governmental Organizations,LT00041,aciclovir,5.0,Adverse reactions,vLess-DILI-Concern,1.0,135398513,1.0,308.0,5.0,3.0,4.0,AAADccBzsAAAAAAAAAAAAAAAAAAAAWAAAAAgAAAAAAAAAEABgAAAHgAQCAAACAihlgYFsBfMFgCoAQdxdACAgC0XEKABUAGoVECBWAhASCAcAIgIAQJDAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one,2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one,2-amino-9-(2-hydroxyethoxymethyl)-1<I>H</I>-purin-6-one,2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one,2-azanyl-9-(2-hydroxyethyloxymethyl)-1H-purin-6-one,2-amino-9-(2-hydroxyethoxymethyl)hypoxanthine,"InChI=1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15)",MKUXAQIIEYXACX-UHFFFAOYSA-N,,225.08618923,C8H11N5O3,225.2,115.0,225.08618923,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc2c(ncn2COCCO)c(=O)[nH]1,-1.9,"11  13  8
4  12  8
4  9  8
5  11  8
5  12  8
6  15  8
6  9  8
7  13  8
7  15  8
9  11  8",
440790466,1978,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01035,acebutolol,20231222,20210312,Curation Efforts|Governmental Organizations,LT01035,acebutolol,3.0,Adverse reactions,vLess-DILI-Concern,2.0,1978,1.0,400.0,5.0,3.0,10.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADDzhmAYyxoLABgCIAqVSUACCCAAlIgAIiIEObMgPNjbEtZuGOWjm9BHb6Ye8yKCOAEAAQAAIAAAAgACAABAAAAAAAAAAAA==,N-[3-acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]butanamide,N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide,<I>N</I>-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide,N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide,N-[3-ethanoyl-4-[2-oxidanyl-3-(propan-2-ylamino)propoxy]phenyl]butanamide,N-[3-acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]butyramide,"InChI=1S/C18H28N2O4/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23)",GOEMGAFJFRBGGG-UHFFFAOYSA-N,1.7,336.20490738,C18H28N2O4,336.4,87.7,336.20490738,0.0,24.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,,"13  14  8
13  17  8
14  16  8
15  16  8
15  18  8
17  18  8
7  2  3",
440790465,71158,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01141,Acamprosate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01141,acamprosate,3.0,Adverse reactions,vLess-DILI-Concern,2.0,71158,1.0,215.0,4.0,2.0,4.0,AAADccBiOABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgQQCAAACADFwASCAALAAIIIAAEQEHBAAAAAAAAAAIAIAAAAAAAAAAAEAAAAFgCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,3-acetamidopropane-1-sulfonic acid,3-acetamido-1-propanesulfonic acid,3-acetamidopropane-1-sulfonic acid,3-acetamidopropane-1-sulfonic acid,3-acetamidopropane-1-sulfonic acid,3-acetamidopropane-1-sulfonic acid,"InChI=1S/C5H11NO4S/c1-5(7)6-3-2-4-11(8,9)10/h2-4H2,1H3,(H,6,7)(H,8,9,10)",AFCGFAGUEYAMAO-UHFFFAOYSA-N,,181.04087901,C5H11NO4S,181.21,91.9,181.04087901,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)NCCCS(=O)(=O)O,-1.2,,
440790464,445354,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00162,Vitamin A,20231222,20210312,Curation Efforts|Governmental Organizations,LT00162,vitamin a,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,445354,1.0,496.0,1.0,1.0,5.0,AAADceB4IAAAAAAAAAAAAAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAGgAACAAADgCggAICAAAAAgCAAiBCAAAAAAAgAAAICAAAAAgIFAIAAQAAEAAAgAAIkAMAgMAPAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-1-nona-2,4,6,8-tetraenol","(2<I>E</I>,4<I>E</I>,6<I>E</I>,8<I>E</I>)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol","(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol","InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+",FPIPGXGPPPQFEQ-OVSJKPMPSA-N,5.7,286.229665576,C20H30O,286.5,20.2,286.229665576,0.0,21.0,0.0,0.0,4.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,,,
440790463,2520,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00332,VERAPAMIL,20210312,20210312,Curation Efforts|Governmental Organizations,LT00332,verapamil,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,2520,1.0,606.0,6.0,0.0,13.0,AAADcfB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAAAAAADwTBmAYyBoMABACQBiBCAAACCAAgIAAIiAAOiIgNpiKEsRuEMCIkwBGKqA+Q0PIPoAABAAAAQABAAAIAAACAAAAAAAAAAA==,"2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile","2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile","2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile","2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile","2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-propan-2-yl-pentanenitrile","2-(3,4-dimethoxyphenyl)-5-[homoveratryl(methyl)amino]-2-isopropyl-valeronitrile","InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",SGTNSNPWRIOYBX-UHFFFAOYSA-N,3.8,454.2831577,C27H38N2O4,454.6,64.0,454.2831577,0.0,33.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,,"11  16  8
11  17  8
16  19  8
17  21  8
19  23  8
21  23  8
24  25  8
24  26  8
25  27  8
26  29  8
27  30  8
29  30  8
7  9  3",
440790462,119607,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01971,Valdecoxib,20250421,20210312,Curation Efforts|Governmental Organizations,LT01971,valdecoxib,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,119607,1.0,462.0,5.0,1.0,3.0,AAADccB7MABAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAAB0AAAHgQUQAAADAyB3gAyhZAQAAKpA6RyQnDCABAkIAAomDkkTNoIJrqAlZOAMYBmwBkIyUeYyOCOkAAAAAAAAAAgAAAAAAAAAAAAAAAAAA==,4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide,4-(5-methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide,"4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide","4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide","4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide",4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide,"InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)",LNPDTQAFDNKSHK-UHFFFAOYSA-N,,314.07251349,C16H14N2O3S,314.4,94.6,314.07251349,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,2.6,"11  15  8
11  16  8
12  15  8
13  16  8
14  18  8
14  19  8
18  20  8
19  21  8
2  10  8
2  5  8
20  22  8
21  22  8
5  9  8
7  10  8
7  9  8
8  12  8
8  13  8",
440790461,5453,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01804,thiotepa,20250421,20210312,Curation Efforts|Governmental Organizations,LT01804,thiotepa,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,5453,1.0,194.0,4.0,0.0,3.0,AAADccBjAAJAAAAAAAAAAAAAFiwAAAAAAAAAAAAAAAAAAAAAAAAAHAAAgAAAAADBAAQAAAIAAAAAAAAAAAAAAAAAAAAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,tris(aziridin-1-yl)-thioxo-lambda5-phosphane,tris(1-aziridinyl)-sulfanylidenephosphorane,tris(aziridin-1-yl)-sulfanylidene-&lambda;<SUP>5</SUP>-phosphane,tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphane,tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphane,triethylenimino(thioxo)phosphorane,"InChI=1S/C6H12N3PS/c11-10(7-1-2-7,8-3-4-8)9-5-6-9/h1-6H2",FOCVUCIESVLUNU-UHFFFAOYSA-N,0.5,189.04895557,C6H12N3PS,189.22,41.1,189.04895557,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",S=P(N1CC1)(N1CC1)N1CC1,,,
440790460,2723601,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00452,thioguanine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00452,thioguanine,2.0,Warnings and precautions,vLess-DILI-Concern,1.0,2723601,1.0,225.0,2.0,3.0,0.0,AAADcYBjgABAAAAAAAAAAAAAAAAAAWAAAAAgAAAAAAAAAEABgAAAHAQQAAAACAgBVgQFsBbJkACkAQZhZACAgC2REKABUYAoVACASABASAAUAAAIAAJAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-amino-3,7-dihydropurine-6-thione","2-amino-3,7-dihydropurine-6-thione","2-amino-3,7-dihydropurine-6-thione","2-amino-3,7-dihydropurine-6-thione","2-azanyl-3,7-dihydropurine-6-thione","2-amino-3,7-dihydropurine-6-thione","InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",WYWHKKSPHMUBEB-UHFFFAOYSA-N,-0.1,167.02656635,C5H5N5S,167.19,111.0,167.02656635,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc(=S)c2[nH]cnc2[nH]1,,"2  10  8
2  8  8
3  11  8
3  7  8
4  11  8
4  8  8
5  10  8
5  9  8
7  8  8
7  9  8",
440790459,54675776,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00036,tetracycline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00036,tetracycline,2.0,Warnings and precautions,vLess-DILI-Concern,1.0,54675776,1.0,971.0,9.0,6.0,2.0,AAADceB7PAAAAAAAAAAAAAAAAAAAAAAAAAAwYIEAAAAAAACBAAAAHgAQCAAADWzBmAQyBoNAAgCIAqFSEAKCAAAgIAAIiAHOCMgJJz6KkTKEcAAn4BEJmQf+/veugAABAAAYAADAAAYAADAAAAAAAAAAAA==,"(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide","(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide","(4<I>S</I>,4<I>a</I><I>S</I>,5<I>a</I><I>S</I>,6<I>S</I>,12<I>a</I><I>R</I>)-4-(dimethylamino)-1,6,10,11,12<I>a</I>-pentahydroxy-6-methyl-3,12-dioxo-4,4<I>a</I>,5,5<I>a</I>-tetrahydrotetracene-2-carboxamide","(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide","(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-6-methyl-1,6,10,11,12a-pentakis(oxidanyl)-3,12-bis(oxidanylidene)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide","(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-diketo-6-methyl-4,4a,5,5a-tetrahydrotetracene-2-carboxamide","InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25-26,29,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15-,21+,22-/m0/s1",NWXMGUDVXFXRIG-WESIUVDSSA-N,-2.0,444.15326573,C22H24N2O8,444.4,182.0,444.15326573,0.0,32.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,,"14  1  6
11  33  6
12  34  6
16  2  5
20  24  8
20  26  8
24  29  8
26  31  8
29  32  8
31  32  8
15  9  6",
440790458,464205,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02224,Tenofovir,20231222,20210312,Curation Efforts|Governmental Organizations,LT02224,tenofovir,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,464205,1.0,354.0,8.0,3.0,5.0,AAADccBzuAIAAAAAAAAAAAAAAAAAAWAAAAAsAAAAAAAAAFgB+AAAHggQCCAACBzhlwYH8L9MFBCgQQZhZICAgC0REKABUCAoVBCCSABASEAVBAgIAALQACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,[(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methylphosphonic acid,[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid,[(2<I>R</I>)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid,[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid,[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid,[(1R)-2-adenin-9-yl-1-methyl-ethoxy]methylphosphonic acid,"InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1",SGOIRFVFHAKUTI-ZCFIWIBFSA-N,-1.6,287.07834094,C9H14N5O4P,287.21,136.0,287.07834094,0.0,19.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,,"13  15  8
15  18  8
11  2  5
6  13  8
6  16  8
7  15  8
7  16  8
8  13  8
8  19  8
9  18  8
9  19  8",
440790457,452548,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01786,teniposide,20250421,20210312,Curation Efforts|Governmental Organizations,LT01786,teniposide,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,452548,1.0,1090.0,14.0,3.0,6.0,AAADcfB8PABAAAAAAAAAAAAAAAAAASJEgAA0aMECAAAAAEjR0AAAGgQACAAADRS02AOyD4AABgiMAiDSCAADCIAgKBBIiBkGiIgdNzKmMRqicCMlwBUvuAfK6PyOoAABCAAQQADAAAYQADCAAAAAAAAAAA==,"(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-(2-thienyl)-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one","(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one","(5<I>S</I>,5<I>a</I><I>R</I>,8<I>a</I><I>R</I>,9<I>R</I>)-5-[[(2<I>R</I>,4<I>a</I><I>R</I>,6<I>R</I>,7<I>R</I>,8<I>R</I>,8<I>a</I><I>S</I>)-7,8-dihydroxy-2-thiophen-2-yl-4,4<I>a</I>,6,7,8,8<I>a</I>-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5<I>a</I>,6,8<I>a</I>,9-tetrahydro-5<I>H</I>-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one","(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one","(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-bis(oxidanyl)-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(3,5-dimethoxy-4-oxidanyl-phenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one","(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-(2-thienyl)-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one","InChI=1S/C32H32O13S/c1-37-19-6-13(7-20(38-2)25(19)33)23-14-8-17-18(42-12-41-17)9-15(14)28(16-10-39-30(36)24(16)23)44-32-27(35)26(34)29-21(43-32)11-40-31(45-29)22-4-3-5-46-22/h3-9,16,21,23-24,26-29,31-35H,10-12H2,1-2H3/t16-,21+,23+,24-,26+,27+,28+,29+,31+,32-/m0/s1",NRUKOCRGYNPUPR-QBPJDGROSA-N,1.2,656.15636224,C32H32O13S,656.7,189.0,656.15636224,0.0,46.0,10.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,,"1  41  8
1  44  8
15  47  6
16  48  5
18  24  6
19  20  8
19  29  8
17  2  5
23  2  5
20  30  8
24  34  8
24  35  8
26  55  5
28  57  6
29  31  8
30  32  8
31  32  8
34  38  8
35  37  8
36  64  5
37  40  8
38  40  8
41  42  8
42  43  8
43  44  8
25  7  6
27  9  5",
440790456,2724354,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01766,Succimer,20250421,20210312,Curation Efforts|Governmental Organizations,LT01766,succimer,2.0,Warnings and precautions,vLess-DILI-Concern,2.0,2724354,1.0,139.0,6.0,4.0,3.0,AAADcYBgOABgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgQACAAACACEwACACAAAAgQIAACQCAAAAAAAAAAAAAEAAAAAABAAAAAAQAAEAAAAAABDAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,3R)-2,3-bis(sulfanyl)butanedioic acid","(2S,3R)-2,3-dimercaptobutanedioic acid","(2<I>S</I>,3<I>R</I>)-2,3-bis(sulfanyl)butanedioic acid","(2S,3R)-2,3-bis(sulfanyl)butanedioic acid","(2S,3R)-2,3-bis(sulfanyl)butanedioic acid","(2S,3R)-2,3-dimercaptosuccinic acid","InChI=1S/C4H6O4S2/c5-3(6)1(9)2(10)4(7)8/h1-2,9-10H,(H,5,6)(H,7,8)/t1-,2+",ACTRVOBWPAIOHC-XIXRPRMCSA-N,,181.97075102,C4H6O4S2,182.2,76.6,181.97075102,0.0,10.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)[C@@H](S)[C@@H](S)C(=O)O,0.1,"7  1  5
8  2  6",
440790455,54454,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00142,simvastatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00142,simvastatin,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,54454,1.0,706.0,5.0,1.0,7.0,AAADcfB4OAAAAAAAAAAAAAAAAAAAAAAAAAAkQIAAAAAAAACAAAAAGgAACAAADxSggAICCAAABgCIAiDSCAAAAAAgAAAICAEAAAgIEBYAAQACQAAF4AAIgAOIzPDPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate","2,2-dimethylbutanoic acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester","[(1<I>S</I>,3<I>R</I>,7<I>S</I>,8<I>S</I>,8<I>a</I><I>R</I>)-8-[2-[(2<I>R</I>,4<I>R</I>)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8<I>a</I>-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate","[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate","[(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R,4R)-4-oxidanyl-6-oxidanylidene-oxan-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate","2,2-dimethylbutyric acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-keto-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester","InChI=1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1",RYMZZMVNJRMUDD-HGQWONQESA-N,4.7,418.27192431,C25H38O5,418.6,72.8,418.27192431,0.0,30.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,,"8  1  5
13  20  5
19  15  5
23  3  6
6  31  6
7  11  6
9  18  6",
440790454,441243,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01746,SAQUINAVIR,20210312,20210312,Curation Efforts|Governmental Organizations,LT01746,saquinavir,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,441243,1.0,1140.0,7.0,5.0,13.0,AAADcfB/uAAAAAAAAAAAAAAAAAAAAAAAAAA8eMECAAAAAACx9AAAHgAQCAAADbzhngYywPPIEgCoAyVyVACCgCAnAiAImKG4ZNgKcPrA1bGUYQhklgDYyYedyKCOgAAAAAACAAAAAAAAACQAAAAAAAAAAA==,"(2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide","(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-[(tert-butylamino)-oxomethyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[[oxo(2-quinolinyl)methyl]amino]butanediamide","(2<I>S</I>)-<I>N</I>-[(2<I>S</I>,3<I>R</I>)-4-[(3<I>S</I>,4<I>a</I><I>S</I>,8<I>a</I><I>S</I>)-3-(<I>tert</I>-butylcarbamoyl)-3,4,4<I>a</I>,5,6,7,8,8<I>a</I>-octahydro-1<I>H</I>-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide","(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide","(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-oxidanyl-1-phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide","(2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinaldoylamino)succinamide","InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",QWAXKHKRTORLEM-UGJKXSETSA-N,,670.38426872,C38H50N6O5,670.8,167.0,670.38426872,0.0,49.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,4.2,"11  41  8
11  43  8
12  50  6
13  51  6
18  22  5
23  2  6
30  33  8
30  34  8
33  36  8
34  37  8
36  38  8
37  38  8
41  42  8
42  44  8
43  45  8
43  46  8
44  45  8
45  47  8
46  48  8
47  49  8
48  49  8
24  8  6
32  9  6",
440790453,5161,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01684,Salsalate,20231222,20210312,Curation Efforts|Governmental Organizations,LT01684,salsalate,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,5161,1.0,341.0,5.0,2.0,4.0,AAADccBwOAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAGgAACAAADASAmAAwDoAABgCIAiDSCAACCAAkIAAIiAEGCMgMJzaGNRqCe2Cl4BEIuYeIyCCOAAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,2-(2-hydroxybenzoyl)oxybenzoic acid,2-[(2-hydroxyphenyl)-oxomethoxy]benzoic acid,2-(2-hydroxybenzoyl)oxybenzoic acid,2-(2-hydroxybenzoyl)oxybenzoic acid,2-(2-hydroxyphenyl)carbonyloxybenzoic acid,2-salicyloyloxybenzoic acid,"InChI=1S/C14H10O5/c15-11-7-3-1-5-9(11)14(18)19-12-8-4-2-6-10(12)13(16)17/h1-8,15H,(H,16,17)",WVYADZUPLLSGPU-UHFFFAOYSA-N,3.0,258.05282342,C14H10O5,258.23,83.8,258.05282342,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(Oc1ccccc1C(=O)O)c1ccccc1O,,"10  14  8
12  15  8
13  17  8
14  15  8
16  18  8
17  18  8
6  10  8
6  8  8
7  13  8
7  9  8
8  12  8
9  16  8",
440790452,446157,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01928,Rosuvastatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01928,rosuvastatin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,446157,1.0,767.0,10.0,3.0,10.0,AAADceB7OQBAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHwQASAAADRyhng6zmJYIEgKoAyTybHCCgCkhAKAJmCE4RJiIPLbA2dGEdAhtoAJI2CeY7MROAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(E,3R,5S)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid","(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-yl-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid","(<I>E</I>,3<I>R</I>,5<I>S</I>)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid","(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid","(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-yl-pyrimidin-5-yl]-3,5-bis(oxidanyl)hept-6-enoic acid","(E,3R,5S)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[mesyl(methyl)amino]pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid","InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1",BPRHUIZQVSMCRT-VEUZHWNKSA-N,,481.16828496,C22H28FN3O6S,481.5,149.0,481.16828496,0.0,33.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,1.6,"11  18  8
11  24  8
13  15  8
15  18  8
25  27  8
25  28  8
27  31  8
28  32  8
16  3  5
31  33  8
32  33  8
17  4  5
9  13  8
9  24  8",
440790451,77999,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00140,rosiglitazone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00140,rosiglitazone,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,77999,1.0,468.0,6.0,1.0,7.0,AAADceB7MABAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAAABwAAAHgQQAAAADATl2ga/tpPIFAioAjN3dACCiClxIjAJ2CE+bJiOJvLkuZuHOCjs1DPY6CeYyKCOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione","5-[[4-[2-[methyl(2-pyridinyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione","5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","5-[4-[2-[methyl(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-quinone","InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",YASAKCUCGLMORW-UHFFFAOYSA-N,,357.11471265,C18H19N3O3S,357.4,96.8,357.11471265,0.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,3.1,"10  13  8
10  14  8
13  17  8
14  18  8
16  17  8
16  18  8
20  22  8
22  23  8
23  25  8
24  25  8
7  20  8
7  24  8
8  9  3",
440790450,3034034,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01923,Quinine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01923,quinine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,3034034,1.0,457.0,4.0,1.0,4.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAAAAAAA8WLFiAAAAAACx8AAAHgAACAAADTzhngY+xvMIFgCgAzRnRACCiCAxIiAI2CA+bJgONuLEsZuEcChkwBHY+Aew4PwOgEABAAACAAAAgAIAAAQAAAAAAAAAAA==,"(R)-(6-methoxy-4-quinolyl)-[(2S,4S,5R)-5-vinylquinuclidin-2-yl]methanol","(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxy-4-quinolinyl)methanol","(<I>R</I>)-[(2<I>S</I>,4<I>S</I>,5<I>R</I>)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol","(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol","(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol","(R)-(6-methoxy-4-quinolyl)-[(2S,4S,5R)-5-vinylquinuclidin-2-yl]methanol","InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1",LOUPRKONTZGTKE-WZBLMQSHSA-N,2.9,324.183778013,C20H24N2O2,324.4,45.6,324.183778013,0.0,24.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,,"12  1  5
14  16  8
14  17  8
16  18  8
16  19  8
17  20  8
18  21  8
19  22  8
21  23  8
22  23  8
4  18  8
4  20  8
5  25  5
6  26  6
8  13  5",
440790449,5002,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00267,quetiapine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00267,quetiapine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,5002,1.0,496.0,5.0,1.0,6.0,AAADceB7MABAAAAAAAAAAAAAAAAAAAAAAAA8YIAABAAAAAABQAAAHgQACAAADAjh2AYxwYMABgigAiZiZACCAAEgChAJiBwoZJgLcKKgmZGXIAhggAC7yAcQgAAOAAAAAAAEAQAAAAAAAAgCAAAAAAAAAA==,"2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol","2-[2-[4-(6-benzo[b][1,4]benzothiazepinyl)-1-piperazinyl]ethoxy]ethanol","2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol","2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol","2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol","2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazino)ethoxy]ethanol","InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2",URKOMYMAXPYINW-UHFFFAOYSA-N,,383.16674822,C21H25N3O2S,383.5,73.6,383.16674822,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,2.1,"14  15  8
14  16  8
15  19  8
16  21  8
17  18  8
17  23  8
18  24  8
19  22  8
21  22  8
23  26  8
24  27  8
26  27  8",
440790448,4993,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01716,pyrimethamine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01716,pyrimethamine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4993,1.0,243.0,4.0,2.0,2.0,AAADccBzgAAEAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHAIQAAAADAqBHiAzsJZIEACgAyZiZACCgCkhBaAJmCAwRpiIKCLB29GEJAhogAJIyCcQgMAOhAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,"5-(4-chlorophenyl)-6-ethyl-pyrimidine-2,4-diamine","5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine","5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine","5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine","5-(4-chlorophenyl)-6-ethyl-pyrimidine-2,4-diamine",[2-amino-5-(4-chlorophenyl)-6-ethyl-pyrimidin-4-yl]amine,"InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)",WKSAUQYGYAYLPV-UHFFFAOYSA-N,2.7,248.0828741,C12H13ClN4,248.71,77.8,248.0828741,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,,"11  15  8
12  16  8
15  17  8
16  17  8
2  14  8
2  7  8
3  10  8
3  14  8
6  10  8
6  7  8
9  11  8
9  12  8",
440790447,1046,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00166,pyrazinamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00166,pyrazinamide,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,1046,1.0,115.0,3.0,1.0,1.0,AAADcYBjIAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAHgAQAAAACAjBlgQsgBJIEACoARV3VACAgCQXEiAIUAG4dEAAQEhAQCAUAIAAAADAAMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,pyrazine-2-carboxamide,2-pyrazinecarboxamide,pyrazine-2-carboxamide,pyrazine-2-carboxamide,pyrazine-2-carboxamide,pyrazinamide,"InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)",IPEHBUMCGVEMRF-UHFFFAOYSA-N,-0.6,123.043261792,C5H5N3O,123.11,68.9,123.043261792,0.0,9.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)c1cnccn1,,"2  5  8
2  8  8
3  6  8
3  9  8
5  6  8
8  9  8",
440790446,4915,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00614,procarbazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00614,procarbazine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4915,1.0,210.0,3.0,3.0,5.0,AAADceBzIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAYAAAADCjBmAQyAILiAACIAiFSEACCAAAkAAIYqIEIBMgIIDKAlRGEIQhglgCIiYcYiACOQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide,4-[(methylhydrazo)methyl]-N-propan-2-ylbenzamide,4-[(2-methylhydrazinyl)methyl]-<I>N</I>-propan-2-ylbenzamide,4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide,4-[(2-methylhydrazinyl)methyl]-N-propan-2-yl-benzamide,N-isopropyl-4-[(N'-methylhydrazino)methyl]benzamide,"InChI=1S/C12H19N3O/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3/h4-7,9,13-14H,8H2,1-3H3,(H,15,16)",CPTBDICYNRMXFX-UHFFFAOYSA-N,0.1,221.152812238,C12H19N3O,221.3,53.2,221.152812238,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNNCc1ccc(C(=O)NC(C)C)cc1,,"12  14  8
13  15  8
6  12  8
6  13  8
7  14  8
7  15  8",
440790445,54687,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00186,pravastatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00186,pravastatin,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,54687,1.0,656.0,7.0,4.0,11.0,AAADcfB4OAAAAAAAAAAAAAAAAAAAAAAAAAAgQAAAAAAAAACAAAAAGgAACAAADRSggAICCAAABgCIAiDSCAAAAAAgAAAICAEAAAgIFBYAAQACUAAF4AAIkAOI7PTOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoic acid","(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid","(3<I>R</I>,5<I>R</I>)-7-[(1<I>S</I>,2<I>S</I>,6<I>S</I>,8<I>S</I>,8<I>a</I><I>R</I>)-6-hydroxy-2-methyl-8-[(2<I>S</I>)-2-methylbutanoyl]oxy-1,2,6,7,8,8<I>a</I>-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid","(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid","(3R,5R)-7-[(1S,2S,6S,8S,8aR)-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-6-oxidanyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-bis(oxidanyl)heptanoic acid","(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-enanthic acid","InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1",TUZYXOIXSAXUGO-PZAWKZKUSA-N,1.6,424.24610348,C23H36O7,424.5,124.0,424.24610348,0.0,30.0,8.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,,"10  1  5
11  20  6
15  2  6
25  28  5
21  3  6
24  5  6
8  31  6
9  12  6",
440790444,54676228,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01679,piroxicam,20210312,20210312,Curation Efforts|Governmental Organizations,LT01679,piroxicam,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,54676228,1.0,611.0,6.0,2.0,2.0,AAADccBzOABAAAAAAAAAAAAAAAAAAAAAAAA8QIAAAAAAAACBwAAAHgQQSAAADAzB2gQ/sZLIEgKoAjd3dHDCgDkxIiAJ2Di4bNiIZuLAmbGUcAhs1QPI2SeQwCAOAAAAAAAEAAAAAAAAAAgAAAAAAAAAAA==,"4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1lambda6,2-benzothiazine-3-carboxamide","4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridinyl)-1lambda6,2-benzothiazine-3-carboxamide","4-hydroxy-2-methyl-1,1-dioxo-<I>N</I>-pyridin-2-yl-1&lambda;<SUP>6</SUP>,2-benzothiazine-3-carboxamide","4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide","2-methyl-4-oxidanyl-1,1-bis(oxidanylidene)-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide","4-hydroxy-1,1-diketo-2-methyl-N-(2-pyridyl)-1lambda6,2-benzothiazine-3-carboxamide","InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)",QYSPLQLAKJAUJT-UHFFFAOYSA-N,3.1,331.06267708,C15H13N3O4S,331.3,108.0,331.06267708,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,,"10  15  8
13  17  8
15  18  8
17  18  8
19  20  8
20  21  8
21  23  8
22  23  8
8  19  8
8  22  8
9  10  8
9  13  8",
440790443,4829,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00134,Pioglitazone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00134,pioglitazone,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,4829,1.0,466.0,5.0,1.0,7.0,AAADceB7MABAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAAABwAAAHgQQAAAADAzl3ga+hpLIFAioAzV3VACCiCBxIjAI2CE+bJgMJvLksZuGOCjm1DHI6AeYyOCOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione","5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione","5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-quinone","InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",HYAFETHFCAUJAY-UHFFFAOYSA-N,,356.11946368,C19H20N2O3S,356.4,93.6,356.11946368,0.0,25.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,3.8,"11  16  8
12  17  8
14  16  8
14  17  8
18  21  8
20  23  8
20  24  8
21  23  8
6  18  8
6  24  8
7  26  3
9  11  8
9  12  8",
440790442,4763,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00030,phenobarbital,20250421,20210312,Curation Efforts|Governmental Organizations,LT00030,phenobarbital,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,4763,1.0,339.0,3.0,2.0,2.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHgAQAAAADgCBmAAzAILAAACIAiFSEAACAAAgAAAIiAEAAIiIIDqI1RGEIAAohSIIiAcYiMCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5-ethyl-5-phenyl-hexahydropyrimidine-2,4,6-trione","5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione","5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione","5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione","5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione",5-ethyl-5-phenyl-barbituric acid,"InChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17)",DDBREPKUVSBGFI-UHFFFAOYSA-N,1.5,232.08479225,C12H12N2O3,232.23,75.3,232.08479225,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,,"12  15  8
13  16  8
15  17  8
16  17  8
8  12  8
8  13  8",
440790441,4748,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01655,perphenazine,20210804,20210312,Curation Efforts|Governmental Organizations,LT01655,perphenazine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4748,1.0,463.0,5.0,1.0,6.0,AAADceB7IABEAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxQAAAHgYACAAACArh0CYwwYMAAgiAACRCQACCAAAhDxAIiBwIZogKcGLh05GUIAhggAD4yAcQAAAAAAIAAAIAAQAABAAABAACAAAAAAAAAA==,2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol,2-[4-[3-(2-chloro-10-phenothiazinyl)propyl]-1-piperazinyl]ethanol,2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol,2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol,2-[4-[3-(2-chloranylphenothiazin-10-yl)propyl]piperazin-1-yl]ethanol,2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazino]ethanol,"InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2",RGCVKNLCSQQDEP-UHFFFAOYSA-N,4.2,403.1485113,C21H26ClN3OS,404.0,55.3,403.1485113,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,,"16  18  8
16  20  8
17  19  8
17  21  8
18  22  8
19  23  8
20  24  8
21  25  8
22  26  8
23  27  8
24  26  8
25  27  8",
440790440,4735,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00129,pentamidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00129,pentamidine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4735,1.0,376.0,4.0,4.0,10.0,AAADceB7sAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAQAAAADAShmAIxBoBABACgAiJiIACCCACgIAAIiAAmDJgMJqKEsRuCOCDkwBEIqAeQ8AgOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,4-[5-(4-carbamimidoylphenoxy)pentoxy]benzamidine,4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide,4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide,4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide,4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide,4-[5-(4-amidinophenoxy)pentoxy]benzamidine,"InChI=1S/C19H24N4O2/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23)",XDRYMKDFEDOLFX-UHFFFAOYSA-N,,340.18992602,C19H24N4O2,340.4,118.0,340.18992602,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",[H]/N=C(\N)c1ccc(OCCCCCOc2ccc(/C(N)=N/[H])cc2)cc1,2.6,"12  14  8
12  16  8
13  15  8
13  17  8
14  20  8
15  21  8
16  22  8
17  23  8
18  20  8
18  22  8
19  21  8
19  23  8",
440790439,5852,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00488,penicillamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00488,penicillamine,2.0,Warnings and precautions,vLess-DILI-Concern,1.0,5852,1.0,124.0,4.0,3.0,2.0,AAADccBiMABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgQQCAAADCjBwAQCCABAAgQIAACQCAAAAAAAAAAAAIGAAAACABAAAAAAQAAEAAAAAAAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(2S)-2-amino-3-methyl-3-sulfanyl-butanoic acid,(2S)-2-amino-3-mercapto-3-methylbutanoic acid,(2<I>S</I>)-2-amino-3-methyl-3-sulfanylbutanoic acid,(2S)-2-amino-3-methyl-3-sulfanylbutanoic acid,(2S)-2-azanyl-3-methyl-3-sulfanyl-butanoic acid,(2S)-2-amino-3-mercapto-3-methyl-butyric acid,"InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m0/s1",VVNCNSJFMMFHPL-VKHMYHEASA-N,-1.8,149.05104977,C5H11NO2S,149.21,64.3,149.05104977,0.0,9.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)(S)[C@@H](N)C(=O)O,,6  4  5,
440790438,34312,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01056,OXCARBAZEPINE,20210312,20210312,Curation Efforts|Governmental Organizations,LT01056,oxcarbazepine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,34312,1.0,382.0,2.0,1.0,0.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABYAAAAABQAAAHgAQAAAADAyBmAAxwINAAACIAqRSUACCAAAlAgAIiAEAZMiIIHrAlZGEIYhghALIyecciMCOAAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide,5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide,5-oxo-6<I>H</I>-benzo[b][1]benzazepine-11-carboxamide,5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide,5-oxidanylidene-6H-benzo[b][1]benzazepine-11-carboxamide,5-keto-6H-benzo[b][1]benzazepine-11-carboxamide,"InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)",CTRLABGOLIVAIY-UHFFFAOYSA-N,,252.08987763,C15H12N2O2,252.27,63.4,252.08987763,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)N1c2ccccc2CC(=O)c2ccccc21,1.7,"11  16  8
12  17  8
13  18  8
14  19  8
16  17  8
18  19  8
5  11  8
5  6  8
6  12  8
8  13  8
8  9  8
9  14  8",
440790437,4614,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00429,oxaprozin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00429,oxaprozin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4614,1.0,361.0,4.0,1.0,5.0,AAADccB6MAAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAAB0AAAHgAACAAADAyBngAwjJIIFkCoA6XyXASCiCAvYCAImCG1TNgOJrLEtTuPeSjkxAHY6Yf/yOCOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3-(4,5-diphenyloxazol-2-yl)propanoic acid","3-(4,5-diphenyl-2-oxazolyl)propanoic acid","3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid","3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid","3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid","3-(4,5-diphenyloxazol-2-yl)propionic acid","InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)",OFPXSFXSNFPTHF-UHFFFAOYSA-N,4.2,293.10519334,C18H15NO3,293.3,63.3,293.10519334,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,,"1  5  8
1  7  8
10  14  8
10  15  8
12  16  8
13  17  8
14  18  8
15  19  8
16  21  8
17  21  8
18  22  8
19  22  8
4  6  8
4  7  8
5  6  8
9  12  8
9  13  8",
440790436,6196,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01624,oxacillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01624,oxacillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,6196,1.0,680.0,7.0,2.0,4.0,AAADceB7OABAAAAAAAAAAAAAAABYAWLAAAAwAAAABYAAAAABwAAAHgQUCAAADCzF3gSyjJPQAgipA6XyWgCCAABkIBAomKGsTNoKZr6o0bOUcchmthi4yUeYyOCOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-isoxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)-oxomethyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2<I>S</I>,5<I>R</I>,6<I>R</I>)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonylamino]-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-7-keto-3,3-dimethyl-6-[(5-methyl-3-phenyl-isoxazole-4-carbonyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI=1S/C19H19N3O5S/c1-9-11(12(21-27-9)10-7-5-4-6-8-10)15(23)20-13-16(24)22-14(18(25)26)19(2,3)28-17(13)22/h4-8,13-14,17H,1-3H3,(H,20,23)(H,25,26)/t13-,14+,17-/m1/s1",UWYHMGVUTGAWSP-JKIFEVAISA-N,2.4,401.10454189,C19H19N3O5S,401.4,138.0,401.10454189,0.0,28.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O,,"10  29  6
12  17  6
19  20  8
19  21  8
22  24  8
22  25  8
24  26  8
25  27  8
26  28  8
27  28  8
6  21  8
6  9  8
13  8  5
9  20  8",
440790435,4583,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01620,ofloxacin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01620,ofloxacin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4583,1.0,634.0,8.0,1.0,2.0,AAADceB7OQAAAAAAAAAAAAAAAAAAAAAAAAA8WIEAAAAAAACxAAAAHwAACAAADCzhmA4yzoMABgCIAqTWSACCCAAlIAAAiAENTMgOZj7M9NuXeajk4BHY+cea2bOeCAABAAQCEAAQAAIACAQgAAAAAAAAAA==,"7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","7-fluoro-2-methyl-6-(4-methyl-1-piperazinyl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0<SUP>5,13</SUP>]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","7-fluoranyl-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxidanylidene-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","7-fluoro-10-keto-2-methyl-6-(4-methylpiperazino)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)",GSDSWSVVBLHKDQ-UHFFFAOYSA-N,-0.4,361.14378429,C18H20FN3O4,361.4,73.3,361.14378429,0.0,26.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,,"11  22  3
12  14  8
12  19  8
13  14  8
13  18  8
18  21  8
18  23  8
19  21  8
20  25  8
23  25  8
7  13  8
7  20  8",
440790434,383414,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01618,Octreotide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01618,octreotide,2.0,Warnings and precautions,vLess-DILI-Concern,2.0,383414,1.0,1740.0,14.0,13.0,17.0,AAADcfB//ABgAAAAAAAAAAAAAAAAAWAAAAAwYMAAAAAAAFgB9AAAHgQQCAAADDzl3ga+wPLJkgCoAzV3VACCgCAxAiAI2aG4ZJgKcPbAkbGUYAhntgDYyAcYicCOgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"10-(4-aminobutyl)-19-[(2-amino-3-phenyl-propanoyl)amino]-16-benzyl-7-(1-hydroxyethyl)-N-[2-hydroxy-1-(hydroxymethyl)propyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide","10-(4-aminobutyl)-19-[(2-amino-1-oxo-3-phenylpropyl)amino]-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-16-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicosane-4-carboxamide","10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-<I>N</I>-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1<I>H</I>-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide","10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide","10-(4-azanylbutyl)-19-[(2-azanyl-3-phenyl-propanoyl)amino]-N-[1,3-bis(oxidanyl)butan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentakis(oxidanylidene)-16-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide","10-(4-aminobutyl)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-methylol-propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaketo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentazacycloeicosane-4-carboxamide","InChI=1S/C49H66N10O10S2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64)",DEQANNDTNATYII-UHFFFAOYSA-N,,1018.44048069,C49H66N10O10S2,1019.2,383.0,1018.44048069,0.0,71.0,0.0,10.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,1.0,"17  38  8
17  39  8
43  20  3
59  22  3
23  25  3
24  26  3
29  34  8
29  38  8
30  40  3
32  37  3
34  39  8
34  44  8
39  51  8
41  50  3
44  54  8
47  57  8
47  58  8
48  56  3
35  5  3
51  55  8
54  55  8
57  63  8
58  64  8
63  65  8
64  65  8
66  67  8
66  68  8
67  69  8
68  70  8
69  71  8
70  71  8
53  9  3",
440790433,4539,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01614,norfloxacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01614,norfloxacin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4539,1.0,519.0,7.0,2.0,3.0,AAADceB7MQAAAAAAAAAAAAAAAAAAAAAAAAA8QIAAAAAAAACBAAAAHwAQCAAADAzBmAwyyIPAAgCIAqTWSACCAAAlAgAAiIEIZMgIZD7I1NGUYYhksADI2ceY2aOeCAAAAAQCAAAQAAAACAQAAAAAAAAAAA==,1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid,1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid,1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,1-ethyl-6-fluoranyl-4-oxidanylidene-7-piperazin-1-yl-quinoline-3-carboxylic acid,1-ethyl-6-fluoro-4-keto-7-piperazino-quinoline-3-carboxylic acid,"InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)",OGJPXUAPXNRGGI-UHFFFAOYSA-N,-1.0,319.13321961,C16H18FN3O3,319.33,72.9,319.13321961,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,"12  14  8
12  16  8
13  14  8
13  15  8
15  17  8
15  19  8
16  17  8
19  21  8
20  21  8
7  13  8
7  20  8",
440790432,4485,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00313,nifedipine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00313,nifedipine,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,4485,1.0,608.0,7.0,1.0,5.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwQAAAAAAAAAABAAAAHgAUAAAADQiBmAIyyILQRACJAiTSSwCCAAAgAgAoiAEAZMoIJDKAsZGAMABkkACI6UeY/+megAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester","dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester","InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3",HYIMSNHJOBLJNT-UHFFFAOYSA-N,2.2,346.1164863,C17H18N2O6,346.3,110.0,346.1164863,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],,"12  15  8
12  16  8
15  21  8
16  22  8
21  23  8
22  23  8",
440790431,156391,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00593,NAPROXEN,20231222,20210312,Curation Efforts|Governmental Organizations,LT00593,naproxen,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,156391,1.0,277.0,3.0,1.0,3.0,AAADccBwMAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAADBUAAAGgAACAAADQSAmAIyDsAABgCIAiDSCAACCAAgIAAIiAEGCIgMJjKENRqAcCAkwBEIqAeIyPCO4AADAAAQAADAAAYAACAAAAAAAAAAAA==,(2S)-2-(6-methoxy-2-naphthyl)propanoic acid,(2S)-2-(6-methoxy-2-naphthalenyl)propanoic acid,(2<I>S</I>)-2-(6-methoxynaphthalen-2-yl)propanoic acid,(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid,(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid,(2S)-2-(6-methoxy-2-naphthyl)propionic acid,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",CMWTZPSULFXXJA-VIFPVBQESA-N,3.3,230.094294304,C14H14O3,230.26,46.5,230.094294304,0.0,17.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,,"12  16  8
13  14  8
14  16  8
4  11  6
5  8  8
5  9  8
6  12  8
6  7  8
6  8  8
7  10  8
7  13  8
9  10  8",
440790430,8982,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01583,nafcillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01583,nafcillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,8982,1.0,699.0,6.0,2.0,5.0,AAADceB7OABAAAAAAAAAAAAAAABYAWAAAAAwYAAABYAAAADBUAAAHgQQCAAADCzl2AayDsPABgiIAiHSGACCCABkIBAIiIGODMgOZj6ktTuWeWjm9hG4qQeYyPCOoAADAAAYAABAAAYAADAAAAAAAAAAAA==,"(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2-ethoxy-1-naphthalenyl)-oxomethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2<I>S</I>,5<I>R</I>,6<I>R</I>)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[(2-ethoxynaphthalen-1-yl)carbonylamino]-3,3-dimethyl-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[(2-ethoxy-1-naphthoyl)amino]-7-keto-3,3-dimethyl-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI=1S/C21H22N2O5S/c1-4-28-13-10-9-11-7-5-6-8-12(11)14(13)17(24)22-15-18(25)23-16(20(26)27)21(2,3)29-19(15)23/h5-10,15-16,19H,4H2,1-3H3,(H,22,24)(H,26,27)/t15-,16+,19-/m1/s1",GPXLMGHLHQJAGZ-JTDSTZFVSA-N,2.9,414.12494298,C21H22N2O5S,414.5,121.0,414.12494298,0.0,29.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O,,"11  16  5
18  19  8
18  20  8
19  21  8
19  23  8
20  22  8
21  24  8
21  25  8
22  24  8
23  26  8
25  27  8
26  27  8
12  8  6
9  30  5",
440790429,4236,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00589,modafinil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00589,modafinil,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4236,1.0,302.0,3.0,1.0,5.0,AAADccByMABAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgQQAAAADACF2ACwAIBAAAqIAiFSEEBCAAAgABAIiAAAAIgIICKgERCAIAAgkAAoiAcAgMAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-benzhydrylsulfinylacetamide,2-(diphenylmethyl)sulfinylacetamide,2-benzhydrylsulfinylacetamide,2-benzhydrylsulfinylacetamide,2-(diphenylmethyl)sulfinylethanamide,2-benzhydrylsulfinylacetamide,"InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)",YFGHCGITMMYXAQ-UHFFFAOYSA-N,,273.08234989,C15H15NO2S,273.4,79.4,273.08234989,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)CS(=O)C(c1ccccc1)c1ccccc1,1.7,"1  8  3
10  14  8
11  15  8
12  16  8
13  17  8
14  18  8
15  17  8
16  18  8
6  11  8
6  9  8
7  10  8
7  12  8
9  13  8",
440790428,4212,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01565,mitoxantrone,20250421,20210312,Curation Efforts|Governmental Organizations,LT01565,mitoxantrone,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4212,1.0,571.0,10.0,8.0,12.0,AAADceB7uAAAAAAAAAAAAAAAAAAAAAAAAAAwYMAAAAAAAADBQAAAHgAQCAAADAzhmAYwxoLAAgCIAqRSQACCAAAlIgAIiIEObMgKdj7ClJOUcchk8BHY2Uff2POOgQCBQAAaAACCAQaAADQAAAAAAAAAAA==,"1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione","1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione","1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione","1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione","1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-bis(oxidanyl)anthracene-9,10-dione","1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-9,10-anthraquinone","InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2",KKZJGLLVHKMTCM-UHFFFAOYSA-N,,444.20088463,C22H28N4O6,444.5,163.0,444.20088463,0.0,32.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,1.0,"11  12  8
11  13  8
12  14  8
13  19  8
14  20  8
15  16  8
15  23  8
16  24  8
19  20  8
23  27  8
24  28  8
27  28  8",
440790427,4205,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01560,mirtazapine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01560,mirtazapine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4205,1.0,345.0,3.0,0.0,0.0,AAADceB7AAAAAAAAAAAAAAAAAAAAAAAAAAA8WIAABYAAAAABwAAAHAAAAAAADCjBGgQ/sJMIEACgAjJnZACCgCkxAiAJ2CA4ZJiIYOLAmZGUIAhogALIyCcQgMAOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene","5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene","5-methyl-2,5,19-triazatetracyclo[13.4.0.0<SUP>2,7</SUP>.0<SUP>8,13</SUP>]nonadeca-1(15),8,10,12,16,18-hexaene","5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene","5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene","5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene","InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3",RONZAEMNMFQXRA-UHFFFAOYSA-N,3.3,265.157897619,C17H19N3,265.35,19.4,265.157897619,0.0,20.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCN2c3ncccc3Cc3ccccc3C2C1,,"10  15  8
12  16  8
14  17  8
15  18  8
16  19  8
17  18  8
19  20  8
3  20  8
3  9  8
4  5  3
8  10  8
8  14  8
9  12  8",
440790426,6010,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00222,methyltestosterone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00222,methyltestosterone,2.0,Warnings and precautions,vLess-DILI-Concern,2.0,6010,1.0,550.0,2.0,1.0,0.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAAD0SAgAACAAAAAgCIAqBSAAAAAAAgAAAACAEAAEgAABIAAQAAQAAEgAAIAQOIyPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1<I>H</I>-cyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17S)-10,13,17-trimethyl-17-oxidanyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one","InChI=1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h12,15-17,22H,4-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1",GCKMFJBGXUYNAG-HLXURNFRSA-N,3.4,302.224580195,C20H30O2,302.5,37.3,302.224580195,0.0,22.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,,"7  1  5
3  14  5
4  23  6
5  24  5
6  25  6
9  19  5",
440790425,4114,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01537,methoxsalen,20231222,20210312,Curation Efforts|Governmental Organizations,LT01537,methoxsalen,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,4114,1.0,325.0,4.0,0.0,1.0,AAADccBwOAAAAAAAAAAAAAAAAAAAASAAAAAwQAAAAAAAAEiB8AAAGgAAAAAADASgmAIyDsAABECIAqjSiAICCAAkIAAIiAFGiMgNJzaENR6CO2Kl4BUKqYeI7PzOIAADCAAIQABAAAYQABCAAAAAAAAAAA==,"9-methoxyfuro[3,2-g]chromen-7-one","9-methoxy-7-furo[3,2-g][1]benzopyranone","9-methoxyfuro[3,2-g]chromen-7-one","9-methoxyfuro[3,2-g]chromen-7-one","9-methoxyfuro[3,2-g]chromen-7-one","9-methoxyfuro[3,2-g]chromen-7-one","InChI=1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3",QXKHYNVANLEOEG-UHFFFAOYSA-N,1.9,216.04225873,C12H8O4,216.19,48.7,216.04225873,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1c2occc2cc2ccc(=O)oc12,,"1  13  8
1  6  8
11  13  8
12  14  8
14  15  8
2  15  8
2  8  8
5  10  8
5  11  8
5  6  8
6  9  8
7  10  8
7  12  8
7  8  8
8  9  8",
440790424,441130,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01525,meropenem,20210312,20210312,Curation Efforts|Governmental Organizations,LT01525,meropenem,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,441130,1.0,679.0,7.0,3.0,5.0,AAADceB7OABAAAAAAAAAAAAAAABYAWIAAAAAAAAABAAAAAAAAAAAHgQQCAAADTzlwAaCCAPAAgiIAAXQWAAAAAAgABAACIGIAEgCVB4ggCAUUAAGtgC4EQOYAQAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-3-[[(3S,5S)-5-[dimethylamino(oxo)methyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4<I>R</I>,5<I>S</I>,6<I>S</I>)-3-[(3<I>S</I>,5<I>S</I>)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1<I>R</I>)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-4-methyl-6-[(1R)-1-oxidanylethyl]-7-oxidanylidene-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","(4R,5S,6S)-3-[[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio]-6-[(1R)-1-hydroxyethyl]-7-keto-4-methyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid","InChI=1S/C17H25N3O5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4/h7-12,18,21H,5-6H2,1-4H3,(H,24,25)/t7-,8-,9+,10+,11-,12-/m1/s1",DMJNNHOOLUXYBV-PQTSNVLCSA-N,,383.15149208,C17H25N3O5S,383.5,135.0,383.15149208,0.0,26.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,-2.4,"18  1  5
10  27  6
11  28  5
12  17  5
22  24  5
16  3  6",
440790423,54677470,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00117,meloxicam,20210312,20210312,Curation Efforts|Governmental Organizations,LT00117,meloxicam,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,54677470,1.0,628.0,7.0,2.0,2.0,AAADccBzOABgAAAAAAAAAAAAAAAAAWAAAAAwQAAAAAAAAACBwAAAHgQQSAAADAzB2gQ/kZLIEgqsAjV3dHDC8LlxKDlJ2ByoSMiIZiLAGTCUcAAswQNImSeAwCAOAAAAAAAEAAAAAAAAAAgAAAAAAAAAAA==,"4-hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide","4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide","4-hydroxy-2-methyl-<I>N</I>-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1&lambda;<SUP>6</SUP>,2-benzothiazine-3-carboxamide","4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide","2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-4-oxidanyl-1,1-bis(oxidanylidene)-1lambda6,2-benzothiazine-3-carboxamide","4-hydroxy-1,1-diketo-2-methyl-N-(5-methylthiazol-2-yl)-1lambda6,2-benzothiazine-3-carboxamide","InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)",ZRVUJXDFFKFLMG-UHFFFAOYSA-N,3.0,351.03474825,C14H13N3O4S2,351.4,136.0,351.03474825,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,,"10  11  8
10  14  8
11  16  8
14  18  8
16  19  8
18  19  8
2  20  8
2  21  8
21  22  8
9  20  8
9  22  8",
440790422,4030,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00308,mebendazole,20250421,20210312,Curation Efforts|Governmental Organizations,LT00308,mebendazole,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,4030,1.0,423.0,4.0,2.0,4.0,AAADccB7MAAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgB9AAAHgAQAAAADAyBngIz2LbJlACoA6RyfACCgC2lEqAJmSEwdNmIaLLAnZGUIQhokQJIyaccicCeCAAAQAAAACAQAACAAAAAQAAAAAAAAA==,methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate,N-(6-benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester,methyl <I>N</I>-(6-benzoyl-1<I>H</I>-benzimidazol-2-yl)carbamate,methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate,methyl N-[6-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate,N-(6-benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester,"InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)",OPXLLQIJSORQAM-UHFFFAOYSA-N,2.8,295.09569129,C16H13N3O3,295.29,84.1,295.09569129,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1,,"11  12  8
15  16  8
15  17  8
16  18  8
17  19  8
18  20  8
19  20  8
4  13  8
4  7  8
5  13  8
5  8  8
7  10  8
7  8  8
8  11  8
9  10  8
9  12  8",
440790421,53232,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00576,lovastatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00576,lovastatin,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,53232,1.0,666.0,5.0,1.0,7.0,AAADcfB4OAAAAAAAAAAAAAAAAAAAAAAAAAAkQIAAAAAAAACAAAAAGgAACAAADRSggAICCAAABgCIAiDSCAAAAAAgAAAICAEAAAgIEBYAAQACQAAF4AAIgAOIzPDOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate","(2S)-2-methylbutanoic acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester","[(1<I>S</I>,3<I>R</I>,7<I>S</I>,8<I>S</I>,8<I>a</I><I>R</I>)-8-[2-[(2<I>R</I>,4<I>R</I>)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8<I>a</I>-hexahydronaphthalen-1-yl] (2<I>S</I>)-2-methylbutanoate","[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate","[(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R,4R)-4-oxidanyl-6-oxidanylidene-oxan-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate","(2S)-2-methylbutyric acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-keto-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester","InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1",PCZOHLXUXFIOCF-BXMDZJJMSA-N,4.3,404.25627424,C24H36O5,404.5,72.8,404.25627424,0.0,29.0,8.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,,"8  1  5
13  20  5
19  15  5
25  28  5
22  3  6
6  30  6
7  11  6
9  18  6",
440790420,3950,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00575,lomustine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00575,lomustine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,3950,1.0,219.0,3.0,1.0,3.0,AAADceBzMAAEAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAAAAAAAHgIcAAAACCvBAEQBAALAAAAJAAAAEAAAAAAAAAAWAIAIAACAAAIAgABEAAAYFgIAAAEQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea,1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea,1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea,1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea,1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea,1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea,"InChI=1S/C9H16ClN3O2/c10-6-7-13(12-15)9(14)11-8-4-2-1-3-5-8/h8H,1-7H2,(H,11,14)",GQYIWUVLTXOXAJ-UHFFFAOYSA-N,2.8,233.0931045,C9H16ClN3O2,233.69,61.8,233.0931045,0.0,15.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=NN(CCCl)C(=O)NC1CCCCC1,,,
440790419,3902,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00572,letrozole,20250421,20210312,Curation Efforts|Governmental Organizations,LT00572,letrozole,2.0,Warnings and precautions,vLess-DILI-Concern,2.0,3902,1.0,420.0,4.0,0.0,3.0,AAADccB7gAAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAAB0AAAHAAIAAAADCjBGAQ1EIYIEACyBiBDJACyAAswgIAdyAAIBIiIqCKAmRGEIAhogAIIiA8QgMAOQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,"4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile","4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile","4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile","4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile","4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzenecarbonitrile","4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile","InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H",HPJKCIUCZWXJDR-UHFFFAOYSA-N,,285.10144537,C17H11N5,285.3,78.3,285.10144537,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,2.7,"1  13  8
1  2  8
10  15  8
11  16  8
12  17  8
14  18  8
15  19  8
16  18  8
17  19  8
2  20  8
3  13  8
3  20  8
7  11  8
7  9  8
8  10  8
8  12  8
9  14  8",
440790418,216326,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01238,Lenalidomide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01238,lenalidomide,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,216326,1.0,437.0,4.0,2.0,1.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgBAAAAHgAQAAAADCjBmAQwwIPAAACIAiVSUACCAAAkAgAIiAGIZMgIYDKA1bGUIQhgliCIyYcci4COgAAAQAASAAAAAACAACQAAAAAAAAAAA==,"3-(4-amino-1-oxo-isoindolin-2-yl)piperidine-2,6-dione","3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione","3-(7-amino-3-oxo-1<I>H</I>-isoindol-2-yl)piperidine-2,6-dione","3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione","3-(7-azanyl-3-oxidanylidene-1H-isoindol-2-yl)piperidine-2,6-dione","3-(4-amino-1-keto-isoindolin-2-yl)piperidine-2,6-quinone","InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)",GOTYRUGSSMKFNF-UHFFFAOYSA-N,,259.09569129,C13H13N3O3,259.26,92.5,259.09569129,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,-0.5,"10  13  8
10  16  8
13  17  8
16  18  8
17  19  8
18  19  8
7  20  3",
440790417,60825,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00569,lamivudine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00569,lamivudine,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,60825,1.0,331.0,4.0,2.0,2.0,AAADccBzMABAAAAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAAAAAAAHgQQCAAACADlwAaBAANABgioACJmdACAAAEAAhAIAAAYABCBEAAAAAAKAAAAFgIjAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one","4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2-pyrimidinone","4-amino-1-[(2<I>R</I>,5<I>S</I>)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one","4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one","4-azanyl-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one","4-amino-1-[(2R,5S)-2-methylol-1,3-oxathiolan-5-yl]pyrimidin-2-one","InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1",JTEGQNOMFQHVDC-NKWVEPMBSA-N,-0.9,229.05211239,C8H11N3O3S,229.26,113.0,229.05211239,0.0,15.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,,"10  11  5
12  14  8
14  15  8
5  12  8
5  13  8
8  5  5
6  13  8
6  15  8",
440790416,3826,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00204,ketorolac,20250421,20210312,Curation Efforts|Governmental Organizations,LT00204,ketorolac,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,3826,1.0,376.0,3.0,1.0,3.0,AAADccByMAAAAAAAAAAAAAAAAAAAAWLAAAAwAAAAAAAWAAABwAAAHgAACAAADQzBngQwiJMMEgCoA6TyTACCgCAnAiAI2CG4ZNgIIPrAlbGEYQhmwAHIyYe8yeCeAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid","5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid","5-benzoyl-2,3-dihydro-1<I>H</I>-pyrrolizine-1-carboxylic acid","5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid","5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid","5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid","InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)",OZWKMVRBQXNZKK-UHFFFAOYSA-N,,255.08954328,C15H13NO3,255.27,59.3,255.08954328,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O,1.9,"10  11  8
14  15  8
14  16  8
15  17  8
16  18  8
17  19  8
18  19  8
4  8  8
4  9  8
5  12  3
8  10  8
9  11  8",
440790415,3825,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00023,ketoprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00023,ketoprofen,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,3825,1.0,331.0,3.0,1.0,4.0,AAADccB4MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAGgAACAAADQSAmAAyCIAAAgCIAqDSCAACAAAkAAAIiAEAAMgIIDKAFRCAYQAkwAEIiYeIyPCOgAACAAAAAAAAAAQAAAAAAAAAAAAAAA==,2-(3-benzoylphenyl)propanoic acid,2-(3-benzoylphenyl)propanoic acid,2-(3-benzoylphenyl)propanoic acid,2-(3-benzoylphenyl)propanoic acid,2-[3-(phenylcarbonyl)phenyl]propanoic acid,2-(3-benzoylphenyl)propionic acid,"InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)",DKYWVDODHFEZIM-UHFFFAOYSA-N,3.1,254.094294304,C16H14O3,254.28,54.4,254.094294304,0.0,19.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,,"10  11  8
14  15  8
14  16  8
15  17  8
16  18  8
17  19  8
18  19  8
4  20  3
5  6  8
5  8  8
6  7  8
7  10  8
8  11  8",
440790414,3672,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00199,ibuprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00199,ibuprofen,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,3672,1.0,203.0,2.0,1.0,4.0,AAADceBwMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgAACAAADQCAmAAyCIAAAgCIAiDSCAACAAAgAAAIiAEAAIgIIDKAFRCAYAAkwAEIiAeIyOCOwAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,2-(4-isobutylphenyl)propanoic acid,2-[4-(2-methylpropyl)phenyl]propanoic acid,2-[4-(2-methylpropyl)phenyl]propanoic acid,2-[4-(2-methylpropyl)phenyl]propanoic acid,2-[4-(2-methylpropyl)phenyl]propanoic acid,2-(4-isobutylphenyl)propionic acid,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",HEFNNWSXXWATRW-UHFFFAOYSA-N,3.5,206.130679813,C13H18O2,206.28,37.3,206.130679813,0.0,15.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)Cc1ccc(C(C)C(=O)O)cc1,,"10  12  8
11  13  8
5  10  8
5  11  8
6  12  8
6  13  8
7  19  3",
440790413,9571107,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01084,Gemifloxacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01084,gemifloxacin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,9571107,1.0,725.0,10.0,2.0,5.0,AAADceB7uQAAAAAAAAAAAAAAGAAAAWAAAAAsQAAAAAAAAACBgAAAHwAUCAAADSzBmg4zuJNYEgCoA6L2bACCgCklACABmKE4RNiIJP7I3JGEYYhssALI2eeY2SKOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"7-[(4Z)-3-(aminomethyl)-4-methoxyimino-pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid","7-[(4Z)-3-(aminomethyl)-4-methoxyimino-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid","7-[(4<I>Z</I>)-3-(aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid","7-[(4Z)-3-(aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid","7-[(4Z)-3-(aminomethyl)-4-methoxyimino-pyrrolidin-1-yl]-1-cyclopropyl-6-fluoranyl-4-oxidanylidene-1,8-naphthyridine-3-carboxylic acid","7-[(4Z)-3-(aminomethyl)-4-methyloximino-pyrrolidino]-1-cyclopropyl-6-fluoro-4-keto-1,8-naphthyridine-3-carboxylic acid","InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+",ZRCVYEYHRGVLOC-HYARGMPZSA-N,,389.1499323,C18H20FN5O4,389.4,121.0,389.1499323,0.0,28.0,0.0,1.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,-0.7,"14  21  8
15  34  3
18  23  8
20  25  8
21  24  8
21  26  8
23  24  8
25  26  8
6  14  8
6  18  8
8  14  8
8  20  8",
440790412,3446,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00300,gabapentin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00300,gabapentin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,3446,1.0,162.0,3.0,2.0,3.0,AAADceByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAAAAAAAHgAQCAAADgDBgAQACABAAgAIAACQCAAAAAAAAAAAAIEAAAAAABIAgAAAQAAEAAAAAAG8yOCPAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-[1-(aminomethyl)cyclohexyl]acetic acid,2-[1-(aminomethyl)cyclohexyl]acetic acid,2-[1-(aminomethyl)cyclohexyl]acetic acid,2-[1-(aminomethyl)cyclohexyl]acetic acid,2-[1-(aminomethyl)cyclohexyl]ethanoic acid,2-[1-(aminomethyl)cyclohexyl]acetic acid,"InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)",UGJMXCAKCUNAIE-UHFFFAOYSA-N,-1.1,171.125928785,C9H17NO2,171.24,63.3,171.125928785,0.0,12.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NCC1(CC(=O)O)CCCCC1,,,
440790411,446155,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00172,fluvastatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00172,fluvastatin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,446155,1.0,590.0,5.0,3.0,8.0,AAADceB6OQAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgB9AAAHwAACAAADDzhng4yyPMMEgCoAyTyTACCgCAhAiAI2CE4ZJgINPbAkZGEcAhloADI2AeY7MROgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"(E,3R,5S)-7-[3-(4-fluorophenyl)-1-isopropyl-indol-2-yl]-3,5-dihydroxy-hept-6-enoic acid","(E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-yl-2-indolyl]-3,5-dihydroxy-6-heptenoic acid","(<I>E</I>,3<I>R</I>,5<I>S</I>)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid","(E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid","(E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-yl-indol-2-yl]-3,5-bis(oxidanyl)hept-6-enoic acid","(E,3R,5S)-7-[3-(4-fluorophenyl)-1-isopropyl-indol-2-yl]-3,5-dihydroxy-hept-6-enoic acid","InChI=1S/C24H26FNO4/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30)/b12-11+/t18-,19-/m1/s1",FJLGEFLZQAZZCD-MCBHFWOFSA-N,,411.18458647,C24H26FNO4,411.5,82.7,411.18458647,0.0,30.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)n1c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,3.5,"10  11  8
11  17  8
15  24  8
15  25  8
16  22  8
17  23  8
18  2  5
22  23  8
24  27  8
25  28  8
27  29  8
28  29  8
21  3  5
6  8  8
6  9  8
8  10  8
9  11  8
9  16  8",
440790410,3339,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00098,fenofibrate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00098,fenofibrate,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,3339,1.0,458.0,4.0,0.0,7.0,AAADceB4OAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAGgIAAAAADFagmCIyDoAABACIAqDSCAICCAAkJQAIiAFGCsgNJjKFNx6COSCkwBEKqYeIzODOJAAAAAAAAABIAAAAAAAAAAAAAAAAAA==,isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoate,2-[4-[(4-chlorophenyl)-oxomethyl]phenoxy]-2-methylpropanoic acid propan-2-yl ester,propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate,propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate,propan-2-yl 2-[4-(4-chlorophenyl)carbonylphenoxy]-2-methyl-propanoate,2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propionic acid isopropyl ester,"InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3",YMTINGFKWWXKFG-UHFFFAOYSA-N,,360.1128368,C20H21ClO4,360.8,52.6,360.1128368,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,5.2,"11  12  8
11  13  8
12  17  8
13  18  8
14  17  8
14  18  8
20  21  8
20  22  8
21  23  8
22  24  8
23  25  8
24  25  8",
440790409,150311,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01153,Ezetimibe,20250421,20210312,Curation Efforts|Governmental Organizations,LT01153,ezetimibe,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,150311,1.0,567.0,5.0,2.0,6.0,AAADceB6MYAAAAAAAAAAAAAAAABYAAAAAAAwYMAAAAAAAAABUAAAHwAACAAADTzhmA4wxoMAAgCIAiVSUACCAAAhIgAIiAEObIgINjrCkZOEcAhkxhHI2AeY3OPOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)azetidin-2-one","(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone","(3<I>R</I>,4<I>S</I>)-1-(4-fluorophenyl)-3-[(3<I>S</I>)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one","(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one","(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-oxidanyl-propyl]-4-(4-hydroxyphenyl)azetidin-2-one","(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)azetidin-2-one","InChI=1S/C24H21F2NO3/c25-17-5-1-15(2-6-17)22(29)14-13-21-23(16-3-11-20(28)12-4-16)27(24(21)30)19-9-7-18(26)8-10-19/h1-12,21-23,28-29H,13-14H2/t21-,22+,23-/m1/s1",OLNTVTPDXPETLC-XPWALMASSA-N,,409.14894986,C24H21F2NO3,409.4,60.8,409.14894986,0.0,30.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1,4.0,"11  15  8
11  16  8
13  17  8
13  18  8
15  20  8
16  21  8
17  23  8
18  24  8
19  25  8
19  26  8
20  22  8
21  22  8
23  27  8
24  27  8
25  28  8
26  29  8
28  30  8
29  30  8
14  4  5
7  9  6
8  11  5",
440790408,2761171,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01348,ethionamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01348,ethionamide,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,2761171,1.0,147.0,2.0,1.0,2.0,AAADccBzAABAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAHAQQAAAADAjBXgQ+gJJIEACkAzRnRACCgCAxAiEI2CA4ZJgIIGLAkZGEIAhggADIyAcQgAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-ethylpyridine-4-carbothioamide,2-ethyl-4-pyridinecarbothioamide,2-ethylpyridine-4-carbothioamide,2-ethylpyridine-4-carbothioamide,2-ethylpyridine-4-carbothioamide,2-ethylthioisonicotinamide,"InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)",AEOCXXJPGCBFJA-UHFFFAOYSA-N,1.1,166.0564695,C8H10N2S,166.25,71.0,166.0564695,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCc1cc(C(N)=S)ccn1,,"2  10  8
2  5  8
5  6  8
6  7  8
7  9  8
9  10  8",
440790407,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01353,Etanercept,20210312,20210312,Curation Efforts|Governmental Organizations,LT01353,etanercept,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790406,148124,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01309,docetaxel,20250421,20210312,Curation Efforts|Governmental Organizations,LT01309,docetaxel,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,148124,1.0,1660.0,14.0,5.0,13.0,AAADcfB+PAAAAAAAAAAAAAAAAABIAAAAAAAwYMEAAAAaIACBQAAAHgAQCAAAD3zhmAYyCILABgCIAqDSGAKCAAAkAAAIiIFIDMkLNj6AtRmOcQhn9gEbuYfa7PzPgAAAAAAAAABCAAYQADCAAAAAAAAAAA==,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetoxy-15-[(2R,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-3-phenyl-propanoyl]oxy-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate","benzoic acid [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-1-oxo-3-phenylpropoxy]-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] ester","[(1<I>S</I>,2<I>S</I>,3<I>R</I>,4<I>S</I>,7<I>R</I>,9<I>S</I>,10<I>S</I>,12<I>R</I>,15<I>S</I>)-4-acetyloxy-1,9,12-trihydroxy-15-[(2<I>R</I>,3<I>S</I>)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0<SUP>3,10</SUP>.0<SUP>4,7</SUP>]heptadec-13-en-2-yl] benzoate","[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate","[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-10,14,17,17-tetramethyl-15-[(2R,3S)-3-[(2-methylpropan-2-yl)oxycarbonylamino]-2-oxidanyl-3-phenyl-propanoyl]oxy-1,9,12-tris(oxidanyl)-11-oxidanylidene-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate","benzoic acid [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetoxy-15-[(2R,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-3-phenyl-propanoyl]oxy-1,9,12-trihydroxy-11-keto-10,14,17,17-tetramethyl-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] ester","InChI=1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1",ZDZOTLJHXYCWBA-VCVYQWHSSA-N,1.6,807.34660536,C43H53NO14,807.9,224.0,807.34660536,0.0,58.0,11.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,,"41  12  5
44  15  5
16  59  5
18  29  6
19  60  5
17  2  5
20  3  5
21  4  6
40  42  8
40  43  8
42  45  8
43  46  8
45  47  8
46  47  8
48  49  8
48  50  8
49  52  8
22  5  6
50  53  8
52  54  8
53  54  8
30  7  6
31  8  5",
440790405,18381,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02041,dicloxacillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT02041,dicloxacillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,18381,1.0,746.0,7.0,2.0,4.0,AAADceB7OABGAAAAAAAAAAAAAABYAWLAAAAwAAAABYAAAAABwAAAHgYUCAAADC7F3iSyjJPQAgipA6XyWgCCAABkJRAomKGsTtoKZj6p07OUcchmthi4yUeYyOCOAAAAAACBAAAAAAAAAQIAAAAAAAAAAA==,"(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2<I>S</I>,5<I>R</I>,6<I>R</I>)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[3-[2,6-bis(chloranyl)phenyl]-5-methyl-1,2-oxazol-4-yl]carbonylamino]-3,3-dimethyl-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-7-keto-3,3-dimethyl-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI=1S/C19H17Cl2N3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1",YFAGHNZHGGCZAX-JKIFEVAISA-N,2.9,469.0265972,C19H17Cl2N3O5S,470.3,138.0,469.0265972,0.0,30.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O,,"15  10  5
11  22  8
12  31  6
14  19  6
21  22  8
21  23  8
24  26  8
24  27  8
26  28  8
27  29  8
28  30  8
29  30  8
8  11  8
8  23  8",
440790404,2955,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00289,dapsone,20250421,20210312,Curation Efforts|Governmental Organizations,LT00289,dapsone,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,2955,1.0,306.0,4.0,2.0,2.0,AAADccBzMABAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHAQQAAAACAiBUAAwwYBAAAqAACRCQHDCAAAgChAIiBgAZIgIICKgkZGAIABgkAAoyAcQAAAAAAQAAAAAAAAACAAAAAAAAAAAAAAAAA==,4-(4-aminophenyl)sulfonylaniline,4-(4-aminophenyl)sulfonylaniline,4-(4-aminophenyl)sulfonylaniline,4-(4-aminophenyl)sulfonylaniline,4-(4-aminophenyl)sulfonylaniline,(4-sulfanilylphenyl)amine,"InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2",MQJKPEGWNLWLTK-UHFFFAOYSA-N,1.0,248.0619488,C12H12N2O2S,248.3,94.6,248.0619488,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,,"10  14  8
11  15  8
12  16  8
13  17  8
14  16  8
15  17  8
6  10  8
6  8  8
7  11  8
7  9  8
8  12  8
9  13  8",
440790403,6098,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01235,cloxacillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01235,cloxacillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,6098,1.0,722.0,7.0,2.0,4.0,AAADceB7OABEAAAAAAAAAAAAAABYAWLAAAAwAAAABYAAAAABwAAAHgYUCAAADC7F3iSyjJPQAgipA6XyWgCCAABkJRAomKGsTtoKZr6p07OUcchmthi4yUeYyOCOAAAAAAABAAAAAAAAAAIAAAAAAAAAAA==,"(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2<I>S</I>,5<I>R</I>,6<I>R</I>)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonylamino]-3,3-dimethyl-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-isoxazole-4-carbonyl]amino]-7-keto-3,3-dimethyl-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI=1S/C19H18ClN3O5S/c1-8-11(12(22-28-8)9-6-4-5-7-10(9)20)15(24)21-13-16(25)23-14(18(26)27)19(2,3)29-17(13)23/h4-7,13-14,17H,1-3H3,(H,21,24)(H,26,27)/t13-,14+,17-/m1/s1",LQOLIRLGBULYKD-JKIFEVAISA-N,2.4,435.0655696,C19H18ClN3O5S,435.9,138.0,435.0655696,0.0,29.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O,,"10  21  8
11  30  6
13  18  6
20  21  8
20  22  8
23  25  8
23  26  8
25  27  8
26  28  8
27  29  8
28  29  8
7  10  8
7  22  8
14  9  5",
440790402,2812,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00248,clotrimazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00248,clotrimazole,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,2812,1.0,396.0,1.0,0.0,4.0,AAADceB7AAAEAAAAAAAAAAAAAAAAAWAAAAAwYMAAAAAAAAAB1AAAHAIAAAAADIrBGiQ9kJcMEACgAjBnZACCgC0xF6AJyAAYNoiIaCKBmxGUIAhogAKIiCcQgMAOgAAAAAABAAAAAAAAAAIAAAAAAAAAAA==,1-[(2-chlorophenyl)-diphenyl-methyl]imidazole,1-[(2-chlorophenyl)-diphenylmethyl]imidazole,1-[(2-chlorophenyl)-diphenylmethyl]imidazole,1-[(2-chlorophenyl)-diphenylmethyl]imidazole,1-[(2-chlorophenyl)-diphenyl-methyl]imidazole,1-[(2-chlorophenyl)-diphenyl-methyl]imidazole,"InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H",VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.0,344.1080262,C22H17ClN2,344.8,17.8,344.1080262,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,,"10  19  8
11  20  8
12  21  8
13  22  8
14  16  8
17  23  8
18  23  8
19  24  8
2  14  8
2  15  8
20  25  8
21  24  8
22  25  8
3  15  8
3  16  8
5  8  8
5  9  8
6  10  8
6  12  8
7  11  8
7  13  8
8  17  8
9  18  8",
440790401,1548953,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00233,clomiphene,20231222,20210312,Curation Efforts|Governmental Organizations,LT00233,clomiphene,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,1548953,1.0,481.0,2.0,0.0,9.0,AAADceB6IAAEAAAAAAAAAAAAAAAAAAAAAAAwYMAAAAAAAAABUAAAHgIAAAAADAbhmAYyBoMABACAAiBCAAACCAAgIAAIiAAOCogOJiKFMRqDOCCkwBGYqAeAwOAOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"2-[4-[(E)-2-chloro-1,2-diphenyl-vinyl]phenoxy]-N,N-diethyl-ethanamine","2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine","2-[4-[(<I>E</I>)-2-chloro-1,2-diphenylethenyl]phenoxy]-<I>N</I>,<I>N</I>-diethylethanamine","2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine","2-[4-[(E)-2-chloranyl-1,2-diphenyl-ethenyl]phenoxy]-N,N-diethyl-ethanamine","2-[4-[(E)-2-chloro-1,2-diphenyl-vinyl]phenoxy]ethyl-diethyl-amine","InChI=1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3/b26-25+",GKIRPKYJQBWNGO-OCEACIFDSA-N,,405.1859422,C26H28ClNO,406.0,12.5,405.1859422,0.0,29.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1,7.2,"10  13  8
10  14  8
11  15  8
11  16  8
13  15  8
14  16  8
17  20  8
17  21  8
19  24  8
19  25  8
20  22  8
21  23  8
22  26  8
23  26  8
24  27  8
25  28  8
27  29  8
28  29  8",
440790400,2796,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00011,clofibrate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00011,clofibrate,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,2796,1.0,232.0,3.0,0.0,5.0,AAADccBwMAAEAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgIAAAAADEagkCIyDoAABACIACDSCAICCAAgJQAIiAFGCogNJiKFMx6COCCkwBEKqAeAQAAAACAAAAAAAAAAQAAAAAAAAAAAAAAAAA==,ethyl 2-(4-chlorophenoxy)-2-methyl-propanoate,2-(4-chlorophenoxy)-2-methylpropanoic acid ethyl ester,ethyl 2-(4-chlorophenoxy)-2-methylpropanoate,ethyl 2-(4-chlorophenoxy)-2-methylpropanoate,ethyl 2-(4-chloranylphenoxy)-2-methyl-propanoate,2-(4-chlorophenoxy)-2-methyl-propionic acid ethyl ester,"InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3",KNHUKKLJHYUCFP-UHFFFAOYSA-N,3.3,242.070972,C12H15ClO3,242.7,35.5,242.070972,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,,"11  13  8
12  14  8
13  16  8
14  16  8
9  11  8
9  12  8",
440790399,446598,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01225,clindamycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01225,clindamycin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,446598,1.0,502.0,7.0,4.0,7.0,AAADcfB7OABEAAAAAAAAAAAAAAAAAWAAAAAkAAAAAAAAAAAAAAAAHgYQCAAADT/lwEaCAAPABggIAAEQEAAAAAAAABAAAIGIAgADUBIhgCBXQAAHFgCTAAH42aOOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide","(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-2-oxanyl]propyl]-1-methyl-4-propyl-2-pyrrolidinecarboxamide","(2<I>S</I>,4<I>R</I>)-<I>N</I>-[(1<I>S</I>,2<I>S</I>)-2-chloro-1-[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>,6<I>R</I>)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide","(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide","(2S,4R)-N-[(1S,2S)-2-chloranyl-1-[(2R,3R,4S,5R,6R)-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide","(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide","InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1",KDLRVYVGXIQJDK-AWPVFWJPSA-N,2.2,424.179871,C18H33ClN2O5S,425.0,128.0,424.179871,0.0,27.0,9.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,"22  1  6
10  17  6
11  19  5
14  34  6
21  2  6
16  4  5
18  5  5
20  6  6
15  9  5",
440790398,441203,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00071,cisplatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00071,cisplatin,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,441203,1.0,7.6,2.0,2.0,0.0,AAADcYADAAAGAAAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,ammonia;dichloroplatinum(2+),ammonia;dichloroplatinum(2+),azane;dichloroplatinum(2+),azane;dichloroplatinum(2+),azane;bis(chloranyl)platinum(2+),ammonia;dichloroplatinum(2+),InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+4/p-2,BSJGASKRWFKGMV-UHFFFAOYSA-L,,298.955598,Cl2H6N2Pt+2,300.05,2.0,298.955598,2.0,5.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",N.N.[Cl][Pt+2][Cl],,,"1  4  6
1  5  6"
440790397,2708,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00286,chlorambucil,20250421,20210312,Curation Efforts|Governmental Organizations,LT00286,chlorambucil,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,2708,1.0,250.0,3.0,1.0,9.0,AAADceByMAAGAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgIACAAADAvBmEQwyIMAAgCIAiTSSACCAAAhAgAIiAEIZIgIIDLAkZHEYAhkgADIyAeYyLCOCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid,4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid,4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid,4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid,4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid,4-[4-[bis(2-chloroethyl)amino]phenyl]butyric acid,"InChI=1S/C14H19Cl2NO2/c15-8-10-17(11-9-16)13-6-4-12(5-7-13)2-1-3-14(18)19/h4-7H,1-3,8-11H2,(H,18,19)",JCKYGMPEJWAADB-UHFFFAOYSA-N,1.7,303.0792842,C14H19Cl2NO2,304.2,40.5,303.0792842,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,,"12  14  8
13  15  8
6  12  8
6  13  8
8  14  8
8  15  8",
440790396,2662,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00252,celecoxib,20250421,20210312,Curation Efforts|Governmental Organizations,LT00252,celecoxib,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,2662,1.0,577.0,7.0,1.0,3.0,AAADccB7MYBAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAAB0AAAHQQYQAAADAiBXhAywZIIAAKiAyRiRHDSBDAhAgAYmDgwZJgIIOLA0dGEpAhgiADIyAcQgMAOQAQAAAAAAACACAAAAAAAAAAAAAAAAA==,4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1-pyrazolyl]benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,"InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",RZEKVGVHFLEQIL-UHFFFAOYSA-N,,381.07588236,C17H14F3N3O2S,381.4,86.4,381.07588236,0.0,26.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,3.4,"10  13  8
11  15  8
11  16  8
12  18  8
12  19  8
13  14  8
15  20  8
16  21  8
17  20  8
17  21  8
18  23  8
19  24  8
22  23  8
22  24  8
7  10  8
7  8  8
8  14  8",
440790395,426756,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00061,carboplatin,20250421,20210312,Curation Efforts|Governmental Organizations,LT00061,carboplatin,3.0,Warnings and precautions,vLess-DILI-Concern,1.0,426756,1.0,177.0,6.0,4.0,0.0,AAADccBjOAAAAAAAAAAABAAAAABgAAAAAAAkAAAAAAAAAAAAAAAAGgAQCAAADgCAgAAACAAAAgAIAACQCAAAAAAAAAAAAAEAAAAAABYIAAAAQAAFIAAAAACIAAANAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+)","azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+)","azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+)","azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+)","azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+)","azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+)","InChI=1S/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6;;;/h1-3H2,(H,7,8)(H,9,10);2*1H2;/q;2*-1;+2",VSRXQHXAPYXROS-UHFFFAOYSA-N,,371.044501,C6H12N2O4Pt,371.25,76.6,371.044501,0.0,13.0,0.0,0.0,0.0,0.0,0.0,4.0,-1.0,"1
5
255",O=C(O)C1(C(=O)O)CCC1.[NH2-].[NH2-].[Pt+2],,,"1  2  6
1  3  6
1  6  6
1  7  6"
440790394,20824,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01159,carbenicillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01159,carbenicillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,20824,1.0,645.0,7.0,3.0,5.0,AAADceB7OABAAAAAAAAAAAAAAABYAWAAAAAwAAAABYAAAAABAAAAHgQQCAAADSjF2ASyCIPAAgiIAiHSGAACAABgABAIiIGIAIgKYD6olTGUYAAm9gG4iAeYyOCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,5R,6R)-6-[(2-carboxy-2-phenyl-acetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[(2-carboxy-1-oxo-2-phenylethyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2<I>S</I>,5<I>R</I>,6<I>R</I>)-6-[(2-carboxy-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[(2-carboxy-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-3,3-dimethyl-7-oxidanylidene-6-[(3-oxidanyl-3-oxidanylidene-2-phenyl-propanoyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[(2-carboxy-2-phenyl-acetyl)amino]-7-keto-3,3-dimethyl-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI=1S/C17H18N2O6S/c1-17(2)11(16(24)25)19-13(21)10(14(19)26-17)18-12(20)9(15(22)23)8-6-4-3-5-7-8/h3-7,9-11,14H,1-2H3,(H,18,20)(H,22,23)(H,24,25)/t9?,10-,11+,14-/m1/s1",FPPNZSSZRUTDAP-UWFZAAFLSA-N,1.1,378.08855747,C17H18N2O6S,378.4,149.0,378.08855747,0.0,26.0,3.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O,,"10  27  6
12  17  6
19  37  3
20  22  8
20  23  8
22  24  8
23  25  8
24  26  8
25  26  8
13  9  5",
440790393,31101,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00279,bromocriptine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00279,bromocriptine,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,31101,1.0,1230.0,6.0,3.0,5.0,AAADcfB/uAAAEAAAAAAAAAAAAAAAAWLFgAA8YIEAAAAAAFjB8AAAHgBQCAABPSzBngQyyPPJlgCoAyVyVAKCgCAhAiQImSH4ZLkaYPrA0bWfYAhklgDcyheYkMIOgAAAQAASAAAQAASAACQAAAAAAAAAAA==,"(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-isobutyl-4-isopropyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6<I>a</I><I>R</I>,9<I>R</I>)-5-bromo-<I>N</I>-[(1<I>S</I>,2<I>S</I>,4<I>R</I>,7<I>S</I>)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.0<SUP>2,6</SUP>]dodecan-4-yl]-7-methyl-6,6<I>a</I>,8,9-tetrahydro-4<I>H</I>-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-5-bromanyl-7-methyl-N-[(1S,2S,4R,7S)-7-(2-methylpropyl)-2-oxidanyl-5,8-bis(oxidanylidene)-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-isobutyl-4-isopropyl-5,8-diketo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1",OZVBMTJYIDMWIL-AYFBDAFISA-N,,653.22128,C32H40BrN5O5,654.6,118.0,653.22128,0.0,43.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,3.8,"11  39  8
11  40  8
12  44  5
14  21  6
27  26  5
28  65  5
13  3  6
35  37  8
35  41  8
36  37  8
36  40  8
37  39  8
39  42  8
41  43  8
42  43  8
16  9  6",
440790392,6918453,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02166,AURANOFIN,20231222,20210312,Curation Efforts|Governmental Organizations,LT02166,auranofin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,6918453,1.0,538.0,10.0,0.0,12.0,AAADcfB4PAJAAAAAAAAAAgAAAAAAAAAAAAAkAAAAAAAAAAAAAAAAGgwAAAAACBSswAKCCAAABCAIAACQCAAAAAAAAAAAAAAAAAABAAIAAAACAAAFAAACAAHAYAwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"gold(1+);(2S,3R,4S,5R,6R)-3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydropyran-2-thiolate;triethylphosphane","gold(1+);(2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)-2-oxanethiolate;triethylphosphine","gold(1+);(2<I>S</I>,3<I>R</I>,4<I>S</I>,5<I>R</I>,6<I>R</I>)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane","gold(1+);(2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane","gold(1+);(2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane","gold(1+);(2S,3R,4S,5R,6R)-3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydropyran-2-thiolate;triethylphosphine","InChI=1S/C14H20O9S.C6H15P.Au/c1-6(15)19-5-10-11(20-7(2)16)12(21-8(3)17)13(14(24)23-10)22-9(4)18;1-4-7(5-2)6-3;/h10-14,24H,5H2,1-4H3;4-6H2,1-3H3;/q;;+1/p-1/t10-,11-,12+,13-,14+;;/m1../s1",AUJRCFUBUPVWSZ-XTZHGVARSA-M,,678.132686,C20H34AuO9PS,678.5,115.0,678.132686,0.0,32.0,5.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",CC(=O)OC[C@H]1O[C@@H]([S-])[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O.CCP(CC)CC.[Au+],,"15  18  5
17  2  5
13  5  6
14  6  5
16  7  6",1  2  6
440790391,148192,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01199,Atazanavir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01199,atazanavir,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,148192,1.0,1110.0,9.0,5.0,18.0,AAADcfB/uAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAAB0AAAHgAYCAAADjzhngY+iJLqFgCoAzV3XACCgCAxAiAa+KG4ZJkKcPLA0bGUYAhklgDYyAeQwOAPQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,"methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate","N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-1-oxobutyl]amino]-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamic acid methyl ester","methyl <I>N</I>-[(2<I>S</I>)-1-[2-[(2<I>S</I>,3<I>S</I>)-2-hydroxy-3-[[(2<I>S</I>)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate","methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate","methyl N-[(2S)-1-[2-[(2S,3S)-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-2-oxidanyl-4-phenyl-butyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxidanylidene-butan-2-yl]carbamate","N-[(1S)-1-[[(1S,2S)-1-benzyl-3-[[[(2S)-2-(carbomethoxyamino)-3,3-dimethyl-butanoyl]amino]-[4-(2-pyridyl)benzyl]amino]-2-hydroxy-propyl]carbamoyl]-2,2-dimethyl-propyl]carbamic acid methyl ester","InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1",AXRYRYVKAWYZBR-GASGPIRDSA-N,,704.38974802,C38H52N6O7,704.9,171.0,704.38974802,0.0,51.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,5.6,"17  1  6
16  10  5
20  12  6
13  46  8
13  50  8
31  34  8
31  35  8
32  37  8
32  38  8
34  39  8
35  40  8
37  42  8
38  43  8
39  41  8
40  41  8
42  44  8
43  44  8
46  48  8
48  49  8
49  51  8
50  51  8
15  8  5",
440790390,6249,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00049,ampicillin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00049,ampicillin,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,6249,1.0,562.0,6.0,3.0,4.0,AAADceB7OABAAAAAAAAAAAAAAABYAWAAAAAwAAAABYAAAAABAAAAHgQQCAAADCjF2ASyCIPAAgiIAiHSGACCAABgABAIiIGIBIgKYDqglTGUYABklgC4iAcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-amino-1-oxo-2-phenylethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2<I>S</I>,5<I>R</I>,6<I>R</I>)-6-[[(2<I>R</I>)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","(2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-7-keto-3,3-dimethyl-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1",AVKUERGKIZMTKX-NJBDSQKTSA-N,-1.1,349.10962727,C16H19N3O4S,349.4,138.0,349.10962727,0.0,24.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O,,"11  16  6
19  20  8
19  21  8
20  22  8
21  23  8
22  24  8
23  24  8
12  7  5
18  8  5
9  25  6",
440790389,14956,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00048,amphotericin b,20231222,20210312,Curation Efforts|Governmental Organizations,LT00048,amphotericin b,3.0,Warnings and precautions,vLess-DILI-Concern,2.0,14956,1.0,1670.0,18.0,12.0,3.0,AAADcfB+PgAAAAAAAAAAAAAAAAAAAAAAAAAkSAAAAAAAAAAAAAAAHgAQCAAADTzxgAcCCABABgCIACDSCAAAAAAgAAAICIEAAAgbFBYAoQAiUAAH8AAPoAPI7OzOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid","(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,33R,35S,36R,37S)-33-[[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-2-oxanyl]oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid","(1<I>R</I>,3<I>S</I>,5<I>R</I>,6<I>R</I>,9<I>R</I>,11<I>R</I>,15<I>S</I>,16<I>R</I>,17<I>R</I>,18<I>S</I>,33<I>R</I>,35<I>S</I>,36<I>R</I>,37<I>S</I>)-33-[(2<I>R</I>,3<I>S</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid","(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid","(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-azanyl-6-methyl-3,5-bis(oxidanyl)oxan-2-yl]oxy-15,16,18-trimethyl-1,3,5,6,9,11,17,37-octakis(oxidanyl)-13-oxidanylidene-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid","(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-13-keto-15,16,18-trimethyl-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid","InChI=1S/C47H73NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-33(51)22-36(53)35(52)20-19-31(49)21-32(50)23-39(55)62-29(3)28(2)42(27)56/h5-18,27-38,40-44,46,49-54,56-58,61H,19-26,48H2,1-4H3,(H,59,60)/t27-,28-,29-,30+,31+,32+,33-,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1",APKFDSVGJQXUKY-KKGHZKTASA-N,,923.48784986,C47H73NO17,924.1,320.0,923.48784986,0.0,65.0,19.0,0.0,0.0,7.0,0.0,1.0,-1.0,"1
5
255",C[C@@H]1[C@H](O)[C@@H](C)C=CC=CC=CC=CC=CC=CC=C[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,0.0,"32  10  6
34  11  5
36  12  5
42  13  5
44  14  5
48  16  5
33  18  6
19  2  5
20  66  5
21  28  5
22  3  6
35  39  6
37  41  1
27  4  5
30  4  6
45  51  1
47  53  6
49  54  6
50  55  6
56  58  1
57  59  1
26  6  5
60  62  1
61  63  1
64  65  1
31  9  5",
440790388,60172,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01155,ADEFOVIR,20231222,20210312,Curation Efforts|Governmental Organizations,LT01155,adefovir,2.0,Warnings and precautions,vLess-DILI-Concern,2.0,60172,1.0,327.0,8.0,3.0,5.0,AAADccBzuAIAAAAAAAAAAAAAAAAAAWAAAAAsAAAAAAAAAFgB+AAAHggQCCAACAjhlwYF8L9MFBCgQQZhZICAgC0REKABUCAoVBCCSABASEAVBAgIAALQACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid,2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid,2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid,2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid,2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid,2-adenin-9-ylethoxymethylphosphonic acid,"InChI=1S/C8H12N5O4P/c9-7-6-8(11-3-10-7)13(4-12-6)1-2-17-5-18(14,15)16/h3-4H,1-2,5H2,(H2,9,10,11)(H2,14,15,16)",SUPKOOSCJHTBAH-UHFFFAOYSA-N,-2.0,273.06269088,C8H12N5O4P,273.19,136.0,273.06269088,0.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ncnc2c1ncn2CCOCP(=O)(O)O,,"13  14  8
14  17  8
6  13  8
6  15  8
7  14  8
7  15  8
8  13  8
8  18  8
9  17  8
9  18  8",
440790387,60490,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00649,ZILEUTON,20210312,20210312,Curation Efforts|Governmental Organizations,LT00649,zileuton,5.0,Warnings and precautions,vMost-DILI-Concern,1.0,60490,1.0,275.0,3.0,2.0,2.0,AAADccBzMABAAAAAAAAAAAAAAAAAASAAAAAwAAAAAAAAAEgB8AAAHgQUCAAADCjBWAQzAcJQAAiMAiBCEACDAIAgCBBoiBgIBIiIICKgkRGEIAhghgIoiAcQgIAOAAAAAAAEAAAAAAAAAAgAAAAAAAAAAA==,1-[1-(benzothiophen-2-yl)ethyl]-1-hydroxy-urea,1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea,1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea,1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea,1-[1-(1-benzothiophen-2-yl)ethyl]-1-oxidanyl-urea,1-[1-(benzothiophen-2-yl)ethyl]-1-hydroxy-urea,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",MWLSOWXNZPKENC-UHFFFAOYSA-N,,236.0619488,C11H12N2O2S,236.29,94.8,236.0619488,0.0,16.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(c1cc2ccccc2s1)N(O)C(N)=O,1.6,"1  10  8
1  7  8
10  13  8
12  14  8
13  15  8
14  15  8
6  11  3
7  9  8
8  10  8
8  12  8
8  9  8",
440790386,5717,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01869,zafirlukast,20210312,20210312,Curation Efforts|Governmental Organizations,LT01869,zafirlukast,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,5717,1.0,1010.0,6.0,2.0,9.0,AAADcfB7OABAAAAAAAAAAAAAAAAAAeIAAAAwYMAAAAAAAFgB9AAAHgQQQAAADBzh3gY+z/PMFAKoAzV3XHDCiDA1IiAI2Dk+bNkMJvLEtZuMMShk1BHI6Ye62PKOwACBQAAOAACAAQKAABwAAAAAAAAAAA==,cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate,N-[3-[[2-methoxy-4-[[(2-methylphenyl)sulfonylamino]-oxomethyl]phenyl]methyl]-1-methyl-5-indolyl]carbamic acid cyclopentyl ester,cyclopentyl <I>N</I>-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate,cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate,cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methyl-indol-5-yl]carbamate,N-[3-[2-methoxy-4-(o-tolylsulfonylcarbamoyl)benzyl]-1-methyl-indol-5-yl]carbamic acid cyclopentyl ester,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",YEEZWCHGZNKEEK-UHFFFAOYSA-N,,575.20900695,C31H33N3O6S,575.7,124.0,575.20900695,0.0,41.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,5.5,"17  18  8
17  19  8
17  22  8
18  23  8
19  24  8
20  22  8
20  25  8
24  25  8
26  28  8
26  29  8
28  30  8
29  32  8
30  31  8
31  32  8
34  35  8
34  37  8
35  38  8
37  40  8
38  41  8
40  41  8
8  19  8
8  23  8",
440790385,71616,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01097,Voriconazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT01097,voriconazole,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,71616,1.0,448.0,8.0,1.0,5.0,AAADccB7oYAAAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAAAB8AAAHwAICAAADUzBngw/kJYIEgCiAzRnZACSgCsxgKAd2CA4TJiKLqLA2dGEdAhuwANY2CeQ0OIOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol","(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1,2,4-triazol-1-yl)-2-butanol","(2<I>R</I>,3<I>S</I>)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol","(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol","(2R,3S)-2-[2,4-bis(fluoranyl)phenyl]-3-(5-fluoranylpyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol","(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol","InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1",BCEHBSKCWLPMDN-MGPLVRAMSA-N,,349.11504457,C16H14F3N5O,349.31,76.7,349.11504457,0.0,25.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,1.5,"11  14  5
13  16  8
13  17  8
15  18  8
16  19  8
17  20  8
18  23  8
19  22  8
20  22  8
10  4  5
5  21  8
5  7  8
6  15  8
6  24  8
7  25  8
8  21  8
8  25  8
9  23  8
9  24  8",
440790384,216237,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00661,Tolvaptan,20231222,20210312,Curation Efforts|Governmental Organizations,LT00661,tolvaptan,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,216237,1.0,673.0,3.0,2.0,3.0,AAADceB7MAAEAAAAAAAAAAAAAAAAAAAAAAAwYMAABYAAAAABUAAAHgIQCAAADB7hmCYywIPAAgCIAiVSUACCAAAlBwAIiAEIbsgINjLBl5GEcQhm1gHI2Ye4yaCeiABAYAASAAAQAIDAACQAAAAAAAAAAA==,"N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide","N-[4-[(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepin-1-yl)-oxomethyl]-3-methylphenyl]-2-methylbenzamide","<I>N</I>-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide","N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide","N-[4-[(7-chloranyl-5-oxidanyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl)carbonyl]-3-methyl-phenyl]-2-methyl-benzamide","N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide","InChI=1S/C26H25ClN2O3/c1-16-6-3-4-7-20(16)25(31)28-19-10-11-21(17(2)14-19)26(32)29-13-5-8-24(30)22-15-18(27)9-12-23(22)29/h3-4,6-7,9-12,14-15,24,30H,5,8,13H2,1-2H3,(H,28,31)",GYHCTFXIZSNGJT-UHFFFAOYSA-N,,448.1553704,C26H25ClN2O3,448.9,69.6,448.1553704,0.0,32.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1,4.8,"11  12  8
11  14  8
12  15  8
14  17  8
15  18  8
16  19  8
16  20  8
17  18  8
19  21  8
9  2  3
20  23  8
21  22  8
22  23  8
26  27  8
26  28  8
27  29  8
28  31  8
29  32  8
31  32  8",
440790383,5487,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00155,tizanidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00155,tizanidine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,5487,1.0,300.0,4.0,2.0,2.0,AAADccBzgABEAAAAAAAAAAAAAAAAAWIAAAAwAAAAAAAAAFgB8AAAHAIQQAAACArBFiQxwLLAAACgASRiZACCAAUhFwAJmKA4dpiIYKLB2tHUJAhokAJIyCcQAAAAAABAAAYAADAAAIAADAAAYAAAAAAAAA==,"5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine","5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine","5-chloro-<I>N</I>-(4,5-dihydro-1<I>H</I>-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine","5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine","5-chloranyl-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine",(5-chloropiazthiol-4-yl)-(2-imidazolin-2-yl)amine,"InChI=1S/C9H8ClN5S/c10-5-1-2-6-8(15-16-14-6)7(5)13-9-11-3-4-12-9/h1-2H,3-4H2,(H2,11,12,13)",XFYDIVBRZNQMJC-UHFFFAOYSA-N,,253.0188941,C9H8ClN5S,253.71,90.4,253.0188941,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Clc1ccc2nsnc2c1NC1=NCCN1,1.1,"11  12  8
11  14  8
12  13  8
13  15  8
14  16  8
15  16  8
2  6  8
2  7  8
6  12  8
7  13  8",
440790382,5472,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00227,ticlopidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00227,ticlopidine,4.0,Warnings and precautions,vMost-DILI-Concern,1.0,5472,1.0,261.0,2.0,0.0,2.0,AAADccByAABEAAAAAAAAAAAAAAAAASAAAAA8QAAAAAAAAFgBwAAAHAYAAAAADALFWCSwAYMAAAiEAiBCAACDAIAgDRBIiBgIBogIICKhkxGEIAhggACoiAcQgAAOAAAAAAABAAAAAAAAAAIAAAAAAAAAAA==,"5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine","5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine","5-[(2-chlorophenyl)methyl]-6,7-dihydro-4<I>H</I>-thieno[3,2-c]pyridine","5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine","5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine","5-(2-chlorobenzyl)-6,7-dihydro-4H-thieno[3,2-c]pyridine","InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",PHWBOXQYWZNQIN-UHFFFAOYSA-N,,263.0535483,C14H14ClNS,263.8,31.5,263.0535483,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Clc1ccccc1CN1CCc2sccc2C1,3.6,"10  13  8
10  14  8
11  12  8
13  15  8
14  16  8
15  17  8
16  17  8
2  12  8
2  8  8
7  11  8
7  8  8",
440790381,5430,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00635,thiabendazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00635,thiabendazole,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,5430,1.0,212.0,3.0,1.0,1.0,AAADcYBzAABAAAAAAAAAAAAAAAAAAWLAAAAwAAAAAAAAAFgB/AAAHAQQAAAACAiFVwS10bbJkAikASZjZACC8K3xGrgJ2TQ4dJiIaKLgmZGUIAhokALIyCcQAAAAAAAAAAAAACAAAAAAAAAAQAAAAAAAAA==,4-(1H-benzimidazol-2-yl)thiazole,4-(1H-benzimidazol-2-yl)thiazole,"4-(1<I>H</I>-benzimidazol-2-yl)-1,3-thiazole","4-(1H-benzimidazol-2-yl)-1,3-thiazole","4-(1H-benzimidazol-2-yl)-1,3-thiazole",4-(1H-benzimidazol-2-yl)thiazole,"InChI=1S/C10H7N3S/c1-2-4-8-7(3-1)12-10(13-8)9-5-14-6-11-9/h1-6H,(H,12,13)",WJCNZQLZVWNLKY-UHFFFAOYSA-N,2.5,201.03606841,C10H7N3S,201.25,69.8,201.03606841,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",c1ccc2[nH]c(-c3cscn3)nc2c1,,"1  13  8
1  14  8
10  12  8
11  12  8
2  5  8
2  7  8
3  6  8
3  7  8
4  14  8
4  8  8
5  6  8
5  9  8
6  10  8
8  13  8
9  11  8",
440790380,6013,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00223,testosterone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00223,testosterone,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,6013,1.0,508.0,2.0,1.0,0.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAACAAADxSggAICAAAAAgCIAqBSAAAAAAAgAAAACAEAAEgAEBIAAQAAQAAEgAAIAQOIyPCPgAAAAAAAAACAAAQAACAAAIAADAAAAA==,"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","(8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-17-oxidanyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",MUMGGOZAMZWBJJ-DYKIIFRCSA-N,3.3,288.208930132,C19H28O2,288.4,37.3,288.208930132,0.0,21.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,,"10  1  5
3  22  6
4  16  5
5  23  5
6  24  6
7  18  5",
440790379,1549008,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00634,terbinafine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00634,terbinafine,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,1549008,1.0,428.0,1.0,0.0,5.0,AAADceB6AAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAADBUAAAHAAAAAAADgDBGAQyAMMAAADAEiBCAAiCAAAgAAAIiAAIBIgIICKAkRGEIAhggACIiAcQgMAOgAACAAAQAAAAAAQAACAAAAAAAAAAAA==,"(E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine","(E)-N,6,6-trimethyl-N-(1-naphthalenylmethyl)-1-hept-2-en-4-ynamine","(<I>E</I>)-<I>N</I>,6,6-trimethyl-<I>N</I>-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine","(E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine","(E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine","[(E)-6,6-dimethylhept-2-en-4-ynyl]-methyl-(1-naphthylmethyl)amine","InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",DOMXUEMWDBAQBQ-WEVVVXLNSA-N,,291.198699802,C21H25N,291.4,3.2,291.198699802,0.0,22.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,5.6,"11  12  8
13  19  8
18  19  8
3  4  8
3  8  8
4  5  8
4  9  8
5  11  8
5  13  8
8  12  8
9  18  8",
440790378,3002190,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01944,Telithromycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01944,telithromycin,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,3002190,1.0,1440.0,13.0,1.0,11.0,AAADcfB/vAAAAAAAAAAAAAAAAAAAAWLAAAAsSAAAAAAAAAAB4AAAHgAACAAADXzxngc/mJcMFgCoA7T3fACCgC0xEqAJ2CE4dJibeP7I2ZG/YAhupgLfyCfa7PzOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone","(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-2-oxanyl]oxy]-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-[4-(3-pyridinyl)-1-imidazolyl]butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone","(1<I>S</I>,2<I>R</I>,5<I>R</I>,7<I>R</I>,8<I>R</I>,9<I>R</I>,11<I>R</I>,13<I>R</I>,14<I>R</I>)-8-[(2<I>S</I>,3<I>R</I>,4<I>S</I>,6<I>R</I>)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone","(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone","(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-6-methyl-3-oxidanyl-oxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone","(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-diquinone","InChI=1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/t25-,26-,27+,28+,29-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1",LJVAJPDWBABPEJ-PNUFFHFMSA-N,,811.47314329,C43H65N5O10,812.0,172.0,811.47314329,0.0,58.0,13.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,4.2,"36  12  5
13  51  8
13  52  8
14  52  8
14  53  8
15  56  8
15  58  8
16  59  5
17  25  6
18  28  6
19  29  5
21  33  6
24  3  6
32  3  5
30  42  5
38  45  5
20  4  6
43  47  5
51  53  8
54  55  8
54  56  8
55  57  8
57  58  8
35  8  6",
440790377,2733526,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00152,tamoxifen,20250421,20210312,Curation Efforts|Governmental Organizations,LT00152,tamoxifen,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,2733526,1.0,463.0,2.0,0.0,8.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAAwYMAAAAAAAAABUAAAHgAAAAAADAThmAYyBoMABACAAiBCAAACCAAgIAAIiAAOCIgOJiKEMRqDOCCkwBEYqAeAwOAOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine","2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine","2-[4-[(<I>Z</I>)-1,2-diphenylbut-1-enyl]phenoxy]-<I>N</I>,<I>N</I>-dimethylethanamine","2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine","2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine","2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-dimethyl-amine","InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-",NKANXQFJJICGDU-QPLCGJKRSA-N,,371.224914549,C26H29NO,371.5,12.5,371.224914549,0.0,28.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,7.1,"10  14  8
12  13  8
12  14  8
15  21  8
16  22  8
17  23  8
18  24  8
21  25  8
22  25  8
23  26  8
24  26  8
5  10  8
5  9  8
7  15  8
7  16  8
8  17  8
8  18  8
9  13  8",
440790376,1548887,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00148,sulindac,20210312,20210312,Curation Efforts|Governmental Organizations,LT00148,sulindac,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,1548887,1.0,616.0,5.0,1.0,4.0,AAADceB4MQBAAAAAAAAAAAAAAAAAAQAAAAAwYAAAAAAAAEABQAAAGwQACAAADACA2AiyCYAAAgqIAiDSCEBCAAAgCBAIiBkAAIgIIDKgERCAYAAkwAAIiAeIyLCOkAAAAAAQAAAgAAAAACAAAAAAAAAAAA==,2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylene]inden-1-yl]acetic acid,2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]-1-indenyl]acetic acid,2-[(3<I>Z</I>)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid,2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid,2-[(3Z)-6-fluoranyl-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]ethanoic acid,2-[(3Z)-6-fluoro-2-methyl-3-(4-methylsulfinylbenzylidene)inden-1-yl]acetic acid,"InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-",MLKXDPUZXIRXEP-MFOYZWKCSA-N,3.4,356.08824374,C20H17FO3S,356.4,73.6,356.08824374,0.0,25.0,0.0,1.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)=O)cc1,,"1  25  3
10  14  8
13  17  8
14  18  8
16  20  8
16  21  8
17  18  8
20  23  8
21  24  8
22  23  8
22  24  8
7  10  8
7  13  8",
440790375,5339,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00147,sulfasalazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00147,sulfasalazine,5.0,Warnings and precautions,vMost-DILI-Concern,2.0,5339,1.0,657.0,9.0,3.0,6.0,AAADccB7uABAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAAB0AAAHgQYSAAADAzB2gQ9/5JIEgKqAjb3bHDCgDk1IiAI2Dk+bNiIJ/bClZOEcUhl8BPI2ae8yCCOAEQAQAAIAAAAiACAABAAAAAAAAAAAA==,2-hydroxy-5-[4-(2-pyridylsulfamoyl)phenyl]azo-benzoic acid,2-hydroxy-5-[4-(2-pyridinylsulfamoyl)phenyl]azobenzoic acid,2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid,2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid,2-oxidanyl-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid,2-hydroxy-5-[4-(2-pyridylsulfamoyl)phenyl]azo-benzoic acid,"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)",NCEXYHBECQHGNR-UHFFFAOYSA-N,-0.7,398.06849073,C18H14N4O5S,398.4,150.0,398.06849073,0.0,28.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,,"11  12  8
11  13  8
12  15  8
13  16  8
14  15  8
14  16  8
17  19  8
18  21  8
18  23  8
19  25  8
20  21  8
20  22  8
22  24  8
23  24  8
25  27  8
26  27  8
9  17  8
9  26  8",
440790374,216239,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01241,Sorafenib,20250421,20210312,Curation Efforts|Governmental Organizations,LT01241,sorafenib,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,216239,1.0,646.0,7.0,3.0,5.0,AAADceB7sYAEAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAAB0AAAHwIQAAAADA7BnjQ/xpLIFACoAzV3VACCiCA3JyAI2KG+btiMZnLFt7uWOSju1hvI6ae6yAAOAEBAQAABAAAAgICAAAIAAAAAAAAAAA==,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide,4-[4-[[[4-chloro-3-(trifluoromethyl)anilino]-oxomethyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-<I>N</I>-methylpyridine-2-carboxamide,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide,4-[4-[[4-chloranyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-picolinamide,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",MLDQJTXFUGDVEO-UHFFFAOYSA-N,,464.0863026,C21H16ClF3N4O3,464.8,92.4,464.0863026,0.0,32.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,4.1,"10  28  8
10  30  8
12  14  8
12  16  8
13  14  8
13  18  8
15  19  8
15  20  8
16  21  8
17  22  8
17  23  8
18  21  8
19  22  8
20  23  8
26  27  8
26  29  8
27  28  8
29  30  8",
440790373,392622,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01737,ritonavir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01737,ritonavir,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,392622,1.0,1040.0,9.0,4.0,18.0,AAADcfB/uABgAAAAAAAAAAAAAAAAAWLAAAAwYAAAAAAAAAAB9AAAHgQQCAAADTzl3ga/iZPIFgisAzV3XACC8KBxCjhI2J24bImKdDLgsTmcYAgulgL4qAeQwPAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate","N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[[methyl-[(2-propan-2-yl-4-thiazolyl)methyl]amino]-oxomethyl]amino]-1-oxobutyl]amino]-1,6-diphenylhexan-2-yl]carbamic acid 5-thiazolylmethyl ester","1,3-thiazol-5-ylmethyl <I>N</I>-[(2<I>S</I>,3<I>S</I>,5<I>S</I>)-3-hydroxy-5-[[(2<I>S</I>)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate","1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate","1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-3-oxidanyl-1,6-diphenyl-hexan-2-yl]carbamate","N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamic acid thiazol-5-ylmethyl ester","InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,,720.312761,C37H48N6O5S2,720.9,202.0,720.312761,0.0,50.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,6.0,"1  44  8
1  45  8
20  10  6
12  42  8
12  44  8
13  49  8
13  50  8
2  43  8
2  50  8
23  27  8
23  28  8
24  30  8
24  31  8
27  33  8
28  34  8
16  3  5
30  35  8
31  36  8
33  37  8
34  37  8
35  38  8
36  38  8
42  45  8
43  49  8
14  8  6
17  9  5",
440790372,5070,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01731,riluzole,20210312,20210312,Curation Efforts|Governmental Organizations,LT01731,riluzole,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,5070,1.0,238.0,7.0,1.0,1.0,AAADcYBzIYBAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgB8AAAHwQQAAAACAyB1hAx17JIFAikASRiZACD+KlhKjlImDw2bJiMJqLksZuEMChkwBNI6CewQAAAAEAABAAAAQAAgAAIAAACAAAAAAAAAA==,"6-(trifluoromethoxy)-1,3-benzothiazol-2-amine","6-(trifluoromethoxy)-1,3-benzothiazol-2-amine","6-(trifluoromethoxy)-1,3-benzothiazol-2-amine","6-(trifluoromethoxy)-1,3-benzothiazol-2-amine","6-(trifluoromethyloxy)-1,3-benzothiazol-2-amine","[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]amine","InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)",FTALBRSUTCGOEG-UHFFFAOYSA-N,3.6,234.00746845,C8H5F3N2OS,234.2,76.4,234.00746845,0.0,15.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc2ccc(OC(F)(F)F)cc2s1,,"1  14  8
1  8  8
10  11  8
11  13  8
12  13  8
6  14  8
6  9  8
8  10  8
8  9  8
9  12  8",
440790371,135398735,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00034,rifampin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00034,rifampin,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,135398735,1.0,1620.0,15.0,6.0,5.0,AAADcfB/vAAAAAAAAAAAAAAAAAAAASAAAAA8YIAAAAAAAEjBUAAAHgAYCAAADRzhmAYCzsPABgCoArXzWAKSCAAlIAAYiAFtTNgedzbWtZ+2eWjn7B3c+Yf6/P/O6QADSgAaEADSAAaUADQgAAAAAAAAAA==,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate","acetic acid [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methyl-1-piperazinyl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] ester","[(7<I>S</I>,9<I>E</I>,11<I>S</I>,12<I>R</I>,13<I>S</I>,14<I>R</I>,15<I>R</I>,16<I>R</I>,17<I>S</I>,18<I>S</I>,19<I>E</I>,21<I>Z</I>)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(<I>E</I>)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<SUP>4,7</SUP>.0<SUP>5,28</SUP>]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate","[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate","[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentakis(oxidanyl)-6,23-bis(oxidanylidene)-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] ethanoate","acetic acid [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-6,23-diketo-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazino)iminomethyl]-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] ester","InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1",JQXXHWHPUNPDRT-WLSIYKJHSA-N,,822.4051233,C43H58N4O12,822.9,220.0,822.4051233,0.0,59.0,9.0,0.0,4.0,0.0,0.0,1.0,-1.0,"1
5
255",CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,4.9,"19  1  5
17  23  5
18  2  5
20  26  6
21  27  6
25  28  5
22  3  5
35  42  5
37  39  8
37  40  8
39  44  8
24  4  6
40  43  8
40  46  8
43  45  8
43  47  8
44  45  8
46  49  8
47  50  8
49  50  8",
440790370,54671008,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00642,Raltegravir,20210312,20210312,Curation Efforts|Governmental Organizations,LT00642,raltegravir,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,54671008,1.0,836.0,9.0,3.0,6.0,AAADceB7uQAAAAAAAAAAAAAAAAAAAWAAAAAwQAAAAAAAAAABwAAAHwAYCAAADIzBmgwzAIPABkCqAidydAKSAAEqIAAbiID4BMgKYCKAmTWfIAhgngCYiUcQgAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"N-[1-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxo-pyrimidin-2-yl]-1-methyl-ethyl]-5-methyl-1,3,4-oxadiazole-2-carboxamide","N-[2-[4-[[(4-fluorophenyl)methylamino]-oxomethyl]-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide","<I>N</I>-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide","N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide","N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-5-oxidanyl-6-oxidanylidene-pyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide","N-[1-[4-[(4-fluorobenzyl)carbamoyl]-5-hydroxy-6-keto-1-methyl-pyrimidin-2-yl]-1-methyl-ethyl]-5-methyl-1,3,4-oxadiazole-2-carboxamide","InChI=1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30)",CZFFBEXEKNGXKS-UHFFFAOYSA-N,,444.15574595,C20H21FN6O5,444.4,150.0,444.15574595,0.0,32.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1,1.1,"11  12  8
11  23  8
12  28  8
17  20  8
18  20  8
25  26  8
25  27  8
26  29  8
27  30  8
29  31  8
30  31  8
5  23  8
5  28  8
8  14  8
8  17  8
9  14  8
9  18  8",
440790369,1775,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00032,phenytoin,20210804,20210312,Curation Efforts|Governmental Organizations,LT00032,phenytoin,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,1775,1.0,350.0,2.0,2.0,2.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAABQAAAHgAQAAAADIiBmAAxAILAAACIAiFSEACCAAAgAAAIiAGABIiIYDKAlTGUIAhohSIIiAcYiMCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"5,5-diphenylimidazolidine-2,4-dione","5,5-diphenylimidazolidine-2,4-dione","5,5-diphenylimidazolidine-2,4-dione","5,5-diphenylimidazolidine-2,4-dione","5,5-diphenylimidazolidine-2,4-dione","5,5-diphenylhydantoin","InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)",CXOFVDLJLONNDW-UHFFFAOYSA-N,2.5,252.08987763,C15H12N2O2,252.27,58.2,252.08987763,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,,"10  14  8
11  15  8
12  16  8
13  17  8
14  18  8
15  19  8
16  18  8
17  19  8
6  10  8
6  12  8
7  11  8
7  13  8",
440790368,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01367,Peginterferon alfa-2b,20210312,20210312,Curation Efforts|Governmental Organizations,LT01367,peginterferon alfa-2b,4.0,Warnings and precautions,vMost-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790367,4680,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01637,papaverine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01637,papaverine,5.0,Warnings and precautions,vMost-DILI-Concern,2.0,4680,1.0,407.0,5.0,0.0,6.0,AAADceB6OAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACx9AAAHgAAAAAADAzBngY+htIIFACgAzRnRACCiCAxIiAI2CA+7JgNJuLEsZuEMCpkwBHK6Aew0PMOoAABAAAQQABAAAIAACCAAAAAAAAAAA==,"1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-isoquinoline","1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline","1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline","1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline","1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-isoquinoline","6,7-dimethoxy-1-veratryl-isoquinoline","InChI=1S/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H3",XQYZDYMELSJDRZ-UHFFFAOYSA-N,,339.14705815,C20H21NO4,339.4,49.8,339.14705815,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,3.9,"10  16  8
10  17  8
11  13  8
12  15  8
13  15  8
14  18  8
16  19  8
17  21  8
19  20  8
20  21  8
5  18  8
5  8  8
6  11  8
6  8  8
6  9  8
9  12  8
9  14  8",
440790366,9887054,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01181,oxaliplatin,20250421,20210312,Curation Efforts|Governmental Organizations,LT01181,oxaliplatin,4.0,Warnings and precautions,vMost-DILI-Concern,2.0,9887054,1.0,123.0,6.0,2.0,0.0,AAADccBzOAAAAAAAAAAABAAAAAAAAAAAAAAwAAAAAAAAAAAAAAAAHgAQAAAACCjBgAQACABAAAAIAACQCAIAAAAAAAAAAIBAAAABQAIAgAAAAAAAEAAAAAEQAAAAAAAAAAAAAAAAAAAAAAAAQAAAAAAAAA==,"(1R,2R)-cyclohexane-1,2-diamine;oxalate;platinum(2+)","(1R,2R)-cyclohexane-1,2-diamine;oxalate;platinum(2+)","(1<I>R</I>,2<I>R</I>)-cyclohexane-1,2-diamine;oxalate;platinum(2+)","(1R,2R)-cyclohexane-1,2-diamine;oxalate;platinum(2+)","(1R,2R)-cyclohexane-1,2-diamine;ethanedioate;platinum(2+)","[(1R,2R)-2-aminocyclohexyl]amine;oxalate;platinum(2+)","InChI=1S/C6H14N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-6H,1-4,7-8H2;(H,3,4)(H,5,6);/q;;+2/p-2/t5-,6-;;/m1../s1",ZROHGHOFXNOHSO-BNTLRKBRSA-L,,397.060151,C8H14N2O4Pt,397.29,132.0,397.060151,0.0,15.0,2.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",N[C@@H]1CCCC[C@H]1N.O=C([O-])C(=O)[O-].[Pt+2],,"8  6  5
9  7  6",
440790365,3034010,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02216,orlistat,20210312,20210312,Curation Efforts|Governmental Organizations,LT02216,orlistat,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,3034010,1.0,579.0,5.0,1.0,23.0,AAADcfB6OAAAAAAAAAAAAAAAAABIAAAAAAAAAAAAAAAAAAAAAAAAHgAQAAAADTzhgAYCCALABAAIAACQmAAAAAAAAAAAAIGIAAACABYAgCAHAAAFNgAQAAGI7OzOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate","(2S)-2-formamido-4-methylpentanoic acid [(2S)-1-[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]tridecan-2-yl] ester","[(2<I>S</I>)-1-[(2<I>S</I>,3<I>S</I>)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2<I>S</I>)-2-formamido-4-methylpentanoate","[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate","[(2S)-1-[(2S,3S)-3-hexyl-4-oxidanylidene-oxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methyl-pentanoate","(2S)-2-formamido-4-methyl-valeric acid [(1S)-1-[[(2S,3S)-3-hexyl-4-keto-oxetan-2-yl]methyl]dodecyl] ester","InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1",AHLBNYSZXLDEJQ-FWEHEUNISA-N,,495.39237379,C29H53NO5,495.7,81.7,495.39237379,0.0,35.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,10.0,"11  2  5
22  6  6
7  9  6
8  10  5",
440790364,4543,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01615,nortriptyline,20231222,20210312,Curation Efforts|Governmental Organizations,LT01615,nortriptyline,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,4543,1.0,307.0,1.0,1.0,3.0,AAADceB6AAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABgAAAAABQAAAHAAQAAAADADBGAQyAILAAACAAiBCAAACAAAgAAAIiIAIAIgIICKAERCEIAAgkAAIiAcAgMAOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine","N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)-1-propanamine","<I>N</I>-methyl-3-(2-tricyclo[9.4.0.0<SUP>3,8</SUP>]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine","N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine","N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine","methyl-[3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propyl]amine","InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3",PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4.5,263.167399674,C19H21N,263.4,12.0,263.167399674,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNCCC=C1c2ccccc2CCc2ccccc21,,"10  15  8
11  16  8
12  18  8
13  19  8
15  18  8
16  19  8
4  10  8
4  7  8
5  11  8
5  8  8
7  12  8
8  13  8",
440790363,6604200,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00125,nitrofurantoin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00125,nitrofurantoin,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,6604200,1.0,390.0,6.0,1.0,2.0,AAADcYBzuAAAAAAAAAAAAAAAAAAAAWJAAAAAAAAAAAAAAAABgAAAHgAcAAAACATBkAQxhILQRECpALFzUwSSCAAsIgA+iAGubNqMZrKEtbuaGSD83zMI6Ya8AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-[(E)-(5-nitro-2-furyl)methyleneamino]imidazolidine-2,4-dione","1-[(E)-(5-nitro-2-furanyl)methylideneamino]imidazolidine-2,4-dione","1-[(<I>E</I>)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione","1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione","1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione",1-[(E)-(5-nitro-2-furyl)methyleneamino]hydantoin,"InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+",NXFQHRVNIOXGAQ-YCRREMRBSA-N,-0.5,238.0338193,C8H6N4O5,238.16,121.0,238.0338193,0.0,17.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,,"1  13  8
1  16  8
13  15  8
15  17  8
16  17  8",
440790362,4493,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01600,nilutamide,20231222,20210312,Curation Efforts|Governmental Organizations,LT01600,nilutamide,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,4493,1.0,515.0,7.0,1.0,1.0,AAADccBzOYAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABAAAAHwAUAAAADIiBmBAzwIPQQACJAiVSUwCCAAAhAgAoiAGAZIqIYCLAkbGUIAholSLIyCcQgAAOAACAQAACAAAAAQCAAAQAAAAAAAAAAA==,"5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione","5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione","5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione","5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione","5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione","5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]hydantoin","InChI=1S/C12H10F3N3O4/c1-11(2)9(19)17(10(20)16-11)6-3-4-8(18(21)22)7(5-6)12(13,14)15/h3-5H,1-2H3,(H,16,20)",XWXYUMMDTVBTOU-UHFFFAOYSA-N,,317.06234029,C12H10F3N3O4,317.22,95.2,317.06234029,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,2.0,"16  17  8
16  18  8
17  19  8
18  21  8
19  20  8
20  21  8",
440790361,938,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00312,niacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00312,niacin,7.0,Warnings and precautions,vMost-DILI-Concern,1.0,938,1.0,114.0,3.0,1.0,1.0,AAADcYBiMAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAHgAACAAADADBmgQ8iJIIEgCoAjD3TACCgCA1AiAI2CE4bNgIJvrAlZGEcYhmwAHI2caYEQIMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,nicotinic acid,3-pyridinecarboxylic acid,pyridine-3-carboxylic acid,pyridine-3-carboxylic acid,pyridine-3-carboxylic acid,nicotinic acid,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",PVNIIMVLHYAWGP-UHFFFAOYSA-N,0.4,123.032028402,C6H5NO2,123.11,50.2,123.032028402,0.0,9.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)c1cccnc1,,"3  6  8
3  8  8
4  5  8
4  6  8
5  7  8
7  8  8",
440790360,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01393,Natalizumab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01393,natalizumab,5.0,Warnings and precautions,vMost-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790359,9677,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02121,NANDROLONE DECANOATE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02121,nandrolone decanoate,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,9677,1.0,680.0,3.0,0.0,10.0,AAADcfB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAAAAAADxSggAICCAAABACIAqDSCAAAAAAgAAAACAEAAEgAABIAAQACAAAEgAAIAQOIyPCPgAAAAAAAAACAAAQAACAAAIAADAAAAA==,"[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] decanoate","decanoic acid [(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] ester","[(8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1<I>H</I>-cyclopenta[a]phenanthren-17-yl] decanoate","[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] decanoate","[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxidanylidene-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] decanoate","capric acid [(8R,9S,10R,13S,14S,17S)-3-keto-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] ester","InChI=1S/C28H44O3/c1-3-4-5-6-7-8-9-10-27(30)31-26-16-15-25-24-13-11-20-19-21(29)12-14-22(20)23(24)17-18-28(25,26)2/h19,22-26H,3-18H2,1-2H3/t22-,23+,24+,25-,26-,28-/m0/s1",JKWKMORAXJQQSR-MOPIKTETSA-N,7.3,428.32904526,C28H44O3,428.6,43.4,428.32904526,0.0,31.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,,"9  1  5
12  42  5
4  32  6
5  15  5
6  33  5
7  34  6",
440790358,54675783,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00416,minocycline,20210312,20210312,Curation Efforts|Governmental Organizations,LT00416,minocycline,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,54675783,1.0,971.0,9.0,5.0,3.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAAwYIEAAAAAAACBAAAAHgAQCAAADWzBmAQyxoNAAgCIAqVSUAKCAAAhIgAIiAHObMgJJz7KkLOEcAhn4BFJ2Qe+zvCugEABQAAaAADAgAaAADQAAAAAAAAAAA==,"(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4<I>S</I>,4<I>a</I><I>S</I>,5<I>a</I><I>R</I>,12<I>a</I><I>R</I>)-4,7-bis(dimethylamino)-1,10,11,12<I>a</I>-tetrahydroxy-3,12-dioxo-4<I>a</I>,5,5<I>a</I>,6-tetrahydro-4<I>H</I>-tetracene-2-carboxamide","(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrakis(oxidanyl)-3,12-bis(oxidanylidene)-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-diketo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide","InChI=1S/C23H27N3O7/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28/h5-6,9,11,17,27-28,31,33H,7-8H2,1-4H3,(H2,24,32)/t9-,11-,17-,23-/m0/s1",FFTVPQUHLQBXQZ-KVUCHLLUSA-N,-0.6,457.18490021,C23H27N3O7,457.5,165.0,457.18490021,0.0,33.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]3(O)C(=O)C1=C2O,,"12  1  6
11  34  6
14  37  6
21  24  8
21  25  8
24  28  8
25  30  8
28  31  8
30  31  8
15  8  6",
440790357,65833,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01263,Milnacipran,20210312,20210312,Curation Efforts|Governmental Organizations,LT01263,milnacipran,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,65833,1.0,295.0,2.0,1.0,5.0,AAADceBzIAAAAAAAAAAAAAAAGAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQAAAADwDBmAQyAINAAACIAiFSEAACAAAgAAAIiIEIAIgIIDKAlRGEIAAglgCIiAccicCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-cyclopropanecarboxamide","(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-1-cyclopropanecarboxamide","(1<I>R</I>,2<I>S</I>)-2-(aminomethyl)-<I>N</I>,<I>N</I>-diethyl-1-phenylcyclopropane-1-carboxamide","(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide","(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-cyclopropane-1-carboxamide","(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-cyclopropanecarboxamide","InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m1/s1",GJJFMKBJSRMPLA-HIFRSBDPSA-N,,246.17321333,C15H22N2O,246.35,46.3,246.17321333,0.0,18.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)C(=O)[C@]1(c2ccccc2)C[C@@H]1CN,1.4,"10  14  8
11  15  8
14  16  8
15  16  8
4  9  5
5  7  5
8  10  8
8  11  8",
440790356,477468,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01187,Micafungin,20250421,20210312,Curation Efforts|Governmental Organizations,LT01187,micafungin,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,477468,1.0,2580.0,24.0,16.0,18.0,AAADcfB//gBAAAAAAAAAAAAAAAAAAWLFgAAwYMAAAAAAAAAB1AAAHgAUCAAADTzhngYyhpPQBoCpA6VyUjCCCAAkIgAomKG+7NsPdr6GtbuWeanm9hmZ+cf+//7OYAABAAAAQADAAAIAAACAAAAAAAAAAA==,"[5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxo-propyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[5-(4-pentoxyphenyl)isoxazol-3-yl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxy-ethyl]-2-hydroxy-phenyl] hydrogen sulfate","sulfuric acid [5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[oxo-[4-[5-(4-pentoxyphenyl)-3-isoxazolyl]phenyl]methyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] ester","[5-[(1<I>S</I>,2<I>S</I>)-2-[(3<I>S</I>,6<I>S</I>,9<I>S</I>,11<I>R</I>,15<I>S</I>,18<I>S</I>,20<I>R</I>,21<I>R</I>,24<I>S</I>,25<I>S</I>,26<I>S</I>)-3-[(1<I>R</I>)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1<I>R</I>)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.0<SUP>9,13</SUP>]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] hydrogen sulfate","[5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] hydrogen sulfate","[5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-azanyl-1-oxidanyl-3-oxidanylidene-propyl]-26-methyl-11,20,21,25-tetrakis(oxidanyl)-15-[(1R)-1-oxidanylethyl]-2,5,8,14,17,23-hexakis(oxidanylidene)-18-[[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]phenyl]carbonylamino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-bis(oxidanyl)ethyl]-2-oxidanyl-phenyl] hydrogen sulfate","sulfuric acid [5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-keto-propyl]-18-[[4-[5-(4-amoxyphenyl)isoxazol-3-yl]benzoyl]amino]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaketo-26-methyl-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxy-ethyl]-2-hydroxy-phenyl] ester","InChI=1S/C56H71N9O23S/c1-4-5-6-17-86-32-14-11-28(12-15-32)39-21-33(63-87-39)27-7-9-29(10-8-27)49(75)58-34-20-38(70)52(78)62-54(80)45-46(72)25(2)23-65(45)56(82)43(37(69)22-41(57)71)60-53(79)44(48(74)47(73)30-13-16-36(68)40(18-30)88-89(83,84)85)61-51(77)35-19-31(67)24-64(35)55(81)42(26(3)66)59-50(34)76/h7-16,18,21,25-26,31,34-35,37-38,42-48,52,66-70,72-74,78H,4-6,17,19-20,22-24H2,1-3H3,(H2,57,71)(H,58,75)(H,59,76)(H,60,79)(H,61,77)(H,62,80)(H,83,84,85)/t25-,26+,31+,34-,35-,37+,38+,42-,43-,44-,45-,46-,47-,48-,52+/m0/s1",PIEUQSKUWLMALL-YABMTYFHSA-N,,1269.43835072,C56H71N9O23S,1270.3,519.0,1269.43835072,0.0,89.0,15.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1,-1.6,"55  11  5
58  13  5
59  14  5
36  2  5
23  33  8
23  78  8
57  31  5
33  76  8
34  38  5
35  91  5
41  98  5
42  99  5
48  110  5
44  5  6
54  114  6
45  6  5
63  65  8
63  66  8
65  67  8
66  68  8
67  70  8
68  70  8
69  71  8
69  72  8
47  7  5
71  73  8
72  74  8
73  75  8
74  75  8
76  77  8
77  78  8
79  80  8
79  81  8
52  8  5
80  82  8
81  83  8
82  84  8
83  84  8",
440790355,38853,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00121,methyldopa,20231222,20210312,Curation Efforts|Governmental Organizations,LT00121,methyldopa,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,38853,1.0,246.0,5.0,4.0,3.0,AAADccByOAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADIyBmAAyDoBAAgCIAiDSCAACAAAgIAAIiAGGiIgLJjKCkROAcAEk0BEJmAeY2PGOIAABAAAAQABAAAIAAACAAAAAAAAAAA==,"(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid","(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid","(2<I>S</I>)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid","(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid","(2S)-2-azanyl-3-[3,4-bis(oxidanyl)phenyl]-2-methyl-propanoic acid","(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propionic acid","InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1",CJCSPKMFHVPWAR-JTQLQIEISA-N,,211.0844579,C10H13NO4,211.21,104.0,211.0844579,0.0,15.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,-1.9,"11  13  8
12  14  8
13  15  8
14  15  8
6  5  5
8  11  8
8  12  8",
440790354,1349907,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00580,methimazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00580,methimazole,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,1349907,1.0,119.0,1.0,1.0,0.0,AAADcYBjAABAAAAAAAAAAAAAAAAAAQAAAAAAAAAAAAAAAAAAAAAAHAQQAAAAAADBAAQDAAPAAACEAAAGQAAAAAAAAgkIAIAIAACAAAAAAAAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,3-methyl-1H-imidazole-2-thione,3-methyl-1H-imidazole-2-thione,3-methyl-1<I>H</I>-imidazole-2-thione,3-methyl-1H-imidazole-2-thione,3-methyl-1H-imidazole-2-thione,1-methyl-4-imidazoline-2-thione,"InChI=1S/C4H6N2S/c1-6-3-2-5-4(6)7/h2-3H,1H3,(H,5,7)",PMRYVIKBURPHAH-UHFFFAOYSA-N,-0.3,114.02516937,C4H6N2S,114.17,47.4,114.02516937,0.0,7.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cn1cc[nH]c1=S,,"2  4  8
2  5  8
3  4  8
3  7  8
5  7  8",
440790353,667490,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00003,mercaptopurine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00003,mercaptopurine,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,667490,1.0,190.0,2.0,2.0,0.0,AAADcYBjgABAAAAAAAAAAAAAAAAAAWAAAAAgAAAAAAAAAEABgAAAHAQQAAAACAgBVgQFsBbJkACkAQZhZACAgC2REKABUYAoVACASABASAAUAAAIAAJAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"3,7-dihydropurine-6-thione","3,7-dihydropurine-6-thione","3,7-dihydropurine-6-thione","3,7-dihydropurine-6-thione","3,7-dihydropurine-6-thione","3,7-dihydropurine-6-thione","InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)",GLVAUDGFNGKCSF-UHFFFAOYSA-N,0.0,152.01566732,C5H4N4S,152.18,85.2,152.01566732,0.0,10.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",S=c1nc[nH]c2nc[nH]c12,,"2  6  8
2  9  8
3  10  8
3  7  8
4  7  8
4  9  8
5  10  8
5  8  8
6  7  8
6  8  8",
440790352,4044,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00116,mefenamic acid,20210312,20210312,Curation Efforts|Governmental Organizations,LT00116,mefenamic acid,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,4044,1.0,292.0,3.0,2.0,3.0,AAADccByMAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAQCAAADAiBmAAyyILAAgCIAiTSSACCAAAlAgAIiAEAbMgIJnrAlZGEcYhm0AHI2ceYyKCOgAAAQAASAAAAAACAACQAAAAAAAAAAA==,"2-(2,3-dimethylanilino)benzoic acid","2-(2,3-dimethylanilino)benzoic acid","2-(2,3-dimethylanilino)benzoic acid","2-(2,3-dimethylanilino)benzoic acid","2-[(2,3-dimethylphenyl)amino]benzoic acid","2-(2,3-dimethylanilino)benzoic acid","InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)",HYYBABOKPJLUIN-UHFFFAOYSA-N,5.1,241.110278721,C15H15NO2,241.28,49.3,241.110278721,0.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cccc(Nc2ccccc2C(=O)O)c1C,,"12  15  8
14  16  8
15  17  8
16  17  8
4  5  8
4  6  8
5  8  8
6  9  8
7  12  8
7  14  8
8  11  8
9  11  8",
440790351,149096,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01488,LEVOFLOXACIN,20210312,20210312,Curation Efforts|Governmental Organizations,LT01488,levofloxacin,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,149096,1.0,634.0,8.0,1.0,2.0,AAADceB7OQAAAAAAAAAAAAAAAAAAAAAAAAA8WIEAAAAAAACxAAAAHwAACAAADCzhmA4yzoMABgCIAqTWSACCCAAlIAAAiAENTMgOZj7M9NuXeajk4BHY+cea2bOeCAABAAQCEAAQAAIACAQgAAAAAAAAAA==,"(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","(2S)-7-fluoro-2-methyl-6-(4-methyl-1-piperazinyl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","(2<I>S</I>)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0<SUP>5,13</SUP>]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","(2S)-7-fluoranyl-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxidanylidene-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","(2S)-7-fluoro-10-keto-2-methyl-6-(4-methylpiperazino)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid","InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1",GSDSWSVVBLHKDQ-JTQLQIEISA-N,-0.4,361.14378429,C18H20FN3O4,361.4,73.3,361.14378429,0.0,26.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,,"11  22  5
12  14  8
12  19  8
13  14  8
13  18  8
18  21  8
18  23  8
19  21  8
20  25  8
23  25  8
7  13  8
7  20  8",
440790350,3878,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01481,lamotrigine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01481,lamotrigine,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,3878,1.0,242.0,5.0,2.0,1.0,AAADcYBzgAAGAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHAIYAAAADAqBHiAxsJZIEACiAyZiZACShC8hFaAdmmAgVpiIaKLBmxGUoABwiAJIyCcQgIAOAAAAIAABAAQAAABAAAIACAAAAAAAAA==,"6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine","6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine","6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine","6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine","6-[2,3-bis(chloranyl)phenyl]-1,2,4-triazine-3,5-diamine","[3-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5-yl]amine","InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)",PYZRQGJRPPTADH-UHFFFAOYSA-N,,255.0078506,C9H7Cl2N5,256.09,90.7,255.0078506,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,1.4,"10  13  8
11  14  8
13  15  8
14  15  8
3  6  8
3  9  8
4  12  8
4  16  8
6  16  8
8  10  8
8  11  8
9  12  8",
440790349,3869,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00112,labetalol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00112,labetalol,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,3869,1.0,385.0,4.0,4.0,8.0,AAADceB7MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAQCAAADDzhmAYyBoLAAgCIAiFSEACCAAAkIAAIiIEODMgKNjaClROEcUBm8BGYmYeY/OTOIAACAAAIAABAAAQAABAAAAAAAAAAAA==,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide,2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide,2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide,2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide,2-oxidanyl-5-[1-oxidanyl-2-(4-phenylbutan-2-ylamino)ethyl]benzamide,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide,"InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)",SGUAFYQXFOLMHL-UHFFFAOYSA-N,3.1,328.17869263,C19H24N2O3,328.4,95.6,328.17869263,0.0,24.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,,"10  33  3
12  14  8
12  15  8
13  16  8
13  17  8
14  18  8
15  19  8
16  21  8
17  22  8
18  20  8
19  20  8
21  23  8
22  23  8
6  25  3",
440790348,55283,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00182,itraconazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00182,itraconazole,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,55283,1.0,1120.0,9.0,0.0,11.0,AAADcfB/+AAGAAAAAAAAAAAAAAAAAWJEAAA8YMEAAAAAAAAB1AAAHgIIAAAADD7hmCY33ocIFACqAiRDdACSCAsxp4AfyAAOboifbiLFu5u3OCjtxhPe6CewwKAOBECAAACBAAAIgQAAAQIAAAAAAAAAAA==,"4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-sec-butyl-1,2,4-triazol-3-one","2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one","2-butan-2-yl-4-[4-[4-[4-[[(2<I>R</I>,4<I>S</I>)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one","2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one","2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one","4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazino]phenyl]-2-sec-butyl-1,2,4-triazol-3-one","InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1",VHVPQPYKVGDNFY-ZPGVKDDISA-N,5.7,704.2393071,C35H38Cl2N8O4,705.6,101.0,704.2393071,0.0,49.0,2.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,,"10  44  8
10  47  8
11  46  8
12  14  8
12  44  8
13  41  8
13  46  8
14  47  8
15  22  6
16  24  6
23  27  8
23  28  8
25  29  8
25  30  8
26  32  8
26  33  8
27  39  8
28  40  8
29  34  8
30  35  8
31  34  8
31  35  8
32  37  8
33  38  8
36  37  8
36  38  8
39  43  8
40  43  8
42  48  3
9  11  8
9  41  8",
440790347,5282379,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00234,Isotretinoin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00234,isotretinoin,5.0,Warnings and precautions,vMost-DILI-Concern,1.0,5282379,1.0,567.0,2.0,1.0,5.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAGgAACAAADgCAgAACCAAAAgCIAiDSCAAAAAAgAAAICAAAAEgIBAIAAQAAEAAAgAAIkQMAgMAPAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid","(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid","(2<I>Z</I>,4<I>E</I>,6<I>E</I>,8<I>E</I>)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid","(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid","(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid","(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid","InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-",SHGAZHPCJJPHSC-XFYACQKRSA-N,6.3,300.208930132,C20H28O2,300.4,37.3,300.208930132,0.0,22.0,0.0,0.0,4.0,0.0,0.0,1.0,-1.0,"1
5
255",CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1,,,
440790346,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01328,Interferon beta-1b,20210312,20210312,Curation Efforts|Governmental Organizations,LT01328,interferon beta-1b,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790345,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01332,Interferon beta-1a,20210312,20210312,Curation Efforts|Governmental Organizations,LT01332,interferon beta-1a,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790344,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01336,Interferon alfacon-1,20210312,20210312,Curation Efforts|Governmental Organizations,LT01336,interferon alfacon-1,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790343,71306834,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01306,INTERFERON ALFA-2B,20250421,20210312,Curation Efforts|Governmental Organizations,LT01306,interferon alfa-2b,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,71306834,1.0,511.0,6.0,0.0,7.0,AAADceB7OCBGAwAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHgYgAAAACAbhkia/lpcMFAKoADBndHACiC0xN+AJyAAcO4iObiOFOxqXOCCsxxOYqCeAQAAAACAAAACACAAAQAAAAQAQAAAAAAAAAA==,"sodium;diiodomethanesulfonate;N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide","sodium;diiodomethanesulfonate;N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1-imidazolecarboxamide","sodium;diiodomethanesulfonate;<I>N</I>-propyl-<I>N</I>-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide","sodium;diiodomethanesulfonate;N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide","sodium;bis(iodanyl)methanesulfonate;N-propyl-N-[2-[2,4,6-tris(chloranyl)phenoxy]ethyl]imidazole-1-carboxamide","sodium;diiodomethanesulfonate;N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide","InChI=1S/C15H16Cl3N3O2.CH2I2O3S.Na/c1-2-4-20(15(22)21-5-3-19-10-21)6-7-23-14-12(17)8-11(16)9-13(14)18;2-1(3)7(4,5)6;/h3,5,8-10H,2,4,6-7H2,1H3;1H,(H,4,5,6);/q;;+1/p-1",MIXCUJKCXRNYFM-UHFFFAOYSA-M,,744.79416,C16H17Cl3I2N3NaO5S,746.5,113.0,744.79416,0.0,31.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",CCCN(CCOc1c(Cl)cc(Cl)cc1Cl)C(=O)n1ccnc1.O=S(=O)([O-])C(I)I.[Na+],,"14  23  8
14  24  8
15  24  8
15  25  8
22  26  8
22  27  8
23  25  8
26  28  8
27  29  8
28  30  8
29  30  8",7  10  7
440790342,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01311,INTERFERON ALFA-2A,20210312,20210312,Curation Efforts|Governmental Organizations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790341,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01350,Infliximab,20210312,20210312,Curation Efforts|Governmental Organizations,LT01350,infliximab,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790340,3715,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00022,indomethacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00022,indomethacin,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,3715,1.0,506.0,4.0,1.0,4.0,AAADceB6OAAEAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgB9AAAHgIACAAADA6BniIyzvMMFgCoAyXyXACCiCAlJyAImCE2btgMJvLFt5uEcShkxBHI6Ye82fOehEABAAACAAAIgAIAAAQAAAAAAAAAAA==,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid,2-[1-[(4-chlorophenyl)-oxomethyl]-5-methoxy-2-methyl-3-indolyl]acetic acid,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid,2-[1-(4-chlorophenyl)carbonyl-5-methoxy-2-methyl-indol-3-yl]ethanoic acid,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",CGIGDMFJXJATDK-UHFFFAOYSA-N,4.3,357.0767857,C19H16ClNO4,357.8,68.5,357.0767857,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,,"12  16  8
13  17  8
16  17  8
18  20  8
18  21  8
20  22  8
21  23  8
22  24  8
23  24  8
6  10  8
6  9  8
7  10  8
7  8  8
8  12  8
8  9  8
9  13  8",
440790339,5291,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00107,Imatinib,20231222,20210312,Curation Efforts|Governmental Organizations,LT00107,imatinib,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,5291,1.0,706.0,7.0,2.0,7.0,AAADceB7oAAAAAAAAAAAAAAAAAAAAAAAAAA8eLECAAAAAAAB9AAAHgAQAAAADAjBngQ/0JfIEACoAzV3dACCgCk1AqAJ2CE4ZNiIaPLA3dGUJQholALIyacYiACOSAAAAAQCAACQAAAACAQAAAAAAAAAAA==,4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide,4-[(4-methylpiperazin-1-yl)methyl]-<I>N</I>-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,4-[(4-methylpiperazino)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",KTUFNOKKBVMGRW-UHFFFAOYSA-N,,493.25900864,C29H31N7O,493.6,86.3,493.25900864,0.0,37.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,3.5,"15  16  8
15  17  8
16  18  8
17  19  8
18  20  8
19  20  8
22  24  8
22  26  8
23  24  8
23  25  8
25  27  8
26  27  8
30  32  8
31  34  8
31  35  8
32  33  8
34  36  8
36  37  8
6  29  8
6  30  8
7  29  8
7  33  8
8  35  8
8  37  8",
440790338,3657,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00106,hydroxyurea,20231222,20210312,Curation Efforts|Governmental Organizations,LT00106,hydroxyurea,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,3657,1.0,42.9,2.0,3.0,0.0,AAADcYADMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABgAUCAAAAAAAAAABAABQAAAIAAAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,hydroxyurea,hydroxyurea,hydroxyurea,hydroxyurea,1-oxidanylurea,hydroxyurea,"InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)",VSNHCAURESNICA-UHFFFAOYSA-N,-1.8,76.027277375,CH4N2O2,76.055,75.4,76.027277375,0.0,5.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)NO,,,
440790337,441140,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00558,griseofulvin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00558,griseofulvin,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,441140,1.0,575.0,6.0,0.0,3.0,AAADceB4OAAEAAAAAAAAAAAAAAAAASAAAAAwQAAAAAAAAEgBAAAAGgIAAAAADUaAmCIyBoAABACIAqBSAAICCAAkJEAAiAFGC8gNJzeFNh6COWCl4BUKqQfK7vzuoCAAKAAICABAQABQABAQAAAAAAAAAA==,"(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione","(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[benzofuran-2,4'-cyclohex-2-ene]-1',3-dione","(2<I>S</I>,5&apos;<I>R</I>)-7-chloro-3&apos;,4,6-trimethoxy-5&apos;-methylspiro[1-benzofuran-2,4&apos;-cyclohex-2-ene]-1&apos;,3-dione","(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione","(2S,5'R)-7-chloranyl-3',4,6-trimethoxy-5'-methyl-spiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione","(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methyl-spiro[coumaran-2,4'-cyclohex-2-ene]-1',3-quinone","InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1",DDUHZTYCFQRHIY-RBHXEPJQSA-N,2.2,352.071366,C17H17ClO6,352.8,71.1,352.071366,0.0,24.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,,"14  15  8
14  18  8
15  19  8
18  20  8
19  21  8
8  2  6
20  21  8
9  13  5",
440790336,3463,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00020,gemfibrozil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00020,gemfibrozil,4.0,Warnings and precautions,vMost-DILI-Concern,1.0,3463,1.0,273.0,3.0,1.0,6.0,AAADceBwMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgAACAAADgSgmAIyDoAABgCIAiDSCAACCAAgIAAIiAEGCIgMJjKEMRqCeCCkwBEIqAeI5DgPQAABAAAIAACAAAIAABAAAAAAAAAAAA==,"5-(2,5-dimethylphenoxy)-2,2-dimethyl-pentanoic acid","5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid","5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid","5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid","5-(2,5-dimethylphenoxy)-2,2-dimethyl-pentanoic acid","5-(2,5-dimethylphenoxy)-2,2-dimethyl-valeric acid","InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17)",HEMJJKBWTPKOJG-UHFFFAOYSA-N,,250.15689456,C15H22O3,250.33,46.5,250.15689456,0.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,3.8,"11  12  8
11  13  8
12  15  8
13  14  8
14  16  8
15  16  8",
440790335,60750,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01407,gemcitabine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01407,gemcitabine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,60750,1.0,426.0,6.0,3.0,2.0,AAADccBzOYAAAAAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAAAAAAAHwAQCAAACBThgBYBAANABgCoACJmdACAAAEAAgAIAAAYABCBEAIAgAAOQAAHFgIDAACwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one","4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-2-pyrimidinone","4-amino-1-[(2<I>R</I>,4<I>R</I>,5<I>R</I>)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one","4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one","4-azanyl-1-[(2R,4R,5R)-3,3-bis(fluoranyl)-5-(hydroxymethyl)-4-oxidanyl-oxolan-2-yl]pyrimidin-2-one","4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidin-2-one","InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1",SDUQYLNIPVEERB-QPPQHZFASA-N,-1.5,263.07176216,C9H11F2N3O4,263.2,108.0,263.07176216,0.0,18.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,,"12  14  5
15  17  8
17  18  8
10  4  6
13  7  5
7  15  8
7  16  8
8  16  8
8  18  8",
440790334,123631,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00402,Gefitinib,20231222,20210312,Curation Efforts|Governmental Organizations,LT00402,gefitinib,4.0,Warnings and precautions,vMost-DILI-Concern,2.0,123631,1.0,545.0,8.0,1.0,8.0,AAADceB7sQAEAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACx9AAAHwIQAAAADA7hni439vfIFACgAyZjZACCiCkxJ6AJ2CA+7piPLuLF+9uHPCru0Bva6Cew0BMOIEABAgICQABAgAIEBASAAAAAAAAAAA==,N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine,<I>N</I>-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine,N-(3-chloranyl-4-fluoranyl-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine,(3-chloro-4-fluoro-phenyl)-[7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl]amine,"InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)",XGALLCVXEZPNRQ-UHFFFAOYSA-N,,446.1520965,C22H24ClFN4O3,446.9,68.7,446.1520965,0.0,31.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,4.1,"17  19  8
17  20  8
18  19  8
18  21  8
18  23  8
20  22  8
21  22  8
24  27  8
24  28  8
27  29  8
28  30  8
29  31  8
30  31  8
8  21  8
8  25  8
9  23  8
9  25  8",
440790333,56339,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01400,Fosphenytoin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01400,fosphenytoin,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,56339,1.0,547.0,6.0,3.0,5.0,AAADccB7OAIAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAAABQAAAHgAQCCAADIiBmAYxAIPAARCIQiFSEICCAAAgAAAIiAGIBIiIYDKAlTGUIAhohyIIiAcYiMCOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2,5-dioxo-4,4-diphenyl-imidazolidin-1-yl)methyl dihydrogen phosphate","(2,5-dioxo-4,4-diphenyl-1-imidazolidinyl)methyl dihydrogen phosphate","(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl dihydrogen phosphate","(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl dihydrogen phosphate","[2,5-bis(oxidanylidene)-4,4-diphenyl-imidazolidin-1-yl]methyl dihydrogen phosphate","(2,5-diketo-4,4-diphenyl-imidazolidin-1-yl)methyl dihydrogen phosphate","InChI=1S/C16H15N2O6P/c19-14-16(12-7-3-1-4-8-12,13-9-5-2-6-10-13)17-15(20)18(14)11-24-25(21,22)23/h1-10H,11H2,(H,17,20)(H2,21,22,23)",XWLUWCNOOVRFPX-UHFFFAOYSA-N,,362.0667732,C16H15N2O6P,362.27,116.0,362.0667732,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O,0.6,"12  16  8
12  18  8
13  17  8
13  19  8
16  20  8
17  21  8
18  22  8
19  23  8
20  24  8
21  25  8
22  24  8
23  25  8",
440790332,3365,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00179,fluconazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00179,fluconazole,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,3365,1.0,358.0,7.0,1.0,5.0,AAADccBzoYAAAAAAAAAAAAAAAAAAAWLAAAAwAAAAAAAAAAAB8AAAHwAICAAADETBmAw1EIYIEgCiAiBDJAASAAswgIAdyAAICIiKLiKA2RGEcAAswAMYmAeQwOAOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol","2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)-2-propanol","2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol","2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol","2-[2,4-bis(fluoranyl)phenyl]-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol","2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol","InChI=1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2",RFHAOTPXVQNOHP-UHFFFAOYSA-N,0.4,306.10406535,C13H12F2N6O,306.27,81.7,306.10406535,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,"13  14  8
13  15  8
14  16  8
15  17  8
16  20  8
17  20  8
4  18  8
4  6  8
5  19  8
5  7  8
6  21  8
7  22  8
8  18  8
8  21  8
9  19  8
9  22  8",
440790331,3342,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00099,fenoprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00099,fenoprofen,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,3342,1.0,271.0,3.0,1.0,4.0,AAADccBwMAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAGgAACAAADQSAmAAyDoAABgCIAiDSCAACCAAgIAAIiAEGCIgMJjKENRqCeCCkwBEIqAeI7PzOgAABAAAAAAAAAAIAAAAAAAAAAAAAAA==,2-(3-phenoxyphenyl)propanoic acid,2-(3-phenoxyphenyl)propanoic acid,2-(3-phenoxyphenyl)propanoic acid,2-(3-phenoxyphenyl)propanoic acid,2-(3-phenoxyphenyl)propanoic acid,2-(3-phenoxyphenyl)propionic acid,"InChI=1S/C15H14O3/c1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13/h2-11H,1H3,(H,16,17)",RDJGLLICXDHJDY-UHFFFAOYSA-N,3.3,242.094294304,C15H14O3,242.27,46.5,242.094294304,0.0,18.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C(=O)O)c1cccc(Oc2ccccc2)c1,,"11  12  8
13  14  8
13  15  8
14  16  8
15  17  8
16  18  8
17  18  8
4  19  3
5  6  8
5  8  8
6  9  8
8  11  8
9  12  8",
440790330,134018,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00554,Febuxostat,20231222,20210312,Curation Efforts|Governmental Organizations,LT00554,febuxostat,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,134018,1.0,448.0,6.0,1.0,5.0,AAADceB7MABAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHgQACAAADQyh3gIyj5IIFgi8ByTyTACi+KBlKDgImDU2TNgMprrksRuGeajmwBHouU+Q0GIOIAACAAAIAABAAAQAABAAAAAAAAAAAA==,2-(3-cyano-4-isobutoxy-phenyl)-4-methyl-thiazole-5-carboxylic acid,2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid,"2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid","2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid","2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid",2-(3-cyano-4-isobutoxy-phenyl)-4-methyl-thiazole-5-carboxylic acid,"InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20)",BQSJTQLCZDPROO-UHFFFAOYSA-N,,316.08816355,C16H16N2O3S,316.4,111.0,316.08816355,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,3.9,"1  17  8
1  19  8
11  13  8
11  14  8
12  15  8
12  16  8
13  15  8
14  16  8
18  19  8
5  17  8
5  18  8",
440790329,60198,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00394,EXEMESTANE,20210312,20210312,Curation Efforts|Governmental Organizations,LT00394,exemestane,4.0,Warnings and precautions,vMost-DILI-Concern,2.0,60198,1.0,653.0,2.0,0.0,0.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYIAAAAAAAGDAAAAAGgAAAAAADwSAgAACAAAAAACIAqBSAAAAAAAgAAAICAEAAEgIABIAAQAAAAAAgAAIgYMIiMCPgAAAAAAAAACAAAQAACAAAAAACAAAAA==,"(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione","(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione","(8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione","(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione","(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione","(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-quinone","InChI=1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1",BFYIZQONLCFLEV-DAELLWKTSA-N,,296.177630004,C20H24O2,296.4,34.1,296.177630004,0.0,22.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,3.1,"3  23  6
4  24  5
5  14  5
6  25  6
9  17  5",
440790328,193962,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00653,Etravirine,20210804,20210312,Curation Efforts|Governmental Organizations,LT00653,etravirine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,193962,1.0,609.0,7.0,2.0,4.0,AAADccB7oAAAEAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAAB0AAAHgBQAAABrAyBmgAz9pbIFACwBiZiZACiiCkhIqAJmCAkbJiMriLE+duOPCju0BtI6C+QwGAOKAACAAAIAABQAAQAABAAAAAAAAAAAA==,"4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethyl-benzonitrile","4-[[6-amino-5-bromo-2-(4-cyanoanilino)-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile","4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile","4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile","4-[6-azanyl-5-bromanyl-2-[(4-cyanophenyl)amino]pyrimidin-4-yl]oxy-3,5-dimethyl-benzenecarbonitrile","4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethyl-benzonitrile","InChI=1S/C20H15BrN6O/c1-11-7-14(10-23)8-12(2)17(11)28-19-16(21)18(24)26-20(27-19)25-15-5-3-13(9-22)4-6-15/h3-8H,1-2H3,(H3,24,25,26,27)",PYGWGZALEOIKDF-UHFFFAOYSA-N,,434.04907,C20H15BrN6O,435.3,121.0,434.04907,0.0,28.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,4.5,"10  12  8
11  13  8
12  14  8
13  14  8
17  20  8
19  22  8
19  23  8
20  21  8
22  24  8
23  25  8
24  26  8
25  26  8
4  17  8
4  18  8
5  18  8
5  21  8
9  10  8
9  11  8",
440790327,3308,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00240,etodolac,20210312,20210312,Curation Efforts|Governmental Organizations,LT00240,etodolac,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,3308,1.0,399.0,3.0,2.0,4.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAWAAAAA0QAAAAAAAAFgB8AAAHgAQCAAADEyhngIyyPLJlgCoAyTyTASCgCAhACAImSEgTJgKJvbAsZmHcAhl4AHY6Ae82POOgAACAAACAAAAAAQAAAQAAAAAAAAAAA==,"2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid","2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid","2-(1,8-diethyl-4,9-dihydro-3<I>H</I>-pyrano[3,4-b]indol-1-yl)acetic acid","2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid","2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)ethanoic acid","2-(1,8-diethyl-4,9-dihydro-3H-pyran[3,4-b]indol-1-yl)acetic acid","InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)",NNYBQONXHNTVIJ-UHFFFAOYSA-N,,287.15214353,C17H21NO3,287.35,62.3,287.15214353,0.0,21.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,2.8,"11  13  8
11  16  8
13  14  8
14  19  8
16  20  8
19  20  8
4  13  8
4  6  8
5  9  3
6  7  8
7  11  8",
440790326,3279,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01345,ethambutol,20210312,20210312,Curation Efforts|Governmental Organizations,LT01345,ethambutol,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,3279,1.0,109.0,4.0,4.0,9.0,AAADceBzMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAACCjhgAYCAALAAgAAAAAAAAAAAAAAAAAAAIAIAAACUAAAAAAUQAAEEACQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-[2-[1-(hydroxymethyl)propylamino]ethylamino]butan-1-ol,2-[2-(1-hydroxybutan-2-ylamino)ethylamino]-1-butanol,2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol,2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol,2-[2-(1-oxidanylbutan-2-ylamino)ethylamino]butan-1-ol,2-[2-(1-methylolpropylamino)ethylamino]butan-1-ol,"InChI=1S/C10H24N2O2/c1-3-9(7-13)11-5-6-12-10(4-2)8-14/h9-14H,3-8H2,1-2H3",AEUTYOVWOVBAKS-UHFFFAOYSA-N,,204.183778013,C10H24N2O2,204.31,64.5,204.183778013,0.0,14.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC(CO)NCCNC(CC)CO,-0.1,"5  9  3
6  10  3",
440790325,259331,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01342,estramustine,20250421,20210312,Curation Efforts|Governmental Organizations,LT01342,estramustine,4.0,Warnings and precautions,vMost-DILI-Concern,2.0,259331,1.0,584.0,3.0,1.0,6.0,AAADceB6MAAGAAAAAAAAAAAAAAAAAYAAAAAwYMAAAAAAAGDBAAAAHgIACAAADxfhmEYyDoMABgCIAiBCGAACCAAgIAAIiAAOCIgMNiKEMRrIciAkxhGIqAeAwPAPoAABAAAQAADAAAYAACAAAIAADAAAAA==,"[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate","N,N-bis(2-chloroethyl)carbamic acid [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] ester","[(8<I>R</I>,9<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] <I>N</I>,<I>N</I>-bis(2-chloroethyl)carbamate","[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate","[(8R,9S,13S,14S,17S)-13-methyl-17-oxidanyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate","N,N-bis(2-chloroethyl)carbamic acid [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] ester","InChI=1S/C23H31Cl2NO3/c1-23-9-8-18-17-5-3-16(29-22(28)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)27/h3,5,14,18-21,27H,2,4,6-13H2,1H3/t18-,19-,20+,21+,23+/m1/s1",FRPJXPJMRWBBIH-RBRWEJTLSA-N,4.0,439.1680992,C23H31Cl2NO3,440.4,49.8,439.1680992,0.0,29.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,,"10  32  6
18  20  8
18  21  8
20  22  8
21  23  8
22  24  8
23  24  8
11  3  5
7  17  5
8  30  6
9  31  5",
440790324,12560,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00092,erythromycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00092,erythromycin,5.0,Warnings and precautions,vMost-DILI-Concern,1.0,12560,1.0,1180.0,14.0,5.0,7.0,AAADcfB+PAAAAAAAAAAAAAAAAAAAAAAAAAAkSAAAAAAAAAAAAAAAHgAACAAADXzxgAcCCAMABgAIAICQCAAAAAAAAAAAAAEIAAATEBYAgAAmQAAHIAAXAAHK7PzOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione","(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-2-oxanyl]oxy]-14-ethyl-7,12,13-trihydroxy-4-[[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-2-oxanyl]oxy]-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione","(3<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>,7<I>R</I>,9<I>R</I>,11<I>R</I>,12<I>R</I>,13<I>S</I>,14<I>R</I>)-6-[(2<I>S</I>,3<I>R</I>,4<I>S</I>,6<I>R</I>)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2<I>R</I>,4<I>R</I>,5<I>S</I>,6<I>S</I>)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione","(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione","(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-6-methyl-3-oxidanyl-oxan-2-yl]oxy-14-ethyl-4-[(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-oxidanyl-oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-7,12,13-tris(oxidanyl)-1-oxacyclotetradecane-2,10-dione","(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-quinone","InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1",ULGZDMOVFRHVEP-RWJQBGPGSA-N,2.7,733.46124119,C37H67NO13,733.9,194.0,733.46124119,0.0,51.0,18.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,"15  1  5
22  1  5
32  10  6
35  11  6
28  14  5
16  25  5
18  2  5
23  2  6
20  40  6
21  41  6
17  3  6
31  43  6
34  46  5
37  47  5
38  45  5
24  7  6
26  8  6
30  9  6",
440790323,176870,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01214,Erlotinib,20210312,20210312,Curation Efforts|Governmental Organizations,LT01214,erlotinib,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,176870,1.0,525.0,7.0,1.0,11.0,AAADceB7OAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACx9AAAHgAQAAAADAyhngY39vbIFADgGyZjZAiCiCkxIqAJ2CA+7JiNLuLE+duGPCru0BvK6Cew0BMOIEABQgACQABAgAKEAASAAAAAAAAAAA==,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine","N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine","<I>N</I>-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine","N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine","N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine","[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-(3-ethynylphenyl)amine","InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)",AAKJLRGGTJKAMG-UHFFFAOYSA-N,,393.16885622,C22H23N3O4,393.4,74.7,393.16885622,0.0,29.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,3.3,"10  11  8
10  12  8
11  14  8
16  21  8
16  22  8
21  23  8
22  24  8
23  25  8
24  25  8
6  18  8
6  9  8
7  13  8
7  18  8
8  12  8
8  13  8
8  9  8
9  14  8",
440790322,64139,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01323,efavirenz,20210312,20210312,Curation Efforts|Governmental Organizations,LT01323,efavirenz,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,64139,1.0,519.0,5.0,1.0,1.0,AAADccByMYAEAAAAAAAAAAAAGAAAAAAAAAA8QAAAAAAAAACxAAAAHwIQAAAADU6BmDAwyILABADIEiRCWAiCAAAhBwAIiAAAbokIJiLBs5mMMAhm1AFI6AeQwOAOgABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one","(4<I>S</I>)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1<I>H</I>-3,1-benzoxazin-2-one","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one","(4S)-6-chloranyl-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one","InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1",XPOQHMRABVBWPR-ZDUSSCGKSA-N,,315.0273907,C14H9ClF3NO2,315.67,38.3,315.0273907,0.0,21.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,4.0,"11  14  5
13  15  8
13  17  8
15  18  8
17  20  8
18  21  8
20  21  8",
440790321,60835,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02035,duloxetine,20210312,20210312,Curation Efforts|Governmental Organizations,LT02035,duloxetine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,60835,1.0,312.0,3.0,1.0,6.0,AAADceB6IABAAAAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAADB1AAAHgQQAAAADBTl2AayB8LABAiEAiBCAAADCIAgKBBIiJgOCIgMJiKksRqGOCCm0BEoqAeQwLAOgAABAAAYAAAAAAIAADAAAAAAAAAAAA==,(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine,(3S)-N-methyl-3-(1-naphthalenyloxy)-3-thiophen-2-yl-1-propanamine,(3<I>S</I>)-<I>N</I>-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine,(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine,(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1-amine,methyl-[(3S)-3-(1-naphthoxy)-3-(2-thienyl)propyl]amine,"InChI=1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m0/s1",ZEUITGRIYCTCEM-KRWDZBQOSA-N,,297.1187354,C18H19NOS,297.4,49.5,297.1187354,0.0,21.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,4.3,"1  18  8
1  7  8
10  14  8
10  16  8
11  17  8
12  15  8
13  20  8
14  15  8
16  21  8
17  18  8
4  2  6
20  21  8
7  11  8
8  12  8
8  9  8
9  10  8
9  13  8",
440790320,208898,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00671,Dronedarone,20250421,20210312,Curation Efforts|Governmental Organizations,LT00671,dronedarone,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,208898,1.0,800.0,7.0,1.0,18.0,AAADcfB7OABAAAAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAEgB9AAAHgQQQAAADAzhmAayxsNABEKIAqRSQHCCCAAkIgAIiAEObMgMJjaMtZuGOWDm8BGI6Ye/3fHeoEAAQAAIAABAgACAABAAAAAAAAAAAA==,N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]benzofuran-5-yl]methanesulfonamide,N-[2-butyl-3-[[4-[3-(dibutylamino)propoxy]phenyl]-oxomethyl]-5-benzofuranyl]methanesulfonamide,<I>N</I>-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide,N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide,N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]phenyl]carbonyl-1-benzofuran-5-yl]methanesulfonamide,N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]benzofuran-5-yl]methanesulfonamide,"InChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3",ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,,556.29709368,C31H44N2O5S,556.8,97.2,556.29709368,0.0,39.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,7.2,"18  19  8
19  21  8
2  18  8
2  25  8
21  25  8
21  28  8
25  32  8
28  30  8
29  34  8
29  35  8
30  33  8
31  36  8
31  37  8
32  33  8
34  36  8
35  37  8",
440790319,3117,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00295,disulfiram,20250421,20210312,Curation Efforts|Governmental Organizations,LT00295,disulfiram,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,3117,1.0,201.0,4.0,0.0,7.0,AAADceBzAABwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAQAAAAAAADBAAQCAAMAAAAEAAAAAAAAAAAAAAgAAAAIAAAAAAAAAAAAAAAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate","N,N-diethylcarbamodithioic acid [[diethylamino(sulfanylidene)methyl]thio] ester","diethylcarbamothioylsulfanyl <I>N</I>,<I>N</I>-diethylcarbamodithioate","diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate","diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate","N,N-diethylcarbamodithioic acid (diethylthiocarbamoylthio) ester","InChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3",AUZONCFQVSMFAP-UHFFFAOYSA-N,3.9,296.05093334,C10H20N2S4,296.5,121.0,296.05093334,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)C(=S)SSC(=S)N(CC)CC,,,
440790318,39186,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01292,diltiazem,20250421,20210312,Curation Efforts|Governmental Organizations,LT01292,diltiazem,4.0,Warnings and precautions,vMost-DILI-Concern,2.0,39186,1.0,565.0,6.0,0.0,7.0,AAADceB7OABAAAAAAAAAAAAAAAAAAAAAAAAwYAAABYAAAAABQAAAHgQAAAAADBzl2Aayz4MABAiIAiXSWAKCCAAhKhAIiB1ObIgOZjLksZ+XMChkxhH46AeYyKCOIAAAAAAAAQBAAAAAAAACAAAAAAAAAA==,"[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate","acetic acid [(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] ester","[(2<I>S</I>,3<I>S</I>)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate","[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate","[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxidanylidene-2,3-dihydro-1,5-benzothiazepin-3-yl] ethanoate","acetic acid [(2S,3S)-5-[2-(dimethylamino)ethyl]-4-keto-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-3-yl] ester","InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m1/s1",HSUGRBWQSSZJOP-RTWAWAEBSA-N,,414.16132849,C22H26N2O4S,414.5,84.4,414.16132849,0.0,29.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,3.1,"12  14  8
12  16  8
13  18  8
13  19  8
14  17  8
16  20  8
17  21  8
18  22  8
19  23  8
9  2  5
20  21  8
22  26  8
23  26  8
8  13  5",
440790317,3059,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00085,diflunisal,20210312,20210312,Curation Efforts|Governmental Organizations,LT00085,diflunisal,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,3059,1.0,311.0,5.0,2.0,2.0,AAADccBwMYAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAGwAACAAADASAmAgwDoAAAgCIAiDSCAACAAAkIAAIiAEGCMgIJzaCFRKAcUAl4BEImYeIyPCOoAACAAAIAABAAAQAABAAAAAAAAAAAA==,"5-(2,4-difluorophenyl)-2-hydroxy-benzoic acid","5-(2,4-difluorophenyl)-2-hydroxybenzoic acid","5-(2,4-difluorophenyl)-2-hydroxybenzoic acid","5-(2,4-difluorophenyl)-2-hydroxybenzoic acid","5-[2,4-bis(fluoranyl)phenyl]-2-oxidanyl-benzoic acid","5-(2,4-difluorophenyl)-2-hydroxy-benzoic acid","InChI=1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)",HUPFGZXOMWLGNK-UHFFFAOYSA-N,4.4,250.04415044,C13H8F2O3,250.2,57.5,250.04415044,0.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,,"10  13  8
11  15  8
12  16  8
13  14  8
15  17  8
16  17  8
6  8  8
6  9  8
7  11  8
7  12  8
8  10  8
9  14  8",
440790316,135398739,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01285,didanosine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01285,didanosine,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,135398739,1.0,348.0,5.0,2.0,2.0,AAADccBzsAAAAAAAAAAAAAAAAAAAAWJAAAAgAAAAAAAAAEABgAAAHgAQCAAACBzhlgYFsBfMFgCoAQdxdACAgC0XEKABUIGoVECBWApAyCAeQIgMAgLDAGCwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-6-one","9-[(2R,5S)-5-(hydroxymethyl)-2-oxolanyl]-1H-purin-6-one","9-[(2<I>R</I>,5<I>S</I>)-5-(hydroxymethyl)oxolan-2-yl]-1<I>H</I>-purin-6-one","9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one","9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one","9-[(2R,5S)-5-methyloltetrahydrofuran-2-yl]hypoxanthine","InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1",BXZVVICBKDXVGW-NKWVEPMBSA-N,-1.2,236.09094026,C10H12N4O3,236.23,88.7,236.09094026,0.0,17.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,,"11  12  6
13  15  8
15  16  8
4  13  8
4  14  8
8  4  6
5  14  8
5  15  8
6  13  8
6  17  8
7  16  8
7  17  8",
440790315,3033,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00084,diclofenac,20231222,20210312,Curation Efforts|Governmental Organizations,LT00084,diclofenac,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,3033,1.0,304.0,3.0,2.0,4.0,AAADccByMAAGAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgIQCAAADAqBmCAwyILAAgCIAiTSSACCAAAhBwAIiAEAZogIIHLBl5HEYAhk0AHIyAe8yKCOAAAAAACCABAAAAAAAQQAIAAAAAAAAA==,"2-[2-(2,6-dichloroanilino)phenyl]acetic acid","2-[2-(2,6-dichloroanilino)phenyl]acetic acid","2-[2-(2,6-dichloroanilino)phenyl]acetic acid","2-[2-(2,6-dichloroanilino)phenyl]acetic acid","2-[2-[[2,6-bis(chloranyl)phenyl]amino]phenyl]ethanoic acid","2-[2-(2,6-dichloroanilino)phenyl]acetic acid","InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",DCOPUUMXTXDBNB-UHFFFAOYSA-N,4.4,295.016684,C14H11Cl2NO2,296.1,49.3,295.016684,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,,"10  12  8
11  13  8
12  13  8
14  17  8
15  18  8
17  19  8
18  19  8
6  10  8
6  7  8
7  11  8
9  14  8
9  15  8",
440790314,213039,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01243,Darunavir,20210312,20210312,Curation Efforts|Governmental Organizations,LT01243,darunavir,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,213039,1.0,853.0,9.0,3.0,12.0,AAADcfB7OABAAAAAAAAAAAAAAAAAASJAAAAwYAAAAAASAAABQAAAHgQQSAAADTzx2AcyyYLABgKIAiRCWHDCABAgAgAIiJgIZIkbMCKA0ZGuYABllgCeyAfQ4KgOAAQAAAAAAAAACAAAAAAAAAAAAAAAAA==,"[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate","N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamic acid [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] ester","[(3<I>a</I><I>S</I>,4<I>R</I>,6<I>a</I><I>R</I>)-2,3,3<I>a</I>,4,5,6<I>a</I>-hexahydrofuro[2,3-b]furan-4-yl] <I>N</I>-[(2<I>S</I>,3<I>R</I>)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate","[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate","[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-oxidanyl-1-phenyl-butan-2-yl]carbamate","N-[(1S,2R)-1-benzyl-2-hydroxy-3-[isobutyl(sulfanilyl)amino]propyl]carbamic acid [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] ester","InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1",CJBJHOAVZSMMDJ-HEXNFIEUSA-N,,547.2352217,C27H37N3O7S,547.7,149.0,547.2352217,0.0,38.0,5.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,2.9,"12  39  5
13  40  5
25  29  8
25  30  8
26  31  8
26  32  8
29  33  8
30  34  8
31  36  8
32  37  8
33  35  8
34  35  8
36  38  8
37  38  8
14  4  6
19  5  6
18  9  5",
440790313,457193,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00079,DACTINOMYCIN,20210312,20210312,Curation Efforts|Governmental Organizations,LT00079,dactinomycin,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,457193,1.0,3030.0,18.0,5.0,8.0,AAADcfB//gAAAAAAAAAAAAAAAAAAAWLAAAAwQIAAAAAAAACBAAAAHgAQAAAADTzhmAYyzoPABACoA6XyXASCCAAkIAAIiIGtTNgOZj6E9buXOajm9hGY6ce6yTCOQAABQAAKEACAAAKAABQgAAAAAAAAAA==,"2-amino-N1,N9-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide","2-amino-4,6-dimethyl-3-oxo-N1,N9-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide","2-amino-4,6-dimethyl-3-oxo-1-<I>N</I>,9-<I>N</I>-bis[(3<I>R</I>,6<I>S</I>,7<I>R</I>,10<I>S</I>,16<I>S</I>)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide","2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide","2-azanyl-4,6-dimethyl-3-oxidanylidene-N1,N9-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentakis(oxidanylidene)-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide","2-amino-N,N'-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide","InChI=1S/C62H86N12O16/c1-27(2)42-59(84)73-23-17-19-36(73)57(82)69(13)25-38(75)71(15)48(29(5)6)61(86)88-33(11)44(55(80)65-42)67-53(78)35-22-21-31(9)51-46(35)64-47-40(41(63)50(77)32(10)52(47)90-51)54(79)68-45-34(12)89-62(87)49(30(7)8)72(16)39(76)26-70(14)58(83)37-20-18-24-74(37)60(85)43(28(3)4)66-56(45)81/h21-22,27-30,33-34,36-37,42-45,48-49H,17-20,23-26,63H2,1-16H3,(H,65,80)(H,66,81)(H,67,78)(H,68,79)/t33-,34-,36+,37+,42-,43-,44+,45+,48+,49+/m1/s1",RJURFGZVJUQBHK-IIXSONLDSA-N,,1254.6284747,C62H86N12O16,1255.4,356.0,1254.6284747,0.0,90.0,10.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,3.8,"13  82  8
13  83  8
53  25  5
54  26  5
27  79  8
27  80  8
29  91  5
30  92  5
38  43  5
40  44  5
57  67  6
58  68  6
59  63  5
60  64  5
77  79  8
77  81  8
78  80  8
78  84  8
80  83  8
81  87  8
82  85  8
83  86  8
84  88  8
85  87  8
86  88  8",
440790312,5284373,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00380,cyclosporine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00380,cyclosporine,7.0,Warnings and precautions,vMost-DILI-Concern,1.0,5284373,1.0,2330.0,12.0,5.0,15.0,AAADcfB//AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQCAAADTzhgAYCAAPAAgCIACFSEAAAAAAgAAAICIGIAAgCUBYAgSAUQAAGtgCYAAMYCAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone","(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone","(3<I>S</I>,6<I>S</I>,9<I>S</I>,12<I>R</I>,15<I>S</I>,18<I>S</I>,21<I>S</I>,24<I>S</I>,30<I>S</I>,33<I>S</I>)-30-ethyl-33-[(<I>E</I>,1<I>R</I>,2<I>R</I>)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone","(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone","(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,1R,2R)-2-methyl-1-oxidanyl-hex-4-enyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone","(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone","InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1",PMATZTZNYRCHOR-CGLBZJNRSA-N,,1201.84136802,C62H111N11O12,1202.6,279.0,1201.84136802,0.0,85.0,12.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,7.5,"28  1  6
24  27  5
25  29  5
26  88  6
30  43  5
33  36  5
48  61  5
49  57  5
51  58  5
54  60  5
59  73  6
72  84  5",
440790311,135398737,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00287,clozapine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00287,clozapine,5.0,Warnings and precautions,vMost-DILI-Concern,1.0,135398737,1.0,446.0,3.0,1.0,1.0,AAADceB7gAAEAAAAAAAAAAAAAAAAAAAAAAA8YIAABAAAAAABQAAAHAIQAAAADArBGCQzwIPAAACgAiZiZACCAAEhBwAJiAAodpgIYOLB25GUIAhgkADIyAcQgAAOAABAAAICACAAAIAABAQAQAAAAAAAAA==,"3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine","3-chloro-6-(4-methyl-1-piperazinyl)-11H-benzo[b][1,4]benzodiazepine","3-chloro-6-(4-methylpiperazin-1-yl)-11<I>H</I>-benzo[b][1,4]benzodiazepine","3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine","3-chloranyl-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine","3-chloro-6-(4-methylpiperazino)-11H-benzo[b][1,4]benzodiazepine","InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3",QZUDBNBUXVUHMW-UHFFFAOYSA-N,,326.1298243,C18H19ClN4,326.8,30.9,326.1298243,0.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,3.1,"11  13  8
11  16  8
13  17  8
14  15  8
14  19  8
15  21  8
16  18  8
17  20  8
18  20  8
19  22  8
21  23  8
22  23  8",
440790310,2801,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00185,clomipramine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00185,clomipramine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,2801,1.0,346.0,2.0,0.0,4.0,AAADceB7AAAEAAAAAAAAAAAAAAAAAAAAAAAwYAAABYAAAAABQAAAHAIAAAAADArBGCQywIMAAACAAiRCQACCAAAhBwAIiAAIZogIIGLB05GEIAhggADIyAcQgMAOBAAAAAICAAAIAAAABAQAAAAAAAAAAA==,"3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine","3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-1-propanamine","3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-<I>N</I>,<I>N</I>-dimethylpropan-1-amine","3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine","3-(2-chloranyl-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine","3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-dimethyl-amine","InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",GDLIGKIOYRNHDA-UHFFFAOYSA-N,5.2,314.1549764,C19H23ClN2,314.9,6.5,314.1549764,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,,"10  16  8
13  17  8
14  18  8
15  19  8
16  20  8
17  19  8
18  20  8
5  13  8
5  9  8
6  10  8
6  14  8
9  15  8",
440790309,84029,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00187,clarithromycin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00187,clarithromycin,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,84029,1.0,1190.0,14.0,4.0,8.0,AAADcfB+PAAAAAAAAAAAAAAAAAAAAAAAAAAkSAAAAAAAAAAAAAAAHgAACAAADXzxgAcCCAMABgAIAICQCAAAAAAAAAAAAAEIAAATEBYAgAAmQAAHIAAXAAHK7PzOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione","(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-2-oxanyl]oxy]-14-ethyl-12,13-dihydroxy-4-[[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-2-oxanyl]oxy]-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione","(3<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>,7<I>R</I>,9<I>R</I>,11<I>R</I>,12<I>R</I>,13<I>S</I>,14<I>R</I>)-6-[(2<I>S</I>,3<I>R</I>,4<I>S</I>,6<I>R</I>)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2<I>R</I>,4<I>R</I>,5<I>S</I>,6<I>S</I>)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione","(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione","(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-6-methyl-3-oxidanyl-oxan-2-yl]oxy-14-ethyl-7-methoxy-4-[(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-oxidanyl-oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-12,13-bis(oxidanyl)-1-oxacyclotetradecane-2,10-dione","(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-quinone","InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",AGOYDEPGAOXOCK-KCBOHYOISA-N,3.2,747.47689126,C38H69NO13,748.0,183.0,747.47689126,0.0,52.0,18.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,"15  1  5
22  1  5
32  10  6
34  11  6
28  14  5
16  23  5
18  2  5
25  2  6
20  40  6
21  41  6
17  3  6
31  43  6
36  47  5
37  48  5
38  45  5
27  7  6
26  8  6
30  9  6",
440790308,2764,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00178,ciprofloxacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00178,ciprofloxacin,7.0,Warnings and precautions,vMost-DILI-Concern,1.0,2764,1.0,571.0,7.0,2.0,3.0,AAADceB7MQAAAAAAAAAAAAAAGAAAAAAAAAA8QIAAAAAAAACBAAAAHwAQCAAADCzBmAwwyIPAAgCIAqTWSACCAAAlAgAAiIEIZMgIZD7I1NGUYYhksADI2ceY2aOeCAAAAAQCAAAQAAAACAQAAAAAAAAAAA==,1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid,1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,1-cyclopropyl-6-fluoranyl-4-oxidanylidene-7-piperazin-1-yl-quinoline-3-carboxylic acid,1-cyclopropyl-6-fluoro-4-keto-7-piperazino-quinoline-3-carboxylic acid,"InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)",MYSWGUAQZAJSOK-UHFFFAOYSA-N,-1.1,331.13321961,C17H18FN3O3,331.34,72.9,331.13321961,0.0,24.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,"11  13  8
11  14  8
12  18  8
13  19  8
13  22  8
14  15  8
15  23  8
18  19  8
22  23  8
5  11  8
5  12  8",
440790307,2733,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00067,chlorzoxazone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00067,chlorzoxazone,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,2733,1.0,185.0,2.0,1.0,0.0,AAADcYBiMAAEAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgBAAAAHgIQAAAACA6BkCAwzoLABACIACRCWACCCAAhJwAIiAAHbokOJiLFs5uNMihk1BFY6AeQQAAAACAAAAIAEAAAQAAABAAgAAAAAAAAAA==,"5-chloro-3H-1,3-benzoxazol-2-one","5-chloro-3H-1,3-benzoxazol-2-one","5-chloro-3<I>H</I>-1,3-benzoxazol-2-one","5-chloro-3H-1,3-benzoxazol-2-one","5-chloranyl-3H-1,3-benzoxazol-2-one","5-chloro-3H-1,3-benzoxazol-2-one","InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10)",TZFWDZFKRBELIQ-UHFFFAOYSA-N,1.8,168.9930561,C7H4ClNO2,169.56,38.3,168.9930561,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=c1[nH]c2cc(Cl)ccc2o1,,"2  10  8
2  6  8
4  10  8
4  5  8
5  6  8
5  7  8
6  8  8
7  9  8
8  11  8
9  11  8",
440790306,2554,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00060,carbamazepine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00060,carbamazepine,7.0,Warnings and precautions,vMost-DILI-Concern,1.0,2554,1.0,326.0,1.0,1.0,0.0,AAADccBzIAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABAAAAAABQAAAHgAQAAAADAiBGAAxwINAAACIAiRCUACCAAAhAgAIiAAAZIiIIGLAkZGEIAhghALIyCcQgAAOAAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,benzo[b][1]benzazepine-11-carboxamide,11-benzo[b][1]benzazepinecarboxamide,benzo[b][1]benzazepine-11-carboxamide,benzo[b][1]benzazepine-11-carboxamide,benzo[b][1]benzazepine-11-carboxamide,benzo[b][1]benzazepine-11-carboxamide,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)",FFGPTBGBLSHEPO-UHFFFAOYSA-N,2.5,236.094963011,C15H12N2O,236.27,46.3,236.094963011,0.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)N1c2ccccc2C=Cc2ccccc21,,"10  15  8
11  16  8
12  17  8
13  18  8
15  17  8
16  18  8
4  10  8
4  6  8
5  11  8
5  7  8
6  12  8
7  13  8",
440790305,2478,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00280,busulfan,20210312,20210312,Curation Efforts|Governmental Organizations,LT00280,busulfan,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,2478,1.0,293.0,6.0,0.0,7.0,AAADccBgOABgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgQAAAAACACggAKCAAAAAAIAAAAAAHAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEAAAAAABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,4-methylsulfonyloxybutyl methanesulfonate,methanesulfonic acid 4-methylsulfonyloxybutyl ester,4-methylsulfonyloxybutyl methanesulfonate,4-methylsulfonyloxybutyl methanesulfonate,4-methylsulfonyloxybutyl methanesulfonate,methanesulfonic acid 4-methylsulfonyloxybutyl ester,"InChI=1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3",COVZYZSDYWQREU-UHFFFAOYSA-N,-0.5,246.02318051,C6H14O6S2,246.3,104.0,246.02318051,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CS(=O)(=O)OCCCCOS(C)(=O)=O,,,
440790304,387447,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01202,Bortezomib,20231222,20210312,Curation Efforts|Governmental Organizations,LT01202,bortezomib,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,387447,1.0,500.0,6.0,4.0,9.0,AAADceJ7uAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAoHgAQCAAADSjBngQ+gJLIEACoAzV3VACCgCQ3EiAI2IG4dMgIYHrA0TGUIIgglgDIiMcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid,[(1R)-3-methyl-1-[[(2S)-1-oxo-2-[[oxo(2-pyrazinyl)methyl]amino]-3-phenylpropyl]amino]butyl]boronic acid,[(1<I>R</I>)-3-methyl-1-[[(2<I>S</I>)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid,[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid,[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazin-2-ylcarbonylamino)propanoyl]amino]butyl]boronic acid,[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazinoylamino)propanoyl]amino]butyl]boronic acid,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",GXJABQQUPOEUTA-RDJZCZTQSA-N,,384.1968855,C19H25BN4O4,384.2,124.0,384.1968855,0.0,28.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,,"17  18  8
17  19  8
18  21  8
19  22  8
21  23  8
22  23  8
24  25  8
26  27  8
11  5  5
12  6  5
7  24  8
7  26  8
8  25  8
8  27  8",
440790303,2375,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00056,bicalutamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00056,bicalutamide,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,2375,1.0,750.0,9.0,2.0,5.0,AAADccB7OcBAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHwQQCAAADEyF2BiywYLAAgqYBiVSUHLiAAAhChAIiBlAZIgKoCLgkZGEIAhglAD4yA8QgIAOiAAAQAAQAAAQAACAACAAAAAAAAAAAA==,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamide,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide,<I>N</I>-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-methyl-2-oxidanyl-propanamide,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propionamide,"InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)",LKJPYSCBVHEWIU-UHFFFAOYSA-N,,430.06104075,C18H14F4N2O4S,430.4,116.0,430.06104075,0.0,29.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,2.3,"16  18  8
16  19  8
17  20  8
17  23  8
18  21  8
19  22  8
20  24  8
21  25  8
22  25  8
23  27  8
24  26  8
26  27  8
12  6  3",
440790302,82146,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01064,Bexarotene,20210312,20210312,Curation Efforts|Governmental Organizations,LT01064,bexarotene,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,82146,1.0,551.0,2.0,1.0,3.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAAAAAAAwYMAAAAAAAADBQAAAGgAACAAADgCAmAAyCIAAAgCIAiDSCAACAAAkAAAIiAEACMgIJjKAFRCAcQAkwAEImYeIyPCPwAACAAAQAACAAAQAACAAAAAAAAAAAA==,"4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid","4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid","4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid","4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid","4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid","4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid","InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)",NAVMQTYZDKMPEU-UHFFFAOYSA-N,,348.208930132,C24H28O2,348.5,37.3,348.208930132,0.0,26.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,7.6,"13  15  8
14  16  8
15  16  8
19  21  8
19  22  8
21  23  8
22  24  8
23  25  8
24  25  8
7  13  8
7  8  8
8  14  8",
440790301,2265,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00006,azathioprine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00006,azathioprine,5.0,Warnings and precautions,vMost-DILI-Concern,1.0,2265,1.0,354.0,7.0,1.0,2.0,AAADcYBzsABAAAAAAAAAAAAAAAAAAWLAAAAsAAAAAAAAAFgB/gAAHAQUAAAACAgBVwQH8b/d0AihAQZhZwCA0C3RGLAhUbQoVBKASABgSEAUBAwIAIJgACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-7H-purine,6-[(3-methyl-5-nitro-4-imidazolyl)thio]-7H-purine,6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7<I>H</I>-purine,6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine,6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-7H-purine,6-[(3-methyl-5-nitro-imidazol-4-yl)thio]-7H-purine,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",LMEKQMALGUDUQG-UHFFFAOYSA-N,0.1,277.03819367,C9H7N7O2S,277.27,143.0,277.03819367,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12,,"10  16  8
10  19  8
11  14  8
12  13  8
12  16  8
4  11  8
4  15  8
5  12  8
5  18  8
6  14  8
6  15  8
7  13  8
7  19  8
8  16  8
8  18  8",
440790300,60823,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00258,atorvastatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00258,atorvastatin,5.0,Warnings and precautions,vMost-DILI-Concern,2.0,60823,1.0,822.0,6.0,4.0,12.0,AAADcfB/OQAAAAAAAAAAAAAAAAAAAWAAAAAwYMAAAAAAAAAB1AAAHwAQCAAADRzhng4yyJPMEgCoAyXyXACCgCAlAiAI2CE4ZNgIMP7A1ZGEYYhntADIyUec/ObOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid","(3R,5R)-7-[4-[anilino(oxo)methyl]-2-(4-fluorophenyl)-3-phenyl-5-propan-2-yl-1-pyrrolyl]-3,5-dihydroxyheptanoic acid","(3<I>R</I>,5<I>R</I>)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid","(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid","(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-bis(oxidanyl)heptanoic acid","(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-enanthic acid","InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1",XUKUURHRXDUEBC-KAYWLYCHSA-N,,558.25300038,C33H35FN2O5,558.6,112.0,558.25300038,0.0,41.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,5.0,"11  15  8
14  15  8
18  25  8
18  26  8
16  2  5
21  27  8
21  28  8
25  29  8
26  30  8
27  31  8
28  32  8
29  33  8
22  3  5
30  33  8
31  36  8
32  36  8
34  37  8
34  38  8
37  39  8
38  40  8
39  41  8
40  41  8
7  11  8
7  9  8
9  14  8",
440790299,54841,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01139,Atomoxetine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01139,atomoxetine,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,54841,1.0,237.0,2.0,1.0,6.0,AAADceB6IAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAQAAAADBThmAYyBoLABACAAiBCAAACCAAgIAAIiIAOCIgMJiKEsRqGOCCm0BEIqAeQwKAOAAAAAAAIAAAAAAAAABAAAAAAAAAAAA==,(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine,(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-1-propanamine,(3<I>R</I>)-<I>N</I>-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine,(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine,(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine,methyl-[(3R)-3-(2-methylphenoxy)-3-phenyl-propyl]amine,"InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1",VHGCDTVCOLNTBX-QGZVFWFLSA-N,,255.162314293,C17H21NO,255.35,21.3,255.162314293,0.0,19.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CNCC[C@@H](Oc1ccccc1C)c1ccccc1,3.7,"3  1  5
10  16  8
11  14  8
12  14  8
13  18  8
16  19  8
18  19  8
5  8  8
5  9  8
7  10  8
7  13  8
8  11  8
9  12  8",
440790298,5460875,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01303,Asparaginase,20250421,20210312,Curation Efforts|Governmental Organizations,LT01303,asparaginase,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,5460875,1.0,128.0,4.0,2.0,2.0,AAADcYBjMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHgAQAAAACCjBgAQACABAAAAIAAGQGAAAAAAAAAAAAIGAAAACABgAwAAAAAAEEAAAAAAnAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2,4-diamino-4-oxo-butanoate","2,4-diamino-4-oxobutanoate","2,4-diamino-4-oxobutanoate","2,4-diamino-4-oxobutanoate","2,4-bis(azanyl)-4-oxidanylidene-butanoate","2,4-diamino-4-keto-butyrate","InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)/p-1",DCXYFEDJOCDNAF-UHFFFAOYSA-M,-2.8,131.04566709,C4H7N2O3-,131.11,109.0,131.04566709,-1.0,9.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)CC(N)C(=O)[O-],,6  4  3,
440790297,135401907,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00043,allopurinol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00043,allopurinol,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,135401907,1.0,190.0,3.0,2.0,0.0,AAADcYBjoAAAAAAAAAAAAAAAAAAAAWAAAAAgAAAAAAAAAEABgAAAHgAYAAAADADBmgQtsJLjAACqAhN3dACQBAOEgAAVMaEoRFAAAIgASEAEhIgACgAAAMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one","1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one","1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one","1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one","1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one","1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one","InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)",OFCNXPDARWKPPY-UHFFFAOYSA-N,,136.03851076,C5H4N4O,136.11,70.1,136.03851076,0.0,10.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=c1[nH]cnc2[nH]ncc12,-0.7,"2  5  8
2  7  8
3  10  8
3  8  8
4  10  8
4  7  8
5  9  8
6  7  8
6  8  8
6  9  8",
440790296,2082,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00499,albendazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT00499,albendazole,7.0,Warnings and precautions,vMost-DILI-Concern,2.0,2082,1.0,290.0,4.0,2.0,5.0,AAADccBzMABAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAFgB8AAAHgQQAAAACAiFVgKz2bbJlAioASRifACCgC2hGrAJmTgwdJmIaKLgmZGUIAxokQJoyCcQAAAAAAQAACAAACAACAAAQAAAQAAAAAAAAA==,methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate,N-[6-(propylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester,methyl <I>N</I>-(6-propylsulfanyl-1<I>H</I>-benzimidazol-2-yl)carbamate,methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate,methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate,N-[6-(propylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester,"InChI=1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)",HXHWSAZORRCQMX-UHFFFAOYSA-N,2.9,265.0884979,C12H15N3O2S,265.33,92.3,265.0884979,0.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,,"11  14  8
4  12  8
4  7  8
5  12  8
5  8  8
7  10  8
7  8  8
8  11  8
9  10  8
9  14  8",
440790295,1986,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00498,acetazolamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00498,acetazolamide,8.0,Warnings and precautions,vMost-DILI-Concern,2.0,1986,1.0,297.0,7.0,2.0,2.0,AAADcYBjsABgAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAABgAAAHgQYQAAAAACBgAADEALAAAouAAEQMHAYAQJAAAkFAAAAAACAAAAACAAAAAAQEQIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide","N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide","<I>N</I>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide","N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide","N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanamide",acetazolamide,"InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)",BZKPWHYZMXOIDC-UHFFFAOYSA-N,-0.3,221.98813241,C4H6N4O3S2,222.3,152.0,221.98813241,0.0,13.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)Nc1nnc(S(N)(=O)=O)s1,,"2  10  8
2  11  8
6  12  1
7  10  8
7  9  8
9  11  8",
440790294,1983,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00004,acetaminophen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00004,acetaminophen,5.0,Warnings and precautions,vMost-DILI-Concern,2.0,1983,1.0,139.0,2.0,2.0,1.0,AAADccByMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAACAyBkAAyxoLAAgCIACVSUACCAAAhIgAIiAAGbIgIJiLCkZOEcAhk1BHI2AewQAAAAEAAAAAAAAAAgAAAAAAAAAAAAAAAAA==,N-(4-hydroxyphenyl)acetamide,N-(4-hydroxyphenyl)acetamide,<I>N</I>-(4-hydroxyphenyl)acetamide,N-(4-hydroxyphenyl)acetamide,N-(4-hydroxyphenyl)ethanamide,N-(4-hydroxyphenyl)acetamide,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",RZVAJINKPMORJF-UHFFFAOYSA-N,0.5,151.06332853,C8H9NO2,151.16,49.3,151.06332853,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)Nc1ccc(O)cc1,,"4  5  8
4  6  8
5  7  8
6  8  8
7  9  8
8  9  8",
440790293,41774,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01034,acarbose,20210312,20210312,Curation Efforts|Governmental Organizations,LT01034,acarbose,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,41774,1.0,962.0,19.0,14.0,9.0,AAADcfB6PgAAAAAAAAAAAAAAAAAAAAAAAAAkSJEAAAAAAAAAAAAAHgAQCAAADDzxgAcCCALABgCAAiBCAACAAAAgAAAACIAIAAgTFAIAgQAnUAAH0ACfEAPw4CwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]tetrahydropyran-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-6-(hydroxymethyl)tetrahydropyran-2,3,4-triol","(3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol","(3<I>R</I>,4<I>R</I>,5<I>S</I>,6<I>R</I>)-5-[(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>S</I>,6<I>R</I>)-5-[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>R</I>)-3,4-dihydroxy-6-methyl-5-[[(1<I>S</I>,4<I>R</I>,5<I>S</I>,6<I>S</I>)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol","(3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol","(3R,4R,5S,6R)-6-(hydroxymethyl)-5-[(2R,3R,4R,5S,6R)-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-5-[[(1S,4R,5S,6S)-3-(hydroxymethyl)-4,5,6-tris(oxidanyl)cyclohex-2-en-1-yl]amino]-6-methyl-3,4-bis(oxidanyl)oxan-2-yl]oxy-3,4-bis(oxidanyl)oxan-2-yl]oxy-oxane-2,3,4-triol","(3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-methylol-cyclohex-2-en-1-yl]amino]tetrahydropyran-2-yl]oxy-3,4-dihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-6-methylol-tetrahydropyran-2,3,4-triol","InChI=1S/C25H43NO18/c1-6-11(26-8-2-7(3-27)12(30)15(33)13(8)31)14(32)19(37)24(40-6)43-22-10(5-29)42-25(20(38)17(22)35)44-21-9(4-28)41-23(39)18(36)16(21)34/h2,6,8-39H,3-5H2,1H3/t6-,8+,9-,10-,11-,12-,13+,14+,15+,16-,17-,18-,19-,20-,21-,22-,23?,24-,25-/m1/s1",XUFXOAAUWZOOIT-UGEKTDRHSA-N,,645.24801352,C25H43NO18,645.6,321.0,645.24801352,0.0,44.0,18.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)C(O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,-8.5,"22  1  6
25  1  5
31  10  5
33  11  6
34  12  5
38  13  5
41  15  6
42  16  3
20  19  5
28  19  5
23  35  6
27  39  5
36  43  5
30  4  6
32  4  6
21  5  6
24  6  5
26  7  5
29  9  6",
440790292,441300,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00040,abacavir,20231222,20210312,Curation Efforts|Governmental Organizations,LT00040,abacavir,8.0,Warnings and precautions,vMost-DILI-Concern,1.0,441300,1.0,414.0,6.0,3.0,4.0,AAADceBzoAAAAAAAAAAAAAAAGAAAAWIAAAAsAAAAAAAAAFgB+AAAHgAQCAAADSjhlwYF8L/MEgCgASZjZACAgC0xEKAJWKAoVBiAWAJAyUAURAgM0ALIACKgAAAMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol","[(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9-purinyl]-1-cyclopent-2-enyl]methanol","[(1<I>S</I>,4<I>R</I>)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol","[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol","[(1S,4R)-4-[2-azanyl-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol","[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol","InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1",MCGSCOLBFJQGHM-SCZZXKLOSA-N,,286.15420922,C14H18N6O,286.33,102.0,286.15420922,0.0,21.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1,0.9,"13  19  5
16  18  8
17  18  8
11  3  5
3  17  8
3  20  8
4  18  8
4  20  8
5  16  8
5  21  8
6  17  8
6  21  8",
440790291,4649,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00505,4-Aminosalicylic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT00505,4-aminosalicylic acid,5.0,Warnings and precautions,vMost-DILI-Concern,1.0,4649,1.0,160.0,4.0,3.0,1.0,AAADcYBiMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQCAAADAyBmAAwzoBAAgCIAiTSSACCAAAkIgAIiAEGbMgIJzaClZOAcUBn8BkI2YeY2SGeCAAAAgAIAAAQAAAEABAAAAAAAAAAAA==,4-amino-2-hydroxy-benzoic acid,4-amino-2-hydroxybenzoic acid,4-amino-2-hydroxybenzoic acid,4-amino-2-hydroxybenzoic acid,4-azanyl-2-oxidanyl-benzoic acid,4-amino-2-hydroxy-benzoic acid,"InChI=1S/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11)",WUBBRNOQWQTFEX-UHFFFAOYSA-N,1.3,153.042593085,C7H7NO3,153.14,83.6,153.042593085,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ccc(C(=O)O)c(O)c1,,"5  6  8
5  9  8
6  8  8
7  10  8
7  8  8
9  10  8",
440790290,54682461,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01220,Tipranavir,20231222,20210312,Curation Efforts|Governmental Organizations,LT01220,tipranavir,8.0,Box warning,vMost-DILI-Concern,1.0,54682461,1.0,1050.0,10.0,2.0,11.0,AAADcfB7OYBAAAAAAAAAAAAAAAAAAAAAAAA8YIEAAAAAAAAB0AAAHwQQSAAADUzB2hQ+yZJIFgKoAjT3THDK0DAxIiAI2Dk4ZNgIJPLAsZGGcAhl0ADI6QeYyOCOgAAAQAAAAAAAAACAAAAAAAAAAAAAAA==,N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide,<I>N</I>-[3-[(1<I>R</I>)-1-[(2<I>R</I>)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3<I>H</I>-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,N-[3-[(1R)-1-[(2R)-4-oxidanyl-6-oxidanylidene-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,N-[3-[(1R)-1-[(2R)-4-hydroxy-6-keto-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,"InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36-37H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1",SUJUHGSWHZTSEU-FYBSXPHGSA-N,,602.20622782,C31H33F3N2O5S,602.7,114.0,602.20622782,0.0,42.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,7.0,"11  37  8
11  41  8
12  14  6
19  22  6
23  27  8
23  28  8
24  29  8
24  30  8
27  31  8
28  32  8
29  34  8
30  35  8
31  33  8
32  33  8
34  36  8
35  36  8
37  38  8
38  39  8
39  40  8
40  41  8",
440790289,3002977,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00640,Maraviroc,20250421,20210312,Curation Efforts|Governmental Organizations,LT00640,maraviroc,3.0,Box warning,vMost-DILI-Concern,1.0,3002977,1.0,751.0,6.0,1.0,8.0,AAADcfB7oYAAAAAAAAAAAAAAAAAAAWLAAAA8YIAABgAAAAABwAAAHwAYAAAADSjBmxQzEIfMEACqAiNyNACSgAsgAKAdyIE4BIiIKDKA2RGEIAhgngKIiAcYiICOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexanecarboxamide","4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]-1-cyclohexanecarboxamide","4,4-difluoro-<I>N</I>-[(1<I>S</I>)-3-[(1<I>R</I>,5<I>S</I>)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide","4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide","4,4-bis(fluoranyl)-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexane-1-carboxamide","4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexanecarboxamide","InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1",GSNHKUDZZFZSJB-HLMSNRGBSA-N,,513.32791727,C29H41F2N5O,513.7,63.1,513.32791727,0.0,37.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,5.1,"10  39  6
23  33  8
23  34  8
33  35  8
34  36  8
35  37  8
36  37  8
5  18  8
5  20  8
6  18  8
6  8  8
19  7  6
8  20  8
9  38  5",
440790288,,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00477,Gemtuzumab ozogamicin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00477,gemtuzumab ozogamicin,8.0,Box warning,vMost-DILI-Concern,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
440790287,135449331,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00663,Eltrombopag olamine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00663,eltrombopag olamine,4.0,Box warning,vMost-DILI-Concern,1.0,135449331,1.0,822.0,11.0,7.0,7.0,AAADcfB7uAAAAAAAAAAAAAAAAAAAAQAAAAAwYMAAAAAAAAABUAAAHgAYCAAADAzhmAYyzoJiAgCKAiXSWACCBAAlIgAaqIGFbMgKdjLSlZOUcQhk1BHI2ceYyPCOiAACQAAYEAAQAASAADAgAAAAAAAAAA==,"2-aminoethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]azo]-2-hydroxy-phenyl]benzoic acid","2-aminoethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]azo]-2-hydroxyphenyl]benzoic acid","2-aminoethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1<I>H</I>-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid","2-aminoethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid","2-azanylethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxidanylidene-1H-pyrazol-4-yl]diazenyl]-2-oxidanyl-phenyl]benzoic acid","2-aminoethanol;3-[3-[[1-(3,4-dimethylphenyl)-5-keto-3-methyl-3-pyrazolin-4-yl]azo]-2-hydroxy-phenyl]benzoic acid","InChI=1S/C25H22N4O4.2C2H7NO/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33;2*3-1-2-4/h4-13,28,30H,1-3H3,(H,32,33);2*4H,1-3H2",DJMJHIKGMVJYCW-UHFFFAOYSA-N,,564.26963289,C29H36N6O6,564.6,207.0,564.26963289,0.0,41.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",Cc1ccc(-n2[nH]c(C)c(/N=N/c3cccc(-c4cccc(C(=O)O)c4)c3O)c2=O)cc1C.NCCO.NCCO,,"13  16  8
13  20  8
14  18  8
15  16  8
15  19  8
17  18  8
19  21  8
20  21  8
25  28  8
25  29  8
26  31  8
26  33  8
27  28  8
27  30  8
29  32  8
30  32  8
31  34  8
33  35  8
34  36  8
35  36  8
7  17  8
7  8  8
8  14  8",
440790286,23663956,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00684,DIVALPROEX SODIUM,20231222,20210312,Curation Efforts|Governmental Organizations,LT00684,divalproex sodium,8.0,Box warning,vMost-DILI-Concern,2.0,23663956,1.0,192.0,4.0,1.0,10.0,AAADceB4OCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgAACAAADQCAgAACCAAAAgAIAACQCAAAAAAAAAAAAAEAAAAAABIAAAAAQAAEAAAAAAGIgAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,sodium;2-propylpentanoate;2-propylpentanoic acid,sodium;2-propylpentanoate;2-propylpentanoic acid,sodium;2-propylpentanoate;2-propylpentanoic acid,sodium;2-propylpentanoate;2-propylpentanoic acid,sodium;2-propylpentanoate;2-propylpentanoic acid,sodium;2-propylvalerate;2-propylvaleric acid,"InChI=1S/2C8H16O2.Na/c2*1-3-5-7(6-4-2)8(9)10;/h2*7H,3-6H2,1-2H3,(H,9,10);/q;;+1/p-1",MSRILKIQRXUYCT-UHFFFAOYSA-M,,310.21200375,C16H31NaO4,310.4,77.4,310.21200375,0.0,21.0,0.0,0.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+],,,1  2  7
440790285,35370,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00163,zidovudine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00163,zidovudine,8.0,Box warning,vMost-DILI-Concern,1.0,35370,1.0,484.0,6.0,2.0,3.0,AAADccBzuAAAAAAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAAAAAAAHgAYCAAADDzhgAYDAAPABgCKAgFWUACAAAAAAAAAAAEIAECDEAIAwQAPQAAOByIDAMCwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione","1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)-2-oxolanyl]-5-methylpyrimidine-2,4-dione","1-[(2<I>R</I>,4<I>S</I>,5<I>S</I>)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione","1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione","1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione","1-[(2R,4S,5S)-4-azido-5-methylol-tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-quinone","InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1",HBOMLICNUCNMMY-XLPZGREQSA-N,0.0,267.09675391,C10H13N5O4,267.24,93.2,267.09675391,0.0,19.0,3.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,,"13  14  6
15  17  8
17  18  8
11  5  6
5  15  8
5  16  8
10  6  5
7  16  8
7  18  8",
440790284,3121,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00160,VALPROIC ACID,20231222,20210312,Curation Efforts|Governmental Organizations,LT00160,valproic acid,8.0,Box warning,vMost-DILI-Concern,1.0,3121,1.0,93.4,2.0,1.0,5.0,AAADceBwMAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGgAACAAADQCAgAACCAAAAgAIAACQCAAAAAAAAAAAAAEAAAAAABIAAAAAQAAEAAAAAAGIgAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-propylpentanoic acid,2-propylpentanoic acid,2-propylpentanoic acid,2-propylpentanoic acid,2-propylpentanoic acid,2-propylvaleric acid,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",NIJJYAXOARWZEE-UHFFFAOYSA-N,2.8,144.115029749,C8H16O2,144.21,37.3,144.115029749,0.0,10.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCC(CCC)C(=O)O,,,
440790283,4659569,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00156,Tolcapone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00156,tolcapone,8.0,Box warning,vMost-DILI-Concern,1.0,4659569,1.0,372.0,5.0,2.0,2.0,AAADccByOAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgAECAAADAyBmAAyxoAQQgCJAqRSQwCCAAAkIgAoiAEH7MoLJjKSlZOAcQFmwFkJ2Yee3PHOYAABQgAAUADAAAKEAACgAAAAAAAAAA==,"(3,4-dihydroxy-5-nitro-phenyl)-(p-tolyl)methanone","(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone","(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone","(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone","(4-methylphenyl)-[3-nitro-4,5-bis(oxidanyl)phenyl]methanone","(3,4-dihydroxy-5-nitro-phenyl)-(p-tolyl)methanone","InChI=1S/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7,16,18H,1H3",MIQPIUSUKVNLNT-UHFFFAOYSA-N,,273.06372245,C14H11NO5,273.24,103.0,273.06372245,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,3.3,"10  12  8
11  13  8
12  17  8
13  17  8
14  18  8
14  19  8
15  18  8
16  19  8
7  10  8
7  11  8
8  15  8
8  16  8",
440790282,5329102,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00565,Sunitinib,20231222,20210312,Curation Efforts|Governmental Organizations,LT00565,sunitinib,8.0,Box warning,vMost-DILI-Concern,1.0,5329102,1.0,636.0,4.0,3.0,7.0,AAADceB7sQAAAAAAAAAAAAAAAAAAAWLAAAAwAAAAAAAAAFgBwAAAHwAQAAAADAjBngwywJPJkACoAyVyVACCgCAlAiAImaE4ZNgIYHrA1ZGUIYhglgDIyccciICOgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,"N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide","N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide","<I>N</I>-[2-(diethylamino)ethyl]-5-[(<I>Z</I>)-(5-fluoro-2-oxo-1<I>H</I>-indol-3-ylidene)methyl]-2,4-dimethyl-1<I>H</I>-pyrrole-3-carboxamide","N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide","N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoranyl-2-oxidanylidene-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide","N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-keto-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide","InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-",WINHZLLDWRZWRT-ATVHPVEESA-N,,398.21180428,C22H27FN4O2,398.5,77.2,398.21180428,0.0,29.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,2.6,"10  11  8
19  21  8
19  26  8
21  27  8
26  28  8
27  29  8
28  29  8
5  11  8
5  13  8
9  10  8
9  13  8",
440790281,18283,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00144,stavudine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00144,stavudine,8.0,Box warning,vMost-DILI-Concern,1.0,18283,1.0,388.0,4.0,2.0,2.0,AAADccBzOAAAAAAAAAAAAAAAAAAAAQAAAAAgAAAAAAAAAAAAAAAAHgAQCAAADBThgAYDAAPABgCIAiFWUACAAAAgAAAICAEIAEiBFAAAIQAOUAAIRyILIMIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione","1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione","1-[(2<I>R</I>,5<I>S</I>)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione","1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione","1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione","5-methyl-1-[(2R,5S)-5-methylol-2,5-dihydrofuran-2-yl]pyrimidine-2,4-quinone","InChI=1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)/t7-,8+/m0/s1",XNKLLVCARDGLGL-JGVFFNPUSA-N,-0.8,224.07970687,C10H12N2O4,224.21,78.9,224.07970687,0.0,16.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,,"12  14  8
14  15  8
5  12  8
5  13  8
7  5  6
6  13  8
6  15  8
8  11  6",
440790280,657298,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00136,propylthiouracil,20210312,20210312,Curation Efforts|Governmental Organizations,LT00136,propylthiouracil,8.0,Box warning,vMost-DILI-Concern,1.0,657298,1.0,222.0,2.0,2.0,2.0,AAADccBjIABAAAAAAAAAAAAAAAAAAAAAAAAgAAAAAAAAAAAAAAAAHgQQAAAACAiBgAADAALAAACMACVSUACAAAAgAgkACAAAAEiAAAAAgQAEAAAIkQIIAUIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,6-propyl-2-thioxo-1H-pyrimidin-4-one,6-propyl-2-sulfanylidene-1H-pyrimidin-4-one,6-propyl-2-sulfanylidene-1<I>H</I>-pyrimidin-4-one,6-propyl-2-sulfanylidene-1H-pyrimidin-4-one,6-propyl-2-sulfanylidene-1H-pyrimidin-4-one,6-propyl-2-thioxo-1H-pyrimidin-4-one,"InChI=1S/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11)",KNAHARQHSZJURB-UHFFFAOYSA-N,,170.05138412,C7H10N2OS,170.23,73.2,170.05138412,0.0,11.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCc1cc(=O)[nH]c(=S)[nH]1,0.8,"3  10  8
3  6  8
4  10  8
4  11  8
6  8  8
8  11  8",
440790279,439693,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01651,pentostatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01651,pentostatin,3.0,Box warning,vMost-DILI-Concern,2.0,439693,1.0,356.0,6.0,4.0,2.0,AAADceBzuAAAAAAAAAAAAAAAAAAAAWJAAAAAAAAABAAAAACBgAAAHgAQCAAACBzhlgYFsBfMFgCgAQZhZAQAgC0xEKABUIA4WAiDfAJAyAEeQAAPAALTUCCwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol","(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol","(8<I>R</I>)-3-[(2<I>R</I>,4<I>S</I>,5<I>R</I>)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4<I>H</I>-imidazo[4,5-d][1,3]diazepin-8-ol","(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol","(8R)-3-[(2R,4S,5R)-5-(hydroxymethyl)-4-oxidanyl-oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol","(8R)-3-[(2R,4S,5R)-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol","InChI=1S/C11H16N4O4/c16-3-8-6(17)1-9(19-8)15-5-14-10-7(18)2-12-4-13-11(10)15/h4-9,16-18H,1-3H2,(H,12,13)/t6-,7+,8+,9+/m0/s1",FPVKHBSQESCIEP-JQCXWYLXSA-N,-2.1,268.117155,C11H16N4O4,268.27,112.0,268.117155,0.0,19.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",OC[C@H]1O[C@@H](n2cnc3c2NC=NC[C@H]3O)C[C@@H]1O,,"12  13  5
14  15  8
11  2  6
17  4  5
5  14  8
5  16  8
9  5  5
6  15  8
6  16  8",
440790278,10113978,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00672,Pazopanib,20231222,20210312,Curation Efforts|Governmental Organizations,LT00672,pazopanib,8.0,Box warning,vMost-DILI-Concern,1.0,10113978,1.0,717.0,8.0,2.0,5.0,AAADceB7sABAAAAAAAAAAAAAAAAAAWAAAAA8YIAAAAAAAFgB/AAAHAQYQAAADAjBXgQ/8ffIEAKiAzZnZHDShDkxgqAZ2Dg4ZJiIKOLA2dGEpAxomALIyCcQgIAOCAAAACQGAAAQAAAASAwAAAAAAAAAAA==,"5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide","5-[[4-[(2,3-dimethyl-6-indazolyl)-methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide","5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide","5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide","5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide","5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide","InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)",CUIHSIWYWATEQL-UHFFFAOYSA-N,,437.16339418,C21H23N7O2S,437.5,127.0,437.16339418,0.0,31.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,3.1,"11  12  8
11  13  8
11  16  8
12  15  8
14  15  8
14  17  8
16  17  8
19  29  8
20  22  8
20  25  8
22  26  8
23  25  8
23  27  8
26  27  8
29  31  8
4  13  8
4  6  8
6  12  8
8  19  8
8  28  8
9  28  8
9  31  8",
440790277,5281034,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00235,oxymetholone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00235,oxymetholone,7.0,Box warning,vMost-DILI-Concern,1.0,5281034,1.0,596.0,3.0,2.0,0.0,AAADcfB4MAAAAAAAAAAAAAAAAAAAAYAAAAAwYMAAAAAAAGDAAAAAGgAACAAAD0SggAICAAAAAgCIAoBSAAAAAAAgIAAAAAEAAEgAEBIAAQAAQAAEgAAAAIGIyPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"(2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylidene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(2<I>Z</I>,5<I>S</I>,8<I>R</I>,9<I>S</I>,10<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-17-hydroxy-2-(hydroxymethylidene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylidene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(2Z,5S,8R,9S,10S,13S,14S,17S)-10,13,17-trimethyl-17-oxidanyl-2-(oxidanylmethylidene)-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","(2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","InChI=1S/C21H32O3/c1-19-11-13(12-22)18(23)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,22,24H,4-11H2,1-3H3/b13-12-/t14-,15+,16-,17-,19-,20-,21-/m0/s1",ICMWWNHDUZJFDW-DHODBPELSA-N,,332.23514488,C21H32O3,332.5,57.5,332.23514488,0.0,24.0,7.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,4.4,"9  1  5
12  32  6
4  25  6
5  17  5
6  26  5
7  27  6
8  19  5",
440790276,5878,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00845,OXANDROLONE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00845,oxandrolone,8.0,Box warning,vMost-DILI-Concern,1.0,5878,1.0,503.0,3.0,1.0,0.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAYAAAAA0YIAAAAAAAGDQAAAAGgAACAAAD0SggAICCAAABgAIAACQCAAAAAAAAAAAAAEAAAAAABIAAAACQAAEAAAAAAGIzPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one","(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h][2]benzopyran-7-one","(1<I>S</I>,3<I>a</I><I>S</I>,3<I>b</I><I>R</I>,5<I>a</I><I>S</I>,9<I>a</I><I>S</I>,9<I>b</I><I>S</I>,11<I>a</I><I>S</I>)-1-hydroxy-1,9<I>a</I>,11<I>a</I>-trimethyl-2,3,3<I>a</I>,3<I>b</I>,4,5,5<I>a</I>,6,9,9<I>b</I>,10,11-dodecahydroindeno[4,5-h]isochromen-7-one","(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one","(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1,9a,11a-trimethyl-1-oxidanyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one","(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroinden[4,5-h]isochromen-7-one","InChI=1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3/t12-,13+,14-,15-,17-,18-,19-/m0/s1",QSLJIVKCVHQPLV-PEMPUTJUSA-N,,306.21949481,C19H30O3,306.4,46.5,306.21949481,0.0,22.0,7.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,3.7,"9  1  5
13  32  6
4  23  6
5  17  5
6  24  5
7  25  6
8  19  5",
440790275,4463,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00260,nevirapine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00260,nevirapine,8.0,Box warning,vMost-DILI-Concern,1.0,4463,1.0,397.0,4.0,1.0,1.0,AAADccBzoAAAAAAAAAAAAAAAGAAAAAAAAAAsWAAABYAAAAAB4AAAHgAQAAAADCjBmgQ/8JPIEACoAjd3dACCgCk1EiAJ2CE4dNiIYPrA3ZGUIYhohALIyeYYAQAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one","2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one","2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.0<SUP>3,8</SUP>]pentadeca-1(11),3,5,7,12,14-hexaen-10-one","2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one","2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one","2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one","InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",NQDJXKOVJZTUJA-UHFFFAOYSA-N,,266.11676108,C15H14N4O,266.3,58.1,266.11676108,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,2.0,"10  12  8
11  13  8
12  15  8
13  16  8
15  20  8
16  17  8
18  20  8
4  17  8
4  9  8
5  10  8
5  18  8
9  11  8",
440790274,4449,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00124,nefazodone,20250421,20210312,Curation Efforts|Governmental Organizations,LT00124,nefazodone,8.0,Box warning,vMost-DILI-Concern,1.0,4449,1.0,649.0,5.0,0.0,10.0,AAADcfB7sAAEAAAAAAAAAAAAAAAAAQAAAAA8YIAAAAAAAAABQAAAHgIIAAAACA7hkCYzxoMABACoACZicACSCAAhJwAfiAA+boiOZiLF+5uXOCjszhPY6AeQQAAAAAAAAAIAAAAAAAAABAAAAAAAAAAAAA==,"2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one","2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one","2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one","2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one","2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one","2-[3-[4-(3-chlorophenyl)piperazino]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one","InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3",VRBKIVRKKCLPHA-UHFFFAOYSA-N,,469.224453,C25H32ClN5O2,470.0,51.6,469.224453,0.0,33.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,4.3,"16  19  8
16  20  8
19  23  8
20  24  8
23  26  8
24  26  8
28  29  8
28  30  8
29  31  8
30  32  8
31  33  8
32  33  8
6  17  8
6  8  8
7  17  8
7  18  8
8  18  8",
440790273,4178,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01553,Mexiletine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01553,mexiletine,3.0,Box warning,vMost-DILI-Concern,1.0,4178,1.0,139.0,2.0,1.0,3.0,AAADceByIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQAAAADCzhmAYyBoBABACAAiBCAAACCAAgIAAIiIAECIgOJiKEMRqDOCCk0BEIqAeAwGAOAAACAAAIAAAAAAQAABAAAAAAAAAAAA==,"1-(2,6-dimethylphenoxy)propan-2-amine","1-(2,6-dimethylphenoxy)-2-propanamine","1-(2,6-dimethylphenoxy)propan-2-amine","1-(2,6-dimethylphenoxy)propan-2-amine","1-(2,6-dimethylphenoxy)propan-2-amine","[2-(2,6-dimethylphenoxy)-1-methyl-ethyl]amine","InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3",VLPIATFUUWWMKC-UHFFFAOYSA-N,2.1,179.131014166,C11H17NO,179.26,35.3,179.131014166,0.0,13.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cccc(C)c1OCC(C)N,,"10  11  8
3  14  3
5  6  8
5  7  8
6  9  8
7  10  8
9  11  8",
440790272,126941,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00026,methotrexate,20231222,20210312,Curation Efforts|Governmental Organizations,LT00026,methotrexate,3.0,Box warning,vMost-DILI-Concern,1.0,126941,1.0,704.0,12.0,5.0,9.0,AAADceB7+AAAAAAAAAAAAAAAAAAAAAAAAAA8WIAAAAAAAACx/AAAHgAQCAAADCjBnwQ/+L/IEgCoAzf3fACCgC01EqAJ2KG4dNiKaHLA3fGUZQhslgLYyae8rwCeCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid","(2S)-2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid","(2<I>S</I>)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid","(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid","(2S)-2-[[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-methyl-amino]phenyl]carbonylamino]pentanedioic acid","(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]glutaric acid","InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1",FBOZXECLQNJBKD-ZDUSSCGKSA-N,-1.8,454.17131583,C20H22N8O5,454.4,211.0,454.17131583,0.0,33.0,1.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,,"10  31  8
10  33  8
11  32  8
11  33  8
16  21  8
16  22  8
19  24  8
19  25  8
21  24  8
22  25  8
26  29  8
30  31  8
30  32  8
14  7  6
8  26  8
8  30  8
9  29  8
9  31  8",
440790271,3899,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00113,leflunomide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00113,leflunomide,8.0,Box warning,vMost-DILI-Concern,1.0,3899,1.0,327.0,6.0,1.0,2.0,AAADccBzMYAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHwAUAAAADAzBmhQ+xJLQAACpArV3UgCCAAAlIgAomCEkbNoIJD7I0ZGEIchitAjIyccQgAAOCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide,5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide,"5-methyl-<I>N</I>-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide","5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide","5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide",5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide,"InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)",VHOGYURTWQBHIL-UHFFFAOYSA-N,,270.06161202,C12H9F3N2O2,270.21,55.1,270.06161202,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,2.5,"10  16  8
10  18  8
11  13  8
12  14  8
4  16  8
4  7  8
7  18  8
8  11  8
8  12  8
9  13  8
9  14  8",
440790270,208908,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02204,Lapatinib,20231222,20210312,Curation Efforts|Governmental Organizations,LT02204,lapatinib,8.0,Box warning,vMost-DILI-Concern,1.0,208908,1.0,898.0,9.0,2.0,11.0,AAADceB7uQBEAAAAAAAAAAAAAAAAASAAAAA8YMEAAAAAAACx/AAAHwYQAAAADA7l3i639vbIFEqoA6ZzZHDCiCk1J/AJ2KG+b9iOLvPF//uHPSjs0BPY6ae42fOeCEACAAICCAAQgAQABAQQAAAAAAAAAA==,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furanyl]-4-quinazolinamine,<I>N</I>-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine,N-[3-chloranyl-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine,[5-[4-[3-chloro-4-(3-fluorobenzyl)oxy-anilino]quinazolin-6-yl]-2-furyl]methyl-(2-mesylethyl)amine,"InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)",BCFGMOOMADDAQU-UHFFFAOYSA-N,,580.1347324,C29H26ClFN4O4S,581.1,115.0,580.1347324,0.0,40.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,5.1,"10  22  8
10  28  8
11  24  8
11  28  8
15  20  8
16  19  8
16  23  8
17  21  8
18  19  8
18  22  8
18  24  8
20  21  8
22  26  8
23  26  8
27  29  8
27  30  8
29  32  8
30  33  8
31  32  8
31  33  8
35  36  8
35  37  8
36  38  8
37  39  8
38  40  8
39  40  8
4  15  8
4  17  8",
440790269,3823,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00111,ketoconazole,20231222,20210312,Curation Efforts|Governmental Organizations,LT00111,ketoconazole,8.0,Box warning,vMost-DILI-Concern,1.0,3823,1.0,735.0,6.0,0.0,7.0,AAADceB7uAAGAAAAAAAAAAAAAAAAAWJAAAA8YIAAAAAAAAAB0AAAHgIAAAAADB7hmiY/3pcMFACoAjV3dACCiC0xN6AJyAAefoifbiLFu5u3OCjtxhPe6CewwKAOBEAAAACBAAAIgAAAAQIAAAAAAAAAAA==,"1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone","1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1-imidazolylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]ethanone","1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone","1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone","1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone","1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazino]ethanone","InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3",XMAYWYJOQHXEEK-UHFFFAOYSA-N,4.3,530.1487608,C26H28Cl2N4O4,531.4,69.1,530.1487608,0.0,36.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,,"10  29  8
10  35  8
11  14  3
12  37  3
15  22  8
15  23  8
21  26  8
21  27  8
22  32  8
23  33  8
24  30  8
24  31  8
26  30  8
27  31  8
28  35  8
32  34  8
33  34  8
9  28  8
9  29  8",
440790268,3767,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00306,isoniazid,20250421,20210312,Curation Efforts|Governmental Organizations,LT00306,isoniazid,8.0,Box warning,vMost-DILI-Concern,1.0,3767,1.0,120.0,3.0,2.0,1.0,AAADcYBjIAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAHgAYAAAADADBmgQ8gJJqEACoAjF3VACCgCA1AiIa+CE4ZNgIIHLAlZGEIQhggADIyYYUAAAKAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,pyridine-4-carbohydrazide,4-pyridinecarbohydrazide,pyridine-4-carbohydrazide,pyridine-4-carbohydrazide,pyridine-4-carbohydrazide,isonicotinohydrazide,"InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)",QRXWMOHMRWLFEY-UHFFFAOYSA-N,-0.7,137.058911855,C6H7N3O,137.14,68.0,137.058911855,0.0,10.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NNC(=O)c1ccncc1,,"3  10  8
3  9  8
5  6  8
5  7  8
6  9  8
7  10  8",
440790267,3397,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00101,flutamide,20210312,20210312,Curation Efforts|Governmental Organizations,LT00101,flutamide,8.0,Box warning,vMost-DILI-Concern,1.0,3397,1.0,352.0,6.0,1.0,2.0,AAADccBzMYAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHwAUAAAADQiBmBAywILQQACJAiVSUwCCAAAhAgAoiAEAZIoIICLAkZGEIAhglADIyAcQgAAOAACAQAACAAAAAQCAAAQAAAAAAAAAAA==,2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,2-methyl-<I>N</I>-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide,"InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)",MKXKFYHWDHIYRV-UHFFFAOYSA-N,3.3,276.0721767,C11H11F3N2O3,276.21,74.9,276.0721767,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,,"10  13  8
10  17  8
12  13  8
12  16  8
16  18  8
17  18  8",
440790266,3331,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00097,felbamate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00097,felbamate,7.0,Box warning,vMost-DILI-Concern,1.0,3331,1.0,246.0,4.0,2.0,7.0,AAADccBzOAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAQAAAADQCgmAIwCIBABACIAiBCGAACAAAgAAAIiAAAAIkIICKAERCIIAAlwAEIiAeAwOAOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(3-carbamoyloxy-2-phenyl-propyl) carbamate,carbamic acid (3-carbamoyloxy-2-phenylpropyl) ester,(3-carbamoyloxy-2-phenylpropyl) carbamate,(3-carbamoyloxy-2-phenylpropyl) carbamate,(3-aminocarbonyloxy-2-phenyl-propyl) carbamate,carbamic acid (3-carbamoyloxy-2-phenyl-propyl) ester,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)",WKGXYQFOCVYPAC-UHFFFAOYSA-N,,238.09535693,C11H14N2O4,238.24,105.0,238.09535693,0.0,17.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)OCC(COC(N)=O)c1ccccc1,0.6,"11  13  8
12  14  8
13  15  8
14  15  8
8  11  8
8  12  8",
440790265,214348,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00563,Deferasirox,20210312,20210312,Curation Efforts|Governmental Organizations,LT00563,deferasirox,7.0,Box warning,vMost-DILI-Concern,1.0,214348,1.0,540.0,6.0,3.0,4.0,AAADccB7OAAAAAAAAAAAAAAAAAAAAWAAAAAwYMAAAAAAAAAB1AAAHgAICAAADAyBmwAx3oYIEgCqAibybACShCslIqAdiCEmbNiILrLCnZOEcQhuyBPI2aeY2SOeCAAAAAAIAAAQAAAAABAAAAAAAAAAAA==,"4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid","4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid","4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid","4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid","4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid","4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid","InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)",BOFQWVMAQOTZIW-UHFFFAOYSA-N,,373.10625597,C21H15N3O4,373.4,108.0,373.10625597,0.0,28.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1,3.8,"10  15  8
10  16  8
12  17  8
12  21  8
13  18  8
14  19  8
15  22  8
16  23  8
17  25  8
18  20  8
19  20  8
21  26  8
22  24  8
23  24  8
25  27  8
26  27  8
5  6  8
5  8  8
6  11  8
7  11  8
7  8  8
9  13  8
9  14  8",
440790264,6914273,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00080,dantrolene,20250421,20210312,Curation Efforts|Governmental Organizations,LT00080,dantrolene,8.0,Box warning,vMost-DILI-Concern,1.0,6914273,1.0,524.0,6.0,1.0,3.0,AAADccBzuAAAAAAAAAAAAAAAAAAAAWJAAAAwAAAAAAAAAAABwAAAHgAcAAAADAzBmAQxxILQRECpArVzUwSSCAAkIgA+iAGubNqMZrKEtbuSOSD83zMI6YeY2fGeCAAAAAAAAAAQAAAAAAAAAAAAAAAAAA==,"1-[(E)-[5-(4-nitrophenyl)-2-furyl]methyleneamino]imidazolidine-2,4-dione","1-[(E)-[5-(4-nitrophenyl)-2-furanyl]methylideneamino]imidazolidine-2,4-dione","1-[(<I>E</I>)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione","1-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione","1-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione",1-[(E)-[5-(4-nitrophenyl)-2-furyl]methyleneamino]hydantoin,"InChI=1S/C14H10N4O5/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22/h1-7H,8H2,(H,16,19,20)/b15-7+",OZOMQRBLCMDCEG-VIZOYTHASA-N,1.7,314.06511943,C14H10N4O5,314.25,121.0,314.06511943,0.0,23.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,,"1  11  8
1  13  8
11  16  8
12  18  8
12  19  8
13  17  8
16  17  8
18  22  8
19  23  8
21  22  8
21  23  8",
440790263,28417,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00539,danazol,20210312,20210312,Curation Efforts|Governmental Organizations,LT00539,danazol,8.0,Box warning,vMost-DILI-Concern,1.0,28417,1.0,677.0,3.0,1.0,1.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAeIAAAAwYIAAAAAAAGDBgAAAHgAECAAAD0TBmgQuhJAQAgDpGrB3QgiCAAAkIAAgmCEkTFoIJBqAkYKAUIBmgAgIyceYyPCPgAAAAAAAAACAAAQAACAAAYAADAAAAA==,"(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol","(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]eicosa-4(8),5,9-trien-17-ol","(1<I>S</I>,2<I>R</I>,13<I>R</I>,14<I>S</I>,17<I>R</I>,18<I>S</I>)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.0<SUP>2,10</SUP>.0<SUP>4,8</SUP>.0<SUP>14,18</SUP>]icosa-4(8),5,9-trien-17-ol","(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol","(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol","(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]eicosa-4(8),5,9-trien-17-ol","InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1",POZRVZJJTULAOH-LHZXLZLDSA-N,,337.204179104,C22H27NO2,337.5,46.3,337.204179104,0.0,25.0,6.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,3.8,"10  1  6
2  23  8
2  3  8
22  23  8
22  24  8
3  24  8
4  26  5
5  16  6
6  27  6
7  28  5
8  19  6",
440790262,2942,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00288,dacarbazine,20250421,20210312,Curation Efforts|Governmental Organizations,LT00288,dacarbazine,6.0,Box warning,vMost-DILI-Concern,1.0,2942,1.0,215.0,5.0,2.0,3.0,AAADccBjoAAAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAABgAAAHgAYAAAACAgBlgQHsBbJkACqAQdxdACAgC2XEKABUYGoVECASAhASCAUAIAIAAJAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,4-(dimethylaminoazo)-1H-imidazole-5-carboxamide,4-(dimethylaminoazo)-1H-imidazole-5-carboxamide,4-(dimethylaminodiazenyl)-1<I>H</I>-imidazole-5-carboxamide,4-(dimethylaminodiazenyl)-1H-imidazole-5-carboxamide,4-(dimethylaminodiazenyl)-1H-imidazole-5-carboxamide,4-(dimethylaminoazo)-1H-imidazole-5-carboxamide,"InChI=1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9)",FDKXTQMXEQVLRF-UHFFFAOYSA-N,-0.6,182.09160896,C6H10N6O,182.18,99.7,182.09160896,0.0,13.0,0.0,0.0,0.0,1.0,0.0,1.0,-1.0,"1
5
255",CN(C)N=Nc1nc[nH]c1C(N)=O,,"2  10  8
2  8  8
4  10  8
4  9  8
5  6  1
8  9  8",
440790261,6253,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00209,cytarabine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00209,cytarabine,3.0,Box warning,vMost-DILI-Concern,1.0,6253,1.0,383.0,5.0,4.0,2.0,AAADccBzOAAAAAAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAAAAAAAHgAQCAAACBThgAYBAANABgCoACJmdACAAAEAAgAIAAAYABCDEAIAgAAOQAAHFgITAADwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one","4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-2-pyrimidinone","4-amino-1-[(2<I>R</I>,3<I>S</I>,4<I>S</I>,5<I>R</I>)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one","4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one","4-azanyl-1-[(2R,3S,4S,5R)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]pyrimidin-2-one","4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidin-2-one","InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1",UHDGCWIWMRVCDJ-CCXZUQQUSA-N,-2.1,243.08552052,C9H13N3O5,243.22,129.0,243.08552052,0.0,17.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,,"12  13  6
14  16  8
16  17  8
9  2  6
10  3  5
11  6  6
6  14  8
6  15  8
7  15  8
7  17  8",
440790260,104865,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01140,Bosentan,20231222,20210312,Curation Efforts|Governmental Organizations,LT01140,bosentan,7.0,Box warning,vMost-DILI-Concern,1.0,104865,1.0,839.0,11.0,2.0,11.0,AAADceB7uABAAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAAAB9AAAHgQQSAAADgTh2wY/t5ZIFgKgAjJnZHTCiDkxYqAJ2Dg/7JiPfqLEeVqfPCquwBvbqCeAwMAPkAAAAAAAQAAgAAAAAACAAAAAAAAAAA==,4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide,4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide,4-<I>tert</I>-butyl-<I>N</I>-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide,4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide,4-tert-butyl-N-[6-(2-hydroxyethyloxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide,4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidyl)pyrimidin-4-yl]benzenesulfonamide,"InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)",GJPICJJJRGTNOD-UHFFFAOYSA-N,,551.18385484,C27H29N5O6S,551.6,154.0,551.18385484,0.0,39.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,3.8,"10  25  8
10  26  8
11  28  8
11  36  8
12  28  8
12  37  8
14  18  8
14  19  8
18  21  8
19  22  8
20  21  8
20  22  8
23  24  8
24  25  8
27  30  8
27  31  8
30  32  8
31  34  8
32  35  8
34  35  8
36  38  8
37  38  8
9  23  8
9  26  8",
440790259,2157,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00046,amiodarone,20210312,20210312,Curation Efforts|Governmental Organizations,LT00046,amiodarone,8.0,Box warning,vMost-DILI-Concern,1.0,2157,1.0,547.0,4.0,0.0,11.0,AAADceB6MAAAAwAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAEgB9AAAHgAgAAAADATjmAYyBsMABECIAqBSAAACCAAkIAAIiAEOCMgOJjaMNRqDOWCk4BGYqYeLzPDOoAAAAAAIAABAAAAAABAAAAAAAAAAAA==,"(2-butylbenzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]methanone","(2-butyl-3-benzofuranyl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone","(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone","(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone","(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-bis(iodanyl)phenyl]methanone","(2-butylbenzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]methanone","InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3",IYIKLHRQXLHMJQ-UHFFFAOYSA-N,7.6,645.02369,C25H29I2NO3,645.3,42.7,645.02369,0.0,31.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,,"11  12  8
11  19  8
12  21  8
19  26  8
20  28  8
20  29  8
21  27  8
25  30  8
25  31  8
26  27  8
28  30  8
29  31  8
3  12  8
3  8  8
8  9  8
9  11  8",
440790258,5284513,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01042,Acitretin,20210312,20210312,Curation Efforts|Governmental Organizations,LT01042,acitretin,5.0,Box warning,vMost-DILI-Concern,1.0,5284513,1.0,539.0,3.0,1.0,6.0,AAADceB4MAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgAACAAADASAmAIyDoAABgCIAiDSCAACCAAgIAAIiAAGCMgMJiKEMRqAMCAkwBEIuQeAwPAO4AADAAAYAADAAAYAADAAAAAAAAAAAA==,"(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid","(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid","(2<I>E</I>,4<I>E</I>,6<I>E</I>,8<I>E</I>)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid","(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid","(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid","(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid","InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+",IHUNBGSDBOWDMA-AQFIFDHZSA-N,,326.18819469,C21H26O3,326.4,46.5,326.18819469,0.0,24.0,0.0,0.0,4.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C,6.1,"4  5  8
4  6  8
5  7  8
6  8  8
7  9  8
8  9  8",
440790257,60919,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00687,TASOSARTAN,20210312,20210312,Curation Efforts|Governmental Organizations,LT00687,tasosartan,8.0,Discontinued,vMost-DILI-Concern,1.0,60919,1.0,625.0,6.0,1.0,4.0,AAADceB7oAAAAAAAAAAAAAAAAAAAAWAAAAA8eIEAAAAAAACx9AAAHgAYAAAADAjBnwQzsJcKEACqAydydACCgCshAKAduCE4RJiIKLLA2dGEJAhohwLIyCcYicAewAAAAAAQAACAAAAAACAAAAAAAAAAAA==,"2,4-dimethyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[2,3-d]pyrimidin-7-one","2,4-dimethyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[2,3-d]pyrimidin-7-one","2,4-dimethyl-8-[[4-[2-(2<I>H</I>-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[2,3-d]pyrimidin-7-one","2,4-dimethyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[2,3-d]pyrimidin-7-one","2,4-dimethyl-8-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[2,3-d]pyrimidin-7-one","2,4-dimethyl-8-[4-[2-(2H-tetrazol-5-yl)phenyl]benzyl]-5,6-dihydropyrido[2,3-d]pyrimidin-7-one","InChI=1S/C23H21N7O/c1-14-18-11-12-21(31)30(23(18)25-15(2)24-14)13-16-7-9-17(10-8-16)19-5-3-4-6-20(19)22-26-28-29-27-22/h3-10H,11-13H2,1-2H3,(H,26,27,28,29)",ADXGNEYLLLSOAR-UHFFFAOYSA-N,,411.18075832,C23H21N7O,411.5,101.0,411.18075832,0.0,31.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CC2,3.0,"10  12  8
10  15  8
16  18  8
16  19  8
18  22  8
19  23  8
21  22  8
21  23  8
24  26  8
24  27  8
26  28  8
27  29  8
28  31  8
29  31  8
3  12  8
3  17  8
4  15  8
4  17  8
5  30  8
5  7  8
6  30  8
6  8  8
7  8  8",
440790256,153270,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00698,Pralnacasan,20231222,20210312,Curation Efforts|Governmental Organizations,LT00698,pralnacasan,8.0,Discontinued,vMost-DILI-Concern,1.0,153270,1.0,960.0,8.0,2.0,6.0,AAADceB7uAAAAAAAAAAAAAAAAAAAASAAAAA8WIAABYAAAACx8AAAHgAYAAAADCjxngc+iNLIFACoAzX3XACCgCA3AiAa2KG4ZNgaYPrAlbG3IQhmlgDcyQdei4COgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"(4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxo-tetrahydrofuran-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide","(4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxo-3-oxolanyl]-7-[[1-isoquinolinyl(oxo)methyl]amino]-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide","(4<I>S</I>,7<I>S</I>)-<I>N</I>-[(2<I>R</I>,3<I>S</I>)-2-ethoxy-5-oxooxolan-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1<I>H</I>-pyridazino[1,2-a]diazepine-4-carboxamide","(4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide","(4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxidanylidene-oxolan-3-yl]-7-(isoquinolin-1-ylcarbonylamino)-6,10-bis(oxidanylidene)-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a][1,2]diazepine-4-carboxamide","(4S,7S)-N-[(2R,3S)-2-ethoxy-5-keto-tetrahydrofuran-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-diketo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide","InChI=1S/C26H29N5O7/c1-2-37-26-18(14-21(33)38-26)29-23(34)19-8-5-13-30-20(32)10-9-17(25(36)31(19)30)28-24(35)22-16-7-4-3-6-15(16)11-12-27-22/h3-4,6-7,11-12,17-19,26H,2,5,8-10,13-14H2,1H3,(H,28,35)(H,29,34)/t17-,18-,19-,26+/m0/s1",CXAGHAZMQSCAKJ-WAHHBDPQSA-N,,523.20669828,C26H29N5O7,523.5,147.0,523.20669828,0.0,38.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN2C(=O)CC[C@H](NC(=O)c3nccc4ccccc34)C(=O)N12,0.9,"23  10  6
17  11  6
12  29  8
12  35  8
13  20  6
29  30  8
30  32  8
30  33  8
32  34  8
32  36  8
33  37  8
34  35  8
36  38  8
37  38  8
24  5  6",
440790255,5480200,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00702,Pafuramidine,20250421,20210312,Curation Efforts|Governmental Organizations,,,,,,,5480200,1.0,477.0,5.0,2.0,6.0,AAADceB7sAAAAAAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAAAB0AAAHgAUAAAADASBmAIzBIBQBECoAqJyIACCCAAkIAAIiAEmDNgMJrKEtRuCOSDkwBEIqYeYyPCOQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,N'-methoxy-4-[5-[4-[(Z)-N'-methoxycarbamimidoyl]phenyl]-2-furyl]benzamidine,4-[5-[4-[(Z)-amino(methoxyimino)methyl]phenyl]-2-furanyl]-N'-methoxybenzenecarboximidamide,<I>N</I>&apos;-methoxy-4-[5-[4-[(<I>Z</I>)-<I>N</I>&apos;-methoxycarbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide,N'-methoxy-4-[5-[4-[(Z)-N'-methoxycarbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide,N'-methoxy-4-[5-[4-[(Z)-N'-methoxycarbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide,N'-methoxy-4-[5-[4-[(Z)-N'-methoxyamidino]phenyl]-2-furyl]benzamidine,"InChI=1S/C20H20N4O3/c1-25-23-19(21)15-7-3-13(4-8-15)17-11-12-18(27-17)14-5-9-16(10-6-14)20(22)24-26-2/h3-12H,1-2H3,(H2,21,23)(H2,22,24)",UKOQVLAXCBRRGH-UHFFFAOYSA-N,,364.15354051,C20H20N4O3,364.4,108.0,364.15354051,0.0,27.0,0.0,0.0,2.0,0.0,0.0,1.0,-1.0,"1
5
255",CO/N=C(\N)c1ccc(-c2ccc(-c3ccc(/C(N)=N/OC)cc3)o2)cc1,3.2,"1  8  8
1  9  8
10  14  8
10  16  8
11  15  8
11  17  8
12  13  8
14  20  8
15  21  8
16  22  8
17  23  8
18  20  8
18  22  8
19  21  8
19  23  8
8  12  8
9  13  8",
440790254,172307,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00701,Fiduxosin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00701,fiduxosin,8.0,Discontinued,vMost-DILI-Concern,1.0,172307,1.0,936.0,8.0,1.0,7.0,AAADceB7uABAAAAAAAAAAAAAAAAAAWJAAAA8eJECAAAAAFiR/AAAHgQQAAAADQzh3gY/x7PIFAisAzV3VACD+KR1OjgI2DU+fNiMZ/rk9duWPazvxzfo6We88e4OgAAACAAIAAAAAAAQABAAAAAAAAAAAA==,"5-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-12-phenyl-8-thia-3,5,10,13-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),9,11-tetraene-4,6-dione","5-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-[1]benzopyrano[3,4-c]pyrrol-2-yl]butyl]-12-phenyl-8-thia-3,5,10,13-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),9,11-tetraene-4,6-dione","5-[4-[(3<I>a</I><I>R</I>,9<I>b</I><I>R</I>)-9-methoxy-3,3<I>a</I>,4,9<I>b</I>-tetrahydro-1<I>H</I>-chromeno[3,4-c]pyrrol-2-yl]butyl]-12-phenyl-8-thia-3,5,10,13-tetrazatricyclo[7.4.0.0<SUP>2,7</SUP>]trideca-1(13),2(7),9,11-tetraene-4,6-dione","5-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-12-phenyl-8-thia-3,5,10,13-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),9,11-tetraene-4,6-dione","5-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-12-phenyl-8-thia-3,5,10,13-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),9,11-tetraene-4,6-dione","5-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-12-phenyl-8-thia-3,5,10,13-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),9,11-tetraene-4,6-quinone","InChI=1S/C30H29N5O4S/c1-38-22-10-7-11-23-24(22)20-16-34(15-19(20)17-39-23)12-5-6-13-35-29(36)27-25(33-30(35)37)26-28(40-27)31-14-21(32-26)18-8-3-2-4-9-18/h2-4,7-11,14,19-20H,5-6,12-13,15-17H2,1H3,(H,33,37)/t19-,20-/m1/s1",WDTAYDBPNYFWDR-WOJBJXKFSA-N,,555.1940256,C30H29N5O4S,555.6,125.0,555.1940256,0.0,40.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1cccc2c1[C@@H]1CN(CCCCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]1CO2,4.2,"1  29  8
1  32  8
10  32  8
10  34  8
11  41  5
12  42  5
16  18  8
16  20  8
18  22  8
20  23  8
22  24  8
23  24  8
27  29  8
29  30  8
30  31  8
31  32  8
33  34  8
35  36  8
35  37  8
36  38  8
37  39  8
38  40  8
39  40  8
7  27  8
7  28  8
8  28  8
8  30  8
9  31  8
9  33  8",
440790253,50313,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01371,FIALURIDINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT01371,fialuridine,8.0,Discontinued,vMost-DILI-Concern,1.0,50313,1.0,418.0,6.0,3.0,2.0,AAADccBzOQAAAgAAAAAAAAAAAAAAASAAAAAgAAAAAAAAAAAAAAAAHwAwCAAACBTjgAYBAAPABgCIAAFWUACAAAAAAAAAAAAIAECBEAIAgAAOQAAPByIDAMCwMAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione","1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-iodopyrimidine-2,4-dione","1-[(2<I>R</I>,3<I>S</I>,4<I>R</I>,5<I>R</I>)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione","1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione","1-[(2R,3S,4R,5R)-3-fluoranyl-5-(hydroxymethyl)-4-oxidanyl-oxolan-2-yl]-5-iodanyl-pyrimidine-2,4-dione","1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-quinone","InChI=1S/C9H10FIN2O5/c10-5-6(15)4(2-14)18-8(5)13-1-3(11)7(16)12-9(13)17/h1,4-6,8,14-15H,2H2,(H,12,16,17)/t4-,5+,6-,8-/m1/s1",IPVFGAYTKQKGBM-BYPJNBLXSA-N,-0.9,371.96185,C9H10FIN2O5,372.09,99.1,371.96185,0.0,18.0,4.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1I,,"13  14  6
16  17  8
17  18  8
12  2  6
10  4  5
11  8  6
8  15  8
8  16  8
9  15  8
9  18  8",
440790252,6918508,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01870,Falnidamol,20210804,20210312,Curation Efforts|Governmental Organizations,LT01870,falnidamol,8.0,Discontinued,vMost-DILI-Concern,1.0,6918508,1.0,479.0,8.0,2.0,4.0,AAADceB7gQAEAAAAAAAAAAAAAAAAAAAAAAA8WLEAAAAAAACx/AAAHQIQAAAACCrBFiw/8LfIEACgATZnZACCgC0xF6AJ2KA4dpiIaOLB29GUJAhokALIyCcQAAAAAAAAAAIAAAAAAAAABAAAAAAAAAAAAA==,"N4-(3-chloro-4-fluoro-phenyl)-N6-(1-methyl-4-piperidyl)pyrimido[5,4-d]pyrimidine-4,6-diamine","N4-(3-chloro-4-fluorophenyl)-N6-(1-methyl-4-piperidinyl)pyrimido[5,4-d]pyrimidine-4,6-diamine","4-<I>N</I>-(3-chloro-4-fluorophenyl)-6-<I>N</I>-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-4,6-diamine","4-N-(3-chloro-4-fluorophenyl)-6-N-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-4,6-diamine","N4-(3-chloranyl-4-fluoranyl-phenyl)-N6-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-4,6-diamine","[4-(3-chloro-4-fluoro-anilino)pyrimido[5,4-d]pyrimidin-6-yl]-(1-methyl-4-piperidyl)amine","InChI=1S/C18H19ClFN7/c1-27-6-4-11(5-7-27)25-18-21-9-15-16(26-18)17(23-10-22-15)24-12-2-3-14(20)13(19)8-12/h2-3,8-11H,4-7H2,1H3,(H,21,25,26)(H,22,23,24)",FTFRZXFNZVCRSK-UHFFFAOYSA-N,,387.1374495,C18H19ClFN7,387.8,78.9,387.1374495,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1,3.4,"17  18  8
17  20  8
18  19  8
21  23  8
21  24  8
23  25  8
24  26  8
25  27  8
26  27  8
5  16  8
5  17  8
6  16  8
6  19  8
8  18  8
8  22  8
9  20  8
9  22  8",
440790251,32756,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00695,Dermatan,20231222,20210312,Curation Efforts|Governmental Organizations,LT00695,dermatan,8.0,Discontinued,vMost-DILI-Concern,1.0,32756,1.0,736.0,15.0,6.0,5.0,AAADceByPABAAAAAAAAAAAAAAAAAAAAAAAAkSAAAAAAAAAAAAAAAHgAQCAAACDzxgAcCCALABgAIAAGQGDIAAAAAAAAAAIFIAAATEBYAgAQnQAAHNgCXAAH6fA9AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"(2R,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-sulfonatooxy-tetrahydropyran-4-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylate","(2R,3S,4S,5R,6R)-6-[[(2R,3R,4R,5R,6R)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-sulfonatooxy-4-oxanyl]oxy]-3,4,5-trihydroxy-2-oxanecarboxylate","(2<I>R</I>,3<I>S</I>,4<I>S</I>,5<I>R</I>,6<I>R</I>)-6-[(2<I>R</I>,3<I>R</I>,4<I>R</I>,5<I>R</I>,6<I>R</I>)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate","(2R,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate","(2R,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-5-acetamido-2-(hydroxymethyl)-6-oxidanyl-3-sulfonatooxy-oxan-4-yl]oxy-3,4,5-tris(oxidanyl)oxane-2-carboxylate","(2R,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2-hydroxy-6-methylol-5-sulfato-tetrahydropyran-4-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylate","InChI=1S/C14H23NO15S/c1-3(17)15-5-10(9(30-31(24,25)26)4(2-16)27-13(5)23)28-14-8(20)6(18)7(19)11(29-14)12(21)22/h4-11,13-14,16,18-20,23H,2H2,1H3,(H,15,17)(H,21,22)(H,24,25,26)/p-2/t4-,5-,6+,7+,8-,9+,10-,11-,13-,14-/m1/s1",AVJBPWGFOQAPRH-FWMKGIEWSA-L,,475.06319014,C14H21NO15S-2,475.4,273.0,475.06319014,-2.0,31.0,10.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)N[C@@H]1[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]2O)[C@@H](OS(=O)(=O)[O-])[C@@H](CO)O[C@H]1O,-4.3,"20  17  6
18  2  5
23  2  5
21  28  5
27  30  6
19  5  5
22  6  5
24  7  6
25  8  5
26  9  6",
440790250,3001322,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00693,aplaviroc,20231222,20210312,Curation Efforts|Governmental Organizations,LT00693,aplaviroc,8.0,Discontinued,vMost-DILI-Concern,1.0,3001322,1.0,915.0,7.0,3.0,10.0,AAADcfB/OAAAAAAAAAAAAAAAAAAAAAAAAAA8eMECAAAAAAABQAAAHgAQCAAADbzhmAYyDoPABgCIAiHSGACCCAAkIAAIiIGODMgOdjaE9TuWeSjm9hGYuYec/K7OIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,"4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid","4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid","4-[4-[[(3<I>R</I>)-1-butyl-3-[(<I>R</I>)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid","4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid","4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexyl(oxidanyl)methyl]-2,5-bis(oxidanylidene)-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid","4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-diketo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid","InChI=1S/C33H43N3O6/c1-2-3-19-36-30(38)28(29(37)24-7-5-4-6-8-24)34-32(41)33(36)17-20-35(21-18-33)22-23-9-13-26(14-10-23)42-27-15-11-25(12-16-27)31(39)40/h9-16,24,28-29,37H,2-8,17-22H2,1H3,(H,34,41)(H,39,40)/t28-,29-/m1/s1",GWNOTCOIYUNTQP-FQLXRVMXSA-N,,577.3151861,C33H43N3O6,577.7,119.0,577.3151861,0.0,42.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2,3.1,"15  1  6
13  47  6
29  31  8
29  32  8
31  33  8
32  34  8
33  35  8
34  35  8
36  37  8
36  38  8
37  39  8
38  40  8
39  41  8
40  41  8",
440790249,5365247,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01874,Zimelidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01874,zimelidine,8.0,Withdrawn,vMost-DILI-Concern,1.0,5365247,1.0,293.0,2.0,0.0,4.0,AAADceB7AAAAEAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHABAAAABrADBGgQ+gJMIEACgAjBnRACCgCAxAiQI2CA4ZLgIIOLAkZGEIAhggADIyhcQgMAOAgAAAAAAAAAEAAAAAAAAAAAAAAAAAA==,"(Z)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl)prop-2-en-1-amine","(Z)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2-propen-1-amine","(<I>Z</I>)-3-(4-bromophenyl)-<I>N</I>,<I>N</I>-dimethyl-3-pyridin-3-ylprop-2-en-1-amine","(Z)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-3-ylprop-2-en-1-amine","(Z)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-3-yl-prop-2-en-1-amine",[(Z)-3-(4-bromophenyl)-3-(3-pyridyl)allyl]-dimethyl-amine,"InChI=1S/C16H17BrN2/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13/h3-10,12H,11H2,1-2H3/b16-9-",OYPPVKRFBIWMSX-SXGWCWSVSA-N,,316.05751,C16H17BrN2,317.22,16.1,316.05751,0.0,19.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1,3.9,"10  16  8
13  18  8
15  17  8
16  17  8
18  19  8
3  14  8
3  19  8
7  10  8
7  9  8
8  13  8
8  14  8
9  15  8",
440790248,9574101,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02033,Ximelagatran,20250421,20210312,Curation Efforts|Governmental Organizations,LT02033,ximelagatran,8.0,Withdrawn,vMost-DILI-Concern,1.0,9574101,1.0,731.0,7.0,4.0,11.0,AAADcfB7uAAAAAAAAAAAAAAAAABYAAAAAAAwYAAAAAAAAAABAAAAHgAUCAAADSjhmAYzCIPQBACoAiPyOACCAAAgAAAIiIGoBJgKYLKAkTGXIAhglgCYiAcciICOQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,ethyl 2-[[(1R)-1-cyclohexyl-2-[(2S)-2-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxo-ethyl]amino]acetate,2-[[(1R)-2-[(2S)-2-[[[4-[(Z)-amino(hydroxyimino)methyl]phenyl]methylamino]-oxomethyl]-1-azetidinyl]-1-cyclohexyl-2-oxoethyl]amino]acetic acid ethyl ester,ethyl 2-[[(1<I>R</I>)-1-cyclohexyl-2-[(2<I>S</I>)-2-[[4-[(<I>Z</I>)-<I>N</I>&apos;-hydroxycarbamimidoyl]phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxoethyl]amino]acetate,ethyl 2-[[(1R)-1-cyclohexyl-2-[(2S)-2-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxoethyl]amino]acetate,ethyl 2-[[(1R)-1-cyclohexyl-2-[(2S)-2-[[4-[(Z)-N'-oxidanylcarbamimidoyl]phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxidanylidene-ethyl]amino]ethanoate,2-[[(1R)-2-[(2S)-2-[[4-[(Z)-aminocarbohydroximoyl]benzyl]carbamoyl]azetidin-1-yl]-1-cyclohexyl-2-keto-ethyl]amino]acetic acid ethyl ester,"InChI=1S/C24H35N5O5/c1-2-34-20(30)15-26-21(17-6-4-3-5-7-17)24(32)29-13-12-19(29)23(31)27-14-16-8-10-18(11-9-16)22(25)28-33/h8-11,17,19,21,26,33H,2-7,12-15H2,1H3,(H2,25,28)(H,27,31)/t19-,21+/m0/s1",ZXIBCJHYVWYIKI-PZJWPPBQSA-N,,473.26381923,C24H35N5O5,473.6,146.0,473.26381923,0.0,34.0,2.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(/C(N)=N/O)cc1)C1CCCCC1,2.2,"17  22  5
26  27  8
26  28  8
27  30  8
28  31  8
30  32  8
31  32  8
12  7  5",
440790247,239062,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01867,Xenazoic acid,20231222,20210312,Curation Efforts|Governmental Organizations,LT01867,xenazoic acid,8.0,Withdrawn,vMost-DILI-Concern,1.0,239062,1.0,501.0,5.0,2.0,8.0,AAADceB6OAAAAAAAAAAAAAAAAAAAAAAAAAAwYMAAAAAAAAABUAAAHgAQCAAADAzhmAYyyILABgCIAqTSSAKCAAAlAgAIiIHIbMkIJjLAlbWOcQhk0AHI2YeY2eOeyAAAAAAAAACQAAAAAAAAAAAAAAAAAA==,4-[[1-ethoxy-2-oxo-2-(4-phenylphenyl)ethyl]amino]benzoic acid,4-[[1-ethoxy-2-oxo-2-(4-phenylphenyl)ethyl]amino]benzoic acid,4-[[1-ethoxy-2-oxo-2-(4-phenylphenyl)ethyl]amino]benzoic acid,4-[[1-ethoxy-2-oxo-2-(4-phenylphenyl)ethyl]amino]benzoic acid,4-[[1-ethoxy-2-oxidanylidene-2-(4-phenylphenyl)ethyl]amino]benzoic acid,4-[[1-ethoxy-2-keto-2-(4-phenylphenyl)ethyl]amino]benzoic acid,"InChI=1S/C23H21NO4/c1-2-28-22(24-20-14-12-19(13-15-20)23(26)27)21(25)18-10-8-17(9-11-18)16-6-4-3-5-7-16/h3-15,22,24H,2H2,1H3,(H,26,27)",BPOMPTVRBWXZBY-UHFFFAOYSA-N,,375.14705815,C23H21NO4,375.4,75.6,375.14705815,0.0,28.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCOC(Nc1ccc(C(=O)O)cc1)C(=O)c1ccc(-c2ccccc2)cc1,4.8,"10  17  8
10  18  8
11  13  8
12  14  8
15  22  8
15  23  8
17  19  8
18  20  8
19  21  8
20  21  8
22  25  8
23  26  8
25  27  8
26  27  8
6  8  3
7  11  8
7  12  8
9  13  8
9  14  8",
440790246,29321,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00700,Triacetyldiphenolisatin,20231222,20210312,Curation Efforts|Governmental Organizations,LT00700,triacetyldiphenolisatin,8.0,Withdrawn,vMost-DILI-Concern,1.0,29321,1.0,742.0,6.0,0.0,6.0,AAADceB6OAAAAAAAAAAAAAAAAAAAAWAAAAAwYMAAAAAAAFgBUAAAHgAAAAAADgyBmAAyzoMABACIAiXSWACCCAAhIgAIiAEGbIgMJjLEtZuGOijkxDHI6AecyPCPoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,[4-[3-(4-acetoxyphenyl)-1-acetyl-2-oxo-indolin-3-yl]phenyl] acetate,acetic acid [4-[1-acetyl-3-(4-acetyloxyphenyl)-2-oxo-3-indolyl]phenyl] ester,[4-[1-acetyl-3-(4-acetyloxyphenyl)-2-oxoindol-3-yl]phenyl] acetate,[4-[1-acetyl-3-(4-acetyloxyphenyl)-2-oxoindol-3-yl]phenyl] acetate,[4-[3-(4-acetyloxyphenyl)-1-ethanoyl-2-oxidanylidene-indol-3-yl]phenyl] ethanoate,acetic acid [4-[3-(4-acetoxyphenyl)-1-acetyl-2-keto-indolin-3-yl]phenyl] ester,"InChI=1S/C26H21NO6/c1-16(28)27-24-7-5-4-6-23(24)26(25(27)31,19-8-12-21(13-9-19)32-17(2)29)20-10-14-22(15-11-20)33-18(3)30/h4-15H,1-3H3",JPGUEMQIAGJQSJ-UHFFFAOYSA-N,,443.13688739,C26H21NO6,443.4,90.0,443.13688739,0.0,33.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)C(=O)N(C(C)=O)c3ccccc32)cc1,3.4,"11  15  8
12  16  8
12  18  8
13  17  8
13  19  8
14  21  8
15  22  8
16  23  8
17  24  8
18  25  8
19  26  8
21  22  8
23  27  8
24  28  8
25  27  8
26  28  8
9  11  8
9  14  8",
440790245,53359,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01822,TOLRESTAT,20231222,20210312,Curation Efforts|Governmental Organizations,LT01822,tolrestat,8.0,Withdrawn,vMost-DILI-Concern,1.0,53359,1.0,486.0,7.0,1.0,4.0,AAADccB6MYBAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAADBUAAAHwQACAAADATB2BYyDsMABgCMAiDSCACCCAAgIAgIiACODIgOJiKEsTuEMChkwBGYqAeQwPAOoAADAAAYAABAAAYAADAAAAAAAAAAAA==,2-[[6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]-methyl-amino]acetic acid,2-[[[6-methoxy-5-(trifluoromethyl)-1-naphthalenyl]-sulfanylidenemethyl]-methylamino]acetic acid,2-[[6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]-methylamino]acetic acid,2-[[6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]-methylamino]acetic acid,2-[[6-methoxy-5-(trifluoromethyl)naphthalen-1-yl]carbothioyl-methyl-amino]ethanoic acid,2-[[6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]-methyl-amino]acetic acid,"InChI=1S/C16H14F3NO3S/c1-20(8-13(21)22)15(24)11-5-3-4-10-9(11)6-7-12(23-2)14(10)16(17,18)19/h3-7H,8H2,1-2H3,(H,21,22)",LUBHDINQXIHVLS-UHFFFAOYSA-N,,357.06464897,C16H14F3NO3S,357.3,81.9,357.06464897,0.0,24.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2c(C(=S)N(C)CC(=O)O)cccc2c1C(F)(F)F,3.7,"10  12  8
10  15  8
11  16  8
12  14  8
13  18  8
14  18  8
15  19  8
16  19  8
9  10  8
9  11  8
9  13  8",
440790244,65592,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00691,Tilbroquinol,20231222,20210312,Curation Efforts|Governmental Organizations,LT00691,tilbroquinol,8.0,Withdrawn,vMost-DILI-Concern,1.0,65592,1.0,188.0,2.0,1.0,0.0,AAADccByIAAAEAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAACx8AAAHgBACAABrAzBngQ+xvIIEgCgAzRnRASCgCAxYiQI2CA9bLgKJuLSkZOEcAhkwBHY2heQwLAOogABUAESFABEAAKgAiQoAAAAAAAAAA==,7-bromo-5-methyl-quinolin-8-ol,7-bromo-5-methyl-8-quinolinol,7-bromo-5-methylquinolin-8-ol,7-bromo-5-methylquinolin-8-ol,7-bromanyl-5-methyl-quinolin-8-ol,7-bromo-5-methyl-quinolin-8-ol,"InChI=1S/C10H8BrNO/c1-6-5-8(11)10(13)9-7(6)3-2-4-12-9/h2-5,13H,1H3",JMOVFFLYGIQXMM-UHFFFAOYSA-N,3.1,236.97893,C10H8BrNO,238.08,33.1,236.97893,0.0,13.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cc(Br)c(O)c2ncccc12,,"12  13  8
3  13  8
3  6  8
4  5  8
4  6  8
4  9  8
5  8  8
6  7  8
7  10  8
8  10  8
9  12  8",
440790243,38409,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00636,Ticrynafen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00636,ticrynafen,8.0,Withdrawn,vMost-DILI-Concern,1.0,38409,1.0,379.0,5.0,1.0,5.0,AAADccBwOABGAAAAAAAAAAAAAAAAASAAAAAwAAAAAAAAAAABwAAAGgYACAAADAak2CKwD4AABgiMAqDSCAIDCIAkLFBIillGC8gNJjOlNx6COSCkwBErrYeIzODOIAAAIQABCARAAABCAAIQCAAAAAAAAA==,"2-[2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy]acetic acid","2-[2,3-dichloro-4-[oxo(thiophen-2-yl)methyl]phenoxy]acetic acid","2-[2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy]acetic acid","2-[2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy]acetic acid","2-[2,3-bis(chloranyl)-4-thiophen-2-ylcarbonyl-phenoxy]ethanoic acid","2-[2,3-dichloro-4-(2-thenoyl)phenoxy]acetic acid","InChI=1S/C13H8Cl2O4S/c14-11-7(13(18)9-2-1-5-20-9)3-4-8(12(11)15)19-6-10(16)17/h1-5H,6H2,(H,16,17)",AGHANLSBXUWXTB-UHFFFAOYSA-N,,329.9520353,C13H8Cl2O4S,331.2,91.8,329.9520353,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl,4.1,"10  13  8
11  14  8
15  16  8
16  18  8
18  19  8
3  15  8
3  19  8
8  10  8
8  11  8
9  13  8
9  14  8",
440790242,5340,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00632,sulfathiazole,20250421,20210312,Curation Efforts|Governmental Organizations,LT00632,sulfathiazole,8.0,Withdrawn,vMost-DILI-Concern,1.0,5340,1.0,320.0,6.0,2.0,3.0,AAADccBzMABgAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHAQQQAAACAjFUgS90ZJIEAqkADRnZHDC8LlxCjlIyBwYZIiIICKAkZGAIABgkAIIyCcQAAAAAAQAAAAAAAAACAAAAAAAAAAAAAAAAA==,4-amino-N-thiazol-2-yl-benzenesulfonamide,4-amino-N-(2-thiazolyl)benzenesulfonamide,"4-amino-<I>N</I>-(1,3-thiazol-2-yl)benzenesulfonamide","4-amino-N-(1,3-thiazol-2-yl)benzenesulfonamide","4-azanyl-N-(1,3-thiazol-2-yl)benzenesulfonamide",4-amino-N-thiazol-2-yl-benzenesulfonamide,"InChI=1S/C9H9N3O2S2/c10-7-1-3-8(4-2-7)16(13,14)12-9-11-5-6-15-9/h1-6H,10H2,(H,11,12)",JNMRHUJNCSQMMB-UHFFFAOYSA-N,0.1,255.01361889,C9H9N3O2S2,255.3,122.0,255.01361889,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1ccc(S(=O)(=O)Nc2nccs2)cc1,,"10  13  8
11  12  8
11  13  8
15  16  8
2  14  8
2  15  8
7  14  8
7  16  8
8  10  8
8  9  8
9  12  8",
440790241,11033,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00699,Sulfacarbamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00699,sulfacarbamide,8.0,Withdrawn,vMost-DILI-Concern,1.0,11033,1.0,301.0,4.0,3.0,2.0,AAADccBjMABAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgQQQAAACAiBUAAxwYBAAAKIACRCUHDCABAgAgAIiBgAZIgIICKAkZGAIABgkAAIyAcQAAAAAAQAAAAAAAAACAAAAAAAAAAAAAAAAA==,(4-aminophenyl)sulfonylurea,(4-aminophenyl)sulfonylurea,(4-aminophenyl)sulfonylurea,(4-aminophenyl)sulfonylurea,1-(4-aminophenyl)sulfonylurea,sulfanilylurea,"InChI=1S/C7H9N3O3S/c8-5-1-3-6(4-2-5)14(12,13)10-7(9)11/h1-4H,8H2,(H3,9,10,11)",WVAKABMNNSMCDK-UHFFFAOYSA-N,-1.5,215.03646233,C7H9N3O3S,215.23,124.0,215.03646233,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)NS(=O)(=O)c1ccc(N)cc1,,"10  13  8
11  12  8
11  13  8
8  10  8
8  9  8
9  12  8",
440790240,5354,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01816,sulcotidil,20231222,20210312,Curation Efforts|Governmental Organizations,LT01816,sulcotidil,8.0,Withdrawn,vMost-DILI-Concern,1.0,5354,1.0,277.0,3.0,2.0,12.0,AAADcfB6IABAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgQQCAAADDzl2AayAYLAAgiAAiBCAAACAAAgCBAIiJgICIgKNiKgkRGEcAAk0AG4mAeQwKAOEAAAAAAAAAAgAAAAAAAAAAAAAAAAAA==,1-(4-isopropylsulfanylphenyl)-2-(octylamino)propan-1-ol,2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol,2-(octylamino)-1-(4-propan-2-ylsulfanylphenyl)propan-1-ol,2-(octylamino)-1-(4-propan-2-ylsulfanylphenyl)propan-1-ol,2-(octylamino)-1-(4-propan-2-ylsulfanylphenyl)propan-1-ol,1-[4-(isopropylthio)phenyl]-2-(octylamino)propan-1-ol,"InChI=1S/C20H35NOS/c1-5-6-7-8-9-10-15-21-17(4)20(22)18-11-13-19(14-12-18)23-16(2)3/h11-14,16-17,20-22H,5-10,15H2,1-4H3",BFCDFTHTSVTWOG-UHFFFAOYSA-N,,337.24393591,C20H35NOS,337.6,57.6,337.24393591,0.0,23.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1,5.8,"13  15  8
13  16  8
15  18  8
16  19  8
18  20  8
19  20  8
4  24  3
9  33  3",
440790239,216235,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02449,Sitaxsentan,20231222,20210312,Curation Efforts|Governmental Organizations,LT02449,sitaxsentan,8.0,Withdrawn,vMost-DILI-Concern,2.0,216235,1.0,720.0,9.0,1.0,6.0,AAADccB7OABkAAAAAAAAAAAAAAAAAWJEgAAwAAAAAAAAAEgB8AAAHgYUQAAADA6F3iOyj5BQBAqtA6VyUnDDCJAkLFBomDk2z9tdJjqk9dqgNaJmwBku6UeIzPDOoAABAAAQQABAAAIAACCAAAAAAAAAAA==,"N-(4-chloro-3-methyl-isoxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide","N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)-1-oxoethyl]-3-thiophenesulfonamide","<I>N</I>-(4-chloro-3-methyl-1,2-oxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide","N-(4-chloro-3-methyl-1,2-oxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide","N-(4-chloranyl-3-methyl-1,2-oxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)ethanoyl]thiophene-3-sulfonamide","N-(4-chloro-3-methyl-isoxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide","InChI=1S/C18H15ClN2O6S2/c1-9-5-13-14(26-8-25-13)7-11(9)6-12(22)17-15(3-4-28-17)29(23,24)21-18-16(19)10(2)20-27-18/h3-5,7,21H,6,8H2,1-2H3",PHWXUGHIIBDVKD-UHFFFAOYSA-N,,454.0060062,C18H15ClN2O6S2,454.9,144.0,454.0060062,0.0,29.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2,3.7,"10  26  1
11  28  8
12  14  8
12  17  8
14  21  8
15  16  8
15  23  8
17  19  8
19  20  8
20  21  8
23  25  8
26  27  8
27  28  8
3  16  8
3  25  8
9  11  8
9  26  8",
440790238,35935,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01680,Pirprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT01680,pirprofen,8.0,Withdrawn,vMost-DILI-Concern,1.0,35935,1.0,311.0,3.0,1.0,3.0,AAADccByMAAEAAAAAAAAAAAAAAAAAQAAAAAwAAAAAAAAAAABAAAAHgIACAAADQrBmCQyyIMAAgCIAiTSSACCAAAhBwAIiAEIZogIIDLBl5HEYAhkwAHIyAeYyOCOiAAAIAAAABAQAABAAAAAIAAAAAAAAA==,"2-[3-chloro-4-(2,5-dihydropyrrol-1-yl)phenyl]propanoic acid","2-[3-chloro-4-(2,5-dihydropyrrol-1-yl)phenyl]propanoic acid","2-[3-chloro-4-(2,5-dihydropyrrol-1-yl)phenyl]propanoic acid","2-[3-chloro-4-(2,5-dihydropyrrol-1-yl)phenyl]propanoic acid","2-[3-chloranyl-4-(2,5-dihydropyrrol-1-yl)phenyl]propanoic acid",2-[3-chloro-4-(3-pyrrolin-1-yl)phenyl]propionic acid,"InChI=1S/C13H14ClNO2/c1-9(13(16)17)10-4-5-12(11(14)8-10)15-6-2-3-7-15/h2-5,8-9H,6-7H2,1H3,(H,16,17)",PIDSZXPFGCURGN-UHFFFAOYSA-N,,251.0713064,C13H14ClNO2,251.71,40.5,251.0713064,0.0,17.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1,2.9,"12  14  8
13  15  8
7  12  8
7  13  8
8  14  8
8  15  8
9  22  3",
440790237,6761,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00697,PIPAMAZINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00697,pipamazine,8.0,Withdrawn,vMost-DILI-Concern,1.0,6761,1.0,514.0,4.0,1.0,5.0,AAADceB7IABEAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxQAAAHgYQAAAADQrB0CQwwYNAAAiIACVSUACCAAAhDxAIiB0IZogIIHLh05GEIAhgkADoyAcUAAAKAAIAAAIAAQAABAAABAACAAAAAAAAAA==,1-[3-(2-chlorophenothiazin-10-yl)propyl]piperidine-4-carboxamide,1-[3-(2-chloro-10-phenothiazinyl)propyl]-4-piperidinecarboxamide,1-[3-(2-chlorophenothiazin-10-yl)propyl]piperidine-4-carboxamide,1-[3-(2-chlorophenothiazin-10-yl)propyl]piperidine-4-carboxamide,1-[3-(2-chloranylphenothiazin-10-yl)propyl]piperidine-4-carboxamide,1-[3-(2-chlorophenothiazin-10-yl)propyl]isonipecotamide,"InChI=1S/C21H24ClN3OS/c22-16-6-7-20-18(14-16)25(17-4-1-2-5-19(17)27-20)11-3-10-24-12-8-15(9-13-24)21(23)26/h1-2,4-7,14-15H,3,8-13H2,(H2,23,26)",OSJJYEUEJRVVOD-UHFFFAOYSA-N,4.4,401.1328613,C21H24ClN3OS,402.0,74.9,401.1328613,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,,"16  18  8
16  20  8
17  19  8
17  21  8
18  22  8
19  23  8
20  24  8
21  25  8
22  26  8
23  27  8
24  26  8
25  27  8",
440790236,71467,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00703,Phenoxypropazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00703,phenoxypropazine,8.0,Withdrawn,vMost-DILI-Concern,1.0,71467,1.0,113.0,3.0,2.0,4.0,AAADccBzIAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAYAAAACCzhkAYyBoBiBACAACBCAAACCAAgIAIYqIAGCIgOJiKEMRqDOCCk0BEIqAeAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,(1-methyl-2-phenoxy-ethyl)hydrazine,1-phenoxypropan-2-ylhydrazine,1-phenoxypropan-2-ylhydrazine,1-phenoxypropan-2-ylhydrazine,1-phenoxypropan-2-yldiazane,(1-methyl-2-phenoxy-ethyl)hydrazine,"InChI=1S/C9H14N2O/c1-8(11-10)7-12-9-5-3-2-4-6-9/h2-6,8,11H,7,10H2,1H3",QNEXFJFTGQBXBJ-UHFFFAOYSA-N,,166.110613074,C9H14N2O,166.22,47.3,166.110613074,0.0,12.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(COc1ccccc1)NN,1.1,"10  12  8
11  12  8
4  13  3
7  8  8
7  9  8
8  10  8
9  11  8",
440790235,4746,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00131,PERHEXILINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT00131,perhexiline,8.0,Withdrawn,vMost-DILI-Concern,1.0,4746,1.0,245.0,1.0,1.0,4.0,AAADcfB6AAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAAAAAAAAHAAQAAAADSjBAAQAAALAAAAAAAAAAAAAAAAAAAAAAIAIAAAAAAIAgAAEAAAAEACAAAEQgMAOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"2-(2,2-dicyclohexylethyl)piperidine","2-(2,2-dicyclohexylethyl)piperidine","2-(2,2-dicyclohexylethyl)piperidine","2-(2,2-dicyclohexylethyl)piperidine","2-(2,2-dicyclohexylethyl)piperidine","2-(2,2-dicyclohexylethyl)piperidine","InChI=1S/C19H35N/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18/h16-20H,1-15H2",CYXKNKQEMFBLER-UHFFFAOYSA-N,,277.276950121,C19H35N,277.5,12.0,277.276950121,0.0,20.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,6.8,10  34  3,
440790234,4723,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00246,pemoline,20231222,20210312,Curation Efforts|Governmental Organizations,LT00246,pemoline,8.0,Withdrawn,vMost-DILI-Concern,1.0,4723,1.0,244.0,2.0,1.0,1.0,AAADccBzMAAAAAAAAAAAAAAAAAAAAQAAAAAwAAAAAAAAAAABAAAAHgAQAAAADBShmAIxAIJABACoAiFSNAICAAEgAAAIiAFACIkKJjKAtR2JMAAkwAEIqAeYyKCOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,2-amino-5-phenyl-oxazol-4-one,2-amino-5-phenyl-4-oxazolone,"2-amino-5-phenyl-1,3-oxazol-4-one","2-amino-5-phenyl-1,3-oxazol-4-one","2-azanyl-5-phenyl-1,3-oxazol-4-one",2-amino-5-phenyl-2-oxazolin-4-one,"InChI=1S/C9H8N2O2/c10-9-11-8(12)7(13-9)6-4-2-1-3-5-6/h1-5,7H,(H2,10,11,12)",NRNCYVBFPDDJNE-UHFFFAOYSA-N,,176.058577502,C9H8N2O2,176.17,64.7,176.058577502,0.0,13.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC1=NC(=O)C(c2ccccc2)O1,0.9,"11  13  8
12  13  8
5  14  3
6  8  8
6  9  8
8  11  8
9  12  8",
440790233,31315,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00690,Oxyphenisatin,20210312,20210312,Curation Efforts|Governmental Organizations,LT00690,oxyphenisatin,8.0,Withdrawn,vMost-DILI-Concern,1.0,31315,1.0,442.0,3.0,3.0,2.0,AAADccB6MAAAAAAAAAAAAAAAAAAAAWAAAAAwYMAAAAAAAFgBUAAAHgAQCAAADgyBmAAwxoLAAgCIAiVSUACCAAAhIgAIiAEGbIgIJjLClZOEcAhk1BHI2AecyPCPoAAAAAACAABAAAAAAAQAAAAAAAAAAA==,"3,3-bis(4-hydroxyphenyl)indolin-2-one","3,3-bis(4-hydroxyphenyl)-1H-indol-2-one","3,3-bis(4-hydroxyphenyl)-1<I>H</I>-indol-2-one","3,3-bis(4-hydroxyphenyl)-1H-indol-2-one","3,3-bis(4-hydroxyphenyl)-1H-indol-2-one","3,3-bis(4-hydroxyphenyl)oxindole","InChI=1S/C20H15NO3/c22-15-9-5-13(6-10-15)20(14-7-11-16(23)12-8-14)17-3-1-2-4-18(17)21-19(20)24/h1-12,22-23H,(H,21,24)",SJDACOMXKWHBOW-UHFFFAOYSA-N,,317.10519334,C20H15NO3,317.3,69.6,317.10519334,0.0,24.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C1Nc2ccccc2C1(c1ccc(O)cc1)c1ccc(O)cc1,3.2,"10  12  8
11  17  8
12  18  8
13  19  8
14  20  8
15  21  8
16  22  8
17  18  8
19  23  8
20  24  8
21  23  8
22  24  8
6  10  8
6  11  8
8  13  8
8  15  8
9  14  8
9  16  8",
440790232,4528,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01611,Nomifensine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01611,nomifensine,8.0,Withdrawn,vMost-DILI-Concern,1.0,4528,1.0,272.0,2.0,1.0,1.0,AAADceB7AAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACxQAAAHAAQAAAADQjBGAQywINAAACAAiRCQACCAAAgAgAIiAAIZIgIICKA0ZGEIAhgkACIyAcQgMAOgAAAQAASAAAAAACAACQAAAAAAAAAAA==,"2-methyl-4-phenyl-3,4-dihydro-1H-isoquinolin-8-amine","2-methyl-4-phenyl-3,4-dihydro-1H-isoquinolin-8-amine","2-methyl-4-phenyl-3,4-dihydro-1<I>H</I>-isoquinolin-8-amine","2-methyl-4-phenyl-3,4-dihydro-1H-isoquinolin-8-amine","2-methyl-4-phenyl-3,4-dihydro-1H-isoquinolin-8-amine","(2-methyl-4-phenyl-3,4-dihydro-1H-isoquinolin-8-yl)amine","InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3",XXPANQJNYNUNES-UHFFFAOYSA-N,,238.146998583,C16H18N2,238.33,29.3,238.146998583,0.0,18.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1Cc2c(N)cccc2C(c2ccccc2)C1,2.6,"10  15  8
12  15  8
13  16  8
14  17  8
16  18  8
17  18  8
3  19  3
5  10  8
5  7  8
7  9  8
8  13  8
8  14  8
9  12  8",
440790231,71900,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01854,Nitrefazole,20210312,20210312,Curation Efforts|Governmental Organizations,LT01854,nitrefazole,8.0,Withdrawn,vMost-DILI-Concern,1.0,71900,1.0,332.0,5.0,0.0,1.0,AAADccBzuAAAAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHAAEAAAACAjBEwQ/8JccUAChADZnZwCCgC0xEqApyAAYdIqIaGLAmZGUIAhogILIyCcQAAAAAACAAAAAAAAAAQAAAAAAAAAAAAAAAA==,2-methyl-4-nitro-1-(4-nitrophenyl)imidazole,2-methyl-4-nitro-1-(4-nitrophenyl)imidazole,2-methyl-4-nitro-1-(4-nitrophenyl)imidazole,2-methyl-4-nitro-1-(4-nitrophenyl)imidazole,2-methyl-4-nitro-1-(4-nitrophenyl)imidazole,2-methyl-4-nitro-1-(4-nitrophenyl)imidazole,"InChI=1S/C10H8N4O4/c1-7-11-10(14(17)18)6-12(7)8-2-4-9(5-3-8)13(15)16/h2-6H,1H3",NMTBSNPBIGRZBL-UHFFFAOYSA-N,,248.05455475,C10H8N4O4,248.19,109.0,248.05455475,0.0,18.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1nc([N+](=O)[O-])cn1-c1ccc([N+](=O)[O-])cc1,2.1,"11  14  8
12  16  8
13  17  8
16  18  8
17  18  8
5  10  8
5  11  8
6  10  8
6  14  8
9  12  8
9  13  8",
440790230,3033952,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01602,Niperotidine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01602,niperotidine,8.0,Withdrawn,vMost-DILI-Concern,1.0,3033952,1.0,574.0,9.0,2.0,11.0,AAADceB7uABAAAAAAAAAAAAAAAAAASJAAAAwAAAAAAAAAEgBwAAAHgQUAAAADATF2AezDoPQREiJAqBWQwCCCAAkIhAIiIGOjMifJjKktTunOSrs0BM+qYe40RIOIAABAAAAQABAAAIAAACAAAAAAAAAAA==,"(Z)-N1'-(1,3-benzodioxol-5-ylmethyl)-N1-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-2-nitro-ethene-1,1-diamine","(Z)-N1'-(1,3-benzodioxol-5-ylmethyl)-N1-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-2-nitroethene-1,1-diamine","(<I>Z</I>)-1-<I>N</I>&apos;-(1,3-benzodioxol-5-ylmethyl)-1-<I>N</I>-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine","(Z)-1-N'-(1,3-benzodioxol-5-ylmethyl)-1-N-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine","(Z)-N1'-(1,3-benzodioxol-5-ylmethyl)-N1-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitro-ethene-1,1-diamine",dimethyl-[[5-[[2-[[(Z)-2-nitro-1-(piperonylamino)vinyl]amino]ethylthio]methyl]-2-furyl]methyl]amine,"InChI=1S/C20H26N4O5S/c1-23(2)11-16-4-5-17(29-16)13-30-8-7-21-20(12-24(25)26)22-10-15-3-6-18-19(9-15)28-14-27-18/h3-6,9,12,21-22H,7-8,10-11,13-14H2,1-2H3/b20-12+",HXRSXEDVVARPHP-UDWIEESQSA-N,,434.16239112,C20H26N4O5S,434.5,130.0,434.16239112,0.0,30.0,0.0,0.0,1.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)Cc1ccc(CSCCN/C(=C\[N+](=O)[O-])NCc2ccc3c(c2)OCO3)o1,2.9,"11  18  8
11  22  8
14  24  8
15  25  8
16  18  8
16  20  8
2  14  8
2  15  8
20  26  8
22  26  8
24  25  8",
440790229,4472,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01594,Nialamide,20250421,20210312,Curation Efforts|Governmental Organizations,LT01594,nialamide,8.0,Withdrawn,vMost-DILI-Concern,1.0,4472,1.0,350.0,4.0,3.0,7.0,AAADceB7sAAAAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABwAAAHgAYAAAADADBmgQ8gJLqEACoAjF3VACCgCA1AiIa+KE4ZNgIIHrA1ZGEIQhglgDIyYcUgAAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,N-benzyl-3-[2-(pyridine-4-carbonyl)hydrazino]propanamide,3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide,<I>N</I>-benzyl-3-[2-(pyridine-4-carbonyl)hydrazinyl]propanamide,N-benzyl-3-[2-(pyridine-4-carbonyl)hydrazinyl]propanamide,N-(phenylmethyl)-3-(2-pyridin-4-ylcarbonylhydrazinyl)propanamide,N-benzyl-3-(N'-isonicotinoylhydrazino)propionamide,"InChI=1S/C16H18N4O2/c21-15(18-12-13-4-2-1-3-5-13)8-11-19-20-16(22)14-6-9-17-10-7-14/h1-7,9-10,19H,8,11-12H2,(H,18,21)(H,20,22)",NOIIUHRQUVNIDD-UHFFFAOYSA-N,0.9,298.14297583,C16H18N4O2,298.34,83.1,298.14297583,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,,"11  12  8
11  13  8
12  14  8
13  15  8
14  17  8
15  17  8
18  19  8
18  20  8
19  21  8
20  22  8
6  21  8
6  22  8",
440790228,4260,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01574,Moxisylyte,20231222,20210312,Curation Efforts|Governmental Organizations,LT01574,moxisylyte,8.0,Withdrawn,vMost-DILI-Concern,1.0,4260,1.0,304.0,4.0,0.0,7.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgAAAAAADQThmAYyDoMABACIAiDSCAACCAAgIAAAiAAOCIgOJiKEMRqDOiCkwBEYqAfAwPAOwQABAAAIAACCAAIAABAAAAAAAAAAAA==,[4-[2-(dimethylamino)ethoxy]-5-isopropyl-2-methyl-phenyl] acetate,acetic acid [4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] ester,[4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] acetate,[4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] acetate,[4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-yl-phenyl] ethanoate,acetic acid [4-[2-(dimethylamino)ethoxy]-5-isopropyl-2-methyl-phenyl] ester,"InChI=1S/C16H25NO3/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6/h9-11H,7-8H2,1-6H3",VRYMTAVOXVTQEF-UHFFFAOYSA-N,3.2,279.18344366,C16H25NO3,279.37,38.8,279.18344366,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C,,"11  12  8
11  13  8
6  7  8
6  8  8
7  12  8
8  13  8",
440790227,6075,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02110,MEPAZINE,20231222,20210312,Curation Efforts|Governmental Organizations,LT02110,mepazine,8.0,Withdrawn,vMost-DILI-Concern,1.0,6075,1.0,352.0,3.0,0.0,2.0,AAADceB7AABAAAAAAAAAAAAAAAAAAAAAAAA8eIEAAAAAAACxQAAAHAQAAAAADQjBUAQywYMAAAiAACRCQACCAAAhChAIiBwIZIgIIGLg0ZGEIAhggADoyAcQAAAMAAAAAAAAAQAAAAAAAAACAAAAAAAAAA==,10-[(1-methyl-3-piperidyl)methyl]phenothiazine,10-[(1-methyl-3-piperidinyl)methyl]phenothiazine,10-[(1-methylpiperidin-3-yl)methyl]phenothiazine,10-[(1-methylpiperidin-3-yl)methyl]phenothiazine,10-[(1-methylpiperidin-3-yl)methyl]phenothiazine,10-[(1-methyl-3-piperidyl)methyl]phenothiazine,"InChI=1S/C19H22N2S/c1-20-12-6-7-15(13-20)14-21-16-8-2-4-10-18(16)22-19-11-5-3-9-17(19)21/h2-5,8-11,15H,6-7,12-14H2,1H3",CBHCDHNUZWWAPP-UHFFFAOYSA-N,5.6,310.15036988,C19H22N2S,310.5,31.8,310.15036988,0.0,22.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,,"11  13  8
11  15  8
12  14  8
12  16  8
13  17  8
14  18  8
15  19  8
16  20  8
17  21  8
18  22  8
19  21  8
20  22  8
4  8  3",
440790226,6179,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01508,Mebanazine,20231222,20210312,Curation Efforts|Governmental Organizations,LT01508,mebanazine,8.0,Withdrawn,vMost-DILI-Concern,1.0,6179,1.0,87.3,2.0,2.0,2.0,AAADccBzAAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHAAYAAAADCjBGAQyAIBiAACAAiBCAACCAAAgAAIYqIAABIgIICKAkRGAIABgkAAIiAcQgIAOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,1-phenylethylhydrazine,1-phenylethylhydrazine,1-phenylethylhydrazine,1-phenylethylhydrazine,1-phenylethyldiazane,1-phenylethylhydrazine,"InChI=1S/C8H12N2/c1-7(10-9)8-5-3-2-4-6-8/h2-7,10H,9H2,1H3",HHRZAEJMHSGZNP-UHFFFAOYSA-N,,136.100048391,C8H12N2,136.19,38.1,136.100048391,0.0,10.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(NN)c1ccccc1,0.9,"3  11  3
4  6  8
4  7  8
6  8  8
7  9  8
8  10  8
9  10  8",
440790225,151166,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00686,Lumiracoxib,20210312,20210312,Curation Efforts|Governmental Organizations,LT00686,lumiracoxib,8.0,Withdrawn,vMost-DILI-Concern,1.0,151166,1.0,342.0,4.0,2.0,4.0,AAADccByMQAEAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHwIQCAAADAqBmCgyyILAAgCIAiTSSACCAAAhBwAIiAEAZogIIHLBl5HEYAhk0AHIyAe8yPCOCAACAAACABAQAAQAAAQAIAAAAAAAAA==,2-[2-(2-chloro-6-fluoro-anilino)-5-methyl-phenyl]acetic acid,2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid,2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid,2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid,2-[2-[(2-chloranyl-6-fluoranyl-phenyl)amino]-5-methyl-phenyl]ethanoic acid,2-[2-(2-chloro-6-fluoro-anilino)-5-methyl-phenyl]acetic acid,"InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20)",KHPKQFYUPIUARC-UHFFFAOYSA-N,4.2,293.0618845,C15H13ClFNO2,293.72,49.3,293.0618845,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,,"11  12  8
13  15  8
13  16  8
15  18  8
16  19  8
18  20  8
19  20  8
6  7  8
6  8  8
7  11  8
8  9  8
9  12  8",
440790224,71169,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00696,Isaxonine,20210312,20210312,Curation Efforts|Governmental Organizations,LT00696,isaxonine,8.0,Withdrawn,vMost-DILI-Concern,1.0,71169,1.0,86.9,3.0,1.0,2.0,AAADccBjAAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAHAAQAAAACCjBEgQ/kJbIEACgADBnZACAgCkRAqAJUKA4ZBCACIBASUAEBAgIEAJAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,N-isopropylpyrimidin-2-amine,N-propan-2-yl-2-pyrimidinamine,<I>N</I>-propan-2-ylpyrimidin-2-amine,N-propan-2-ylpyrimidin-2-amine,N-propan-2-ylpyrimidin-2-amine,isopropyl(2-pyrimidyl)amine,"InChI=1S/C7H11N3/c1-6(2)10-7-8-4-3-5-9-7/h3-6H,1-2H3,(H,8,9,10)",FTCYIGBVOHNHCD-UHFFFAOYSA-N,,137.095297364,C7H11N3,137.18,37.8,137.095297364,0.0,10.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)Nc1ncccn1,1.3,"2  7  8
2  8  8
3  7  8
3  9  8
8  10  8
9  10  8",
440790223,3748,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00109,iproniazid,20250421,20210312,Curation Efforts|Governmental Organizations,LT00109,iproniazid,8.0,Withdrawn,vMost-DILI-Concern,1.0,3748,1.0,164.0,3.0,2.0,3.0,AAADccBzIAAAAAAAAAAAAAAAAAAAAAAAAAAsAAAAAAAAAAABgAAAHgAYAAAADCjBmgQ+gJJqEACoAjF3VACCgCA1AiIa+KE4ZNgIIHLAlZGEIQhgkADIyYYUAAAKAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,N'-isopropylpyridine-4-carbohydrazide,N'-propan-2-yl-4-pyridinecarbohydrazide,<I>N</I>&apos;-propan-2-ylpyridine-4-carbohydrazide,N'-propan-2-ylpyridine-4-carbohydrazide,N'-propan-2-ylpyridine-4-carbohydrazide,N'-isopropylisonicotinohydrazide,"InChI=1S/C9H13N3O/c1-7(2)11-12-9(13)8-3-5-10-6-4-8/h3-7,11H,1-2H3,(H,12,13)",NYMGNSNKLVNMIA-UHFFFAOYSA-N,0.4,179.105862047,C9H13N3O,179.22,54.0,179.105862047,0.0,13.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)NNC(=O)c1ccncc1,,"10  12  8
11  13  8
4  12  8
4  13  8
9  10  8
9  11  8",
440790222,15250,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00560,Ibufenac,20231222,20210312,Curation Efforts|Governmental Organizations,LT00560,ibufenac,8.0,Withdrawn,vMost-DILI-Concern,1.0,15250,1.0,179.0,2.0,1.0,4.0,AAADceBwMAAAAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgAACAAADQCAmAAyCIAAAgCIAiDSCAACAAAgAAAIiAEAAIgIIDKAFRCAYAAkwAEIiAeIyOCOQAAAAAAAAACAAAAAAAAAAAAAAAAAAA==,2-(4-isobutylphenyl)acetic acid,2-[4-(2-methylpropyl)phenyl]acetic acid,2-[4-(2-methylpropyl)phenyl]acetic acid,2-[4-(2-methylpropyl)phenyl]acetic acid,2-[4-(2-methylpropyl)phenyl]ethanoic acid,2-(4-isobutylphenyl)acetic acid,"InChI=1S/C12H16O2/c1-9(2)7-10-3-5-11(6-4-10)8-12(13)14/h3-6,9H,7-8H2,1-2H3,(H,13,14)",CYWFCPPBTWOZSF-UHFFFAOYSA-N,3.1,192.115029749,C12H16O2,192.25,37.3,192.115029749,0.0,14.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C)Cc1ccc(CC(=O)O)cc1,,"10  11  8
10  12  8
5  8  8
5  9  8
8  11  8
9  12  8",
440790221,3474,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02092,glafenine,20231222,20210312,Curation Efforts|Governmental Organizations,LT02092,glafenine,8.0,Withdrawn,vMost-DILI-Concern,1.0,3474,1.0,467.0,6.0,3.0,7.0,AAADceB7OAAEAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACx9AAAHgIQCAAADB7hniY8yPLIFgCoAzT3TACCgCA1ByAI2CE4btgJNvrB99mGdYhn0AHL6ceYyKCOBAAAAAICAAAIAAAABAQAAAAAAAAAAA==,"2,3-dihydroxypropyl 2-[(7-chloro-4-quinolyl)amino]benzoate","2-[(7-chloro-4-quinolinyl)amino]benzoic acid 2,3-dihydroxypropyl ester","2,3-dihydroxypropyl 2-[(7-chloroquinolin-4-yl)amino]benzoate","2,3-dihydroxypropyl 2-[(7-chloroquinolin-4-yl)amino]benzoate","2,3-bis(oxidanyl)propyl 2-[(7-chloranylquinolin-4-yl)amino]benzoate",2-[(7-chloro-4-quinolyl)amino]benzoic acid glyceryl ester,"InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22)",GWOFUCIGLDBNKM-UHFFFAOYSA-N,,372.0876847,C19H17ClN2O4,372.8,91.7,372.0876847,0.0,26.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12,3.5,"10  11  8
10  17  8
11  19  8
12  20  8
15  22  8
16  23  8
17  24  8
19  25  8
20  26  8
23  26  8
24  25  8
13  3  3
7  12  8
7  22  8
8  15  8
8  9  8
9  12  8
9  16  8",
440790220,3351,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01372,fipexide,20250421,20210312,Curation Efforts|Governmental Organizations,LT01372,fipexide,8.0,Withdrawn,vMost-DILI-Concern,1.0,3351,1.0,492.0,5.0,0.0,5.0,AAADceB7OAAEAAAAAAAAAAAAAAAAASAAAAA8YIAAAAAAAEgBQAAAHgIAAAAADAbhmCcwDoMABACIAiFSEAKCCAAgJQAIiABOjogfZiKFsx+3OCrkxhGeqAew0BIOICABAAAAQABAQAIAAACAAAAAAAAAAA==,"1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(4-chlorophenoxy)ethanone","1-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-2-(4-chlorophenoxy)ethanone","1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(4-chlorophenoxy)ethanone","1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(4-chlorophenoxy)ethanone","1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(4-chloranylphenoxy)ethanone",2-(4-chlorophenoxy)-1-(4-piperonylpiperazino)ethanone,"InChI=1S/C20H21ClN2O4/c21-16-2-4-17(5-3-16)25-13-20(24)23-9-7-22(8-10-23)12-15-1-6-18-19(11-15)27-14-26-18/h1-6,11H,7-10,12-14H2",BFUJHVVEMMWLHC-UHFFFAOYSA-N,,388.1189848,C20H21ClN2O4,388.8,51.2,388.1189848,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1,3.2,"13  15  8
13  16  8
15  18  8
16  20  8
18  19  8
19  20  8
22  23  8
22  24  8
23  25  8
24  26  8
25  27  8
26  27  8",
440790219,28858,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01846,Fenclozic acid,20210312,20210312,Curation Efforts|Governmental Organizations,LT01846,fenclozic acid,8.0,Withdrawn,vMost-DILI-Concern,1.0,28858,1.0,256.0,4.0,1.0,3.0,AAADccByMABEAAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHgYACAAADAqF3iCwiZIIEgisAyTyTACC8KBhDzgIiDUwJpgIILqhlxGEYAhmwAGoiAcQgAAOBAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,2-[2-(4-chlorophenyl)thiazol-4-yl]acetic acid,2-[2-(4-chlorophenyl)-4-thiazolyl]acetic acid,"2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]acetic acid","2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]acetic acid","2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]ethanoic acid",2-[2-(4-chlorophenyl)thiazol-4-yl]acetic acid,"InChI=1S/C11H8ClNO2S/c12-8-3-1-7(2-4-8)11-13-9(6-16-11)5-10(14)15/h1-4,6H,5H2,(H,14,15)",APBSKHYXXKHJFK-UHFFFAOYSA-N,,252.9964274,C11H8ClNO2S,253.71,78.4,252.9964274,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)Cc1csc(-c2ccc(Cl)cc2)n1,2.7,"11  13  8
12  14  8
13  15  8
14  15  8
2  10  8
2  7  8
5  7  8
5  8  8
6  11  8
6  12  8
8  10  8",
440790218,40399,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01359,EXIFONE,20210804,20210312,Curation Efforts|Governmental Organizations,LT01359,exifone,8.0,Withdrawn,vMost-DILI-Concern,1.0,40399,1.0,349.0,7.0,6.0,2.0,AAADccBwOAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAGgAACAAADASAmAAwBoAAAgCIAqBSAAACAAAkIAAIiAEGiMgJJzaCFRKAcUEl4BUJmYeK7PTOIAABCAAIQABAAAIQABCAAAAAAAAAAA==,"(2,3,4-trihydroxyphenyl)-(3,4,5-trihydroxyphenyl)methanone","(2,3,4-trihydroxyphenyl)-(3,4,5-trihydroxyphenyl)methanone","(2,3,4-trihydroxyphenyl)-(3,4,5-trihydroxyphenyl)methanone","(2,3,4-trihydroxyphenyl)-(3,4,5-trihydroxyphenyl)methanone","[2,3,4-tris(oxidanyl)phenyl]-[3,4,5-tris(oxidanyl)phenyl]methanone","(2,3,4-trihydroxyphenyl)-(3,4,5-trihydroxyphenyl)methanone","InChI=1S/C13H10O7/c14-7-2-1-6(11(18)13(7)20)10(17)5-3-8(15)12(19)9(16)4-5/h1-4,14-16,18-20H",XEDWWPGWIXPVRQ-UHFFFAOYSA-N,,278.04265265,C13H10O7,278.21,138.0,278.04265265,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(c1cc(O)c(O)c(O)c1)c1ccc(O)c(O)c1O,1.7,"11  15  8
12  17  8
13  16  8
14  19  8
15  20  8
16  18  8
17  18  8
19  20  8
8  11  8
8  14  8
9  12  8
9  13  8",
440790217,2898,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01250,cyclofenil,20231222,20210312,Curation Efforts|Governmental Organizations,LT01250,cyclofenil,8.0,Withdrawn,vMost-DILI-Concern,1.0,2898,1.0,503.0,4.0,0.0,6.0,AAADceB4OAAAAAAAAAAAAAAAAAAAAAAAAAAwYMAAAAAAAAABQAAAGgAAAAAADASAmAAyDoAABACIAiDSCAACCAAgIAAIiAAGCIgMJiKEMRqCOiCkwBEIqAeAwOAOIAAAAAAAAABAAAAAAAAAAAAAAAAAAA==,[4-[(4-acetoxyphenyl)-cyclohexylidene-methyl]phenyl] acetate,acetic acid [4-[(4-acetyloxyphenyl)-cyclohexylidenemethyl]phenyl] ester,[4-[(4-acetyloxyphenyl)-cyclohexylidenemethyl]phenyl] acetate,[4-[(4-acetyloxyphenyl)-cyclohexylidenemethyl]phenyl] acetate,[4-[(4-acetyloxyphenyl)-cyclohexylidene-methyl]phenyl] ethanoate,acetic acid [4-[(4-acetoxyphenyl)-cyclohexylidene-methyl]phenyl] ester,"InChI=1S/C23H24O4/c1-16(24)26-21-12-8-19(9-13-21)23(18-6-4-3-5-7-18)20-10-14-22(15-11-20)27-17(2)25/h8-15H,3-7H2,1-2H3",GVOUFPWUYJWQSK-UHFFFAOYSA-N,,364.16745924,C23H24O4,364.4,52.6,364.16745924,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(=O)Oc1ccc(C(=C2CCCCC2)c2ccc(OC(C)=O)cc2)cc1,5.5,"12  14  8
12  16  8
13  15  8
13  17  8
14  18  8
15  19  8
16  20  8
17  21  8
18  22  8
19  23  8
20  22  8
21  23  8",
440790216,33176,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01228,Clometacin,20231222,20210312,Curation Efforts|Governmental Organizations,LT01228,clometacin,8.0,Withdrawn,vMost-DILI-Concern,1.0,33176,1.0,506.0,4.0,1.0,5.0,AAADceB6OAAEAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgB9AAAHgIACAAADA7BniYyzvMMFgCoA6TyTACCiCAlJyAI2CG+btgOJvrFt7uEMahmwBnY6cec2POOpAAAAgACAABIAAAEAAQAAAAAAAAAAA==,2-[3-(4-chlorobenzoyl)-6-methoxy-2-methyl-indol-1-yl]acetic acid,2-[3-[(4-chlorophenyl)-oxomethyl]-6-methoxy-2-methyl-1-indolyl]acetic acid,2-[3-(4-chlorobenzoyl)-6-methoxy-2-methylindol-1-yl]acetic acid,2-[3-(4-chlorobenzoyl)-6-methoxy-2-methylindol-1-yl]acetic acid,2-[3-(4-chlorophenyl)carbonyl-6-methoxy-2-methyl-indol-1-yl]ethanoic acid,2-[3-(4-chlorobenzoyl)-6-methoxy-2-methyl-indol-1-yl]acetic acid,"InChI=1S/C19H16ClNO4/c1-11-18(19(24)12-3-5-13(20)6-4-12)15-8-7-14(25-2)9-16(15)21(11)10-17(22)23/h3-9H,10H2,1-2H3,(H,22,23)",DGMZLCLHHVYDIS-UHFFFAOYSA-N,,357.0767857,C19H16ClNO4,357.8,68.5,357.0767857,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1,4.0,"12  16  8
13  17  8
16  17  8
18  20  8
18  21  8
20  22  8
21  23  8
22  24  8
23  24  8
6  7  8
6  9  8
7  12  8
7  8  8
8  10  8
8  13  8
9  10  8",
440790215,21382,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00694,Clomacran,20231222,20210312,Curation Efforts|Governmental Organizations,LT00694,clomacran,8.0,Withdrawn,vMost-DILI-Concern,1.0,21382,1.0,333.0,2.0,1.0,4.0,AAADceB7AAAEAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACxQAAAHAIQAAAADQrBGCQywIPAAACAAiRCQACCAAAhBwAIiAAIZogIIGLBk5GEIAhgkADIyAcQgMAOgABAIAACAAAAAIBAAAQAAAAAAAAAAA==,"3-(2-chloro-9,10-dihydroacridin-9-yl)-N,N-dimethyl-propan-1-amine","3-(2-chloro-9,10-dihydroacridin-9-yl)-N,N-dimethyl-1-propanamine","3-(2-chloro-9,10-dihydroacridin-9-yl)-<I>N</I>,<I>N</I>-dimethylpropan-1-amine","3-(2-chloro-9,10-dihydroacridin-9-yl)-N,N-dimethylpropan-1-amine","3-(2-chloranyl-9,10-dihydroacridin-9-yl)-N,N-dimethyl-propan-1-amine","3-(2-chloro-9,10-dihydroacridin-9-yl)propyl-dimethyl-amine","InChI=1S/C18H21ClN2/c1-21(2)11-5-7-14-15-6-3-4-8-17(15)20-18-10-9-13(19)12-16(14)18/h3-4,6,8-10,12,14,20H,5,7,11H2,1-2H3",JFRLWWDJCFYFSU-UHFFFAOYSA-N,,300.1393264,C18H21ClN2,300.8,15.3,300.1393264,0.0,21.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN(C)CCCC1c2ccccc2Nc2ccc(Cl)cc21,4.6,"10  15  8
12  16  8
13  17  8
14  18  8
15  19  8
16  18  8
17  19  8
4  5  3
6  12  8
6  9  8
7  10  8
7  13  8
9  14  8",
440790214,8593,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01219,Cinchophen,20210804,20210312,Curation Efforts|Governmental Organizations,LT01219,cinchophen,8.0,Withdrawn,vMost-DILI-Concern,1.0,8593,1.0,325.0,3.0,1.0,2.0,AAADccB6MAAAAAAAAAAAAAAAAAAAAAAAAAA8YIAAAAAAAACx9AAAHgAACAAADAiBngAwyPIIEgCoAyTyTACCgCAlAiAImCEwbNgIJvLAlZGEcQhkwAHI2Ye8yPCOgAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,2-phenylquinoline-4-carboxylic acid,2-phenyl-4-quinolinecarboxylic acid,2-phenylquinoline-4-carboxylic acid,2-phenylquinoline-4-carboxylic acid,2-phenylquinoline-4-carboxylic acid,2-phenylcinchoninic acid,"InChI=1S/C16H11NO2/c18-16(19)13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10H,(H,18,19)",YTRMTPPVNRALON-UHFFFAOYSA-N,,249.078978594,C16H11NO2,249.26,50.2,249.078978594,0.0,19.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)c1cc(-c2ccccc2)nc2ccccc12,3.4,"10  12  8
11  13  8
12  13  8
14  17  8
15  18  8
17  19  8
18  19  8
3  5  8
3  6  8
4  10  8
4  5  8
4  7  8
5  11  8
6  8  8
7  8  8
9  14  8
9  15  8",
440790213,60726,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00519,Bromfenac,20250421,20210312,Curation Efforts|Governmental Organizations,LT00519,bromfenac,8.0,Withdrawn,vMost-DILI-Concern,1.0,60726,1.0,366.0,4.0,2.0,4.0,AAADccByMAAAEAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgBQCAABrAyBmAAwyIBAAgCIAqTSSACCAAAkAAQIiAEAROgIIDqAlZGAYYBkwAEIy9e8yPCOAgACAAACAAAEAAQAAAQAAAAAAAAAAA==,2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid,2-[2-amino-3-[(4-bromophenyl)-oxomethyl]phenyl]acetic acid,2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid,2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid,2-[2-azanyl-3-(4-bromophenyl)carbonyl-phenyl]ethanoic acid,2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid,"InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)",ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,,333.00006,C15H12BrNO3,334.16,80.4,333.00006,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1,3.3,"10  14  8
12  14  8
13  15  8
13  16  8
15  18  8
16  19  8
18  20  8
19  20  8
6  10  8
6  8  8
7  12  8
7  8  8",
440790212,6237,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01121,BENZIODARONE,20250421,20210312,Curation Efforts|Governmental Organizations,LT01121,benziodarone,8.0,Withdrawn,vMost-DILI-Concern,1.0,6237,1.0,405.0,3.0,1.0,3.0,AAADccB4MAAAAwAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAEgB9AAAGgAgCAAADASCmAAyBsAABkCIAqBSAAACCAAkIAAIiAEGCMgMJjaONRqCeWCk4BEIuYeLzPDOoAAAAAAIAABAAAAAABAAAAAAAAAAAA==,"(2-ethylbenzofuran-3-yl)-(4-hydroxy-3,5-diiodo-phenyl)methanone","(2-ethyl-3-benzofuranyl)-(4-hydroxy-3,5-diiodophenyl)methanone","(2-ethyl-1-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone","(2-ethyl-1-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone","[3,5-bis(iodanyl)-4-oxidanyl-phenyl]-(2-ethyl-1-benzofuran-3-yl)methanone","(2-ethylbenzofuran-3-yl)-(4-hydroxy-3,5-diiodo-phenyl)methanone","InChI=1S/C17H12I2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3",CZCHIEJNWPNBDE-UHFFFAOYSA-N,5.6,517.88759,C17H12I2O3,518.08,50.4,517.88759,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1,,"12  16  8
13  18  8
13  19  8
14  17  8
16  17  8
18  21  8
19  20  8
20  22  8
21  22  8
3  8  8
3  9  8
6  7  8
6  8  8
7  12  8
7  9  8
9  14  8",
440790211,2333,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00278,benzbromarone,20250421,20210312,Curation Efforts|Governmental Organizations,LT00278,benzbromarone,8.0,Withdrawn,vMost-DILI-Concern,1.0,2333,1.0,405.0,3.0,1.0,3.0,AAADccB4MAAAGAAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAEgB9AAAGgBACAABrASAmAAyBsAABkCIAqBSAAACCAAkIAQIiAEGCOgMJjaONRqCeWCk4BEIu5eLzPDOoAAAEAAoBABAAAAgAFAIAAAAAAAAAA==,"(3,5-dibromo-4-hydroxy-phenyl)-(2-ethylbenzofuran-3-yl)methanone","(3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-3-benzofuranyl)methanone","(3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone","(3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone","[3,5-bis(bromanyl)-4-oxidanyl-phenyl]-(2-ethyl-1-benzofuran-3-yl)methanone","(3,5-dibromo-4-hydroxy-phenyl)-(2-ethylbenzofuran-3-yl)methanone","InChI=1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3",WHQCHUCQKNIQEC-UHFFFAOYSA-N,5.7,423.91327,C17H12Br2O3,424.1,50.4,421.91532,0.0,22.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,,"12  16  8
13  18  8
13  19  8
14  17  8
16  17  8
18  21  8
19  20  8
20  22  8
21  22  8
3  8  8
3  9  8
6  7  8
6  8  8
7  12  8
7  9  8
9  14  8",
440790210,255968,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01120,Benzarone,20250421,20210312,Curation Efforts|Governmental Organizations,LT01120,benzarone,8.0,Withdrawn,vMost-DILI-Concern,1.0,255968,1.0,346.0,3.0,1.0,3.0,AAADccB4MAAAAAAAAAAAAAAAAAAAASAAAAAwYAAAAAAAAEgB9AAAGgAACAAADASAmAAyBsAABkCIAqBSAAACCAAkIAAIiAEGCMgMJjaONRqCeWCk4BEIuYeLzPDOoAAAAAAIAABAAAAAABAAAAAAAAAAAA==,(2-ethylbenzofuran-3-yl)-(4-hydroxyphenyl)methanone,(2-ethyl-3-benzofuranyl)-(4-hydroxyphenyl)methanone,(2-ethyl-1-benzofuran-3-yl)-(4-hydroxyphenyl)methanone,(2-ethyl-1-benzofuran-3-yl)-(4-hydroxyphenyl)methanone,(2-ethyl-1-benzofuran-3-yl)-(4-hydroxyphenyl)methanone,(2-ethylbenzofuran-3-yl)-(4-hydroxyphenyl)methanone,"InChI=1S/C17H14O3/c1-2-14-16(13-5-3-4-6-15(13)20-14)17(19)11-7-9-12(18)10-8-11/h3-10,18H,2H2,1H3",RFRXIWQYSOIBDI-UHFFFAOYSA-N,4.3,266.094294304,C17H14O3,266.29,50.4,266.094294304,0.0,20.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCc1oc2ccccc2c1C(=O)c1ccc(O)cc1,,"1  6  8
1  7  8
10  14  8
11  15  8
12  16  8
12  17  8
14  15  8
16  18  8
17  19  8
18  20  8
19  20  8
4  5  8
4  6  8
5  10  8
5  7  8
7  11  8",
440790209,39941,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00513,Benoxaprofen,20231222,20210312,Curation Efforts|Governmental Organizations,LT00513,benoxaprofen,8.0,Withdrawn,vMost-DILI-Concern,1.0,39941,1.0,384.0,4.0,1.0,3.0,AAADccB6MAAEAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgB9AAAHgIACAAADQ6BniAyzrIIFkCoA6XyXASCiCAvZyAImCG3btgOJrLFt7uPeSjkxBHY6YeY2fOepAAAQAAAEABIAACAAAAgAAAAAAAAAA==,"2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid","2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid","2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid","2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid","2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid","2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propionic acid","InChI=1S/C16H12ClNO3/c1-9(16(19)20)11-4-7-14-13(8-11)18-15(21-14)10-2-5-12(17)6-3-10/h2-9H,1H3,(H,19,20)",MITFXPHMIHQXPI-UHFFFAOYSA-N,,301.0505709,C16H12ClNO3,301.72,63.3,301.0505709,0.0,21.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1,4.1,"10  12  8
11  12  8
15  17  8
15  18  8
17  19  8
18  20  8
19  21  8
2  10  8
2  14  8
20  21  8
5  14  8
5  8  8
6  13  3
7  11  8
7  9  8
8  10  8
8  9  8",
440790208,2313,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01117,bendazac,20231222,20210312,Curation Efforts|Governmental Organizations,LT01117,bendazac,8.0,Withdrawn,vMost-DILI-Concern,1.0,2313,1.0,357.0,4.0,1.0,5.0,AAADccB7MAAAAAAAAAAAAAAAAAAAAWAAAAAwYAAAAAAAAFgB9AAAHgAICAAADAjhngYwzPIIBgCqAyTyTAKSDAAhogAY2CB8bJgNJqLE8d+OvCjmyBnL6AeQwCAOAAAAAAACAAAAAAAAAAQAAAAAAAAAAA==,2-(1-benzylindazol-3-yl)oxyacetic acid,2-[[1-(phenylmethyl)-3-indazolyl]oxy]acetic acid,2-(1-benzylindazol-3-yl)oxyacetic acid,2-(1-benzylindazol-3-yl)oxyacetic acid,2-[1-(phenylmethyl)indazol-3-yl]oxyethanoic acid,2-(1-benzylindazol-3-yl)oxyacetic acid,"InChI=1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)",BYFMCKSPFYVMOU-UHFFFAOYSA-N,,282.10044231,C16H14N2O3,282.29,64.4,282.10044231,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)COc1nn(Cc2ccccc2)c2ccccc12,3.1,"10  15  8
10  16  8
11  13  8
12  14  8
13  14  8
15  17  8
16  18  8
17  20  8
18  20  8
4  5  8
4  6  8
5  9  8
6  11  8
6  8  8
8  12  8
8  9  8",
440790207,54897,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01060,ALPIDEM,20210804,20210312,Curation Efforts|Governmental Organizations,LT01060,alpidem,8.0,Withdrawn,vMost-DILI-Concern,1.0,54897,1.0,478.0,2.0,0.0,7.0,AAADceB7IAAGAAAAAAAAAAAAAAAAAWAAAAA8QAAAAAAAAFgB8AAAHgIAAAAADArBnyQ/sJ8MGACoAzd3dACCgC0xF6AJ2CE4dpiIaPrB35HUIAhohgLIyCcciICOBAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,"2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropyl-acetamide","2-[6-chloro-2-(4-chlorophenyl)-3-imidazo[1,2-a]pyridinyl]-N,N-dipropylacetamide","2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-<I>N</I>,<I>N</I>-dipropylacetamide","2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide","2-[6-chloranyl-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropyl-ethanamide","2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropyl-acetamide","InChI=1S/C21H23Cl2N3O/c1-3-11-25(12-4-2)20(27)13-18-21(15-5-7-16(22)8-6-15)24-19-10-9-17(23)14-26(18)19/h5-10,14H,3-4,11-13H2,1-2H3",JRTIDHTUMYMPRU-UHFFFAOYSA-N,4.8,403.1218178,C21H23Cl2N3O,404.3,37.6,403.1218178,0.0,27.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12,,"15  18  8
16  23  8
16  24  8
17  21  8
18  22  8
21  22  8
23  25  8
24  26  8
25  27  8
26  27  8
5  15  8
5  17  8
5  7  8
6  12  8
6  15  8
7  12  8",
440790206,30951,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00692,alclofenac,20231222,20210312,Curation Efforts|Governmental Organizations,LT00692,alclofenac,8.0,Withdrawn,vMost-DILI-Concern,1.0,30951,1.0,230.0,3.0,1.0,5.0,AAADccBwMAAEAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAGgIACAAADAagmCIwDoAABgCIAiDSCAACCAAgJUAIiAEGC4gMJjOFNxqCeCCkwBEIqAeIyKCOIAAAIAAACABAAABAAAAQAAAAAAAAAA==,2-(4-allyloxy-3-chloro-phenyl)acetic acid,2-(3-chloro-4-prop-2-enoxyphenyl)acetic acid,2-(3-chloro-4-prop-2-enoxyphenyl)acetic acid,2-(3-chloro-4-prop-2-enoxyphenyl)acetic acid,2-(3-chloranyl-4-prop-2-enoxy-phenyl)ethanoic acid,2-(4-allyloxy-3-chloro-phenyl)acetic acid,"InChI=1S/C11H11ClO3/c1-2-5-15-10-4-3-8(6-9(10)12)7-11(13)14/h2-4,6H,1,5,7H2,(H,13,14)",ARHWPKZXBHOEEE-UHFFFAOYSA-N,2.5,226.0396719,C11H11ClO3,226.65,46.5,226.0396719,0.0,15.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",C=CCOc1ccc(CC(=O)O)cc1Cl,,"5  7  8
5  8  8
7  10  8
8  11  8
9  10  8
9  11  8",
440790205,5282517,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00461,Alatrofloxacin mesylate,20250421,20210312,Curation Efforts|Governmental Organizations,LT00461,alatrofloxacin mesylate,8.0,Withdrawn,vMost-DILI-Concern,1.0,5282517,1.0,1180.0,15.0,5.0,7.0,AAADceB7vYBAAAAAAAAAAAAAGAAAAWAAAAA8WIEAAAAAAACBwAAAHwQQCAAADSzBmgyz+JPIEoKoAqf2fHCCgCklAiAJmKGoZNiIZP7I3bGUYYhstgLI2eeY2SKOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"7-[(1S,5R)-6-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid","7-[(1S,5R)-6-[[(2S)-2-[[(2S)-2-amino-1-oxopropyl]amino]-1-oxopropyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid","7-[(1<I>S</I>,5<I>R</I>)-6-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-aminopropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid","7-[(1S,5R)-6-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid","7-[(1S,5R)-6-[[(2S)-2-[[(2S)-2-azanylpropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-[2,4-bis(fluoranyl)phenyl]-6-fluoranyl-4-oxidanylidene-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid","7-[(1S,5R)-6-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-keto-1,8-naphthyridine-3-carboxylic acid;mesylic acid","InChI=1S/C26H25F3N6O5.CH4O3S/c1-10(30)24(37)31-11(2)25(38)32-20-14-7-34(8-15(14)20)23-18(29)6-13-21(36)16(26(39)40)9-35(22(13)33-23)19-4-3-12(27)5-17(19)28;1-5(2,3)4/h3-6,9-11,14-15,20H,7-8,30H2,1-2H3,(H,31,37)(H,32,38)(H,39,40);1H3,(H,2,3,4)/t10-,11-,14-,15+,20?;/m0./s1",CYETUYYEVKNSHZ-RSUMCGCKSA-N,,654.17196756,C27H29F3N6O8S,654.6,221.0,654.17196756,0.0,45.0,4.0,0.0,0.0,0.0,0.0,2.0,-1.0,"1
5
255",CS(=O)(=O)O.C[C@H](N)C(=O)N[C@@H](C)C(=O)NC1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12,,"15  24  8
15  29  8
26  16  5
17  29  8
17  34  8
37  18  6
19  46  5
20  47  5
24  27  8
27  28  8
28  31  8
29  31  8
31  33  8
33  35  8
34  35  8
36  40  8
36  41  8
40  42  8
41  43  8
42  44  8
43  44  8",
440790204,2081,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT02213,Alaproclate,20231222,20210312,Curation Efforts|Governmental Organizations,LT02213,alaproclate,8.0,Withdrawn,vMost-DILI-Concern,1.0,2081,1.0,260.0,3.0,1.0,5.0,AAADceByMAAEAAAAAAAAAAAAAAAAAAAAAAAwAAAAAAAAAAABAAAAHgIQAAAADG7BmCQyCIBABACIAiDSCAACAAAgBQAIiIGAAogKICKBExCDIAAk0AEIiAeAwOAOBAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,"[2-(4-chlorophenyl)-1,1-dimethyl-ethyl] 2-aminopropanoate",2-aminopropanoic acid [1-(4-chlorophenyl)-2-methylpropan-2-yl] ester,[1-(4-chlorophenyl)-2-methylpropan-2-yl] 2-aminopropanoate,[1-(4-chlorophenyl)-2-methylpropan-2-yl] 2-aminopropanoate,[1-(4-chlorophenyl)-2-methyl-propan-2-yl] 2-azanylpropanoate,"2-aminopropionic acid [2-(4-chlorophenyl)-1,1-dimethyl-ethyl] ester","InChI=1S/C13H18ClNO2/c1-9(15)12(16)17-13(2,3)8-10-4-6-11(14)7-5-10/h4-7,9H,8,15H2,1-3H3",FZSPJBYOKQPKCD-UHFFFAOYSA-N,,255.1026065,C13H18ClNO2,255.74,52.3,255.1026065,0.0,17.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1,2.8,"11  26  3
12  14  8
13  15  8
14  17  8
15  17  8
9  12  8
9  13  8",
440790203,62959,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00645,Trovafloxacin,20210804,20210312,Curation Efforts|Governmental Organizations,LT00645,trovafloxacin,8.0,Withdrawn,vMost-DILI-Concern,1.0,62959,1.0,770.0,10.0,2.0,3.0,AAADccB7sYAAAAAAAAAAAAAAGAAAAWAAAAA8WIEAAAAAAACBwAAAHwAQCAAADSzBmgwx+JNIEgCoAqb2bACCgCklAiAJmKEoZNiIJP7I3ZGEYYhssALI2eeY2SKOAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid","7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid","7-[(1<I>S</I>,5<I>R</I>)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid","7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid","7-[(1S,5R)-6-azanyl-3-azabicyclo[3.1.0]hexan-3-yl]-1-[2,4-bis(fluoranyl)phenyl]-6-fluoranyl-4-oxidanylidene-1,8-naphthyridine-3-carboxylic acid","7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-keto-1,8-naphthyridine-3-carboxylic acid","InChI=1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)/t10-,11+,16?",WVPSKSLAZQPAKQ-SOSAQKQKSA-N,0.3,416.10962484,C20H15F3N4O3,416.4,99.8,416.10962484,0.0,30.0,2.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12,,"10  18  8
10  22  8
11  31  5
12  32  5
16  17  8
17  19  8
18  20  8
19  20  8
20  21  8
21  23  8
22  23  8
24  25  8
24  26  8
25  28  8
26  29  8
28  30  8
29  30  8
9  16  8
9  18  8",
440790202,5591,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00168,troglitazone,20231222,20210312,Curation Efforts|Governmental Organizations,LT00168,troglitazone,8.0,Withdrawn,vMost-DILI-Concern,1.0,5591,1.0,681.0,6.0,2.0,5.0,AAADceB6OABAAAAAAAAAAAAAAAAAAWAAAAA0YIAAAAAAAACRQAAAHgQQCAAADESl2AKyBoLABgiIAiFSEAACCABgIBAIiAEGCIgNJjKmsRqGeCCk1DEKuAfYyPCO4QADAAAYAADCAAYAADAAAAAAAAAAAA==,"5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl)methoxy]phenyl]methyl]thiazolidine-2,4-dione","5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]thiazolidine-2,4-dione","5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","5-[[4-[(2,5,7,8-tetramethyl-6-oxidanyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","5-[4-[(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl)methoxy]benzyl]thiazolidine-2,4-quinone","InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28)",GXPHKUHSUJUWKP-UHFFFAOYSA-N,,441.16099414,C24H27NO5S,441.5,110.0,441.16099414,0.0,31.0,0.0,2.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,5.1,"11  12  8
11  15  8
12  16  8
15  18  8
16  17  8
17  18  8
22  24  8
22  25  8
23  28  8
23  29  8
24  28  8
25  29  8
27  55  3
8  14  3",
440790201,57394584,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01858,Tetrabamate,20250421,20210312,Curation Efforts|Governmental Organizations,LT01858,tetrabamate,8.0,Withdrawn,vMost-DILI-Concern,1.0,57394584,1.0,1850.0,18.0,6.0,33.0,AAADcfB//gAAAAAAAAAAAAAAAAAAAAAAAAA8ePECAAAAAAABUAAAHgAQAAAADhTxmAczCIPABACIAiFSGAACAAAgAAAIiAEIAImbIDqI1RGvIAAuhyKeiAeYiMCPgAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==,"[1-(butoxymethyl)-2-[3-(2-carbamoyloxy-2-pentoxy-ethyl)-5-ethyl-2,4,6-trioxo-5-phenyl-hexahydropyrimidin-1-yl]ethyl] carbamate;[1-(butoxymethyl)-2-(5-ethyl-2,4,6-trioxo-5-phenyl-hexahydropyrimidin-1-yl)ethyl] carbamate;5-ethyl-5-phenyl-hexahydropyrimidine-2,4,6-trione","carbamic acid [1-butoxy-3-[3-(2-carbamoyloxy-2-pentoxyethyl)-5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl]propan-2-yl] ester;carbamic acid [1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)propan-2-yl] ester;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione","[1-butoxy-3-[3-(2-carbamoyloxy-2-pentoxyethyl)-5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl]propan-2-yl] carbamate;[1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)propan-2-yl] carbamate;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione","[1-butoxy-3-[3-(2-carbamoyloxy-2-pentoxyethyl)-5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl]propan-2-yl] carbamate;[1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)propan-2-yl] carbamate;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione","[1-[3-(2-aminocarbonyloxy-2-pentoxy-ethyl)-5-ethyl-2,4,6-tris(oxidanylidene)-5-phenyl-1,3-diazinan-1-yl]-3-butoxy-propan-2-yl] carbamate;[1-butoxy-3-[5-ethyl-2,4,6-tris(oxidanylidene)-5-phenyl-1,3-diazinan-1-yl]propan-2-yl] carbamate;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione","carbamic acid [1-[[3-(2-amoxy-2-carbamoyloxy-ethyl)-5-ethyl-2,4,6-triketo-5-phenyl-hexahydropyrimidin-1-yl]methyl]-2-butoxy-ethyl] ester;carbamic acid [1-(butoxymethyl)-2-(5-ethyl-2,4,6-triketo-5-phenyl-hexahydropyrimidin-1-yl)ethyl] ester;5-ethyl-5-phenyl-barbituric acid","InChI=1S/C28H42N4O9.C20H27N3O6.C12H12N2O3/c1-4-7-12-16-39-22(41-26(30)36)18-32-24(34)28(6-3,20-13-10-9-11-14-20)23(33)31(27(32)37)17-21(40-25(29)35)19-38-15-8-5-2;1-3-5-11-28-13-15(29-18(21)26)12-23-17(25)20(4-2,16(24)22-19(23)27)14-9-7-6-8-10-14;1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h9-11,13-14,21-22H,4-8,12,15-19H2,1-3H3,(H2,29,35)(H2,30,36);6-10,15H,3-5,11-13H2,1-2H3,(H2,21,26)(H,22,24,27);3-7H,2H2,1H3,(H2,13,14,15,16,17)",YADPKIAGCVAODE-UHFFFAOYSA-N,,1215.56995677,C60H81N9O18,1216.3,384.0,1215.56995677,0.0,87.0,0.0,5.0,0.0,0.0,0.0,3.0,-1.0,"1
5
255",CCC1(c2ccccc2)C(=O)NC(=O)NC1=O.CCCCCOC(CN1C(=O)N(CC(COCCCC)OC(N)=O)C(=O)C(CC)(c2ccccc2)C1=O)OC(N)=O.CCCCOCC(CN1C(=O)NC(=O)C(CC)(c2ccccc2)C1=O)OC(N)=O,,"28  29  3
32  38  8
32  39  8
37  33  3
41  35  3
38  45  8
39  46  8
40  43  3
45  49  8
46  49  8
47  55  8
47  56  8
52  50  3
55  63  8
56  64  8
63  67  8
64  67  8
71  80  8
71  81  8
80  84  8
81  85  8
84  86  8
85  86  8",
440790200,4495,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00314,nimesulide,20250421,20210312,Curation Efforts|Governmental Organizations,LT00314,nimesulide,8.0,Withdrawn,vMost-DILI-Concern,1.0,4495,1.0,450.0,6.0,1.0,4.0,AAADccBzOABAAAAAAAAAAAAAAAAAAAAAAAAwYAAAAAAAAAABQAAAHgQUQAAACAyBkACyxoBQRAKBACRCQ3CCCAAgIgAoiAAHbIoOJiKEsZuDOCDm0BkI6AeQUAEAAACAAgAAEAAAAQAEAAAgAAAAAAAAAA==,N-(4-nitro-2-phenoxy-phenyl)methanesulfonamide,N-(4-nitro-2-phenoxyphenyl)methanesulfonamide,<I>N</I>-(4-nitro-2-phenoxyphenyl)methanesulfonamide,N-(4-nitro-2-phenoxyphenyl)methanesulfonamide,N-(4-nitro-2-phenoxy-phenyl)methanesulfonamide,N-(4-nitro-2-phenoxy-phenyl)methanesulfonamide,"InChI=1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3",HYWYRSMBCFDLJT-UHFFFAOYSA-N,2.6,308.04669266,C13H12N2O5S,308.31,110.0,308.04669266,0.0,21.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,,"10  12  8
11  14  8
12  13  8
13  14  8
16  17  8
16  18  8
17  19  8
18  20  8
19  21  8
20  21  8
9  10  8
9  11  8",
440790199,65869,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01849,Ebrotidine,20210312,20210312,Curation Efforts|Governmental Organizations,LT01849,ebrotidine,8.0,Withdrawn,vMost-DILI-Concern,1.0,65869,1.0,586.0,7.0,3.0,9.0,AAADceBzsABgEAAAAAAAAAAAAAAAAWAAAAAwAAAAAAAAAAABwAAAHARQQAABqAjFVgSxkZJIEAqkASRjZHBC8LlhCjwIiJwQIKiIICKgERCAIAAggAIoijcAAAAAAAEAAAAAAAAAAgAAAAAAAAAAAAAAAA==,N-(4-bromophenyl)sulfonyl-N'-[2-[(2-guanidinothiazol-4-yl)methylsulfanyl]ethyl]formamidine,N-(4-bromophenyl)sulfonyl-N'-[2-[[2-(diaminomethylideneamino)-4-thiazolyl]methylthio]ethyl]methanimidamide,"<I>N</I>-(4-bromophenyl)sulfonyl-<I>N</I>&apos;-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]methanimidamide","N-(4-bromophenyl)sulfonyl-N'-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]methanimidamide","N'-[2-[[2-[bis(azanyl)methylideneamino]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N-(4-bromophenyl)sulfonyl-methanimidamide",N-brosyl-N'-[2-[(2-guanidinothiazol-4-yl)methylthio]ethyl]formamidine,"InChI=1S/C14H17BrN6O2S3/c15-10-1-3-12(4-2-10)26(22,23)19-9-18-5-6-24-7-11-8-25-14(20-11)21-13(16)17/h1-4,8-9H,5-7H2,(H,18,19)(H4,16,17,20,21)",ZQHFZHPUZXNPMF-UHFFFAOYSA-N,,475.97585,C14H17BrN6O2S3,477.4,198.0,475.97585,0.0,26.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",NC(N)=Nc1nc(CSCC/N=C/NS(=O)(=O)c2ccc(Br)cc2)cs1,1.5,"13  16  8
13  17  8
16  20  8
17  21  8
19  24  8
20  23  8
21  23  8
4  24  8
4  25  8
9  19  8
9  25  8",
440790198,65679,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01318,Droxicam,20231222,20210312,Curation Efforts|Governmental Organizations,LT01318,droxicam,8.0,Withdrawn,vMost-DILI-Concern,1.0,65679,1.0,741.0,7.0,0.0,1.0,AAADccB7OABAAAAAAAAAAAAAAAAAAAAAAAA8QIEAAAAAAACxwAAAHgQAQAAADAzB2gQ/uZMIFAKoAjd3fHDCiDkxIiAJ2Di4bNiIZuLAubmcMAhsxSPI6SeQwCAOAAAAAAAEAAAAAAAAAAgAAAAAAAAAAA==,"5-methyl-6,6-dioxo-3-(2-pyridyl)-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4-dione","5-methyl-6,6-dioxo-3-(2-pyridinyl)-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4-dione","5-methyl-6,6-dioxo-3-pyridin-2-yl-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4-dione","5-methyl-6,6-dioxo-3-pyridin-2-yl-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4-dione","5-methyl-6,6-bis(oxidanylidene)-3-pyridin-2-yl-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4-dione","6,6-diketo-5-methyl-3-(2-pyridyl)-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4-quinone","InChI=1S/C16H11N3O5S/c1-18-13-14(10-6-2-3-7-11(10)25(18,22)23)24-16(21)19(15(13)20)12-8-4-5-9-17-12/h2-9H,1H3",OEHFRZLKGRKFAS-UHFFFAOYSA-N,,357.04194163,C16H11N3O5S,357.3,105.0,357.04194163,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O,1.2,"10  13  8
10  14  8
11  12  8
11  16  8
12  17  8
16  19  8
17  20  8
19  20  8
2  13  8
2  18  8
21  22  8
22  23  8
23  25  8
24  25  8
8  14  8
8  18  8
9  21  8
9  24  8",
440790197,2717,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT01201,chlormezanone,20231222,20210312,Curation Efforts|Governmental Organizations,LT01201,chlormezanone,8.0,Withdrawn,vMost-DILI-Concern,1.0,2717,1.0,395.0,3.0,0.0,1.0,AAADccByMABEAAAAAAAAAAAAAAAAAAAAAAA8QAAAAAAAAAABAAAAHgYAAAAADALF2CSyAIMAAAqIAiFSEHDKAABgBRAIiAEIBogIICKhkxGEIAhghgCoiAcQgAAOBAAAAAAAAAAIAAAAAAAAAAAAAAAAAA==,"2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one","2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one","2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one","2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one","2-(4-chlorophenyl)-3-methyl-1,1-bis(oxidanylidene)-1,3-thiazinan-4-one","2-(4-chlorophenyl)-1,1-diketo-3-methyl-1,3-thiazinan-4-one","InChI=1S/C11H12ClNO3S/c1-13-10(14)6-7-17(15,16)11(13)8-2-4-9(12)5-3-8/h2-5,11H,6-7H2,1H3",WEQAYVWKMWHEJO-UHFFFAOYSA-N,,273.0226421,C11H12ClNO3S,273.74,62.8,273.0226421,0.0,17.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1,1.1,"10  13  8
10  14  8
13  15  8
14  16  8
15  17  8
16  17  8
7  10  3",
440790196,34870,Drug Induced Liver Injury Rank (DILIrank) Dataset,LT00045,Amineptine,20231222,20210312,Curation Efforts|Governmental Organizations,LT00045,amineptine,8.0,Withdrawn,vMost-DILI-Concern,1.0,34870,1.0,387.0,3.0,2.0,8.0,AAADceB6MAAAAAAAAAAAAAAAAAAAAAAAAAAwYAAABgAAAAABQAAAHgAQCAAADCjBmAQwCILAAgCIAiDSCACCAAAgAAAIiIEIBIgIIDKAkRGEYAhkkACIiAeYyOCOgAAAAAAQAAAAAAAAACAAAAAAAAAAAA==,"7-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylamino)heptanoic acid","7-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylamino)heptanoic acid","7-(2-tricyclo[9.4.0.0<SUP>3,8</SUP>]pentadeca-1(15),3,5,7,11,13-hexaenylamino)heptanoic acid","7-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylamino)heptanoic acid","7-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylamino)heptanoic acid","7-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylamino)enanthic acid","InChI=1S/C22H27NO2/c24-21(25)13-3-1-2-8-16-23-22-19-11-6-4-9-17(19)14-15-18-10-5-7-12-20(18)22/h4-7,9-12,22-23H,1-3,8,13-16H2,(H,24,25)",ONNOFKFOZAJDHT-UHFFFAOYSA-N,,337.204179104,C22H27NO2,337.5,49.3,337.204179104,0.0,25.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0,"1
5
255",O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21,2.1,"10  18  8
14  20  8
15  21  8
17  22  8
18  23  8
20  22  8
21  23  8
5  14  8
5  9  8
6  10  8
6  15  8
9  17  8",
